FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Pontillo, A
   Bricher, P
   Leal, VNC
   Lima, S
   Souza, PRE
   Crovella, S
AF Pontillo, A.
   Bricher, P.
   Leal, V. N. C.
   Lima, S.
   Souza, P. R. E.
   Crovella, S.
TI Role of Inflammasome Genetics in Susceptibility to HPV Infection and
   Cervical Cancer Development
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HPV; inflammasome; NLRP3; IL-1 beta; IL-18
ID PROMOTER POLYMORPHISMS; ASSOCIATION; GENES; BCL-2; RISK
AB Problem: Only a small proportion of HPV+ women develop virus-associated lesions and cervical cancer, suggesting that other factors are involved in HPV+ keratinocyte transformation. Immune response plays an important role in clearing HPV infection, and host genetic variants resulting in defective immune response have been associated with virus persistence and/or cervical cancer. Considering that genetic variations in inflammasome genes were previously associated with viral infection and cancer development, the present study investigates selected single nucleotide polymorphisms (SNPs) in inflammasome genes as a possible risk factor for HPV infection susceptibility and/or for progression to cervical cancer. Patients and methods: 12 SNPs in seven inflammasome-related genes (NLRP1, NLRP3, NLRP6, CARD8, IL1B, IL18, TNFAIP3) were genotyped in a Brazilian HPV+ case/control cohort (n = 246/310). Multivariate analysis was performed in case/control as well as in HPV+ women stratified by the presence or severity of histologic lesion, HPV persistence, and type of virus. Results: IL1B rs1143643 was associated with protection against HPV infection in case/control analysis. NLRP1 rs11651270 plays a protection role against HPV persistence and/or oncogenesis. NLRP3 rs10754558 and IL18 rs1834481 exert a beneficial role against HPV persistence. NLRP3 rs10754558 variant resulted significantly associated with a lower risk to be infected with a high-risk HPV. Conclusion: Our findings for the first time demonstrated that inflammasome genetics could affect HPV/host interaction in terms of virus susceptibility as well as of virus/persistence and cervical cancer progression. (C) 2016 Wiley Periodicals, Inc.
C1 [Pontillo, A.; Bricher, P.; Leal, V. N. C.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Immunogenet Lab, Sao Paulo, SP, Brazil.
   [Lima, S.] Univ Fed Pernambuco, Lab Immunopathol Keiko Azami, Recife, PE, Brazil.
   [Souza, P. R. E.] Univ Fed Rural Pernambuco, Dept Biol, Genet Area, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Inst Ciencias Biomed, Dept Imunol, Lab Imunogenet, Ave Prof Lineu Prestes 1730, Sao Paulo, Brazil.
EM alepontillo@usp.br
RI Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016;
   Pontillo, Alessandra/ABC-6266-2020; Leal, Vinicius N C/H-9502-2016;
   Pontillo, Alessandra/AAD-4790-2019
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Leal, Vinicius N C/0000-0001-6049-6907; Pontillo,
   Alessandra/0000-0002-7883-0640; Bricher Choque, Pamela
   Nithzi/0000-0002-7587-1578; Souza, Paulo/0000-0002-9186-9849
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/06142-1]
FX Grant sponsor: Sao Paulo Research Foundation (FAPESP); Grant number:
   2013/06142-1
CR Alibek K, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-44
   Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045
   Chagas BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132570
   Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412
   Coelho AVC, 2015, GENET MOL RES, V14, P2876, DOI 10.4238/2015.March.31.18
   Deshpande A, 2005, J INFECT DIS, V191, P969, DOI 10.1086/427826
   Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106
   Gao C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-570
   Gosmann C, 2014, J IMMUNOL, V193, P2248, DOI 10.4049/jimmunol.1400216
   Haghshenas MR, 2009, J GASTROEN HEPATOL, V24, P1119, DOI 10.1111/j.1440-1746.2009.05791.x
   Kamada AJ, 2014, MEM I OSWALDO CRUZ, V109, P960, DOI 10.1590/0074-0276140154
   Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848
   Khalili-Azad T, 2009, NEOPLASMA, V56, P22, DOI 10.4149/neo_2009_01_22
   Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110
   Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296
   Motavaf M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.19879
   Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536
   Palmieri RT, 2008, CANCER EPIDEM BIOMAR, V17, P3567, DOI 10.1158/1055-9965.EPI-08-0548
   Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
   Pontillo A, 2013, JAIDS-J ACQ IMM DEF, V63, P147, DOI 10.1097/QAI.0b013e31828f93bb
   Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe
   Reinholz M, 2013, ARCH DERMATOL RES, V305, P723, DOI 10.1007/s00403-013-1375-0
   Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256
   Verma D, 2012, PIGM CELL MELANOMA R, V25, P506, DOI 10.1111/j.1755-148X.2012.01008.x
   Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667
   Wright TC, 2006, INT J GYNECOL OBSTET, V95, pS239, DOI 10.1016/S0020-7292(06)60039-8
   Zhang ZY, 2014, GYNECOL ONCOL, V135, P69, DOI 10.1016/j.ygyno.2014.07.106
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
NR 28
TC 25
Z9 27
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2016
VL 88
IS 9
BP 1646
EP 1651
DI 10.1002/jmv.24514
PG 6
WC Virology
SC Virology
GA DZ3BN
UT WOS:000385718800023
PM 26945813
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Alberi, G
   Moratelli, G
   Croce, SL
   Masutti, F
   Pozzato, G
   Crovella, S
   Segat, L
AF Zupin, L.
   Polesello, V.
   Alberi, G.
   Moratelli, G.
   Croce, S. L.
   Masutti, F.
   Pozzato, G.
   Crovella, S.
   Segat, L.
TI MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral
   Clearance and Pegylated Interferon Plus Ribavirin Treatment Response
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID MANNOSE-BINDING LECTIN; C VIRUS-INFECTION; CHRONIC HEPATITIS-C; PROTEIN
   GENE; PEGINTERFERON ALPHA-2B; POLYMORPHISMS; ASSOCIATION; METAANALYSIS;
   MUTATIONS; IMMUNITY
AB Hepatitis C is disease that damages the liver, and it is caused by the hepatitis C virus (HCV). The pathology became chronic in about 80% of the cases due to virus persistence in the host organism. The standard of care consists of pegylated interferon plus ribavirin; however, the treatment response is very variable and different host/viral factors may concur in the disease outcome. The mannose-binding protein C (MBL) is a component of the innate immune system, able to recognize HCV and consecutively activating the immune response. MBL is encoded by MBL2 gene, and polymorphisms, two in the promoter region (H/L and X/Y) and three in exon 1 (at codon 52, 54 and 57), have been described as functionally influencing protein expression. In this work, 203 Italian HCV patients and 61 healthy controls were enrolled and genotyped for the five MBL2 polymorphisms mentioned above to investigate their role in HCV infection susceptibility, spontaneous viral clearance and treatment response. MBL2 polymorphisms were not associated with HCV infection susceptibility and with spontaneous viral clearance, while MBL2 O allele, O/O genotype, HYO haplotype and DP combined genotype (all correlated with low or deficient MBL expression) were associated with sustained virological response. Moreover, a meta-analysis to assess the role of MBL2 polymorphisms in HCV infection susceptibility was also performed: YA haplotype could be associated with protection towards HCV infection.
C1 [Zupin, L.; Moratelli, G.; Croce, S. L.; Masutti, F.; Pozzato, G.; Crovella, S.] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Polesello, V.; Alberi, G.; Crovella, S.; Segat, L.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
RP Zupin, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM luisa.zupin@burlo.trieste.it
RI Zupin, Luisa/I-5228-2018; croce', lory saveria l/E-2565-2011; Crovella,
   Sergio/K-5050-2016
OI Zupin, Luisa/0000-0001-5886-9129; croce', lory saveria
   l/0000-0001-9890-7011; Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC 13/ 2012]; IRCCS Burlo Garofolo
FX This work was supported by IRCCS Burlo Garofolo (RC 13/ 2012). VP is
   recipient of fellowships from IRCCS Burlo Garofolo.
CR [Anonymous], 2014, GUID SCREEN CAR TREA
   ARAI T, 1993, Q J MED, V86, P575
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dumestre-Perard C, 2002, CLIN EXP IMMUNOL, V127, P131, DOI 10.1046/j.1365-2249.2002.01729.x
   Dustin LB, 2014, J LEUKOCYTE BIOL, V96, P535, DOI 10.1189/jlb.4RI0214-126R
   EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810
   Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283
   GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x
   GARRED P, 1995, LANCET, V346, P941, DOI 10.1016/S0140-6736(95)91559-1
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Halla MC, 2010, HUM IMMUNOL, V71, P883, DOI 10.1016/j.humimm.2010.05.021
   Heggelund L, 2005, EUR J CLIN INVEST, V35, P765, DOI 10.1111/j.1365-2362.2005.01579.x
   Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005
   Kamal SM, 2005, GUT, V54, P858, DOI 10.1136/gut.2004.057182
   Kanto T, 2006, INTERNAL MED, V45, P183, DOI 10.2169/internalmedicine.45.1530
   Kilpatrick DC, 2003, CLIN EXP IMMUNOL, V132, P92, DOI 10.1046/j.1365-2249.2003.02122.x
   Komur S, 2014, TURK J GASTROENTEROL, V25, P702, DOI 10.5152/tjg.2014.6583
   Koutsounaki E, 2008, J CLIN IMMUNOL, V28, P495, DOI 10.1007/s10875-008-9201-8
   Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35
   Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Matsushita M, 1998, J HEPATOL, V29, P695, DOI 10.1016/S0168-8278(98)80248-1
   Matsushita M, 1998, ARCH VIROL, V143, P645, DOI 10.1007/s007050050320
   Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003
   Pedroso MLA, 2008, CLIN EXP IMMUNOL, V152, P258, DOI 10.1111/j.1365-2249.2008.03614.x
   R Core Team, LANG ENV STAT COMP
   Rau M, 2012, VIRUSES-BASEL, V4, P3281, DOI 10.3390/v4123281
   Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573
   Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861
   Rosina F, 2014, DIGEST LIVER DIS, V46, P826, DOI 10.1016/j.dld.2014.05.014
   Sasaki K, 2000, SCAND J GASTROENTERO, V35, P960, DOI 10.1080/003655200750023039
   SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175
   Segat L, 2007, CLIN IMMUNOL, V124, P13, DOI 10.1016/j.clim.2007.04.006
   Tarr AW, 2012, VIRUSES-BASEL, V4, P1, DOI 10.3390/v4010001
   Vallinoto ACR, 2009, HUM IMMUNOL, V70, P754, DOI 10.1016/j.humimm.2009.06.014
   Vukasovic T, 2015, PSYCHOL BULL, V141, P769, DOI 10.1037/bul0000017
NR 43
TC 2
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD JUL
PY 2016
VL 84
IS 1
BP 61
EP 69
DI 10.1111/sji.12444
PG 9
WC Immunology
SC Immunology
GA DR5DO
UT WOS:000379923400007
PM 27136459
OA Bronze
DA 2020-12-08
ER

PT J
AU Kamada, AJ
   Bianco, AM
   Zupin, L
   Girardelli, M
   Matte, MCC
   de Medeiros, RM
   Almeida, SED
   Rocha, MM
   Segat, L
   Chies, JAB
   Kuhn, L
   Crovella, S
AF Kamada, Anselmo J.
   Bianco, Anna M.
   Zupin, Luisa
   Girardelli, Martina
   Matte, Maria C. C.
   de Medeiros, Rubia Marilia
   de Matos Almeida, Sabrina Esteves
   Rocha, Marineide M.
   Segat, Ludovica
   Chies, Jose A. B.
   Kuhn, Louise
   Crovella, Sergio
TI Protective Role of BST2 Polymorphisms in Mother-to-Child Transmission of
   HIV-1 and Adult AIDS Progression
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE HIV-1; BST-2; SNPs; mother-to-child transmission of HIV-1; AIDS
   progression
ID PLASMACYTOID DENDRITIC CELLS; RELEASE; ASSOCIATION; INFECTION;
   RESPONSES; IMMUNITY; DISEASE; PROTEIN; SURFACE; GENE
AB Bone marrow stromal cell antigen-2 (BST-2)/Tetherin is a restriction factor that prevents Human immunodeficiency virus type 1 (HIV-1) release from infected cells and mediates proinflammatory cytokine production. This study investigated the risk conferred by single nucleotide polymorphisms (rs919266, rs9192677, and rs9576) at BST-2 coding gene (BST2) in HIV-1 mother-to-child transmission and in disease progression. Initially, 101 HIV-1+ pregnant women and 331 neonates exposed to HIV-1 from Zambia were enrolled. Additional BST2 single nucleotide polymorphism analyses were performed in 2 cohorts with acquired immunodeficiency syndrome (AIDS) progression: an adult Brazilian cohort (37 rapid, 30 chronic and 21 long-term non-progressors) and an Italian pediatric cohort (21 rapid and 67 slow progressors). The rs9576A allele was nominally associated with protection during breastfeeding (P = 0.019) and individuals carrying rs919266 GA showed slower progression to AIDS (P = 0.033). Despite the influence of rs919266 and rs9576 on BST2 expression being still undetermined, a preventive role by BST2 polymorphisms was found during HIV-1 infection.
C1 [Kamada, Anselmo J.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Bianco, Anna M.; Zupin, Luisa; Girardelli, Martina; Segat, Ludovica; Crovella, Sergio] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Matte, Maria C. C.; de Medeiros, Rubia Marilia; Chies, Jose A. B.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
   [de Matos Almeida, Sabrina Esteves] Fundacao Estadual Prod & Pesquisa Saude, Porto Alegre, RS, Brazil.
   [Rocha, Marineide M.] Hosp Nossa Senhora Conceicao, Infect Dis Sect, Porto Alegre, RS, Brazil.
   [Kuhn, Louise] Columbia Univ, Dept Epidemiol, New York, NY USA.
RP Kamada, AJ (corresponding author), Univ Fed Pernambuco UFPE, Dept Genet, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM anselmojiro@gmail.com
RI Zupin, Luisa/I-5228-2018; Crovella, Sergio/K-5050-2016; de Medeiros,
   Rubia M/L-2761-2015; BIANCO, ANNA MONICA/D-3098-2014; Chies, Jose Artur
   Bogo/K-9664-2015; Kamada, Anselmo Jiro/H-3006-2012
OI Zupin, Luisa/0000-0001-5886-9129; Crovella, Sergio/0000-0001-8493-1168;
   de Medeiros, Rubia M/0000-0001-7403-5650; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Chies, Jose Artur Bogo/0000-0001-7025-0660;
   Kamada, Anselmo Jiro/0000-0002-0437-0151; Segat,
   Ludovica/0000-0002-6024-1485
FU CAPES/CNPqNational Council for Scientific and Technological Development
   (CNPq)CAPES [Casadinho 06/2011]; IRCCS "Burlo Garofolo" [RC13/12];
   National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HD57617]; EUNICE
   KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01HD057617,
   R01HD057617, R01HD057617, R01HD057617, R01HD057617] Funding Source: NIH
   RePORTER
FX Supported by CAPES/CNPq (Casadinho 06/2011), IRCCS "Burlo Garofolo"
   (RC13/12) and National Institute of Health (HD57617).
CR Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   [Anonymous], 1998, MMWR Recomm Rep, V47, P1
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547
   CDC, 1994, REV CLASS SYST HUM I
   Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108
   Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007
   Giese S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004189
   Hancock DB, 2015, AIDS, V29, P767, DOI 10.1097/QAD.0000000000000604
   ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H
   Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6
   Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Laplana M, 2013, J INFECT DIS, V207, P411, DOI 10.1093/infdis/jis685
   Loschko J, 2011, J IMMUNOL, V186, P6718, DOI 10.4049/jimmunol.1004029
   Madison MN, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0102-z
   Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553
   Pereira NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084917
   Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039
   Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x
   Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277
   Schuller SS, 2013, J LEUKOCYTE BIOL, V93, P781, DOI 10.1189/jlb.1011525
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001
NR 25
TC 6
Z9 6
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD JUL 1
PY 2016
VL 72
IS 3
BP 237
EP 241
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DO8UM
UT WOS:000378059800007
PM 26885809
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Segat, L
   Kuhn, L
   Crovella, S
AF Zupin, Luisa
   Polesello, Vania
   Segat, Ludovica
   Kuhn, Louise
   Crovella, Sergio
TI MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in
   Zambia
SO IMMUNOLOGIC RESEARCH
LA English
DT Article
DE MBL2; HIV-1; Mother-to-child transmission; Innate immunity
ID MANNOSE-BINDING LECTIN; VERTICAL TRANSMISSION; AFRICAN POPULATIONS;
   VARIANT ALLELES; INFECTION; PROTEIN; SUSCEPTIBILITY; PROGRESSION; AIDS;
   ASSOCIATION
AB Since antiretroviral drugs have been introduced to prevent mother-to-child transmission, the risk of HIV-1 infection in infants has decreased considerably worldwide. Nevertheless, many factors are involved in viral transmission and host susceptibility to infection. The immune system and its components, including mannose binding protein C (encoding by MBL2 gene), are already known to play an important role in this scenario. In the present study, 313 children and 98 of their mothers from Zambia were genotyped for the MBL2 promoter HL (rs11003125) and XY (rs7096206) polymorphisms and exon 1 D (rs5030737, at codon 52) B (rs1800450, at codon 54) and C (rs1800451, at codon 57) polymorphisms in order to investigate the potential role of these genetic variants in HIV-1 mother-to-child transmission. No statistical significant association was observed comparing transmitter and non-transmitter mothers and also confronting HIV-positive and HIV-negative children. The findings of the current study obtained on mother and children from Zambia evidence lack of association between MBL2 functional polymorphisms and HIV-1 mother-to-child transmission.
C1 [Zupin, Luisa; Polesello, Vania; Segat, Ludovica; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Zupin, Luisa; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Mailman Sch Publ Hlth, New York, NY 10027 USA.
   [Kuhn, Louise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
RP Zupin, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.; Zupin, L (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
EM luisa.zupin@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC06/11, RC13/12]; Eunice Kennedy
   Shriver, National Institute of Child Health and Human Development
   (NICHD), National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [HD39611, HD40777, HD57617]; IRCCS Burlo Garofolo
FX This work has been supported by RC06/11 and RC13/12 grants from IRCCS
   Burlo Garofolo Trieste (Italy). This study was supported in part by
   grants from the Eunice Kennedy Shriver, National Institute of Child
   Health and Human Development (NICHD), National Institutes of Health
   (NIH) (HD39611, HD40777, HD57617). VP is recipient of fellowship from
   IRCCS Burlo Garofolo.
CR Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P134, DOI 10.1016/S1081-1206(10)62586-0
   Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P142
   Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P141
   Boldt ABW, 2002, HUM MUTAT, V19, P296, DOI 10.1002/humu.10051
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200
   Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712
   Chatterjee K, 2010, J GENET, V89, P109, DOI 10.1007/s12041-010-0003-4
   Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706
   Crovella S, 2005, J MATERN-FETAL NEO M, V17, P253, DOI 10.1080/14767050500072599
   da Silva GK, 2011, AIDS, V25, P411, DOI 10.1097/QAD.0b013e328342fef1
   DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V
   EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602
   Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008
   Garred P, 1997, SCAND J IMMUNOL, V46, P204, DOI 10.1046/j.1365-3083.1997.d01-111.x
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   Kuhn L, 2006, AM J CLIN NUTR, V84, P610
   Li H, 2013, INFECT GENET EVOL, V20, P163, DOI 10.1016/j.meegid.2013.09.010
   Lian YC, 2004, SCAND J IMMUNOL, V60, P615, DOI 10.1111/j.0300-9475.2004.01492.x
   Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4
   Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498
   McBride MO, 1998, INT J STD AIDS, V9, P683, DOI 10.1258/0956462981921350
   Mhandire K, 2014, OMICS, V18, P454, DOI 10.1089/omi.2013.0131
   Mofenson LM, 1997, OBSTET GYN CLIN N AM, V24, P759, DOI 10.1016/S0889-8545(05)70343-0
   Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979
   Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3
   NEWELL ML, 1992, LANCET, V339, P1007
   NIELSEN SL, 1995, CLIN EXP IMMUNOL, V100, P219
   Pareja E, 1997, TISSUE ANTIGENS, V50, P421, DOI 10.1111/j.1399-0039.1997.tb02896.x
   Pastinen T, 1998, AIDS RES HUM RETROV, V14, P695, DOI 10.1089/aid.1998.14.695
   Petersen SV, 2001, MOL IMMUNOL, V38, P133
   Prohaszka Z, 1997, IMMUNOL LETT, V58, P171, DOI 10.1016/S0165-2478(97)00084-9
   R Core Team, 2015, R LANG ENV STAT COMP
   Segat L, 2014, TISSUE ANTIGENS, V83, P161, DOI 10.1111/tan.12296
   SENALDI G, 1995, J INFECTION, V31, P145, DOI 10.1016/S0163-4453(95)92185-0
   Sheng A, 2010, INT J IMMUNOGENET, V37, P445, DOI 10.1111/j.1744-313X.2010.00946.x
   SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9
   Tan YJ, 2009, MOL IMMUNOL, V47, P632, DOI 10.1016/j.molimm.2009.08.020
   Thea DM, 2004, CONTROL CLIN TRIALS, V25, P353, DOI 10.1016/j.cct.2004.06.005
   Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0
   Turner M W, 2000, Rev Immunogenet, V2, P305
   Turner MW, 1998, IMMUNOBIOLOGY, V199, P327, DOI 10.1016/S0171-2985(98)80037-5
   UNAIDS, 2015, GLOB AIDS RESP PROGR
   Wallis R, 2002, J IMMUNOL, V168, P4553, DOI 10.4049/jimmunol.168.9.4553
   WHO, 2014, HIV AIDS DAT STAT
NR 59
TC 2
Z9 2
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0257-277X
EI 1559-0755
J9 IMMUNOL RES
JI Immunol. Res.
PD JUN
PY 2016
VL 64
IS 3
BP 775
EP 784
DI 10.1007/s12026-015-8779-1
PG 10
WC Immunology
SC Immunology
GA DL2JV
UT WOS:000375461800013
PM 26740328
DA 2020-12-08
ER

PT J
AU da Silva, RC
   da Cruz, HLA
   Brandao, LAC
   Guimaraes, RL
   Montenegro, LML
   Schindler, HC
   Segat, L
   Crovella, S
AF da Silva, Ronaldo Celerino
   Alves da Cruz, Heidi Lacerda
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Lapa Montenegro, Lilian Maria
   Schindler, Haiana Charifker
   Segat, Ludovica
   Crovella, Sergio
TI DEFB1 gene polymorphisms and tuberculosis in a Northeastern Brazilian
   population
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Tuberculosis; Innate immunity; DEFB1; Genotyping; Polymorphism
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1; HIV-1 INFECTION;
   INNATE IMMUNITY; MYCOBACTERIUM-TUBERCULOSIS; BETA-DEFENSINS;
   ASSOCIATION; EXPRESSION; BINDING; ALTERS
AB beta-Defensin-1, an antimicrobial peptide encoded by the DEFB1 gene, is known to play an important role in lung mucosal immunity. In our association study we analyzed three DEFB1 functional polymorphisms -52G>A (rs1799946), -44C>G (rs1800972) and -20G>A (rs11362) in 92 tuberculosis patients and 286 healthy controls, both from Northeast Brazil: no association was found between the studied DEFB1 polymorphisms and the disease. However we cannot exclude that this lack of association could be due to the low number of subjects analyzed, as suggested by the low statistical power achieved for the three analyzed SNPs (values between 0.16 and 0.50). (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.
C1 [da Silva, Ronaldo Celerino; Alves da Cruz, Heidi Lacerda; Guimaraes, Rafael Lima; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Lapa Montenegro, Lilian Maria; Schindler, Haiana Charifker] CPqAM FIOCRUZ Pernambuco, Aggeu Magalhaes Res Ctr, Dept Immunol, Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; Alves da Cruz, Heidi Lacerda; Cavalcanti Brandao, Lucas Andre; Guimaraes, Rafael Lima; Crovella, Sergio] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Segat, Ludovica] Inst Maternal & Child Hlth, IRCCS Burlo Garofolo, Trieste, Italy.
RP da Silva, RC (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.; da Silva, RC (corresponding author), Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
EM ronaldocelerino@yahoo.com.br
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors thank all the health professionals from the hospitals
   involved in the study that collaborated with the research. We thank the
   Laboratory of Immunoepidemiology - Centro de Pesquisas Aggeu
   Magalhoes/Fundacao Oswaldo Cruz (CPqAW/FIOCRUZ), the Laboratory of
   Immunopathology Keizo Asami, the Department of Genetics, Federal
   University of Pernambuco, the Graduate Program in Genetics for
   supporting physical and scientific, as well as Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), Coordenacao de
   Aperfeicoamento Pessoal de Nivel Superior (CAPES) and Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), for financial
   support.
CR Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002
   Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614
   Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903
   Coelho AVC, 2015, GENET MOL RES, V14, P2876, DOI 10.4238/2015.March.31.18
   Crovella S, 2011, CLIN CHEM LAB MED, V49, P49, DOI 10.1515/CCLM.2011.023
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Freguja R, 2012, NEW MICROBIOL, V35, P249
   Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350
   Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003
   Campos GNL, 2014, INT J IMMUNOGENET, V41, P54, DOI 10.1111/iji.12080
   Matsushita I, 2002, BIOCHEM BIOPH RES CO, V291, P17, DOI 10.1006/bbrc.2002.6395
   McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   Nurjadi D, 2013, J INFECT DIS, V207, P666, DOI 10.1093/infdis/jis735
   Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2
   de Oca EPM, 2009, INFECT GENET EVOL, V9, P617, DOI 10.1016/j.meegid.2009.03.006
   Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454
   Sandrin-Garcia P, 2012, LUPUS, V21, P625, DOI 10.1177/0961203312436858
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Tiszlavicz Z, 2012, ACTA NEUROL SCAND, V126, P109, DOI 10.1111/j.1600-0404.2011.01613.x
   Van Crevel R, 2003, ADV EXP MED BIOL, V531, P241
   Wallace AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-76
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wu Xiao-mai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P912
   Zanin V, 2012, CLINICS, V67, P395, DOI 10.6061/clinics/2012(04)14
NR 38
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD APR-JUN
PY 2016
VL 47
IS 2
BP 389
EP 393
DI 10.1016/j.bjm.2015.09.001
PG 5
WC Microbiology
SC Microbiology
GA DM0EV
UT WOS:000376016600016
PM 26991287
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Vozzi, D
   Girardelli, M
   Tricarico, PM
   Knowles, A
   Crovella, S
   Vuch, J
   Tommasini, A
   Piscianz, E
   Bianco, AM
AF Marcuzzi, Annalisa
   Vozzi, Diego
   Girardelli, Martina
   Tricarico, Paola Maura
   Knowles, Alessandra
   Crovella, Sergio
   Vuch, Josef
   Tommasini, Alberto
   Piscianz, Elisa
   Bianco, Anna Monica
TI Putative modifier genes in mevalonate kinase deficiency
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE gene; correlation genotype-phenotype; orphan disease; mevalonate kinase
   deficiency; whole exome sequencing
ID HYPERIMMUNOGLOBULINEMIA-D SYNDROME; PERIODIC FEVER SYNDROME; PEROXISOME
   PROLIFERATION; RETINITIS-PIGMENTOSA; MUTATIONS; METABOLISM; GENOTYPE;
   DIVISION; SPECTRUM; ACIDURIA
AB Mevalonate kinase deficiency (MKD) is an autosomal recessive auto-inflammatory disease, caused by impairment of the mevalonate pathway. Although the molecular mechanism remains to be elucidated, there is clinical evidence suggesting that other regulatory genes may be involved in determining the phenotype. The identification of novel target genes may explain non-homogeneous genotype-phenotype correlations, and provide evidence in support of the hypothesis that novel regulatory genes predispose or amplify deregulation of the mevalonate pathway in this orphan disease. In the present study, DNA samples were obtained from five patients with MKD, which were then analyzed using whole exome sequencing. A missense variation in the PEX11 gamma gene was observed in homozygosis in P2, possibly correlating with visual blurring. The UNG rare gene variant was detected in homozygosis in P5, without correlating with a specific clinical phenotype. A number of other variants were found in the five analyzed DNA samples from the MKD patients, however no correlation with the phenotype was established. The results of the presents study suggested that further analysis, using next generation sequencing approaches, is required on a larger sample size of patients with MKD, who share the same MVK mutations and exhibit 'extreme' clinical phenotypes. As MVK mutations may be associated with MKD, the identification of specific modifier genes may assist in providing an earlier diagnosis.
C1 [Marcuzzi, Annalisa; Vozzi, Diego; Girardelli, Martina; Knowles, Alessandra; Crovella, Sergio; Tommasini, Alberto; Piscianz, Elisa; Bianco, Anna Monica] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, Via Istria 65-1, I-34137 Trieste, Italy.
   [Tricarico, Paola Maura; Crovella, Sergio; Vuch, Josef] Univ Trieste, Dept Med Surg & Hlth Sci, I-34128 Trieste, Italy.
RP Bianco, AM (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, Via Istria 65-1, I-34137 Trieste, Italy.
EM annamonicarosaria.bianco@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; Tommasini, Alberto/AAE-3882-2020;
   BIANCO, ANNA MONICA/D-3098-2014; Knowles, Alessandra/AAB-7765-2020;
   tricarico, paola/AAB-8972-2019; Crovella, Sergio/K-5050-2016
OI Marcuzzi, Annalisa/0000-0003-3427-618X; Tommasini,
   Alberto/0000-0002-6943-7927; BIANCO, ANNA MONICA/0000-0001-8101-9659;
   Knowles, Alessandra/0000-0003-4504-6371; tricarico,
   paola/0000-0002-1954-4126; Crovella, Sergio/0000-0001-8493-1168;
   Piscianz, Elisa/0000-0001-7374-1684; vozzi, diego/0000-0002-2902-8184
FU Institute for Maternal and Child Health IRCCS 'Burlo Garofolo' [RC
   42/11]; Associazione Azzurra Malattie Rare and Beneficentia Stiftung
   (Vaduz, Liechtenstein)
FX This study was supported by a grant from the Institute for Maternal and
   Child Health IRCCS 'Burlo Garofolo' (grant no. RC 42/11) and the
   Associazione Azzurra Malattie Rare and Beneficentia Stiftung (Vaduz,
   Liechtenstein).
CR Adzhubei I., 2013, CURR PROTOC HUM GENE
   Al-Saud BK, 2013, J CLIN IMMUNOL, V33, P1325, DOI 10.1007/s10875-013-9951-9
   Balgobind B, 2005, J INHERIT METAB DIS, V28, P1143, DOI 10.1007/s10545-005-0178-7
   Bianco AM, 2014, GUT, V63, P1367, DOI 10.1136/gutjnl-2013-306555
   Caso F., 2013, INT J RHEUMATOL, V2013, DOI DOI 10.1155/2013/513782
   Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   D'Osualdo A, 2005, EUR J HUM GENET, V13, P314, DOI 10.1038/sj.ejhg.5201323
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016
   DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   Drenth JPH, 1999, NAT GENET, V22, P178
   Ebberink MS, 2012, J MED GENET, V49, P307, DOI 10.1136/jmedgenet-2012-100778
   Frenkel J, 2000, CLIN EXP RHEUMATOL, V18, P525
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9
   Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974
   KIMURA M, 1991, JPN J GENET, V66, P367, DOI 10.1266/jjg.66.367
   Klasen IS, 2001, CLIN DIAGN LAB IMMUN, V8, P58, DOI 10.1128/CDLI.8.1.58-61.2001
   Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907
   Levy M, 2013, PEDIATRICS, V132, pE779, DOI 10.1542/peds.2012-3344
   Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028
   Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376
   Mandey SHL, 2006, HUM MUTAT, V27, P796, DOI 10.1002/humu.20361
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   Moura R, 2015, RHEUMATOL INT, V35, P657, DOI 10.1007/s00296-014-3115-y
   Opalinski L, 2011, INT J BIOCHEM CELL B, V43, P847, DOI 10.1016/j.biocel.2011.03.006
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Prietsch V, 2013, PEDIATRICS, V111, P258
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Shendi HM, 2012, RHEUMATOL INT, V32, P249, DOI 10.1007/s00296-009-1322-8
   SHOEMAKER JD, 1991, J CHROMATOGR-BIOMED, V562, P125, DOI 10.1016/0378-4347(91)80571-S
   Siemiatkowska AM, 2013, OPHTHALMOLOGY, V120, P2697, DOI 10.1016/j.ophtha.2013.07.052
   Simon A, 2004, NEUROLOGY, V62, P994, DOI 10.1212/01.WNL.0000115390.33405.F7
   Simon A, 2014, NEW ENGL J MED, V371, P1933, DOI 10.1056/NEJMcibr1412016
   Stabile A, 2013, RHEUMATOL INT, V33, P3039, DOI 10.1007/s00296-012-2577-z
   Steinberg SJ, 2006, BIOCHIM BIOPHYS ACTA, V1763, P1733
   Subramani S, 1997, J CELL BIOL, V136, P71
   Torseth K, 2012, DNA REPAIR, V11, P559, DOI 10.1016/j.dnarep.2012.03.006
   Tricarico PM, 2014, INT J MOL SCI, V15, P6843, DOI 10.3390/ijms15046843
   Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956
   Vuch J, 2013, MED HYPOTHESES, V80, P67, DOI 10.1016/j.mehy.2012.10.016
   Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
NR 46
TC 1
Z9 1
U1 0
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD APR
PY 2016
VL 13
IS 4
BP 3181
EP 3189
DI 10.3892/mmr.2016.4918
PG 9
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA DI6AR
UT WOS:000373582100031
PM 26935981
OA Bronze
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Grasso, DL
   Crovella, S
   Segat, L
AF Zupin, Luisa
   Polesello, Vania
   Grasso, Domenico Leonardo
   Crovella, Sergio
   Segat, Ludovica
TI DEFB1 polymorphisms and susceptibility to recurrent tonsillitis in
   Italian children
SO INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
LA English
DT Article
DE Innate immunity; Beta-defensins; Recurrent tonsillitis
ID BETA-DEFENSIN 1; HUMAN PALATINE TONSIL; ANTIMICROBIAL PEPTIDES; HUMAN
   BETA-DEFENSIN-1; EPITHELIAL-CELLS; INNATE IMMUNITY; EXPRESSION;
   POPULATION; IMMUNOLOGY; DISEASE
AB Introduction: The tonsils are secondary lymphoid organs fundamental for immune system response against pathogens within the oral cavity. Tonsillitis refers to inflammation of the pharyngeal tonsils that may include the adenoids and the lingual tonsils and that can be acute, recurrent, and chronic. Viral or bacterial infections, as well as immunologic factors are the main trigger to tonsillitis and disease's chronicity: the host immune responses, especially the innate one, could play an important role in susceptibility to the disease.
   Objectives: The current study aims at investigating the role of functional polymorphisms in the 5'UTR (c.-52G>A, c.-44G>C and c.-20G>A) of DEFB1 gene, encoding for the antimicrobial peptide human beta-defensin 1, in the predisposition to recurrent tonsillitis in children from North Eastern Italy.
   Results: No significant correlation was found between DEFB1 allele, genotype and haplotype frequencies and recurrent tonsillitis susceptibility with the exception of an increased risk to disease development in patients carrying DEFB1 rare haplotypes.
   Conclusion: Our results may suggest that DEFB1 polymorphisms alone may not influence pathology susceptibility, however they could possibly concur, together with other factors involved in the genetic control of innate immune system, in the predisposition towards recurrent tonsillitis. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Zupin, Luisa; Polesello, Vania; Grasso, Domenico Leonardo; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Zupin, Luisa; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Zupin, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Med Surg & Hlth Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM luisa.zupin@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Segat, Ludovica/0000-0002-6024-1485
FU Institute for Maternal and Child Health, IRCCS "Burlo Garofolo",
   Trieste, Italy [RC 06/2011]; IRCCS Burlo Garofolo
FX This work was supported by Institute for Maternal and Child Health,
   IRCCS "Burlo Garofolo", Trieste, Italy (RC 06/2011).; V.P. is recipient
   of fellowship from IRCCS Burlo Garofolo.
CR Abiko Y, 2007, MED MOL MORPHOL, V40, P179, DOI 10.1007/s00795-007-0381-8
   Abiko Yoshihiro, 2003, Medical Electron Microscopy, V36, P247, DOI 10.1007/s00795-003-0225-0
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Arslan F, 2015, INT J PEDIATR OTORHI, V79, P557, DOI 10.1016/j.ijporl.2015.01.028
   Bell S, 2012, MOL ORAL MICROBIOL, V27, P160, DOI 10.1111/j.2041-1014.2012.640.x
   Bogefors J, 2012, FEMS IMMUNOL MED MIC, V65, P431, DOI 10.1111/j.1574-695X.2012.00959.x
   Chae SW, 2001, ACTA OTO-LARYNGOL, V121, P414
   da Silva BR, 2012, PEPTIDES, V36, P315, DOI 10.1016/j.peptides.2012.05.015
   Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119
   Dunsche A, 2001, J ORAL PATHOL MED, V30, P154, DOI 10.1034/j.1600-0714.2001.300305.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Grasso DL, 2007, INT J PEDIATR OTORHI, V71, P1013, DOI 10.1016/j.ijporl.2007.02.015
   Grasso DL, 2009, INT J PEDIATR OTORHI, V73, P1550, DOI 10.1016/j.ijporl.2009.07.022
   Kalus Andrea A, 2009, BMC Oral Health, V9, P21, DOI 10.1186/1472-6831-9-21
   Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000
   Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222
   Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36
   Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999
   Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5
   Meyer JE, 2006, EUR ARCH OTO-RHINO-L, V263, P319, DOI 10.1007/s00405-005-1004-4
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210
   Nurjadi D, 2013, J INFECT DIS, V207, P666, DOI 10.1093/infdis/jis735
   Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3
   Polesello V, 2015, ARCH ORAL BIOL, V60, P1054, DOI 10.1016/j.archoralbio.2015.03.009
   Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021
   Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391
   R Core Team, 2015, R LANG ENV STAT COMP
   Schwaab M, 2010, EUR ARCH OTO-RHINO-L, V267, P821, DOI 10.1007/s00405-009-1086-5
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Stelter K., 2014, GMS CURR TOP OTORHIN, V13
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
NR 33
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-5876
EI 1872-8464
J9 INT J PEDIATR OTORHI
JI Int. J. Pediatr. Otorhinolaryngol.
PD APR
PY 2016
VL 83
IS 4
BP 12
EP 15
DI 10.1016/j.ijporl.2016.01.025
PG 4
WC Otorhinolaryngology; Pediatrics
SC Otorhinolaryngology; Pediatrics
GA DH6ZX
UT WOS:000372941700003
PM 26968045
DA 2020-12-08
ER

PT J
AU dos Santos, EUD
   de Lima, GDC
   Oliveira, MD
   Heraclio, SD
   da Silva, HDA
   Crovella, S
   Maia, MDD
   de Souza, PRE
AF Damasceno dos Santos, Erinaldo Ubirajara
   Cordeiro de Lima, Gessica Dayane
   de Lucena Oliveira, Micheline
   Heraclio, Sandra de Andrade
   Angelo da Silva, Hildson Dornelas
   Crovella, Sergio
   Diniz Maia, Maria de Mascena
   Eleuterio de Souza, Paulo Roberto
TI CCR2 and CCR5 genes polymorphisms in women with cervical lesions from
   Pernambuco, Northeast Region of Brazil: a case-control study
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE chemokine receptors; cervical intraepithelial neoplasia; cervical
   cancer; single nucleotide polymorphism
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTORS; INTRAEPITHELIAL
   NEOPLASIA; CCR2-V64I POLYMORPHISM; CANCER; RISK; EXPRESSION; INFECTION;
   INCREASE; INFILTRATION
AB Polymorphisms in chemokine receptors play an important role in the progression of cervical intraepithelial neoplasia (CIN) to cervical cancer (CC). Our study examined the association of CCR2-64I (rs1799864) and CCR5-Delta 32 (rs333) polymorphisms with susceptibility to develop cervical lesion (CIN and CC) in a Brazilian population. The genotyping of 139 women with cervical lesions and 151 women without cervical lesions for the CCR2-64I and CCR5-Delta 32 polymorphisms were performed using polymerase chain reaction-restriction fragment length polymorphism. The individuals carrying heterozygous or homozygous genotypes (GA+AA) for CCR2-64I polymorphisms seem to be at lower risk for cervical lesion [ odds ratio (OR) = 0.37, p = 0.0008)]. The same was observed for the A allele (OR = 0.39, p = 0.0002), while no association was detected (p > 0.05) with CCR5-Delta 32 polymorphism. Regarding the human papillomavirus (HPV) type, patients carrying the CCR2-64I polymorphism were protected against infection by HPV type 16 (OR = 0.35, p = 0.0184). In summary, our study showed a protective effect of CCR2-64I rs1799864 polymorphism against the development of cervical lesions (CIN and CC) and in the susceptibility of HPV 16 infection.
C1 [Damasceno dos Santos, Erinaldo Ubirajara; Diniz Maia, Maria de Mascena; Eleuterio de Souza, Paulo Roberto] Univ Fed Rural Pernambuco, Programa Posgrad Ciencia Anim Trop, Recife, PE, Brazil.
   [Cordeiro de Lima, Gessica Dayane; Eleuterio de Souza, Paulo Roberto] Univ Fed Pernambuco, Programa Posgrad Biol Celular & Mol Aplicada, Recife, PE, Brazil.
   [de Lucena Oliveira, Micheline] Lab Cent Saude Publ Pernambuco, Recife, PE, Brazil.
   [Heraclio, Sandra de Andrade] Inst Med Integral Prof Fernando Figuei, Recife, PE, Brazil.
   [Angelo da Silva, Hildson Dornelas] Inst Fed Pernambuco, Garanhuns, PE, Brazil.
   [Angelo da Silva, Hildson Dornelas; Crovella, Sergio] Univ Fed Pernambuco, Programa Posgrad Genet, Recife, PE, Brazil.
RP de Souza, PRE (corresponding author), Univ Fed Rural Pernambuco, Programa Posgrad Ciencia Anim Trop, Recife, PE, Brazil.; de Souza, PRE (corresponding author), Univ Fed Pernambuco, Programa Posgrad Biol Celular & Mol Aplicada, Recife, PE, Brazil.
EM prsouza30@gmail.com
RI Santos, Erinaldo/N-4051-2017; Crovella, Sergio/K-5050-2016
OI Santos, Erinaldo/0000-0003-2077-4794; Crovella,
   Sergio/0000-0001-8493-1168; Souza, Paulo/0000-0002-9186-9849
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX FACEPE, CNPq
CR Ahmadabadi BN, 2013, INFLAMMATION, V36, P136, DOI 10.1007/s10753-012-9528-4
   Al-Abdulhadi SA, 2010, ANN SAUDI MED, V30, P115, DOI 10.4103/0256-4947.60516
   Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677
   Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657
   Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
   Bonanni Paolo, 2015, Ther Adv Vaccines, V3, P3, DOI 10.1177/2051013614557476
   Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8
   Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240
   CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752
   Chatterjee K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-278
   Coelho A, 2005, GYNECOL ONCOL, V96, P760, DOI 10.1016/j.ygyno.2004.11.028
   de Oliveira CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-357
   Evans EML, 1997, CANCER RES, V57, P2943
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Ghaderi M, 2000, CANCER EPIDEM BIOMAR, V9, P1067
   Gonzalez P, 2001, GENES IMMUN, V2, P191, DOI 10.1038/sj.gene.6363760
   Hall IP, 1999, LANCET, V354, P1264, DOI 10.1016/S0140-6736(99)03425-X
   Huang YY, 2013, GENE, V524, P54, DOI 10.1016/j.gene.2013.04.011
   Ivansson EL, 2007, INT J CANCER, V121, P2451, DOI 10.1002/ijc.22989
   Kleine-Lowinski K, 2003, INT J CANCER, V107, P407, DOI 10.1002/ijc.11411
   Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x
   Kristiansen TB, 2001, J IMMUNOL METHODS, V252, P147, DOI 10.1016/S0022-1759(01)00349-0
   Lawhorn C, 2013, CYTOKINE, V64, P571, DOI 10.1016/j.cyto.2013.08.008
   Lehner T, 2002, TRENDS IMMUNOL, V23, P347, DOI 10.1016/S1471-4906(02)02252-4
   Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396
   Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x
   Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2
   Miyagishi R, 2003, J NEUROIMMUNOL, V145, P135, DOI 10.1016/j.jneuroim.2003.09.003
   Mulherin SA, 2003, AIDS, V17, P377, DOI 10.1097/00002030-200302140-00012
   Nahon P, 2008, WORLD J GASTROENTERO, V14, P713, DOI 10.3748/wjg.14.713
   Nyquist PA, 2009, CEREBROVASC DIS, V28, P124, DOI 10.1159/000223437
   O'Brien PM, 2001, CANCER IMMUNOL IMMUN, V50, P523, DOI 10.1007/s00262-001-0234-6
   Ohta M, 2002, INT J CANCER, V102, P220, DOI 10.1002/ijc.10705
   Rabelo-Santos SH, 2003, MEM I OSWALDO CRUZ, V98, P181, DOI 10.1590/S0074-02762003000200003
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Silva AMTC, 2003, BIOTECNOL CIENC DESE, V29, P48
   Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   SPINILLO A, 1993, GYNECOL ONCOL, V48, P210, DOI 10.1006/gyno.1993.1035
   Tavares MCM, 2015, ANN HUM BIOL, P1
   TAY SK, 1987, BRIT J OBSTET GYNAEC, V94, P1094, DOI 10.1111/j.1471-0528.1987.tb02296.x
   Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201
   Zafiropoulos A, 2004, J MED GENET, V41, DOI 10.1136/JMG.2003.013649
   Zapico I, 2000, GENES IMMUN, V1, P288, DOI 10.1038/sj.gene.6363673
   Zhang TS, 2003, CIRC J, V67, P54, DOI 10.1253/circj.67.54
   Zheng B, 2006, ANTICANCER RES, V26, P3669
NR 46
TC 8
Z9 8
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2016
VL 111
IS 3
BP 174
EP 180
DI 10.1590/0074-02760150367
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DI1TF
UT WOS:000373278000005
PM 26982176
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Moura, RR
   Balbino, VD
   Crovella, S
   Brandao, LAC
AF de Moura, Ronald R.
   Balbino, Valdir de Queiroz
   Crovella, Sergio
   Brandao, Lucas A. C.
TI On the use of Chinese population as a proxy of Amerindian ancestors in
   genetic admixture studies with Latin American populations
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Letter
C1 [de Moura, Ronald R.; Balbino, Valdir de Queiroz; Crovella, Sergio; Brandao, Lucas A. C.] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [de Moura, Ronald R.; Crovella, Sergio; Brandao, Lucas A. C.] Lab Immunopathol Keizo Asami LIKA UFPE, Recife, PE, Brazil.
   [Brandao, Lucas A. C.] Fed Univ Pernambuco UFPE, Dept Pathol, Recife, PE, Brazil.
RP de Moura, RR (corresponding author), Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.; de Moura, RR (corresponding author), Lab Immunopathol Keizo Asami LIKA UFPE, Recife, PE, Brazil.
EM ronaldmoura1989@gmail.com
RI Moura, Ronald/F-7769-2012; Brandao, Lucas Andre Cavalcanti/G-8333-2012;
   Moura, Ronald/AAE-2318-2020; Crovella, Sergio/K-5050-2016; Balbino,
   Valdir de Queiroz/H-6877-2014
OI Moura, Ronald/0000-0002-9112-7167; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Moura, Ronald/0000-0002-9112-7167;
   Crovella, Sergio/0000-0001-8493-1168; Balbino, Valdir de
   Queiroz/0000-0002-4319-3952
CR 1000 Genomes Project Consortium, 2012, NATURE, V135
   Besnier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070651
   da Silva TM, 2015, EUR J HUM GENET, V23, P984, DOI 10.1038/ejhg.2014.215
   Ding LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-622
   Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
   Pritchard JK, 2000, GENETICS, V155, P945
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Qu HQ, 2012, DIABETES CARE, V35, P2591, DOI 10.2337/dc12-0636
   R Core Team, 2015, R LANG ENV STAT COMP
   Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003
   Sandoval JR, 2013, J HUM GENET, V58, P627, DOI 10.1038/jhg.2013.73
   Via M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016513
   Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037
NR 16
TC 0
Z9 0
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAR
PY 2016
VL 24
IS 3
BP 326
EP 327
DI 10.1038/ejhg.2015.184
PG 2
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DE2PP
UT WOS:000370469500004
PM 26328507
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Crovella, S
   Bianco, AM
   Vuch, J
   Zupin, L
   Moura, RR
   Trevisan, E
   Schneider, M
   Brollo, A
   Nicastro, EM
   Cosenzi, A
   Zabucchi, G
   Borelli, V
AF Crovella, Sergio
   Bianco, Anna Monica
   Vuch, Joseph
   Zupin, Luisa
   Moura, Ronald Rodrigues
   Trevisan, Elisa
   Schneider, Manuela
   Brollo, Alessandro
   Nicastro, Enza Maria
   Cosenzi, Alessandro
   Zabucchi, Giuliano
   Borelli, Violetta
TI Iron signature in asbestos-induced malignant pleural mesothelioma: A
   population-based autopsy study
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
LA English
DT Article
ID S-TRANSFERASE M1; GENETIC SUSCEPTIBILITY; OXIDATIVE STRESS; EXPOSURE;
   RISK; POLYMORPHISMS; HOMEOSTASIS; BODIES; MECHANISM; CANCER
AB Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. The development of MPM is frequently linked to inhalation of asbestos fibers. A genetic component of susceptibility to this disease is suggested by the observation that some individuals develop MPM following lower doses of asbestos exposure, whereas others exposed to higher quantities do not seem to be affected. This hypothesis is supported also by frequent reports of MPM familial clustering. Despite the widely recognized role of iron (Fe) in cellular asbestos-induced pulmonary toxicity, the role of the related gene polymorphisms in the etiology of MPM has apparently not been evaluated. Eighty-six single-nucleotide polymorphisms (SNPs) of 10 Fe-metabolism genes were examined by exploiting formalin-fixed paraffin-embedded postmortem samples from 77 patients who died due to MPM (designated AEM) and compared with 48 who were exposed to asbestos but from died in old age of cause other than asbestos (designated AENM). All subjects showed objective signs of asbestos exposure. Three SNPs, localized in the ferritin heavy polypeptide, transferrin, and hephaestin genes, whose frequencies were distributed differently in AEM and AENM populations, were identified. For ferritin and transferrin the C/C and the G/G genotypes, respectively, representing intronic polymorphisms, were significantly associated with protection against MPM and need to be considered as possible genetic markers of protection. Similarly, the C/C hephaestin SNP, a missense variation of this multicopper ferroxidase encoding gene, may be related, also functionally, with protection against MPM. In conclusion, it is proposed that three Fe metabolism-associated genes, significantly associated with protection against development of MPM, may serve as protective markers for this aggressive tumor.
C1 [Crovella, Sergio; Bianco, Anna Monica; Vuch, Joseph; Zupin, Luisa; Moura, Ronald Rodrigues] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Trevisan, Elisa; Zabucchi, Giuliano; Borelli, Violetta] Univ Trieste, Dept Life Sci, Via Valerio 28,Bldg R,Room 122, I-34127 Trieste, Italy.
   [Schneider, Manuela; Brollo, Alessandro; Nicastro, Enza Maria] Hosp Monfalcone GO, Anat Pathol Lab, Ass2, Gorizia, Italy.
   [Cosenzi, Alessandro] Hosp Monfalcone GO, Dept Med, Ass2, Gorizia, Italy.
RP Borelli, V (corresponding author), Univ Trieste, Dept Life Sci, Via Valerio 28,Bldg R,Room 122, I-34127 Trieste, Italy.
EM borelliv@units.it
RI BIANCO, ANNA MONICA/D-3098-2014; Crovella, Sergio/K-5050-2016; Zupin,
   Luisa/I-5228-2018; Moura, Ronald/F-7769-2012; Moura,
   Ronald/AAE-2318-2020
OI BIANCO, ANNA MONICA/0000-0001-8101-9659; Crovella,
   Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129; Moura,
   Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167
FU Associazione Esposti Amianto di Monfalcone; University of Trieste, FRA
FX This work was supported by Associazione Esposti Amianto di Monfalcone
   and by a grant from the University of Trieste, FRA 2011 (Local Research
   Grant).
CR Ascoli V, 2007, AM J IND MED, V50, P357, DOI 10.1002/ajim.20451
   Aust AE, 2000, INHAL TOXICOL, V12, P75, DOI 10.1080/08958378.2000.11463232
   Aust AE, 2011, J TOXICOL ENV HEAL B, V14, P40, DOI 10.1080/10937404.2011.556046
   Betti M, 2009, INT J HYG ENVIR HEAL, V212, P322, DOI 10.1016/j.ijheh.2008.08.001
   Bianchi C, 2004, IND HEALTH, V42, P235, DOI 10.2486/indhealth.42.235
   Bianchi C, 1991, IARC Sci Publ, P127
   Bianchi C, 2001, IND HEALTH, V39, P161, DOI 10.2486/indhealth.39.161
   Bianchi C, 1997, AM J IND MED, V32, P445, DOI 10.1002/(SICI)1097-0274(199711)32:5<445::AID-AJIM3>3.0.CO;2-R
   BIANCHI C, 1993, AM J IND MED, V24, P149, DOI 10.1002/ajim.4700240203
   Bianchi C, 2007, EUR J ONCOL, V12, P189
   Bianchi C, 2007, IND HEALTH, V45, P379, DOI 10.2486/indhealth.45.379
   Bianchi Claudio, 2009, Indian J Occup Environ Med, V13, P80, DOI 10.4103/0019-5278.55124
   Borelli V, 2007, J TOXICOL ENV HEAL A, V70, P1232, DOI 10.1080/15287390701380906
   Borelli V, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0022-0
   Cadby G, 2013, LUNG CANCER, V82, P1, DOI 10.1016/j.lungcan.2013.04.018
   Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724
   Casali M, 2015, ANN OCCUP HYG, V59, P909, DOI 10.1093/annhyg/mev028
   Chew SH, 2015, FREE RADICAL BIO MED, V86, P166, DOI 10.1016/j.freeradbiomed.2015.05.002
   de Klerk N, 2013, INT J CANCER, V132, P1423, DOI 10.1002/ijc.27758
   Dianzani I, 2006, MUTAT RES-FUND MOL M, V599, P124, DOI 10.1016/j.mrfmmm.2006.02.005
   Gemignani F, 2009, MUTAT RES-FUND MOL M, V671, P76, DOI 10.1016/j.mrfmmm.2009.09.003
   Ghio AJ, 2004, TOXICOL PATHOL, V32, P643, DOI 10.1080/01926230490885733
   Ghio AJ, 2008, ANTIOXID REDOX SIGN, V10, P371, DOI 10.1089/ars.2007.1909
   Ghio AJ, 2009, J ENVIRON PATHOL TOX, V28, P153, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.70
   Ghio AJ, 2009, BBA-GEN SUBJECTS, V1790, P731, DOI 10.1016/j.bbagen.2008.11.004
   Girardelli M, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-25
   Hirvonen A, 1996, J NATL CANCER I, V88, P1853, DOI 10.1093/jnci/88.24.1853
   HIRVONEN A, 1995, CANCER RES, V55, P2981
   Jiang L, 2012, J PATHOL, V228, P366, DOI 10.1002/path.4075
   Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316
   Kane AB, 2003, HUM PATHOL, V34, P735, DOI 10.1016/S0046-8177(03)00420-9
   Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797
   Landi S, 2007, INT J CANCER, V120, P2739, DOI 10.1002/ijc.22590
   Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163
   Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942
   LONDON SJ, 1995, J NATL CANCER I, V87, P1246, DOI 10.1093/jnci/87.16.1246
   Matullo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061253
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047
   Murakami A, 2012, LUNG, V190, P333, DOI 10.1007/s00408-012-9371-2
   Neri M, 2005, MUTAT RES-FUND MOL M, V592, P36, DOI 10.1016/j.mrfmmm.2005.06.003
   Neri M, 2008, MUTAT RES-REV MUTAT, V659, P126, DOI 10.1016/j.mrrev.2008.02.002
   Neri M, 2006, INT J HYG ENVIR HEAL, V209, P393, DOI 10.1016/j.ijheh.2006.03.002
   Puntoni R, 2003, MUTAT RES-REV MUTAT, V544, P385, DOI 10.1016/j.mrrev.2003.06.012
   SMITH MJ, 1972, AM J CLIN PATHOL, V58, P250
   Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912
   Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170
   Turi JL, 2004, FREE RADICAL BIO MED, V36, P850, DOI 10.1016/j.freeradbiomed.2003.12.008
   Ugolini D, 2008, MUTAT RES-REV MUTAT, V658, P162, DOI 10.1016/j.mrrev.2007.08.001
NR 49
TC 14
Z9 14
U1 0
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1528-7394
EI 1087-2620
J9 J TOXICOL ENV HEAL A
JI J. Toxicol. Env. Health Part A
PD FEB 1
PY 2016
VL 79
IS 3
BP 129
EP 141
DI 10.1080/15287394.2015.1123452
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DG5CZ
UT WOS:000372092100004
PM 26818092
DA 2020-12-08
ER

PT J
AU Garziera, M
   Catamo, E
   Crovella, S
   Montico, M
   Cecchin, E
   Lonardi, S
   Mini, E
   Nobili, S
   Romanato, L
   Toffoli, G
AF Garziera, M.
   Catamo, E.
   Crovella, S.
   Montico, M.
   Cecchin, E.
   Lonardi, S.
   Mini, E.
   Nobili, S.
   Romanato, L.
   Toffoli, G.
TI Association of the HLA-G 3 ' UTR polymorphisms with colorectal cancer in
   Italy: a first insight
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID 3' UNTRANSLATED REGION; G GENE POLYMORPHISMS; INDICATOR; CELLS; HOST
AB This study aimed to explore functional and regulatory polymorphisms and haplotypes at the HLA-G 3'UTR region in colorectal cancer development. The presence of nonpolymorphic variants was also evaluated. Three-hundred and eight patients with colorectal cancer and 294 healthy controls were analysed at the germinal level. We found an association with increased risk of colorectal cancer for +2960 14-bp INDEL, +3196 C>G SNPs and UTR-2 haplotype, and a 'protective' role for +3003 T>C, +3010 C>G polymorphisms and UTR-4 haplotype. We detected in 3 distinct patients, a novel nucleotide change (+3037 C>A) and 2 already described rare variants, +3032 G/C (EUR MAF = 0.1%) and +3092 G/T (EUR MAF = 0%). This is the first study showing associations between different polymorphisms in the HLA-G 3'UTR and colorectal cancer susceptibility.
C1 [Garziera, M.; Montico, M.; Cecchin, E.; Romanato, L.; Toffoli, G.] Aviano Natl Canc Inst, IRCCS, CRO, Expt & Clin Pharmacol Unit, I-33081 Aviano, PN, Italy.
   [Catamo, E.; Crovella, S.] Univ Trieste, Dept Med Sci, Trieste, TS, Italy.
   [Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, TS, Italy.
   [Lonardi, S.] Ist Oncol Veneto IRCCS, Med Oncol Unit 1, Padua, Italy.
   [Mini, E.] Univ Florence, Dept Expt & Clin Med, Sect Internal Med, Florence, FI, Italy.
   [Nobili, S.] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, FI, Italy.
RP Garziera, M (corresponding author), Aviano Natl Canc Inst, IRCCS, CRO, Expt & Clin Pharmacol Unit, Via F Gallini 2, I-33081 Aviano, PN, Italy.
EM mgarziera@cro.it
RI Crovella, Sergio/K-5050-2016; Montico, Marcella/B-5290-2013; Cecchin,
   Erika/K-2448-2018; Lonardi, Sara/F-4228-2014; Toffoli,
   Giuseppe/F-6642-2018; Nobili, Stefania/AAA-5917-2019; Mini,
   Enrico/AAA-5908-2019; ROMANATO, LOREDANA/ABA-7995-2020; Catamo,
   Eulalia/K-9399-2016; Garziera, Marica/S-8383-2019
OI Crovella, Sergio/0000-0001-8493-1168; Montico,
   Marcella/0000-0003-0377-8232; Cecchin, Erika/0000-0001-7517-7490;
   Lonardi, Sara/0000-0002-7593-8138; Toffoli,
   Giuseppe/0000-0002-5323-4762; ROMANATO, LOREDANA/0000-0001-5524-7332;
   Catamo, Eulalia/0000-0002-4701-9134; Garziera,
   Marica/0000-0001-6902-210X
FU "Application of advanced nanotechnology in the development of innovative
   cancer diagnostic tools" AIRC 5x1000 Special Program Molecular
   OncologyAssociazione Italiana per la Ricerca sul Cancro (AIRC) [12214]
FX All the authors declare no conflicts of interest. This work was
   supported by "Application of advanced nanotechnology in the development
   of innovative cancer diagnostic tools" AIRC 5x1000 Special Program
   Molecular Oncology (12214).
CR Amodio G, 2014, TISSUE ANTIGENS, V84, P255, DOI 10.1111/tan.12427
   Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x
   Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00476
   Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068
   Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138
   Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028
   Catamo E, 2015, HUM IMMUNOL, V76, P36, DOI 10.1016/j.humimm.2014.12.006
   Cecchin E, 2015, PHARMACOGENOMICS J, V15, P219, DOI 10.1038/tpj.2014.64
   Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31
   Curigliano G, 2013, CLIN CANCER RES, V19, P5564, DOI 10.1158/1078-0432.CCR-12-3697
   Dias FC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00009
   Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7
   Fehlker M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-64
   Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356
   Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027
   Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287
   Garziera M, 2014, WORLD J GASTROENTERO, V20, P3778, DOI 10.3748/wjg.v20.i14.3778
   Guo ZY, 2015, CELL IMMUNOL, V293, P10, DOI 10.1016/j.cellimm.2014.10.003
   Hansel Donna E, 2005, Int J Gastrointest Cancer, V35, P15, DOI 10.1385/IJGC:35:1:015
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015
   LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101
   Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122
   Ong CW, 2015, ONCOTARGET, V6, P12763
   Rouas-Freiss N, 2005, CANCER RES, V65, P10139, DOI 10.1158/0008-5472.CAN-05-0097
   Sabbagh A, 2014, GENES IMMUN, V15, P95, DOI 10.1038/gene.2013.67
   Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220
   Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501
   Ye SR, 2007, MODERN PATHOL, V20, P375, DOI 10.1038/modpathol.3800751
   Zeestraten ECM, 2014, BRIT J CANCER, V110, P459, DOI 10.1038/bjc.2013.696
   Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372
NR 34
TC 13
Z9 14
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
EI 1744-313X
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD FEB
PY 2016
VL 43
IS 1
BP 32
EP 39
DI 10.1111/iji.12243
PG 8
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA DA3AU
UT WOS:000367669100005
PM 26752414
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Coelho, AVC
   Arraes, LC
   Brandao, LAC
   Guimaraes, RL
   Crovella, S
AF da Silva, Ronaldo Celerino
   Campos Coelho, Antonio Victor
   Arraes, Luiz Claudio
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Crovella, Sergio
TI Chemokines SNPs in HIV-1+Patients and Healthy Controls from Northeast
   Brazil: Association with Protection against HIV-1 Infection
SO CURRENT HIV RESEARCH
LA English
DT Article
DE CCL3; CCL4; SNPs; HIV-1; infection
ID PROMOTER POLYMORPHISMS; GENETIC ASSOCIATION; AIDS PROGRESSION; COPY
   NUMBER; TRANSMISSION; RANTES; SDF-1; CCR5; CXCR6; RISK
AB Background: HIV-1 virus is known to infect the host mainly through CD4(+) T-lymphocyte cells, by interactions among the viral envelope proteins, CD4 receptor and HIV-1 coreceptors, such as chemokines receptors. Variations in the genes encoding HIV-1 coreceptors and their natural ligands have been shown to modify HIV-1 infection susceptibility and disease progression.
   Methods and Results: We analysed the distribution of SNPs in chemokines (CCL3, CCL4, CCL5, CXCL12) and chemokine receptor (CXCR6) genes, in 268 HIV-1 infected patients (HIV-1+) and 221 healthy controls from Northeast Brazil, and their possible connection with susceptibility to HIV-1 infection. The genotyping were performed through allele specific fluorogenic probes using real time PCR. We observed that the T alleles and AT genotype of rs1719153 CCL4 SNP were more frequent in healthy controls (19.8% and 35.0%, respectively) than in HIV-1+ patients (T allele: 14.1%; OR=0.67; 95% CI=0.47-0.95; p-value=0.020; and AT genotype: 24.4%; OR=0.61; 95% CI=0.40-0.93; p-value=0.021) after correcting for age and sex. The rs1719134 (CCL3) and rs1719153 (CCL4) SNPs presented linkage disequilibrium (D'=0.83). The AT haplotype frequency was increased in healthy controls (17.3%) in relation to HIV-1+ patients (11.0%; OR=0.62; 95% CI=0.42-0.93; p-value=0.020).
   Conclusion: Since our results revealed an increased frequency of alleles and genotypes of CCL3/CCL4 SNPs and haplotype (CCL3-CCL4) among healthy controls, we suggest that these variations might have a potential protective role against HIV-1 infection.
C1 [da Silva, Ronaldo Celerino; Campos Coelho, Antonio Victor; Guimaraes, Rafael Lima; Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; Campos Coelho, Antonio Victor; Cavalcanti Brandao, Lucas Andre; Guimaraes, Rafael Lima; Crovella, Sergio] Fed Univ Pernambuco UFPE, LIKA, Recife, PE, Brazil.
   [Arraes, Luiz Claudio] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Pathol, Recife, PE, Brazil.
RP da Silva, RC (corresponding author), Fed Univ Pernambuco UFPE, Dept Genet, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM ronaldocelerino@yahoo.com.br
RI Coelho, Antonio Victor C/E-6795-2015; Crovella, Sergio/K-5050-2016;
   Cavalcanti Brandao, Lucas Andre/G-8333-2012
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Crovella,
   Sergio/0000-0001-8493-1168; Cavalcanti Brandao, Lucas
   Andre/0000-0002-8588-4559
FU "Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco"
   (FACEPE); "Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico" (CNPq)National Council for Scientific and Technological
   Development (CNPq); "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior" (CAPES)CAPES
FX The authors wish to thank the Laboratory of Immunopathology Keizo Asami,
   the Institute of Integral Medicine Professor Fernando Figueira (IMIP),
   the Institute of Hemathology and Hemotherapy of Pernambuco State
   (HEMOPE) and the Pos-graduate Program in Genetics of Federal University
   of Pernambuco for technical scientific support. We also thank to
   "Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco"
   (FACEPE), "Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico" (CNPq) and "Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior" (CAPES) for financial support.
CR Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529
   An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799
   An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002
   Anastassopoulou CG, 2003, CURR HIV RES, V1, P185, DOI 10.2174/1570162033485311
   [Anonymous], 2014, GLOB REP UNAIDS REP
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Blaak H, 2005, J VIROL, V73, P1687
   Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005
   Coelho AVC, 2015, GENET MOL RES, V14, P2876, DOI 10.4238/2015.March.31.18
   Colobran R, 2008, GENES IMMUN, V9, P279, DOI 10.1038/gene.2008.15
   Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   da Silva RC, 2011, HUM IMMUNOL, V72, P305, DOI 10.1016/j.humimm.2011.01.012
   de Souza PR, 2006, J REPROD IMMUNOL, V69, P77, DOI 10.1016/j.jri.2005.09.001
   Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950
   Garcia-Moruja C, 2009, CURR HIV RES, V7, P384, DOI 10.2174/157016209788680543
   Gianesin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044460
   Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898
   Guerini FR, 2008, BIOMED PHARMACOTHER, V62, P26, DOI 10.1016/j.biopha.2007.04.005
   Hu L, 2012, GENES IMMUN, V13, P202, DOI 10.1038/gene.2011.70
   Jang DH, 2008, INT J IMMUNOGENET, V35, P101, DOI 10.1111/j.1744-313X.2007.00743.x
   Katz DA, 2010, INT J IMMUNOGENET, V37, P301, DOI 10.1111/j.1744-313X.2010.00924.x
   Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902
   Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225
   Levine Andrew J, 2009, Neurobehav HIV Med, V1, P1
   Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782
   Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738
   Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0
   Modi WS, 2006, AM J HUM GENET, V79, P120, DOI 10.1086/505331
   Modi WS, 2005, GENES IMMUN, V6, P691, DOI 10.1038/sj.gene.6364258
   Murdoch C, 2000, BLOOD, V95, P3032
   Passam AM, 2007, AIDS RES HUM RETROV, V23, P1026, DOI 10.1089/aid.2006.0248
   Paximadis M, 2009, INT J IMMUNOGENET, V36, P21, DOI 10.1111/j.1744-313X.2008.00815.x
   Paximadis M, 2013, GENES IMMUN, V14, P42, DOI 10.1038/gene.2012.51
   Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201
   Shrestha S, 2006, J INFECT DIS, V193, P16, DOI 10.1086/498532
   Singh P, 2008, VACCINE, V26, P2966, DOI 10.1016/j.vaccine.2008.01.012
   Singh UP, 2003, BLOOD, V101, P807
   Tiensiwakul P, 2004, INTERVIROLOGY, V47, P87, DOI 10.1159/000077831
   Verma R, 2007, J CLIN VIROL, V38, P198, DOI 10.1016/j.jcv.2006.12.006
   Wasik Tomasz J, 2005, Wiad Lek, V58, P500
   Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075
NR 44
TC 4
Z9 4
U1 0
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-162X
EI 1873-4251
J9 CURR HIV RES
JI Curr. HIV Res.
PY 2016
VL 14
IS 4
BP 340
EP 345
DI 10.2174/1570162X14666160120152237
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DO8UA
UT WOS:000378058100006
PM 26785888
DA 2020-12-08
ER

PT J
AU Tavares, MCM
   de Lima, SF
   Coelho, AVC
   Marques, TRNM
   de Araujo, DHT
   Heraclio, SD
   Amorim, MMR
   de Souza, PRE
   Crovella, S
AF Mansur Tavares, Mayara C.
   de Lima Junior, Sergio F.
   Coelho, Antonio V. C.
   Marques, Tricia Ruschelle N. M.
   de Araujo, Diego Henrique T.
   Heraclio, Sandra de A.
   Ramos Amorim, Melania M.
   de Souza, Paulo Roberto E.
   Crovella, Sergio
TI Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes
   polymorphisms are correlated with susceptibility to HPV infection in
   patients with and without cervical intraepithelial lesion
SO ANNALS OF HUMAN BIOLOGY
LA English
DT Article
DE Cytokine; invasive cervical cancer; single nucleotide polymorphism
ID HUMAN-PAPILLOMAVIRUS; PROMOTER POLYMORPHISM; BRAZILIAN WOMEN; RISK;
   ASSOCIATION; EXPRESSION; SMOKING; IL-18; CANCER; CARCINOGENESIS
AB Background: The Human Papillomavirus (HPV) predisposes 500 000 women to cervical cancer. Host genetic background may facilitate virus persistence in the uterine cervix. Polymorphisms in regulatory and coding regions of cytokine genes have been associated with susceptibility to some human diseases.
   Aim: This study aims at investigating whether TNFA -308 G/A and IL18 -137 G/C and -607 C/A polymorphisms are associated with susceptibility to HPV infection/progression to high-grade squamous intraepithelial lesion (HSIL).
   Subjects and methods: One hundred and twenty-two HPV infected and 132 HPV negative women (the latter used as healthy controls) were analysed. TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were analysed using specific sequence polymorphism PCR (SSP-PCR). Univariate statistical analysis and a logistic regression were performed.
   Results: The TNFA -308A allele was associated with susceptibility to HPV infection (p = 0.0008), while the IL18 -607A allele conferred protection against HPV infection (p = 0.0043). TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were not associated with development of cervical lesions (p > 0.05). An association was also observed between smoking and susceptibility to the development of HSIL.
   Conclusion: The findings suggest an association between two TNFA SNPs and susceptibility to HPV infection in women from Northeast Brazil. The results need to be functionally validated and replicated in other populations with different ethnic backgrounds.
C1 [Mansur Tavares, Mayara C.; de Lima Junior, Sergio F.] Univ Fed Pernambuco UFPE, Appl Mol Biol, Recife, PE, Brazil.
   [Coelho, Antonio V. C.; Crovella, Sergio] Univ Fed Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [Marques, Tricia Ruschelle N. M.; de Araujo, Diego Henrique T.] Univ Fed Rural Pernambuco UFRPE, Biol Sci, Recife, PE, Brazil.
   [Heraclio, Sandra de A.] Womens Healthcare Ctr, Dept Lower Genital Tract Pathol, Recife, PE, Brazil.
   [Ramos Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Maternal & Child Healthcare Dept, Recife, PE, Brazil.
   [de Souza, Paulo Roberto E.] Univ Fed Rural Pernambuco UFRPE, Dept Biol, Recife, PE, Brazil.
RP Tavares, MCM (corresponding author), Univ Fed Pernambuco UFPE, Biol Appl Hlth Appl Mol Biol, Recife, PE, Brazil.
EM mayaramansur@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015; Crovella, Sergio/K-5050-2016;
   Amorim, Melania M/C-5807-2013
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Crovella,
   Sergio/0000-0001-8493-1168; Amorim, Melania M/0000-0003-1047-2514
CR Arimitsu J, 2006, BIOCHEM BIOPH RES CO, V342, P1413, DOI 10.1016/j.bbrc.2006.02.096
   Associacao Brasileira de Genitoscopia, 2002, NOM LAUD COLP
   Ayres Andréia Rodrigues Gonçalves, 2010, Rev. Saúde Pública, V44, P963
   Barth RJ, 1996, CANCER, V78, P1168, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1168::AID-CNCR2>3.0.CO;2-6
   Basile JR, 2001, J BIOL CHEM, V276, P22522, DOI 10.1074/jbc.M010505200
   Bequet-Romero M, 2000, BIOCHEM BIOPH RES CO, V277, P55, DOI 10.1006/bbrc.2000.3628
   Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x
   BRASIL. INCA, 2014, CANC PREV EST 2014
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   Castelar L, 2010, TISSUE ANTIGENS, V76, P126, DOI 10.1111/j.1399-0039.2010.01471.x
   Corchado S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066619
   Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523
   Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369
   Duarte I, 2005, BIOCHEM BIOPH RES CO, V334, P588, DOI 10.1016/j.bbrc.2005.06.137
   Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007
   Esfandiari E, 2001, J IMMUNOL, V167, P5338, DOI 10.4049/jimmunol.167.9.5338
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fernandes APM, 2008, EUR J OBSTET GYN R B, V140, P241, DOI 10.1016/j.ejogrb.2008.04.007
   Fernandes JV, 2013, ANN MED HEALTH SCI R, V3, P504, DOI 10.4103/2141-9248.122060
   Fernandes JV, 2009, INT J GYNECOL OBSTET, V105, P21, DOI 10.1016/j.ijgo.2008.12.004
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201
   Govan VA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-24
   Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313
   Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6
   Hallermalm K, 2001, BLOOD, V98, P1108, DOI 10.1182/blood.V98.4.1108
   Haukim N, 2002, GENES IMMUN, V3, P313, DOI 10.1038/sj.gene.6363881
   HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
   Johnson GCL, 2000, CURR OPIN GENET DEV, V10, P330, DOI 10.1016/S0959-437X(00)00075-7
   Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996
   Kirkpatrick A, 2004, GYNECOL ONCOL, V92, P675, DOI 10.1016/j.ygyno.2003.11.025
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7
   Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x
   Lamb J, 2013, Nurs Prax N Z, V29, P24
   Lippman SA, 2010, INT J STD AIDS, V21, P105, DOI 10.1258/ijsa.2009.008436
   Lizano M, 2009, ARCH MED RES, V40, P428, DOI 10.1016/j.arcmed.2009.06.001
   LOWY DR, 2001, PAPILLOMAVIRUSES, P2231
   Mammas IN, 2014, INFECT GENET EVOL, V21, P220, DOI 10.1016/j.meegid.2013.11.002
   MANOS MM, 1989, CANCER CEL, V7, P209
   Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2
   Matsumoto K, 2010, CANCER SCI, V101, P2065, DOI 10.1111/j.1349-7006.2010.01642.x
   Min KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072142
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Oliveira-Silva M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-4
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6
   Piskin IE, 2013, DNA CELL BIOL, V32, P336, DOI 10.1089/dna.2013.1997
   Ribeiro AA, 2011, INT J GYNECOL PATHOL, V30, P288, DOI 10.1097/PGP.0b013e3181fde259
   Santos AM, 2005, CANCER GENET CYTOGEN, V159, P143, DOI 10.1016/j.cancergencyto.2004.10.005
   Sobti RC, 2008, ONCOL RES, V17, P159, DOI 10.3727/096504008785114156
   Solomon M., 2002, CONSUMER BEHAV EUROP
   Stanczuk GA, 2003, INT J GYNECOL CANCER, V13, P148, DOI 10.1046/j.1525-1438.2003.13046.x
   Szarewski A, 1996, LANCET, V347, P941, DOI 10.1016/S0140-6736(96)91417-8
   Tjiong MY, 2001, CYTOKINE, V14, P357, DOI 10.1006/cyto.2001.0909
   Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002
   Trimble CL, 2005, OBSTET GYNECOL, V105, P174, DOI 10.1097/01.AOG.0000148268.43584.03
   von Linsingen R, 2009, J INTERF CYTOK RES, V29, P285, DOI 10.1089/jir.2008.0081
   WHO, 2013, HUM PAP HPV CERV CAN
   Wilkerson M, 2010, AIDS CARE, V22, P1115, DOI 10.1080/09540121003599240
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   Yang YC, 2013, HUM IMMUNOL, V74, P882, DOI 10.1016/j.humimm.2013.04.001
   Ylitalo N, 2000, CANCER RES, V60, P6027
   Yu JT, 2009, BRAIN RES, V1253, P169, DOI 10.1016/j.brainres.2008.11.083
   Yue M, 2013, IMMUNOL LETT, V154, P54, DOI 10.1016/j.imlet.2013.08.007
NR 65
TC 7
Z9 8
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0301-4460
EI 1464-5033
J9 ANN HUM BIOL
JI Ann. Hum. Biol.
PY 2016
VL 43
IS 3
BP 261
EP 268
DI 10.3109/03014460.2014.1001436
PG 8
WC Anthropology; Biology; Public, Environmental & Occupational Health
SC Anthropology; Life Sciences & Biomedicine - Other Topics; Public,
   Environmental & Occupational Health
GA DO2EM
UT WOS:000377592700010
PM 26079218
DA 2020-12-08
ER

PT J
AU Addobbati, C
   Silva, JD
   Tavares, NAC
   Monticielo, O
   Xavier, RM
   Brenol, JCT
   Crovella, S
   Chies, JAB
   Sandrin-Garcia, P
AF Addobbati, Catarina
   Silva, Jaqueline de Azevedo
   Tavares, Nathalia A. C.
   Monticielo, Odirlei
   Xavier, Ricardo M.
   Brenol, Joao Carlos T.
   Crovella, Sergio
   Chies, Jose Artur B.
   Sandrin-Garcia, Paula
TI Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and
   Rheumatoid Arthritis
SO ANNALS OF HUMAN GENETICS
LA English
DT Article
DE Autoimmunity; rheumatology; genetic variants; complement system
ID SINGLE NUCLEOTIDE POLYMORPHISMS; LECTIN PATHWAY; CLASSIFICATION
   CRITERIA; DISEASE-ACTIVITY; COMPLEMENT; INDEX; DNA
AB Systemic lupus erythemathosus (SLE) and rheumatoid arthritis (RA) are complex autoimmune diseases characterized by an immune balance breakdown and by chronic inflammation. Several findings link SLE and RA development with the complement system and ficolin components have emerged as candidates for disease development. Since genetic association studies with ficolin genes in SLE and RA have not yet been conducted in a Brazilian population, the aim of this study was to determine whether polymorphisms of ficolin-1(FCN1) and ficolin-2 (FCN2) genes are associated with SLE and RA susceptibility as well as disease manifestation. Two SNPs within FCN1 (rs2989727 and 1071583) and three in FCN2 (rs17514136, rs3124954, and rs7851696) were studied in 208 SLE and 184 RA patients as well as 264 healthy individuals in a Southeast Brazilian population. For SLE patients, the FCN2 rs17514136 SNP was associated with a more severe disease (SLICC) (p = 0.0067). Furthermore, an association between the occurrence of nephritis and the T/T genotype for FCN2 rs3124954 SNP (p = 0.047, OR = 3.17, 95% CI = 1.34-7.5) was observed. No association was observed between the studied polymorphisms and RA development. Thus, our data support involvement of the FCN2 gene in the SLE phenotype.
C1 [Addobbati, Catarina; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, BR-50760901 Recife, PE, Brazil.
   [Addobbati, Catarina; Silva, Jaqueline de Azevedo; Tavares, Nathalia A. C.; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Keizo Asami Immunopathol Lab LIKA, BR-50760901 Recife, PE, Brazil.
   [Monticielo, Odirlei; Xavier, Ricardo M.; Brenol, Joao Carlos T.] Clin Hosp, Div Rheumatol, Sao Paulo, Brazil.
   [Monticielo, Odirlei; Xavier, Ricardo M.; Brenol, Joao Carlos T.] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil.
   [Chies, Jose Artur B.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
RP Addobbati, C (corresponding author), Univ Fed Pernambuco, Dept Genet, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM catarinaaddobbati@hotmail.com
RI Chies, Jose Artur Bogo/K-9664-2015; Xavier, Ricardo Machado/G-4426-2012;
   Monticielo, Odirlei/H-3880-2013; Brenol, Joao Carlos
   Tavares/V-7062-2019; Crovella, Sergio/K-5050-2016
OI Chies, Jose Artur Bogo/0000-0001-7025-0660; Xavier, Ricardo
   Machado/0000-0001-6570-4533; Monticielo, Odirlei/0000-0003-0720-2097;
   Brenol, Joao Carlos Tavares/0000-0002-8745-566X; Crovella,
   Sergio/0000-0001-8493-1168
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do
   Rio Grande do Sul)Foundation for Research Support of the State of Rio
   Grande do Sul (FAPERGS); FACEPE (Fundacao de Amparo a Ciencia e
   Tecnologia de Pernambuco); FIPE/HCPA (Fundo de Incentivo a Pesquisa e
   Eventos do Hospital de Clinicas de Porto Alegre)
FX This work was supported by the following Brazilian funding agencies:
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior),
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul),
   FACEPE (Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco), and
   FIPE/HCPA (Fundo de Incentivo a Pesquisa e Eventos do Hospital de
   Clinicas de Porto Alegre).
CR Ammitzboll CG, 2012, RHEUMATOL INT, V32, P1457, DOI 10.1007/s00296-011-1879-x
   Ammitzboll CG, 2013, ARTHRITIS RHEUM-US, V65, P3045, DOI 10.1002/art.38179
   Bezalel S, 2014, ISR MED ASSOC J, V16, P246
   Boldt ABW, 2013, J CLIN IMMUNOL, V33, P210, DOI 10.1007/s10875-012-9770-4
   BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606
   Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x
   Chen X, 2006, J DERMATOL SCI, V43, P201, DOI 10.1016/j.jdermsci.2006.05.010
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266
   Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419
   Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Hein E, 2015, MOL IMMUNOL, V63, P209, DOI 10.1016/j.molimm.2014.07.003
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173
   Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002
   Kay J, 2012, RHEUMATOLOGY, V51, P5, DOI 10.1093/rheumatology/kes279
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150
   Luz PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060237
   Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017
   Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P393, DOI 10.1038/icb.2013.15
   Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x
   Nisihara RM, 2013, HUM IMMUNOL, V74, P907, DOI 10.1016/j.humimm.2013.04.030
   Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546
   Ostergaard O, 2013, ARTHRITIS RHEUM-US, V65, P2680, DOI 10.1002/art.38065
   Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2
   Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Sterner RM, 2014, J CLIN CELL IMMUNOL, V5, P205, DOI DOI 10.4172/2155-9899.1000205
   Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003
NR 36
TC 11
Z9 12
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-4800
EI 1469-1809
J9 ANN HUM GENET
JI Ann. Hum. Genet.
PD JAN
PY 2016
VL 80
IS 1
BP 1
EP 6
DI 10.1111/ahg.12129
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA DA8RG
UT WOS:000368073200001
PM 26464189
DA 2020-12-08
ER

PT J
AU Cavalcanti, C
   Silva, JD
   Pita, WD
   Veit, TD
   Monticielo, OA
   Xavier, RM
   Brenol, JCT
   Brenol, CV
   Fragoso, TS
   Barbosa, AD
   Duarte, ALBP
   Oliveira, RDR
   Louzada, P
   Donadi, EA
   Crovella, S
   Chies, JAB
   Sandrin-Garcia, P
AF Jordao Cavalcanti, Catarina Addobbati
   Silva, Jaqueline de Azevedo
   Pita, Will de Barros
   Veit, Tiago Degani
   Monticielo, Odirlei Andre
   Xavier, Ricardo Machado
   Tavares Brenol, Joao Carlos
   Brenol, Cleiton Viegas
   Fragoso, Thiago Sotero
   Barbosa, Alexandre Domingues
   Branco Pinto Duarte, Angela Luiza
   Ribeiro Oliveira, Ren Donizeti
   Louzada-Junior, Paulo
   Donadi, Eduardo Antonio
   Crovella, Sergio
   Bogo Chies, Jose Artur
   Sandrin-Garcia, Paula
TI Vitamin D receptor polymorphisms and expression profile in rheumatoid
   arthritis brazilian patients
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE VDR; Rheumatoid arthritis; SNPs; mRNA; Monocytes
ID VDR GENE POLYMORPHISMS; 1,25-DIHYDROXYVITAMIN D-3; DISEASE-ACTIVITY;
   T-CELLS; D DEFICIENCY; SUSCEPTIBILITY; AUTOIMMUNITY; ASSOCIATIONS;
   PREVALENCE; RISK
AB Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and important joint commitment, being the most common systemic autoimmune disease worldwide. RA displays important genetic background with a variety of genes contributing to the immune balance breakdown. Recent studies have demonstrated that vitamin D, through its receptor (VDR), is able to regulate the immune balance and suppress the autoimmunity process, being a potential target in autoimmune diseases. In the present genetic association study, we assessed 5 Tag single nucleotide polymorphisms (SNPs) (rs11168268, rs2248098, rs1540339, rs4760648 and rs3890733), which cover most of the VDR gene, in three different Brazilian populations (from Northeast, Southeast and South Brazil). We also evaluated the VDR expression profile in whole blood and monocytes from RA patients. For genotyping study, 428 RA patients and 616 healthy controls were genotyped with fluorogenic allele specific probes on an ABI7500 platform. For gene expression study, VDR mRNA levels of 15 RA patients and 26 healthy individuals were assessed by RT-PCR. Our results showed that SNPs rs4760648 and rs3890733 are associated to RA susceptibility (p value = 0.0026, OR 1.31 and p value = 0.0091, OR 1.28 with statistical power = 0.999 and 0.993, respectively). Regarding RA clinical features, the studied SNPs did not show significant associations. The gene expression assays showed that VDR mRNA levels were down regulated in both whole blood (-3.3 fold) and monocytes (-3.2 fold) of RA patients when compared to healthy controls. Our results, the first reported for distinct Brazilian populations, support a role of the VDR gene in the susceptibility to RA.
C1 [Jordao Cavalcanti, Catarina Addobbati; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, BR-50760901 Recife, PE, Brazil.
   [Jordao Cavalcanti, Catarina Addobbati; Silva, Jaqueline de Azevedo; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, LIKA, BR-50760901 Recife, PE, Brazil.
   [Pita, Will de Barros] Univ Fed Pernambuco, Dept Antibiot, BR-50760901 Recife, PE, Brazil.
   [Veit, Tiago Degani; Bogo Chies, Jose Artur] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
   [Monticielo, Odirlei Andre; Xavier, Ricardo Machado; Tavares Brenol, Joao Carlos; Brenol, Cleiton Viegas] Univ Fed Rio Grande do Sul, Clin Hosp, Div Rheumatol, Porto Alegre, RS, Brazil.
   [Fragoso, Thiago Sotero] Univ Fed Alagoas, Clin Hosp, Rheumatol Serv, Maceio, Alagoas, Brazil.
   [Barbosa, Alexandre Domingues; Branco Pinto Duarte, Angela Luiza] Univ Fed Pernambuco, Clin Hosp, Div Rheumatol, BR-50760901 Recife, PE, Brazil.
   [Ribeiro Oliveira, Ren Donizeti; Louzada-Junior, Paulo; Donadi, Eduardo Antonio] Univ Sao Paulo, Med Fac Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Silva, JD (corresponding author), Univ Fed Pernambuco, LIKA, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM j.azvedo@gmail.com
RI de Barros Pita, Will/H-2227-2012; Brenol, Joao Carlos
   Tavares/V-7062-2019; Oliveira, Rene/C-4467-2012; Crovella,
   Sergio/K-5050-2016; donadi, eduardo A/H-7080-2013; Chies, Jose Artur
   Bogo/K-9664-2015; Brenol, Claiton V/D-5235-2009; Louzada-Junior,
   Paulo/E-4132-2012; Xavier, Ricardo Machado/G-4426-2012; Monticielo,
   Odirlei/H-3880-2013
OI de Barros Pita, Will/0000-0002-8492-3712; Brenol, Joao Carlos
   Tavares/0000-0002-8745-566X; Oliveira, Rene/0000-0003-0229-6864;
   Crovella, Sergio/0000-0001-8493-1168; donadi, eduardo
   A/0000-0002-9457-9601; Chies, Jose Artur Bogo/0000-0001-7025-0660;
   Brenol, Claiton V/0000-0003-0229-7912; Louzada-Junior,
   Paulo/0000-0003-2585-3870; Xavier, Ricardo Machado/0000-0001-6570-4533;
   Monticielo, Odirlei/0000-0003-0720-2097; Sotero Fragoso,
   Thiago/0000-0002-0192-0760
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); FAPESP (Fundacao Amparo a Pesquisa do Estado de Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do
   Sul)Foundation for Research Support of the State of Rio Grande do Sul
   (FAPERGS); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia de
   Pernambuco); FIPE/HCPA (Fundo de Incentivo a Pesquisa e Eventos do
   Hospital de Clinicas de Porto Alegre)
FX This work was supported by the following Brazilian funding agencies:
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior),
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   FAPESP (Fundacao Amparo a Pesquisa do Estado de Sao Paulo), FAPERGS
   (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul), FACEPE
   (Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco) and FIPE/HCPA
   (Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de
   Porto Alegre).
CR Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002
   Ardalan MR, 2007, TRANSPL P, V39, P951, DOI 10.1016/j.transproceed.2007.04.012
   Boissier MC, 2012, J AUTOIMMUN, V39, P222, DOI 10.1016/j.jaut.2012.05.021
   Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974
   BRENNAN A, 1987, IMMUNOLOGY, V61, P457
   Cantorna MT, 1998, J NUTR, V128, P68
   Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Silva JD, 2013, LUPUS, V22, P1110, DOI 10.1177/0961203313500549
   Furuya T, 2013, CLIN RHEUMATOL, V32, P1081, DOI 10.1007/s10067-013-2216-4
   Garcia-Lozano JR, 2001, EUR J IMMUNOGENET, V28, P89, DOI 10.1046/j.1365-2370.2001.00233.x
   Garcia-Martin E, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0065487
   Goertz B, 2003, CLIN EXP RHEUMATOL, V21, P333
   Gopinath K, 2011, INT J RHEUM DIS, V14, P332, DOI 10.1111/j.1756-185X.2011.01684.x
   Haga HJ, 2013, CLIN RHEUMATOL, V32, P629, DOI 10.1007/s10067-012-2154-6
   Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x
   Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387
   Hitchon Carol A, 2011, Open Rheumatol J, V5, P107, DOI 10.2174/1874312901105010107
   Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369
   Huang J, 2012, J NEUROL SCI, V313, P79, DOI 10.1016/j.jns.2011.09.024
   Hussien YM, 2013, MOL BIOL REP, V40, P3675, DOI 10.1007/s11033-012-2443-9
   Jacob N, 2012, RHEUM DIS CLIN N AM, V38, P243, DOI 10.1016/j.rdc.2012.05.001
   Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11
   Karray EF, 2012, JOINT BONE SPINE, V79, P144, DOI 10.1016/j.jbspin.2011.06.003
   Kay J, 2012, RHEUMATOL OXF S6, V51, pvi5
   Kerr GS, 2011, J RHEUMATOL, V38, P53, DOI 10.3899/jrheum.100516
   Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Laragione T, 2012, MOL MED, V18, P194, DOI 10.2119/molmed.2011.00410
   Lee CK, 2001, J KOREAN MED SCI, V16, P188, DOI 10.3346/jkms.2001.16.2.188
   LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maalej A, 2005, GENES IMMUN, V6, P707, DOI 10.1038/sj.gene.6364260
   Merlino LA, 2004, ARTHRITIS RHEUM, V50, P72, DOI 10.1002/art.11434
   Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P393, DOI 10.1038/icb.2013.15
   Mosaad YM, 2014, HUM IMMUNOL, V75, P452, DOI 10.1016/j.humimm.2014.02.009
   Oelzner P, 1998, CALCIFIED TISSUE INT, V62, P193, DOI 10.1007/s002239900416
   Okamoto H, 2008, FEBS J, V275, P4463, DOI 10.1111/j.1742-4658.2008.06582.x
   Penna G, 2006, J IMMUNOL, V177, P8504, DOI 10.4049/jimmunol.177.12.8504
   Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050
   PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107
   PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748
   Rossini M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3195
   Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x
   Silva JD, 2013, AUTOIMMUNITY, V46, P382, DOI 10.3109/08916934.2013.795952
   Song GG, 2012, CLIN RHEUMATOL, V31, P1733, DOI 10.1007/s10067-012-2080-7
   Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005
   Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543
   Tetlow LC, 1999, ANN RHEUM DIS, V58, P118, DOI 10.1136/ard.58.2.118
   Tizaoui K, 2014, J STEROID BIOCHEM, V143, P240, DOI 10.1016/j.jsbmb.2014.03.011
   Tizaoui K, 2014, CELL IMMUNOL, V290, P66, DOI 10.1016/j.cellimm.2014.05.002
   Tobon GJ, 2010, AUTOIMMUN REV, V9, pA288, DOI 10.1016/j.autrev.2009.11.019
   van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K
   Zhou HY, 2009, CLIN ENDOCRINOL, V70, P938, DOI 10.1111/j.1365-2265.2008.03413.x
   Zwerina K, 2011, ANN RHEUM DIS, V70, P1122, DOI 10.1136/ard.2010.142331
NR 55
TC 9
Z9 10
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JAN
PY 2016
VL 43
IS 1
BP 41
EP 51
DI 10.1007/s11033-015-3937-z
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DA8OB
UT WOS:000368063700005
PM 26686848
DA 2020-12-08
ER

PT J
AU Girardelli, M
   Arrigo, S
   Barabino, A
   Loganes, C
   Morreale, G
   Crovella, S
   Tommasini, A
   Bianco, AM
AF Girardelli, Martina
   Arrigo, Serena
   Barabino, Arrigo
   Loganes, Claudia
   Morreale, Giuseppe
   Crovella, Sergio
   Tommasini, Alberto
   Bianco, Anna Monica
TI The diagnostic challenge of very early-onset enterocolitis in an infant
   with XIAP deficiency
SO BMC PEDIATRICS
LA English
DT Article
DE XIAP; Primary Immunodeficiency; Very early onset IBD; Crohn's like;
   Intractable colitis; Periodic fever
ID X-LINKED INHIBITOR; CHRONIC GRANULOMATOUS-DISEASE; MUTATIONS; CHILDREN
AB Background: Aggressive course and resistance to treatments usually characterize very early onset inflammatory bowel disease (VEO-IBD). Some VEO-IBD cases are due to monogenic immune defects and can benefit from hematopoietic stem cell transplantation (HSCT).
   Case presentation: We describe a Caucasian male baby who presented in the first months of life macrophage activation syndrome, followed by intractable colitis, recurrent episodes of fever and mild splenomegaly. After several immunological, genetic and clinical investigations, subsequently a therapeutic attempt with colectomy, analysis of VEO-IBD-associated genes, revealed a causative mutation in XIAP. The genetic diagnosis of a primary immune deficiency allowed curing the boy with hematopoietic stem cell transplantation.
   Conclusion: Our report, together with novel findings from recent literature, should contribute to increase awareness of monogenic immune defects as a cause of VEO-IBD. Comprehensive genetic analysis can allow a prompt diagnosis, resulting in the choice of effective treatments and sparing useless and damaging procedures.
C1 [Girardelli, Martina; Crovella, Sergio; Tommasini, Alberto; Bianco, Anna Monica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Adv Diagnost & Clin Trials, Trieste, Italy.
   [Arrigo, Serena; Barabino, Arrigo] G Gaslini Childrens Hosp IRCCS, Gastroenterol & Endoscopy Unit, Genoa, Italy.
   [Loganes, Claudia; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Morreale, Giuseppe] G Gaslini Childrens Res Inst, Haematol Oncol Dept, Hematopoiet Stem Cell Transplantat Unit, Genoa, Italy.
RP Girardelli, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Adv Diagnost & Clin Trials, Trieste, Italy.
EM martina.girardelli@burlo.trieste.it
RI Arrigo, Serena/K-6006-2016; BIANCO, ANNA MONICA/D-3098-2014; Crovella,
   Sergio/K-5050-2016; Tommasini, Alberto/AAE-3882-2020
OI Arrigo, Serena/0000-0002-5564-7018; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Crovella, Sergio/0000-0001-8493-1168;
   Tommasini, Alberto/0000-0002-6943-7927; Loganes,
   Claudia/0000-0003-1096-042X
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Italy
   [RC 40/2011]
FX This work was supported by the grants from the Institute for Maternal
   and Child Health IRCCS "Burlo Garofolo", Italy (RC 40/2011).
CR Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031
   Ammann S, 2014, CLIN EXP IMMUNOL, V176, P394, DOI 10.1111/cei.12306
   Avitzur Y, 2014, GASTROENTEROLOGY, V146, P1028, DOI 10.1053/j.gastro.2014.01.015
   Cannioto Z, 2009, EUR J PEDIATR, V168, P149, DOI 10.1007/s00431-008-0721-2
   Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090
   Freudenberg F, 2010, J ALLERGY CLIN IMMUN, V125, P943, DOI 10.1016/j.jaci.2010.01.035
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Jaggi P, 2012, J CLIN IMMUNOL, V32, P78, DOI 10.1007/s10875-011-9608-5
   Levy M, 2013, PEDIATRICS, V132, pE779, DOI 10.1542/peds.2012-3344
   Marsh RA, 2013, BLOOD, V121, P877, DOI 10.1182/blood-2012-06-432500
   Marsh RA, 2010, BLOOD, V116, P1079, DOI 10.1182/blood-2010-01-256099
   Moraes-Vasconcelos D, 2008, J CLIN IMMUNOL, V28, pS11, DOI 10.1007/s10875-008-9176-5
   Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698
   Oretti C, 2006, SCAND J GASTROENTERO, V41, P430, DOI 10.1080/00365520500327743
   Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257
   Rumble JM, 2009, CELL IMMUNOL, V259, P82, DOI 10.1016/j.cellimm.2009.05.017
   Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372
   Speckmann C, 2013, CLIN IMMUNOL, V149, P133, DOI 10.1016/j.clim.2013.07.004
   Tsuma Y, 2015, PEDIATR TRANSPLANT, V19, pE25, DOI 10.1111/petr.12405
   Uhlig HH, 2014, GASTROENTEROLOGY, V147, P990, DOI 10.1053/j.gastro.2014.07.023
   Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956
   Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158
   Yang X, 2012, J CLIN IMMUNOL, V32, P411, DOI 10.1007/s10875-011-9638-z
   Zeissig Y, 2015, GUT, V64, P66, DOI 10.1136/gutjnl-2013-306520
NR 24
TC 14
Z9 17
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD DEC 15
PY 2015
VL 15
AR 208
DI 10.1186/s12887-015-0522-5
PG 7
WC Pediatrics
SC Pediatrics
GA CY5UH
UT WOS:000366472500002
PM 26671016
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Barrani, M
   Massei, F
   Scaglione, M
   Paolicchi, A
   Vitali, S
   Ciancia, EM
   Crovella, S
   Caparello, MC
   Consolini, R
AF Barrani, M.
   Massei, F.
   Scaglione, M.
   Paolicchi, A.
   Vitali, S.
   Ciancia, E. M.
   Crovella, S.
   Caparello, M. C.
   Consolini, R.
TI Unusual onset of a case of chronic recurrent multifocal osteomyelitis
SO PEDIATRIC RHEUMATOLOGY
LA English
DT Article
DE Chronic recurrent multifocal osteomyelitis; CRMO; Acute painful headache
ID PYODERMA-GANGRENOSUM; OSTEITIS; MANAGEMENT; CHILDREN; BONE
AB Background: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare condition that commonly affects the clavicle and pelvis.
   Case presentation: We report here a case a 12 years old girl with CRMO arising with recurrent episodes of left supraorbital headache, followed by the appearance of a periorbital dyschromia. Magnetic resonance imaging (MRI) of the skull and orbits revealed an important subacute inflammatory process. Few months after, the child presented a painful swelling of the left clavicle; the histological examination of the related biopsy allowed to establish the diagnosis of CRMO.
   Conclusion: CRMO presenting as acute headache involving neurocranium is rare; to our knowledge this is the first recognized case in the world literature.
   This pathological condition is frequently misdiagnosed as infection or neoplasm and needs a deep investigation for the differential diagnosis. The physical, laboratoristic and instrumental diagnostic investigations of the patient and the treatment employed are described in detail.
C1 [Barrani, M.; Massei, F.; Caparello, M. C.; Consolini, R.] Univ Pisa, Dept Pediat, Immunol & Rheumatol Sect, Pisa, Italy.
   [Scaglione, M.] Univ Pisa, Dept Orthoped, Pisa, Italy.
   [Paolicchi, A.; Vitali, S.] Univ Pisa, Dept Diagnost Radiol, Pisa, Italy.
   [Ciancia, E. M.] Univ Pisa, Dept Pathol, Pisa, Italy.
   [Crovella, S.] Univ Trieste, Dept Genet, Trieste, Italy.
RP Consolini, R (corresponding author), Univ Pisa, Dept Pediat, Immunol & Rheumatol Sect, Pisa, Italy.
EM rita.consolini@med.unipi.it
RI Crovella, Sergio/K-5050-2016; Vitali, Saverio/AAB-8266-2019
OI Crovella, Sergio/0000-0001-8493-1168; Vitali,
   Saverio/0000-0002-9284-8214
CR Catalano-Pons C, 2008, RHEUMATOLOGY, V47, P1397, DOI 10.1093/rheumatology/ken249
   CHAMOT AM, 1987, REV RHUM, V54, P187
   DAGAN O, 1995, PEDIATR DERMATOL, V12, P39, DOI 10.1111/j.1525-1470.1995.tb00122.x
   Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x
   Deutschmann A, 2005, PEDIATRICS, V116, P1231, DOI 10.1542/peds.2004-2206
   EDWARDS TC, 1986, AM J DIS CHILD, V140, P817, DOI 10.1001/archpedi.1986.02140220099042
   Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492
   Ferguson PJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0239-5
   FLANAGAN AM, 1989, BONE MINER, V6, P33, DOI 10.1016/0169-6009(89)90021-4
   Gattorno M, 2008, J CLIN IMMUNOL, V28, pS73, DOI 10.1007/s10875-008-9178-3
   Giedion A, 1972, Ann Radiol (Paris), V15, P329
   Huber AM, 2002, J PEDIATR-US, V141, P198, DOI 10.1067/mpd.2002.126457
   Jansson A, 2007, RHEUMATOLOGY, V46, P154, DOI 10.1093/rheumatology/kel190
   Omidi CJ, 1998, PEDIATR DERMATOL, V15, P435, DOI 10.1046/j.1525-1470.1998.1998015435.x
   PELKONEN P, 1988, AM J DIS CHILD, V142, P1167, DOI 10.1001/archpedi.1988.02150110045017
   Schultz C, 1999, PEDIATR INFECT DIS J, V18, P1008, DOI 10.1097/00006454-199911000-00015
   Vittecoq O, 2000, ARTHRITIS RHEUM, V43, P109, DOI 10.1002/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3
   Wipff J, 2011, JOINT BONE SPINE, V78, P555, DOI 10.1016/j.jbspin.2011.02.010
NR 18
TC 5
Z9 6
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1546-0096
J9 PEDIATR RHEUMATOL
JI Pediatr. Rheumatol.
PD DEC 12
PY 2015
VL 13
AR 60
DI 10.1186/s12969-015-0058-0
PG 5
WC Pediatrics; Rheumatology
SC Pediatrics; Rheumatology
GA CY2WV
UT WOS:000366269800001
PM 26653878
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Angelo, HD
   Silva, IIFG
   Oliveira, RDR
   Louzada-Junior, P
   Donadi, EA
   Crovella, S
   Maia, MMD
   de Souza, PRE
   Sandrin-Garcia, P
AF Angelo, H. D.
   Silva, I. I. F. Gomes
   Oliveira, R. D. R.
   Louzada-Junior, P.
   Donadi, E. A.
   Crovella, S.
   Maia, M. M. D.
   de Souza, P. R. E.
   Sandrin-Garcia, P.
TI Interleukin-18, interleukin-12B and interferon-gamma gene polymorphisms
   in Brazilian patients with rheumatoid arthritis: a pilot study
SO TISSUE ANTIGENS
LA English
DT Article
DE arthritis; cytokines; polymorphism; rheumatoid
ID ASSOCIATION; DISEASE; 105A/C; ASTHMA; IL-18
AB Polymorphisms in interleukin (IL)-18, IL-12 and interferon (IFN)-gamma genes are associated with different levels of cytokines expression and have been associated with rheumatoid arthritis (RA). IL-18 + 105 A/C, IL-12B + 1188 A/C and IFN-gamma + 874 T/A polymorphisms were analyzed by restriction fragment length polymorphism-polymerase chain reaction (PCR) and amplification refractory mutation system PCR from 90 RA patients and 186 healthy individuals. There were significant differences to IL-18 + 105 A/C polymorphism between the RA and control groups (odds ratio = 3.77; P < 0.0001). Individual carriers of the variant allele C had a 3.77-fold increased risk of for RA (P = 0.0032). No association was observed for IL-12B and IFN-. polymorphisms. Our finds suggest a possible role for IL-18 polymorphism in the RA susceptibility in studied population.
C1 [Angelo, H. D.] Fed Inst Pernambuco, Dept Gen Format, Garanhuns, Pernambuco, Brazil.
   [Angelo, H. D.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Postgrad Program Genet, Recife, PE, Brazil.
   [Silva, I. I. F. Gomes] Univ Pernambuco ICB UPE, Postgrad Program Appl Mol & Cellular Biol, Recife, PE, Brazil.
   [Oliveira, R. D. R.; Louzada-Junior, P.; Donadi, E. A.] Univ Sao Paulo, Dept Med, Div Clin Immunol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Maia, M. M. D.; de Souza, P. R. E.] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
RP de Souza, PRE (corresponding author), Univ Fed Rural Pernambuco, Dept Biol, Rua Dom Manoel Medeiros, S-N Dois Irmaos, BR-52171900 Recife, PE, Brazil.
EM prsouza30@gmail.com
RI Crovella, Sergio/K-5050-2016; donadi, eduardo A/H-7080-2013;
   Louzada-Junior, Paulo/E-4132-2012; Oliveira, Rene/C-4467-2012
OI Crovella, Sergio/0000-0001-8493-1168; donadi, eduardo
   A/0000-0002-9457-9601; Louzada-Junior, Paulo/0000-0003-2585-3870;
   Oliveira, Rene/0000-0003-0229-6864; Gomes-Silva,
   Isaura/0000-0002-6188-8483; Souza, Paulo/0000-0002-9186-9849
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Estado de Sao Paulo
   (FAPESP)
FX The authors thank the patients and their families whose collaboration
   and understanding have made this work possible. This study was supported
   by Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Estado de Sao
   Paulo (FAPESP).
CR da Silva HDA, 2014, MOL BIOL REP, V41, P2493, DOI 10.1007/s11033-014-3106-9
   Arimitsu J, 2006, BIOCHEM BIOPH RES CO, V342, P1413, DOI 10.1016/j.bbrc.2006.02.096
   Britsemmer K, 2011, ANN RHEUM DIS, V70, P1468, DOI 10.1136/ard.2010.148619
   Chen SY, 2009, J CLIN LAB ANAL, V23, P71, DOI 10.1002/jcla.20292
   Chen TY, 2011, HUM IMMUNOL, V72, P603, DOI 10.1016/j.humimm.2011.03.018
   Dagan AL, 2011, J ALLERGY CLIN IMMUN, V128, P524
   Danneskiold-Samsoe Bente, 2007, Ugeskr Laeger, V169, P2440
   Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X
   do Carmo Vasconcelos de Carvalho V., 2012, MOL BIOL REP, V39, P7627
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Garcia-Bermudez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047166
   HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805
   Higa S, 2003, CLIN EXP ALLERGY, V33, P1097, DOI 10.1046/j.1365-2222.2003.01739.x
   Lee CC, 2007, IMMUNOGENETICS, V59, P433, DOI 10.1007/s00251-007-0212-z
   Leung BP, 2000, ARTHRITIS RHEUM, V43, pS275
   Lin YJ, 2008, LUPUS, V17, P124, DOI 10.1177/0961203307086031
   McInnes IB, 2005, ARTHRITIS RES THER, V7, P38, DOI 10.1186/ar1497
   Morita Y, 1998, ARTHRITIS RHEUM, V41, P306, DOI 10.1002/1529-0131(199802)41:2<306::AID-ART15>3.0.CO;2-4
   Stanilova SA, 2005, INTENS CARE MED, V31, P401, DOI 10.1007/s00134-005-2575-7
   Zhu KJ, 2013, RHEUMATOL INT, V33, P1785, DOI 10.1007/s00296-012-2637-4
NR 20
TC 13
Z9 13
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD OCT
PY 2015
VL 86
IS 4
BP 276
EP 278
DI 10.1111/tan.12645
PG 3
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA CT8SL
UT WOS:000363086700004
PM 26302971
DA 2020-12-08
ER

PT J
AU De Moura, RR
   Coelho, AVC
   Balbino, VD
   Crovella, S
   Brandao, LAC
AF De Moura, Ronald Rodrigues
   Campos Coelho, Antonio Victor
   Balbino, Valdir De Queiroz
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
TI Meta-analysis of Brazilian genetic admixture and comparison with other
   Latin America countries
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Article
ID GENOMIC ANCESTRY; INTERETHNIC ADMIXTURE; ALLELIC FREQUENCIES; ADMIXED
   POPULATION; RACIAL ADMIXTURE; MINAS-GERAIS; RACE MIXTURE; SKIN COLOR;
   SAO-PAULO; STR LOCI
AB ObjectivesThis study aims at performing a systematic review and meta-analysis with the studies of genetic admixture inference of Brazilian population and to compare these results with the genetic admixture levels in other Latin American countries.
   MethodsWe searched for articles regarding the estimation of Brazilian genetic admixture published between 1980 and 2014 that used autosomal markers. Then, conducted meta-analyses at the whole-country and regional level. Finally, we compared the results of Brazil with other estimates from other South, Central and North American countries.
   ResultsWe analyzed data from 25 studies in 38 different Brazilian populations. European (EUR) ancestry is the major contributor to the genetic background of Brazilians, followed by African (AFR), and Amerindian (AMR) ancestries. The pooled ancestry contributions were 0.62 EUR, 0.21 AFR, and 0.17AMR. The Southern region had a greater EUR contribution (0.77) than other regions. Individuals from the Northeast (NE) region had the highest AFR contribution (0.27) whereas individuals from the North regions had more AMR contribution (0.32). In the Latin America context, Brazil has the 5th high EUR contribution, the 12th for the AFR component and the 10th for the AMR ancestry.
   ConclusionsAdmixture proportions vary greatly among Brazilian populations and also through Latin America. More studies in the Center-West, North and NE regions are needed to capture a more complete picture of the genomic ancestry of Brazil. Am. J. Hum. Biol. 27:674-680, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [De Moura, Ronald Rodrigues; Campos Coelho, Antonio Victor; Balbino, Valdir De Queiroz; Crovella, Sergio; Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [De Moura, Ronald Rodrigues; Campos Coelho, Antonio Victor; Crovella, Sergio; Cavalcanti Brandao, Lucas Andre] Lab Immunopatol Keizo Asami LIKA UFPE, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Pathol, Recife, PE, Brazil.
RP De Moura, RR (corresponding author), Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
EM ronaldmoura1989@gmail.com
RI Moura, Ronald/F-7769-2012; Moura, Ronald/AAE-2318-2020; Crovella,
   Sergio/K-5050-2016; Coelho, Antonio Victor C/E-6795-2015; Brandao, Lucas
   Andre Cavalcanti/G-8333-2012; Balbino, Valdir de Queiroz/H-6877-2014
OI Moura, Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167;
   Crovella, Sergio/0000-0001-8493-1168; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Balbino, Valdir de
   Queiroz/0000-0002-4319-3952
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE)
   [APQ-1530-2.02/12]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [475350/2011-1]
FX Contract grant sponsor: Fundacao de Amparo a Pesquisa do Estado de
   Pernambuco (FACEPE); Contract grant number: APQ-1530-2.02/12; Contract
   grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq); Contract grant number: 475350/2011-1.
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Bernardo S, 2014, MOL BIOL REP, V41, P1945, DOI 10.1007/s11033-014-3041-9
   Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7
   Callegari-Jacques Sidia M., 1999, Ciencia e Cultura (Sao Paulo), V51, P166
   Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217
   Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
   Carvalho M, 2010, GENET MOL BIOL, V33, P422, DOI 10.1590/S1415-47572010005000067
   Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931
   Conrad R., 1973, DESTRUCTION BRAZILIA, P368
   Francez PAD, 2012, FORENSIC SCI INT-GEN, V6, P132, DOI 10.1016/j.fsigen.2011.04.002
   Francez PAD, 2011, GENET MOL BIOL, V34, P35, DOI 10.1590/S1415-47572011000100007
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ding LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-622
   DOSSANTOS SEB, 1995, REV BRAS GENET, V18, P311
   Felix Gabriela E. S., 2010, Rev. Bras. Hematol. Hemoter., V32, P282
   Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124
   Ferreira FL, 2005, GENET MOL BIOL, V28, P22, DOI 10.1590/S1415-47572005000100004
   Ferreira LB, 2006, AM J HUM BIOL, V18, P702, DOI 10.1002/ajhb.20474
   FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756
   Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144
   Godinho NMO, 2008, FORENS SCI INT-GEN S, V1, P329, DOI 10.1016/j.fsigss.2007.10.069
   Gravlee CC, 2005, AM J PUBLIC HEALTH, V95, P2191, DOI 10.2105/AJPH.2005.065615
   GUERREIRO JF, 1993, REV BRAS GENET, V16, P1075
   Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001
   Instituto Brasileiro de Estatistica (IBGE), 2013, ATL CENS DEM 2010, P216
   Instituto Brasileiro de Estatistica (IBGE), 2007, BRAS 500 AN POV, P237
   Kimura L, 2013, AM J HUM BIOL, V25, P35, DOI 10.1002/ajhb.22335
   Knight FW, 1997, GEN HIST CARIBBEAN, P380
   KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x
   Leite TKM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027162
   Levy M S, 1974, Rev Saude Publica, VSuppl, P49
   Lins TC, 2011, GENET MOL BIOL, V34, P377, DOI 10.1590/S1415-47572011000300003
   Lins TC, 2011, J EPIDEMIOL, V21, P240, DOI 10.2188/jea.JE20100164
   Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
   Maciel LGL, 2011, HUM BIOL, V83, P627, DOI 10.3378/027.083.0504
   Manta FSN, 2012, ANN HUM BIOL, V40, P1
   Marrero AR, 2005, AM J HUM BIOL, V17, P496, DOI 10.1002/ajhb.20404
   Martins JA, 2011, MOL BIOL REP, V38, P5397, DOI 10.1007/s11033-011-0693-6
   Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151
   Palha T, 2012, FORENSIC SCI INT-GEN, V6, P413, DOI 10.1016/j.fsigen.2011.08.003
   Pamphile Leon Denius, 2001, HAITIANS AFRICAN AM
   Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440
   Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100
   Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026
   Pena SDJ, 2005, HIST CIENC SAUDE-MAN, V12, P319
   Pena SDJ, 2006, REV USP, V68, P10
   Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
   Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684
   Pinto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047498
   Queiroz EM, 2013, GENET MOL RES, V12, P5124, DOI 10.4238/2013.October.29.6
   R Core Team, 2013, R LANG ENV STAT COMP
   RIBEIRODOSSANTOS AKC, 1995, BRAZ J GENET, V18, P469
   Rosa VL, 1984, BRAZ J GENET, V7, P569
   Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572
   Salzano FM, 1997, AM J HUM BIOL, V9, P505, DOI 10.1002/(SICI)1520-6300(1997)9:4<505::AID-AJHB10>3.0.CO;2-Q
   Salzano FM, 1988, S AM INDIANS CASE ST, P259
   Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003
   Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159
   SANTOS SEB, 1987, REV BRAS GENET, V10, P745
   SANTOS SEB, 1983, J HUM EVOL, V12, P373, DOI 10.1016/S0047-2484(83)80165-1
   SCHNEIDER H, 1979, HUM GENET, V53, P101, DOI 10.1007/BF00289458
   SCHULER L, 1982, J HUM EVOL, V11, P549, DOI 10.1016/S0047-2484(82)80001-8
   Scliar MO, 2009, AM J PHYS ANTHROPOL, V139, P591, DOI 10.1002/ajpa.21046
   Silva DA, 2006, AM J HUM BIOL, V18, P829, DOI 10.1002/ajhb.20567
   Silva MCF, 2010, GENET MOL RES, V9, P2069, DOI 10.4238/vol9-4gmr911
   Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856
   Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191
   Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954
   Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727
   Wright S., 1978, VARIABILITY NATURAL, V4
NR 71
TC 49
Z9 50
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD SEP-OCT
PY 2015
VL 27
IS 5
BP 674
EP 680
DI 10.1002/ajhb.22714
PG 7
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA CP1ZX
UT WOS:000359677700011
PM 25820814
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Girardelli, M
   Kleiner, G
   Knowles, A
   Valencic, E
   Crovella, S
   Marcuzzi, A
AF Tricarico, Paola Maura
   Girardelli, Martina
   Kleiner, Giulio
   Knowles, Alessandra
   Valencic, Erica
   Crovella, Sergio
   Marcuzzi, Annalisa
TI Alendronate, a double-edged sword acting in the mevalonate pathway
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE alendronate; mevalonate kinase deficiency; programmed cell death;
   cytokines
ID PERIODIC FEVER SYNDROME; HYPERIMMUNOGLOBULINEMIA-D SYNDROME;
   INTERLEUKIN-1-BETA SECRETION; KINASE-DEFICIENCY; AMINOBISPHOSPHONATE;
   BISPHOSPHONATES; OSTEOPOROSIS; ACIDURIA; ATTACKS; VIVO
AB Aminobisphosphonate aledronate is a compound commonly used clinically for the treatment of osteoporosis and other bone diseases, as a result of it preventing bone resorption. However, in previous years it has also been used to obtain cellular and animal models of a rare genetic disorder termed Mevalonate Kinase Deficiency (MKD). MKD is caused by mutations affecting the mevalonate kinase enzyme, in the cholesterol pathway and alendronate can be used to biochemically mimic the genetic defect as it inhibits farnesyl pyrophosphate synthase in the same pathway. Despite evidence in favor of the inhibition exerted on the mevalonate pathway, there is at least one clinical case of MKD in which alendronate improved not only skeletal and bone fractures, as expected, but also MKD clinical features. Based on this finding, the present study assessed the anti-inflammatory properties of this aminobisphosphonate in vitro. No anti-inflammatory effects of alendronate were observed in the in-vitro experiments. Since MKD lacks specific treatments, these results may assist scientists and physicians in making the decision as to the most suitable choice of therapeutic compounds for this neglected disease.
C1 [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy.
   [Girardelli, Martina; Kleiner, Giulio; Knowles, Alessandra; Valencic, Erica; Crovella, Sergio; Marcuzzi, Annalisa] IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Marcuzzi, A (corresponding author), IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM annalisa.marcuzzi@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; tricarico, paola/AAB-8972-2019;
   Crovella, Sergio/K-5050-2016; Knowles, Alessandra/AAB-7765-2020;
   Valencic, Erica/G-3067-2014
OI Marcuzzi, Annalisa/0000-0003-3427-618X; tricarico,
   paola/0000-0002-1954-4126; Crovella, Sergio/0000-0001-8493-1168;
   Knowles, Alessandra/0000-0003-4504-6371; Valencic,
   Erica/0000-0002-7380-8014; Kleiner, Giulio/0000-0002-1830-3961
FU Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo' [RC
   42/11]
FX This study was supported by a grant from the Institute for Maternal and
   Child Health, IRCCS 'Burlo Garofolo' (grant no. RC 42/11).
CR Amagase K, 2011, J PHYSIOL PHARMACOL, V62, P609
   Attout H, 2008, EUR J INTERN MED, V19, pe82
   Cantarini L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-196
   Diel Ingo J, 2007, J Support Oncol, V5, P475
   DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586
   Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   HOFFMANN GF, 1993, PEDIATRICS, V91, P915
   Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P162, DOI 10.1590/0004-2730000003039
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/501305
   Richards PJ, 1999, RHEUMATOLOGY, V38, P984, DOI 10.1093/rheumatology/38.10.984
   Silverman SL, 2008, JCR-J CLIN RHEUMATOL, V14, P299, DOI 10.1097/RHU.0b013e318188b1f3
   Simon A, 2004, CLIN PHARMACOL THER, V75, P476, DOI 10.1016/j.clpt.2004.01.012
   Sugawara S, 1998, BRIT J PHARMACOL, V125, P735, DOI 10.1038/sj.bjp.0702151
   Tricarico PM, 2013, INT J MOL SCI, V14, P23274, DOI 10.3390/ijms141223274
   van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7
   Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947
NR 20
TC 5
Z9 5
U1 0
U2 5
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD SEP
PY 2015
VL 12
IS 3
BP 4238
EP 4242
DI 10.3892/mmr.2015.3957
PG 5
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CP5OW
UT WOS:000359933900142
PM 26096667
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Borelli, V
   Moura, RR
   Trevisan, E
   Crovella, S
AF Borelli, Violetta
   Moura, Ronal R.
   Trevisan, Elisa
   Crovella, Sergio
TI NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos
   exposed individuals a population-based autopsy study from North East
   Italy
SO INFECTIOUS AGENTS AND CANCER
LA English
DT Letter
DE Mesothelioma; Inflammasome; NLRP1 and NLRP3 polymorphisms; Asbestos
   exposure; Haplotypes
ID INFLAMMASOME; MECHANISMS
AB NRLP1 (rs12150220, rs9889625, rs9900356, rs6502867, rs2670660) and NLRP3 (rs35829419, rs10754558) polymorphisms have been analyzed in 69 subjects with documented asbestos exposure and death for malignant pleural mesothelioma and 59 patients with documented asbestos exposure but death for other causes, all from a North East Italy. No association was found between NLRP1 and NLRP3 polymorphisms and susceptibility to develop mesothelioma using the general, dominant or recessive models. Also haplotype analysis did not reveal any significant association with mesothelioma. Our findings, being controversial with respect to another study on Italian patients, do suggest the need of further studies to unravel the contribution of NLRP1 and NLRP3 in susceptibility to mesothelioma.
C1 [Borelli, Violetta; Trevisan, Elisa] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Moura, Ronal R.; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
EM crovelser@gmail.com
RI Moura, Ronald/F-7769-2012; Crovella, Sergio/K-5050-2016; Moura,
   Ronald/AAE-2318-2020
OI Moura, Ronald/0000-0002-9112-7167; Crovella, Sergio/0000-0001-8493-1168;
   Moura, Ronald/0000-0002-9112-7167; Borelli, Violetta/0000-0002-8166-3513
CR Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Girardelli M, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-25
   Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008
   Hillegass JM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-39
   Matullo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061253
   Mossman BT, 2013, AM J PATHOL, V182, P1065, DOI 10.1016/j.ajpath.2012.12.028
   Panagopoulos I, 2015, CANCER LETT, V357, P502, DOI 10.1016/j.canlet.2014.12.002
NR 8
TC 5
Z9 5
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-9378
J9 INFECT AGENTS CANCER
JI Infect. Agents Cancer
PD AUG 1
PY 2015
VL 10
AR 26
DI 10.1186/s13027-015-0022-0
PG 3
WC Oncology; Immunology
SC Oncology; Immunology
GA CO0HR
UT WOS:000358831200001
PM 26236392
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Piscianz, E
   Monasta, L
   Kleiner, G
   Crovella, S
   Marcuzzi, A
AF Tricarico, Paola Maura
   Piscianz, Elisa
   Monasta, Lorenzo
   Kleiner, Giulio
   Crovella, Sergio
   Marcuzzi, Annalisa
TI Microglia activation and interaction with neuronal cells in a
   biochemical model of mevalonate kinase deficiency
SO APOPTOSIS
LA English
DT Article
DE Mevalonic aciduria; Mevalonate kinase deficiency; Microglial activation;
   Apoptosis; Lovastatin
ID HYPERIMMUNOGLOBULINEMIA-D SYNDROME; ALZHEIMERS-DISEASE; ACIDURIA;
   INFLAMMATION; APOPTOSIS; LINE; CHOLESTEROL; EXPRESSION; ANAKINRA; STRESS
AB Mevalonate kinase deficiency is a rare disease whose worst manifestation, characterised by severe neurologic impairment, is called mevalonic aciduria. The progressive neuronal loss associated to cell death can be studied in vitro with a simplified model based on a biochemical block of the mevalonate pathway and a subsequent inflammatory trigger. The aim of this study was to evaluate the effect of the mevalonate blocking on glial cells (BV-2) and the following effects on neuronal cells (SH-SY5Y) when the two populations were cultured together. To better understand the cross-talk between glial and neuronal cells, as it happens in vivo, BV-2 and SH-SY5Y were co-cultured in different experimental settings (alone, transwell, direct contact); the effect of mevalonate pathway biochemical block by Lovastatin, followed by LPS inflammatory trigger, were evaluated by analysing programmed cell death and mitochondrial membrane potential, cytokines' release and cells' morphology modifications. In this experimental condition, glial cells underwent an evident activation, confirmed by elevated pro-inflammatory cytokines release, typical of these disorders, and a modification in morphology. Moreover, the activation induced an increase in apoptosis. When glial cells were co-cultured with neurons, their activation caused an increase of programmed cell death also in neuronal cells, but only if the two populations were cultured in direct contact. Our findings, being aware of the limitations related to the cell models used, represent a preliminary step towards understanding the pathological and neuroinflammatory mechanisms occurring in mevalonate kinase diseases. Contact co-culture between neuronal and microglial cells seems to be a good model to study mevalonic aciduria in vitro, and to contribute to the identification of potential drugs able to block microglial activation for this orphan disease. In fact, in such a pathological condition, we demonstrated that microglial cells are activated and contribute to neuronal cell death. We can thus hypothesise that the use of microglial activation blockers could prevent this additional neuronal death.
C1 [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
   [Piscianz, Elisa; Monasta, Lorenzo; Kleiner, Giulio; Crovella, Sergio; Marcuzzi, Annalisa] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Univ Trieste, Piazzale Europa 1, I-34127 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016;
   tricarico, paola/AAB-8972-2019; Monasta, Lorenzo/B-1388-2012
OI Marcuzzi, Annalisa/0000-0003-3427-618X; Crovella,
   Sergio/0000-0001-8493-1168; tricarico, paola/0000-0002-1954-4126;
   Monasta, Lorenzo/0000-0001-7774-548X; Kleiner,
   Giulio/0000-0002-1830-3961; Piscianz, Elisa/0000-0001-7374-1684
FU Institute for Maternal and Child Health - IRCCS "Burlo Garofolo",
   Trieste, Italy [RC 42/2011]
FX This study was supported by a grant from the Institute for Maternal and
   Child Health - IRCCS "Burlo Garofolo", Trieste, Italy (RC 42/2011). We
   would like to thank Dr. A. Tommasini (Institute for Maternal and Child
   Health - IRCCS "Burlo Garofolo", Trieste, Italy) for kindly providing
   the BV-2 cell line, and Prof. S. Gustincich (Department of Neurobiology,
   International School for Advanced Studied S.I.S.S.A.-I.S.A.S. Trieste,
   Italy) for kindly providing the SH-SY5Y cell line.
CR Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004
   Bodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   Celsi F, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0048-5
   Chen CH, 2013, NEUROSCIENCE, V242, P39, DOI 10.1016/j.neuroscience.2013.02.017
   Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486
   Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230
   DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586
   Galeotti C, 2012, RHEUMATOLOGY, V51, P1855, DOI 10.1093/rheumatology/kes097
   Griffin WST, 2013, NEW ENGL J MED, V368, P770, DOI 10.1056/NEJMcibr1214546
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7
   Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805
   HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504
   Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Li Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/437483
   Liu SH, 2010, CELL MOL LIFE SCI, V67, P1465, DOI 10.1007/s00018-009-0255-4
   Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Neven B, 2007, NEW ENGL J MED, V356, P2700, DOI 10.1056/NEJMoa070715
   Normand S, 2009, EUR CYTOKINE NETW, V20, P101, DOI 10.1684/ecn.2009.0163
   Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002
   Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105
   Gomez AR, 2012, PEDIATRICS, V129, pE535, DOI 10.1542/peds.2010-2192
   Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086
   van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920
   vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965
   Wake H, 2011, NEURON GLIA BIOL, V7, P47, DOI 10.1017/S1740925X12000063
   Zanin V, 2013, J CARDIOVASC TRANSL, V6, P981, DOI 10.1007/s12265-013-9506-8
   Zhang YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-372
   Zhu J, 2014, CELL PHYSIOL BIOCHEM, V34, P768, DOI 10.1159/000363041
NR 34
TC 11
Z9 11
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1360-8185
EI 1573-675X
J9 APOPTOSIS
JI Apoptosis
PD AUG
PY 2015
VL 20
IS 8
BP 1048
EP 1055
DI 10.1007/s10495-015-1139-8
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CL2IS
UT WOS:000356767600004
PM 26003816
DA 2020-12-08
ER

PT J
AU Chagas, BS
   Comar, M
   Gurgel, APAD
   Paiva, S
   Seraceni, S
   de Freitas, AC
   Crovella, S
AF Chagas, Barbara Simas
   Comar, Manola
   Almeida Diniz Gurgel, Ana Pavla
   Paiva, Sergio
   Seraceni, Silva
   de Freitas, Antonio Carlos
   Crovella, Sergio
TI Association Study between Cervical Lesions and Single or Multiple
   Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types
   in Women from Northeastern Brazil
SO PLOS ONE
LA English
DT Article
ID HPV-16/18 AS04-ADJUVANTED VACCINE; CROSS-PROTECTIVE EFFICACY; OF-STUDY
   ANALYSIS; HIGH-RISK; CONCURRENT INFECTIONS; VARIANT LINEAGES; E7
   ONCOGENES; E6 VARIANTS; CANCER; PREVALENCE
AB We performed an association between high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and single or multiple vaccine-target as well as non-vaccine target Human papillomavirus (HPV) types. Using bead-based HPV genotyping, 594 gynecological samples were genotyped. An association between squamous intraepithelial lesion (SIL) and presence of HPV16, 18, 31, 58 and 56 types were calculated. The risk was estimated by using odds ratio (OR) and 95% of confidence intervals (CI). A total of 370 (62.3%) women were HPV positive. Among these, 157 (42.7%) presented a single HPV infection, and 212 (57.3%) were infected by more than one HPV type. HPV31 was the most prevalent genotype, regardless single and multiple HPV infections. Single infection with HPV31 was associated with LSIL (OR=2.32; 95% CI: 1.01 to 5.32; p=0.04); HPV31 was also associated with LSIL (OR=3.28; 95% CI: 1.74 to 6.19; p=0.0002) and HSIL (OR=3.82; 95% CI: 2.10 to 6.97; p<0.001) in multiple HPV infections. Risk to harbor cervical lesions was observed in multiple HPV infections with regard to the HPV56 (OR=5.39; 95% CI: 2.44 to 11.90; p<0.001 for LSIL; OR=5.37; 95% CI: 2.71 to 10.69; p<0.001) and HPV58 (OR=3.29; 95% CI: 1.34 to 8.09; p=0.0091 for LSIL; OR=3.55; 95% CI: 1.56 to 8.11; p=0.0026) genotypes. In addition, women coinfected with HPV16/31/56 types had 6 and 5-fold increased risk of HSIL (OR=6.46; 95% CI: 1.89 to 22.09; p=0.002) and LSIL (OR=5.22; 95% CI: 1.10 to 24.70; p=0.03), respectively. Multiple HPV infections without HPV16/18 has 2-fold increased risk of HSIL (OR=2.57; 95% CI: 1.41 to 4.70; p=0.002) and LSIL OR=2.03; 95% CI: 1.08 to 3.79; p=0.02). The results of this study suggest that single and multiple vaccine target as well as non-vaccine target HPV types are associated with LSIL and HSIL. These finding should be taken into consideration in the design of HPV vaccination strategies.
C1 [Chagas, Barbara Simas; Almeida Diniz Gurgel, Ana Pavla; Paiva, Sergio; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil.
   [Comar, Manola; Seraceni, Silva; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Seraceni, Silva; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP de Freitas, AC (corresponding author), Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Caruaru, PE, Brazil.
EM acf_ufpe@yahoo.com.br
RI Crovella, Sergio/K-5050-2016; Comar, Manola/K-4613-2016; Chagas,
   Barbara/M-9327-2019; Freitas, Antonio/G-1843-2012; COMAR,
   Manola/K-4613-2016
OI Crovella, Sergio/0000-0001-8493-1168; Comar, Manola/0000-0001-6310-3320;
   Freitas, Antonio/0000-0002-4957-9549; Simas Chagas,
   Barbara/0000-0003-3917-9055; COMAR, Manola/0000-0002-9487-861X; Gurgel,
   Ana Pavla A.D./0000-0001-5848-6419
FU Brazilian Institute CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico)National Council for Scientific and
   Technological Development (CNPq); Brazilian Institute FACEPE (Fundacao
   de Amparo a Ciencia e Tecnologia do Estado de Pernambuco); Brazilian
   Institute PPSUS (Programa Pesquisa para o Sistema Unico de Saude);
   Brazilian Institute CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)
FX This work was supported by Brazilian Institutes CNPq (Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico), - FACEPE (Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco), PPSUS (Programa
   Pesquisa para o Sistema Unico de Saude), CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior).
CR Ah Lee S, 2003, CANC LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4
   Alencar TR, 2007, VIRUS GENES, V35, P1, DOI 10.1007/s11262-006-0040-5
   Gurgel APAD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546354
   Gurgel APAD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/130828
   Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015
   Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677
   da Silva MFPTB, 2012, GENET MOL RES, V11, P462, DOI 10.4238/2012.March.1.3
   Beca F, 2014, DIAGN CYTOPATHOL, V42, P919, DOI 10.1002/dc.23143
   Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325
   Burk RD, 2003, CANCER RES, V63, P7215
   Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018
   Burroni E, 2013, J MED VIROL, V85, P83, DOI 10.1002/jmv.23417
   Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010
   Castro MM, 2011, GENET MOL RES, V10, P186, DOI 10.4238/vol10-1gmr992
   Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008
   Chagas BS, 2013, INFECT GENET EVOL, V16, P13, DOI 10.1016/j.meegid.2013.02.001
   Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724
   Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P599, DOI 10.7314/APJCP.2012.13.2.599
   Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139
   Comar M, 2012, J CLIN MICROBIOL, V50, P4041, DOI 10.1128/JCM.02105-12
   Combita A, 2013, REV COLOMB CANCEROL, V17, P103, DOI 10.1016/S0123-9015(13)70012-X
   Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4
   Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12
   Cruz MR, 2004, MEM I OSWALDO CRUZ, V99, P281, DOI 10.1590/S0074-02762004000300007
   Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68
   Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214
   de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047
   Fernandes TAADM, 2008, BRAZ J MICROBIOL, V39, P573, DOI 10.1590/S1517-838220080003000031
   de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5
   de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8
   De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033
   Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552
   Dickson EL, 2013, INT J GYNECOL CANCER, V23, P1295, DOI 10.1097/IGC.0b013e31829e9fb4
   Fernandes Jose V, 2010, BMC Res Notes, V3, P96, DOI 10.1186/1756-0500-3-96
   Fernandes JV, 2011, MOL MED REP, V4, P1321, DOI 10.3892/mmr.2011.579
   Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746
   Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05
   Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187
   Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057
   Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038
   Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587
   Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198
   Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8
   Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396
   Londesborough P, 1996, INT J CANCER, V69, P364
   Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1
   Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x
   Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148
   Nielsen A, 2008, SEX TRANSM DIS, V35, P276, DOI 10.1097/OLQ.0b013e31815ac5c7
   Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717
   Pista A, 2011, CLIN MICROBIOL INFEC, V17, P941, DOI 10.1111/j.1469-0691.2010.03387.x
   Quint KD, 2010, GYNECOL ONCOL, V117, P297, DOI 10.1016/j.ygyno.2010.02.003
   Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
   Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006
   Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481
   Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2
   Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054
   Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129
   Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959
   Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X
   XI LF, 1995, J INFECT DIS, V172, P747, DOI 10.1093/infdis/172.3.747
   Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297
   Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997
   Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77
   Zuna RE, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-19
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
   zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046
NR 67
TC 14
Z9 14
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2015
VL 10
IS 7
AR e0132570
DI 10.1371/journal.pone.0132570
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RL
UT WOS:000358197600126
PM 26176537
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Polesello, V
   Zupin, L
   Di Lenarda, R
   Biasotto, M
   Ottaviani, G
   Gobbo, M
   Cecco, L
   Alberi, G
   Pozzato, G
   Crovella, S
   Segat, L
AF Polesello, Vania
   Zupin, Luisa
   Di Lenarda, Roberto
   Biasotto, Matteo
   Ottaviani, Giulia
   Gobbo, Margherita
   Cecco, Luca
   Alberi, Giulia
   Pozzato, Gabriele
   Crovella, Sergio
   Segat, Ludovica
TI Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary
   concentration
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE DEFB1; SNP; Antimicrobial peptide; Saliva
ID HUMAN BETA-DEFENSIN-1 GENE; ANTIMICROBIAL PEPTIDES; TRANSCRIPTION;
   EXPRESSION; DEFENSINS
AB Objectives: Human B-defensin 1 (hBD-1) is an antimicrobial peptide involved in epithelial defence of various tissues, also present in the saliva. Individual genetic variations within the DEFB1 gene, encoding for hBD-1, could influence gene expression and protein production.
   Design: Three DEFB1 polymorphisms at 5' untranslated region (UTR), -52G > A (rs1799946), -44C> G (rs1800972) and -20G > A (rs11362), and two polymorphisms at DEFB1 3' UTR, c*5G > A (rs1047031) and c*87A > G (rs1800971), were analysed by direct sequencing and correlated with hDB-1 salivary concentration (tested with enzyme-linked immunosorbent assay (ELISA)) in 40 healthy subjects.
   Results: Significant associations were found between individuals presenting different DEFB1 polymorphisms at positions -52 and -44 of the gene and hBD-1 salivary concentrations: -52 GIG carriers had higher levels of protein than G/A and A/A; -44C/G subjects showed a higher protein concentration than homozygous wild-type C/C. For the -20G> A, c*5G > A and c*87A > G polymorphisms, no statistically significant differences were found. Combined haplotype analysis confirmed the results obtained considering the single-nucleotide polymorphisms (SNPs) singularly.
   Conclusion: Polymorphisms in the DEFB1 gene influence hBD-1 production and, therefore, could modify the innate immune system responses and, consequently, the oral health. (c) 2015 Elsevier Ltd. All rights reserved.
C1 [Polesello, Vania; Zupin, Luisa; Alberi, Giulia; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Di Lenarda, Roberto; Biasotto, Matteo; Ottaviani, Giulia; Gobbo, Margherita; Cecco, Luca] Univ Trieste, Dent Sci Dept, Div Oral Med & Pathol, Trieste, Italy.
   [Pozzato, Gabriele; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Gobbo, Margherita/ABD-4691-2020; Zupin, Luisa/I-5228-2018; Ottaviani,
   Giulia/W-4164-2019; Crovella, Sergio/K-5050-2016
OI Zupin, Luisa/0000-0001-5886-9129; Ottaviani, Giulia/0000-0002-3427-0514;
   Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485; BIASOTTO, Matteo/0000-0001-6024-6115
FU IRCCS Burlo Garofolo [RC06/11]
FX This work has been funded by a grant from IRCCS Burlo Garofolo
   (RC06/11).
CR Abiko Yoshihiro, 2003, Medical Electron Microscopy, V36, P247, DOI 10.1007/s00795-003-0225-0
   Baltzer SA, 2011, J MOL MICROB BIOTECH, V20, P228, DOI 10.1159/000331009
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Chen HQ, 2006, PEPTIDES, V27, P931, DOI 10.1016/j.peptides.2005.08.018
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001
   Ikuta T, 2013, ODONTOLOGY
   James C, 2014, ARCH DIS CHILD FE S1, V99, pA12
   Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008
   Kalus Andrea A, 2009, BMC Oral Health, V9, P21, DOI 10.1186/1472-6831-9-21
   Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Nurjadi D, 2013, J INFECT DIS, V207, P666, DOI 10.1093/infdis/jis735
   Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021
   R Core Team, 2014, R LANG ENV STAT COMP
   Sahasrabudhe KS, 2000, J DENT RES, V79, P1669, DOI 10.1177/00220345000790090601
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001
   Zhu BD, 2003, ACTA PHARMACOL SIN, V24, P907
NR 22
TC 17
Z9 18
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JUL
PY 2015
VL 60
IS 7
BP 1054
EP 1058
DI 10.1016/j.archoralbio.2015.03.009
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CK3KK
UT WOS:000356114800011
PM 25939140
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Crovella, S
   Celsi, F
AF Tricarico, Paola Maura
   Crovella, Sergio
   Celsi, Fulvio
TI Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A
   Possible Link
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE autophagy; mevalonate pathway; mitochondrial dysfunction; inflammation;
   Mevalonate Kinase Deficiency; statins
ID HMG-COA REDUCTASE; LOVASTATIN-INDUCED APOPTOSIS; ELEMENT-BINDING
   PROTEINS; KINASE-DEFICIENCY; OXIDATIVE STRESS; CANCER-CELLS;
   PHOSPHOMEVALONATE KINASE; IL-1-BETA RELEASE; DENDRITIC CELLS;
   UP-REGULATION
AB The mevalonate pathway, crucial for cholesterol synthesis, plays a key role in multiple cellular processes. Deregulation of this pathway is also correlated with diminished protein prenylation, an important post-translational modification necessary to localize certain proteins, such as small GTPases, to membranes. Mevalonate pathway blockade has been linked to mitochondrial dysfunction: especially involving lower mitochondrial membrane potential and increased release of pro-apoptotic factors in cytosol. Furthermore a severe reduction of protein prenylation has also been associated with defective autophagy, possibly causing inflammasome activation and subsequent cell death. So, it is tempting to hypothesize a mechanism in which defective autophagy fails to remove damaged mitochondria, resulting in increased cell death. This mechanism could play a significant role in Mevalonate Kinase Deficiency, an autoinflammatory disease characterized by a defect in Mevalonate Kinase, a key enzyme of the mevalonate pathway. Patients carrying mutations in the MVK gene, encoding this enzyme, show increased inflammation and lower protein prenylation levels. This review aims at analysing the correlation between mevalonate pathway defects, mitochondrial dysfunction and defective autophagy, as well as inflammation, using Mevalonate Kinase Deficiency as a model to clarify the current pathogenetic hypothesis as the basis of the disease.
C1 [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, I-34128 Trieste, Italy.
   [Crovella, Sergio; Celsi, Fulvio] Inst Maternal & Child Hlth Burlo Garofolo, I-34137 Trieste, Italy.
RP Tricarico, PM (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Piazzale Europa 1, I-34128 Trieste, Italy.
EM paola.tricarico@burlo.trieste.it; sergio.crovella@burlo.trieste.it;
   fulvio.celsi@gmail.com
RI Crovella, Sergio/K-5050-2016; tricarico, paola/AAB-8972-2019
OI Crovella, Sergio/0000-0001-8493-1168; tricarico,
   paola/0000-0002-1954-4126
FU Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"-Trieste,
   Italy [RC 42/2011]
FX This study was supported by a grant from the Institute for Maternal and
   Child Health-IRCCS "Burlo Garofolo"-Trieste, Italy (RC 42/2011).
CR Agarwal B, 1999, CLIN CANCER RES, V5, P2223
   Alegret M, 2006, METHOD FIND EXP CLIN, V28, P627, DOI 10.1358/mf.2006.28.9.1003573
   Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463
   Araki M, 2012, EUR J PHARMACOL, V674, P95, DOI 10.1016/j.ejphar.2011.10.044
   AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907
   Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005
   Bartolome A, 2014, DIABETES, V63, P2996, DOI 10.2337/db13-0970
   Bento CF, 2013, J CELL SCI, V126, P1059, DOI 10.1242/jcs.123075
   Bergamini E, 2004, J ALZHEIMERS DIS, V6, P129
   Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011
   Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022
   Bodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922
   Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018
   Boonsri P, 2013, BIOCHEM BIOPH RES CO, V430, P313, DOI 10.1016/j.bbrc.2012.10.130
   Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052
   Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   CIOSEK CP, 1993, J BIOL CHEM, V268, P24832
   CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077
   Dursun S, 2014, ANATOL J CARDIOL, V14, P229, DOI 10.5152/akd.2013.4708
   ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346
   Galeotti C, 2012, RHEUMATOLOGY, V51, P1855, DOI 10.1093/rheumatology/kes097
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009
   Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911
   Hinson DD, 1997, J LIPID RES, V38, P2216
   HOFFMANN GF, 1993, PEDIATRICS, V91, P915
   Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091
   Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009
   Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344
   Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li YJ, 2014, PHARMAZIE, V69, P610, DOI 10.1691/ph.2014.4508
   Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204
   Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883
   Murphy C, 2007, BIOCHEM BIOPH RES CO, V355, P359, DOI 10.1016/j.bbrc.2007.01.155
   Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208
   Olivier LM, 1999, J LIPID RES, V40, P672
   Olsson AG, 2002, AM HEART J, V144, P1044, DOI 10.1067/mhj.2002.128049
   Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011
   Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110
   Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773
   Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036
   Schointuch MN, 2014, GYNECOL ONCOL, V134, P346, DOI 10.1016/j.ygyno.2014.05.015
   Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212
   Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
   Shepherd J., 2002, LANCET, V23, P360
   Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Simon A, 2004, NEUROLOGY, V62, P994, DOI 10.1212/01.WNL.0000115390.33405.F7
   Sirvent P, 2008, CURR OPIN PHARMACOL, V8, P333, DOI 10.1016/j.coph.2007.12.010
   Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4
   Tavintharan S, 2007, TOXICOL APPL PHARM, V223, P173, DOI 10.1016/j.taap.2007.05.013
   Tricarico PM, 2014, INT J MOL SCI, V15, P6843, DOI 10.3390/ijms15046843
   Tricarico PM, 2013, INT J MOL SCI, V14, P23274, DOI 10.3390/ijms141223274
   van der Burgh R, 2014, J BIOL CHEM, V289, P27757, DOI 10.1074/jbc.M114.571810
   van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920
   Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081
   Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111
   Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612
   Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476
   Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.103
NR 80
TC 45
Z9 46
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2015
VL 16
IS 7
BP 16067
EP 16084
DI 10.3390/ijms160716067
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CP5CY
UT WOS:000359900100098
PM 26184189
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Kleiner, G
   Zanin, V
   Monasta, L
   Crovella, S
   Caruso, L
   Milani, D
   Marcuzz, A
AF Kleiner, Giulio
   Zanin, Valentina
   Monasta, Lorenzo
   Crovella, Sergio
   Caruso, Lorenzo
   Milani, Daniela
   Marcuzz, Annalisa
TI Pediatric patients with inflammatory bowel disease exhibit increased
   serum levels of proinflammatory cytokines and chemokines, but decreased
   circulating levels of macrophage inhibitory protein-1 beta,
   interleukin-2 and interleukin-17
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE inflammatory bowel disease; cytokines; chemokines
ID CROHNS-DISEASE; TH17 CELLS; TH17-RELATED CYTOKINES; EXPRESSION; IL-17;
   IBD; DIAGNOSIS; IMMUNITY; COLITIS; RANTES
AB Inflammatory bowel disease (IBD) is a chronic and progressive inflammatory condition of the gastrointestinal tract. Although the causative events that lead to the onset of IBD are yet to be fully elucidated, deregulation of immune and inflammatory mechanisms are hypothesized to significantly contribute to this disorder. Since the onset of IBD is often during infancy, in the present study, the serum values of a large panel of cytokines and chemokines in pediatric patients (<18 years; n=26) were compared with age-matched controls (n=37). While elevations in the serum level of several proinflammatory and immune regulating cytokines were confirmed, such as interleukin (IL)-1 beta, IL-5, IL-7, interferon (IFN)-gamma-inducible protein-10, IL-16, cutaneous T-cell-attracting chemokine, leukemia inhibitory factor, monokine induced by gamma-IFN, IFN-alpha 2 and IFN-gamma, notably decreased levels of IL-2, IL-17 and macrophage inhibitory protein-1 beta were also observed. Therefore, while a number of proinflammatory cytokines exhibit increased levels in IBD patients, pediatric IBD patients may also exhibit certain aspects of a reduced immunological response.
C1 [Kleiner, Giulio; Zanin, Valentina; Monasta, Lorenzo; Crovella, Sergio; Marcuzz, Annalisa] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy.
   [Caruso, Lorenzo; Milani, Daniela] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy.
RP Kleiner, G (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Trials, Via Istria 65-1, I-34137 Trieste, Italy.
EM giulio.kleiner@burlo.trieste.it
RI Monasta, Lorenzo/B-1388-2012; Crovella, Sergio/K-5050-2016; Milani,
   Daniela/G-5579-2015
OI Monasta, Lorenzo/0000-0001-7774-548X; Crovella,
   Sergio/0000-0001-8493-1168; Milani, Daniela/0000-0002-9540-7801;
   Marcuzzi, Annalisa/0000-0003-3427-618X; Kleiner,
   Giulio/0000-0002-1830-3961
FU Institute for Maternal and Child Health - IRCCS 'Burlo Garofolo' [RC
   40/2011]
FX This study was supported by a grant from the Institute for Maternal and
   Child Health - IRCCS 'Burlo Garofolo' (no. RC 40/2011).
CR Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245
   Bianco AM, 2014, GUT, V63, P1367, DOI 10.1136/gutjnl-2013-306555
   Cassinotti A, 2014, AUTOIMMUN REV, V13, P1, DOI 10.1016/j.autrev.2013.06.007
   Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]
   Damen GM, 2006, J PEDIATR GASTR NUTR, V42, P142, DOI 10.1097/01.mpg.0000189336.70021.8a
   Del Zotto B, 2003, CLIN EXP IMMUNOL, V134, P120, DOI 10.1046/j.1365-2249.2003.02250.x
   Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014
   Fitzpatrick LR, 2013, INT REV IMMUNOL, V32, P544, DOI 10.3109/08830185.2013.821118
   Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236
   Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004
   Grimm MC, 1996, INFLAMM BOWEL DIS, V2, P88, DOI 10.1002/ibd.3780020204
   Heikenen JB, 1999, INFLAMM BOWEL DIS, V5, P158, DOI 10.1097/00054725-199908000-00002
   Jiang WY, 2014, INFLAMM RES, V63, P943, DOI 10.1007/s00011-014-0768-7
   Katz LH, 2014, CLIN RES HEPATOL GAS, V38, P491, DOI 10.1016/j.clinre.2014.01.010
   Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058
   Marcuzzi A, 2012, GENE, V493, P282, DOI 10.1016/j.gene.2011.11.043
   Marion R, 2004, CLIN NUTR, V23, P579, DOI 10.1016/j.clnu.2003.10.011
   Mayer L, 2014, GUT, V63, P442, DOI 10.1136/gutjnl-2012-303424
   Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4
   Monteleone I, 2012, CURR MOL MED, V12, P592, DOI 10.2174/156652412800620066
   Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661
   Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831
   Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]
   Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528
   Scaldaferri F, 2007, J DIGEST DIS, V8, P171, DOI 10.1111/j.1751-2980.2007.00310.x
   Seegert D, 2001, GUT, V48, P326, DOI 10.1136/gut.48.3.326
   Seow CH, 2008, COCHRANE DB SYST REV, V3
   Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230
   Tillack C, 2014, GUT, V63, P567, DOI 10.1136/gutjnl-2012-302853
   Tisato V, 2013, CYTOKINE, V63, P92, DOI 10.1016/j.cyto.2013.04.018
   Tisato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039543
   Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709
   Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004
   Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6
   WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002
NR 35
TC 8
Z9 10
U1 0
U2 1
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JUN
PY 2015
VL 9
IS 6
BP 2047
EP 2052
DI 10.3892/etm.2015.2370
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CJ4ZI
UT WOS:000355496800004
PM 26136934
OA Other Gold, Green Published
DA 2020-12-08
ER

PT J
AU Catamo, E
   Addobbati, C
   Segat, L
   Fragoso, TS
   Dantas, AT
   Mariz, HD
   Ferreira da Rocha Junior, L
   Branco PintoDuarte, AL
   Coelho, AVC
   de Moura, RR
   Polesello, V
   Crovella, S
   Sandrin Garcia, P
AF Catamo, E.
   Addobbati, C.
   Segat, L.
   Sotero Fragoso, T.
   Tavares Dantas, A.
   de Ataide Mariz, H.
   Ferreira da Rocha Junior, L.
   Branco PintoDuarte, A. L.
   Coelho, A. V. C.
   de Moura, R. R.
   Polesello, V.
   Crovella, S.
   Sandrin Garcia, P.
TI Comprehensive analysis of polymorphisms in the HLA-G 5 ' upstream
   regulatory and 3 ' untranslated regions in Brazilian patients with
   systemic lupus erythematosus
SO TISSUE ANTIGENS
LA English
DT Article
DE human leukocyte antigen-G; mRNA stability; polymorphisms; systemic lupus
   erythematosus
ID G MESSENGER-RNA; G EXPRESSION; ASSOCIATION; GENE; POPULATION; DISEASE;
   CELLS; RISK; CLASSIFICATION; CRITERIA
AB This study aims to comprehensively analyze human leucocyte antigen (HLA)-G polymorphisms association with susceptibility to systemic lupus erythematosus (SLE) development and clinical manifestations. The HLA-G 5 upstream regulatory region (URR), 3 untranslated region (UTR) and a cytosine deletion at exon 3 (C, HLA-G*0105N allele) were analyzed in 114 SLE patients and 128 healthy controls from North East Brazil. The +3003T>C (rs1707) C allele and the HG010101c extended HLA-G allele were significantly more frequent in SLE patients than healthy controls (+3003C allele frequency: 12% in SLE patients vs 6% in controls; odds ratio (OR), 2.10, 95% confidence interval (CI), 1.06-4.28, P=0.026; HG010101c frequency: 11.8% in SLE patients and 6.3% in controls; OR, 2.14, 95% CI, 1.01-4.51, P=0.046) and were associated with susceptibility for disease development. Other polymorphisms were associated with different clinical manifestations. Although HLA-G role in SLE disease is far from being elucidated yet, our association study results along with a systematic review and meta-analysis suggest that HLA-G might be able to slightly modulate the complex SLE phenotype (pooled OR, 1.14, 95% CI, 1.02-1.27, P=0.021).
C1 [Catamo, E.] Univ Trieste, Trieste, Italy.
   [Addobbati, C.; Sotero Fragoso, T.; Branco PintoDuarte, A. L.; Coelho, A. V. C.; de Moura, R. R.; Sandrin Garcia, P.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Segat, L.; Polesello, V.; Crovella, S.] IRCCS Burlo Garofolo, Trieste, Italy.
   [Tavares Dantas, A.; de Ataide Mariz, H.; Ferreira da Rocha Junior, L.] Hosp Clin, Rheumatol Resident, Recife, PE, Brazil.
   [Crovella, S.] Human Genet Univ Trieste, Trieste, Italy.
RP Catamo, E (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, Trieste, Italy.
EM eulalia.catamo@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015; Moura, Ronald/AAE-2318-2020;
   Crovella, Sergio/K-5050-2016; Moura, Ronald/F-7769-2012; Catamo,
   Eulalia/K-9399-2016
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Moura,
   Ronald/0000-0002-9112-7167; Crovella, Sergio/0000-0001-8493-1168; Moura,
   Ronald/0000-0002-9112-7167; Catamo, Eulalia/0000-0002-4701-9134; Segat,
   Ludovica/0000-0002-6024-1485; Sotero Fragoso, Thiago/0000-0002-0192-0760
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [552195/2011-1, 471942/2010-3]; Italian Ministry of
   HealthMinistry of Health, Italy [RC06/11]; IRCCS Burlo Garfolo RC, Italy
   [06/11]
FX This work has been supported by the Brazilian National Counsel of
   Technological and Scientific Development (CNPq) with grants no.
   552195/2011-1, no. 471942/2010-3, and grants by Italian Ministry of
   Health grant RC06/11, a fellowship from IRCCS Burlo Garfolo RC 06/11,
   Italy.
CR Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6
   Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4
   Carosella ED, 2008, HUM IMMUNOL, V69, P700, DOI 10.1016/j.humimm.2008.08.280
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138
   Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028
   Consiglio CR, 2011, TISSUE ANTIGENS, V77, P540, DOI 10.1111/j.1399-0039.2011.01635.x
   Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027
   Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338
   Gomez-Casado E, 1999, CELL MOL LIFE SCI, V56, P356, DOI 10.1007/s000180050436
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hviid TVF, 2006, SARCOIDOSIS VASC DIF, V23, P30
   Khosrotehrani K, 2001, J INVEST DERMATOL, V117, P750, DOI 10.1046/j.0022-202x.2001.01487.x
   Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764
   Lucena-Silva N, 2013, J RHEUMATOL, V40, P1104, DOI 10.3899/jrheum.120814
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Murphy G, 2013, RHEUMATOLOGY, V52, P2108, DOI 10.1093/rheumatology/ket160
   Park KS, 2007, TISSUE ANTIGENS, V69, P139, DOI 10.1111/j.1399-0039.2006.00742.x
   Renaudineau Y, 2004, AUTOIMMUN REV, V3, P516, DOI 10.1016/j.autrev.2004.07.035
   Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x
   Rothstein H, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, pIX
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Suryanarayana V, 2008, REPROD SCI, V15, P817, DOI 10.1177/1933719107314061
   Takeuchi T, 2004, INT REV IMMUNOL, V23, P273, DOI 10.1080/08830180490452594
   Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Veit TD, 2008, TISSUE ANTIGENS, V71, P440, DOI 10.1111/j.1399-0039.2008.01019.x
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Wu FX, 2009, LUPUS, V18, P1259, DOI 10.1177/0961203309345756
   Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059
NR 30
TC 8
Z9 8
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD JUN
PY 2015
VL 85
IS 6
BP 458
EP 465
DI 10.1111/tan.12545
PG 8
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA CH6DW
UT WOS:000354127500003
PM 25762019
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Casalicchio, G
   Freato, N
   Maestri, I
   Comar, M
   Crovella, S
   Segat, L
AF Zupin, Luisa
   Polesello, Vania
   Casalicchio, Giorgia
   Freato, Nadia
   Maestri, Iva
   Comar, Manola
   Crovella, Sergio
   Segat, Ludovica
TI MBL2 Polymorphisms in Women With Atypical Squamous Cells of Undetermined
   Significance
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE SNPs; HPV infection; MBL; innate immunity
ID MANNOSE-BINDING LECTIN; HUMAN-PAPILLOMAVIRUS INFECTION; GENE
   POLYMORPHISMS; IMMUNE-RESPONSES; CERVICAL-CANCER; HPV INFECTION;
   SUSCEPTIBILITY; COMPLEMENT; SYSTEM; VARIANTS
AB Infection with high risk Human papillomavirus (HPV) is the main known cause of cervical cancer. HPV induces different grades of lesions: among them, Atypical squamous cells of undetermined significance are abnormal lesions that could evolve in pre-cancer lesions or spontaneously regress. The mannose binding lectin (MBL) is an innate immunity serum protein also found in cervico-vaginal mucosa, whose expression is known to be affected by polymorphisms in exon 1 and promoter of the MBL2 gene. In the present study the possible association between MBL2 functional polymorphisms and susceptibility to develop atypical squamous cells of undetermined significance was investigated in a group of women from North-East of Italy, stratified for HPV infection status. The MBL2 D and O alleles and the deficient producer combined genotypes, responsible for low MBL production, were more represented among atypical squamous cells of undetermined significance positive women than healthy controls and the results were confirmed when only HPV negative samples were considered. These results suggest a possible involvement of MBL2 functional polymorphisms in atypical squamous cells of undetermined significance susceptibility. J. Med. Virol. 87:851-859, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Zupin, Luisa; Polesello, Vania; Casalicchio, Giorgia; Comar, Manola; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Freato, Nadia; Comar, Manola; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Maestri, Iva] Univ Ferrara, Sect Pathol Anat, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018; Comar,
   Manola/K-4613-2016; COMAR, Manola/K-4613-2016
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Comar, Manola/0000-0001-6310-3320; maestri, iva/0000-0002-3485-4640;
   COMAR, Manola/0000-0002-9487-861X; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC06/11]; Friuli Venezia Region [R3A2]
FX Grant Sponsor: IRCCS Burlo Garofolo; Grant number: RC06/11; Grant
   Sponsor: Friuli Venezia Region; Grant number:
   R<SUP>3</SUP>A<SUP>2</SUP>.
CR Asiaf A, 2014, EUR J CANCER PREV, V23, P206, DOI 10.1097/CEJ.0b013e328364f273
   Bierl C, 2005, GYNECOL ONCOL, V99, pS262, DOI 10.1016/j.ygyno.2005.07.100
   Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200
   Coelho AVC, 2013, J MED VIROL, V85, P1829, DOI 10.1002/jmv.23656
   Carvalho JK, 2013, SAO PAULO MED J, V131, P338, DOI 10.1590/1516-3180.2013.1315519
   Casalicchio G, 2014, J MED VIROL, V86, P1999, DOI 10.1002/jmv.23878
   Chironna M, 2010, J Prev Med Hyg, V51, P139
   Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026
   Downing I, 2005, SCAND J IMMUNOL, V62, P507, DOI 10.1111/j.1365-3083.2005.01693.x
   Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
   Evans-Osses I, 2013, SCI WORLD J, DOI 10.1155/2013/675898
   Ferraroni NR, 2012, INT J IMMUNOGENET, V39, P32, DOI 10.1111/j.1744-313X.2011.01052.x
   FUJITA T, 1995, JPN J CANCER RES, V86, P187, DOI 10.1111/j.1349-7006.1995.tb03038.x
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   Goncalves AKS, 2006, EUR J OBSTET GYN R B, V124, P227, DOI 10.1016/j.ejogrb.2005.06.028
   Guimaraes V, 2008, HUM IMMUNOL, V69, P273, DOI 10.1016/j.humimm.2008.03.002
   Guzzetta G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091698
   Han CP, 1997, CANCER LETT, V120, P217, DOI 10.1016/S0304-3835(97)00312-1
   Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002
   HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8
   IKEDA K, 1987, J BIOL CHEM, V262, P7451
   Ingels C, 2014, PEDIATR RES, V75, P99, DOI 10.1038/pr.2013.180
   Jha AN, 2014, INFECT IMMUN, V82, P52, DOI 10.1128/IAI.01041-13
   Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200
   Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32
   Lu S, 2013, INT J CANCER, V133, P2325, DOI 10.1002/ijc.28251
   LUFF R, 1992, AM J SURG PATHOL, V16, P914
   Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Muto S, 2001, BBA-GEN SUBJECTS, V1527, P39, DOI 10.1016/S0304-4165(01)00136-2
   Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888
   Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7
   Nguyen HH, 2005, GYNECOL ONCOL, V96, P452, DOI 10.1016/j.ygyno.2004.10.019
   NIELSEN SL, 1995, CLIN EXP IMMUNOL, V100, P219
   Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226
   Parrella P, 2007, EUR J EPIDEMIOL, V22, P159, DOI 10.1007/s10654-007-9111-8
   R Core Team, 2014, R LANG ENV STAT COMP
   Ramos GP, 2013, HUM IMMUNOL, V74, P67, DOI 10.1016/j.humimm.2012.09.008
   Rassu M, 2005, SCAND J INFECT DIS, V37, P476, DOI 10.1080/00365540510036633
   Reading PC, 1995, BIOCHEM BIOPH RES CO, V217, P1128, DOI 10.1006/bbrc.1995.2886
   Rezza G, 1997, EUR J EPIDEMIOL, V13, P937, DOI 10.1023/A:1007466908865
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861
   Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666
   Sasagawa T, 2012, J INFECT CHEMOTHER, V18, P807, DOI 10.1007/s10156-012-0485-5
   Schmiegelow K, 2002, BLOOD, V100, P3757, DOI 10.1182/blood-2002-06-1627
   Segat L, 2009, HUM IMMUNOL, V70, P436, DOI 10.1016/j.humimm.2009.03.006
   Shrestha S, 2007, CANCER EPIDEM BIOMAR, V16, P1626, DOI 10.1158/1055-9965.EPI-06-0881
   Smith JHF, 2002, CYTOPATHOLOGY, V13, P4, DOI 10.1046/j.1365-2303.2002.00397.x
   Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   St Jwierzko A, 2007, CANCER IMMUNOL IMMUN, V56, P959, DOI 10.1007/s00262-006-0250-7
   Swierzko AS, 2013, MOL IMMUNOL, V55, P16, DOI 10.1016/j.molimm.2012.09.005
   Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]
   Tang YQ, 2012, BBA-PROTEINS PROTEOM, V1824, P253, DOI 10.1016/j.bbapap.2011.05.021
   Terai I, 2003, EUR J IMMUNOL, V33, P2755, DOI 10.1002/eji.200323955
   Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113
   Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0
   Tulio S, 2011, HUM IMMUNOL, V72, P912, DOI 10.1016/j.humimm.2011.06.016
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003
   Wan QQ, 2013, TRANSPL P, V45, P3289, DOI 10.1016/j.transproceed.2013.05.008
   Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064
   Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520
   zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046
NR 70
TC 2
Z9 2
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2015
VL 87
IS 5
BP 851
EP 859
DI 10.1002/jmv.24080
PG 9
WC Virology
SC Virology
GA CE0AW
UT WOS:000351465000017
PM 25693844
DA 2020-12-08
ER

PT J
AU De Pieri, C
   Vuch, J
   De Martino, E
   Bianco, AM
   Ronfani, L
   Athanasakis, E
   Bortot, B
   Crovella, S
   Taddio, A
   Severini, GM
   Tommasini, A
AF De Pieri, Carlo
   Vuch, Josef
   De Martino, Eleonora
   Bianco, Anna M.
   Ronfani, Luca
   Athanasakis, Emmanouil
   Bortot, Barbara
   Crovella, Sergio
   Taddio, Andrea
   Severini, Giovanni M.
   Tommasini, Alberto
TI Genetic profiling of autoinflammatory disorders in patients with
   periodic fever: a prospective study
SO PEDIATRIC RHEUMATOLOGY
LA English
DT Article
DE Auto-inflammatory diseases; Periodic fever syndromes; Genetics
ID FAMILIAL MEDITERRANEAN FEVER; ARTICULAR SYNDROME; SOMATIC MOSAICISM;
   MEFV MUTATIONS; DISEASES; DIAGNOSIS; CHILDREN; VARIANT; MULTICENTER;
   POPULATION
AB Background: Periodic fever syndromes (PFS) are an emerging group of autoinflammatory disorders. Clinical overlap exists and multiple genetic analyses may be needed to assist diagnosis. We evaluated the diagnostic value of a 5-gene sequencing panel (5GP) in patients with undiagnosed PFS.
   Methods: Simultaneous double strand Sanger sequencing of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12 genes was performed in 42 patients with unexplained PFS. Clinical features were correlated with genetic results.
   Results: None of 42 patients analyzed displayed a causative genotype. However, single or multiple genetic variants of uncertain significance were detected in 24 subjects. Only in 5 subjects a definite diagnosis was made by taking into account both genetic and clinical data (2 TRAPS syndrome; 2 FMF; 1 FCAS). Statistical analysis showed that patients carrying genetic variants in one or more of the five selected genes displayed a significantly lower response to glucocorticoids compared with subjects who had completely negative genetic results.
   Conclusions: The sequencing of multiple genes is of little help in the diagnostics of PFS and can often lead to results of uncertain interpretation, thus the clinically driven sequencing of single genes should remain the recommended approach. However, the presence of single or multiple genetic variants of uncertain significance, even if not allowing any specific diagnosis, correlated with a poorer response to glucocorticoids, possibly indicating a multifactorial subgroup of PFS with differential response to pharmacological treatment.
C1 [De Pieri, Carlo; De Martino, Eleonora; Bianco, Anna M.; Ronfani, Luca; Athanasakis, Emmanouil; Bortot, Barbara; Crovella, Sergio; Taddio, Andrea; Severini, Giovanni M.; Tommasini, Alberto] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Vuch, Josef; Crovella, Sergio; Taddio, Andrea] Univ Trieste, Trieste, Italy.
RP Taddio, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
EM andrea.taddio@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Tommasini, Alberto/AAE-3882-2020; Ronfani,
   Luca/B-6668-2013; BIANCO, ANNA MONICA/D-3098-2014; Athanasakis,
   Emmanouil/K-1326-2018
OI Crovella, Sergio/0000-0001-8493-1168; Tommasini,
   Alberto/0000-0002-6943-7927; Ronfani, Luca/0000-0001-5710-3914; BIANCO,
   ANNA MONICA/0000-0001-8101-9659; Athanasakis,
   Emmanouil/0000-0002-7707-2665; DE MARTINO, ELEONORA/0000-0003-0733-7231;
   De Pieri, Carlo/0000-0002-3138-3070; Taddio, Andrea/0000-0001-6817-4953
FU IRCCS Burlo Garofolo [RC36/11]; project "Genetic profiling of periodic
   fever" of the "Associazione Azzurra Malattie Rare"
FX The study was funded by the research grant #RC36/11 of the IRCCS Burlo
   Garofolo and by the project "Genetic profiling of periodic fever" of the
   "Associazione Azzurra Malattie Rare".
CR Aldea A, 2004, AM J MED GENET A, V124A, P67, DOI 10.1002/ajmg.a.20296
   Arostegui JI, 2010, ARTHRITIS RHEUM-US, V62, P1158, DOI 10.1002/art.27342
   Bader-Meunier B, 2011, PEDIATRICS, V128, pE152, DOI 10.1542/peds.2010-3639
   Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919
   Berkun Y, 2014, AUTOIMMUN REV, V13, P388, DOI 10.1016/j.autrev.2014.01.045
   Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858
   Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326
   Bortot B, 2011, DIAGN MOL PATHOL, V20, P175, DOI 10.1097/PDM.0b013e31820b34fb
   Chandrakasan S, 2014, J CLIN IMMUNOL, V34, P104, DOI 10.1007/s10875-013-9960-8
   De Pieri C, 2014, CLIN EXP RHEUMATOL, V32, P993
   Federici S, 2014, BEST PRACT RES CL RH, V28, P263, DOI 10.1016/j.berh.2014.05.005
   Federici S, 2012, ANN RHEUM DIS, V71, P1961, DOI 10.1136/annrheumdis-2011-200977
   Gattorno M, 2008, ARTHRITIS RHEUM-US, V58, P1823, DOI 10.1002/art.23474
   Gattorno M, 2009, PEDIATRICS, V124, pE721, DOI 10.1542/peds.2009-0088
   Giaglis S, 2007, CLIN GENET, V71, P458, DOI 10.1111/j.1399-0004.2007.00789.x
   Henke W, NUCL ACIDS RES
   Hofer M, 2014, RHEUMATOLOGY, V53, P1125, DOI 10.1093/rheumatology/ket460
   Kubota K, 2013, J CLIN IMMUNOL, V33, P325, DOI 10.1007/s10875-012-9805-x
   McDermott MF, 2002, CURR OPIN ALLERGY CL, V2, P511, DOI 10.1097/00130832-200212000-00006
   Nakagawa K, 2013, ARTHRITIS RHEUM
   Ozen S, 2014, NAT REV RHEUMATOL, V10, P135, DOI 10.1038/nrrheum.2013.174
   Saito M, 2005, ARTHRITIS RHEUM-US, V52, P3579, DOI 10.1002/art.21404
   Savic S, 2011, CLIN MED, V11, P396, DOI 10.7861/clinmedicine.11-4-396
   Savic S, 2012, BEST PRACT RES CL RH, V26, P505, DOI 10.1016/j.berh.2012.07.009
   Shinar Y, 2012, ANN RHEUM DIS, V71, P1599, DOI 10.1136/annrheumdis-2011-201271
   Stoffels M, 2014, ANN RHEUM DIS, V73, P455, DOI 10.1136/annrheumdis-2012-202580
   Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512
   Timerman D, 2013, JCR-J CLIN RHEUMATOL, V19, P452, DOI 10.1097/RHU.0000000000000044
   Toplak N, 2012, ANN RHEUM DIS, V71, P1177, DOI 10.1136/annrheumdis-2011-200549
   Touitou I, 2008, BEST PRACT RES CL RH, V22, P811, DOI 10.1016/j.berh.2008.08.009
   Verma D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034977
   Zeft AS, 2012, CLEV CLIN J MED, V79, P569, DOI 10.3949/ccjm.79a.11184
NR 32
TC 13
Z9 13
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1546-0096
J9 PEDIATR RHEUMATOL
JI Pediatr. Rheumatol.
PD APR 10
PY 2015
VL 13
AR 11
DI 10.1186/s12969-015-0006-z
PG 8
WC Pediatrics; Rheumatology
SC Pediatrics; Rheumatology
GA CF5LN
UT WOS:000352598700001
PM 25866490
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Coelho, AVC
   Boniotto, M
   Arraes, LC
   Segat, L
   Crovella, S
AF Zupin, Luisa
   Polesello, Vania
   Campos Coelho, Antonio Victor
   Boniotto, Michele
   Arraes, Luiz Claudio
   Segat, Ludovica
   Crovella, Sergio
TI Lactotransferrin gene functional polymorphisms do not influence
   susceptibility to human immunodeficiency virus-1 mother-to-child
   transmission in different ethnic groups
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE AIDS; HIV-1; innate immunity; lactoferrin; SNPs; vertical transmission
ID SINGLE-NUCLEOTIDE POLYMORPHISM; LTF GENE; AGGRESSIVE PERIODONTITIS;
   CIRCULATING LACTOFERRIN; MILK-PROTEINS; HIV; ASSOCIATION; TYPE-1;
   POPULATION; INFECTION
AB Lactotransferrin, also known as lactoferrin, is an iron binding glycoprotein that displays antiviral activity against many different infectious agents, including human immunodeficiency virus (HIV)-1. Lactotransferrin is present in the breast milk and in the female genitourinary mucosa and it has been hypothesised as a possible candidate to prevent mother- to-child HIV-1 transmission. To verify if two functional polymorphisms, Thr29Ala and Arg47Lys, in the lactotransferrin encoding gene (LTF) could affect HIV-1 infection and vertical transmission, a preliminary association study was performed in 238 HIV-1 positive and 99 HIV-1 negative children from Brazil, Italy, Africa and India. No statistically significant association for the Thr29Ala and Arg47Lys LTF polymorphisms and HIV-1 susceptibility in the studied populations was found. Additionally LTF polymorphisms frequencies were compared between the four different ethnic groups.
C1 [Zupin, Luisa; Polesello, Vania; Segat, Ludovica; Crovella, Sergio] Hospitalizat & Care Burlo Garofolo, Inst Maternal & Child Hlth, Sci Inst Res, Trieste, Italy.
   [Campos Coelho, Antonio Victor] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Boniotto, Michele] Univ Paris Est Creteil, Natl Inst Hlth & Med Res, Fac Med, Creteil, France.
   [Arraes, Luiz Claudio] Inst Med Integrada Prof Fernando Figueira, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Segat, L (corresponding author), Hospitalizat & Care Burlo Garofolo, Inst Maternal & Child Hlth, Sci Inst Res, Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; Coelho, Antonio Victor C/E-6795-2015;
   Zupin, Luisa/I-5228-2018; Crovella, Sergio/K-5050-2016; Boniotto,
   Michele/AAB-4302-2020
OI Boniotto, Michele/0000-0002-9548-2254; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Zupin, Luisa/0000-0001-5886-9129; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
FU Italian Ministry of HealthMinistry of Health, Italy; IRCCS Burlo
   Garofolo
FX Italian Ministry of Health (RC 2007) (FVG 2006) LZ and VP have
   fellowships from IRCCS Burlo Garofolo.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Alves TP, 2014, ARCH ORAL BIOL, V59, P775, DOI 10.1016/j.archoralbio.2014.04.010
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011
   Berkhout B, 2002, ANTIVIR RES, V55, P341, DOI 10.1016/S0166-3542(02)00069-4
   Cao LQ, 2011, ACTA BIOCH BIOPH SIN, V43, P884, DOI 10.1093/abbs/gmr089
   Clayton D, 2013, SNPSTATS SNPMATRIX X
   Dapsanse V, 2001, AIDS RES HUM RETROV, V17, P1041, DOI 10.1089/088922201300343726
   DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134
   DEFER MC, 1995, CELL MOL BIOL, V41, P417
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Ferreira SM, 2014, J INVESTIG CLIN DENT, V6, P16
   Fine DH, 2013, INFECT IMMUN, V81, P1596, DOI 10.1128/IAI.01063-12
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005
   Jordan WJ, 2005, GENES IMMUN, V6, P632, DOI 10.1038/sj.gene.6364239
   Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05
   Legardy-Williams JK, 2010, CLIN PERINATOL, V37, P777, DOI 10.1016/j.clp.2010.08.013
   Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943
   Ng TB, 2001, LIFE SCI, V69, P2217, DOI 10.1016/S0024-3205(01)01311-X
   R Development Core Team, 2014, R LANG ENV STAT COMP
   SCHANBACHER FL, 1993, J DAIRY SCI, V76, P3812, DOI 10.3168/jds.S0022-0302(93)77725-5
   Semba RD, 1998, AIDS, V12, P331
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Teng CT, 2006, BIOCHEM CELL BIOL, V84, P381, DOI 10.1139/O06-035
   van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4
   Velliyagounder K, 2003, INFECT IMMUN, V71, P6141, DOI 10.1128/IAI.71.11.6141-6147.2003
   Videm V, 2012, HUM IMMUNOL, V73, P554, DOI 10.1016/j.humimm.2012.02.014
   WHO - World Health Organization, 2013, GLOB SUMM HIV EP
   Wong JH, 2014, PEPTIDES, V62, P183, DOI 10.1016/j.peptides.2014.07.006
   Wu YM, 2009, J PERIODONTAL RES, V44, P418, DOI 10.1111/j.1600-0765.2008.01120.x
   Zhou YH, 2012, MED ONCOL, V29, P1456, DOI 10.1007/s12032-011-0079-6
NR 34
TC 3
Z9 3
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2015
VL 110
IS 2
BP 222
EP 229
DI 10.1590/0074-02760140447
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CH5HN
UT WOS:000354066400009
PM 25946246
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Moura, R
   Tricarico, PM
   Coelho, AVC
   Crovella, S
AF Moura, Ronald
   Tricarico, Paola Maura
   Campos Coelho, Antonio Victor
   Crovella, Sergio
TI GRID2 a novel gene possibly associated with mevalonate kinase deficiency
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Article
DE Mevalonate kinase deficiency; Exome analysis; GRID2 gene
ID CEREBELLAR-ATAXIA
AB Mevalonate kinase deficiency (MKD) is a rare autosomal disease caused by mutations in the mevalonate kinase gene (MVK). The genotype-phenotype correlation is sometimes problematic due to the great genetic and clinical heterogeneity; so we hypothesize that genes other than MVK are able to modulate MKD clinical phenotypes. This hypothesis was tested by analyzing the exome of 22 patients with MKD all carrying MVK gene mutations, and 20 patients with recurrent fevers (RF) not carrying MVK mutations. Our preliminary findings suggest a possible role of GRID2 in the susceptibility to develop MKD. GRID2 gene (4q22.2), encoding for human glutamate receptor delta-2, associated with MKD: The rs1450500 SNP was differently distributed in patients with MKD with respect to those with RF. Being aware of the small number of patients analyzed, we hypothesized a possible role for GRID2 as possible phenotype modifier in MKD patients, especially in those with severe phenotypes.
C1 [Moura, Ronald; Campos Coelho, Antonio Victor] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Tricarico, Paola Maura] Univ Trieste, I-34128 Trieste, Italy.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Tricarico, PM (corresponding author), Univ Trieste, Piazzale Europa 1, I-34128 Trieste, Italy.
EM ronaldmoura1989@gmail.com; paola.tricarico@burlo.trieste.it;
   avccbio@gmail.com; sergio.crovella@burlo.trieste.it
RI Moura, Ronald/AAE-2318-2020; Coelho, Antonio Victor C/E-6795-2015;
   Crovella, Sergio/K-5050-2016; Moura, Ronald/F-7769-2012; tricarico,
   paola/AAB-8972-2019
OI Moura, Ronald/0000-0002-9112-7167; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Crovella, Sergio/0000-0001-8493-1168; Moura,
   Ronald/0000-0002-9112-7167; tricarico, paola/0000-0002-1954-4126
FU Institute for Maternal and Child Health IRCCS - "Burlo Garofolo" [RC
   42/11]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS - "Burlo Garofolo" (RC 42/11). We really appreciate
   the contribution of Dr. Joost Frenkel (UMC Utrecht, the Netherlands) for
   kindly providing DNA samples of MKD patients.
CR Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479
   Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3
   Hu W, 1998, GENOMICS, V47, P143, DOI 10.1006/geno.1997.5108
   Maier A, 2014, MUSCLE NERVE, V49, P289, DOI 10.1002/mus.24096
   Marcuzzi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/501305
   Ozen S, 2014, NAT REV RHEUMATOL, V10, P135, DOI 10.1038/nrrheum.2013.174
   Utine GE, 2013, J CHILD NEUROL, V28, P926, DOI 10.1177/0883073813484967
   Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266
NR 9
TC 9
Z9 9
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD APR
PY 2015
VL 35
IS 4
BP 657
EP 659
DI 10.1007/s00296-014-3115-y
PG 3
WC Rheumatology
SC Rheumatology
GA CE1QF
UT WOS:000351586100011
PM 25146332
DA 2020-12-08
ER

PT J
AU Santos, RDA
   Crovella, S
   Celsi, F
AF Santos, Ruda de Luna Almeida
   Crovella, Sergio
   Celsi, Fulvio
TI Comment to Santos et al., "Hyper-Ign and periodic fever syndrome: A new
   MVK mutation (p.R277G) associated with a severe phenotype"
SO GENE
LA English
DT Letter
DE Mevalonate Kinase; Mevalonate Kinase Deficiency; Mevalonic aciduria;
   HIDS; Periodic fevers; Molecular modeling; Immune system
ID V-GAMMA-2V-DELTA-2 T-CELLS; ISOPRENOID METABOLISM; MEVALONATE KINASE
C1 [Santos, Ruda de Luna Almeida] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.
   [Crovella, Sergio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Crovella, Sergio; Celsi, Fulvio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Celsi, F (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Immunobiol Lab, Via Istria 65-1, I-34137 Trieste, Italy.
EM fulvio.celsi@gmail.com
RI Crovella, Sergio/K-5050-2016; Celsi, Fulvio/H-2775-2019
OI Crovella, Sergio/0000-0001-8493-1168; Celsi, Fulvio/0000-0002-9760-8463;
   de Luna Almeida Santos, Ruda/0000-0001-6620-619X
CR Fu Z, 2008, BIOCHEMISTRY-US, V47, P3715, DOI 10.1021/bi7024386
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Hinson DD, 1997, J LIPID RES, V38, P2216
   Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RamosValdivia AC, 1997, NAT PROD REP, V14, P591, DOI 10.1039/np9971400591
   Santos JA, 2014, GENE, V542, P217, DOI 10.1016/j.gene.2014.03.031
   Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45
   Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 10
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAR 15
PY 2015
VL 559
IS 1
BP 99
EP 101
DI 10.1016/j.gene.2015.01.029
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA CC1IR
UT WOS:000350094900014
DA 2020-12-08
ER

PT J
AU Zupin, L
   Catamo, E
   Polesello, V
   Crovella, S
   Segat, L
AF Zupin, Luisa
   Catamo, Eulalia
   Polesello, Vania
   Crovella, Sergio
   Segat, Ludovica
TI Interleukin-18 gene promoter polymorphisms and celiac disease in Italian
   patients
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Interleukin-18; Celiac disease; Polymorphism; Genetic susceptibility
ID INFLAMMATORY-BOWEL-DISEASE; RISK VARIANTS; IL-18; ASSOCIATION; HLA;
   SUSCEPTIBILITY; EXPRESSION; DIAGNOSIS; RESPONSES; IMMUNITY
AB Celiac disease (CD) is the most common food-sensitive enteropathy in genetically susceptible individuals. The major genetic risk factors known are specific human leukocyte antigen (HLA)-DQ haplotypes, but other genetic factors are supposed to be involved. Interleukin-18 (IL-18) is a pro-inflammatory cytokine that has an important role in the immune defense and it has the potential to influence inflammatory disorders. IL-18 is able to promote Th1 cell development and it is expressed in the mucosa of the small intestine in celiac patients. Given the IL-18 biological role, and since a few studies have previously suggested its involvement in CD, in order to investigate the role of IL18 gene in the susceptibility to CD we have performed a case-control study, analyzing two IL18 gene promoter polymorphisms, previously reported to impair the transcriptional activity of the gene, (-137G > C and -607C > A, rs187238 and rs1946518 respectively). A total of 556 CD Italian patients and 582 controls, further stratified for HLA class II (DQ) CD risk haplotypes were enrolled. The -607A > C A allele and A/A genotype, as well as the combination of this allele with the -137G allele in the AG haplotype, were associated with an increased risk towards CD development, in particular in HLA-DQ2.2 patients. Although the association was very moderate, our results indicate the possible involvement of IL18 gene in the susceptibility to CD, and for this reason we do think it should deserve further investigation.
C1 [Zupin, Luisa; Polesello, Vania; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Catamo, Eulalia; Crovella, Sergio] Univ Trieste, I-34137 Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018; Catamo,
   Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Catamo, Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC13/12]
FX This work has been supported by RC13/12 Grants from IRCCS Burlo Garofolo
   Trieste (Italy).
CR Ben Aleya W, 2011, DIGESTION, V83, P269, DOI 10.1159/000319755
   Boniotto M, 2005, J MOL MED, V83, P308, DOI 10.1007/s00109-004-0623-3
   Brophy K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-76
   Coruh B, 2001, GASTROENTEROLOGY, V120, pA122
   Dong GP, 2007, INT J IMMUNOGENET, V34, P75, DOI 10.1111/j.1744-313X.2007.00665.x
   Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543
   Dziedziejko V, 2012, POSTEP HIG MED DOSW, V66, P409, DOI 10.5604/17322693.1000980
   Eaton AD, 2003, IMMUNOLOGY, V108, P196, DOI 10.1046/j.1365-2567.2003.01570.x
   Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754
   Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600
   Holopainen P, 2001, GUT, V48, P696, DOI 10.1136/gut.48.5.696
   Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102
   Jarvinen TT, 2004, SCAND J GASTROENTERO, V39, P428, DOI 10.1080/00365520310008773
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320
   Kim SH, 2012, J KOREAN MED SCI, V27, P382, DOI 10.3346/jkms.2012.27.4.382
   Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x
   Leon AJ, 2006, CLIN EXP IMMUNOL, V146, P479, DOI 10.1111/j.1365-2249.2006.03239.x
   Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x
   McCabe MA, 2012, AM J NURS, V112, P33, DOI 10.1097/01.NAJ.0000421019.77542.65
   Merendino RA, 2003, IMMUNOL LETT, V85, P257, DOI 10.1016/S0165-2478(02)00243-2
   Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0
   Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752
   Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351
   Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004
   Rueda B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-29
   Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186
   Song GG, 2013, MOL BIOL REP, V40, P2581, DOI 10.1007/s11033-012-2344-y
   Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047
   Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052
   Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998
   Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100
   van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
NR 36
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 2015
VL 42
IS 2
BP 525
EP 533
DI 10.1007/s11033-014-3796-z
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CA6FZ
UT WOS:000349006900024
PM 25374428
DA 2020-12-08
ER

PT J
AU Celsi, F
   Piscianz, E
   Romano, M
   Crovella, S
AF Celsi, Fulvio
   Piscianz, Elisa
   Romano, Maurizio
   Crovella, Sergio
TI Knockdown of MVK does not lead to changes in NALP3 expression or
   activation
SO JOURNAL OF INFLAMMATION-LONDON
LA English
DT Article
DE Immunology; Inflammation; Autoimmunity; Mevalonate kinase deficiency
ID PERIODIC FEVER; MEVALONATE KINASE; HYPERIMMUNOGLOBULINEMIA-D;
   CELL-DEATH; HYPER-IGD; APOPTOSIS; INTERLEUKIN-1-BETA; AUTOPHAGY
AB Background: Mutations in the Mevalonate Kinase gene (MVK) are causes of a rare autoinflammatory disease: Mevalonate Kinase Deficiency and its more acute manifestation, Mevalonic Aciduria. The latter is characterized, among other features, by neuroinflammation, developmental delay and ataxia, due to failed cerebellar development or neuronal death through chronic inflammation. Pathogenesis of neuroinflammation in Mevalonate Kinase Deficiency and Mevalonic Aciduria has not yet been completely clarified, however different research groups have been suggesting the inflammasome complex as the key factor in the disease development. A strategy to mimic this disease is blocking the mevalonate pathway, using HMG-CoA reductase inhibitors (Statins), while knock-out mice for Mevalonate Kinase are non-vital and their hemyzygous (i.e only one copy of gene preserved) littermate display almost no pathological features.
   Findings: We sought to generate a murine cellular model closely resembling the pathogenic conditions found in vivo, by direct silencing of Mevalonate Kinase gene. Knockdown of Mevalonate Kinase in a murine microglial cellular model (BV-2 cells) results in neither augmented NALP3 expression nor increase of apoptosis. On the contrary, statin treatment of BV-2 cells produces an increase both in Mevalonate Kinase and NALP3 expression.
   Conclusions: MKD deficiency could be due or affected by protein accumulation leading to NALP3 activation, opening novel questions about strategies to tackle this disease.
C1 [Celsi, Fulvio; Piscianz, Elisa; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Romano, Maurizio; Crovella, Sergio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
RP Celsi, F (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM fulvio.celsi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Romano, Maurizio/G-9431-2012
OI Crovella, Sergio/0000-0001-8493-1168; Romano,
   Maurizio/0000-0002-4820-2897; Piscianz, Elisa/0000-0001-7374-1684
CR Drenth JPH, 1996, IMMUNOLOGY, V88, P355, DOI 10.1046/j.1365-2567.1996.d01-672.x
   DRENTH JPH, 1995, EUR J CLIN INVEST, V25, P683, DOI 10.1111/j.1365-2362.1995.tb01986.x
   Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Frenkel J, 2001, RHEUMATOLOGY, V40, P579, DOI 10.1093/rheumatology/40.5.579
   Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61
   Ghavami S, 2014, BBA-MOL CELL RES, V1843, P1259, DOI 10.1016/j.bbamcr.2014.03.006
   Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7
   Houten SM, 1999, NAT GENET, V22, P175
   Houten SM, 2002, HUM MOL GENET, V11, P3115, DOI 10.1093/hmg/11.25.3115
   Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Neven B, 2007, NEW ENGL J MED, V356, P2700, DOI 10.1056/NEJMoa070715
   Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045
   Gomez AR, 2012, PEDIATRICS, V129, pE535, DOI 10.1542/peds.2010-2192
   Tricarico PM, 2013, INT J MOL SCI, V14, P23274, DOI 10.3390/ijms141223274
   Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003
   van der Burgh R, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.536920, DOI 10.1074/JBC.M113.536920]
NR 18
TC 8
Z9 8
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-9255
J9 J INFLAMM-LOND
JI J. Inflamm.-Lond.
PD JAN 31
PY 2015
VL 12
AR 7
DI 10.1186/s12950-015-0048-5
PG 5
WC Immunology
SC Immunology
GA CD4HC
UT WOS:000351042300001
PM 25663823
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Maranhao, RMD
   Esteves, FAM
   Crovella, S
   Segat, L
   Souza, PRE
AF de Albuquerque Maranhao, R. M.
   Martins Esteves, F. A.
   Crovella, S.
   Segat, L.
   Eleuterio Souza, P. R.
TI Tumor necrosis factor-alpha and interleukin-6 gene polymorphism
   association with susceptibility to celiac disease in Italian patients
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Celiac disease; IL-6; TNF-alpha; HLA-DQ
ID TNF-ALPHA; PROMOTER POLYMORPHISM; MULTIPLE-SCLEROSIS; IL-10; RISK;
   SERUM; GAMMA
AB The aim of this research was to study polymorphisms in the genes encoding cytokines interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in patients with celiac disease (CD) antigens DQ2 (DQ2-positive) or DQ8 (DQ8-positive). We compared the results with healthy controls to determine whether any of the polymorphisms have a role in susceptibility to CD. A case-control of 192 patients with CD (96 DQ2-positive and 96 DQ8-positive) and 96 healthy controls from northeast Italy were included in the study. Analysis of single nucleotide polymorphisms (SNPs) was carried out using the polymerase chain reaction-restriction fragment length polymorphism method. Significant differences for the TNF-alpha (-308 G>A) polymorphism were observed when we compared the flowing groups: DQ2-positive with controls [odds ratio (OR) = 0.45, P = 0.0002]; DQ8-positive with controls (OR = 3.55, P < 0.0001); and DQ2-positive with DQ8-positive (OR = 0.12, P < 0.0001). We did not observe a statistically significant association between IL-6 (-174 G>C) polymorphism and CD (P > 0.05). Our results suggest that TNF-alpha (-308 G>A) polymorphism may play a role in susceptibility to CD in Italian patients.
C1 [de Albuquerque Maranhao, R. M.] Univ Fed Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Martins Esteves, F. A.; Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Eleuterio Souza, P. R.] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Martins Esteves, F. A.; Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Crovella, S.; Segat, L.] Ist Ricovero & Cura Carattere Sci Materno Infanti, Trieste, Italy.
RP Esteves, FAM (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.; Esteves, FAM (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
EM andrade.fab@gmail.com
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
FU National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Foundation to Support Science and Technology in the State of
   Pernambuco (FACEPE); Coordination Enhancement Senior Staff (CAPES)CAPES
FX Research supported by the National Counsel of Technological and
   Scientific Development (CNPq), the Foundation to Support Science and
   Technology in the State of Pernambuco (FACEPE), and the Coordination
   Enhancement Senior Staff (CAPES).
CR Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915
   Abbas D, 2011, EGYPT RHEUMATOL, V33, P69, DOI 10.1016/j.ejr.2011.03.002
   Angelo HD, 2012, HUM IMMUNOL, V73, P1166, DOI 10.1016/j.humimm.2012.07.336
   Arman A, 2012, RHEUMATOL INT, V32, P2199, DOI 10.1007/s00296-011-2057-x
   Barisani D, 2006, GENET MED, V8, P169, DOI 10.1097/01.gim.0000204464.87540.39
   Barkhordari E, 2010, J CLIN IMMUNOL, V30, P74, DOI 10.1007/s10875-009-9342-4
   Batikhan H, 2010, EUR ARCH OTO-RHINO-L, V267, P903, DOI 10.1007/s00405-009-1167-5
   Capilla A, 2007, TISSUE ANTIGENS, V70, P324, DOI 10.1111/j.1399-0039.2007.00899.x
   Cataldo F, 2003, AM J GASTROENTEROL, V98, P850, DOI 10.1016/S0002-9270(03)00041-8
   Chernavsky AC, 2008, CYTOKINE, V42, P48, DOI 10.1016/j.cyto.2008.01.015
   Clot F, 2000, MOL GENET METAB, V71, P76, DOI 10.1006/mgme.2000.3045
   de la Concha EG, 2000, HUM IMMUNOL, V61, P513, DOI 10.1016/S0198-8859(99)00187-1
   Dema B, 2009, HUM IMMUNOL, V70, P191, DOI 10.1016/j.humimm.2009.01.010
   Depboylu C, 2004, DEMENT GERIATR COGN, V17, P170, DOI 10.1159/000076352
   Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018
   Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007
   Garrote J A, 2005, Allergol Immunopathol (Madr), V33, P245, DOI 10.1157/13080926
   Garrote JA, 2002, IMMUNOGENETICS, V54, P551, DOI 10.1007/s00251-002-0498-9
   Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q
   Hamdy E., 2012, Comparative Clinical Pathology, V21, P975, DOI 10.1007/s00580-011-1211-x
   Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015
   Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8
   Jrad BBH, 2007, EUR J HAEMATOL, V78, P117, DOI 10.1111/j.1600-0609.2006.00784.x
   Kekik C, 2011, TURK J IMMUNOL, V16, P11
   Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916
   Kroeger KM, 2000, CYTOKINE, V12, P110, DOI 10.1006/cyto.1999.0529
   Lio D, 2005, DIGEST LIVER DIS, V37, P756, DOI 10.1016/j.dld.2005.04.027
   Manavalan JS, 2010, HUM IMMUNOL, V71, P50, DOI 10.1016/j.humimm.2009.09.351
   McManus R, 1996, EUR J IMMUNOL, V26, P2113, DOI 10.1002/eji.1830260923
   Mirowska-Guzel D, 2011, J NEUROIMMUNOL, V236, P87, DOI 10.1016/j.jneuroim.2011.04.014
   Mosaad YM, 2012, HUM IMMUNOL, V73, P560, DOI 10.1016/j.humimm.2012.02.001
   Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9
   Romaldini CC, 2002, J PEDIATR GASTR NUTR, V35, P513, DOI 10.1097/00005176-200210000-00010
   Santhosh S, 2010, Trop Gastroenterol, V31, P30
   Schotte H, 2001, RHEUMATOLOGY, V40, P393, DOI 10.1093/rheumatology/40.4.393
   Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003
   Wen SR, 2012, J NEUROIMMUNOL, V244, P94, DOI 10.1016/j.jneuroim.2011.12.004
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   Woolley N, 2005, SCAND J IMMUNOL, V61, P51, DOI 10.1111/j.0300-9475.2005.01525.x
NR 39
TC 2
Z9 4
U1 0
U2 0
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
EI 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 16343
EP 16352
DI 10.4238/2015.December.9.2
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG3PV
UT WOS:000371983000049
OA Bronze
DA 2020-12-08
ER

PT J
AU Silva, JD
   Tavares, NAC
   Santos, MMS
   Moura, R
   Guimaraes, RL
   Araujo, J
   Crovella, S
   Brandao, LAC
AF de Azevedo Silva, J.
   Tavares, N. A. C.
   Santos, M. M. S.
   Moura, R.
   Guimaraes, R. L.
   Araujo, J.
   Crovella, S.
   Brandao, L. A. C.
TI Meta-analysis of STAT4 and IFIH1 polymorphisms in type 1 diabetes
   mellitus patients with autoimmune polyglandular syndrome type III
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE STAT4; IFIH1; Autoimmune polyglandular syndrome type III; SNP; Type 1
   diabetes
ID DOMAIN 1 IFIH1; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; ASSOCIATION;
   SUSCEPTIBILITY; LOCUS; VARIANTS
AB Type 1 diabetes mellitus (T1D) is an organ-specific autoimmune disease characterized by T-cell mediated self-destruction of insulin-producing beta cells in the pancreas. T1D patients are prone to develop other glandular autoimmune disorders, such as autoimmune thyroid disease that occurs simultaneously with autoimmune polyglandular syndrome type III (APSIII). Signal transducer and activator of transcription 4 (STAT4) is a well-known regulator of proinflammatory cytokines, and interferon-induced with helicase C domain 1 (IFIH1) is activated in the interferon type I response. Both genes have been examined separately in autoimmune diseases and, in this study, we assessed their joint role in T1D and APSIII. We conducted a case-control study, enrolling 173 T1D patients and 191 healthy controls from northeastern Brazil, to assess the distribution of the rs7574865 and rs3024839 SNPs in STAT4 and the rs3747517 and rs1990760 SNPs in IFIH1 in T1D and APSIII patients. Additionally, we conducted a metaanalysis with the rs7574865 SNP in STAT4 (1392 T1D patients and 1629 controls) and the rs1990760 SNP in IFIH1 (25092 T1D patients and 28544 controls) to examine their association with T1D. Distribution of STAT4 and IFIH1 allelic frequencies did not show statistically significant differences between T1D patients and controls in our study population; however, the meta-analysis indicated that SNPs in STAT4 and IFIH1 are associated with T1D worldwide. Our findings indicate that although STAT4 and IFIH1 SNPs are not associated with T1D in a Brazilian population, they might play a role in susceptibility to T1D on a larger worldwide scale.
C1 [de Azevedo Silva, J.; Tavares, N. A. C.; Santos, M. M. S.; Moura, R.; Guimaraes, R. L.; Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Santos, M. M. S.; Moura, R.; Guimaraes, R. L.; Crovella, S.; Brandao, L. A. C.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Araujo, J.] Univ Fed Pernambuco, Hosp Clin, Unidade Endocrinol Pediat, Recife, PE, Brazil.
   [Brandao, L. A. C.] Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
RP Silva, JD (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
EM j.azvedo@gmail.com
RI Moura, Ronald/F-7769-2012; Moura, Ronald/AAE-2318-2020; Crovella,
   Sergio/K-5050-2016; Brandao, Lucas Andre Cavalcanti/G-8333-2012
OI Moura, Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167;
   Crovella, Sergio/0000-0001-8493-1168; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia de
   Pernambuco)
FX Research supported by the following Brazilian Funding agencies: CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and
   FACEPE (Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco).
CR Aminkeng F, 2009, HUM IMMUNOL, V70, P706, DOI 10.1016/j.humimm.2009.06.013
   Bi C, 2013, TISSUE ANTIGENS, V81, P137, DOI 10.1111/tan.12057
   Boucas AP, 2013, PLOS ONE, V12
   Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071
   Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705
   Dittmar M, 2010, THYROID, V20, P737, DOI 10.1089/thy.2010.1639
   Fourati H, 2012, HUM IMMUNOL, V73, P740, DOI 10.1016/j.humimm.2012.04.013
   Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108
   Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244
   Howson JMM, 2011, DIABETES, V60, P2645, DOI 10.2337/db11-0364
   Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140
   Jaidane H, 2009, DIABETES-METAB RES, V25, P591, DOI 10.1002/dmrr.995
   Jermendy A, 2010, DIABETOLOGIA, V53, P98, DOI 10.1007/s00125-009-1561-y
   Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614
   Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34
   Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494
   Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346
   Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013
   Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z
   Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909
   Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1
   Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342
   Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792
   Martinez A, 2008, EUR J HUM GENET, V16, P861, DOI 10.1038/ejhg.2008.16
   Moura R, 2013, GENE, V516, P66, DOI 10.1016/j.gene.2012.11.066
   Palomino-Morales RJ, 2010, J RHEUMATOL, V37, P1016, DOI 10.3899/jrheum.091007
   Park Y, 2011, DIABETES-METAB RES, V27, P867, DOI 10.1002/dmrr.1263
   Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857
   Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009
   Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260
   Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072
   Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800
   Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917
   Stark K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2699
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134
   Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006
   Zervou MI, 2008, HUM IMMUNOL, V69, P647, DOI 10.1016/j.humimm.2008.07.004
   Zheng JF, 2013, HUM IMMUNOL, V74, P986, DOI 10.1016/j.humimm.2013.04.034
   Zurawek M, 2015, DIABETES RES CLIN PR, V107, P259, DOI 10.1016/j.diabres.2014.11.008
NR 40
TC 4
Z9 4
U1 0
U2 1
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
EI 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 17730
EP 17738
DI 10.4238/2015.December.21.46
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DF8DN
UT WOS:000371587400046
PM 26782418
OA Bronze
DA 2020-12-08
ER

PT J
AU Rabelo, KCN
   Albuquerque, CMR
   Tavares, VB
   Santos, SM
   Souza, CA
   Oliveira, TC
   Oliveira, NCL
   Crovella, S
AF Rabelo, K. C. N.
   Albuquerque, C. M. R.
   Tavares, V. B.
   Santos, S. M.
   Souza, C. A.
   Oliveira, T. C.
   Oliveira, N. C. L.
   Crovella, S.
TI Trace samples of human blood in mosquitoes as a forensic investigation
   tool
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Mosquitoes blood meal; Forensic DNA; Forensic entomology
ID OLIGONUCLEOTIDE LIGATION ASSAY; INTERPRETING DNA MIXTURES; AEDES-AEGYPTI
   DIPTERA; CULICIDAE
AB Investigations of any type of crime invariably starts at the crime scene by collecting evidence. Thus, the purpose of this research was to collect and analyze an entomological trace from an environment that is similar to those of indoor crime scenes. Hematophagous mosquitoes were collected from two residential units; saliva of volunteers that were residents in the units was also collected for genetic analysis as reference samples. We examined the allele frequencies of 15 short tandem repeat loci (D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, D18S51, D5S818, and FGA) and amelogenin. A total of 26 female hematophagous mosquitoes were identified as Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus; we were able to obtain 11 forensically valid genetic profiles, with a minimum of 0.028203 ng/mu L of human DNA. Thus, the results of this study showed that it was possible to correlate human genetic information from mosquitoes with the volunteer reference samples, which validates the use of this information as forensic evidence. Furthermore, we observed mixed genetic profiles from one mosquito. Therefore, it is clearly important to collect these insects indoors where crimes were committed, because it may be possible to find intact genetic profiles of suspects in the blood found in the digestive tract of hematophagous mosquitoes for later comparison to identify an offender and/or exclude suspects.
C1 [Rabelo, K. C. N.; Oliveira, T. C.; Oliveira, N. C. L.; Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Albuquerque, C. M. R.] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil.
   [Tavares, V. B.] Lab Cent Saude Publ Pernambuco, Lab Endemias, Recife, PE, Brazil.
   [Rabelo, K. C. N.; Santos, S. M.; Souza, C. A.; Oliveira, T. C.] Secretaria Defesa Social Pernambuco, Lab Pericia & Pesquisa Genet Forense, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Rabelo, KCN (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
EM kaynaracecilia@yahoo.com.br
RI Albuquerque, Cleide MR/I-2521-2012; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Albuquerque,
   Cleide/0000-0003-4335-7424
CR Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007
   Anzai-Kanto Evelyn, 2005, Braz. oral res., V19, P216, DOI 10.1590/S1806-83242005000300011
   Baron H, 1996, NAT BIOTECHNOL, V14, P1279, DOI 10.1038/nbt1096-1279
   Brady J, 1997, ANN TROP MED PARASIT, V91, P121
   Brouwer R, 1960, TROP GEOGR MED, V12, P182
   Budowle B, 1998, P 2 EUR S HUM ID PRO, P73
   Butler J.M., 2005, FORENSIC DNA TYPING
   Canyon DV, 1998, ANN TROP MED PARASIT, V92, P311, DOI 10.1080/00034989859889
   Chadee DD, 1997, ANN TROP MED PARASIT, V91, P199, DOI 10.1080/00034983.1997.11813130
   Chadee DD, 1996, J VECTOR ECOL, V21, P150
   Clayton TM, 1998, FORENSIC SCI INT, V91, P55, DOI 10.1016/S0379-0738(97)00175-8
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Curic G, 2014, FORENSIC SCI INT-GEN, V8, P109, DOI 10.1016/j.fsigen.2013.07.011
   Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578
   Forattini OP, 2002, CULICIDOLOGIA MED
   Geier M, 1996, MOSQUITO OLFACTION O, P178
   Gill P, 1998, FORENSIC SCI INT, V95, P213, DOI 10.1016/S0379-0738(98)00094-2
   Gonzalez-Andrade F, 2006, INT C SER, V1288, P580
   GROSSMAN PD, 1994, NUCLEIC ACIDS RES, V22, P4527, DOI 10.1093/nar/22.21.4527
   Haned H, 2015, FORENSIC SCI INT-GEN, V16, P17, DOI 10.1016/j.fsigen.2014.11.014
   Hu YQ, 2003, INT J LEGAL MED, V117, P39, DOI 10.1007/s00414-002-0321-z
   Mehlhorn H, 2008, ENCY PARASITOLOGY
   Primorac DS, 2014, FORENSIC DNA APPL IN
   Riancho JA, 2003, FORENSIC SCI INT, V135, P232, DOI 10.1016/S0379-0738(03)00217-2
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   Spitaleri S, 2006, INT C SER, V1288, P574, DOI DOI 10.1016/J.ICS.2005.11.055
   Sweet D, 1997, J FORENSIC SCI, V42, P320
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Wallace HM, 2014, EGYPT J FORENSIC SCI, V4, P57, DOI DOI 10.1016/J.EJFS.2014.04.002
   Weir BS, 1997, J FORENSIC SCI, V42, P213
NR 30
TC 2
Z9 2
U1 0
U2 29
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 14847
EP 14856
DI 10.4238/2015.November.18.50
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CX4QK
UT WOS:000365685200072
PM 26600546
OA Bronze
DA 2020-12-08
ER

PT J
AU Coelho, AVC
   Moura, RR
   Cavalcanti, CAJ
   Guimaraes, RL
   Sandrin-Garcia, P
   Crovella, S
   Brandao, LAC
AF Coelho, A. V. C.
   Moura, R. R.
   Cavalcanti, C. A. J.
   Guimaraes, R. L.
   Sandrin-Garcia, P.
   Crovella, S.
   Brandao, L. A. C.
TI A rapid screening of ancestry for genetic association studies in an
   admixed population from Pernambuco, Brazil
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Brazilian genetic admixture; Population structure; Ethnicity; Ancestry
   informative markers; SNP; Association studies
ID MULTILOCUS GENOTYPE DATA; STATISTICAL-METHODS; AFRICAN-AMERICANS;
   GENOMIC ANCESTRY; ADMIXTURE; INFERENCE; MARKERS; MAP
AB Genetic association studies determine how genes influence traits. However, non-detected population substructure may bias the analysis, resulting in spurious results. One method to detect substructure is to genotype ancestry informative markers (AIMs) besides the candidate variants, quantifying how much ancestral populations contribute to the samples' genetic background. The present study aimed to use a minimum quantity of markers, while retaining full potential to estimate ancestries. We tested the feasibility of a subset of the 12 most informative markers from a previously established study to estimate influence from three ancestral populations: European, African and Amerindian. The results showed that in a sample with a diverse ethnicity (N = 822) derivedm from 1000 Genomes database, the 12 AIMs had the same capacity to estimate ancestries when compared to the original set of 128 AIMs, since estimates from the two panels were closely correlated. Thus, these 12 SNPs were used to estimate ancestry in a new sample (N = 192) from an admixed population in Recife, Northeast Brazil. The ancestry estimates from Recife subjects were in accordance with previous studies, showing that Northeastern Brazilian populations show great influence from European ancestry (59.7%), followed by African (23.0%) and Amerindian (17.3%) ancestries. Ethnicity self-classification according to skin-color was confirmed to be a poor indicator of population substructure in Brazilians, since ancestry estimates overlapped between classifications. Thus, our streamlined panel of 12 markers may substitute panels with more markers, while retaining the capacity to control for population substructure and admixture, thereby reducing sample processing time.
C1 [Coelho, A. V. C.; Moura, R. R.; Cavalcanti, C. A. J.; Guimaraes, R. L.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Coelho, A. V. C.; Moura, R. R.; Cavalcanti, C. A. J.; Guimaraes, R. L.; Sandrin-Garcia, P.; Brandao, L. A. C.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Crovella, S.] IRCCS Burlo Garofolo, Trieste, Italy.
   [Brandao, L. A. C.] Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
RP Moura, RR (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
EM ronaldmoura1989@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Crovella, Sergio/K-5050-2016; Moura,
   Ronald/F-7769-2012; Moura, Ronald/AAE-2318-2020
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Crovella, Sergio/0000-0001-8493-1168;
   Moura, Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD
   program); Fundacao de Amparo a Pesquisa do Estado de Pernambuco
   [APQ-1530-2.02/12]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); IRCCS Burlo Garofolo [RC06/11]; Fundacao de Amparo a
   Pesquisa do Estado de Pernambuco (FACEPE, IBPG) [0926-2.02/11]
FX Research supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/PNPD program), Fundacao de Amparo a Pesquisa do Estado
   de Pernambuco (APQ-1530-2.02/12), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), and IRCCS Burlo Garofolo (RC06/11).
   R.R. Moura is the recipient of a postgraduation fellowship from Fundacao
   de Amparo a Pesquisa do Estado de Pernambuco (FACEPE, IBPG
   #0926-2.02/11).
CR Abecasis GR, 2012, NATURE, V491, P56
   Aldrich MC, 2008, AM J EPIDEMIOL, V168, P1035, DOI 10.1093/aje/kwn224
   Ali-Khan Sarah E, 2011, Hugo J, V5, P47, DOI 10.1007/s11568-011-9154-5
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916
   Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7
   Falush D, 2003, GENETICS, V164, P1567
   Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x
   IBGE, 2010, ATL CENS DEM 2010
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146
   Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
   Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806
   Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100
   Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026
   Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959
   Ribeiro D., 1995, POVO BRASILEIRO FORM
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416
   Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149
   Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159
   Seldin MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040005
   Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856
NR 25
TC 29
Z9 30
U1 0
U2 90
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 1
BP 2876
EP 2884
DI 10.4238/2015.March.31.18
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CL7ZV
UT WOS:000357192700141
PM 25867437
OA Bronze
DA 2020-12-08
ER

PT J
AU Santos, SM
   Souza, CA
   Rabelo, KCN
   Souza, PRE
   Moura, RR
   Oliveira, TC
   Crovella, S
AF Santos, S. M.
   Souza, C. A.
   Rabelo, K. C. N.
   Souza, P. R. E.
   Moura, R. R.
   Oliveira, T. C.
   Crovella, S.
TI Distribution of forensic marker allelic frequencies in Pernambuco,
   Northestern Brazil
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Autosomal STRs; Human identification; Population data
ID DNA DATABASES; STR MARKERS; POPULATION-DATA; LOCI; ADMIXTURE; HISPANICS;
   ANCESTRY; REGION; STATES
AB Pernambuco is one of the 27 federal units of Brazil, ranking seventh in the number of inhabitants. We examined the allele frequencies of 13 short tandem repeat loci (CFS1PO, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D21S11, FGA, TH01, vWA, and TPOX), the minimum recommended by the Federal Bureau of Investigation and commonly used in forensic genetics laboratories in Brazil, in a sample of 609 unrelated individuals from all geographic regions of Pernambuco. The allele frequencies ranged from 5 to 47.2%. No significant differences for any loci analyzed were observed compared with other publications in other various regions of Brazil. Most of the markers observed were in Hardy-Weinberg equilibrium. The occurrence of the allele 47.2 (locus FGA) and alleles 35.1 and 39 (locus D21S11), also described in a single study of the Brazilian population, was observed. The other forensic parameters analyzed (matching probability, power of discrimination, polymorphic information content, paternity exclusion, complement factor I, observed heterozygosity, expected heterozygosity) indicated that the studied markers are very informative for human forensic identification purposes in the Pernambuco population.
C1 [Santos, S. M.; Rabelo, K. C. N.; Moura, R. R.; Oliveira, T. C.; Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Santos, S. M.; Souza, C. A.; Rabelo, K. C. N.; Oliveira, T. C.] Secretaria Defesa Social Pernambuco, Lab Pericia & Pesquisa Genet Forense Gerencia Ger, Recife, PE, Brazil.
   [Souza, P. R. E.] Univ Fed Pernambuco, Lab Genoma, Recife, PE, Brazil.
   [Moura, R. R.; Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Santos, SM (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
EM sandra.santos@sds.pe.gov.br
RI Crovella, Sergio/K-5050-2016; Moura, Ronald/F-7769-2012; Moura,
   Ronald/AAE-2318-2020
OI Crovella, Sergio/0000-0001-8493-1168; Moura, Ronald/0000-0002-9112-7167;
   Moura, Ronald/0000-0002-9112-7167; Souza, Paulo/0000-0002-9186-9849
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE) [IBPG
   0926-2.02/11]
FX The authors would like to acknowledge the Secretaria de Defesa Social de
   Pernambuco (SDS/PE/ Brasil). R. Moura is recipient of a post-graduate
   scholarship from Fundacao de Amparo a Pesquisa do Estado de Pernambuco
   (FACEPE, IBPG 0926-2.02/11).
CR Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103
   Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x
   Budowle B, 1998, P 2 EUR S HUM ID PRO, P73
   Butler J.M., 2005, FORENSIC DNA TYPING
   Choi Jong Young, 2009, Biotechnology Journal, V4, P1530, DOI 10.1002/biot.200900202
   Corte-Real F, 2004, FORENSIC SCI INT, V146, pS143, DOI 10.1016/j.forsciint.2004.09.043
   Aguiar VRD, 2012, FORENSIC SCI INT-GEN, V6, P504, DOI 10.1016/j.fsigen.2011.07.005
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   del Castillo Dora Mendez, 2009, Legal Medicine, V11, P45, DOI 10.1016/j.legalmed.2008.07.005
   Dellalibera E, 2004, FORENSIC SCI INT, V146, P57, DOI 10.1016/j.forsciint.2004.04.005
   EXCOFFIER L, 2010, ARLEQUIN VER 3 5 1 2
   Fridman C, 2008, FORENSIC SCI INT-GEN, V2, P382, DOI 10.1016/j.fsigen.2008.06.001
   Ge Jianye, 2012, Investig Genet, V3, P1, DOI 10.1186/2041-2223-3-1
   Gershaw CJ, 2011, FORENSIC SCI INT-GEN, V5, P16, DOI 10.1016/j.fsigen.2010.07.005
   Gill P, 2006, FORENSIC SCI INT, V156, P242, DOI 10.1016/j.forsciint.2005.05.036
   Grattapaglia D, 2001, FORENSIC SCI INT, V118, P91, DOI 10.1016/S0379-0738(00)00348-0
   Gusmao L, 2001, ANN HUM GENET, V65, P285, DOI 10.1046/j.1469-1809.2001.6530285.x
   Hares DR, 2012, FORENSIC SCI INT-GEN, V6, pE52, DOI 10.1016/j.fsigen.2011.04.012
   IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010
   Jacques GS, 2007, PERICIA FEDERAL BRAS, V26, P17
   Krzyzannska Agnieszka, 2006, Arch Med Sadowej Kryminol, V56, P236
   Leite FPN, 2003, FORENSIC SCI INT, V132, P223, DOI 10.1016/S0379-0738(03)00017-3
   Li Cheng-Tao, 2008, Fa Yi Xue Za Zhi, V24, P214
   Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3
   Martins JA, 2010, INT J LEGAL MED, V124, P427, DOI 10.1007/s00414-010-0478-9
   Michelin K, 2008, PARICIA FEDERAL BRAS, V26, P13
   Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026
   Pernambuco, 2007, PACT PEL VID
   Rodrigues EMR, 2008, FORENSIC SCI INT-GEN, V2, P154, DOI 10.1016/j.fsigen.2007.10.179
   Salzano FM, 2004, REV BIOL TROP, V52, P405
   Silva DA, 2004, FORENSIC SCI INT, V139, P173, DOI 10.1016/j.forsciint.2003.10.017
   Tang H, 2007, AM J HUM GENET, V81, P626, DOI 10.1086/520769
   Tereba A, 1999, TOOLS ANAL POPULATIO
   Walsh SJ, 2004, EXPERT REV MOL DIAGN, V4, P31, DOI 10.1586/14737159.4.1.31
   Zietkiewicz E, 2012, J APPL GENET, V53, P41, DOI 10.1007/s13353-011-0068-7
NR 35
TC 1
Z9 1
U1 0
U2 4
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 2
BP 4303
EP 4310
DI 10.4238/2015.April.30.2
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CL7WT
UT WOS:000357183700146
PM 25966202
OA Bronze
DA 2020-12-08
ER

PT J
AU Coelho, AVC
   De Moura, RR
   Da Silva, RC
   Kamada, AJ
   Guimaraes, RL
   Brandao, LAC
   Coelho, HFC
   Crovella, S
AF Campos Coelho, Antonio Victor
   De Moura, Ronald Rodrigues
   Da Silva, Ronaldo Celerino
   Kamada, Anselmo Jiro
   Guimaraes, Rafael Lima
   Cavalcanti Brandao, Lucas Andre
   Campos Coelho, Hemilio Fernandes
   Crovella, Sergio
TI Meta-Analysis and Time Series Modeling Allow a Systematic Review of
   Primary HIV-1 Drug-Resistant Prevalence in Latin America and Caribbean
SO CURRENT HIV RESEARCH
LA English
DT Review
DE Drug resistance mutation; HAART; primary drug resistance; meta-analysis;
   systematic review; time series
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RIO-DE-JANEIRO; ANTIRETROVIRAL-NAIVE
   PATIENTS; NEWLY-DIAGNOSED INDIVIDUALS; TYPE-1 SUBTYPE-C;
   REVERSE-TRANSCRIPTASE; GENETIC DIVERSITY; SAO-PAULO; MOLECULAR
   EPIDEMIOLOGY; GENOTYPIC-RESISTANCE
AB Here we review the prevalence of HIV-1 primary drug resistance in Latin America and Caribbean using meta-analysis as well as time-series modeling. We also discuss whether there could be a drawback to HIV/AIDS programs due to drug resistance in Latin America and Caribbean in the next years. We observed that, although some studies report low or moderate primary drug resistance prevalence in Caribbean countries, this evidence needs to be updated. In other countries, such as Brazil and Argentina, the prevalence of drug resistance appears to be rising. Mutations conferring resistance against reverse transcriptase inhibitors were the most frequent in the analyzed populations (70% of all mutational events). HIV-1 subtype B was the most prevalent in Latin America and the Caribbean, although subtype C and B/F recombinants have significant contributions in Argentina and Brazil. Thus, we suggest that primary drug resistance in Latin America and the Caribbean could have been underestimated. Clinical monitoring should be improved to offer better therapy, reducing the risk for HIV-1 resistance emergence and spread, principally in vulnerable populations, such as men who have sex with men transmission group, sex workers and intravenous drug users.
C1 [Campos Coelho, Antonio Victor; De Moura, Ronald Rodrigues; Da Silva, Ronaldo Celerino; Kamada, Anselmo Jiro; Guimaraes, Rafael Lima; Cavalcanti Brandao, Lucas Andre; Campos Coelho, Hemilio Fernandes; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-50740600 Recife, PE, Brazil.
RP Coelho, AVC (corresponding author), Univ Fed Pernambuco, Dept Genet, Ave Engn,Cidade Univ, BR-50740600 Recife, PE, Brazil.
EM avccbio@gmail.com
RI Crovella, Sergio/K-5050-2016; Kamada, Anselmo Jiro/H-3006-2012; Moura,
   Ronald/F-7769-2012; Brandao, Lucas Andre Cavalcanti/G-8333-2012; Coelho,
   Antonio Victor C/E-6795-2015
OI Crovella, Sergio/0000-0001-8493-1168; Kamada, Anselmo
   Jiro/0000-0002-0437-0151; Moura, Ronald/0000-0002-9112-7167; Brandao,
   Lucas Andre Cavalcanti/0000-0002-8588-4559; Coelho, Antonio Victor
   C/0000-0003-2143-9701
FU CAPESCAPES; FACEPE; Department of Statistics from Federal University of
   Paraiba (UFPB), Brazil
FX We thank Drs. Marcelo Rodrigo Portela Ferreira and Tatiene Correia de
   Souza, both from the Department of Statistics from Federal University of
   Paraiba (UFPB), Brazil, for additional support during time series
   analysis and Jailson Araujo Junior for manuscript proofreading. We also
   would like to thank CAPES and FACEPE for financial support.
CR Acevedo W, 2007, REV MED CHILE, V135, P1406, DOI [/S0034-98872007001100006, 10.4067/S0034-98872007001100006]
   Afani A, 2005, REV MED CHILE, V133, P295, DOI 10.4067/S0034-98872005000300004
   Afani SA, 2010, REV MED CHILE, V138, P669, DOI 10.4067/S0034-98872010000600002
   Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392
   Arruda LB, 2010, AIDS RES HUM RETROV, V26, P105, DOI 10.1089/aid.2009.0179
   Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024
   Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812
   Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338
   Barrow GJ, 2013, ANTIVIR THER, V18, P941, DOI 10.3851/IMP2648
   Beerenwinkel N, 2005, J INFECT DIS, V191, P1953, DOI 10.1086/430005
   Bennett DE, 2008, ANTIVIR THER, V13, P25
   Bermudez-Aza EH, 2011, JAIDS-J ACQ IMM DEF, V57, pS186, DOI 10.1097/QAI.0b013e31821e9c36
   Bittencourt-Passaes C, 2009, JAIDS-J ACQ IMM DEF, V51, P7, DOI 10.1097/QAI.0b013e31819df3b3
   Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P517, DOI 10.1093/jac/dkl501
   Bouchard M, 2007, AIDS RES HUM RETROV, V23, P482, DOI 10.1089/aid.2006.0219
   Box G. E. P., 2013, TIME SERIES ANAL FOR
   Brasil. Ministerio da Saude, 2013, PROT CLIN DIR TER MA
   Brigido LFM, 2011, AIDS RES HUM RETROV, V27, P339, DOI 10.1089/aid.2010.0157
   Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673
   Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102
   Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Brito AM, 2000, REV SOC BRAS MED TRO, V34, P207, DOI DOI 10.1590/S0037-86822001000200010
   Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805
   Carobene MG, 2004, JAIDS-J ACQ IMM DEF, V35, P207, DOI 10.1097/00126334-200402010-00018
   Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]
   Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025
   Castillo J, 2009, AIDS RES HUM RETROV, V25, P1329, DOI 10.1089/aid.2009.0118
   Cecchini DM, 2013, HIV MED, V14, P125, DOI 10.1111/j.1468-1293.2012.01058.x
   Cesaire R, 1999, J ACQ IMMUN DEF SYND, V22, P401
   Cunha RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046622
   da Costa ZB, 2013, AIDS PATIENT CARE ST, V27, P439, DOI 10.1089/apc.2012.0448
   Reis MND, 2014, J MED VIROL, V86, P8, DOI 10.1002/jmv.23738
   da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128
   de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004
   de Medeiros RM, 2011, J MED VIROL, V83, P1682, DOI 10.1002/jmv.22188
   Ferreira JLD, 2008, MEM I OSWALDO CRUZ, V103, P800, DOI 10.1590/S0074-02762008000800010
   de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073
   Delgado E, 2001, AIDS RES HUM RETROV, V17, P753, DOI 10.1089/088922201750237022
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   Diaz RS, 2008, JAIDS-J ACQ IMM DEF, V47, P399, DOI 10.1097/QAI.0b013e31815b0d48
   DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006
   DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348
   Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068
   Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494
   Dumans AT, 2009, INFECT GENET EVOL, V9, P62, DOI 10.1016/j.meegid.2008.10.002
   Dumans AT, 2002, ANTIMICROB AGENTS CH, V46, P3075, DOI 10.1128/AAC.46.9.3075-3079.2002
   El-Far F, 2005, INFECT CONT HOSP EP, V26, P782, DOI 10.1086/502617
   Escoto-Delgadillo M, 2005, HIV MED, V6, P403, DOI 10.1111/j.1468-1293.2005.00326.x
   Eshleman SH, 2007, AIDS RES HUM RETROV, V23, P1593, DOI 10.1089/aid.2007.0130
   Eshleman SH, 2009, AIDS RES HUM RETROV, V25, P343, DOI 10.1089/aid.2008.0236
   Eyer-Silva WA, 2005, MEM I OSWALDO CRUZ, V100, P869, DOI 10.1590/S0074-02762005000800008
   Eyer-Silva WA, 2008, MEM I OSWALDO CRUZ, V103, P143, DOI 10.1590/S0074-02762008000200004
   Ferreira AS, 2011, J MED VIROL, V83, P1301, DOI 10.1002/jmv.22128
   Gaspareto KV, 2012, REV INST MED TROP SP, V54, P207, DOI 10.1590/S0036-46652012000400005
   Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519
   Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021
   Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011
   Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008
   Hamilton CLC, 2012, AIDS RES HUM RETROV, V28, P923, DOI [10.1089/aid.2011.0312, 10.1089/AID.2011.0312]
   Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264
   Hyndman R.J., 2014, FORECAST FORECASTING
   Iamarino A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034324
   Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20
   Jack N, 2012, CLIN INFECT DIS, V54, pS290, DOI 10.1093/cid/cir1044
   Kijak GH, 2001, ANTIVIR THER, V6, P71
   Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd
   Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914
   LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207
   Lloyd B, 2008, AIDS RES HUM RETROV, V24, P529, DOI 10.1089/aid.2007.0172
   Araujo LAL, 2012, J CLIN VIROL, V54, P6, DOI 10.1016/j.jcv.2012.01.005
   Machado LY, 2013, AIDS RES HUM RETROV, V29, P411, DOI [10.1089/aid.2012.0183, 10.1089/AID.2012.0183]
   Mantel N, 1959, STAT ASPECTS ANAL DA
   Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013
   Murphy G, 2008, EURO SURVEILLANCE B, V13
   Myers JE, 2012, AIDS RES HUM RETROV, V28, P667, DOI [10.1089/aid.2010.0355, 10.1089/AID.2010.0355]
   Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814
   Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103
   Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013
   Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58
   Ferreira JLP, 2013, ADV VIROL, V2013, DOI 10.1155/2013/878237
   Perez L, 2007, AIDS RES HUM RETROV, V23, P407, DOI 10.1089/aid.2006.0155
   Petroni A, 2006, JAIDS-J ACQ IMM DEF, V42, P506, DOI 10.1097/01.qai.0000222285.44460.e2
   Pfrimer IAH, 2013, AIDS RES HUM RETROV, V29, P205, DOI [10.1089/aid.2012.0012, 10.1089/AID.2012.0012]
   Pilcher CD, 1999, J INFECT DIS, V179, P1259, DOI 10.1086/314709
   Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]
   Pires IL, 2004, J CLIN MICROBIOL, V42, P426, DOI 10.1128/JCM.42.1.426-430.2004
   Prellwitz IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069033
   R Core Team, 2014, LANG ENV STAT COMP
   Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020
   Rangel HR, 2010, AIDS RES HUM RETROV, V26, P923, DOI 10.1089/aid.2010.0039
   Rios M, 2007, J MED VIROL, V79, P647, DOI 10.1002/jmv.20881
   Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004
   Rodriguez-Rodrigues N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18519
   Ruibal-Brunet I J, 2001, Rev Panam Salud Publica, V10, P174, DOI 10.1590/S1020-49892001000900005
   Cavalcanti AMS, 2012, MEM I OSWALDO CRUZ, V107, P450, DOI 10.1590/S0074-02762012000400002
   Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869
   Santos AF, 2011, J CLIN VIROL, V52, P373, DOI 10.1016/j.jcv.2011.09.005
   Schwarzer G., 2014, META METANALYSIS R R
   Shafer RW, 2008, AIDS REV, V10, P67
   Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4
   Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730
   Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004
   Soria J, 2012, AIDS RES HUM RETROV, V28, P333, DOI 10.1089/aid.2011.0131
   Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012
   Teixeira C, 2010, AIDS RES HUM RETROV, V26, P307, DOI 10.1089/aid.2008.0297
   Teixeira SLM, 2006, J MED VIROL, V78, P764, DOI 10.1002/jmv.20621
   Tupinambas U, 2013, MEM I O CRUZ, V108, P470
   UNAIDS, 2013, GLOB REP UNAIDS REP
   Valle-Bahena OM, 2006, ARCH MED RES, V37, P1022, DOI 10.1016/j.arcmed.2006.05.014
   Varella RB, 2007, J MED VIROL, V79, P1033, DOI 10.1002/jmv.20845
   Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120
   Cardoso LPV, 2010, J MED VIROL, V82, P351, DOI 10.1002/jmv.21722
   Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009
   Velasco-de-Castro CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087622
   Vella S, 2005, CLIN INFECT DIS, V41, pS239, DOI 10.1086/430784
   Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505
   Viani RM, 2007, INT J STD AIDS, V18, P235, DOI 10.1258/095646207780658962
NR 118
TC 1
Z9 1
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-162X
EI 1873-4251
J9 CURR HIV RES
JI Curr. HIV Res.
PY 2015
VL 13
IS 2
BP 125
EP 142
DI 10.2174/1570162X13999150317155040
PG 18
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA CG4UW
UT WOS:000353283700005
PM 25777517
DA 2020-12-08
ER

PT J
AU Catamo, E
   Zupin, L
   Segat, L
   Celsi, F
   Crovella, S
AF Catamo, Eulalia
   Zupin, Luisa
   Segat, Ludovica
   Celsi, Fulvio
   Crovella, Sergio
TI HLA-G and susceptibility to develop celiac disease
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Human Leukocyte Antigen (HLA)-G; Celiac disease; Inflammation; mRNA
   stability
ID G MESSENGER-RNA; ANTIGEN-PRESENTING CELLS; ULCERATIVE-COLITIS; G
   POLYMORPHISM; G MOLECULES; EXPRESSION; ASSOCIATION; REGION; LYMPHOCYTES;
   MACROPHAGES
AB The Human Leukocyte Antigen-G has immunomodulatory function and its expression has been associated with several diseases. In our study we analyzed HLA-G polymorphisms in order to evaluate their possible association with susceptibility to celiac disease development. A total of 420 celiac patients and 509 controls were genotyped for HLA-G polymorphisms. We sequenced 800 bp upstream the ATG codon (5' upstream regulatory region) and the whole 3' untranslated region of the HLA-G gene, whereas the Delta C deletion at exon 3 was detected by RFLP-PCR.
   Five polymorphisms (namely -477 C>G, -369 C>A, 14 bp del/ins, 3187 A>G, 3196 C>G) and one haplotype (TCGGTACGAAITCCCGAG) were significantly more frequent in celiac patients than controls and associated with increased disease susceptibility. The 14 bp I/I, 3187 GIG, 3196 GIG genotypes and TCGGTACGAAITCCCGAG haplotype, were still significantly associated with increased disease susceptibility (and in addition also the 3003 C/C genotype) when the analysis was restricted to patients and controls presenting the DQ2.5 or DQ8 HLA-DQ celiac disease risk haplotypes.
   Our findings indicate an association between HLA-G gene polymorphisms and susceptibility to celiac disease development, suggesting that HLA-G molecule is possibly involved in the pathogenesis of the disease. (C) 2014 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.
C1 [Catamo, Eulalia; Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
   [Zupin, Luisa; Segat, Ludovica; Celsi, Fulvio; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Catamo, E (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM eulalia.catamo@gmail.com
RI Celsi, Fulvio/H-2775-2019; Zupin, Luisa/I-5228-2018; Crovella,
   Sergio/K-5050-2016; Catamo, Eulalia/K-9399-2016
OI Celsi, Fulvio/0000-0002-9760-8463; Zupin, Luisa/0000-0001-5886-9129;
   Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485; Catamo, Eulalia/0000-0002-4701-9134
FU IRCCS Burlo Garofolo [RC 40/11, RC 06/11]
FX This study has been supported by a grant (RC 40/11) from IRCCS Burlo
   Garofolo. L.Z. is recipient of a fellowship from IRCCS Bur lo Garofolo
   (RC 06/11).
CR Carosella ED, 2001, TRENDS IMMUNOL, V22, P553, DOI 10.1016/S1471-4906(01)02007-5
   Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005
   Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4
   Carosella ED, 2008, HUM IMMUNOL, V69, P700, DOI 10.1016/j.humimm.2008.08.280
   Castelli EC, 2008, TISSUE ANTIGENS, V72, P149, DOI 10.1111/j.1399-0039.2008.01091.x
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068
   Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138
   Cordero EAA, 2009, TISSUE ANTIGENS, V74, P308, DOI 10.1111/j.1399-0039.2009.01331.x
   Crispim JCO, 2008, TISSUE ANTIGENS, V71, P35, DOI 10.1111/j.1399-0039.2007.00961.x
   Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027
   Dieterich W, 2003, INT ARCH ALLERGY IMM, V132, P98, DOI 10.1159/000073710
   Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fabris A, 2011, AM J GASTROENTEROL, V106, P139, DOI 10.1038/ajg.2010.340
   Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919
   Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100
   Glas J, 2007, INT IMMUNOL, V19, P621, DOI 10.1093/intimm/dxm027
   Gomez-Casado E, 1999, CELL MOL LIFE SCI, V56, P356, DOI 10.1007/s000180050436
   Horuzsko A, 2001, INT IMMUNOL, V13, P385, DOI 10.1093/intimm/13.3.385
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2
   Jarvinen TT, 2004, SCAND J GASTROENTERO, V39, P428, DOI 10.1080/00365520310008773
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320
   Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006
   Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106
   Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015
   LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101
   LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Ober C, 2006, HUM REPROD, V21, P1743, DOI 10.1093/humrep/del036
   Onno M, 2000, J IMMUNOL, V164, P6426, DOI 10.4049/jimmunol.164.12.6426
   Pangault C, 2002, HUM IMMUNOL, V63, P83, DOI 10.1016/S0198-8859(01)00373-1
   Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004
   Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x
   Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0
   Rosadoab S, 2008, HUM IMMUNOL, V69, P9, DOI 10.1016/j.humimm.2007.11.001
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885
   Suryanarayana V, 2008, REPROD SCI, V15, P817, DOI 10.1177/1933719107314061
   Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389
   Torres MI, 2007, WORLD J GASTROENTERO, V13, P1156, DOI 10.3748/wjg.v13.i8.1156
   Torres MI, 2004, INT IMMUNOL, V16, P579, DOI 10.1093/intimm/dxh061
   Urosevic M, 2003, SEMIN CANCER BIOL, V13, P337, DOI 10.1016/S1044-579X(03)00024-5
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059
NR 49
TC 8
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JAN
PY 2015
VL 76
IS 1
BP 36
EP 41
DI 10.1016/j.humimm.2014.12.006
PG 6
WC Immunology
SC Immunology
GA CA6YZ
UT WOS:000349065100007
PM 25500250
DA 2020-12-08
ER

PT J
AU Addobbati, CJC
   Silva, JD
   Tavares, NAC
   Araujo, J
   Guimaraes, RL
   Brandao, L
   Crovella, S
   Sandrin-Garcia, P
AF Addobbati, C. J. C.
   de Azevedo Silva, J.
   Tavares, N. A. C.
   Araujo, J.
   Guimaraes, R. L.
   Brandao, L.
   Crovella, S.
   Sandrin-Garcia, P.
TI FYB polymorphisms in Brazilian patients with type I diabetes mellitus
   and autoimmune polyglandular syndrome type III
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE T1DM; Autoimmune polyglandular syndrome type III; Fyn-binding protein;
   Polymorphisms
ID ADAP
AB The aim of this study was to perform an association study between seven Fyn-binding protein gene (FYB)-tag single nucleotide polymorphisms (SNPs) and type I diabetes mellitus (T1DM), as well as with disease age of onset. We also assessed the role of FYB SNPs in the insurgence of autoimmune polyglandular syndrome type III (APSIII), characterized by the simultaneous presence of autoimmune thyroid disease and celiac disease, in patients with T1DM from a Northeastern Brazilian population. One hundred and seventy-seven patients with T1DM and 190 healthy individuals were genotyped for seven tag SNPs, covering most of the FYB locus, using real-time polymerase chain reaction amplification. There was no significant difference in the distribution of allele and genotype frequencies among patients and healthy individuals. Moreover, none of the tag SNPs were associated either to T1DM age of onset or to the insurgence of APSIII. However, since the FYB protein is a key component in T cell response, its gene variants might play a role in protein function, which might be testable in a population with different genetic backgrounds or by using functional assays.
C1 [Addobbati, C. J. C.; Guimaraes, R. L.; Brandao, L.; Crovella, S.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Addobbati, C. J. C.; de Azevedo Silva, J.; Tavares, N. A. C.; Guimaraes, R. L.; Crovella, S.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Araujo, J.] Univ Fed Pernambuco, Hosp Clin, Serv Endocrinol Pediat, Recife, PE, Brazil.
   [Brandao, L.] Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
RP Addobbati, CJC (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
EM catarinaaddobbati@hotmail.com
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Ciencia e Tecnologia de
   Pernambuco (FACEPE)
FX Research supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), and Fundacao de Amparo a Ciencia e Tecnologia de
   Pernambuco (FACEPE).
CR Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc12-s064, 10.2337/dc11-S062]
   Araujo J, 2009, CLIN IMMUNOL, V131, P254, DOI 10.1016/j.clim.2008.12.010
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Dittmar M, 2010, THYROID, V20, P737, DOI 10.1089/thy.2010.1639
   Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397
   Pauker MH, 2011, MOL CELL BIOL, V31, P2653, DOI 10.1128/MCB.01358-10
   Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005
   Zou LX, 2008, EUR J IMMUNOL, V38, P986, DOI 10.1002/eji.200737881
NR 8
TC 2
Z9 2
U1 0
U2 2
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
EI 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 1
BP 29
EP 33
DI 10.4238/2015.January.15.4
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AZ3RU
UT WOS:000348145200004
PM 25729932
OA Bronze
DA 2020-12-08
ER

PT J
AU Tavares, NAC
   Santos, MMS
   Moura, R
   Araujo, J
   Guimaraes, RL
   Crovella, S
   Brandao, LAC
AF Tavares, N. A. C.
   Santos, M. M. S.
   Moura, R.
   Araujo, J.
   Guimaraes, R. L.
   Crovella, S.
   Brandao, L. A. C.
TI Association of TNF-alpha, CTLA4, and PTPN22 polymorphisms with type 1
   diabetes and other autoimmune diseases in Brazil
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Type 1 diabetes mellitus; Autoimmune disease; CTLA-4; PTPN22; TNF-alpha
ID T-LYMPHOCYTE ANTIGEN-4; POLYGLANDULAR SYNDROME; GENETIC SUSCEPTIBILITY;
   RHEUMATOID-ARTHRITIS; THYROID-DISEASES; MELLITUS
AB Type 1 diabetes mellitus (T1D) is a complex disorder characterized by an autoimmune response against human pancreatic beta-cells. Patients with T1D can also develop a response toward one or more other factors, such as in autoimmune thyroiditis (AITD) and celiac disease (CD). In the presence of T1D + AITD, the patient is diagnosed with autoimmune polyglandular syndrome type III (APSIII); patients with APSIII may also present with CD. These diseases have a strong genetic component and share many susceptibility genes, suggesting potentially overlapping pathogenic pathways. Polymorphisms in the TNF-alpha (rs1800629), CTLA4 (rs231775), and PTPN22 (rs2476601) genes have been previous associated with T1D; however, there is no consensus regarding their role in T1D and scarce literature focusing on AIDT and/or CD. Thus, we analyzed these genetic variants in 205 Northeast Brazilian patients with T1D and with/without AITD and/or CD, and in 308 healthy controls. The PTPN22 gene variants were associated with T1D susceptibility and APSIII [odds ratio (OR) = 2.57 and 2.77, respectively]. CTLA4 rs231775 and TNF-alpha rs1800629 were not associated with T1D onset in the Brazilian population. However, when comparing APSIII individuals in the T1D only group, we observed an association of the TNF-alpha SNP in the allelic (P = 0.0442; OR = 0.44) and dominant models (P = 0.0387; OR = 0.40). This study reinforces the importance of CTLA-4 and other variants in unraveling the pathogenic mechanisms of T1D in different populations and in understanding their relationships with the development of other T1D-related autoimmune diseases.
C1 [Tavares, N. A. C.; Santos, M. M. S.; Moura, R.; Guimaraes, R. L.; Crovella, S.; Brandao, L. A. C.] Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
   [Araujo, J.] Univ Fed Pernambuco, Hosp Clin, Unidade Endocrinol Pediat, Recife, PE, Brazil.
   [Santos, M. M. S.; Moura, R.; Guimaraes, R. L.; Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Brandao, L. A. C.] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
RP Tavares, NAC (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
EM nathaliadealencar@gmail.com
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Moura,
   Ronald/AAE-2318-2020; Moura, Ronald/F-7769-2012; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Moura,
   Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167; Crovella,
   Sergio/0000-0001-8493-1168
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD
   program); Fundacao Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE)
FX The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/PNPD program) for financial support. NT, RN, and MS are
   recipients of post-graduate and post-doctoral fellowships from Fundacao
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE).
CR Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc12-s064, 10.2337/dc11-S062]
   Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263
   Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032
   Camarca ME, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-10
   Celmeli F, 2013, J CLIN RES PEDIATR E, V5, P40, DOI 10.4274/Jcrpe.879
   Chen ZX, 2013, GENE, V516, P263, DOI 10.1016/j.gene.2012.12.030
   Deja G, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/19724
   Duffy DL, 2007, CURR OPIN ALLERGY CL, V7, P468, DOI 10.1097/ACI.0b013e3282f1dc99
   Dultz G, 2009, THYROID, V19, P143, DOI 10.1089/thy.2008.0301
   Eyre S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3139
   Feng Ren-Nan, 2009, Diabetes Res Clin Pract, V85, pe4, DOI 10.1016/j.diabres.2009.04.026
   Fourati H, 2012, HUM IMMUNOL, V73, P740, DOI 10.1016/j.humimm.2012.04.013
   Horie I, 2012, J CLIN ENDOCR METAB, V97, pE1043, DOI 10.1210/jc.2011-3109
   Howson JMM, 2012, DIABETES, V61, P3012, DOI 10.2337/db11-1694
   Ikegami H, 2006, J CLIN ENDOCR METAB, V91, P1087, DOI 10.1210/jc.2005-1407
   Karman J, 2012, J BIOL CHEM, V287, P11098, DOI 10.1074/jbc.M111.283705
   Kosmaczewska A, 2001, ARCH IMMUNOL THER EX, V49, P39
   Lee LF, 2005, P NATL ACAD SCI USA, V102, P15995, DOI 10.1073/pnas.0508122102
   Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170
   Lee YH, 2013, MOL BIOL REP, V40, P211, DOI 10.1007/s11033-012-2051-8
   Luo LM, 2012, ENDOCR J, V59, P439, DOI 10.1507/endocrj.EJ11-0381
   Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275
   Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732
   Nong LM, 2011, ARCH MED RES, V42, P698, DOI 10.1016/j.arcmed.2011.12.001
   Pan Tian-rong, 2012, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V29, P347, DOI 10.3760/cma.j.issn.1003-9406.2012.03.022
   Pastuszak-Lewandoska D, 2012, ARCH MED SCI, V8, P415, DOI 10.5114/aoms.2012.28593
   Payne F, 2007, J LEUKOCYTE BIOL, V81, P581, DOI 10.1189/jlb.0906577
   Pradhan V, 2010, J POSTGRAD MED, V56, P239, DOI 10.4103/0022-3859.68651
   Rodriguez A, 2015, J DIABETES, V7, P402, DOI 10.1111/1753-0407.12192
   Si XY, 2012, GENET TEST MOL BIOMA, V16, P1336, DOI 10.1089/gtmb.2012.0169
   Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221
   Sugihara Shigetaka, 2012, Pediatr Endocrinol Rev, V10 Suppl 1, P62
   Tang ST, 2012, DIABETES RES CLIN PR, V97, P446, DOI 10.1016/j.diabres.2012.04.011
   Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621
   Van den Driessche A, 2009, NETH J MED, V67, P376
   Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897
   Villano MJB, 2009, J CLIN ENDOCR METAB, V94, P1458, DOI 10.1210/jc.2008-2193
   Wemeau JL, 2013, HORM-INT J ENDOCRINO, V12, P39, DOI 10.1007/BF03401285
   Witek Przemyslaw R, 2012, Med Wieku Rozwoj, V16, P23
NR 39
TC 12
Z9 13
U1 0
U2 2
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
EI 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 18936
EP 18944
DI 10.4238/2015.December.28.42
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DF8DN
UT WOS:000371587400171
PM 26782543
OA Bronze
DA 2020-12-08
ER

PT J
AU Catamo, E
   Zupin, L
   Crovella, S
   Celsi, F
   Segat, L
AF Catamo, Eulalia
   Zupin, Luisa
   Crovella, Sergio
   Celsi, Fulvio
   Segat, Ludovica
TI Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic
   viral infections and in hepatocellular carcinoma
SO HUMAN IMMUNOLOGY
LA English
DT Review
DE Hepatocellular carcinoma; HLA-G; HCV; HBV
ID HEPATITIS-C VIRUS; G MESSENGER-RNA; 14-BP INSERTION/DELETION
   POLYMORPHISM; HUMAN CYTOMEGALOVIRUS-INFECTION; BREAST-CANCER PATIENTS;
   CD4(+) T-CELLS; G EXPRESSION; B-VIRUS; NATURAL-HISTORY; G MOLECULES
AB The human leukocyte antigen (HLA)-G is a "nonclassical" major histocompatibility complex (MHC) class lb gene, located at chromosome 6, in the 6p21.3 region.
   The HLA-G presents immunomodulatory functions essential in pregnancy for the tolerance of the semi-allogenic fetus, but an abnormal expression of HLA-G has been observed in numerous pathological conditions, such as tumors, autoimmune diseases and viral infections. In recent years, numerous studies have assessed the clinical relevance of HLA-G expression in different types of cancer: in general, a higher HLA-G expression correlates with a lower survival rate or a shorter disease-free survival.
   Altered expression of HLA-G has been found in both HCV and HBV infection, and some genetic polymorphisms have been associated with altered susceptibility/disease development for these infections, however, whether the biologic role of HLA-G in HCV and HBV infection is beneficial or hazardous, it is not completely clear. In the context of hepatocellular carcinoma, HLA-G has shown a potential diagnostic role, moreover a prognostic value in HCC patients has been also attributed to HLA-G molecules.
   We revise here the role of HLA-G in hepatotropic HBV/HCV infections and in hepatocellular carcinoma (HCC). (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Catamo, Eulalia; Crovella, Sergio] Univ Trieste, Dept Med Sci, I-34127 Trieste, Italy.
   [Zupin, Luisa; Crovella, Sergio; Celsi, Fulvio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018; Catamo,
   Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Catamo, Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
CR Alvarez M, 2009, INT J IMMUNOGENET, V36, P361, DOI 10.1111/j.1744-313X.2009.00875.x
   Amiot L, 2014, J HEPATOL, V60, P245, DOI 10.1016/j.jhep.2013.09.006
   Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449
   Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331
   Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199
   Cai MB, 2012, INT J BIOL SCI, V8, P891, DOI 10.7150/ijbs.4383
   Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463
   Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x
   Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662
   Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4
   Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570
   Chu WJ, 1998, HUM IMMUNOL, V59, P435, DOI 10.1016/S0198-8859(98)00045-7
   Chu WJ, 1999, J REPROD IMMUNOL, V42, P1, DOI 10.1016/S0165-0378(98)00077-1
   Cordero EAA, 2009, TISSUE ANTIGENS, V74, P308, DOI 10.1111/j.1399-0039.2009.01331.x
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   da Silva GK, 2014, INFECT GENET EVOL, V21, P418, DOI 10.1016/j.meegid.2013.12.013
   de Kruijf EM, 2010, J IMMUNOL, V185, P7452, DOI 10.4049/jimmunol.1002629
   Crispim JCD, 2012, HUM IMMUNOL, V73, P258, DOI 10.1016/j.humimm.2011.12.004
   Dienstag JL, 2010, HARRISONS INFECTION, P929
   Dienstag JL, 2010, HARRISONS INFECTION, P902
   Dienstag JL, 2010, HARRISONS INFECTION, P899
   Dienstag JL, 2010, HARRISONS INFECTION, P918
   Du LT, 2011, CANCER SCI, V102, P1272, DOI 10.1111/j.1349-7006.2011.01951.x
   Dunn GP, 2012, NEUROSURGERY, V71, P201, DOI 10.1227/NEU.0b013e31824f840d
   Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991
   Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919
   Gan LH, 2010, HUM IMMUNOL, V71, P899, DOI 10.1016/j.humimm.2010.06.012
   GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145
   Gobin SJP, 1998, J IMMUNOL, V161, P2276
   Gobin SJP, 1999, J IMMUNOL, V163, P1428
   Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343
   Gros F, 2008, EUR J IMMUNOL, V38, P742, DOI 10.1002/eji.200736918
   Guo QY, 2011, LEUKEMIA RES, V35, P1350, DOI 10.1016/j.leukres.2011.05.036
   Hahn YS, 2003, CURR OPIN IMMUNOL, V15, P443, DOI 10.1016/S0952-7915(03)00076-1
   Han Q, 2012, CLIN EXP MED, V14, P35
   Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Jiang YT, 2011, DNA CELL BIOL, V30, P1027, DOI 10.1089/dna.2011.1238
   Kim SK, 2013, HEPATO-GASTROENTEROL, V60, P796, DOI 10.5754/hge11180
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Kren L, 2011, NEUROPATHOLOGY, V31, P129, DOI 10.1111/j.1440-1789.2010.01149.x
   Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125
   Lafon M, 2008, DEV BIOLOGICALS, V131, P413
   Lafon M, 2005, J VIROL, V79, P15226, DOI 10.1128/JVI.79.24.15226-15237.2005
   Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346
   Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351
   LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101
   LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547
   Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398
   Lin A, 2007, ANN ONCOL, V18, P1804, DOI 10.1093/annonc/mdm356
   Lin A, 2010, J CELL MOL MED, V14, P2162, DOI 10.1111/j.1582-4934.2009.00917.x
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Martinetti M, 2006, INT J IMMUNOPATH PH, V19, P369, DOI 10.1177/039463200601900213
   Massard J, 2006, J HEPATOL, V44, pS19, DOI 10.1016/j.jhep.2005.11.009
   McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898
   Menier C, 2004, BLOOD, V104, P3153, DOI 10.1182/blood-2004-03-0809
   Moreau P, 2003, P NATL ACAD SCI USA, V100, P1191, DOI 10.1073/pnas.0337539100
   Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803
   Nuckel H, 2005, BLOOD, V105, P1694, DOI 10.1182/blood-2004-08-3335
   Onno M, 2000, J IMMUNOL, V164, P6426, DOI 10.4049/jimmunol.164.12.6426
   Park Y, 2012, TISSUE ANTIGENS, V79, P97, DOI 10.1111/j.1399-0039.2011.01814.x
   Paul P, 1999, CANCER RES, V59, P1954
   Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Pizzato N, 2004, HUM IMMUNOL, V65, P1389, DOI 10.1016/j.humimm.2004.07.239
   Polakova K, 2000, NEOPLASMA, V47, P342
   Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018
   Riteau B, 2003, HUM IMMUNOL, V64, P1064, DOI 10.1016/j.humimm.2003.08.344
   Rizzo R, 2005, J ALLERGY CLIN IMMUN, V115, P508, DOI 10.1016/j.jaci.2004.11.031
   Rosadoab S, 2008, HUM IMMUNOL, V69, P9, DOI 10.1016/j.humimm.2007.11.001
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Sayed D, 2010, TISSUE ANTIGENS, V75, P40, DOI 10.1111/j.1399-0039.2009.01393.x
   Shi WW, 2011, HUM IMMUNOL, V72, P1068, DOI 10.1016/j.humimm.2011.06.012
   Singer G, 2003, CLIN CANCER RES, V9, P4460
   Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770
   Solier C, 2001, IMMUNOGENETICS, V53, P617, DOI 10.1007/s00251-001-0373-0
   Souto FJD, 2011, J VIRAL HEPATITIS, V18, P102, DOI 10.1111/j.1365-2893.2010.01286.x
   Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200
   Teixeira AC, 2013, TISSUE ANTIGENS, V81, P408, DOI 10.1111/tan.12097
   Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U
   Urosevic M, 2003, SEMIN CANCER BIOL, V13, P337, DOI 10.1016/S1044-579X(03)00024-5
   Villeneuve JP, 2005, J CLIN VIROL, V34, pS139, DOI 10.1016/S1386-6532(05)80024-1
   Wang Y, 2011, HEPATOB PANCREAT DIS, V10, P158, DOI 10.1016/S1499-3872(11)60025-8
   Weng PJ, 2011, HUM IMMUNOL, V72, P406, DOI 10.1016/j.humimm.2011.02.008
   Wiendl H, 2007, HUM IMMUNOL, V68, P286, DOI 10.1016/j.humimm.2006.10.021
   Yan WH, 2009, J INFECT DIS, V200, P820, DOI 10.1086/604733
   Yang YP, 1996, J IMMUNOL, V156, P4224
   Yang YP, 1995, J REPROD IMMUNOL, V29, P179, DOI 10.1016/0165-0378(95)00942-E
   Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059
   Zhang J, 2012, IMMUNOGENETICS, V64, P251, DOI 10.1007/s00251-011-0580-2
   Zheng N, 2011, TISSUE ANTIGENS, V77, P218, DOI 10.1111/j.1399-0039.2010.01607.x
NR 93
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD DEC
PY 2014
VL 75
IS 12
BP 1225
EP 1231
DI 10.1016/j.humimm.2014.09.019
PG 7
WC Immunology
SC Immunology
GA AW1HP
UT WOS:000346041100014
PM 25318079
DA 2020-12-08
ER

PT J
AU Casalicchio, G
   Freato, N
   Maestri, I
   Comar, M
   Crovella, S
   Segat, L
AF Casalicchio, Giorgia
   Freato, Nadia
   Maestri, Iva
   Comar, Manola
   Crovella, Sergio
   Segat, Ludovica
TI Beta Defensin-1 Gene Polymorphisms and Susceptibility to Atypical
   Squamous Cells of Undetermined Significance Lesions in Italian
   Gynecological Patients
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE DEFB1; functional polymorphisms; ASCUS; human papillomavirus; host
   genetic factors
ID HUMAN BETA-DEFENSIN-1 GENE; HUMAN-PAPILLOMAVIRUS; BETHESDA SYSTEM;
   INNATE; WOMEN; TRANSCRIPTION; EXPRESSION; INDUCTION; CANCER; HBD-1
AB The role of the human beta-defensin 1 (hBD-1) in the susceptibility to the onset of the Atypical Squamous Cells of Undetermined Significance (ASCUS) lesion, in the presence or not of HPV infection, is still unknown. In the current study, the three functional single nucleotide polymorphisms (SNPs) -52G>A, -44C>G, and -20G>A at the 5 un-translated region (UTR) of DEFB1 gene, encoding hBD-1, were analyzed in ASCUS lesion gynecological patients and healthy women from the north-east of Italy (Trieste). Cervical samples from 249 European-Caucasian women were collected, screened for HPV and cytologically evaluated; DEFB1 genotyping has been performed by direct sequencing. No significant differences were found for -52G>A, -44C>G, and -20G>A SNPs allele and genotype frequencies between women with and without ASCUS lesions. DEFB1 minor haplotypes were significantly more frequent in ASCUS lesion positive than negative women, associating with an increased risk of this type of lesion. When women were stratified according to HPV infection status, significant differences in the distribution of -52G>A SNP genotype frequencies were found: the presence of the A allele in the homozygous genotype A/A associated with a lower risk of developing ASCUS lesions in HPV negative women. DEFB1 minor haplotypes were also associated with an increased risk of developing ASCUS lesions, being significantly more frequent in HPV negative women with lesions, than without lesions. Although these results highlight the possible involvement of DEFB1, further studies are needed to support the role of DEFB1 in the modulation of the susceptibility to ASCUS lesions. J. Med. Virol. 86:1999-2004, 2014. (c) 2014 Wiley Periodicals, Inc.
C1 [Casalicchio, Giorgia; Comar, Manola; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Freato, Nadia; Comar, Manola; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Maestri, Iva] Univ Ferrara, Sect Pathol Anat, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Comar, Manola/K-4613-2016; COMAR,
   Manola/K-4613-2016
OI Crovella, Sergio/0000-0001-8493-1168; Comar, Manola/0000-0001-6310-3320;
   maestri, iva/0000-0002-3485-4640; COMAR, Manola/0000-0002-9487-861X;
   Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC06/11]; Friuli Venezia Region (R3A2)
FX Grant sponsor: IRCCS Burlo Garofolo; Grant number: RC06/11; Grant
   sponsor: Friuli Venezia Region (R<SUP>3</SUP>A<SUP>2</SUP>).
CR Arbyn M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008054.pub2
   Bose SK, 2009, MOL IMMUNOL, V46, P1140, DOI 10.1016/j.molimm.2008.11.004
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   BRODER S, 1992, JAMA-J AM MED ASSOC, V267, P1892, DOI 10.1001/jama.267.14.1892
   Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026
   Chong KT, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-75
   Comar M, 2012, J CLIN MICROBIOL, V50, P4041, DOI 10.1128/JCM.02105-12
   Erhart W, 2011, J INFECT DIS, V204, P391, DOI 10.1093/infdis/jir079
   Galani E, 2009, CLIN MICROBIOL INFEC, V15, P977, DOI 10.1111/j.1469-0691.2009.03032.x
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1995, IARC MONOGRAPHS EVAL
   Izadi Mood A, 2004, ACTA MED IRN, V4, P295
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   LUFF R, 1992, AM J SURG PATHOL, V16, P914
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   de Oca EPM, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/923943
   Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Naslavsky MS, 2010, IMMUNOL LETT, V129, P53, DOI 10.1016/j.imlet.2009.12.024
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Pantelis A, 2009, ORAL ONCOL, V45, P526, DOI 10.1016/j.oraloncology.2008.07.014
   Pieralli A, 2007, GINECOLOGIA ONLINE
   Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784
   Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021
   Rombaldi RL, 2009, VIROL J, V6, P83, DOI DOI 10.1186/1743-422X-6-83
   Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0
   Smith MCG, 2006, BJOG-INT J OBSTET GY, V113, P1321, DOI 10.1111/j.1471-0528.2006.01065.x
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Syrjanen K, 2008, EUR J GYNAECOL ONCOL, V29, P205
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F
   Wenghoefer M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-290
   Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453
   Zhu BD, 2003, ACTA PHARMACOL SIN, V24, P907
NR 36
TC 4
Z9 4
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2014
VL 86
IS 12
BP 1999
EP 2004
DI 10.1002/jmv.23878
PG 6
WC Virology
SC Virology
GA AS3LN
UT WOS:000344179400001
PM 24435641
DA 2020-12-08
ER

PT J
AU De Pieri, C
   Vuch, J
   Athanasakis, E
   Severini, GM
   Crovella, S
   Bianco, AM
   Tommasini, A
AF De Pieri, C.
   Vuch, J.
   Athanasakis, E.
   Severini, G. M.
   Crovella, S.
   Bianco, A. M.
   Tommasini, A.
TI F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and
   in healthy controls
SO CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA English
DT Letter
C1 [De Pieri, C.; Vuch, J.; Bianco, A. M.; Tommasini, A.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat, I-34137 Trieste, Italy.
   [Vuch, J.; Crovella, S.] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Athanasakis, E.; Severini, G. M.; Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Adv Diagnost & Clin Trials, Trieste, Italy.
RP De Pieri, C (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat, Via Istria 65-1, I-34137 Trieste, Italy.
EM carlodepieri@gmail.com
RI Tommasini, Alberto/AAE-3882-2020; BIANCO, ANNA MONICA/D-3098-2014;
   Crovella, Sergio/K-5050-2016; Athanasakis, Emmanouil/K-1326-2018
OI Tommasini, Alberto/0000-0002-6943-7927; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Crovella, Sergio/0000-0001-8493-1168; De
   Pieri, Carlo/0000-0002-3138-3070; Athanasakis,
   Emmanouil/0000-0002-7707-2665
CR Ciccarelli F, 2014, CURR MED CHEM, V21, P261
   Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105
   Jeru I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069757
   Marcuzzi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/501305
   Vitale A, 2013, CLIN EXP RHEUMATOL, V31, pS155
NR 5
TC 15
Z9 15
U1 0
U2 1
PU CLINICAL & EXPER RHEUMATOLOGY
PI PISA
PA VIA SANTA MARIA 31, 56126 PISA, ITALY
SN 0392-856X
EI 1593-098X
J9 CLIN EXP RHEUMATOL
JI Clin. Exp. Rheumatol.
PD NOV-DEC
PY 2014
VL 32
IS 6
BP 993
EP 994
PG 2
WC Rheumatology
SC Rheumatology
GA AY9KW
UT WOS:000347869700026
PM 25327218
DA 2020-12-08
ER

PT J
AU Segat, L
   Zupin, L
   Moura, RR
   Coelho, AVC
   Chagas, BS
   de Freitas, AC
   Crovella, S
AF Segat, Ludovica
   Zupin, Luisa
   Moura, Ronald Rodrigues
   Campos Coelho, Antonio Victor
   Chagas, Barbara Simas
   de Freitas, Antonio Carlos
   Crovella, Sergio
TI DEFB1 polymorphisms are involved in susceptibility to human
   papillomavirus infection in Brazilian gynaecological patients
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE DEFB1; antimicrobial peptides; human papillomavirus; genetic
   polymorphisms; cervical lesion
ID HUMAN BETA-DEFENSIN-1; HIV-1 INFECTION; BETA-DEFENSINS; LESIONS;
   INDUCTION; CHILDREN; CANCER; GENE; SETS
AB The human beta defensin 1 (hBD-1) antimicrobial peptide is a member of the innate immune system known to act in the first line of defence against microorganisms, including viruses such as human papillomavirus (HPV). In this study, five functional polymorphisms (namely g-52G>A, g-44C>G and g-20G>A in the 5'UTR and c.*5G>A and c.*87A>G in the 3'UTR) in the DEFB1 gene encoding for hBD-1 were analysed to investigate the possible involvement of these genetic variants in susceptibility to HPV infection and in the development of HPV-associated lesions in a population of Brazilian women. The DEFB1 g-52G>A and c.*5G>A single-nucleotide polymorphisms (SNPs) and the GCAAA haplotype showed associations with HPV-negative status; in particular, the c.*5G>A SNP was significantly associated after multiple test corrections. These findings suggest a possible role for the constitutively expressed beta defensin-1 peptide as a natural defence against HPV in the genital tract mucosa.
C1 [Segat, Ludovica; Zupin, Luisa] Inst Maternal & Child Hlth Burlo Garofolo, Trieste, Italy.
   [Moura, Ronald Rodrigues; Campos Coelho, Antonio Victor; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Lab Patol & Med Genom, Recife, PE, Brazil.
   [Chagas, Barbara Simas; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Dept Genet, Lab Estudos Mol & Terapia Expt, Recife, PE, Brazil.
RP Segat, L (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Moura, Ronald/AAE-2318-2020; Zupin, Luisa/I-5228-2018; Moura,
   Ronald/F-7769-2012; Coelho, Antonio Victor C/E-6795-2015; Crovella,
   Sergio/K-5050-2016; Chagas, Barbara/M-9327-2019; Freitas,
   Antonio/G-1843-2012
OI Moura, Ronald/0000-0002-9112-7167; Zupin, Luisa/0000-0001-5886-9129;
   Moura, Ronald/0000-0002-9112-7167; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Crovella, Sergio/0000-0001-8493-1168; Freitas,
   Antonio/0000-0002-4957-9549; Simas Chagas, Barbara/0000-0003-3917-9055;
   Segat, Ludovica/0000-0002-6024-1485
FU FACEPE (Brazil) [APQ-1530-2.02/12]; Italian Ministry of HealthMinistry
   of Health, Italy [RC06/11]; CNPq (Brazil)National Council for Scientific
   and Technological Development (CNPq); IRCCS Burlo Garofolo, Trieste,
   Italy
FX FACEPE (Brazil), APQ-1530-2.02/12, the Italian Ministry of Health
   (RC06/11); BSC is a recipient of a postdoctoral fellowship from CNPq
   (Brazil) and LZ is a recipient of a fellowship from IRCCS Burlo
   Garofolo, Trieste, Italy.
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103
   Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026
   Casalicchio G, 2014, J MED VIROL, V86, P1999, DOI 10.1002/jmv.23878
   Chong KT, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-75
   Coelho AVC, 2014, GENET MOL R IN PRESS
   Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6
   Erhart W, 2011, J INFECT DIS, V204, P391, DOI 10.1093/infdis/jir079
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Hubert P, 2007, FASEB J, V21, P2765, DOI 10.1096/fj.06-7646com
   Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   MANOS MM, 1989, CANCER CEL, V7, P209
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0
   Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
NR 20
TC 8
Z9 8
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2014
VL 109
IS 7
BP 918
EP +
DI 10.1590/0074-0276140220
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AU2FD
UT WOS:000345430900011
PM 25410996
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Kamada, AJ
   Pontillo, A
   Guimaraes, RL
   Loureiro, P
   Crovella, S
   Brandao, LAC
AF Kamada, Anselmo Jiro
   Pontillo, Alessandra
   Guimaraes, Rafael Lima
   Loureiro, Paula
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
TI NLRP3 polymorphism is associated with protection against human
   T-lymphotropic virus 1 infection
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE NLRP3; NLRP1; single nucleotide polymorphisms; innate immunity; HTLV-1
ID CELLS; DISEASE; HTLV-1; SUSCEPTIBILITY; INFLAMMASOME; VITILIGO; RISK;
   GENE; LOAD; SNP
AB Inter-individual heterogeneity in the response to human T-lymphotropic virus 1 (HTLV-1) infection has been partially attributed to host genetic background. The antiviral activity of the inflammasome cytoplasmic complex recognises viral molecular patterns and regulates immune responses via the activation of interleukin (IL)-1 family (IL-1, IL-18 and IL-33) members. The association between polymorphisms in the inflammasome receptors NLRP1 and NLRP3 and HTLV-1 infection was evaluated in a northeastern Brazilian population (84 HTLV-1 carriers and 155 healthy controls). NLRP3 rs10754558 G/G was associated with protection against HTLV-1 infection (p = 0.012; odds ratio = 0.37). rs10754558 affects NLRP3 mRNA stability; therefore, our results suggest that higher NLRP3 expression may augment first-line defences, leading to the effective protection against HTLV-1 infection.
C1 [Kamada, Anselmo Jiro; Guimaraes, Rafael Lima; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
   [Pontillo, Alessandra] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunogenet, BR-05508 Sao Paulo, Brazil.
   [Loureiro, Paula] Fundacao Hematol & Hemoterapia Pernambuco, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunogenet, BR-05508 Sao Paulo, Brazil.
EM alepontillo@usp.br
RI Loureiro, Paula/A-2965-2013; Pontillo, Alessandra/ABC-6266-2020;
   Crovella, Sergio/K-5050-2016; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Pontillo, Alessandra/AAD-4790-2019; Kamada,
   Anselmo Jiro/H-3006-2012; Pontillo, ALESSANDRA/D-4352-2012
OI Loureiro, Paula/0000-0003-1849-0047; Pontillo,
   Alessandra/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Pontillo,
   Alessandra/0000-0002-7883-0640; Kamada, Anselmo
   Jiro/0000-0002-0437-0151; Pontillo, ALESSANDRA/0000-0002-7883-0640
FU FACEPE [APQ-0757-2.02/10]
FX FACEPE (APQ-0757-2.02/10)
CR Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006
   Glinskii AB, 2009, CELL CYCLE, V8, P3925, DOI 10.4161/cc.8.23.10113
   Gram AM, 2012, J GEN VIROL, V93, P2063, DOI 10.1099/vir.0.042978-0
   Haddad R, 2011, AIDS RES HUM RETROV, V27, P283, DOI 10.1089/aid.2010.0165
   Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Lairmore MD, 2012, CURR OPIN VIROL, V2, P474, DOI 10.1016/j.coviro.2012.06.007
   Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110
   Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146
   Liu D, 2013, FRONT IMMUNOL, V44, P1
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Pique C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00378
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968
   Rocha MC, 2012, TISSUE ANTIGENS, V80, P143, DOI 10.1111/j.1399-0039.2012.01887.x
   Takahashi M, 2013, BLOOD, V122, P715, DOI 10.1182/blood-2013-03-493718
   Verma D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034977
   Vine AM, 2002, J INFECT DIS, V186, P932, DOI 10.1086/342953
NR 21
TC 15
Z9 15
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2014
VL 109
IS 7
BP 960
EP +
DI 10.1590/0074-0276140154
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AU2FD
UT WOS:000345430900019
PM 25411003
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Tavares, NDC
   Moura, R
   Coelho, A
   Guimaraes, RL
   Araujo, J
   Crovella, S
   Brandao, LAC
   Silva, JD
AF da Silva, Ronaldo Celerino
   Cunha Tavares, Nathalia de Alencar
   Moura, Ronald
   Coelho, Antonio
   Guimaraes, Rafael Lima
   Araujo, Jacqueline
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
   Silva, Jaqueline de Azevedo
TI DC-SIGN polymorphisms are associated to type 1 diabetes mellitus
SO IMMUNOBIOLOGY
LA English
DT Article
ID GENES; ETIOLOGY; ORGANIZATION; RECOGNITION; MECHANISM; INFECTION;
   DIAGNOSIS; PROMOTER
C1 [da Silva, Ronaldo Celerino; Moura, Ronald; Coelho, Antonio; Guimaraes, Rafael Lima; Crovella, Sergio] Univ Fed Pernambuco UFPE, Dept Genet, BR-50760901 Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; Cunha Tavares, Nathalia de Alencar; Moura, Ronald; Coelho, Antonio; Guimaraes, Rafael Lima; Crovella, Sergio; Cavalcanti Brandao, Lucas Andre; Silva, Jaqueline de Azevedo] Univ Fed Pernambuco, LIKA, BR-50760901 Recife, PE, Brazil.
   [Araujo, Jacqueline] Univ Fed Pernambuco, Clin Hosp, Pediat Endocrinol Unit, BR-50760901 Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, BR-50760901 Recife, PE, Brazil.
RP Silva, JD (corresponding author), Univ Fed Pernambuco, LIKA, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM j.azvedo@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Moura, Ronald/AAE-2318-2020; Moura,
   Ronald/F-7769-2012; Crovella, Sergio/K-5050-2016
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Moura, Ronald/0000-0002-9112-7167;
   Moura, Ronald/0000-0002-9112-7167; Crovella, Sergio/0000-0001-8493-1168
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; Facepe [BCT 0484-2.02/12, BCT 0485-2.02/12]
FX This work was supported by the following Brazilian Funding Agencies:
   CNPq, CAPES and Facepe (BCT 0484-2.02/12 and BCT 0485-2.02/12).
CR Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024
   Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635
   Atkinson M.A., 2013, LANCET, V6736, P1
   Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061
   Calderon B, 2012, CURR OPIN IMMUNOL, V24, P119, DOI 10.1016/j.coi.2011.11.005
   da Silva RC, 2012, HUM IMMUNOL, V73, P1159, DOI 10.1016/j.humimm.2012.07.338
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108
   Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0
   Ilyas R, 2011, IMMUNOBIOLOGY, V216, P126, DOI 10.1016/j.imbio.2010.06.002
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7
   Lloyd DH, 2007, VET DERMATOL, V18, P197, DOI 10.1111/j.1365-3164.2007.00594.x
   Mahla RS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00248
   Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200
   Morel PA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00415
   Naarding M.A., 2005, J CLIN INVEST, P115
   Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406
   Noble JA, 1996, AM J HUM GENET, V59, P1134
   Pugliese A., 2010, INT DIABETES MONIT, V22, P101
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Sinclair D, 2006, ANN CLIN BIOCHEM, V43, P173, DOI 10.1258/000456306776865043
   Stankov K, 2013, PEDIATRICS, V132, P1112, DOI 10.1542/peds.2013-1652
   Steck AK, 2005, DIABETES, V54, P2482, DOI 10.2337/diabetes.54.8.2482
   Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001
   Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   Zhou T, 2006, CELL MOL IMMUNOL, V3, P279
NR 33
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2014
VL 219
IS 11
BP 859
EP 865
DI 10.1016/j.imbio.2014.07.011
PG 7
WC Immunology
SC Immunology
GA AT3JP
UT WOS:000344831700007
PM 25092567
DA 2020-12-08
ER

PT J
AU Catamo, E
   Addobbati, C
   Segat, L
   Fragoso, TS
   Barbosa, AD
   Dantas, AT
   Mariz, HD
   da Rocha, LF
   Duarte, ALBP
   Monasta, L
   Sandrin-Garcia, P
   Crovella, S
AF Catamo, E.
   Addobbati, C.
   Segat, L.
   Sotero Fragoso, T.
   Domingues Barbosa, A.
   Tavares Dantas, A.
   de Ataide Mariz, H.
   da Rocha, L. F., Jr.
   Duarte, A. L. Branco Pinto
   Monasta, L.
   Sandrin-Garcia, P.
   Crovella, S.
TI HLA-G gene polymorphisms associated with susceptibility to rheumatoid
   arthritis disease and its severity in Brazilian patients
SO TISSUE ANTIGENS
LA English
DT Article
DE Brazilian patients; genetic polymorphisms; human leukocyte antigen-G;
   mRNA instability; rheumatoid arthritis
ID METHOTREXATE RESPONSE; REGION; TRANSACTIVATION; CLASSIFICATION;
   TRANSCRIPTION; POPULATIONS; EXPRESSION; NETWORKS; CRITERIA; MARKER
AB We analyzed the possible association between human leukocyte antigen-G (HLA-G) genetic variants, supposed to regulate HLA-G expression, and the susceptibility to develop rheumatoid arthritis (RA) as well as its clinical manifestations. The 5'upstream regulatory region (5'URR) and 3'untranslated region (3'UTR) regions of the HLA-G gene were screened in 127 RA patients and 128 controls: 10 5'URR and 3 3'UTR HLA-G polymorphisms as well as two haplotypes were associated with risk for RA development, while a polymorphism in the 5'URR showed an association with the degree of disease activity. These findings, although the number of cases analyzed is limited and the P-values are modest, indicate a possible association between HLA-G gene polymorphisms and susceptibility to develop RA disease and its severity.
C1 [Catamo, E.; Crovella, S.] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Addobbati, C.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Addobbati, C.; Sotero Fragoso, T.; Domingues Barbosa, A.; Sandrin-Garcia, P.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Segat, L.; Monasta, L.; Crovella, S.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Adv Diagnost & Clin Sperimentat, Trieste, Italy.
   [Sotero Fragoso, T.; Domingues Barbosa, A.; Tavares Dantas, A.; de Ataide Mariz, H.; da Rocha, L. F., Jr.; Duarte, A. L. Branco Pinto] Univ Fed Pernambuco, Clin Hosp, Div Rheumatol, Recife, PE, Brazil.
RP Catamo, E (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM eulalia.catamo@gmail.com
RI Monasta, Lorenzo/B-1388-2012; Crovella, Sergio/K-5050-2016; Catamo,
   Eulalia/K-9399-2016
OI Monasta, Lorenzo/0000-0001-7774-548X; Crovella,
   Sergio/0000-0001-8493-1168; Sotero Fragoso, Thiago/0000-0002-0192-0760;
   Catamo, Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
FU FACEPE/CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); 'Ricerca Corrente' from IRCCS Burlo Garofolo
   (Trieste, Italy) [RC40/11]
FX We acknowledge the financial support of FACEPE/CNPq (Brazil) and
   'Ricerca Corrente' RC40/11 from IRCCS Burlo Garofolo (Trieste, Italy).
CR Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100
   Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI 10.1136/ard.2010.138461
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Baricordi OR, 2007, ANN RHEUM DIS, V66, P1125, DOI 10.1136/ard.2006.064022
   Carosella ED, 2008, HUM IMMUNOL, V69, P700, DOI 10.1016/j.humimm.2008.08.280
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138
   Coelho AV, GENET MOL R IN PRESS
   Donadi EA, 2010, REV CELL MOL LIFE SC, V68, P369
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661
   Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
   GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669
   Gobin SJP, 1998, J IMMUNOL, V161, P2276
   Gobin SJP, 2002, J BIOL CHEM, V277, P39525, DOI 10.1074/jbc.M112273200
   Gomez-Casado E, 1999, CELL MOL LIFE SCI, V56, P356, DOI 10.1007/s000180050436
   Hviid TVF, 2006, SARCOIDOSIS VASC DIF, V23, P30
   Hviid TVF, 1999, HUM IMMUNOL, V60, P1237, DOI 10.1016/S0198-8859(99)00130-5
   Kim SK, 2012, RHEUMATOL INT, V32, P509, DOI 10.1007/s00296-010-1735-4
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3364
   LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547
   MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B
   Moreau P, 2003, P NATL ACAD SCI USA, V100, P1191, DOI 10.1073/pnas.0337539100
   Ober C, 2006, HUM REPROD, V21, P1743, DOI 10.1093/humrep/del036
   Park KS, 2007, TISSUE ANTIGENS, V69, P139, DOI 10.1111/j.1399-0039.2006.00742.x
   Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018
   Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0
   Rizzo R, 2006, PHARMACOGENET GENOM, V16, P615, DOI 10.1097/01.fpc.0000230115.41828.3a
   Rizzo R, 2013, HUM IMMUNOL, V74, P425, DOI 10.1016/j.humimm.2012.11.024
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Silva GL, 2009, ANN NY ACAD SCI, V1173, P521, DOI 10.1111/j.1749-6632.2009.04629.x
   Solier C, 2001, IMMUNOGENETICS, V53, P617, DOI 10.1007/s00251-001-0373-0
   Stamp LK, 2009, ANN RHEUM DIS, V68, P154, DOI 10.1136/ard.2008.089383
   Suryanarayana V, 2008, REPROD SCI, V15, P817, DOI 10.1177/1933719107314061
   Svendsen SG, 2013, HUM IMMUNOL, V74, P818, DOI 10.1016/j.humimm.2013.03.003
   Veit TD, 2014, TISSUE ANTIGENS, V83, P260, DOI 10.1111/tan.12311
   Verbruggen LA, 2006, HUM IMMUNOL, V67, P561, DOI 10.1016/j.humimm.2006.03.023
NR 39
TC 13
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD SEP
PY 2014
VL 84
IS 3
BP 308
EP 315
DI 10.1111/tan.12396
PG 8
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA AO3RM
UT WOS:000341252500008
PM 24957665
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Segat, L
   da Cruz, HLA
   Schindler, HC
   Montenegro, LML
   Crovella, S
   Guimaraes, RL
AF da Silva, Ronaldo Celerino
   Segat, Ludovica
   Alves da Cruz, Heidi Lacerda
   Schindler, Haiana Charifker
   Lapa Montenegro, Lilian Maria
   Crovella, Sergio
   Guimaraes, Rafael Lima
TI Association of CD209 and CD209L polymorphisms with tuberculosis
   infection in a Northeastern Brazilian population
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Polymorphisms; CD209; CD209L; Tuberculosis
ID DC-SIGN CD209; DENDRITIC CELL; GENE POLYMORPHISMS; LENGTH VARIATION;
   NECK-REGION; PROMOTER; RECEPTOR; DISEASE; IMPACT; FORMS
AB Tuberculosis (TB) caused by Mycobacterium tuberculosis, is major cause of morbidity and mortality worldwide. So far, many candidate genes have been investigated for their possible association with TB. Dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3) grabbing non-integrin (DC-SIGN) and Liver/lymph node-specific intercellular adhesion molecule-grabbing non-integrin (L-SIGN), encoded by CD209 and CD209L genes respectively, are known for binding to M. tuberculosis on human dendritic cells and macrophages. We screened 4 single nucleotide polymorphisms (SNPs) in the promoter region of CD209, namely -939G > A (rs735240), -871A > G (rs735239), -336A > G (rs4804803) and -139G > A (rs2287886) and tandem repeat polymorphisms in exon 4 of CD209 and CD209L genes looking for association with TB in a Northeastern Brazilian population (295 subjects, 131 TB patients and 164 healthy controls). The -139G > A and -939G > A SNPs were associated with susceptibility to TB, and in particular with pulmonary and extra-pulmonary forms respectively. The -871A > G and -336A > G SNPs were associated, the first with protection to both pulmonary and extra-pulmonary TB, the latter only with the pulmonary form. An association between GGAG haplotype and protection to TB infection was also found. Also tandem repeat polymorphism in CD209L exon 4 was associated with TB infection. This study provides evidence of an association between CD209 and CD209L polymorphisms and TB development in a Brazilian population, suggesting that variations in these genes may influence the protection and susceptibility to infection caused by M. tuberculosis.
C1 [da Silva, Ronaldo Celerino; Alves da Cruz, Heidi Lacerda; Crovella, Sergio; Guimaraes, Rafael Lima] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; Alves da Cruz, Heidi Lacerda; Crovella, Sergio; Guimaraes, Rafael Lima] Fed Univ Pernambuco UFPE, LIKA, Recife, PE, Brazil.
   [Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Schindler, Haiana Charifker; Lapa Montenegro, Lilian Maria] Aggeu Magalhaes Res Ctr CPqAM FIOCRUZ Pernambuco, Dept Immunol, Recife, PE, Brazil.
RP da Silva, RC (corresponding author), Fed Univ Pernambuco UFPE, Dept Genet, Av Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
EM ronaldocelerino@yahoo.com.br
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We thank the Laboratory of Immunopathology Keizo Asami, the Department
   of Genetics, Federal University of Pernambuco, the Graduate Program in
   Genetics for supporting physical and scientific, as well as FACEPE and
   CNPq, for financial support. We thank the Program for Technological
   Development in Tools for Health-PDTIS/FIOCRUZ for use of its facilities.
CR Alagarasu K, 2009, INDIAN J MED RES, V130, P444
   Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017
   Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020
   Barreiro LB, 2007, HUM IMMUNOL, V68, P106, DOI 10.1016/j.humimm.2006.10.020
   Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671
   Ben-Ali M, 2007, HUM IMMUNOL, V68, P908, DOI 10.1016/j.humimm.2007.09.003
   Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Gomez LM, 2006, HUM IMMUNOL, V67, P808, DOI 10.1016/j.humimm.2006.07.003
   Gramberg T, 2006, VIROLOGY, V347, P354, DOI 10.1016/j.virol.2005.11.033
   Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200
   Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9
   Kashima S, 2009, J GEN VIROL, V90, P927, DOI 10.1099/vir.0.008367-0
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Kobayashi K, 2011, HUM IMMUNOL, V72, P741, DOI 10.1016/j.humimm.2011.04.004
   Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7
   Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Rathore A, 2008, J CLIN IMMUNOL, V28, P50, DOI 10.1007/s10875-007-9131-x
   Sainz J, 2010, Methods Find Exp Clin Pharmacol, V32 Suppl A, P9
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Selvaraj P, 2009, INFECT GENET EVOL, V9, P256, DOI 10.1016/j.meegid.2008.12.003
   Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445
   Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381
   Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388
   WHO, 2010, GLOB TUB CONTR SURV
   World Health Organization, 1998, TUB HDB
   Xu LJ, 2010, J CLIN IMMUNOL, V30, P402, DOI 10.1007/s10875-010-9376-7
   Zheng RJ, 2011, HUM IMMUNOL, V72, P183, DOI 10.1016/j.humimm.2010.11.004
   Zhou T, 2006, CELL MOL IMMUNOL, V3, P279
NR 35
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD AUG
PY 2014
VL 41
IS 8
BP 5449
EP 5457
DI 10.1007/s11033-014-3416-y
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AM5OY
UT WOS:000339910900060
PM 24874302
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Girardelli, M
   Vozzi, D
   Crovella, S
   Kleiner, G
   Marcuzzi, A
AF Bianco, Anna Monica
   Girardelli, Martina
   Vozzi, Diego
   Crovella, Sergio
   Kleiner, Giulio
   Marcuzzi, Annalisa
TI Mevalonate kinase deficiency and IBD: shared genetic background
SO GUT
LA English
DT Letter
C1 [Bianco, Anna Monica; Girardelli, Martina; Vozzi, Diego; Crovella, Sergio; Kleiner, Giulio; Marcuzzi, Annalisa] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Hlth Genet Unit, I-34137 Trieste 65, Italy.
   [Crovella, Sergio] Univ Trieste, Med Surg & Hlth Sci Dept, Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Hlth Genet Unit, Via Istria, I-34137 Trieste 65, Italy.
EM annalisa.marcuzzi@burlo.trieste.it
RI BIANCO, ANNA MONICA/D-3098-2014; Crovella, Sergio/K-5050-2016; Marcuzzi,
   Annalisa/AAA-6038-2020; Girardelli, Martina/K-7199-2016
OI BIANCO, ANNA MONICA/0000-0001-8101-9659; Crovella,
   Sergio/0000-0001-8493-1168; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Girardelli, Martina/0000-0003-1186-4907; vozzi,
   diego/0000-0002-2902-8184; Kleiner, Giulio/0000-0002-1830-3961
CR Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717
   Levy M, 2013, PEDIATRICS, V132, pE779, DOI 10.1542/peds.2012-3344
   Patra Kamakshya P, 2011, Pediatr Rev, V32, P299, DOI 10.1542/pir.32-7-299
   Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956
NR 4
TC 19
Z9 19
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD AUG
PY 2014
VL 63
IS 8
BP 1367
EP U219
DI 10.1136/gutjnl-2013-306555
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AL5HK
UT WOS:000339164200024
PM 24531851
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Travan, L
   Lega, S
   Crovella, S
   Montico, M
   Panontin, E
   Demarini, S
AF Travan, Laura
   Lega, Sara
   Crovella, Sergio
   Montico, Marcella
   Panontin, Elisa
   Demarini, Sergio
TI Severe Neonatal Hyperbilirubinemia and UGT1A1 Promoter Polymorphism
SO JOURNAL OF PEDIATRICS
LA English
DT Article
ID GILBERTS-SYNDROME; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; (TA)(8)
   ALLELE; TERM NEWBORNS; GENE PROMOTER; HEALTHY TERM; NEAR-TERM; JAUNDICE;
   PREDICTION; MANAGEMENT
AB Objective To assess whether UGT1A1 promoter polymorphisms associated with Gilbert Syndrome (GS) occur with a greater frequency in neonates with severe hyperbilirubinemia.
   Study design In a case-control study performed at a single hospital center in Italy, 70 case subjects with severe hyperbilirubinemia (defined as bilirubin level >= 20 mg/dL or 340 mu mol/L) and 70 controls (bilirubin level <12 mg/dL or 210 mu mol/L) were enrolled. Both case and control subjects were full term newborns. Polymerase chain reaction analysis on blood spot was performed to determine the frequency of UGTA1A1 promoter polymorphisms in cases and controls.
   Results No statistical difference in the prevalence of UGTA1A1 gene variants was found between cases and controls (P = 1). Thirteen infants homozygous for (TA)7 polymorphism associated with GS were in the case group (18.6%) and 14 in the control group (20.0%). A heterozygous group was also equally distributed between cases (44.3%) and controls (42.9%). No (TA)8 repeat was found in the 2 groups.
   Conclusions In our study population, GS polymorphism alone does not appear to play a major role in severe neonatal hyperbilirubinemia in neonates without signs of hemolysis.
C1 [Travan, Laura; Crovella, Sergio; Montico, Marcella; Demarini, Sergio] IRCCS Burlo Grofolo, Inst Maternal & Child Hlth, I-34134 Trieste, Italy.
   [Lega, Sara; Panontin, Elisa] Univ Trieste, Trieste, Italy.
RP Travan, L (corresponding author), IRCCS Burlo Grofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34134 Trieste, Italy.
EM laura.travan@burlo.trieste.it
RI LEGA, SARA/AAB-8758-2019; Crovella, Sergio/K-5050-2016; Montico,
   Marcella/B-5290-2013
OI Crovella, Sergio/0000-0001-8493-1168; Montico,
   Marcella/0000-0003-0377-8232; Laura, Travan/0000-0001-9861-0832
CR Bancroft JD, 1998, J PEDIATR-US, V132, P656, DOI 10.1016/S0022-3476(98)70356-7
   BERGMAN DA, 1994, PEDIATRICS, V94, P558
   Bertini G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e41
   Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170
   Bhutani Vinod K, 2004, J Perinatol, V24, P650, DOI 10.1038/sj.jp.7211152
   Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6
   Borlak J, 2000, HEPATOLOGY, V32, P792, DOI 10.1053/jhep.2000.18193
   BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
   BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802
   Chang RJ, 2012, PEDIATR NEONATOL, V53, P41, DOI 10.1016/j.pedneo.2011.11.008
   Iolascon A, 1999, HAEMATOLOGICA, V84, P106
   Kaplan M, 2000, LANCET, V356, P652, DOI 10.1016/S0140-6736(00)02610-6
   Kaplan M, 2009, J PERINATOL, V29, pS46, DOI 10.1038/jp.2008.216
   Kaplan Michael, 2002, Semin Neonatol, V7, P121, DOI 10.1053/siny.2002.0099
   KAWADE N, 1981, BIOCHEM J, V196, P257, DOI 10.1042/bj1960257
   Keren R, 2009, ARCH DIS CHILD-FETAL, V94, pF317, DOI 10.1136/adc.2008.150714
   Laforgia N, 2002, J PERINAT MED, V30, P166, DOI 10.1515/JPM.2002.021
   Long J, 2011, PEDIATR INT, V53, P530, DOI 10.1111/j.1442-200X.2011.03337.x
   Maisels MJ, 2004, PEDIATRICS, V114, P297
   Maisels MJ, 1998, PEDIATRICS, V101, P995, DOI 10.1542/peds.101.6.995
   Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8
   Moyer VA, 2000, ARCH PEDIAT ADOL MED, V154, P391, DOI 10.1001/archpedi.154.4.391
   Muslu N, 2007, J TROP PEDIATRICS, V53, P64, DOI 10.1093/tropej/fml067
   Ostanek B, 2007, BLOOD CELL MOL DIS, V38, P78, DOI 10.1016/j.bcmd.2006.10.160
   Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8
   Roy-Chowdhury N, 2002, ACTA PAEDIATR, V91, P100, DOI 10.1080/080352502753458058
   Sarici SU, 2004, PEDIATRICS, V113, P775, DOI 10.1542/peds.113.4.775
   Ulgenalp A, 2003, BIOL NEONATE, V83, P258, DOI 10.1159/000069487
   Watchko JF, 2009, PEDIATRICS, V124, pE868, DOI 10.1542/peds.2009-0460
NR 29
TC 15
Z9 18
U1 7
U2 11
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD JUL
PY 2014
VL 165
IS 1
BP 42
EP 45
DI 10.1016/j.jpeds.2014.03.013
PG 4
WC Pediatrics
SC Pediatrics
GA AM3BS
UT WOS:000339727100012
PM 24726540
DA 2020-12-08
ER

PT J
AU Zupin, L
   Polesello, V
   Catamo, E
   Crovella, S
   Segat, L
AF Zupin, Luisa
   Polesello, Vania
   Catamo, Eulalia
   Crovella, Sergio
   Segat, Ludovica
TI Interleukin-10 gene promoter polymorphisms in celiac patients from
   north-eastern Italy
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Interleukin-10; Celiac disease; Polymorphism; Genetic susceptibility
ID SELECTIVE IGA DEFICIENCY; TNF-ALPHA; SPANISH POPULATION; HLA-DQ;
   DISEASE; IL-10; CELL; ASSOCIATION; EXPRESSION; INFLAMMATION
AB Celiac disease is a complex chronic intestinal disorder driven by an immune response against the gliadin fraction of gluten: many factors are involved in the pathogenesis of the disease, and among these Interleukin-10 could play an important role. In the present study, the -1082A>G, -819T>C and -592A>C IL10 functional polymorphisms were analyzed in 565 celiac patients and 576 healthy controls from north-eastern Italy, stratified for HLA class II celiac disease risk haplotypes. No significant differences were observed for the three IL10 polymorphisms distribution between celiac patients and controls with the exception of a slightly increased risk for the -1082A allele in HLA-DQ8 male individuals. Although our findings suggest that the IL10 genetic variants analyzed do not have a major role in the susceptibility to the development of celiac disease in north-eastern Italian patients, we think that the possible involvement of IL10 gene in CD should deserve further investigation and that large-scale studies are recommended to confirm our findings. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Zupin, Luisa; Polesello, Vania; Crovella, Sergio; Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Catamo, Eulalia; Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Zupin, Luisa/I-5228-2018; Crovella, Sergio/K-5050-2016; Catamo,
   Eulalia/K-9399-2016
OI Zupin, Luisa/0000-0001-5886-9129; Crovella, Sergio/0000-0001-8493-1168;
   Catamo, Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC13/12]
FX This work has been supported by RC13/12 grants from IRCCS Burlo Garofolo
   Trieste (Italy).
CR Boniotto M, 2005, J MOL MED, V83, P308, DOI 10.1007/s00109-004-0623-3
   Cataldo F, 2003, PEDIAT ALLERG IMM-UK, V14, P320, DOI 10.1034/j.1399-3038.2003.00053.x
   Cataldo F, 2003, AM J GASTROENTEROL, V98, P850, DOI 10.1016/S0002-9270(03)00041-8
   Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355
   Gallagher PM, 2003, THORAX, V58, P154, DOI 10.1136/thorax.58.2.154
   Garrote J A, 2005, Allergol Immunopathol (Madr), V33, P245, DOI 10.1157/13080926
   Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600
   Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5
   Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102
   Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657
   KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001
   Lio D, 2005, DIGEST LIVER DIS, V37, P756, DOI 10.1016/j.dld.2005.04.027
   Megiorni F, 2008, AM J GASTROENTEROL, V103, P997, DOI 10.1111/j.1572-0241.2007.01716.x
   Mizrachi A, 2002, SCAND J GASTROENTERO, V37, P924, DOI 10.1080/003655202760230883
   Nunez C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-32
   Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714
   Rad R, 2004, GUT, V53, P1082, DOI 10.1136/gut.2003.029736
   Ramkumar HL, 2012, GRAEF ARCH CLIN EXP, V250, P1541, DOI 10.1007/s00417-012-2037-1
   Romanos J, 2009, J MED GENET, V46, P60, DOI 10.1136/jmg.2008.061457
   Salvati VM, 2005, GUT, V54, P46, DOI 10.1136/gut.2003.023150
   Sato K, 1999, J IMMUNOL, V162, P3865
   SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345
   Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x
   Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Zoric MH, 2003, J CLIN IMMUNOL, V23, P291, DOI 10.1023/A:1024588800754
NR 30
TC 1
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUL
PY 2014
VL 75
IS 7
BP 656
EP 661
DI 10.1016/j.humimm.2014.04.011
PG 6
WC Immunology
SC Immunology
GA AJ8ER
UT WOS:000337936000010
PM 24768947
DA 2020-12-08
ER

PT J
AU Wilson, TJ
   Jobim, M
   Segat, L
   Bianco, AM
   Salim, PH
   Portela, P
   Jobim, LF
   Damin, DC
   Schwartsmann, G
   Roesler, R
   Crovella, S
AF Wilson, T. J.
   Jobim, M.
   Segat, L.
   Bianco, A. M.
   Salim, P. H.
   Portela, P.
   Jobim, L. F.
   Damin, D. C.
   Schwartsmann, G.
   Roesler, R.
   Crovella, S.
TI DEFB1 gene 5' untranslated region ( UTR) polymorphisms are marginally
   involved in inflammatory bowel disease in south Brazilians
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1 GENE;
   CROHNS-DISEASE; INNATE; PATHOGENESIS; ASSOCIATION; DEFENSINS; IMMUNITY
AB The possible association of three DEFB1 gene polymorphisms with susceptibility to develop ulcerative colitis (UC) and Crohn's disease (CD) was investigated in Brazilian patients and controls. Although a clear and strong association between functional 5-UTR DEFB1 SNPs and susceptibility/protection to IBDs cannot be drawn, our results suggest a possible involvement of DEFB1 gene in inflammatory bowel diseases, especially with the colonic localization of Crohn's disease.
C1 [Wilson, T. J.; Jobim, M.; Salim, P. H.; Portela, P.; Jobim, L. F.] Hosp Clin, Dept Immunol, Porto Alegre, RS, Brazil.
   [Segat, L.; Bianco, A. M.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Jobim, L. F.; Schwartsmann, G.] Univ Fed Rio Grande do Sul, Fac Med, Dept Internal Med, Porto Alegre, RS, Brazil.
   [Damin, D. C.] Hosp Clin Porto Alegre, Div Coloproctol, Porto Alegre, RS, Brazil.
   [Damin, D. C.] Univ Fed Rio Grande do Sul, Dept Surg, Porto Alegre, RS, Brazil.
   [Schwartsmann, G.; Roesler, R.] Univ Hosp Res Ctr CPE HCPA, Canc Res Lab, Porto Alegre, RS, Brazil.
   [Schwartsmann, G.; Roesler, R.] Natl Inst Translat Med, Porto Alegre, RS, Brazil.
   [Roesler, R.] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Pharmacol, Lab Neuropharmacol & Neural Tumor Biol, Porto Alegre, RS, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Jobim, M (corresponding author), Hosp Clin, Dept Immunol, Ramiro Barcelos 2350, Porto Alegre, RS, Brazil.
EM mjobim@hcpa.ufrgs.br
RI Crovella, Sergio/K-5050-2016; BIANCO, ANNA MONICA/D-3098-2014; Roesler,
   Rafael/U-9261-2019; Schwartsmann, Gilberto/G-4256-2016; Jobim, Luiz
   Fernando Job/W-5493-2019
OI Crovella, Sergio/0000-0001-8493-1168; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Schwartsmann, Gilberto/0000-0002-7850-1644;
   Segat, Ludovica/0000-0002-6024-1485; Roesler, Rafael/0000-0001-6016-2261
FU Italian Ministry of HealthMinistry of Health, Italy [RC 40/11]; Regione
   Friuli Venezia GiuliaRegione Friuli Venezia Giulia [R3A2]
FX This work was partially supported by a grant from Italian Ministry of
   Health RC 40/11 and 'Regione Friuli Venezia Giulia' (R3A2).
CR Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Brant SR, 2013, CLIN GASTROENTEROL H, V11, P22, DOI 10.1016/j.cgh.2012.11.001
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615
   Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107
   Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831
   Rodriguez-Jimenez FJ, 2003, GENOMICS, V81, P175, DOI 10.1016/S0888-7543(02)00034-4
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1
   Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001
   Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Tommasini A, 2010, SCAND J GASTROENTERO, V45, P1141, DOI 10.3109/00365521.2010.492529
   Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Zanin V, 2012, CLINICS, V67, P395, DOI 10.6061/clinics/2012(04)14
NR 24
TC 3
Z9 3
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
EI 1744-313X
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD APR
PY 2014
VL 41
IS 2
BP 138
EP 142
DI 10.1111/iji.12089
PG 5
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA AC3KV
UT WOS:000332418300008
PM 24034632
DA 2020-12-08
ER

PT J
AU Silva, JD
   Pancotto, JAT
   Donadi, EA
   Crovella, S
   Sandrin-Garcia, P
AF Silva, Jaqueline De Azevedo
   Tres Pancotto, Joao Alexandre
   Donadi, Eduardo Antonio
   Crovella, Sergio
   Sandrin-Garcia, Paula
TI LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus
   erythematosus
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE SNPs; LIG4; RAD52 and SLE
ID STRAND BREAK REPAIR; RECOMBINATION; EXPRESSION; XRCC1
AB Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with a strong genetic background. Nevertheless, SLE might also be triggered due to environmental factors, such as UV light exposure. DNA double strand breaks (DSBs) may be induced secondarily by UV radiation, increasing DNA immunogenicity and in SLE patients DNA repair is diminished, allowing the accumulation of DSBs and genomic instability. LIG4 and RAD52 genes play important roles in DNA repair mechanisms and a recent microarray analysis showed their differential expression in active SLE patients. In this study we investigated a potential association between LIG4 and RAD52 single nucleotide polymorphisms (SNPs) and SLE predisposition in a Southeast Brazilian population. We assessed four Tag SNPs in LIG4 and three in RAD52 gene region, encompassing most of the gene sequence, in 158 SLE patients and 212 healthy controls. We also performed SNPs analysis considering clinical manifestation, gender and ethnicity in SLE patients. Our data did not show association between LIG4 and RAD52 SNPs and SLE, its clinical manifestations or ethnicity in the tested population. The analysis regarding ethnicity and SLE clinical manifestations indicated Caucasian-derived patients as more susceptible to cutaneous and hematological alterations than the African-derived. To our knowledge, this is the first association study involving LIG4 and RAD52 genes and SLE predisposition.
C1 [Silva, Jaqueline De Azevedo; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, BR-50740600 Recife, PE, Brazil.
   [Silva, Jaqueline De Azevedo; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, LIKA, BR-50740600 Recife, PE, Brazil.
   [Tres Pancotto, Joao Alexandre] UFES, Sao Mateus, Espirito Santo, Brazil.
   [Donadi, Eduardo Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Sandrin-Garcia, P (corresponding author), Univ Fed Pernambuco, Dept Genet, Av Moraes Rego 1235, BR-50740600 Recife, PE, Brazil.
EM paula.sandrin@ufpe.br
RI Crovella, Sergio/K-5050-2016; donadi, eduardo A/H-7080-2013
OI Crovella, Sergio/0000-0001-8493-1168; donadi, eduardo
   A/0000-0002-9457-9601
FU CapesCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FACEPE
FX This work was supported by the Brazilian funding agencies: Capes, CNPq
   and FACEPE. We also like to thank Dr. Rafael Guimaraes for reading and
   providing insightful suggestions to the manuscript.
CR Bassi CL, 2008, LUPUS, V17, P988, DOI 10.1177/0961203308093461
   Bezerra Elaine Lira Medeiros, 2005, Rev. Bras. Reumatol., V45, P339, DOI 10.1590/S0482-50042005000600002
   Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200
   Chistiakov DA, 2009, EUR J MED GENET, V52, P373, DOI 10.1016/j.ejmg.2009.05.009
   Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516
   Fonseca AMD, 2013, GENE, V527, P435, DOI 10.1016/j.gene.2013.06.074
   Davies RC, 2012, ARTHRITIS RHEUM-US, V64, P568, DOI 10.1002/art.33334
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Grabarz A, 2012, AM J CANCER RES, V2, P249
   Hiom K, 1999, CURR BIOL, V9, pR446, DOI 10.1016/S0960-9822(99)80278-4
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108
   Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6
   Mark TW, 2011, CARCINOGENESIS, V3, P581, DOI [10.1093/carcin/bgr300, DOI 10.1093/CARCIN/BGR300]
   Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010
   O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7
   Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007
   Robinson M, 2011, J AM ACAD NURSE PRAC, V23, P629, DOI 10.1111/j.1745-7599.2011.00675.x
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sandrin-Garcia P, 2009, ANN NY ACAD SCI, V1173, P493, DOI 10.1111/j.1749-6632.2009.04636.x
   Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159
   Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061
   Sestak AL, 2008, LUPUS, V17, P1004, DOI 10.1177/0961203308091969
   Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028
   Takeda Y, 2001, FRONT BIOSCI, V6, P1412, DOI DOI 10.2741/TAKEDA
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Vilar MJP, 2002, LUPUS, V11, P528, DOI 10.1191/0961203302lu244xx
   Warchol T, 2012, DNA CELL BIOL, V31, P50, DOI 10.1089/dna.2011.1246
   Wei YF, 1999, MOL CELL BIOL, V6, P3206
NR 30
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD APR
PY 2014
VL 41
IS 4
BP 2249
EP 2256
DI 10.1007/s11033-014-3076-y
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE1DN
UT WOS:000333707100039
PM 24415301
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Kleiner, G
   Valencic, E
   Campisciano, G
   Girardelli, M
   Crovella, S
   Knowles, A
   Marcuzzi, A
AF Tricarico, Paola Maura
   Kleiner, Giulio
   Valencic, Erica
   Campisciano, Giuseppina
   Girardelli, Martina
   Crovella, Sergio
   Knowles, Alessandra
   Marcuzzi, Annalisa
TI Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory
   Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE isoprenoids; mevalonate; inflammation; phytol; lycopene
ID KINASE-DEFICIENCY; HYPERIMMUNOGLOBULINEMIA-D; IL-1-BETA RELEASE;
   APOPTOSIS; CYTOKINES; INHIBITION; ACTIVATION; EXPRESSION; SECRETION;
   LYCOPENE
AB Deregulation of the mevalonate pathway is known to be involved in a number of diseases that exhibit a systemic inflammatory phenotype and often neurological involvements, as seen in patients suffering from a rare disease called mevalonate kinase deficiency (MKD). One of the molecular mechanisms underlying this pathology could depend on the shortage of isoprenoid compounds and the subsequent mitochondrial damage, leading to oxidative stress and pro-inflammatory cytokines' release. Moreover, it has been demonstrated that cellular death results from the balance between apoptosis and pyroptosis, both driven by mitochondrial damage and the molecular platform inflammasome. In order to rescue the deregulated pathway and decrease inflammatory markers, exogenous isoprenoid compounds were administered to a biochemical model of MKD obtained treating a murine monocytic cell line with a compound able to block the mevalonate pathway, plus an inflammatory stimulus. Our results show that isoprenoids acted in different ways, mainly increasing the expression of the evaluated markers [apoptosis, mitochondrial dysfunction, nucleotide-binding oligomerization-domain protein-like receptors 3 (NALP3), cytokines and nitric oxide (NO)]. Our findings confirm the hypothesis that inflammation is triggered, at least partially, by the shortage of isoprenoids. Moreover, although further studies are necessary, the achieved results suggest a possible role for exogenous isoprenoids in the treatment of MKD.
C1 [Tricarico, Paola Maura; Campisciano, Giuseppina; Crovella, Sergio] Univ Trieste, Dept Med & Surg & Hlth, I-34128 Trieste, Italy.
   [Kleiner, Giulio; Valencic, Erica; Girardelli, Martina; Crovella, Sergio; Knowles, Alessandra; Marcuzzi, Annalisa] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
EM tricaricopa@gmail.com; giulio.kleiner@burlo.trieste.it;
   erica.valencic@gmail.com; g.campisciano@gmail.com;
   martina.girardelli@burlo.trieste.it; sergio.crovella@burlo.trieste.it;
   alessandra.knowles@burlo.trieste.it; annalisa.marcuzzi@burlo.trieste.it
RI Valencic, Erica/G-3067-2014; Campisciano, Giuseppina/J-3737-2018;
   Crovella, Sergio/K-5050-2016; Knowles, Alessandra/AAB-7765-2020;
   Marcuzzi, Annalisa/AAA-6038-2020; Girardelli, Martina/K-7199-2016
OI Valencic, Erica/0000-0002-7380-8014; Campisciano,
   Giuseppina/0000-0002-2307-5537; Crovella, Sergio/0000-0001-8493-1168;
   Knowles, Alessandra/0000-0003-4504-6371; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Kleiner, Giulio/0000-0002-1830-3961;
   Girardelli, Martina/0000-0003-1186-4907
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo" [RC
   42/11]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo" (RC 42/11).
CR Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   Clayton PT, 1998, ARCH DIS CHILD, V78, P185, DOI 10.1136/adc.78.2.185
   DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586
   Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004
   Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Furniss B. S., 1989, VOGELS TXB PRACTICAL, P1019
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Houten SM, 2002, HUM MOL GENET, V11, P3115, DOI 10.1093/hmg/11.25.3115
   Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001
   Kleiner G, 2013, IN VIVO, V27, P715
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112
   Marcuzzi A, 2013, PEDIATR RES, V74, P266, DOI 10.1038/pr.2013.96
   Marcuzzi A, 2012, CURR PHARM DESIGN, V18, P5746, DOI 10.2174/138161212803530835
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Moebius FF, 2000, TRENDS ENDOCRIN MET, V11, P106, DOI 10.1016/S1043-2760(00)00235-6
   Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065
   Normand S, 2009, EUR CYTOKINE NETW, V20, P101, DOI 10.1684/ecn.2009.0163
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013
   Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014
   Tricarico PM, 2013, INT J MOL SCI, V14, P23274, DOI 10.3390/ijms141223274
   Ungvari Zoltan, 2005, Current Vascular Pharmacology, V3, P221, DOI 10.2174/1570161054368607
   van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920
   Yonar ME, 2013, ENVIRON TOXICOL, V28, P609, DOI 10.1002/tox.20757
NR 29
TC 21
Z9 21
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2014
VL 15
IS 4
BP 6843
EP 6856
DI 10.3390/ijms15046843
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AI4ND
UT WOS:000336841200109
PM 24758928
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Girardelli, M
   Vuch, J
   Tommasini, A
   Crovella, S
   Bianco, AM
AF Girardelli, Martina
   Vuch, Josef
   Tommasini, Alberto
   Crovella, Sergio
   Bianco, Anna Monica
TI Novel Missense Mutation in the NOD2 Gene in a Patient with Early Onset
   Ulcerative Colitis: Causal or Chance Association?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE complex disease; digenic heterozygosis; early onset-inflammatory bowel
   disease; IL10R; NOD2
ID INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; RECEPTOR
AB Deregulated immune response to gut microflora in genetically predisposed individuals is typical for inflammatory bowel diseases. It is reasonable to assume that genetic association with the disease will be more pronounced in subjects with early onset than adult onset. The nucleotide-binding oligomerization domain containing-2 gene, commonly involved in multifactorial risk of Crohn's disease, and interleukin 10 receptor genes, associated with rare forms of early onset inflammatory bowel diseases, were sequenced in an early onset patient. We identified a novel variant in the NOD2 gene (c.2857A > G p.K953E) and two already described missense variants in the IL10RA gene (S159G and G351R). The new NOD2 missense variant was examined in silico with two online bioinformatics tools to predict the potentially deleterious effects of the mutation. Although cumulative effect of these variations in the early onset of the disease can be only hypothesized, we demonstrated that family information and in silico studies can be used to predict association with the disease.
C1 [Girardelli, Martina; Tommasini, Alberto; Crovella, Sergio; Bianco, Anna Monica] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Vuch, Josef; Crovella, Sergio] Univ Trieste, Dept Med & Surg & Hlth, I-34128 Trieste, Italy.
RP Girardelli, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM martina.girardelli@burlo.trieste.it; josef.vuch@burlo.trieste.it;
   alberto.tommasini@burlo.trieste.it; sergio.crovella@burlo.trieste.it;
   annamonicarosaria.bianco@burlo.trieste.it
RI Tommasini, Alberto/AAE-3882-2020; Crovella, Sergio/K-5050-2016; BIANCO,
   ANNA MONICA/D-3098-2014; Girardelli, Martina/K-7199-2016
OI Tommasini, Alberto/0000-0002-6943-7927; Crovella,
   Sergio/0000-0001-8493-1168; BIANCO, ANNA MONICA/0000-0001-8101-9659;
   Girardelli, Martina/0000-0003-1186-4907
FU Institute for Maternal and Child Health, IRCCS "Burlo Garofolo",
   Trieste, Italy [RC 40/2011]
FX We would like to thank Stefano Martelossi (Institute for Maternal and
   Child Health, IRCCS "Burlo Garofolo", Trieste, Italy) and Paolo Lionetti
   (Department of Sciences for Woman and Child's Health, University of
   Florence, Meyer Children's University Hospital, Florence, Italy) for
   kindly providing their contribution. This work was supported by a grant
   from the Institute for Maternal and Child Health, IRCCS "Burlo
   Garofolo", Trieste, Italy (RC 40/2011).
CR Adzhubei I., 2013, CURR PROTOC HUM GENE, DOI [10.1002/0471142905.hg0720s76, DOI 10.1002/0471142905. HG0720S76]
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Finsterbusch M, 2011, GENES IMMUN, V12, P575, DOI 10.1038/gene.2011.12
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Grundtner P, 2009, GENES IMMUN, V10, P84, DOI 10.1038/gene.2008.72
   Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043
   Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114
   Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63
   Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831
   Ruemmele FM, 2006, J PEDIATR GASTR NUTR, V43, P603, DOI 10.1097/01.mpg.0000237938.12674.e3
   Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713
NR 13
TC 6
Z9 6
U1 0
U2 2
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2014
VL 15
IS 3
BP 3834
EP 3841
DI 10.3390/ijms15033834
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AF0ZU
UT WOS:000334444700028
PM 24595243
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Celsi, F
   Tommasini, A
   Crovella, S
AF Celsi, Fulvio
   Tommasini, Alberto
   Crovella, Sergio
TI "Hyper-IgD syndrome" or "mevalonate kinase deficiency": an old syndrome
   needing a new name?
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Letter
C1 [Celsi, Fulvio; Tommasini, Alberto; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Celsi, F (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
EM celsi@burlo.trieste.it
RI Tommasini, Alberto/AAE-3882-2020; Crovella, Sergio/K-5050-2016; Celsi,
   Fulvio/H-2775-2019
OI Tommasini, Alberto/0000-0002-6943-7927; Crovella,
   Sergio/0000-0001-8493-1168; Celsi, Fulvio/0000-0002-9760-8463
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ammouri W, 2007, RHEUMATOLOGY, V46, P1597, DOI 10.1093/rheumatology/kem200
   Stabile A, 2012, RHEUMATOL INT
   Van der Burgh R, 2012, CLIN IMMUNOL
   van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7
NR 5
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD MAR
PY 2014
VL 34
IS 3
BP 423
EP 424
DI 10.1007/s00296-013-2702-7
PG 2
WC Rheumatology
SC Rheumatology
GA AB5MK
UT WOS:000331832500018
PM 23412692
DA 2020-12-08
ER

PT J
AU Segat, L
   Zupin, L
   Kim, HY
   Catamo, E
   Thea, DM
   Kankasa, C
   Aldrovandi, GM
   Kuhn, L
   Crovella, S
AF Segat, L.
   Zupin, L.
   Kim, H. -Y.
   Catamo, E.
   Thea, D. M.
   Kankasa, C.
   Aldrovandi, G. M.
   Kuhn, L.
   Crovella, S.
TI HLA-G 14 bp deletion/insertion polymorphism and mother-to-child
   transmission of HIV
SO TISSUE ANTIGENS
LA English
DT Article
DE human leukocyte antigen-G; human immunodeficiency virus-1; 14 bp
   insertion/deletion; vertical transmission; genetic polymorphism
ID VERTICAL TRANSMISSION; CLASS-I; PLACENTAL TROPHOBLASTS; TYPE-1 VARIANTS;
   VIRUS; INFECTION; ASSOCIATION; CONCORDANCE; RISK; REGION
AB The human leukocyte antigen HLA-G, highly expressed at the maternal-fetal interface, has a pivotal role in mediating immune tolerance. In this study we investigated the influence of HLA-G 14 bp insertion polymorphism in human immunodeficiency virus (HIV)-1 mother-to-child HIV-1 transmission. The 14 bp insertion polymorphism was analyzed among 99 HIV-1 positive mothers and 329 infants born to HIV-positive mothers in Zambia, among whom vertical transmission status and timing had been determined. HLA-G 14 bp insertion polymorphism was detected using a custom TaqMan single nucleotide polymorphisms (SNPs) genotyping assay. Logistic regression was conducted to examine the associations between HLA-G alleles and the risk of HIV transmission. The 14 bp insertion allele was more frequent in HIV exposed-uninfected (EU) infants than in infected infants, and was associated with reduced risk of both in utero (IU) and intrapartum (IP) HIV transmission, after adjusting for maternal cluster of differentiation 4 (CD4) cell count and plasma viral load. Maternal HLA-G 14 bp insertion genotype and HLA-G concordance between mother and child were not associated with the risk of perinatal HIV transmission. The presence of the 14 bp insertion associates with protection toward IU and IP HIV infection in children from Zambia, suggesting that HLA-G could be involved in the vertical transmission of HIV.
C1 [Segat, L.; Zupin, L.; Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Catamo, E.; Crovella, S.] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
   [Kim, H. -Y.; Kuhn, L.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.
   [Kim, H. -Y.; Kuhn, L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Thea, D. M.] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA.
   [Kankasa, C.] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia.
   [Aldrovandi, G. M.] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM ludovica.segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Zupin, Luisa/I-5228-2018; Catamo,
   Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Zupin, Luisa/0000-0001-5886-9129;
   Catamo, Eulalia/0000-0002-4701-9134; Thea, Donald/0000-0002-6933-1030;
   Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC06/11, RC13/12]; Eunice Kennedy
   Shriver, National Institute of Child Health and Human Development
   (NICHD), National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [HD39611, HD40777, HD57617]; EUNICE KENNEDY SHRIVER
   NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [R01HD040777, R01HD057617, R01HD039611,
   R01HD040777, R01HD057617, R01HD040777, R01HD039611, R01HD057617,
   R01HD039611, R01HD040777, R01HD040777, R01HD040777, R01HD039611,
   R01HD039611, R01HD040777, R01HD039611, R01HD040777, R01HD039611,
   R01HD039611, R01HD040777, R01HD057617, R01HD057617] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [UM1AI106716, UM1AI106716, UM1AI106716, UM1AI106716,
   UM1AI106716, UM1AI106716, UM1AI106716] Funding Source: NIH RePORTER
FX This work has been supported by RC06/11 and RC13/12 grants from IRCCS
   Burlo Garofolo Trieste (Italy). This study was supported in part by
   grants from the Eunice Kennedy Shriver, National Institute of Child
   Health and Human Development (NICHD), National Institutes of Health
   (NIH) (HD39611, HD40777, HD57617). Authors contribution: LS conceived
   the study and drafted the manuscript; LZ performed DNA extraction and
   HLA-G genotyping; HYK conducted the statistical analyses; EC
   participated in HLA-G genotyping; DT designed original study; CK
   conducted original study; GA undertook all laboratory analyses on
   original study; LK designed original study and conducted statistical
   analysis; SC critically revised the manuscript.
CR Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Blaschitz A, 2005, MOL HUM REPROD, V11, P699, DOI 10.1093/molehr/gah185
   BOURINBAIAR AS, 1993, ACTA VIROL, V37, P21
   Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284
   DeAndreis C, 1996, AIDS, V10, P711, DOI 10.1097/00002030-199606001-00004
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048
   Kilani RT, 1997, J VIROL, V71, P6359, DOI 10.1128/JVI.71.9.6359-6372.1997
   Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6
   Kourtis AP, 2013, J INFECT DIS, V208, P653, DOI 10.1093/infdis/jit221
   Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010
   Lagaye S, 2001, J VIROL, V75, P4780, DOI 10.1128/JVI.75.10.4780-4791.2001
   Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924
   LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547
   Luo M, 2013, HUM IMMUNOL, V74, P459, DOI 10.1016/j.humimm.2012.11.023
   MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243
   Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528
   Martinetti M, 2006, INT J IMMUNOPATH PH, V19, P369, DOI 10.1177/039463200601900213
   Matte C, 2002, AIDS, V16, P2491, DOI 10.1097/00002030-200212060-00021
   Matte C, 2001, MOL MED, V7, P583, DOI 10.1007/BF03401864
   Mendes-Junior CT, 2013, GENES IMMUN      OCT
   Menicucci A, 1999, HUM IMMUNOL, V60, P1054, DOI 10.1016/S0198-8859(99)00108-1
   Menu E, 1999, J INFECT DIS, V179, P44, DOI 10.1086/314542
   Moodley S, 2011, PLACENTA, V32, P778, DOI 10.1016/j.placenta.2011.07.012
   Moussa M, 1999, AM J REPROD IMMUNOL, V41, P312
   Newell Marie-Louise, 2004, Expert Rev Anti Infect Ther, V2, P717, DOI 10.1586/14789072.2.5.717
   Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477
   Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x
   Robert-Gangneux F, 2011, CLIN IMMUNOL, V138, P129, DOI 10.1016/j.clim.2010.12.004
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Svendsen SG, 2013, HUM IMMUNOL, V74, P818, DOI 10.1016/j.humimm.2013.03.003
   Tao Y, 2013, INT J IMMUNOGENET, V40, P93, DOI 10.1111/j.1744-313X.2012.01137.x
   Tscherning-Casper C, 1999, J VIROL, V73, P9673, DOI 10.1128/JVI.73.11.9673-9678.1999
   World Health Organization, 2010, ANT THER HIV INF AD
   World Health Organization (WHO), 2010, ANT DRUGS TREAT PREG
   Zachar V, 1999, AIDS RES HUM RETROV, V15, P1673, DOI 10.1089/088922299309711
NR 39
TC 18
Z9 21
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD MAR
PY 2014
VL 83
IS 3
BP 161
EP 167
DI 10.1111/tan.12296
PG 7
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA AB0WC
UT WOS:000331511800004
PM 24571474
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Da Silva, RC
   Moura, R
   Crovella, S
AF Pontillo, Alessandra
   Da Silva, Ronaldo C.
   Moura, Ronald
   Crovella, Sergio
TI Host genomic HIV restriction factors modulate the response to dendritic
   cell-based treatment against HIV-1
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE DC-based immune-treatment; HIV vaccine; PARD3B; host genome and response
   to vaccine
ID VACCINE; INFECTION
AB Host genome is still poorly investigated in the context of vaccine or immunotherapy, however recently findings emphasized that it may affect the response to those treatments. In our retrospective study we evaluated the effect of HIV-1 genetic restriction factors on the response to dendritic cell (DC)-based immunotherapy in a Brazilian cohort of HIV positive (HIV+) patients that underwent a phase I clinical trial in 2004.
   Genomic DNA from 18 HIV+ individuals that underwent DC-based immunotherapy was analyzed for selected polymorphisms known to be associated with susceptibility to HIV-1 infection and/or AIDS progression. Allelic and genotypic distribution of the 22 polymorphisms was evaluated considering the response to the treatment.
   The rs11884476 SNP in PARD3B resulted associated with good response to immune treatment according to an over-dominant model. Even if functional effect of this variation is still unknown, our data suggested that it could play a role in the control of viral replication.
   Our findings, being aware of the limitation represented by the small number of subjects analyzed, suggest that genetic factors involved in AIDS progression could affect the response to immunotherapy, reinforcing the idea that deeper investigation on host genetic variations will be fundamental for a rational vaccine development.
C1 [Pontillo, Alessandra] Univ Sao Paulo, Inst Biol Sci, Dept Immunol, Sao Paulo, Brazil.
   [Da Silva, Ronaldo C.; Moura, Ronald; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Inst Biol Sci, Dept Immunol, Sao Paulo, Brazil.
EM alepontillo@usp.br
RI Moura, Ronald/AAE-2318-2020; Pontillo, Alessandra/AAD-4790-2019; Moura,
   Ronald/F-7769-2012; Pontillo, ALESSANDRA/D-4352-2012; Crovella,
   Sergio/K-5050-2016; Pontillo, Alessandra/ABC-6266-2020
OI Moura, Ronald/0000-0002-9112-7167; Pontillo,
   Alessandra/0000-0002-7883-0640; Moura, Ronald/0000-0002-9112-7167;
   Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640
FU Pernambuco Research Foundation (FACEPE); Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/06142-1]; Brazilian National Council for Scientific and
   Technologic Development (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX This work was supported by the Pernambuco Research Foundation (FACEPE),
   Sao Paulo Research Foundation (FAPESP, n. 2013/06142-1) and Brazilian
   National Council for Scientific and Technologic Development (CNPq).
CR An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002
   Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125
   Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682
   Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043
   Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147
   Kulkarni H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003671
   Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147
   Segat L, 2010, VACCINE, V28, P2201, DOI 10.1016/j.vaccine.2009.12.056
   Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046
NR 9
TC 9
Z9 9
U1 0
U2 3
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD FEB
PY 2014
VL 10
IS 2
BP 512
EP 518
DI 10.4161/hv.27125
PG 7
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA AI1YV
UT WOS:000336652500045
PM 24240316
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Silva, JD
   Addobbati, C
   Sandrin-Garcia, P
   Crovella, S
AF De Azevedo Silva, J.
   Addobbati, C.
   Sandrin-Garcia, P.
   Crovella, S.
TI Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus
   Clinical Manifestations
SO CURRENT GENOMICS
LA English
DT Article
DE Autoimmunity; B cells; Clinical manifestations; DSBs; IFN; SLE; SNPs; T
   cells.
ID INTERLEUKIN-10 PROMOTER POLYMORPHISMS; GENOME-WIDE ASSOCIATION;
   TOLL-LIKE RECEPTOR-9; I INTERFERON SYSTEM; TYROSINE KINASE 2; VITAMIN-D;
   R620W POLYMORPHISM; DNA-REPAIR; B-CELLS; MICROSATELLITE POLYMORPHISMS
AB Systemic Lupus Erythematosus (SLE) is one of the most relevant world-wide autoimmune disorders. The formation of autoantibodies and the deposition of antibody-containing immune complexes in blood vessels throughout the body is the main pathogenic mechanism of SLE leading to heterogeneous clinical manifestations and target tissue damage. The complexity of etiology and pathogenesis in SLE, enclosing genetic and environmental factors, apparently is one of the greatest challenges for both researchers and clinicians. Strong indications for a genetic background in SLE come from studies in families as well as in monozygotic and dizygotic twins, discovering several SLE-associated loci and genes (e. g. IRF5, PTPN22, CTLA4, STAT4 and BANK1). As SLE has a complex genetic background, none of these genes is likely to be entirely responsible for triggering autoimmune response in SLE even if they disclosure a potentially novel molecular mechanisms in the pathogenesis' disease. The clinical manifestations and disease severity varies greatly among patients, thus several studies try to associate clinical heterogeneity and prognosis with specific genetic polymorphisms in SLE associated genes. The continue effort to describe new predisposing or modulating genes in SLE is justified by the limited knowledge about the pathogenesis, assorted clinical manifestation and the possible prevention strategies. In this review we describe newly discovered, as well as the most studied genes associated to SLE susceptibility, and relate them to clinical manifestations of the disease.
C1 [De Azevedo Silva, J.; Addobbati, C.; Sandrin-Garcia, P.; Crovella, S.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Addobbati, C.; Sandrin-Garcia, P.; Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Silva, JD (corresponding author), Univ Fed Pernambuco, LIKA, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM j.azvedo@gmail.com
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FACEPE
FX Research in our lab is supported by the following funding agencies:
   CAPES, CNPq and FACEPE.
CR Addobbati C, 2013, HUM IMMUNOL, V74, P1009, DOI 10.1016/j.humimm.2013.04.026
   Ahmed S, 2001, RHEUMATOLOGY, V40, P662, DOI 10.1093/rheumatology/40.6.662
   Alarcon-Riquelme ME, 2003, J AUTOIMMUN, V21, P117, DOI 10.1016/S0896-8411(03)00093-3
   Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100
   Bassi CL, 2008, LUPUS, V17, P988, DOI 10.1177/0961203308093461
   Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064
   Bertsias GK, 2009, ARTHRITIS RHEUM-US, V60, P207, DOI 10.1002/art.24227
   Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018
   Castillejo-Lopez C, 2012, ANN RHEUM DIS, V71, P136, DOI 10.1136/annrheumdis-2011-200085
   Cen H, 2013, INFLAMMATION, V36, P444, DOI 10.1007/s10753-012-9564-0
   Chai HC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/963730
   Cham CM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/780436
   Chang YK, 2009, GENES IMMUN, V10, P414, DOI 10.1038/gene.2009.16
   Chen JY, 2006, CLIN EXP IMMUNOL, V143, P281, DOI 10.1111/j.1365-2249.2005.02984.x
   Cherian TS, 2012, ARTHRITIS RHEUM-US, V64, P3383, DOI 10.1002/art.34571
   Chistiakov DA, 2003, J MOL ENDOCRINOL, V31, P21, DOI 10.1677/jme.0.0310021
   Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071
   Chong WP, 2004, GENES IMMUN, V5, P484, DOI 10.1038/sj.gene.6364119
   Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323
   Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111
   Conti F, 2011, CLIN REV ALLERG IMMU, V40, P192, DOI 10.1007/s12016-010-8208-0
   Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179
   Criswell LA, 2008, BULL HOSP JT DIS, V66, P176
   D'Alfonso S, 2000, ARTHRITIS RHEUM, V43, P120, DOI 10.1002/1529-0131(200001)43:1<120::AID-ANR15>3.0.CO;2-3
   Fonseca AMD, 2013, GENE, V527, P435, DOI 10.1016/j.gene.2013.06.074
   Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963
   DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206
   Davies RC, 2012, ARTHRITIS RHEUM-US, V64, P568, DOI 10.1002/art.33334
   Silva JD, 2013, LUPUS, V22, P1110, DOI 10.1177/0961203313500549
   De Azevedo Silva J, 2013, MOL BIO REP, V1
   Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003
   dos Santos BP, 2012, LUPUS, V21, P302, DOI 10.1177/0961203311425522
   Eliopoulos E, 2011, LUPUS, V20, P501, DOI 10.1177/0961203310392423
   Eskdale J, 1996, IMMUNOGENETICS, V45, P82, DOI 10.1007/s002510050174
   ESKDALE J, 1995, IMMUNOGENETICS, V42, P444
   Fasching PA, 2009, MOL ONCOL, V3, P171, DOI 10.1016/j.molonc.2009.01.008
   Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x
   Gantier MP, 2010, HUM MUTAT, V31, P1069, DOI 10.1002/humu.21321
   Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468
   Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998
   GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757
   Gomez LM, 2005, GENES IMMUN, V6, P628, DOI 10.1038/sj.gene.6364261
   Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47
   Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341
   Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x
   Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300
   Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397
   Guan M, 2011, RHEUMATOLOGY, V50, P473, DOI 10.1093/rheumatology/keq353
   Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844
   Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013
   Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472
   He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135
   Jacob CO, 2003, J IMMUNOL, V171, P1564, DOI 10.4049/jimmunol.171.3.1564
   Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263
   Jarvinen TM, 2010, EXP DERMATOL, V19, P123, DOI 10.1111/j.1600-0625.2009.00982.x
   Johansson M, 2005, ARTHRITIS RHEUM-US, V52, P1665, DOI 10.1002/art.21058
   Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216
   Khoa PD, 2005, CLIN RHEUMATOL, V24, P11, DOI 10.1007/s10067-004-0952-1
   Khoury SJ, 2004, IMMUNITY, V20, P529, DOI 10.1016/S1074-7613(04)00116-5
   Kimkong I, 2011, ASIAN PAC J ALLERGY, V29, P229
   Kozyrev SV, 2012, GENES IMMUN, V13, P129, DOI 10.1038/gene.2011.62
   Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79
   KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001
   Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801
   Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790
   Kyogoku C, 2009, MOD RHEUMATOL, V19, P401, DOI 10.1007/s10165-009-0173-1
   LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R
   Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8
   Lee KJ, 2002, J IMMUNOL, V169, P3413, DOI 10.4049/jimmunol.169.6.3413
   Lee YH, 2012, INFLAMM RES, V61, P949, DOI 10.1007/s00011-012-0486-y
   Lenert P, 2010, CLIN EXP IMMUNOL, V161, P208, DOI 10.1111/j.1365-2249.2010.04176.x
   Li P, 2011, J RHEUMATOL, V38, P177, DOI 10.3899/jrheum.100424
   Li PH, 2013, RHEUMATOLOGY, V52, P337, DOI 10.1093/rheumatology/kes261
   Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6
   Lin YJ, 2009, LUPUS, V18, P1246, DOI 10.1177/0961203309345777
   Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290
   Luo XY, 2012, LUPUS, V21, P53, DOI 10.1177/0961203311422709
   Luo Xiong-yan, 2012, Zhonghua Nei Ke Za Zhi, V51, P131
   MALEFYT RD, 1991, J EXP MED, V174, P915
   Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439
   Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6
   Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040
   Moez P, 2012, RHEUMATOL INT, V32, P2753, DOI 10.1007/s00296-011-2063-z
   Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128
   Monticielo OA, 2012, CLIN RHEUMATOL, V31, P1411, DOI 10.1007/s10067-012-2021-5
   Montoya-Diaz E, 2011, IMMUNOL INVEST, V40, P614, DOI 10.3109/08820139.2011.570402
   Mory DB, 2009, HUM IMMUNOL, V70, P447, DOI 10.1016/j.humimm.2009.03.007
   Mostowska A, 2013, MOL BIOL REP, V40, P803, DOI 10.1007/s11033-012-2118-6
   Mostowska M, 2008, CLIN EXP RHEUMATOL, V26, P457
   Moura R., 2013, J MOL BIOL REP, P1
   Murphy G., 2013, RHEUMATOLOGY, DOI [10.1093/rheumatology/ket160, DOI 10.1093/RHEUMAT0L0GY/KET160]
   Niewold TB, 2008, ARTHRITIS RHEUM-US, V58, P2113, DOI 10.1002/art.23619
   Ntali S, 2010, TRANSL RES, V156, P317, DOI 10.1016/j.trsl.2010.08.006
   Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010
   Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771
   Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363
   Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504
   Panierakis C, 2009, CLIN IMMUNOL, V133, P276, DOI 10.1016/j.clim.2009.08.004
   Papadimitraki ED, 2009, LUPUS, V18, P831, DOI 10.1177/0961203309103054
   Pavlovic M, 2010, AUTOIMMUN DIS, V2010, DOI 10.4061/2010/462841
   Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486
   Piotrowski P, 2008, CLIN EXP RHEUMATOL, V26, P1099
   Piotrowski P, 2012, MOL BIOL REP, V39, P8861, DOI 10.1007/s11033-012-1752-3
   Prokunina L, 2004, ARTHRITIS RHEUM, V50, P327, DOI 10.1002/art.11442
   Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020
   Qin LX, 2010, NEPHROLOGY, V15, P710, DOI 10.1111/j.1440-1797.2010.01327.x
   Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297
   Rajabi P, 2012, INFLAMM RES, V61, P1347, DOI 10.1007/s00011-012-0535-6
   Reddy MVPL, 2005, GENES IMMUN, V6, P658, DOI 10.1038/sj.gene.6364252
   Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003
   Rhodes KA, 2008, EUR J IMMUNOL, V38, P2274, DOI 10.1002/eji.200838354
   Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009
   Rood MJ, 1999, ANN RHEUM DIS, V58, P85, DOI 10.1136/ard.58.2.85
   Rosado S, 2008, INT J IMMUNOGENET, V35, P235, DOI 10.1111/j.1744-313X.2008.00762.x
   ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890
   Salloum R, 2011, TRANSL RES, V157, P326, DOI 10.1016/j.trsl.2011.01.006
   Sanchez E, 2012, ARTHRITIS RHEUM-US, V64, P3687, DOI 10.1002/art.34650
   Sanchez E, 2011, ARTHRITIS RHEUM-US, V63, P3493, DOI 10.1002/art.30563
   Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104
   Sandrin-Garcia P, 2009, ANN NY ACAD SCI, V1173, P493, DOI 10.1111/j.1749-6632.2009.04636.x
   Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066
   Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061
   Schotte H, 2004, RHEUMATOLOGY, V43, P1357, DOI 10.1093/rheumatology/keh353
   Shelly S, 2012, AUTOIMMUN REV, V11, pA465, DOI 10.1016/j.autrev.2011.11.009
   Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013
   Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480
   Sobkowiak A, 2009, RHEUMATOL INT, V29, P921, DOI 10.1007/s00296-008-0776-4
   Stevens A, 2001, ARTHRITIS RHEUM-US, V44, P2358, DOI 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K
   Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082
   Stone RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054487
   Suarez A, 2005, ANN RHEUM DIS, V64, P1605, DOI 10.1136/ard.2004.035048
   Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698
   Sugimoto K, 2008, CLIN EXP NEPHROL, V12, P149, DOI 10.1007/s10157-007-0019-0
   Takeda Y, 2001, FRONT BIOSCI, V6, P1412, DOI DOI 10.2741/TAKEDA
   Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084
   Tseng RC, 2009, CANCER-AM CANCER SOC, V115, P2939, DOI 10.1002/cncr.24327
   Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x
   Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014
   Ulker M, 2009, INT J IMMUNOGENET, V36, P245, DOI 10.1111/j.1744-313X.2009.00856.x
   Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673
   Wang CY, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds2
   Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9
   Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001
   Warchol T, 2012, DNA CELL BIOL, V31, P50, DOI 10.1089/dna.2011.1246
   Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200
   Xu YX, 2012, CELL IMMUNOL, V278, P125, DOI 10.1016/j.cellimm.2012.07.007
   Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270
   Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841
   Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83
   Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904
   Zhang SQ, 2011, RHEUMATOL INT, V31, P227, DOI 10.1007/s00296-009-1247-2
   Zheng JF, 2013, HUM IMMUNOL, V74, P986, DOI 10.1016/j.humimm.2013.04.034
   Zhou XJ, 2012, ARTHRITIS RHEUM-US, V64, P222, DOI 10.1002/art.33318
   Zhu LJ, 2005, CLIN EXP RHEUMATOL, V23, P854
NR 158
TC 19
Z9 19
U1 0
U2 14
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PD FEB
PY 2014
VL 15
IS 1
BP 52
EP 65
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AC8FG
UT WOS:000332768300007
PM 24653663
OA Green Published
DA 2020-12-08
ER

PT J
AU Moura, R
   Pontillo, A
   D'Adamo, P
   Pirastu, N
   Coelho, AC
   Crovella, S
AF Moura, Ronald
   Pontillo, Alessandra
   D'Adamo, Pio
   Pirastu, Nicola
   Coelho, Antonio Campos
   Crovella, Sergio
TI Exome analysis of HIV patients submitted to dendritic cells therapeutic
   vaccine reveals an association of CNOT1 gene with response to the
   treatment
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Article
DE DC immunotherapy; HIV; exome analysis; CNOT1; TTP
ID COMPLEX
AB Introduction: With the aim of searching genetic factors associated with the response to an immune treatment based on autologous monocyte-derived dendritic cells pulsed with autologous inactivated HIV, we performed exome analysis by screening more than 240,000 putative functional exonic variants in 18 HIV-positive Brazilian patients that underwent the immune treatment.
   Methods: Exome analysis has been performed using the ILLUMINA Infinium HumanExome BeadChip. zCall algorithm allowed us to recall rare variants. Quality control and SNP-centred analysis were done with GenABEL R package. An in-house implementation of the Wang method permitted gene-centred analysis.
   Results: CCR4-NOT transcription complex, subunit 1 (CNOT1) gene (16q21), showed the strongest association with the modification of the response to the therapeutic vaccine (p = 0.00075). CNOT1 SNP rs7188697 A/G was significantly associated with DC treatment response. The presence of a G allele indicated poor response to the therapeutic vaccine (p = 0.0031; OR = 33.00; CI = 1.74 = 624.66), and the SNP behaved in a dominant model (A/A vs. A/G + G/G p = 0.0009; OR = 107.66; 95% CI = 3.85-3013.31), being the A/G genotype present only in weak/transient responders, conferring susceptibility to poor response to the immune treatment.
   Discussion: CNOT1 is known to be involved in the control of mRNA deadenylation and mRNA decay. Moreover, CNOT1 has been recently described as being involved in the regulation of inflammatory processes mediated by tristetraprolin (TTP). The TTP-CCR4-NOT complex (CNOT1 in the CCR4-NOT complex is the binding site for TTP) has been reported as interfering with HIV replication, through post-transcriptional control. Therefore, we can hypothesize that genetic variation occurring in the CNOT1 gene could impair the TTP-CCR4-NOT complex, thus interfering with HIV replication and/or host immune response.
   Conclusions: Being aware that our findings are exclusive to the 18 patients studied with a need for replication, and that the genetic variant of CNOT1 gene, localized at intron 3, has no known functional effect, we propose a novel potential candidate locus for the modulation of the response to the immune treatment, and open a discussion on the necessity to consider the host genome as another potential variant to be evaluated when designing an immune therapy study.
C1 [Moura, Ronald; Coelho, Antonio Campos] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Pontillo, Alessandra] Univ San Paolo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
   [D'Adamo, Pio; Pirastu, Nicola; Crovella, Sergio] Univ Trieste, IRCCS Burlo Garofolo, Dept Reprod Sci & Dev, Trieste, Italy.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Moura, Ronald/F-7769-2012; Pontillo, Alessandra/AAD-4790-2019; Coelho,
   Antonio Victor C/E-6795-2015; Moura, Ronald/AAE-2318-2020; Pontillo,
   Alessandra/ABC-6266-2020; Pontillo, ALESSANDRA/D-4352-2012; d'Adamo,
   Adamo Pio/G-4064-2011; Crovella, Sergio/K-5050-2016
OI Moura, Ronald/0000-0002-9112-7167; Pontillo,
   Alessandra/0000-0002-7883-0640; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Moura, Ronald/0000-0002-9112-7167; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; d'Adamo, Adamo Pio/0000-0001-9367-4909;
   Crovella, Sergio/0000-0001-8493-1168; Pirastu,
   Nicola/0000-0002-5363-3886
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD
   program); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/06142-1]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Facepe - Fundacao de Amparo a Ciencia e Tecnologia
   de Pernambuco (FACEPE); IRCCS Burlo Garofolo [RC06/11]; Fundacao Amparo
   a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [IBPG
   0926-2.02/11]
FX The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/PNPD program), Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP, n. 2013/06142-1), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Facepe - Fundacao de
   Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE) and IRCCS Burlo
   Garofolo (RC06/11) for financial support. R. Moura is recipient of a
   post-graduate from Fundacao Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco (FACEPE, IBPG 0926-2.02/11).
CR An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542
   Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572
   Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682
   Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043
   Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104
   Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479
   Ito K, 2011, PROTEIN CELL, V2, P755, DOI 10.1007/s13238-011-1092-4
   Kaufmann Daniel E, 2003, J HIV Ther, V8, P19
   Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147
   Maeda M, 2006, MICROBES INFECT, V8, P2647, DOI 10.1016/j.micinf.2006.07.010
   McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674
   Miedema F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00298
   Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023
   Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f
   Segat L, 2010, VACCINE, V28, P2201, DOI 10.1016/j.vaccine.2009.12.056
   Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266
NR 18
TC 12
Z9 12
U1 0
U2 12
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JAN 10
PY 2014
VL 17
AR 18938
DI 10.7448/IAS.17.1.18938
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 287BI
UT WOS:000329512600001
PM 24433985
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Lenarduzzi, S
   Morgutti, M
   Crovella, S
   Coiana, A
   Rosatelli, MC
AF Lenarduzzi, S.
   Morgutti, M.
   Crovella, S.
   Coiana, A.
   Rosatelli, M. C.
TI Novel truncating mutations in the CFTR gene causing a severe form of
   cystic fibrosis in Italian patients
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Cystic fibrosis; Novel mutation; Pancreatic insufficiency; Severe
   mutations
ID IDENTIFICATION; DOMAIN; SWEAT
AB Cystic fibrosis (CF) is a common recessive genetic disease caused by mutations in the gene encoding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. More than 1800 different mutations have been described to date. Here, we report 3 novel mutations in CFTR in 3 Italian CF patients. To detect and identify 36 frequent mutations in Caucasians, we used the INNO-LiPA CFTR19 and INNO-LiPA CFTR17+Tn Update kits (Innogenetics; Ghent, Belgium). Our first analysis did not reveal both of the responsible mutations; thus, direct sequencing of the CFTR gene coding region was performed. The 3 patients were compound heterozygous. In one allele, the F508del (c. 1521_1523delCTT, p.PHE508del) mutation in exon 11 was observed in each case. For the second allele, in patient No. 1, direct sequencing revealed an 11-base pair deletion (GAGGCGATACT) in exon 14 (c.2236_2246del; pGlu746Alafs*29). In patient No. 2, direct sequencing revealed a nonsense mutation at nucleotide 3892 (c.3892G>T) in exon 24. In patient No. 3, direct sequencing revealed a deletion of cytosine in exon 27 (c.4296delC; p.Asn1432Lysfs*16). These 3 novel mutations indicate the production of a truncated protein, which consequently results in a non-functional polypeptide.
C1 [Lenarduzzi, S.; Morgutti, M.; Crovella, S.] Inst Maternal & Child Hlth Burlo Garofolo, Trieste, Italy.
   [Crovella, S.] Univ Trieste, Dept Hlth Med & Surg Sci, Trieste, Italy.
   [Coiana, A.; Rosatelli, M. C.] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy.
RP Lenarduzzi, S (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Trieste, Italy.
EM stefania.lenarduzzi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Coiana,
   Alessandra/0000-0002-1039-5486; ROSATELLI, MARIA
   CRISTINA/0000-0001-6821-3190
FU IRCCS Burlo Garofolo (Trieste, Italy) [RC37/07]
FX Research supported by a grant (#RC37/07) from IRCCS Burlo Garofolo
   (Trieste, Italy)
CR Bienvenu T, 1997, ANN BIOL CLIN-PARIS, V55, P113
   CHEVALIERPORST F, 1993, HUM MOL GENET, V2, P1071, DOI 10.1093/hmg/2.7.1071
   Claustres M, 2008, CYSTIC FIBROSIS MUTA
   Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731
   GIBSON LE, 1959, PEDIATRICS, V23, P545
   Jezequel P, 2000, MOL HUM REPROD, V6, P1063, DOI 10.1093/molehr/6.12.1063
   Kirk KL, 2000, CELL MOL LIFE SCI, V57, P623, DOI 10.1007/PL00000724
   Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729
   Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453
   Naren AP, 2000, NEWS PHYSIOL SCI, V15, P57
   Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5
   Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021
NR 12
TC 1
Z9 1
U1 0
U2 2
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2014
VL 13
IS 4
BP 9636
EP 9641
DI 10.4238/2014.November.14.8
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AT7LX
UT WOS:000345119600084
PM 25501174
OA Bronze
DA 2020-12-08
ER

PT J
AU Pellegrin, MC
   Matarazzo, L
   Neri, E
   Pennesi, M
   Crovella, S
AF Pellegrin, M. C.
   Matarazzo, L.
   Neri, E.
   Pennesi, M.
   Crovella, S.
TI HLA-B35, a common genetic trait, in a familial case of Henoch-Schoenlein
   purpura and Berger's disease
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE IgA nephropathy; Henoch Schoenlein purpura; Berger's disease; HLA-B35
ID SCHONLEIN PURPURA; IGA NEPHROPATHY; RENAL MANIFESTATIONS; HLA;
   ASSOCIATION; FREQUENCIES
AB Nephritis characterized by IgA mesangial depositions has been described both in Henoch-Schoenlein purpura (HSP) and in Berger's disease (BD), but common genetic traits are still uncertain. We report here the case of two brothers, the first affected by HSP with persistent nephritis and the second by BD, accidentally discovered as silent microhematuria 1 year after HSP onset in the first brother. HLA genotyping demonstrated the presence of HLA-B35 in both patients. Our findings reinforce the need to screen for urinary abnormalities in family members of patients affected by HSP nephritis to identify a silent IgA nephropathy.
C1 [Pellegrin, M. C.; Matarazzo, L.; Crovella, S.] Univ Trieste, Trieste, Italy.
   [Neri, E.; Pennesi, M.; Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Pellegrin, MC (corresponding author), Univ Trieste, Trieste, Italy.
EM mariachiara.pellegrin@gmail.com
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Pennesi,
   Marco/0000-0001-5207-6232; Matarazzo, Lorenza/0000-0001-7635-3791
CR ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8
   Amoli MM, 2002, J RHEUMATOL, V29, P948
   Amoli MM, 2001, J RHEUMATOL, V28, P1266
   Amoroso A, 1997, EUR J IMMUNOGENET, V24, P323, DOI 10.1046/j.1365-2370.1997.d01-112.x
   Bulut IK, 2012, INT J NEPHROL RENOV, V5, P23, DOI 10.2147/IJNRD.S24684
   Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720
   Chang WL, 2005, PEDIATR NEPHROL, V20, P1269, DOI 10.1007/s00467-005-1903-z
   Chishiki Mina, 2010, Fukushima J Med Sci, V56, P157, DOI 10.5387/fms.56.157
   Doxiadis IIN, 2001, TISSUE ANTIGENS, V57, P344, DOI 10.1034/j.1399-0039.2001.057004344.x
   Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076
   HIKI Y, 1990, NEPHRON, V54, P264, DOI 10.1159/000185867
   Jauhola O, 2010, ARCH DIS CHILD, V95, P877, DOI 10.1136/adc.2009.182394
   KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244
   LEVY M, 1989, AM J MED, V87, P246
   Lilien M R, 1996, Ned Tijdschr Geneeskd, V140, P316
   MONTOLIU J, 1990, NEPHRON, V54, P77, DOI 10.1159/000185813
   Motoyama O, 2005, PEDIATR INT, V47, P612, DOI 10.1111/j.1442-200x.2005.02138.x
   NATHWANI D, 1992, J INFECTION, V25, P205, DOI 10.1016/0163-4453(92)94127-J
   Peru H, 2008, CLIN RHEUMATOL, V27, P5, DOI 10.1007/s10067-007-0640-z
   Zhang Y, 2008, PEDIATR DERMATOL, V25, P393, DOI 10.1111/j.1525-1470.2008.00693.x
NR 20
TC 1
Z9 1
U1 0
U2 4
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2014
VL 13
IS 2
BP 2669
EP 2673
DI 10.4238/2014.April.8.9
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AI3AC
UT WOS:000336729500035
PM 24782055
OA Bronze
DA 2020-12-08
ER

PT J
AU da Silva, GK
   Vianna, P
   Veit, TD
   Crovella, S
   Catamo, E
   Cordero, EAA
   Mattevi, VS
   Lazzaretti, RK
   Sprinz, E
   Kuhmmer, R
   Chies, JAB
AF da Silva, G. K.
   Vianna, Priscila
   Veit, Tiago Degani
   Crovella, Sergio
   Catamo, Eulalia
   Aparicio Cordero, Elvira Alicia
   Mattevi, Vanessa Sune
   Lazzaretti, Rosmeri Kuhmmer
   Sprinz, Eduardo
   Kuhmmer, Regina
   Bogo Chies, Jose Artur
TI Influence of HLA-G polymorphisms in human immunodeficiency virus
   infection and hepatitis C virus co-infection in Brazilian and Italian
   individuals
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HLA-G; Polymorphism; HIV; HCV; Ethnicity
ID HIV VERTICAL TRANSMISSION; LEUKOCYTE ANTIGEN-G; G GENE; REGION;
   SUSCEPTIBILITY; ASSOCIATION; DELETION; RISK; EXPRESSION; HAPLOTYPES
AB Objective: This study aimed to investigate the role of Human Leukocyte Antigen (HLA)-G in the susceptibility to HIV-1 infection through the analysis of the HLA-G 3' untranslated region (UTR) polymorphisms 14 bp insertion/deletion (rs66554220) and + 3142C>G (rs1063320).
   Design: We analyzed 582 HIV-1 infected patients and 626 uninfected individuals from Brazil and Italy in a case-control study.
   Methods: HLA-G polymorphisms were genotyped using PCR, PCR-RFLP assays or direct sequencing. All analyses were stratified by ethnicity. Genotypic, allelic and diplotypic frequencies were compared between HIV-1 infected subjects and controls using Chi-square or Fischer exact tests. Also, haplotypic frequencies were estimated using MLocus software.
   Results: African-derived HIV-infected individuals presented a higher frequency of the 14 bp insertion allele as compared to non-infected individuals (0.468 versus 0.373, respectively; p(Bonf) = 0.010). A higher frequency of the 14 bp insertion + 3142G (insG) haplotype (0.456 versus 0.346, p < 0.001) and the insG/insG diplotype (OR = 1.88, 95% CI = 1.08-3.23, p = 0.021) was observed among African-derived patients as compared to uninfected controls. Also, we observed a higher frequency of the ins/ins genotype among African-derived HIV patients co-infected with HCV (OR = 2.78, 95% CI = 1.20-6.49, p = 0.008).
   Conclusions: Our data point out to an increased frequency of alleles and genotypes associated with low HLA-G expression among African-derived patients, suggesting a potential role for HLA-G in the susceptibility to HIV-1 infection and HCV co-infection in those individuals. (C) 2013 Published by Elsevier B.V.
C1 [da Silva, G. K.; Vianna, Priscila; Veit, Tiago Degani; Aparicio Cordero, Elvira Alicia; Bogo Chies, Jose Artur] Univ Fed Rio Grande do Sul, BR-91501970 Porto Alegre, RS, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Catamo, Eulalia] Univ Trieste, Immunogenet Lab, I-34127 Trieste, Italy.
   [Mattevi, Vanessa Sune] Fed Univ Hlth Sci Porto Alegre, Porto Alegre, RS, Brazil.
   [Lazzaretti, Rosmeri Kuhmmer; Sprinz, Eduardo; Kuhmmer, Regina] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
RP Chies, JAB (corresponding author), Univ Fed Rio Grande do Sul, Immunogenet Lab, Inst Biosci, Dept Genet, Av Bento Goncalves 9500,Campus Vale,POB 15053, BR-91501970 Porto Alegre, RS, Brazil.
EM jabchies@terra.com.br
RI vianna, Priscila/M-3927-2015; Mattevi, Vanessa S./B-3915-2014; sprinz,
   eduardo/V-7961-2019; Chies, Jose Artur Bogo/K-9664-2015; Crovella,
   Sergio/K-5050-2016; Catamo, Eulalia/K-9399-2016
OI Mattevi, Vanessa S./0000-0002-2697-4909; sprinz,
   eduardo/0000-0003-4343-8304; Chies, Jose Artur Bogo/0000-0001-7025-0660;
   Crovella, Sergio/0000-0001-8493-1168; Catamo,
   Eulalia/0000-0002-4701-9134
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [306349/2011-6]; FAPERGS (Fundacao de Amparo a
   Pesquisa no Rio Grande do Sul)Foundation for Research Support of the
   State of Rio Grande do Sul (FAPERGS) [1015166]
FX The present work was supported by CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico) grant 306349/2011-6 and
   FAPERGS (Fundacao de Amparo a Pesquisa no Rio Grande do Sul), grant
   1015166.
CR Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6
   Aghafar MZKA, 2012, TISSUE ANTIGENS, V79, P367, DOI 10.1111/j.1399-0039.2012.01843.x
   Apetrei C, 2007, J VIROL, V81, P7913, DOI 10.1128/JVI.00281-07
   Carosella ED, 1999, CELL MOL LIFE SCI, V55, P327, DOI 10.1007/s000180050295
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028
   Chen XY, 2008, TISSUE ANTIGENS, V72, P335, DOI 10.1111/j.1399-0039.2008.01107.x
   Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706
   Cordero EAA, 2009, TISSUE ANTIGENS, V74, P308, DOI 10.1111/j.1399-0039.2009.01331.x
   Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Favier B, 2007, TISSUE ANTIGENS, V69, P150, DOI 10.1111/j.1399-0039.2006.763_6.x
   Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767
   Fregni G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-33
   Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825
   Larsen MH, 2010, TISSUE ANTIGENS, V75, P253, DOI 10.1111/j.1399-0039.2009.01435.x
   Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015
   Long J. C., 1999, MULTIPLE LOCUS HAPLO
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008
   Menier C, 2010, TISSUE ANTIGENS, V75, P201, DOI 10.1111/j.1399-0039.2009.01438.x
   Mindel A, 2001, BRIT MED J, V322, P1290, DOI 10.1136/bmj.322.7297.1290
   Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159
   Segat L, 2010, AIDS, V24, P1961, DOI 10.1097/QAD.0b013e32833c3324
   Segat L, 2009, AIDS, V23, P1916, DOI 10.1097/QAD.0b013e32832f8104
   Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200
   Tripathi P, 2007, AIDS, V21, P1395, DOI 10.1097/QAD.0b013e32810c8bbc
   Turk WJR, 2013, AIDS, V27, P7, DOI 10.1097/QAD.0b013e32835ab1f2
   UNAIDS/WHO, 2013, UNAIDS REP GLOB AIDS
   van der Ven K, 2000, PLACENTA, V21, pS86, DOI 10.1053/plac.1999.0515
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Veit TD, 2009, TRANSPL IMMUNOL, V20, P229, DOI 10.1016/j.trim.2008.11.001
   Vianna P, 2007, HUM IMMUNOL, V68, P668, DOI 10.1016/j.humimm.2007.05.006
NR 38
TC 29
Z9 30
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JAN
PY 2014
VL 21
BP 418
EP 423
DI 10.1016/j.meegid.2013.12.013
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA AC1RN
UT WOS:000332273800049
PM 24389119
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Girardelli, M
   Catamo, E
   Duarte, AJ
   Crovella, S
AF Pontillo, A.
   Girardelli, M.
   Catamo, E.
   Duarte, A. J.
   Crovella, S.
TI Polymorphisms in TREX1 and susceptibility to HIV-1 infection
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID LUPUS-ERYTHEMATOSUS; EXONUCLEASE TREX1; TYPE-1
AB TREX-1 is a restriction factor against HIV-1. The coding sequence of TREX1 gene was analysed in HIV+ subjects searching for genetic variations possibly associated with the susceptibility to HIV infection. The single nucleotide polymorphism rs3135945 was significantly associated with HIV infection, emphasizing the involvement of TREX-1 in the anti-HIV response.
C1 [Pontillo, A.] Univ Sao Paulo, Inst Biol Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil.
   [Girardelli, M.; Catamo, E.; Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Duarte, A. J.] Univ Sao Paulo, Fac Med, LIM 56, Lab Med Invest Dermatol & Immunodeficiency, BR-05508900 Sao Paulo, Brazil.
   [Crovella, S.] Univ Trieste, Trieste, Italy.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Inst Biol Sci, Lab Immunegent, Dept Immunol, Av Prof Lineu Prestes 1730,Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   Duarte, Alberto J S/D-4382-2012; Pontillo, ALESSANDRA/D-4352-2012;
   Crovella, Sergio/K-5050-2016; Girardelli, Martina/K-7199-2016; Catamo,
   Eulalia/K-9399-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Girardelli, Martina/0000-0003-1186-4907; Catamo,
   Eulalia/0000-0002-4701-9134
FU IRCCS 'Burlo Garofolo' (Trieste, Italy) [RC 07/08]; Brazilian Minister
   for Sciences and Technology/CNPq [311949/2011-8]
FX We thank the Service of Virology of the IRCCS 'Burlo Garofolo' (Trieste,
   Italy) for HIV+ patients' recruitment. This work was supported by a
   grant RC 07/08 from IRCCS 'Burlo Garofolo' (Trieste, Italy). At the time
   of article submission Pontillo A. was recipient of a fellowship grant
   from Brazilian Minister for Sciences and Technology/CNPq
   (n.311949/2011-8).
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293
   Geijtenbeek TBH, 2010, NAT IMMUNOL, V11, P979, DOI 10.1038/ni1110-979
   Hedrich CM, 2008, CLIN RHEUMATOL, V27, P949, DOI 10.1007/s10067-008-0942-9
   Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269
   Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x
   Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162
   Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941
NR 11
TC 5
Z9 5
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
EI 1744-313X
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD DEC
PY 2013
VL 40
IS 6
BP 492
EP 494
DI 10.1111/iji.12071
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 251XR
UT WOS:000326967900009
PM 23773365
DA 2020-12-08
ER

PT J
AU Coelho, AVC
   Silva, SPS
   de Alencar, LCA
   Stocco, G
   Crovella, S
   Brandao, LAC
   Guimaraes, RL
AF Coelho, Antonio V. C.
   Silva, Suedja P. S.
   de Alencar, Luiz C. A.
   Stocco, Gabriele
   Crovella, Sergio
   Brandao, Lucas A. C.
   Guimaraes, Rafael L.
TI ABCB1 and ABCC1 Variants Associated With Virological Failure of
   First-Line Protease Inhibitors Antiretroviral Regimens in Northeast
   Brazil Patients
SO JOURNAL OF CLINICAL PHARMACOLOGY
LA English
DT Article
DE HIV-1; pharmacogenetics; pharmacodynamics
ID EFAVIRENZ; POLYMORPHISMS; CYP2B6; RESISTANCE; THERAPY; PHARMACOKINETICS;
   PHARMACOGENETICS; TRANSPORTERS; INDIVIDUALS; EFFLUX
AB The present study aims at evaluating the association between seven single nucleotide polymorphisms (SNPs) in five genes involved on antiretroviral pharmacokinetic pathways and virological failure in first line highly active antiretroviral therapy. Seven candidate polymorphisms (rs3842 and rs1045642 in ABCB1, rs212091 and rs3743527 in ABCC1, rs3745274 in CYP2B6, rs628031 in SLC22A1 and rs1517618 in SLCO3A1) were evaluated if they were associated with virological failure through logistic regression analysis. The study design was a retrospective cohort, analyzing 187 patients from Recife metropolitan region (Pernambuco, Brazil): among these 160 obtained complete suppression of HIV-1 replication (responders) and were compared to 27 non-responders, which underwent virological failure. There was no association between CYP2B6, SLC22A1, and SLCO3A1 SNPs and virological failure. Using logistic regression analysis, a significant association was detected between rs1045642 (3435C>T, ABCB1) and rs212091 (198217T>C; 3-UTR, ABCC1) with virological failure of first-line antiretroviral regimens containing protease inhibitors, when controlled by clinical factors, such as sex, age and race. The present results could contribute to unravel the influence of genetic background in anti-HIV-1 therapy outcome and help in treatment personalization of Northeast Brazil HIV infected patients.
C1 [Coelho, Antonio V. C.; Crovella, Sergio; Brandao, Lucas A. C.; Guimaraes, Rafael L.] Univ Fed Pernambuco, Dept Genet, BR-50670901 Recife, PE, Brazil.
   [Coelho, Antonio V. C.; Silva, Suedja P. S.; Crovella, Sergio] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, BR-50670901 Recife, PE, Brazil.
   [Silva, Suedja P. S.] Univ Fed Pernambuco, Postgrad Program Therapeut Innovat PPGIT, BR-50670901 Recife, PE, Brazil.
   [de Alencar, Luiz C. A.] Integral Med Inst Prof Fernando Figueira, Recife, PE, Brazil.
   [Stocco, Gabriele] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Brandao, Lucas A. C.] Univ Fed Pernambuco, Dept Pathol, BR-50670901 Recife, PE, Brazil.
RP Coelho, AVC (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM antonio.victor@ufpe.br
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Coelho, Antonio Victor
   C/E-6795-2015; Stocco, Gabriele/K-3798-2018; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Coelho, Antonio
   Victor C/0000-0003-2143-9701; Stocco, Gabriele/0000-0003-0964-5879;
   Crovella, Sergio/0000-0001-8493-1168
FU FACEPE [APQ-0568-2.02/10]
FX This work was supported by an APQ-0568-2.02/10 grant from FACEPE.
CR Alves S, 2012, PROGR REPORT BRAZILI
   [Anonymous], 2012, GUIDELINES USE ANTIR
   Brasil. Ministerio da Saude, 2008, REC TER ANT AD INF P
   Brumme ZL, 2003, AIDS, V17, P201, DOI 10.1097/00002030-200301240-00010
   Cressey TR, 2007, INFECT GENET EVOL, V7, P333, DOI 10.1016/j.meegid.2006.08.004
   De Cock KM, 2011, EMERG INFECT DIS, V17, P1044, DOI [10.3201/eid1706.100184, 10.3201/eid/1706.100184]
   de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004
   Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8
   Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007
   Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Giraud C, 2010, EXPERT OPIN DRUG MET, V6, P571, DOI 10.1517/17425251003601953
   Haas DW, 2009, J INFECT DIS, V199, P872, DOI 10.1086/597125
   Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003
   Hochman JH, 2001, J PHARMACOL EXP THER, V298, P323
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   Hutchinson JF, 2001, ANNU REV ANTHROPOL, V30, P85, DOI 10.1146/annurev.anthro.30.1.85
   Janneh O, 2009, ANTIVIR THER, V14, P965, DOI 10.3851/IMP1399
   Jung N, 2008, DRUG METAB DISPOS, V36, P1616, DOI 10.1124/dmd.108.020826
   Manrique L, 2010, JAIDS-J ACQ IMM DEF, V54, P332, DOI 10.1097/QAI.0b013e3181d2eef1
   Ministerio da Saude, 2012, B EP AIDS DST
   Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225
   Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37
   Paintsil E, 2011, ANTIMICROB AGENTS CH, V55, P895, DOI 10.1128/AAC.01303-10
   Princeton DC., 2003, MANUAL HIV AIDS THER
   Purcet S, 2006, ANTIVIR THER, V11, P803
   R Development Core Team, R LANG ENV STAT COMP
   Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470
   Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871
   Soares MA, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406003-00003
   Suarez-Kurtz G, 2004, PHARMACOGENOMICS J, V4, P347, DOI 10.1038/sj.tpj.6500287
   Telenti A, 2008, ANNU REV PHARMACOL, V48, P227, DOI 10.1146/annurev.pharmtox.48.113006.094753
   Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001
   Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116
   UNAIDS, 2010, GLOB REP UNAIDS REP
   Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710
   Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601
   WHO, 2007, WHO CAS DEF HIV SURV
NR 39
TC 16
Z9 16
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0091-2700
EI 1552-4604
J9 J CLIN PHARMACOL
JI J. Clin. Pharmacol.
PD DEC
PY 2013
VL 53
IS 12
BP 1286
EP 1293
DI 10.1002/jcph.165
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 252OB
UT WOS:000327015000008
PM 23996099
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Marcuzzi, A
   Piscianz, E
   Monasta, L
   Crovella, S
   Kleiner, G
AF Tricarico, Paola Maura
   Marcuzzi, Annalisa
   Piscianz, Elisa
   Monasta, Lorenzo
   Crovella, Sergio
   Kleiner, Giulio
TI Mevalonate Kinase Deficiency and Neuroinflammation: Balance between
   Apoptosis and Pyroptosis
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mevalonate; inflammation; neurodegeneration; apoptosis
ID PERIODIC FEVER SYNDROME; CENTRAL-NERVOUS-SYSTEM; NEUROBLASTOMA-CELL
   LINE; INTERLEUKIN-1-BETA SECRETION; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE
   STRESS; NEURODEGENERATIVE DISEASES; HYPERIMMUNOGLOBULINEMIA-D; EMBRYONIC
   LETHALITY; NATURAL ISOPRENOIDS
AB Mevalonic aciduria, a rare autosomal recessive disease, represents the most severe form of the periodic fever, known as Mevalonate Kinase Deficiency. This disease is caused by the mutation of the MVK gene, which codes for the enzyme mevalonate kinase, along the cholesterol pathway. Mevalonic aciduria patients show recurrent fever episodes with associated inflammatory symptoms, severe neurologic impairments, or death, in early childhood. The typical neurodegeneration occurring in mevalonic aciduria is linked both to the intrinsic apoptosis pathway (caspase-3 and -9), which is triggered by mitochondrial damage, and to pyroptosis (caspase-1). These cell death mechanisms seem to be also related to the assembly of the inflammasome, which may, in turn, activate pro-inflammatory cytokines and chemokines. Thus, this particular molecular platform may play a crucial role in neuroinflammation mechanisms. Nowadays, a specific therapy is still lacking and the pathogenic mechanisms involving neuroinflammation and neuronal dysfunction have not yet been completely understood, making mevalonic aciduria an orphan drug disease. This review aims to analyze the relationship among neuroinflammation, mitochondrial damage, programmed cell death, and neurodegeneration. Targeting inflammation and degeneration in the central nervous system might help identify promising treatment approaches for mevalonic aciduria or other diseases in which these mechanisms are involved.
C1 [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, I-34128 Trieste, Italy.
   [Marcuzzi, Annalisa; Piscianz, Elisa; Crovella, Sergio; Kleiner, Giulio] Inst Maternal & Child Hlth Burlo Garofolo, Hlth Genet Unit, I-34137 Trieste, Italy.
   [Monasta, Lorenzo] Inst Maternal & Child Hlth Burlo Garofolo, Epidemiol & Biostat Unit, I-34137 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Hlth Genet Unit, Via Istria 65-1, I-34137 Trieste, Italy.
EM paola.tricarico@burlo.trieste.it; annalisa.marcuzzi@burlo.trieste.it;
   elisa.piscianz@gmail.com; lorenzo.monasta@burlo.trieste.it;
   sergio.crovella@burlo.trieste.it; giulio.kleiner@burlo.trieste.it
RI Monasta, Lorenzo/B-1388-2012; tricarico, paola/AAB-8972-2019; Marcuzzi,
   Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016
OI Monasta, Lorenzo/0000-0001-7774-548X; tricarico,
   paola/0000-0002-1954-4126; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Crovella, Sergio/0000-0001-8493-1168; Piscianz,
   Elisa/0000-0001-7374-1684; Kleiner, Giulio/0000-0002-1830-3961
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664
   Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bodar EJ, 2007, BLOOD, V109, P2416, DOI 10.1182/blood-2005-10-039578
   Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377
   Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002
   Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049
   Byrne BG, 2013, MBIO, V4, DOI 10.1128/mBio.00620-12
   Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89
   Case Christopher L., 2011, Yale Journal of Biology and Medicine, V84, P333
   Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86
   Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219
   DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135
   Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324
   Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194
   Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142
   Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Garcia-Escudero V, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/162152
   Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Henneman L, 2010, J INHERIT METAB DIS, V33, P625, DOI 10.1007/s10545-010-9173-8
   Herrero-Martin G, 2008, FEBS LETT, V582, P2589, DOI 10.1016/j.febslet.2008.06.034
   Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138
   Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Lawlor K. E., 2013, BIOCH BIOPH IN PRESS
   Liao YH, 2013, J LEUKOCYTE BIOL, V93, P289, DOI 10.1189/jlb.0812409
   Loda E, 2012, REV NEUROSCIENCE, V23, P145, DOI 10.1515/revneuro-2011-068
   Long AB, 2013, CELL DEATH DIFFER, V20, P1510, DOI 10.1038/cdd.2013.97
   Mailman T, 2011, J NEUROCHEM, V119, P1002, DOI 10.1111/j.1471-4159.2011.07474.x
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2012, CURR PHARM DESIGN, V18, P5746, DOI 10.2174/138161212803530835
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357
   Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550
   Moosmann B, 2004, TRENDS CARDIOVAS MED, V14, P273, DOI 10.1016/j.tcm.2004.08.003
   Ng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042298
   Normand S, 2009, EUR CYTOKINE NETW, V20, P101, DOI 10.1684/ecn.2009.0163
   Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200
   Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266
   Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916
   Omenetti A., 2013, ANN RHEUM D IN PRESS
   Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8
   Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002
   PITAS RE, 1987, J BIOL CHEM, V262, P14352
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644
   Rodriguez-Martinez E, 2013, NEUROSCIENCE, V252, P384, DOI 10.1016/j.neuroscience.2013.08.018
   Rubartelli A, 2011, TRENDS IMMUNOL, V32, P559, DOI 10.1016/j.it.2011.08.005
   Gomez AR, 2012, PEDIATRICS, V129, pE535, DOI 10.1542/peds.2010-2192
   SAITO M, 1987, J NEUROSCI RES, V18, P319, DOI 10.1002/jnr.490180208
   Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102
   Shastri A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/342931
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014
   Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Strle K, 2001, CRIT REV IMMUNOL, V21, P427
   Suzuki H, 2009, STROKE, V40, P3872, DOI 10.1161/STROKEAHA.109.566109
   Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843
   Tricarico PM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/715465
   van der Burgh R, 2013, CLIN IMMUNOL, V147, P197, DOI 10.1016/j.clim.2012.09.011
   Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27
   Yu ZQ, 2005, BASIC CLIN PHARMACOL, V97, P222, DOI 10.1111/j.1742-7843.2005.pto_138.x
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 83
TC 22
Z9 24
U1 0
U2 36
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2013
VL 14
IS 12
BP 23274
EP 23288
DI 10.3390/ijms141223274
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 296XX
UT WOS:000330219800005
PM 24287904
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zanin, V
   Marcuzzi, A
   Kleiner, G
   Piscianz, E
   Monasta, L
   Zacchigna, S
   Crovella, S
   Zauli, G
AF Zanin, Valentina
   Marcuzzi, Annalisa
   Kleiner, Giulio
   Piscianz, Elisa
   Monasta, Lorenzo
   Zacchigna, Serena
   Crovella, Sergio
   Zauli, Giorgio
TI Lovastatin Dose-Dependently Potentiates the Pro-inflammatory Activity of
   Lipopolysaccharide Both In Vitro and In Vivo
SO JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
LA English
DT Article
DE Statin; Cytokines; Inflammation; Cholesterol
ID MEVALONATE KINASE-DEFICIENCY; NATURAL ISOPRENOIDS; HUMAN MONOCYTES;
   STATIN THERAPY; SEVERE SEPSIS; NITRIC-OXIDE; MOUSE MODEL; CELLS;
   INHIBITION; LPS
AB Since contradictory findings have been reported on potential effects of statins in modulating the inflammatory response, we have analysed the biological activity of lovastatin both in vitro using the Raw 264.7 murine macrophagic cell line and in vivo using BALB/c mice. When added to Raw 264.7 cells in combination with lipopolysaccharide, lovastatin significantly potentiated the release of interleukin-1 beta, interleukin-6 and interleukin-12 with respect to lipopolysaccharide alone and showed an additive effect on the release of nitric oxide. Similarly, when lovastatin was intraperitoneally administrated to BALB/c mice, it did not induce any pro-inflammatory effect when used alone, but it significantly potentiated the pro-inflammatory activity of lipopolysaccharide, in terms of number of intraperitoneal cells and serum levels of serum amyloid A, interleukin-1 beta, interleukin-6 and interleukin-12. A potential clinical implication of our study is that lovastatin might exert a pro-inflammatory activity in subjects affected by inflammatory processes, with clinically evident or subclinical infections.
C1 [Zanin, Valentina; Marcuzzi, Annalisa; Kleiner, Giulio; Piscianz, Elisa; Monasta, Lorenzo; Crovella, Sergio; Zauli, Giorgio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, I-34128 Trieste, Italy.
   [Zacchigna, Serena] ICGEB, Mol Med Lab, I-34149 Trieste, Italy.
RP Kleiner, G (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM giulio.kleiner@burlo.trieste.it
RI Zauli, Giorgio/ABE-8001-2020; Crovella, Sergio/K-5050-2016; Marcuzzi,
   Annalisa/AAA-6038-2020; Monasta, Lorenzo/B-1388-2012; ZACCHIGNA,
   SERENA/E-9496-2017
OI Crovella, Sergio/0000-0001-8493-1168; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Monasta, Lorenzo/0000-0001-7774-548X;
   Kleiner, Giulio/0000-0002-1830-3961; Piscianz,
   Elisa/0000-0001-7374-1684; Zauli, Giorgio/0000-0002-3750-8698;
   ZACCHIGNA, SERENA/0000-0001-6705-3076
FU Institute for Maternal and Child Health-IRCCS "Burlo Garofolo"- Trieste,
   Italy [RC42/2011]
FX This study was supported by a grant from the Institute for Maternal and
   Child Health-IRCCS "Burlo Garofolo"- Trieste, Italy (RC42/2011).
CR Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1
   Bellosta S, 2012, EXPERT OPIN DRUG SAF, V11, P933, DOI 10.1517/14740338.2012.712959
   Biasucci LM, 2010, CLIN CHEM LAB MED, V48, P1685, DOI 10.1515/CCLM.2010.277
   Collins GS, 2012, HEART, V98, P1091, DOI 10.1136/heartjnl-2012-302014
   Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200
   Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284
   Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005
   Dessap AM, 2011, CRIT CARE, V15, DOI 10.1186/cc10317
   Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326
   Endres M, 2006, ATHEROSCLEROSIS SUPP, V7, P31, DOI 10.1016/j.atherosclerosissup.2006.01.005
   Ernanuela M, 2007, BIOMED PHARMACOTHER, V61, P360, DOI 10.1016/j.biopha.2007.03.002
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Ikeda Uichi, 2001, Current Drug Targets - Cardiovascular and Haematological Disorders, V1, P51, DOI 10.2174/1568006013338187
   JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2012, CYTOKINE, V60, P43, DOI 10.1016/j.cyto.2012.06.001
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Massonnet B, 2009, EUR CYTOKINE NETW, V20, P112, DOI 10.1684/ecn.2009.0162
   Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377
   Monick MM, 2003, J IMMUNOL, V171, P2625, DOI 10.4049/jimmunol.171.5.2625
   Muniyappa R, 2000, AM J PHYSIOL-HEART C, V278, pH1762
   Ni WH, 2001, CIRC RES, V89, P415, DOI 10.1161/hh1701.096614
   Paoletti R, 2002, ATHEROSCLEROSIS SUPP, V3, P35, DOI 10.1016/S1567-5688(02)00002-8
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086
   Rodriguez AL, 2012, J THROMB THROMBOLYS, V33, P371, DOI 10.1007/s11239-012-0687-9
   Satoh S, 2006, INT J CARDIOL, V111, P405, DOI 10.1016/j.ijcard.2005.08.021
   Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x
   Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x
NR 31
TC 10
Z9 10
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1937-5387
EI 1937-5395
J9 J CARDIOVASC TRANSL
JI J. Cardiovasc. Transl. Res.
PD DEC
PY 2013
VL 6
IS 6
SI SI
BP 981
EP 988
DI 10.1007/s12265-013-9506-8
PG 8
WC Cardiac & Cardiovascular Systems; Medicine, Research & Experimental
SC Cardiovascular System & Cardiology; Research & Experimental Medicine
GA 258KW
UT WOS:000327459200010
PM 23959762
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Kleiner, G
   Celsi, F
   Tricarico, PM
   Zacchigna, S
   Crovella, S
   Marcuzzi, A
AF Kleiner, Giulio
   Celsi, Fulvio
   Tricarico, Paola Maura
   Zacchigna, Serena
   Crovella, Sergio
   Marcuzzi, Annalisa
TI Systemic and Neuronal Inflammatory Markers in a Mouse Model of
   Mevalonate Kinase Deficiency: a Strain-comparative Study
SO IN VIVO
LA English
DT Article
DE Mevalonate kinase deficiency; BALB/c; C57BL/6; alendronate; muramyl
   dipeptide; inflammasome
ID HYPERIMMUNOGLOBULINEMIA-D; NATURAL ISOPRENOIDS; NALP3 INFLAMMASOME;
   INHIBITION; ACTIVATION; CYTOKINES; ACIDURIA; MICE; LPS
AB Background/Aim: There is a lack of reliable animal models for the study of the rare auto-inflammatory disease mevalonate kinase deficiency (MKD). The one most frequently used is a biochemical model, obtained by treating BALB/c mice in order to block the mevalonate pathway, thus attempting to reproduce the inflammatory pattern presented in patients. This study aims to assess the role played in pathology by the inflammasome and the reliability of this model. Materials and Methods: We mimicked MKD using two different mice strains (BALB/c and C57BL/6), evaluating typical inflammatory markers of MKD and inflammasome modulation. Results: Without significant differences, both strains exhibited a general MKD-like inflammation, including the modulation of the molecular platform inflammasome, mimicking the characteristics observed in human patients. Conclusion: Although with some limitations, the mouse model appears robust and suitable for studying MKD. Results do not seem to vary with the mouse strain used, and appear to be treatment-dependent. Finally, in vivo inflammasome activation was assessed for the first time here.
C1 [Kleiner, Giulio; Celsi, Fulvio; Crovella, Sergio; Marcuzzi, Annalisa] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Hlth Genet Unit, I-34137 Trieste, Italy.
   [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Dept Med & Surg & Hlth Sci, Trieste, Italy.
   [Zacchigna, Serena] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy.
RP Kleiner, G (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM giulio.kleiner@burlo.trieste.it
RI tricarico, paola/AAB-8972-2019; Marcuzzi, Annalisa/AAA-6038-2020;
   Crovella, Sergio/K-5050-2016; ZACCHIGNA, SERENA/E-9496-2017
OI tricarico, paola/0000-0002-1954-4126; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Crovella, Sergio/0000-0001-8493-1168;
   ZACCHIGNA, SERENA/0000-0001-6705-3076; Kleiner,
   Giulio/0000-0002-1830-3961
FU Institute for Maternal and Child Health IRCCS Burlo Garofolo [RC 42/11]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS Burlo Garofolo (RC 42/11).
CR Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586
   Galeotti C, 2012, RHEUMATOLOGY, V51, P1855, DOI 10.1093/rheumatology/kes097
   Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7
   Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636
   HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Lira SA, 2012, IMMUNOL RES, V54, P111, DOI 10.1007/s12026-012-8313-7
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2013, PEDIATR RES, V74, P266, DOI 10.1038/pr.2013.96
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Neven B, 2007, NEW ENGL J MED, V356, P2700, DOI 10.1056/NEJMoa070715
   Normand S, 2009, EUR CYTOKINE NETW, V20, P101, DOI 10.1684/ecn.2009.0163
   Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350
   Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528
   Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559
   Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73
   Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208
   Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077
NR 25
TC 5
Z9 5
U1 0
U2 5
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
EI 1791-7549
J9 IN VIVO
JI In Vivo
PD NOV-DEC
PY 2013
VL 27
IS 6
BP 715
EP 722
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 264WZ
UT WOS:000327913000006
PM 24292573
DA 2020-12-08
ER

PT J
AU Callea, M
   Teggi, R
   Yavuz, I
   Tadini, G
   Priolo, M
   Crovella, S
   Clarich, G
   Grasso, DL
AF Callea, Michele
   Teggi, Roberto
   Yavuz, Izzet
   Tadini, Gianluca
   Priolo, Manuela
   Crovella, Sergio
   Clarich, Gabriella
   Grasso, Domenico Leonardo
TI Ear nose throat manifestations in hypoidrotic ectodermal dysplasia
SO INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
LA English
DT Review
DE Ectodermal dysplasia; Hypohidrosis; Chronic rhinitis; Chronic otitis
   media; Hearing loss; Hypodontia
ID OTOLARYNGOLOGIC MANIFESTATIONS; PATIENT
AB The ectodermal dysplasias (EDs) are a large and complex group of inherited disorders. In various combinations, they all share anomalies in ectodermal derived structures: hair, teeth, nails and sweat gland function. Clinical overlap is present among EDs. Few causative genes have been identified, to date. Altered gene expression is not limited to the ectoderm but a concomitant effect on developing mesenchymal structures, with modification of ectodermal-mesenchymal signaling, takes place. The two major categories of ED include the hidrotic and hypohidrotic form, the latter more frequent; they differentiate each other for the presence or absence of sweat glands.
   We report Ear Nose Throat manifestations of ED, linked to the reduction of mucous glands in the nasal fossae with reduced ciliar function, and decrease salivary glands function.
   Often patients report an increased rate of infections of the upper respiratory tract and of the ear. Nasal obstruction due to the presence of nasal crusting, hearing loss and throat hoarseness are the most represented symptoms.
   Environmental measures, including a correct air temperature and humidification, is mandatory above all in subjects affected by hypohidrotic form. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Callea, Michele; Crovella, Sergio; Clarich, Gabriella; Grasso, Domenico Leonardo] IRCCS Bur Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Teggi, Roberto] Ist Sci San Raffaele, I-20132 Milan, Italy.
   [Yavuz, Izzet] Dicle Univ, Fac Dent, Dept Pediat Dent, TR-21280 Diyarbakir, Turkey.
   [Tadini, Gianluca] Univ Milan, Ctr Inherited Cutaneous Dis, Dept Pediat Dermatol, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy.
   [Tadini, Gianluca] Univ Milan, Osped Maggiore Policlin Milano, Fdn IRCCS Ca Granda, Dept Pediat Clin 1, Milan, Italy.
   [Priolo, Manuela] UOC Genet Med Azienda Osped Bianchi Melacrino Mor, I-89100 Reggio Di Calabria, Italy.
   [Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Callea, M (corresponding author), IRCCS Bur Garofolo, Inst Maternal & Child Hlth, Dept Pediat Stomatol, Trieste, Italy.
EM mcallea@gmail.com
RI yavuz, izzet/A-6758-2016; Crovella, Sergio/K-5050-2016; Teggi,
   Roberto/AAN-3101-2020
OI yavuz, izzet/0000-0001-6953-747X; Crovella, Sergio/0000-0001-8493-1168;
   Teggi, Roberto/0000-0003-2948-4638
CR Acarturk TO, 2007, J CRANIOFAC SURG, V18, P1179, DOI 10.1097/scs.0b013e31811ec1ca
   AlJassim AH, 1996, J LARYNGOL OTOL, V110, P379, DOI 10.1017/S0022215100133687
   Bhat KV, 2009, INT J PEDIAT OTOR EX, V4, P114, DOI 10.1016/j.pedex.2008.09.001
   Cankaya H, 2002, AURIS NASUS LARYNX, V29, P313, DOI 10.1016/S0385-8146(02)00005-6
   CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659
   Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384
   Daniel E, 2002, LARYNGOSCOPE, V112, P962, DOI 10.1097/00005537-200206000-00005
   de Aquino SN, 2012, HEAD NECK PATHOL, V6, P460, DOI 10.1007/s12105-012-0349-4
   Dietz J, 2013, EUR J PEDIATR, V172, P1023, DOI 10.1007/s00431-013-1985-8
   Freire-Maia N., 1987, AM J MED GENET, V28, P1025
   Garcia JG, 2005, ACTA OTORRINOLAR ESP, V56, P176, DOI 10.1016/S0001-6519(05)78595-2
   Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446
   Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418
   MARTINI A, 1984, INT J PEDIATR OTORHI, V8, P97, DOI 10.1016/S0165-5876(84)80030-0
   MASSE JF, 1994, ARCH DIS CHILD, V71, P1, DOI 10.1136/adc.71.1.1
   Mehta U, 2007, AM J RHINOL, V21, P55, DOI 10.2500/ajr.2007.21.2989
   Mills R, 2004, J LARYNGOL OTOL, V118, P406, DOI 10.1258/002221504323219482
   MYER CM, 1986, INT J PEDIATR OTORHI, V11, P307, DOI 10.1016/S0165-5876(86)80044-1
   Nordgarden H, 1998, Oral Dis, V4, P152
   Priolo M, 2001, J MED GENET, V38, P579, DOI 10.1136/jmg.38.9.579
   Sevenson A.C., 1967, MUTAL RES, V4, P339
   Shin JJ, 2004, ARCH OTOLARYNGOL, V130, P1104, DOI 10.1001/archotol.130.9.1104
   SIEGEL MB, 1990, INT J PEDIATR OTORHI, V19, P265, DOI 10.1016/0165-5876(90)90006-D
   Weech AA, 1929, AM J DIS CHILD, V37, P766, DOI 10.1001/archpedi.1929.01930040075005
   Wiesmiller K, 2005, RHINOLOGY, V43, P233
   Winter SCA, 2002, J LARYNGOL OTOL, V116, P742, DOI 10.1258/002221502760238109
   Wright JT, 1993, GENE REV
   Yildirim Muzeyyen, 2012, Ear Nose Throat J, V91, pE28
   Zhang J, 2011, EUR J MED GENET, V54, pE377, DOI 10.1016/j.ejmg.2011.03.005
NR 29
TC 18
Z9 20
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-5876
EI 1872-8464
J9 INT J PEDIATR OTORHI
JI Int. J. Pediatr. Otorhinolaryngol.
PD NOV
PY 2013
VL 77
IS 11
BP 1801
EP 1804
DI 10.1016/j.ijporl.2013.09.004
PG 4
WC Otorhinolaryngology; Pediatrics
SC Otorhinolaryngology; Pediatrics
GA 246TC
UT WOS:000326561000002
PM 24080322
DA 2020-12-08
ER

PT J
AU Moura, R
   Pontillo, A
   D'Adamo, P
   Crovella, S
AF Moura, R.
   Pontillo, A.
   D'Adamo, P.
   Crovella, S.
TI May Host Genome Affect the Response to Dendritic Cell Based Immune
   Treatment Against HIV-1?
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT Conference on AIDS Vaccine
CY OCT 07-10, 2013
CL Barcelona, SPAIN
C1 [Moura, R.; Crovella, S.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Pontillo, A.] Univ Sao Paulo, ICB, BR-09500900 Sao Paulo, Brazil.
   [D'Adamo, P.] IRCCS Burlo Garofolo, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; d'Adamo, Adamo Pio/G-4064-2011
OI Crovella, Sergio/0000-0001-8493-1168; d'Adamo, Adamo
   Pio/0000-0001-9367-4909
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV 1
PY 2013
VL 29
IS 11
SI SI
BP A90
EP A90
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 239PI
UT WOS:000326037500228
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Laurentino, W
   Crovella, S
   Pereira, AC
AF Pontillo, Alessandra
   Laurentino, Weber
   Crovella, Sergio
   Pereira, Ana Carla
TI NLRP1 haplotypes associated with leprosy in Brazilian patients
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE NALP1/NLRP1; Leprosy; Inflammasome; IL-1 beta; Innate immunity;
   Polymorphisms
ID CROHNS-DISEASE SUSCEPTIBILITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
   MYCOBACTERIUM-TUBERCULOSIS; INFLAMMASOME ACTIVATION; HIV-1 INFECTION;
   CELIAC-DISEASE; GENE; POLYMORPHISMS; PREDISPOSITION; IDENTIFICATION
AB Polymorphisms in innate immunity genes are known to be involved in the multifactorial susceptibility to Mycobacterium leprae infection. M. leprae can downregulate IL-1 beta secretion escaping monocyte digestion. The intracellular receptors NLRPs (NACHT, LRR and PYD domains-containing proteins) sense pathogen associated molecular patterns (PAMPs) activating caspase-1 and IL-1 beta secretion in the context of inflammasome. Considering the possible role of inflammasome in the immune response against M. leprae, known single nucleotide polymorphisms (SNPs) in two NLRP genes, NLRP1 and NLRP3, were analyzed in Brazilian leprosy patients.
   Disease-associated SNPs (5 in NLRP1 and 2 in NLRP3), previously associated to infections and to immunologic disorders, were genotyped in 467 leprosy patients (327 multibacillary, MB; 96 paucibacillary, PB) and in 380 healthy controls (HC) from the state of Sao Paulo (Brazil), and in 183 patients (147 MB; 64 PB) and 186 HC from Mato Grosso (Brazil). Logistic regression analysis was performed considering susceptibility to leprosy di per se (leprosy versus HC) and clinical form (MB versus PB), adjusting for gender and ethnicity.
   Whereas none of the considered SNPs were statistically associated with leprosy, the NLRP1 combined haplotype rs2137722/G-rs12150220/T-rs2670660/G resulted significantly more frequent in patients than in HC as well as in PB than in MB. While both associations were lost after correction for gender and ethnicity, the NLRP1 combined haplotype rs2137722/G-rs12150220/A-rs2670660/G resulted strongly associated to PB.
   NLRP1 might be involved in the susceptibility to leprosy with particular emphasis for PB clinical form. Although preliminary, this is the first report linking NLRPs and inflammasome with leprosy: replication studies as well as functional assays are envisaged to deeper investigate the role of NLRP1 in M. leprae infection. Interestingly, NLRP1 SNPs were previously associated to susceptibility to Crohn disease, suggesting that NLRP1 could be a new modifier gene in common between leprosy and Crohn disease. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Pontillo, Alessandra] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Immunogenet Lab, Sao Paulo, Brazil.
   [Laurentino, Weber; Pereira, Ana Carla] Inst Lauro de Souza Lima, Sao Paulo, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Immunogenet Lab, Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Pontillo, Alessandra/AAD-4790-2019; Crovella, Sergio/K-5050-2016;
   Pereira, Ana C/E-3671-2013; Pontillo, Alessandra/ABC-6266-2020;
   Pontillo, ALESSANDRA/D-4352-2012
OI Pontillo, Alessandra/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, ALESSANDRA/0000-0002-7883-0640
CR Abdalla H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040722
   Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559
   Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x
   Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x
   Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521
   Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/fmb.11.39, 10.2217/FMB.11.39]
   Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x
   Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548
   Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x
   FINE PEM, 1988, PHILOS T ROY SOC B, V321, P365, DOI 10.1098/rstb.1988.0097
   Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323
   Geluk A, 2006, HUM IMMUNOL, V67, P439, DOI 10.1016/j.humimm.2006.03.009
   Glinskii AB, 2009, CELL CYCLE, V8, P3925, DOI 10.4161/cc.8.23.10113
   Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588
   Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2
   Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
   Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745
   Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229
   Lee HM, 2012, IMMUNOL CELL BIOL, V90, P601, DOI 10.1038/icb.2011.72
   Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039
   Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110
   Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Makino M, 2006, EUR J IMMUNOL, V36, P1443, DOI 10.1002/eji.200535727
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003
   Misch EA, 2010, MICROBIOL MOL BIOL R, V74, P589, DOI 10.1128/MMBR.00025-10
   Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x
   Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001
   Murray RA, 2007, J IMMUNOL, V178, P338, DOI 10.4049/jimmunol.178.1.338
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Pontillo A, 2012, ALZ DIS ASSOC DIS, V26, P277, DOI 10.1097/WAD.0b013e318231a8ac
   Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532
   Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe
   Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11
   Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690
   Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09
   Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286
   Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285
   Walker SL, 2006, BRIT MED BULL, V77-78, P103, DOI 10.1093/bmb/ldl010
   Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
NR 50
TC 12
Z9 12
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD OCT
PY 2013
VL 19
BP 274
EP 279
DI 10.1016/j.meegid.2013.06.006
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 261XT
UT WOS:000327698700038
PM 23770116
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Bedin, E
   Mangano, A
   Aulicino, P
   Pontillo, A
   Brandao, L
   Guimaraes, R
   Arraes, LC
   Sen, L
   Crovella, S
AF Celerino da Silva, R.
   Bedin, E.
   Mangano, A.
   Aulicino, P.
   Pontillo, A.
   Brandao, L.
   Guimaraes, R.
   Arraes, L. C.
   Sen, L.
   Crovella, S.
TI HIV mother-to-child transmission: A complex genetic puzzle tackled by
   Brazil and Argentina research teams
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Mother-to-child transmission; HIV; Host genome; Immunogenetics markers;
   Susceptibility; Protection
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CCR5 PROMOTER POLYMORPHISMS; POSITIVE
   PREGNANT-WOMEN; HUMAN BETA-DEFENSINS; VERTICAL TRANSMISSION; HLA-G;
   DISEASE PROGRESSION; AIDS PROGRESSION; PERINATAL TRANSMISSION; DEFB1
   GENE
AB Human immunodeficiency virus (HIV) mother-to-child transmission is a complex event, depending upon environmental factors and is affected by host genetic factors from mother and child, as well as viral genetic elements. The integration of multiple parameters (CD4 cell count, virus load, HIV subtype, and host genetic markers) could account for the susceptibility to HIV infection, a multifactorial trait. The goal of this manuscript is to analyze the immunogenetic factors associated to HIV mother-to-child transmission, trying to unravel the genetic puzzle of HIV mother-to-child transmission and considering the experience in this topic of two research groups from Brazil and Argentina. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Celerino da Silva, R.; Guimaraes, R.] Univ Fed Pernambuco, Dept Genet, BR-50670420 Recife, PE, Brazil.
   [Celerino da Silva, R.] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, BR-50670420 Recife, PE, Brazil.
   [Bedin, E.; Crovella, S.] IRCCS BurloGarofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Mangano, A.; Aulicino, P.; Sen, L.] Consejo Nacl Invest Cient & Tecn, NationalPediat Hosp JP Garrahan, Lab Cellular Biol & Retroviruses, RA-1245 Buenos Aires, DF, Argentina.
   [Pontillo, A.] Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency LIM 56, BR-05403903 Sao Paulo, Brazil.
   [Brandao, L.] Univ Fed Pernambuco, Dept Pathol, BR-50670420 Recife, PE, Brazil.
   [Arraes, L. C.] Inst Integral Med Prof Fernando Figueira IMIP, BR-50070550 Recife, PE, Brazil.
   [Crovella, S.] Univ Trieste, I-34127 Trieste, Italy.
RP Crovella, S (corresponding author), IRCCS BurloGarofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovelser@gmail.com
RI Pontillo, ALESSANDRA/D-4352-2012; Pontillo, Alessandra/AAD-4790-2019;
   Pontillo, Alessandra/ABC-6266-2020; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Crovella, Sergio/K-5050-2016
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Crovella, Sergio/0000-0001-8493-1168
CR Aguilar-Jimenez W, 2011, BIOMEDICA, V31, P44, DOI 10.1590/S0120-41572011000100007
   Ahmad N, 2011, LIFE SCI, V88, P980, DOI 10.1016/j.lfs.2010.09.023
   Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002
   Aikhionbare FO, 2001, AIDS, V15, P2196, DOI 10.1097/00002030-200111090-00019
   Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5
   Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297
   Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975
   Baroncelli S, 2008, AIDS, V22, P1515, DOI 10.1097/QAD.0b013e3282fd6e0c
   Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Chaichompoo P, 2010, CELL IMMUNOL, V263, P176, DOI 10.1016/j.cellimm.2010.03.014
   Contopoulos-Ioannidis DG, 2003, JAIDS-J ACQ IMM DEF, V32, P70, DOI 10.1097/00126334-200301010-00010
   Crovella S, 2005, J MATERN-FETAL NEO M, V17, P253, DOI 10.1080/14767050500072599
   da Silva RC, 2011, HUM IMMUNOL, V72, P305, DOI 10.1016/j.humimm.2011.01.012
   da Silva RC, 2012, HUM IMMUNOL, V73, P1159, DOI 10.1016/j.humimm.2012.07.338
   de Souza PR, 2006, J REPROD IMMUNOL, V69, P77, DOI 10.1016/j.jri.2005.09.001
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004
   GREGGIO NA, 1993, DIS MARKERS, V11, P29, DOI 10.1155/1993/292684
   Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006
   Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10
   Hunt JS, 2000, HUM IMMUNOL, V61, P1113, DOI 10.1016/S0198-8859(00)00195-6
   Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007
   Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348
   Jia HP, 2001, J PEDIATR-US, V138, P109, DOI 10.1067/mpd.2001.109375
   John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000
   John GC, 2001, J INFECT DIS, V184, P89, DOI 10.1086/321006
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   KILPATRICK DC, 1991, DIS MARKERS, V9, P21
   Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a
   LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0
   Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528
   Mandl CW, 1998, J MED VIROL, V55, P51, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;51::AID-JMV9&gt;3.0.CO;2-N
   Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498
   Mangano A, 2000, J ACQ IMMUN DEF SYND, V23, P52
   Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705
   Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   Moodley S, 2011, PLACENTA, V32, P778, DOI 10.1016/j.placenta.2011.07.012
   Newell ML, 1996, AIDS, V10, P1675
   Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478
   Padovan L, 2011, AIDS, V25, P535, DOI 10.1097/QAD.0b013e3283428b7c
   Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541
   Perez-Nunez D., 2011, HIV HOST INTERACTION
   Philpott S, 1999, J ACQ IMMUN DEF SYND, V21, P189, DOI 10.1097/00126334-199907010-00002
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
   Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49
   Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249
   Segat L, 2006, IMMUNOGENETICS, V58, P471, DOI 10.1007/s00251-006-0104-7
   Segat L, 2006, J MATERN-FETAL NEO M, V19, P13, DOI 10.1080/14767050500381123
   Segat L, 2009, AIDS, V23, P1916, DOI 10.1097/QAD.0b013e32832f8104
   Segat L, 2009, AIDS, V23, P649, DOI [10.1097/QAD.0b013e328327726a, 10.1097/QAD.0b013e3283277247]
   Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003
   Singh KK, 2009, PEDIATR RES, V65, p55R, DOI 10.1203/PDR.0b013e31819dca03
   Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155
   Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005
   Taborda-Vanegas Natalia, 2011, Open Virol J, V5, P35, DOI 10.2174/1874357901105010035
   Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D
   Tresoldi E, 2002, J INFECT DIS, V185, P696, DOI 10.1086/339004
   Vidricaire G, 2007, J INFECT DIS, V195, P1461, DOI 10.1086/515576
   Winchester R, 1995, P NATL ACAD SCI USA, V92, P12374, DOI 10.1073/pnas.92.26.12374
   Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389
NR 71
TC 1
Z9 1
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD OCT
PY 2013
VL 19
BP 312
EP 322
DI 10.1016/j.meegid.2013.03.005
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA 261XT
UT WOS:000327698700042
PM 23524206
DA 2020-12-08
ER

PT J
AU da Cruz, HLA
   da Silva, RC
   Segat, L
   de Carvalho, MSZDG
   Brandao, LAC
   Guimaraes, RL
   Santos, FCF
   de Lira, LAS
   Montenegro, LML
   Schindler, HC
   Crovella, S
AF Alves da Cruz, Heidi Lacerda
   da Silva, Ronaldo Celerino
   Segat, Ludovica
   de Mendonca Gomes de Carvalho, Marcia Schneider Zuzarte
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Fulco Santos, Fabiana Cristina
   Siqueira de Lira, Lais Ariane
   Lapa Montenegro, Lilian Maria
   Schindler, Haiana Charifker
   Crovella, Sergio
TI MBL2 gene polymorphisms and susceptibility to tuberculosis in a
   northeastern Brazilian population
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Tuberculosis; Innate immunity; MBL2; Pulmonary; Polymorphisms
ID MANNOSE-BINDING LECTIN; PULMONARY TUBERCULOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; CLINICAL TUBERCULOSIS; CONFERS PROTECTION;
   HIV-INFECTION; ASSOCIATION; VARIANTS; PROTEIN; STRATIFICATION
AB The innate immune system represents the first line of host defense against pathogens. Genetics factors regulating the immune responses play a role in the susceptibility to infectious diseases, such as tuberculosis (TB). We analyzed MBL2 promoter and exon 1 functional single nucleotide polymorphisms (SNPs) in a group of 155 TB patients and 148 healthy controls in order to evaluate their influence on the onset of infection and TB development. There was no association between MBL2 -550 HL promoter polymorphisms and susceptibility to develop TB, but heterozygous -221 Y/X genotype was significantly more frequent in pulmonary TB patients than controls. Moreover, MBL2 exon 1 O allele, was significantly associated with susceptibility to TB development in general (p = 0.023, OR = 1.61, 95% CI 1.05-2.49) and pulmonary TB (p = 0.0008, OR = 2.16, 95% CI 1.35-3.46); C allele at codon 57, as well as A/C genotype, were significantly more frequent in TB patients than in controls. Our results indicate that MBL2 polymorphisms, especially at codon 57, could be considered as risk factors for TB development. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Alves da Cruz, Heidi Lacerda; de Mendonca Gomes de Carvalho, Marcia Schneider Zuzarte; Fulco Santos, Fabiana Cristina; Siqueira de Lira, Lais Ariane; Lapa Montenegro, Lilian Maria; Schindler, Haiana Charifker] Aggeu Magalhaes Res Ctr CPqAM FIOCRUZ, Dept Immunol, BR-50670420 Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; de Mendonca Gomes de Carvalho, Marcia Schneider Zuzarte; Guimaraes, Rafael Lima] Univ Fed Pernambuco, Dept Genet, BR-50670420 Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino; Cavalcanti Brandao, Lucas Andre; Guimaraes, Rafael Lima] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, BR-50670420 Recife, PE, Brazil.
   [Segat, Ludovica; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, BR-50670420 Recife, PE, Brazil.
RP Crovella, S (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovelser@gmail.com
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; SANTOS, FABIANA/0000-0002-3252-8622; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors thank all the health professionals from the Hospitals
   involved in the study that collaborated with the research. We thank the
   Laboratory of Immunoepidemiology - CPqAM/FIOCRUZ, the Laboratory of
   Immunopathology Keizo Asami, the Department of Genetics, Federal
   University of Pernambuco, the Graduate Program in Genetics for
   supporting physical and scientific, as well as FACEPE and CNPq, for
   financial support.
CR Alagarasu K, 2007, TUBERCULOSIS, V87, P535, DOI 10.1016/j.tube.2007.07.007
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Araujo M.S., 2012, HUM IMMUNOL
   Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002
   Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614
   Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897
   Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116
   Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Brazil. Ministry of Health, 2008, NAT HLTH SURV PROGR
   Capparelli R, 2009, J INFECT DIS, V199, P666, DOI 10.1086/596658
   Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903
   Cosar H, 2008, EUR J CLIN MICROBIOL, V27, P1165, DOI 10.1007/s10096-008-0573-8
   Davies J, 2001, Paediatr Respir Rev, V2, P70, DOI 10.1053/prrv.2000.0104
   Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x
   Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141
   El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860
   Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283
   Goldfeld AE, 1998, JAMA-J AM MED ASSOC, V279, P226, DOI 10.1001/jama.279.3.226
   Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012
   Hijjar M.A., 2001, B PNEUMOLOGIA SANITA, V9
   Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002
   Khlat M, 2004, CANCER EPIDEM BIOMAR, V13, P1660
   Lee WC, 2008, AM J EPIDEMIOL, V167, P86, DOI 10.1093/aje/kwm257
   Liu W, 2006, INT J TUBERC LUNG D, V10, P1098
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031
   Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656
   Oliveira M.M., 2004, J BRAS PNEUMOL, V4, P371
   Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Remus N, 2004, J INFECT DIS, V190, P580, DOI 10.1086/422534
   Selvaraj P, 2006, FEMS IMMUNOL MED MIC, V46, P433, DOI 10.1111/j.1574-695X.2006.00053.x
   SINGH SPN, 1983, J INFECT DIS, V148, P676, DOI 10.1093/infdis/148.4.676
   Soborg C, 2003, J INFECT DIS, V188, P777, DOI 10.1086/377183
   Solgun HA, 2011, TUBERK TORAK, V59, P48, DOI 10.5578/tt.2385
   Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8
   Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908
   Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151
   WALLIS R, 2003, MOL B INT U, P34
   Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6
   World Health Organization, 2011, GLOB TUB CONTR
NR 45
TC 23
Z9 23
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD OCT
PY 2013
VL 19
BP 323
EP 329
DI 10.1016/j.meegid.2013.03.002
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA 261XT
UT WOS:000327698700043
PM 23524205
DA 2020-12-08
ER

PT J
AU Silva, JD
   Fernandes, KM
   Pancotto, JAT
   Fragoso, TS
   Donadi, EA
   Crovella, S
   Sandrin-Garcia, P
AF de Azevedo Silva, J.
   Monteiro Fernandes, K.
   Tres Pancotto, J. A.
   Sotero Fragoso, T.
   Donadi, E. A.
   Crovella, S.
   Sandrin-Garcia, P.
TI Vitamin D receptor (VDR) gene polymorphisms and susceptibility to
   systemic lupus erythematosus clinical manifestations
SO LUPUS
LA English
DT Article
DE SNPs; VDR gene; SLE; SLE clinical manifestations
ID TYPE-1 DIABETES-MELLITUS; D DEFICIENCY; ASSOCIATION; SLE; PREVALENCE;
   PROFILES; PROTECTS; CANCER; DAMAGE; BSMI
AB Systemic lupus erythematosus (SLE) is an autoimmune disorder with heterogeneous clinical manifestations and target tissue damage. Currently, several genes have been associated with SLE susceptibility, including vitamin D receptor (VDR), which is a mediator of immune responses through the action of vitamin D. Polymorphisms in the VDR gene can impair the vitamin D (D-3) function role, and since SLE patients show deficient D-3 blood levels, it leads to a possible connection to the disease's onset. In our study we searched for an association between VDR polymorphisms and risk of developing SLE, as well as the disease's clinical manifestations. We enrolled 158 SLE patients and 190 Southeast Brazilian healthy controls, genotyped for five Tag single nucleotide polymorphisms (SNPs), covering most of the VDR gene region. We found an association between VDR SNPs and SLE for the following clinical manifestations: rs11168268 and cutaneous alterations (p=0.036), rs3890733 (p=0.003) rs3890733 and arthritis (p=0.001), rs2248098 and immunological alterations (p=0.040), rs4760648 and antibody anti-dsDNA (p=0.036). No association was reported between VDR polymorphisms and SLE susceptibility.
C1 [de Azevedo Silva, J.; Crovella, S.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Dept Genet, BR-50760901 Recife, PE, Brazil.
   [de Azevedo Silva, J.; Monteiro Fernandes, K.; Sotero Fragoso, T.; Crovella, S.; Sandrin-Garcia, P.] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami LIKA, BR-50760901 Recife, PE, Brazil.
   [Tres Pancotto, J. A.] Fed Univ Espirito Santo UFES, Vitoria, ES, Brazil.
   [Donadi, E. A.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-05508 Sao Paulo, Brazil.
RP Sandrin-Garcia, P (corresponding author), Univ Fed Pernambuco, Dept Genet, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM paula.sandrin@ufpe.br
RI donadi, eduardo A/H-7080-2013; Crovella, Sergio/K-5050-2016
OI donadi, eduardo A/0000-0002-9457-9601; Crovella,
   Sergio/0000-0001-8493-1168; Sotero Fragoso, Thiago/0000-0002-0192-0760
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado
   de Pernambuco (FACEPE)
FX This work was supported by the Brazilian funding agencies: Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), National
   Council for Scientific and Technological Development (CNPq) and Fundacao
   de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE).
CR Abbasi M, 2010, RHEUMATOL INT, V30, P1537, DOI 10.1007/s00296-010-1504-4
   Alonso-Perez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029033
   Angel B, 2004, EUR J EPIDEMIOL, V19, P1085, DOI 10.1007/s10654-004-1026-z
   Bezerra Elaine Lira Medeiros, 2005, Rev. Bras. Reumatol., V45, P339, DOI 10.1590/S0482-50042005000600002
   Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200
   Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018
   Cojocaru Manole, 2011, Maedica (Bucur), V6, P330
   Damian DL, 2010, EXP DERMATOL, V19, pE23, DOI 10.1111/j.1600-0625.2009.00955.x
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hutchinson PE, 2000, CLIN CANCER RES, V6, P498
   Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013
   Khanh VQL, 2012, CLIN RHEUMATOL, V31, P1423, DOI 10.1007/s10067-012-2033-1
   Kostner K, 2009, ANTICANCER RES, V29, P3511
   Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008
   Li PH, 2013, RHEUMATOLOGY, V52, P337, DOI 10.1093/rheumatology/kes261
   Luo Xiong-yan, 2012, Zhonghua Nei Ke Za Zhi, V51, P131
   Maalej A, 2008, J CLIN IMMUNOL, V28, P21, DOI 10.1007/s10875-007-9124-9
   Merlino LA, 2004, ARTHRITIS RHEUM, V50, P72, DOI 10.1002/art.11434
   Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165
   Mohammadnejad Z, 2012, MOL BIOL REP, V39, P831, DOI 10.1007/s11033-011-0805-3
   Mok CC, 2012, LUPUS, V21, P36, DOI 10.1177/0961203311422094
   Mok CC, 2013, EXPERT REV CLIN IMMU, V9, P453, DOI [10.1586/eci.13.19, 10.1586/ECI.13.19]
   Monticielo OA, 2012, CLIN RHEUMATOL, V31, P1411, DOI 10.1007/s10067-012-2021-5
   Mory DB, 2009, HUM IMMUNOL, V70, P447, DOI 10.1016/j.humimm.2009.03.007
   Nejentsev S, 2004, DIABETES, V53, P2709, DOI 10.2337/diabetes.53.10.2709
   Norman AW, 1998, AM J CLIN NUTR, V67, P1108
   Ozaki Y, 2000, NEPHRON, V85, P86, DOI 10.1159/000045635
   Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504
   Panierakis C, 2009, CLIN IMMUNOL, V133, P276, DOI 10.1016/j.clim.2009.08.004
   Qiao SW, 2012, SEMIN IMMUNOPATHOL, V34, P523, DOI 10.1007/s00281-012-0314-z
   Ramos-Lopez E, 2006, ANN NY ACAD SCI, V1079, P327, DOI 10.1196/annals.1375.050
   Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121
   Sakulpipatsin W, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1910
   Sambrook J., 1989, MOL CLONING LAB MANU
   Santos BR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-62
   Sestak AL, 2008, LUPUS, V17, P1004, DOI 10.1177/0961203308091969
   Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002
   Singh A, 2012, DERM-ENDOCRINOL, V4, P146, DOI 10.4161/derm.20443
   Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578
   Uva L, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/834291
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001
   Zhang J, 2012, MOL CELL ENDOCRINOL, V355, P135, DOI 10.1016/j.mce.2012.02.003
NR 46
TC 13
Z9 13
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD OCT
PY 2013
VL 22
IS 11
BP 1110
EP 1117
DI 10.1177/0961203313500549
PG 8
WC Rheumatology
SC Rheumatology
GA 220YT
UT WOS:000324624200004
PM 23945129
DA 2020-12-08
ER

PT J
AU Coelho, AVC
   Brandao, LAC
   Guimaraes, RL
   Loureiro, P
   de Lima, JL
   de Alencar, LCA
   Crovella, S
   Segat, L
AF Campos Coelho, Antonio Victor
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Loureiro, Paula
   de Lima Filho, Jose Luiz
   Arraes de Alencar, Luiz Claudio
   Crovella, Sergio
   Segat, Ludovica
TI Mannose binding lectin and mannose binding lectin-associated serine
   protease-2 genes polymorphisms in human T-lymphotropic virus infection
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HTLV; innate immunity; MBL2; MASP2; SNPs
ID HTLV-I INFECTION; PROVIRAL LOAD; SPASTIC PARAPARESIS; IMMUNE-RESPONSE;
   INNATE IMMUNITY; COMPLEMENT; CARRIERS; DEFICIENCY; ACTIVATION; MUTATIONS
AB Variations in genes involved in the immune response pathways may influence the interaction between viruses (such as Human T-lymphotropic virus, HTLV-1) and the host. The mannose binding lectin (MBL) and its associated serine protease type 2 (MASP-2) promote the activation of the lectin pathway of the complement system. As the interaction of complement system with HTLV-1 is not well understood, the MBL2 promoter/exon 1 polymorphisms and a MASP2 missense polymorphism were examined in a Northeast Brazilian population, looking for a possible relationship between these variations and the susceptibility to HTLV-1 infection. The present study describes an association between a polymorphism in the MASP2 gene and susceptibility to HTLV-1 infection, and provides further evidence of an association between the MBL2 gene and HTLV-1 infection. These findings suggest an important role of the complement system activation, via the lectin pathway, in the susceptibility to HTLV-1 infection. (c) 2013 Wiley Periodicals, Inc.
C1 [Campos Coelho, Antonio Victor; Guimaraes, Rafael Lima; Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [Campos Coelho, Antonio Victor; Cavalcanti Brandao, Lucas Andre; Guimaraes, Rafael Lima; de Lima Filho, Jose Luiz; Crovella, Sergio] Univ Fed Pernambuco, Keizo Asami Immunopathol Lab LIKA, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Loureiro, Paula] Hematol & Hemotherapy Fdn Pernambuco HEMOPE, Recife, PE, Brazil.
   [Arraes de Alencar, Luiz Claudio] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Segat, Ludovica] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Coelho, Antonio Victor
   C/E-6795-2015; Crovella, Sergio/K-5050-2016; Loureiro,
   Paula/A-2965-2013; Filho, Jose Luiz Lima/M-8076-2019
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Coelho, Antonio
   Victor C/0000-0003-2143-9701; Crovella, Sergio/0000-0001-8493-1168;
   Loureiro, Paula/0000-0003-1849-0047; Segat, Ludovica/0000-0002-6024-1485
FU CNPq grant from the Ministerio da Saude, Secretaria de Vigilancia em
   Saude-SVS Departamento de DST, Aids e Hepatites Virais [401635/2009-0];
   IRCCS Burlo Garofolo [RC 77/08]; FACEPE [APQ-0020-4.01/08]
FX Grant sponsor: CNPq grant from the Ministerio da Saude, Secretaria de
   Vigilancia em Saude-SVS Departamento de DST, Aids e Hepatites Virais;
   Grant number: 401635/2009-0.; Grant sponsor: IRCCS Burlo Garofolo; Grant
   number: RC 77/08.; Grant sponsor: FACEPE (to L. S.); Grant number:
   APQ-0020-4.01/08.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alves AEM, 2007, MEM I OSWALDO CRUZ, V102, P991, DOI 10.1590/S0074-02762007000800015
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0
   Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81
   Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980
   Degn SE, 2007, IMMUNOBIOLOGY, V212, P301, DOI 10.1016/j.imbio.2006.12.004
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800
   Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   GESSAIN A, 1986, LANCET, V2, P698
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410
   Maeda N, 2008, REV MED VIROL, V18, P387, DOI 10.1002/rmv.592
   Manns A, 1999, J INFECT DIS, V180, P1487, DOI 10.1086/315088
   Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nishimura M, 2003, HUM IMMUNOL, V64, P453, DOI 10.1016/S0198-8859(02)00829-7
   OSAME M, 1986, LANCET, V1, P1031
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Pontes GS, 2005, HUM IMMUNOL, V66, P892, DOI 10.1016/j.humimm.2005.06.006
   R Core Team, 2012, R LANG ENV STAT COMP
   Rajagopalan R, 2009, IMMUNOL LETT, V123, P114, DOI 10.1016/j.imlet.2009.02.013
   Segat L, 2010, VACCINE, V28, P2201, DOI 10.1016/j.vaccine.2009.12.056
   Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836
   Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373
   Vine AM, 2002, J INFECT DIS, V186, P932, DOI 10.1086/342953
   Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200
   Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727
NR 33
TC 8
Z9 8
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2013
VL 85
IS 10
BP 1829
EP 1835
DI 10.1002/jmv.23656
PG 7
WC Virology
SC Virology
GA 199JZ
UT WOS:000322992100018
PM 23861212
DA 2020-12-08
ER

PT J
AU Fonseca, AMD
   Silva, JD
   Pancotto, JAT
   Donadi, EA
   Segat, L
   Crovella, S
   Sandrin-Garcia, P
AF da Silva Fonseca, Andreia Maria
   Silva, Jaqueline de Azevedo
   Tres Pancotto, Joao Alexandre
   Donadi, Eduardo Antonio
   Segat, Ludovica
   Crovella, Sergio
   Sandrin-Garcia, Paula
TI Polymorphisms in STK17A gene are associated with systemic lupus
   erythematosus and its clinical manifestations
SO GENE
LA English
DT Review
DE Systemic lupus erythematosus; Serine/threonine protein kinase 17A;
   STK17A; Single nucleotide polymorphisms
ID PROTEIN-KINASE; DNA-REPAIR; XRCC1; RISK
AB Systemic lupus erythematosus (SLE) is an autoimmune disorder with several clinical manifestations. SLE etiology has a strong genetic component, which plays a key role in disease's predisposition, as well as participation of environmental factors, such and UV light exposure. In this regard, we investigated whether polymorphisms in STK17A, a DNA repair related gene, encoding for serine/threonine-protein kinase 17A, are associated with SLE susceptibility. A total of 143 SLE patients and 177 healthy controls from Southern Brazil were genotyped for five STK17A TagSNPs. Our results indicated association of rs7805969 SNP (A and G/A genotype, OR = 1.40 and OR = 1.73, respectively) with SLE predisposition and the following clinical manifestations: arthritis, cutaneous and immunological alterations. When analyzing haplotypes distribution, we found association between TGGTC, TAGTC and AAGAT haplotypes and risk to develop SLE. When considering clinical manifestations, the haplotypes TGGTT and TAGTC were associated with protection against cutaneous alterations and the haplotype TAGTC to hematological alterations. We also observed association between SLE clinical manifestations and ethnicity, with the European-derived patients being more susceptible to cutaneous and hematological alterations. (C) 2013 Elsevier B.V. All rights reserved.
C1 [da Silva Fonseca, Andreia Maria; Silva, Jaqueline de Azevedo; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, BR-50760901 Recife, PE, Brazil.
   [Tres Pancotto, Joao Alexandre] Univ Fed Espirito Santo, Sao Mateus, ES, Brazil.
   [Donadi, Eduardo Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, BR-50760901 Recife, PE, Brazil.
RP Sandrin-Garcia, P (corresponding author), Univ Fed Pernambuco, Dept Genet, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM paula.sandrin@ufpe.br
RI Crovella, Sergio/K-5050-2016; donadi, eduardo A/H-7080-2013
OI Crovella, Sergio/0000-0001-8493-1168; donadi, eduardo
   A/0000-0002-9457-9601; Segat, Ludovica/0000-0002-6024-1485
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FACEPE; European Project "Talents for an
   International House" within the framework of the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND
   (Co-Funding of Regional, National and International Programmes)European
   Union (EU)
FX This work was supported by the following Brazilian funding agencies:
   CNPq, CAPES and FACEPE. The authors also acknowledge the Program for
   Technological Development in Tools for Health-PDTISFIOCRUZ. SC is
   recipient of a fellowship grant from the European Project "Talents for
   an International House" within the framework of the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND
   (Co-Funding of Regional, National and International Programmes).
CR Alonso-Perez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029033
   Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135
   Bassi CL, 2008, LUPUS, V17, P988, DOI 10.1177/0961203308093461
   Bezerra Elaine Lira Medeiros, 2005, Rev. Bras. Reumatol., V45, P339, DOI 10.1590/S0482-50042005000600002
   Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998
   Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229
   Jarvinen TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014212
   Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790
   Lee KJ, 2002, J IMMUNOL, V169, P3413, DOI 10.4049/jimmunol.169.6.3413
   Lee YH, 2005, HUM GENET, V116, P361, DOI 10.1007/s00439-004-1244-1
   Lin YJ, 2009, LUPUS, V18, P1246, DOI 10.1177/0961203309345777
   Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6
   Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040
   Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010
   Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007
   Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sandrin-Garcia P, 2009, ANN NY ACAD SCI, V1173, P493, DOI 10.1111/j.1749-6632.2009.04636.x
   Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066
   Sauma Maria de Fátima Lobato da Cunha, 2004, Rev. Bras. Reumatol., V44, P192, DOI 10.1590/S0482-50042004000300003
   Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480
   Takeda Y, 2001, FRONT BIOSCI, V6, P1412, DOI DOI 10.2741/TAKEDA
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1
   Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9
   Warchot T., 2012, DNA CELL BIOL, V1, P50
   Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810
   Yang WD, 2006, CANCER LETT, V243, P217, DOI 10.1016/j.canlet.2005.11.033
NR 32
TC 8
Z9 8
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD SEP 25
PY 2013
VL 527
IS 2
BP 435
EP 439
DI 10.1016/j.gene.2013.06.074
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 210YW
UT WOS:000323872300001
PM 23860322
DA 2020-12-08
ER

PT J
AU Silva, JD
   Guimaraes, RL
   Brandao, LAC
   Araujo, J
   Segat, L
   Crovella, S
   Sandrin-Garcia, P
AF Silva, Jaqueline De Azevedo
   Guimaraes, Rafael Lima
   Cavalcanti Brandao, Lucas Andre
   Araujo, Jacqueline
   Segat, Ludovica
   Crovella, Sergio
   Sandrin-Garcia, Paula
TI Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1
   diabetes mellitus
SO AUTOIMMUNITY
LA English
DT Article
DE SNPs; T1DM; VDR
ID SUSCEPTIBILITY; ASSOCIATION; ORGANIZATION; DIAGNOSIS; RISK; FOKI
AB Vitamin D receptor is a mediator of immune responses through the action of vitamin D, which is capable of regulate the insulin secretion by the pancreas. Since polymorphisms in the vitamin D receptor (VDR) gene might modulate vitamin D function, and thus immunologic response, VDR is possibly able to influence the predisposition to type 1 diabetes mellitus (T1DM). The aim of this work was to perform an association study among VDR polymorphisms and T1DM susceptibility, as well as the correlation with the disease onset. Two hundred and four T1DM patients and 217 controls, from Northeast Brazil, were genotyped for five tagSNPs, covering the whole VDR gene. Our results indicated an association between rs1540339 and rs4760648 SNPs (p=0.02 and p=0.03, respectively) and T1DM. No association was found with T1DM onset and age at diagnose. To our knowledge, this is the first association study in T1DM where the whole VDR gene was analyzed, and our results indicate that VDR polymorphisms could be important for T1DM susceptibility, but do not seem to be associated to age at disease onset.
C1 [Silva, Jaqueline De Azevedo; Guimaraes, Rafael Lima; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, BR-50760901 Recife, PE, Brazil.
   [Silva, Jaqueline De Azevedo; Guimaraes, Rafael Lima; Cavalcanti Brandao, Lucas Andre; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami LIKA, BR-50760901 Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, BR-50760901 Recife, PE, Brazil.
   [Araujo, Jacqueline] Univ Fed Pernambuco, Clin Hosp, Pediat Endocrinol Unit, BR-50760901 Recife, PE, Brazil.
RP Sandrin-Garcia, P (corresponding author), Univ Fed Pernambuco, Dept Genet, Av Moraes Rego 1235, BR-50760901 Recife, PE, Brazil.
EM paula.sandrin@ufpe.br
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Crovella,
   Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
FU Brazilian funding agency CapesCAPES; Brazilian funding agency
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Brazilian funding agency FACEPE
FX This work was supported by the Brazilian funding agencies: Capes, CNPq
   and FACEPE. We also thank Ronald Moura, Master's student, for
   statistical support.
CR Angel B, 2004, EUR J EPIDEMIOL, V19, P1085, DOI 10.1007/s10654-004-1026-z
   Audi L, 2004, DIABETIC MED, V21, P393, DOI 10.1111/j.1464-5491.2004.01126.x
   Boraska V, 2008, J HUM GENET, V53, P210, DOI 10.1007/s10038-007-0234-2
   Boucher BJ, 2004, DIABETIC MED, V21, P803, DOI 10.1111/j.1464-5491.2004.1217a.x
   Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820
   Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108
   Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278
   Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96
   Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1
   Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516
   Kocabas A, 2010, J PEDIATR ENDOCR MET, V23, P1289, DOI 10.1515/jpem.2010.203
   Kostner K, 2009, ANTICANCER RES, V29, P3511
   Larsson P, 1998, CLIN EXP IMMUNOL, V114, P277
   Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008
   Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x
   Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3
   McDermott MF, 1997, DIABETOLOGIA, V40, P971, DOI 10.1007/s001250050776
   Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165
   Mory DB, 2009, HUM IMMUNOL, V70, P447, DOI 10.1016/j.humimm.2009.03.007
   Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881
   Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5
   Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169
   Nejentsev S, 2004, DIABETES, V53, P2709, DOI 10.2337/diabetes.53.10.2709
   Norman AW, 1998, AM J CLIN NUTR, V67, P1108
   Pani MA, 2000, DIABETES, V49, P504, DOI 10.2337/diabetes.49.3.504
   Panierakis C, 2009, CLIN IMMUNOL, V133, P276, DOI 10.1016/j.clim.2009.08.004
   Ramos-Lopez E, 2006, ANN NY ACAD SCI, V1079, P327, DOI 10.1196/annals.1375.050
   San-Pedro JI, 2005, AUTOIMMUNITY, V38, P439, DOI 10.1080/08916930500288455
   Turpeinen H, 2003, EUR J ENDOCRINOL, V149, P591, DOI 10.1530/eje.0.1490591
   Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014
   Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001
   Zhang J, 2012, MOL CELL ENDOCRINOL, V355, P135, DOI 10.1016/j.mce.2012.02.003
   Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837
NR 36
TC 13
Z9 13
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0891-6934
EI 1607-842X
J9 AUTOIMMUNITY
JI Autoimmunity
PD SEP
PY 2013
VL 46
IS 6
BP 382
EP 387
DI 10.3109/08916934.2013.795952
PG 6
WC Immunology
SC Immunology
GA 213SG
UT WOS:000324079700005
PM 23721405
DA 2020-12-08
ER

PT J
AU Pastor, AF
   Moura, LR
   Neto, JWD
   Nascimento, EJM
   Calzavara-Silva, CE
   Gomes, ALV
   da Silva, AM
   Cordeiro, MT
   Braga-Neto, U
   Crovella, S
   Gil, LHVG
   Marques, ETA
   Acioli-Santos, B
AF Pastor, Andre F.
   Moura, Lais Rodrigues
   Neto, Jose W. D.
   Nascimento, Eduardo J. M.
   Calzavara-Silva, Carlos E.
   Gomes, Ana Lisa V.
   da Silva, Ana Maria
   Cordeiro, Marli T.
   Braga-Neto, Ulisses
   Crovella, Sergio
   Gil, Laura H. V. G.
   Marques, Ernesto T. A., Jr.
   Acioli-Santos, Bartolomeu
TI Complement factor H gene (CFH) polymorphisms C-257T, G257A and
   haplotypes are associated with protection against severe dengue
   phenotype, possible related with high CFH expression
SO HUMAN IMMUNOLOGY
LA English
DT Article
ID HEMOLYTIC-UREMIC SYNDROME; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS;
   INTERFERON-GAMMA; DISEASE SEVERITY; PROTEIN NS1; RISK-FACTOR; VIRAL
   LOAD; ACTIVATION; SURVEILLANCE
AB Four genetic polymorphisms located at the promoter (C-257T) and coding regions of CFH gene (exon 2 G257A, exon 14 A2089G and exon 19 G2881T) were investigated in 121 dengue patients (DENV-3) in order to assess the relationship between allele/haplotypes variants and clinical outcomes. A statistical value was found between the CFH-257T allele (TT/TC genotypes) and reduced susceptibility to severe dengue (SD). Statistical associations indicate that individuals bearing a T allele presented significantly higher protein levels in plasma. The -257T variant is located within a NF-kappa B binding site, suggesting that this variant might have effect on the ability of the CFH gene to respond to signals via the NF-kappa B pathway. The G257A allelic variant showed significant protection against severe dengue. When CFH haplotypes effect was considered, the ancestral CG/CG promoter-exon 2 SNP genotype showed significant risk to SD either in a general comparison (ancestral x all variant genotypes), as well as in individual genotypes comparison (ancestral x each variant genotype), where the most prevalent effect was observed in the CG/CG x CA/TG comparison. These findings support the involvement of -257T, 257A allele variants and haplotypes on severe dengue phenotype protection, related with high basal CFH expression. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Pastor, Andre F.; Moura, Lais Rodrigues; Neto, Jose W. D.; Calzavara-Silva, Carlos E.; Gomes, Ana Lisa V.; da Silva, Ana Maria; Cordeiro, Marli T.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.; Acioli-Santos, Bartolomeu] FIOCRUZ PE, Virol & Expt Therapy Lab, Recife, PE, Brazil.
   [Braga-Neto, Ulisses] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA.
   [Pastor, Andre F.; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Acioli-Santos, B (corresponding author), FIOCRUZ PE, Virol & Expt Therapy Lab, Av Prof Moraes Rego S-N Campus UFPE Cidade Univ, Recife, PE, Brazil.
EM bartacioli@yahoo.com
RI Nascimento, Eduardo/J-4590-2014; Neto, Jose Manoel Duarte/AAH-6963-2020;
   Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013;
   Crovella, Sergio/K-5050-2016
OI Nascimento, Eduardo/0000-0002-9851-2332; Neto, Jose Manoel
   Duarte/0000-0002-3588-2934; Marques, Ernesto T. A/0000-0003-3826-9358;
   Marques, Ernesto/0000-0003-3826-9358; Crovella,
   Sergio/0000-0001-8493-1168; CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, N01 AI 40085]; Brazilian National
   Research Council (CNPq)National Council for Scientific and Technological
   Development (CNPq) [DCR 35.0382/2004.2]; FACEPE (Fundacao de Amparo
   Ciencia e Tecnologia do Estado de Pernambuco, Brazil); NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI056541, U19AI056541, U19AI056541]
   Funding Source: NIH RePORTER; Division of Computing and Communication
   FoundationsNational Science Foundation (NSF)NSF - Directorate for
   Computer & Information Science & Engineering (CISE) [0845407] Funding
   Source: National Science Foundation
FX The author also acknowledge the support of the National Institute of
   Allergy and Infectious Diseases (NIAID/NIH), under Grants U19 AI56541
   and N01 AI 40085, the Brazilian National Research Council (CNPq), under
   Grant DCR 35.0382/2004.2 (to Dr. Braga-Neto), and the FACEPE (Fundacao
   de Amparo Ciencia e Tecnologia do Estado de Pernambuco, Brazil) for A.
   Pastor's fellowship.
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   Alencar LXE, 2013, J TROPICAL MED, V2013, DOI DOI 10.1155/2013/648475
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Bokisch V A, 1973, Trans Assoc Am Physicians, V86, P102
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363
   CHIEWSILP P, 1981, AM J TROP MED HYG, V30, P1100, DOI 10.4269/ajtmh.1981.30.1100
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Fang X, 2012, FEMS IMMUNOL MED MIC, P1
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Friese MA, 1999, MOL IMMUNOL, V36, P809, DOI 10.1016/S0161-5890(99)00101-7
   Furlan M, 2000, NEPHROL DIAL TRANSPL, V15, P1112, DOI 10.1093/ndt/15.8.1112
   Gubler D, 1997, DENGUE DENGUE HEMORR
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Halme J, 2009, MOL IMMUNOL, V46, P2284, DOI 10.1016/j.molimm.2009.04.005
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Luo W, 1999, SCAND J IMMUNOL, V49, P487
   Marques ETA, 2008, CAD SAUDE PUBLICA, V24, P547, DOI 10.1590/S0102-311X2008000300008
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Nishioka K, 1974, Allerg Immunol (Leipz), V20-21, P385
   Organization WH, 2004, DENGUE GUIDELINES DI
   PEREZ MLP, 1987, HAEMATOLOGIA, V20, P83
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12
   Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32
   Timar KK, 2006, MOL IMMUNOL, V43, P317, DOI 10.1016/j.molimm.2005.02.009
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Warwicker P, 1997, IMMUNOGENETICS, V46, P437, DOI 10.1007/s002510050300
   Williams SA, 1997, SCAND J IMMUNOL, V45, P7, DOI 10.1046/j.1365-3083.1997.d01-364.x
NR 43
TC 12
Z9 12
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD SEP
PY 2013
VL 74
IS 9
BP 1225
EP 1230
DI 10.1016/j.humimm.2013.05.005
PG 6
WC Immunology
SC Immunology
GA 198RG
UT WOS:000322939400026
PM 23747994
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Zanin, V
   Kleiner, G
   Monasta, L
   Crovella, S
AF Marcuzzi, Annalisa
   Zanin, Valentina
   Kleiner, Giulio
   Monasta, Lorenzo
   Crovella, Sergio
TI Mouse model of mevalonate kinase deficiency: comparison of cytokine and
   chemokine profile with that of human patients
SO PEDIATRIC RESEARCH
LA English
DT Article
ID PERIODIC FEVER SYNDROME; HYPER-IGD SYNDROME; HYPERIMMUNOGLOBULINEMIA-D;
   INTERLEUKIN-1-BETA SECRETION; NATURAL ISOPRENOIDS; INFLAMMATION;
   GERANIOL; ATTACKS; LPS; CHOLESTEROL
AB BACKGROUND: Mevalonate kinase deficiency (MKD) is a rare genetic autoinflammatory disease caused by blocking of the enzyme mevalonate kinase in the pathway of cholesterol and isoprenoids. The pathogenic mechanism originating an immune response in MKD patients has not been clearly understood.
   METHODS: We investigated the dysregulation of expression of selected cytokines and chemokines in the serum of MKD patients. The results have been compared with those observed in an MKD mouse model obtained by treating the mice with aminobisphosphonate, a molecule that is able to inhibit the cholesterol pathway, mimicking the genetic block characteristic of the disease.
   RESULTS: Interleukin (IL)-1 beta, IL-5, IL-6, IL-9, IL-17, granulocyte colony stimulating factor, monocyte chemotactic protein-1, tumor necrosis factor-alpha, and IL-4 expression were dysregulated in sera from MKD patients and mice. Moreover, geraniol, an exogenous isoprenoid, when administered to MKD mice, restored cytokines and chemokines levels with values similar to those of untreated mice.
   CONCLUSION: Our findings, which were obtained in patients and a mouse model mimicking the human disease, suggest that these cytokines and chemokines could be MKD specific and that isoprenoids could be considered as potential therapeutic molecules. The mouse model, even if with some limitations, was robust and suitable for routine testing of potential MKD drugs.
C1 [Marcuzzi, Annalisa; Zanin, Valentina; Kleiner, Giulio; Crovella, Sergio] IRCCS, Inst Maternal & Child Hlth, Hlth Genet Unit, Trieste, Italy.
   [Monasta, Lorenzo] IRCCS, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Med & Surg & Hlth Sci, Trieste, Italy.
RP Marcuzzi, A (corresponding author), IRCCS, Inst Maternal & Child Hlth, Hlth Genet Unit, Trieste, Italy.
EM annalisa.marcuzzi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Monasta, Lorenzo/B-1388-2012; Marcuzzi,
   Annalisa/AAA-6038-2020
OI Crovella, Sergio/0000-0001-8493-1168; Monasta,
   Lorenzo/0000-0001-7774-548X; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Kleiner, Giulio/0000-0002-1830-3961
FU Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste,
   Italy [42/11]; European Project "Talents for an International House" of
   the Marie Curie Co-Funding of Regional, National and International
   Programmes (COFUND) within the "People" Specific Programme of the 7th
   Framework Programme
FX This work was supported by a grant from the Institute for Maternal and
   Child Health-IRCCS "Burlo Garofolo", Trieste, Italy (42/11). S.C. is the
   recipient of a fellowship grant from the European Project "Talents for
   an International House" of the Marie Curie Co-Funding of Regional,
   National and International Programmes (COFUND) within the "People"
   Specific Programme of the 7th Framework Programme.
CR Ahmad ST, 2011, TOXICOLOGY, V290, P69, DOI 10.1016/j.tox.2011.08.020
   Bodar EJ, 2005, NETH J MED, V63, P260
   Chomarat P, 1997, EUR CYTOKINE NETW, V8, P333
   Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005
   DINARELLO CA, 1978, J INFECT DIS, V138, P760, DOI 10.1093/infdis/138.6.760
   Drenth JPH, 2001, J PHARMACOL EXP THER, V298, P1221
   DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586
   Drenth JPH, 1996, J IMMUNOL, V157, P400
   FEARS R, 1981, BIOCHEM J, V199, P1
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Hartel C, 2005, CLIN EXP IMMUNOL, V142, P446, DOI 10.1111/j.1365-2249.2005.02928.x
   Houten SM, 2001, EUR J HUM GENET, V9, P253, DOI 10.1038/sj.ejhg.5200595
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Marcuzzi A, 2011, IN VIVO, V25, P87
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Ong TP, 2006, CARCINOGENESIS, V27, P1194, DOI 10.1093/carcin/bgi291
   Yu ZQ, 2005, BASIC CLIN PHARMACOL, V97, P222, DOI 10.1111/j.1742-7843.2005.pto_138.x
NR 23
TC 12
Z9 12
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD SEP
PY 2013
VL 74
IS 3
BP 266
EP 271
DI 10.1038/pr.2013.96
PG 6
WC Pediatrics
SC Pediatrics
GA 220TA
UT WOS:000324608600004
PM 23760140
OA Bronze
DA 2020-12-08
ER

PT J
AU Girardelli, M
   Bianco, AM
   Marcuzzi, A
   Crovella, S
AF Girardelli, M.
   Bianco, A. M.
   Marcuzzi, A.
   Crovella, S.
TI A comparative analysis of serologic parameters and oxidative stress in
   osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Letter
DE Cholesterol; Inflammation; Mevalonate kinase deficiency
ID INFLAMMATION
AB In chronic diseases such as rheumatoid arthritis and osteoarthritis, the progression of the disease is characterized by stress oxidative, inflammation, and elevated levels of cholesterol. In mevalonate kinase deficiency, an auto-inflammatory disease, the correlation between inflammation and cholesterol levels is opposite. The metabolic pathway that underlies the production of cholesterol is the mevalonate pathway; it is also essential for the biosynthesis of isoprenoids involved in the control of several cell functions. This divergence of cholesterol levels, associated with these two inflammatory disorders, is probably due to a different etiology, pathogenesis, and progression.
C1 [Girardelli, M.; Bianco, A. M.; Marcuzzi, A.; Crovella, S.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, S.] Univ Trieste, Trieste, Italy.
RP Girardelli, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
EM martina.girardelli@yahoo.it
RI Crovella, Sergio/K-5050-2016; BIANCO, ANNA MONICA/D-3098-2014; Marcuzzi,
   Annalisa/AAA-6038-2020; Girardelli, Martina/K-7199-2016
OI Crovella, Sergio/0000-0001-8493-1168; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Girardelli, Martina/0000-0003-1186-4907
CR DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   Mishra R, 2012, RHEUMATOL INT, V32, P2377, DOI 10.1007/s00296-011-1964-1
   Mizuno Y, 2011, J ATHEROSCLER THROMB, V18, P351, DOI 10.5551/jat.7591
NR 6
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD SEP
PY 2013
VL 33
IS 9
BP 2445
EP 2446
DI 10.1007/s00296-012-2436-y
PG 2
WC Rheumatology
SC Rheumatology
GA 206FU
UT WOS:000323505000036
PM 22562750
DA 2020-12-08
ER

PT J
AU Addobbati, C
   Brandao, LAC
   Guimaraes, RL
   Pancotto, JAT
   Donadi, EA
   Crovella, S
   Segat, L
   Sandrin-Garcia, P
AF Addobbati, Catarina
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Tres Pancotto, Joao Alexandre
   Donadi, Eduardo Antonio
   Crovella, Sergio
   Segat, Ludovica
   Sandrin-Garcia, Paula
TI FYB gene polymorphisms are associated with susceptibility for systemic
   lupus erythemathosus (SLE)
SO HUMAN IMMUNOLOGY
LA English
DT Article
ID ACTIVATION; ADHESION
AB Systemic Lupus Erythematosus (SLE) is a multifactorial autoimmune disease affecting different organs or systems. Several genes have been associated with SLE susceptibility so far. A previous study has reported, in SLE patients, a differential expression of Fyn Binding Protein gene (FYB), encoding for a protein participating in the T cells signaling cascade and in the interleukin-2A expression modulation.
   This study investigates the association of 10 FYB SNPs with differential susceptibility to SLE in 143 SLE patients and 184 controls from Southern Brazil. Significant differences were observed when comparing allele and genotype frequencies distribution in patients and controls: the T allele for rs6863066 C > T SNP and C for rs358501 T > C SNP were significantly more frequent in SLE patients than in controls (p = 0.0002 and p = 0.008) and associated with an increased risk for SLE (OR = 1.93 and OR = 1.69). The frequencies of rs6863066 C/T and TIT and rs358501 C/C genotypes were significantly higher in patients than in controls (p = 0.001, p = 0.006 and p = 0.008). A significant association was also found for the rs6863066-rs358501 T-T and T-C haplotypes (OR = 2.06, p = 0.002 and OR = 2.93, p = 0.001).
   When considering clinical and laboratorial manifestations, an association was found between rs2161612 G allele and G/G genotype and hematological alterations (p = 0.008) and rs379707 A/C genotype and anti-dsDNA (p = 0.01).
   In conclusion, our findings indicate an association between polymorphisms located in FYB gene and SLE, suggesting their possible involvement in disease susceptibility and clinical manifestations. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Addobbati, Catarina; Sandrin-Garcia, Paula] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Guimaraes, Rafael Lima; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Tres Pancotto, Joao Alexandre; Donadi, Eduardo Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, BR-14049 Ribeirao Preto, Brazil.
   [Segat, Ludovica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; donadi, eduardo
   A/H-7080-2013; Crovella, Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; donadi, eduardo
   A/0000-0002-9457-9601; Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE [APQ-0087-2.02/08]; FACEPE/CNPqNational Council for Scientific
   and Technological Development (CNPq) [DCR-0089-2.02/08]; CNPqNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   471942/2010-3]; European Project "Talents for an International House"
   within the framework of the 7th Research & Development Framework
   Programme PEOPLE - Marie Curie Actions - COFUND (Co-Funding of Regional,
   National and International Programmes)European Union (EU)
FX We acknowledge FACEPE (APQ-0087-2.02/08) and FACEPE/CNPq
   (DCR-0089-2.02/08) and CNPq (CNPq 471942/2010-3) for the financial
   support. The authors thank the Program for Technological Development in
   Tools for Health-PDTISFIOCRUZ for the use of its facilities. SC is
   recipient of a fellowship grant from the European Project "Talents for
   an International House" within the framework of the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND
   (Co-Funding of Regional, National and International Programmes).
CR Abbas AK, 2008, CELLULAR MOL IMMUNOL
   Ardoin SP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2488
   Assis MR, 2009, REV BRAS MED, V66, P274
   Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005
   Criswell LA, 2008, BULL HOSP JT DIS, V66, P176
   DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493
   Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397
   Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3
   Kyttaris VC, 2010, METHODS MOL BIOL, V662, P265, DOI 10.1007/978-1-60761-800-3_13
   Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sandrin-Garcia P, 2009, ANN NY ACAD SCI, V1173, P493, DOI 10.1111/j.1749-6632.2009.04636.x
   Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002
   Tan Filemon K., 1998, Current Opinion in Rheumatology, V10, P399, DOI 10.1097/00002281-199809000-00002
   TAYLOR KE, 2011, PLOS GENET, V7
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261
   Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005
NR 19
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD AUG
PY 2013
VL 74
IS 8
BP 1009
EP 1014
DI 10.1016/j.humimm.2013.04.026
PG 6
WC Immunology
SC Immunology
GA 183DY
UT WOS:000321795600020
PM 23628395
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Carvalho, MS
   Kamada, AJ
   Moura, R
   Schindler, HC
   Duarte, AJS
   Crovella, S
AF Pontillo, Alessandra
   Carvalho, Marcia S.
   Kamada, Anselmo J.
   Moura, Ronald
   Schindler, Haiana C.
   Duarte, Alberto J. S.
   Crovella, Sergio
TI Susceptibility to Mycobacterium tuberculosis Infection in HIV-Positive
   Patients Is Associated With CARD8 Genetic Variant
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE inflammasome; SNPs; HIV-1; tuberculosis; HIV-TB coinfection;
   HIV-associated opportunistic infections
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFLAMMASOME ACTIVATION; P2X(7) GENE;
   PROTEIN; POLYMORPHISM; NLRP3; DISEASE
AB HLA and other genetic variants, playing an important role in innate and adaptive immunity, are known to influence tuberculosis (TB) development in HIV-1-positive (HIV+) patients. Because inflammasome genes contribute to HIV-1 susceptibility, we investigated the possible association between polymorphisms in inflammasome genes with HIV-1 and Mycobacterium tuberculosis coinfection (HIV+ TB+) in a case/control cohort of Brazilian individuals. Nineteen single-nucleotide polymoprhims in 8 inflammasome genes (NLRP1, NLRP3, AIM2, CARD8, CASP1, IL1B, IL1R, and HSP90) were analyzed in HIV+ TB+ Brazilian patients (from Recife, Pernambuco). CARD8 rs6509365 polymorphism was associated with HIV+ TB+ (P = 5 x 10(-5)), suggesting a predisposing role of this variant in M. tuberculosis susceptibility in HIV+ subjects (odds ratio = 2.45). This effect is even strong when this allele is combined to CARD8 rs2043211 single-nucleotide polymoprhim. The results of this study support the novel association between CARD8 gene and HIV+ TB+ coinfection, demonstrating that inflammasome genetics could influence HIV-1 infection and the development of opportunistic infection.
C1 [Pontillo, Alessandra; Duarte, Alberto J. S.] Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, LIM 56, BR-05403000 Sao Paulo, Brazil.
   [Carvalho, Marcia S.; Kamada, Anselmo J.; Moura, Ronald; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Schindler, Haiana C.] Aggeu Magalhaes Res Ctr CPqAM FIOCRUZ, Dept Immunol, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, LIM 56, Av Dr Eneas de Caravalho Aguiar 500, BR-05403000 Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Kamada, Anselmo Jiro/H-3006-2012; Moura, Ronald/AAE-2318-2020; Moura,
   Ronald/F-7769-2012; Duarte, Alberto J S/D-4382-2012; Pontillo,
   Alessandra/AAD-4790-2019; Pontillo, ALESSANDRA/D-4352-2012; Crovella,
   Sergio/K-5050-2016; Pontillo, Alessandra/ABC-6266-2020
OI Kamada, Anselmo Jiro/0000-0002-0437-0151; Moura,
   Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Pontillo, Alessandra/0000-0002-7883-0640
FU Pernambuco Research Foundation (FACEPE) [APQ-0757-2.02/10]; Sao Paulo
   Research foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [09/53575-5]; Brazilian National Council of Research
   and Technology (CNPq)National Council for Scientific and Technological
   Development (CNPq) [311949/2011-8]
FX Supported by the Pernambuco Research Foundation (FACEPE) (project number
   APQ-0757-2.02/10) and Sao Paulo Research foundation (FAPESP) (project
   number 09/53575-5). A. Pontillo was recipient of a visiting researcher
   grant from Brazilian National Council of Research and Technology (CNPq)
   (no. 311949/2011-8). We did not receive any funding for this work from
   any of the following organizations: National Institutes of Health,
   Wellcome Trust, Howard Hughes Medical Institute.
CR Abdalla H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040722
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200
   Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604
   Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570
   Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141
   Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC
   Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
   Ko DC, 2009, AM J HUM GENET, V85, P214, DOI 10.1016/j.ajhg.2009.07.012
   Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745
   Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003
   Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x
   Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200
   Pontillo A, 2012, ALZ DIS ASSOC DIS, V26, P277, DOI 10.1097/WAD.0b013e318231a8ac
   Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532
   Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004
   Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200
   Sambasivan V, 2010, DIS MARKERS, V28, P43, DOI [10.1155/2010/843729, 10.3233/DMA-2010-0682]
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x
NR 28
TC 24
Z9 25
U1 0
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD JUN 1
PY 2013
VL 63
IS 2
BP 147
EP 151
DI 10.1097/QAI.0b013e31828f93bb
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 146SY
UT WOS:000319112500012
PM 23507658
DA 2020-12-08
ER

PT J
AU Chagas, BS
   Batista, MVD
   Crovella, S
   Gurgel, APAD
   Neto, JDS
   Serra, IGSS
   Amaral, CMM
   Balbino, VQ
   Muniz, MTC
   Freitas, AC
AF Chagas, Barbara Simas
   de Aragao Batista, Marcus Vinicius
   Crovella, Sergio
   Almeida Diniz Gurgel, Ana Pavla
   Silva Neto, Jacinto da Costa
   Soares Santos Serra, Ivi Goncalves
   Medeiros Amaral, Carolina Maria
   Balbino, Valdir Queiroz
   Cartaxo Muniz, Maria Tereza
   Freitas, Antonio Carlos
TI Novel E6 and E7 oncogenes variants of human papillomavirus type 31 in
   Brazilian women with abnormal cervical cytology
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Cervical cancer; Genomic diversity; E6 oncogene; E7 oncogene; Human
   papillomavirus variants
ID WORLDWIDE GENOMIC DIVERSITY; HUMAN-PAPILLOMAVIRUS-16 E6; NATURAL
   VARIANTS; RISK; CANCER; ASSOCIATION; PREDICTION; LESIONS; POLYMORPHISM;
   PERSISTENCE
AB HPV-31 has been widely described as an important oncogenic type, showing high incidence in worldwide and especially in Northeastern Brazil. We sought to identify the presence of specific mutations in HPV-31 E6 and E7 oncogenes in women with abnormal cervical smear. We enrolled 150 gynecological patients from Sergipe State, Northeastern Brazil. HPV screening was carried out by polymerase chain reaction (MY09/11). E6 and E7 oncogenes were amplified with specific primers and sequenced. The sequences obtained were aligned with the GenBank reference sequences in order to search for genetic variants. We identified genetic variants in E6 and E7 sequences from HPV-31. Two new nucleotide changes in E6 and E7 were described for the first time in this study. A novel mutation in E6 resulted in amino acid change in a site belonging to T-cell epitope with MHC II binding activity. There was no significant difference in the distribution of HPV-31 E6 and E7 variants when compared to all selected clinical/epidemiological characteristics. HPV-31 isolates have been clustered into three main groups called lineages A, B and C. We describe new HPV-31 variants in Brazil, contributing to better understand the genomic diversity of these viruses. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chagas, Barbara Simas; Almeida Diniz Gurgel, Ana Pavla; Medeiros Amaral, Carolina Maria; Freitas, Antonio Carlos] Univ Fed Pernambuco, Dept Genet, Lab Mol Studies & Expt Therapy, Recife, Brazil.
   [de Aragao Batista, Marcus Vinicius; Balbino, Valdir Queiroz] Univ Fed Pernambuco, Dept Genet, Lab Bioinforrnat & Evolutionary Biol, Recife, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Lab Variabil & Human Genet, Recife, Brazil.
   [Crovella, Sergio] Genet Serv IRCCS Burlo Garofolo, Trieste, Italy.
   [Silva Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol, Mol & Cytol Res Lab, Recife, Brazil.
   [Soares Santos Serra, Ivi Goncalves] Ctr Integrated Med Sergipe, CEMISE, Gynaecol Unit, Sergipe, Brazil.
   [Cartaxo Muniz, Maria Tereza] Univ Pernambuco, Ctr Pediat Oncohematol, Mol Biol Lab, Pernambuco, Brazil.
RP Chagas, BS (corresponding author), Av Prof Moraes Rego,1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM babisimas@gmail.com; antonio.freitas@pq.cnpq.br
RI Freitas, Antonio/G-1843-2012; Chagas, Barbara/M-9327-2019; da Costa
   Silva Neto, Jacintoda/R-5602-2017; Batista, Marcus VA/E-3223-2013;
   Crovella, Sergio/K-5050-2016; Balbino, Valdir de Queiroz/H-6877-2014
OI Freitas, Antonio/0000-0002-4957-9549; da Costa Silva Neto,
   Jacintoda/0000-0003-4418-801X; Batista, Marcus VA/0000-0003-4745-8919;
   Crovella, Sergio/0000-0001-8493-1168; cartaxo muniz, maria
   tereza/0000-0001-9498-5223; Gurgel, Ana Pavla A.D./0000-0001-5848-6419;
   Balbino, Valdir de Queiroz/0000-0002-4319-3952; Simas Chagas,
   Barbara/0000-0003-3917-9055
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; FACEPE; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES
FX This research was supported by the Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco (FACEPE), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). FACEPE, CNPq and
   CAPES have provided Research Grants for B.S.C. and C.M.M.A, M.V.A.B.,
   and A.P.A.D.G Doctoral Degree, respectively.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978
   Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677
   da Silva MFPTB, 2012, GENET MOL RES, V11, P462, DOI 10.4238/2012.March.1.3
   Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
   Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325
   Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244
   Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186
   Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005
   Cento V, 2011, J MED VIROL, V83, P1752, DOI 10.1002/jmv.22201
   Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008
   Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183
   Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026
   de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047
   de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
   ELLIS JRM, 1995, NAT MED, V1, P464, DOI 10.1038/nm0595-464
   Ferenczy A, 2002, LANCET ONCOL, V3, P11, DOI 10.1016/S1470-2045(01)00617-9
   Garbuglia AR, 2007, NEW MICROBIOL, V30, P377
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024
   Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996
   KAST WM, 1994, J IMMUNOL, V152, P3904
   Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003
   Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038
   Londesborough P, 1996, INT J CANCER, V69, P364
   Ma HX, 2006, CANCER LETT, V240, P261, DOI 10.1016/j.canlet.2005.09.019
   MANOS MM, 1989, CANCER CEL, V7, P209
   Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Prado JC, 2005, VIROLOGY, V340, P95, DOI 10.1016/j.virol.2005.06.024
   Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93
   Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197
   Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
   SCHIFFMAN MH, 1993, J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958
   Sichero L, 2006, BRAZ J MED BIOL RES, V39, P707, DOI 10.1590/S0100-879X2006000600002
   Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481
   Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F
   XI LF, 1995, J INFECT DIS, V172, P747, DOI 10.1093/infdis/172.3.747
   Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670
   Xi LF, 2012, INT J CANCER, V131, P2300, DOI 10.1002/ijc.27520
   Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8
   Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9
   Zehbe I, 2001, CANCER RES, V61, P608
   Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77
NR 49
TC 10
Z9 10
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUN
PY 2013
VL 16
BP 13
EP 18
DI 10.1016/j.meegid.2013.02.001
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 166PM
UT WOS:000320569500003
PM 23403356
DA 2020-12-08
ER

PT J
AU Tavares, NAC
   Santos, MMS
   Moura, R
   Araujo, J
   Guimaraes, R
   Crovella, S
   Brandao, L
AF Tavares, Nathalia A. C.
   Santos, Manuella M. S.
   Moura, Ronald
   Araujo, Jacqueline
   Guimaraes, Rafael
   Crovella, Sergio
   Brandao, Lucas
TI Interleukin 18 (IL18) gene promoter polymorphisms are associated with
   type 1 diabetes mellitus in Brazilian patients
SO CYTOKINE
LA English
DT Article
DE IL18; Type 1 diabetes; Autoimmune thyroiditis; Celiac disease;
   Association study
ID AUTOIMMUNE-DISEASES; IL-18 PROMOTER; CHILDREN; BALANCE
AB Interleukin 18 (IL-18) is a cytokine that plays an important role in the Th1 response, by its ability to induce IFN-gamma production in T cells and natural killer cells. Functional variants of IL18 gene has been reported as associated with type 1 diabetes (T1D). In the present study were analyzed three promoter single nucleotide polymorphisms (SNPs), at -656 (rs1946519), -607 (rs1946518) and -137 (rs187238) position, in 181 children and adolescents with T1D and 122 healthy individuals, both from metropolitan area of Recife, Northeast of Brazil. T1D patients were stratified according to the presence autoimmune thyroiditis and celiac disease. Allele and genotype frequencies of IL18 SNPs were Hardy-Weinberg equilibrium in patients and controls. The allele -137G and the haplotype -656G/-607C/-137G were more frequent in T1D patients (OR = 1.82 and 1.97, respectively) then in healthy controls. However, those SNPs were not associated with the age of T1D onset as well as with the insurgence of AITD and/or CD in concomitant with T1D patients. Our findings suggest an association between IL18 promoter SNPs and susceptibility to T1D in Brazilian patients. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tavares, Nathalia A. C.; Santos, Manuella M. S.; Moura, Ronald; Guimaraes, Rafael; Crovella, Sergio; Brandao, Lucas] Univ Fed Pernambuco, Keizo Asami Immunopathol Lab LIKA, Recife, PE, Brazil.
   [Araujo, Jacqueline] Univ Fed Pernambuco, Pediat Endocrinol Unity Clin Hosp, Recife, PE, Brazil.
   [Santos, Manuella M. S.; Moura, Ronald; Guimaraes, Rafael; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Brandao, Lucas] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
RP Brandao, L (corresponding author), Av Prof Moraes Rego S-N, BR-50670901 Recife, PE, Brazil.
EM lucabrand@gmail.com
RI Moura, Ronald/AAE-2318-2020; Moura, Ronald/F-7769-2012; Crovella,
   Sergio/K-5050-2016; Brandao, Lucas Andre Cavalcanti/G-8333-2012
OI Moura, Ronald/0000-0002-9112-7167; Moura, Ronald/0000-0002-9112-7167;
   Crovella, Sergio/0000-0001-8493-1168; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559
FU "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"
   (CAPES/PNPD program); "Fundacao Amparo a Ciencia e Tecnologia do Estado
   de Pernambuco" (FACEPE)
FX The authors thank to "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior" (CAPES/PNPD program) for the financial support. NT, MS, RN, RG
   and LB are recipients of pos-graduate and pos-doctoral fellowship from
   "Fundacao Amparo a Ciencia e Tecnologia do Estado de Pernambuco"
   (FACEPE).
CR Abiru N, 2002, DIABETES-METAB RES, V18, P357, DOI 10.1002/dmrr.323
   Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43
   Baumann B, 2012, CURR DIABETES REP, V12, P499, DOI 10.1007/s11892-012-0299-y
   Cebeci AN, 2006, ALLERGY ASTHMA PROC, V27, P365, DOI 10.2500/aap.2006.27.2894
   Dong GP, 2007, INT J IMMUNOGENET, V34, P75, DOI 10.1111/j.1744-313X.2007.00665.x
   Giedraitis V, 1999, EUR J IMMUNOGENET, V26, P257, DOI 10.1046/j.1365-2370.1999.00140.x
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213
   Ide A, 2004, J AUTOIMMUN, V22, P73, DOI 10.1016/j.jaut.2003.10.001
   Kretowski A, 2002, DIABETES, V51, P3347, DOI 10.2337/diabetes.51.11.3347
   Kunz M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/979258
   Larizza D, 2012, AUTOIMMUNITY, V45, P470, DOI 10.3109/08916934.2012.697594
   Marleau AM, 2011, J AUTOIMMUN, V36, P263, DOI 10.1016/j.jaut.2011.02.005
   Martin RJL, 2005, GENES IMMUN, V6, P171, DOI 10.1038/sj.gene.6364161
   Mojtahedi Z, 2006, DIABETIC MED, V23, P235, DOI 10.1111/j.1464-5491.2006.01786.x
   Nicoletti F, 2001, DIABETOLOGIA, V44, P309, DOI 10.1007/s001250051619
   Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8
   Novota P, 2005, IMMUNOL LETT, V96, P247, DOI 10.1016/j.imlet.2004.08.016
   Pan HF, 2011, LUPUS, V20, P945, DOI 10.1177/0961203311400114
   Pham-Short A, 2012, DIABETIC MED, V29, pE286, DOI 10.1111/j.1464-5491.2012.03720.x
   Rachmiel M, 2006, CYTOKINE, V34, P170, DOI 10.1016/j.cyto.2006.04.012
   Rachmiel M, 2011, PEDIATR DIABETES, V12, P596, DOI 10.1111/j.1399-5448.2010.00751.x
   Reddy P, 2004, CURR OPIN HEMATOL, V11, P405, DOI 10.1097/01.moh.0000141926.95319.42
   Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917
   Szeszko JS, 2006, DIABETES, V55, P559, DOI 10.2337/diabetes.55.02.06.db05-0826
NR 25
TC 11
Z9 11
U1 0
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD MAY
PY 2013
VL 62
IS 2
BP 286
EP 289
DI 10.1016/j.cyto.2013.03.004
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 142WQ
UT WOS:000318828700015
PM 23557801
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Girardelli, M
   Agostinis, C
   Masat, E
   Bulla, R
   Crovella, S
AF Pontillo, A.
   Girardelli, M.
   Agostinis, C.
   Masat, E.
   Bulla, R.
   Crovella, S.
TI Bacterial LPS Differently Modulates Inflammasome Gene Expression and
   IL-1 beta Secretion in Trophoblast Cells, Decidual Stromal Cells, and
   Decidual Endothelial Cells
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE trophoblast; placental immunity; inflammasome; NLRP3; IL-1 beta
ID TISSUES; PREGNANCY; C1Q
AB Three Nod-like receptors (NLR family, pyrin domain containing 1/NLRP1, NLR family, pyrin domain containing 3/NLRP3, NLR family, CARD domain containing 4/NLRC4) and the adaptor molecule PYD and CARD domain containing protein/PYCARD are involved in the assembling of multiprotein complexes known as inflammasomes, leading to caspase 1 activation and consequent interleukin (IL)-1 beta secretion. Considering that inflammasomes are involved in sensing pathogens and in triggering inflammatory and immune response, we hypothesized that they could also act in the placenta as an efficient innate mechanism during pregnancy infections. For this reason the activation of inflammasome was tested in 3 human placental cell populations in the presence of a common gram-negative compound (lipopolysaccharide [LPS]). The transcription of NLRP1, NLRP3, NLRC4, PYCARD, CASP1, and IL1B genes and the secretion of IL-1 beta were evaluated in human first trimester cytotrophoblasts (CTBs), decidual stromal cells (DSCs), and endothelial cells (DECs) stimulated with LPS. In CTBs and DSCs, LPS induced an augmented expression of CASP1 and IL1B and the specific upregulation of NLRP3 within the 3 NLRs tested. Moreover, LPS induced secretion of IL-1 beta from CTBs and DSCs. These results suggest the involvement of NLRP3 inflammasome in the placental innate response. The LPS did not affect inflammasome gene transcription and IL-1 beta production in DECs. Bacterial LPS enhances NLRP3 inflammasome components in trophoblast and DSCs, suggesting that this innate immune complex could play a key role in placental immune defense.
C1 [Pontillo, A.] Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, Sao Paulo, Brazil.
   [Girardelli, M.; Agostinis, C.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Masat, E.; Bulla, R.] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Crovella, S.] IRCCS, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, S.] Univ Trieste, Trieste, Italy.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, LIM 56, Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   Pontillo, ALESSANDRA/D-4352-2012; Bulla, Roberta/F-9957-2015; Crovella,
   Sergio/K-5050-2016; Girardelli, Martina/K-7199-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Bulla, Roberta/0000-0003-1737-5776;
   Crovella, Sergio/0000-0001-8493-1168; Agostinis,
   Chiara/0000-0002-8315-2258; Girardelli, Martina/0000-0003-1186-4907
FU IRCCS "Burlo Garofolo" (Trieste, Italy) [RC 03/11]; Brazilian National
   Council for Science and Technology (CNPq)National Council for Scientific
   and Technological Development (CNPq); TALENTS Programme (7th R&D
   Framework Programme, Specific Programme: PEOPLE - Marie Curie Actions -
   COFUND)
FX This work was supported by a grant RC 03/11 from IRCCS "Burlo Garofolo"
   (Trieste, Italy). A. P. is recipient of a fellowship grant from
   Brazilian National Council for Science and Technology (CNPq). S.C. is
   recipient of a grant from the TALENTS Programme (7th R&D Framework
   Programme, Specific Programme: PEOPLE - Marie Curie Actions - COFUND).
CR Abrahams VM, 2011, J REPROD IMMUNOL, V88, P112, DOI 10.1016/j.jri.2010.12.003
   Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Bulla R, 2008, MOL IMMUNOL, V45, P2629, DOI 10.1016/j.molimm.2007.12.025
   Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965
   Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x
   Kolly L, 2010, IMMUNOLOGY, V129, P178, DOI 10.1111/j.1365-2567.2009.03174.x
   Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mulla MJ, 2011, AM J REPROD IMMUNOL, V65, P542, DOI 10.1111/j.1600-0897.2010.00960.x
   Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308
   Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f
   Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208
NR 17
TC 40
Z9 40
U1 2
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
J9 REPROD SCI
JI Reprod. Sci.
PD MAY
PY 2013
VL 20
IS 5
BP 563
EP 566
DI 10.1177/1933719112459240
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 131KF
UT WOS:000317991200009
PM 23184659
DA 2020-12-08
ER

PT J
AU Kleiner, G
   Marcuzzi, A
   Campisciano, G
   Crovella, S
AF Kleiner, Giulio
   Marcuzzi, Annalisa
   Campisciano, Giuseppina
   Crovella, Sergio
TI Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory
   effect. Comment to "Inhibition of protein geranylgeranylation and
   farnesylation protects against graft-versus-host disease via effects on
   CD4 effector T cells" Haematologica. 2013;98(1):31-40
SO HAEMATOLOGICA
LA English
DT Letter
DE farnesyl transferase inhibitor; geranyl geranyl transferase inhibitor;
   inflammatory response; mevalonate kinase deficiency
ID MEVALONATE KINASE-DEFICIENCY; INTERLEUKIN-1-BETA SECRETION;
   FARNESYLTRANSFERASE; TIPIFARNIB; ADULTS; TRIAL; MODEL
C1 [Kleiner, Giulio; Marcuzzi, Annalisa; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Campisciano, Giuseppina; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Kleiner, G (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
EM kleiner@burlo.trieste.it
RI Campisciano, Giuseppina/J-3737-2018; Crovella, Sergio/K-5050-2016;
   Marcuzzi, Annalisa/AAA-6038-2020
OI Campisciano, Giuseppina/0000-0002-2307-5537; Crovella,
   Sergio/0000-0001-8493-1168; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Kleiner, Giulio/0000-0002-1830-3961
CR De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Hechinger AK, 2013, HAEMATOLOGICA, V98, P31, DOI 10.3324/haematol.2012.065789
   Karp JE, 2001, BLOOD, V97, P3361, DOI 10.1182/blood.V97.11.3361
   Karp JE, 2012, BLOOD, V119, P55, DOI 10.1182/blood-2011-08-370825
   Kouchi H, 1999, BIOCHEM BIOPH RES CO, V264, P915, DOI 10.1006/bbrc.1999.1546
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325
NR 10
TC 0
Z9 0
U1 0
U2 5
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
J9 HAEMATOLOGICA
JI Haematologica
PD APR
PY 2013
VL 98
IS 4
BP E44
EP E45
DI 10.3324/haematol.2012.082040
PG 2
WC Hematology
SC Hematology
GA 157LN
UT WOS:000319897700004
PM 23543155
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Tricarico, PM
   Piscianz, E
   Kleiner, G
   Brumatti, LV
   Crovella, S
AF Marcuzzi, A.
   Tricarico, P. M.
   Piscianz, E.
   Kleiner, G.
   Brumatti, L. Vecchi
   Crovella, S.
TI Lovastatin induces apoptosis through the mitochondrial pathway in an
   undifferentiated SH-SY5Y neuroblastoma cell line
SO CELL DEATH & DISEASE
LA English
DT Letter
C1 [Marcuzzi, A.; Tricarico, P. M.; Piscianz, E.; Kleiner, G.; Brumatti, L. Vecchi; Crovella, S.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Crovella, S.] Univ Trieste, Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI tricarico, paola/AAB-8972-2019; Crovella, Sergio/K-5050-2016; Vecchi
   Brumatti, Liza/J-4968-2016; Marcuzzi, Annalisa/AAA-6038-2020
OI tricarico, paola/0000-0002-1954-4126; Crovella,
   Sergio/0000-0001-8493-1168; Vecchi Brumatti, Liza/0000-0001-8149-1873;
   Marcuzzi, Annalisa/0000-0003-3427-618X; Kleiner,
   Giulio/0000-0002-1830-3961; Piscianz, Elisa/0000-0001-7374-1684
CR Arnold DE, 2010, MOL CELL BIOCHEM, V345, P1, DOI 10.1007/s11010-010-0553-z
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Herrero-Martin G, 2008, FEBS LETT, V582, P2589, DOI 10.1016/j.febslet.2008.06.034
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Morabito R, 2012, TOXICOL IN VITRO, V26, P694, DOI 10.1016/j.tiv.2012.03.002
   Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002
NR 8
TC 21
Z9 21
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR
PY 2013
VL 4
AR e585
DI 10.1038/cddis.2013.112
PG 2
WC Cell Biology
SC Cell Biology
GA 132NL
UT WOS:000318075500019
PM 23579272
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Moura, R
   Araujo, J
   Guimaraes, R
   Crovella, S
   Brandao, L
AF Moura, Ronald
   Araujo, Jacqueline
   Guimaraes, Rafael
   Crovella, Sergio
   Brandao, Lucas
TI Interferon induced with helicase C domain 1 (IFIH1): Trends on helicase
   domain and type 1 diabetes onset
SO GENE
LA English
DT Article
DE Enterovirus response; Autoimmune diseases; Genetic susceptibility;
   Single nucleotide polymorphism
ID GRAVES-DISEASE; RIG-I; VIRUSES; LOCUS; AUTOIMMUNITY; POLYMORPHISM;
   THYROIDITIS; INFECTIONS; VARIANTS; ETIOLOGY
AB The Interferon-induced with helicase C domain 1 (IFIH1) gene has been hypothesized as involved in the viral etiology of type 1 diabetes (T1D) and other autoimmune disorders, since it is implicated in viral recognition. In our study we analyzed IFIH1 rs6432714 and rs10930046 SNPs in T1D patients stratified for the presence of celiac disease and autoimmune thyroid disease. No association with susceptibility to develop the diseases was found. The rs6432714, a tag-SNP that represents part of helicase domain of IF1H1 protein showed a trend of association only with T1D development (P>0.025 after Bonferroni adjustment) in log-additive model (OR=1.45, P=0.0365, power=0.99), indicating that helicase domain of IFIH1 protein could be associated with the susceptibility to T1D. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Moura, Ronald; Guimaraes, Rafael; Crovella, Sergio; Brandao, Lucas] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Recife, PE, Brazil.
   [Araujo, Jacqueline] Univ Fed Pernambuco, Pediat Endocrinol Serv Clin Hosp, Recife, PE, Brazil.
   [Moura, Ronald; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Brandao, Lucas] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
RP Brandao, L (corresponding author), Av Prof Moraes Rego S-N, BR-50670901 Recife, PE, Brazil.
EM lucabrand@gmail.com
RI Crovella, Sergio/K-5050-2016; Moura, Ronald/AAE-2318-2020; Moura,
   Ronald/F-7769-2012; Brandao, Lucas Andre Cavalcanti/G-8333-2012
OI Crovella, Sergio/0000-0001-8493-1168; Moura, Ronald/0000-0002-9112-7167;
   Moura, Ronald/0000-0002-9112-7167; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD
   program); Fundacao Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE) [IBPG 0926-2.02/11, BCT-0199-2.02/11]
FX The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/PNPD program) for the financial support. R. Moura, R.
   Guimaraes and L Brandao are recipients of post-graduate and
   post-doctoral fellowship from Fundacao Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE, IBPG 0926-2.02/11 and BCT-0199-2.02/11,
   respectively).
CR Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc12-s064, 10.2337/dc11-S062]
   Barera G, 2002, PEDIATRICS, V109, P833, DOI 10.1542/peds.109.5.833
   Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071
   Desailloud R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-5
   Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646
   Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008
   Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025
   Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3
   Jaidane H, 2008, DIABETES METAB, V34, P537, DOI 10.1016/j.diabet.2008.05.008
   Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614
   Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125
   Li YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/jid.2010.214
   Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728
   Penna-Martinez M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-126
   PERROS P, 1995, DIABETIC MED, V12, P622, DOI 10.1111/j.1464-5491.1995.tb00553.x
   [R C.T. R.F.f.S.], 2012, COMP
   Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260
   Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200
   Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800
   Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173
   SZOPA TM, 1993, DIABETOLOGIA, V36, P687, DOI 10.1007/BF00401138
   Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001
   Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010
   van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695
   Vasseur E, 2011, HUM MOL GENET, V20, P4462, DOI 10.1093/hmg/ddr377
   Zipris D, 2009, CLIN IMMUNOL, V131, P11, DOI 10.1016/j.clim.2008.12.011
NR 26
TC 7
Z9 8
U1 1
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAR
PY 2013
VL 516
IS 1
BP 66
EP 68
DI 10.1016/j.gene.2012.11.066
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA 095XE
UT WOS:000315367500009
PM 23246693
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Marcuzzi, A
   Zanin, V
   Girardelli, M
   Vuch, J
   Crovella, S
AF Bianco, Anna Monica
   Marcuzzi, Annalisa
   Zanin, Valentina
   Girardelli, Martina
   Vuch, Josef
   Crovella, Sergio
TI Database tools in genetic diseases research
SO GENOMICS
LA English
DT Review
DE Genetic diseases; Mutation; NCBI; Ensembl; SNPs; GWAS; IBD
ID GENOME-WIDE ASSOCIATION; SOMATIC MUTATIONS; MENDELIAN-INHERITANCE;
   HISTONE VARIANTS; ENSEMBL; PROJECTS; CATALOG; CANCER; GOLD;
   POLYMORPHISMS
AB The knowledge of the human genome is in continuous progression: a large number of databases have been developed to make meaningful connections among worldwide scientific discoveries. This paper reviews bioinformatics resources and database tools specialized in disseminating information regarding genetic disorders. The databases described are useful for managing sample sequences, gene expression and post-transcriptional regulation. In relation to data sets available from genome-wide association studies, we describe databases that could be the starting point for developing studies in the field of complex diseases, particularly those in which the causal genes are difficult to identify. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Bianco, Anna Monica; Marcuzzi, Annalisa; Zanin, Valentina; Girardelli, Martina; Vuch, Josef; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
RP Bianco, AM (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM bianco@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; BIANCO, ANNA MONICA/D-3098-2014; Marcuzzi,
   Annalisa/AAA-6038-2020; Girardelli, Martina/K-7199-2016
OI Crovella, Sergio/0000-0001-8493-1168; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Girardelli, Martina/0000-0003-1186-4907
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo," Italy
   [RC 40/2011]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo," Italy (RC 40/2011).
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Arenas M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-268
   Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020
   Azzam N, 2012, INT J MOL SCI, V13, P4268, DOI 10.3390/ijms13044268
   Baker PG, 1998, CURR OPIN BIOTECH, V9, P54, DOI 10.1016/S0958-1669(98)80084-0
   Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894
   Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349
   Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baxevanis A.D., 2006, CURR PROTOC BIOINFOR, V1, P11
   Baxevanis A.D., 2009, CURR PROTOC BIOINFOR, V1, P11
   Baxevanis AD, 2001, NUCLEIC ACIDS RES, V29, P1, DOI 10.1093/nar/29.1.1
   Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255
   Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126
   Bianco AM, 2012, MED HYPOTHESES, V78, P520, DOI 10.1016/j.mehy.2012.01.023
   Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133
   BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332
   Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762
   Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951
   Church DM, 2010, NAT GENET, V42, P813, DOI 10.1038/ng1010-813
   Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004
   Ding J, 2006, BIOINFORMATICS, V22, P378, DOI 10.1093/bioinformatics/bti821
   Dogan RI, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap018
   Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055
   Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44
   Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100
   Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991
   Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929
   Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995
   Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963
   Galperin MY, 2012, NUCLEIC ACIDS RES, V40, pD1, DOI 10.1093/nar/gkr1196
   Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514
   Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012
   Jorda J, 2012, PROTEOMICS, V12, P1333, DOI 10.1002/pmic.201100534
   Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871
   Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003
   Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919
   Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Kyrpides NC, 1999, BIOINFORMATICS, V15, P773, DOI 10.1093/bioinformatics/15.9.773
   Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679
   Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432
   Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182
   Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036
   Mailman MD, 2007, NAT GENET, V39, P1181
   Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127
   Marcuzzi A, 2012, GENE, V493, P282, DOI 10.1016/j.gene.2011.11.043
   Marino-Ramirez L, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar048
   McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346
   Neuman MG, 2012, TRANSL RES, V160, P45, DOI 10.1016/j.trsl.2011.10.006
   Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100
   Palleja A, 2012, NUCLEIC ACIDS RES, V40, pD1036, DOI 10.1093/nar/gkr899
   Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408
   Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950
   Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804
   Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939
   Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012
   Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103
   Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184
   Severin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-240
   Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539
   Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212
   Sullivan SA, 2000, NUCLEIC ACIDS RES, V28, P320, DOI 10.1093/nar/28.1.320
   Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861
   Tsai RTH, 2009, BIOINFORMATICS, V25, P3031, DOI 10.1093/bioinformatics/btp475
   Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107
   Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056
   Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003
NR 75
TC 8
Z9 8
U1 1
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
EI 1089-8646
J9 GENOMICS
JI Genomics
PD FEB
PY 2013
VL 101
IS 2
BP 75
EP 85
DI 10.1016/j.ygeno.2012.11.001
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 084TI
UT WOS:000314561600001
PM 23147677
OA Bronze
DA 2020-12-08
ER

PT J
AU Vecile, E
   Dobrina, A
   Salloum, FN
   Van Tassell, BW
   Falcione, A
   Gustini, E
   Secchiero, S
   Crovella, S
   Sinagra, G
   Finato, N
   Nicklin, MJ
   Abbate, A
AF Vecile, Elena
   Dobrina, Aldo
   Salloum, Fadi N.
   Van Tassell, Benjamin W.
   Falcione, Antonella
   Gustini, Edoardo
   Secchiero, Samuele
   Crovella, Sergio
   Sinagra, Gianfranco
   Finato, Nicoletta
   Nicklin, Martin J.
   Abbate, Antonio
TI Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic
   Cardiomyocytes
SO PLOS ONE
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; CYTOCHROME-C RELEASE; IN-VIVO;
   AUTOINFLAMMATORY DISEASE; CASPASE ACTIVATION; GENE-EXPRESSION; IAP
   PROTEINS; APOPTOSIS; INHIBITION; CELLS
AB Background: Loss of cardiac myocytes due to apoptosis is a relevant feature of ischemic heart disease. It has been described in infarct and peri-infarct regions of the myocardium in coronary syndromes and in ischemia-linked heart remodeling. Previous studies have provided protection against ischemia-induced cardiomyocyte apoptosis by the anti-inflammatory cytokine interleukin-1 receptor-antagonist (IL-1Ra). Mitochondria triggering of caspases plays a central role in ischemia-induced apoptosis. We examined the production of IL-1Ra in the ischemic heart and, based on dual intra/extracellular function of some other interleukins, we hypothesized that IL-1Ra may also directly inhibit mitochondria-activated caspases and cardiomyocyte apoptosis.
   Methodology/Principal Findings: Synthesis of IL-1Ra was evidenced in the hearts explanted from patients with ischemic heart disease. In the mouse ischemic heart and in a mouse cardiomyocyte cell line exposed to long-lasting hypoxia, IL-1Ra bound and inhibited mitochondria-activated caspases, whereas inhibition of caspase activation was not observed in the heart of mice lacking IL-1Ra (Il-1ra-/-) or in siRNA to IL-1Ra-interfered cells. An impressive 6-fold increase of hypoxia-induced apoptosis was observed in cells lacking IL-1Ra. IL-1Ra down-regulated cells were not protected against caspase activation and apoptosis by knocking down of the IL-1 receptor, confirming the intracellular, receptor-independent, antiapoptotic function of IL-1Ra. Notably, the inhibitory effect of IL-1Ra was not influenced by enduring ischemic conditions in which previously described physiologic inhibitors of apoptosis are neutralized.
   Conclusions/Significance: These observations point to intracellular IL-1Ra as a critical mechanism of the cell self-protection against ischemia-induced apoptosis and suggest that this cytokine plays an important role in the remodeling of heart by promoting survival of cardiomyocytes in the ischemic regions.
C1 [Vecile, Elena; Dobrina, Aldo; Falcione, Antonella; Gustini, Edoardo; Secchiero, Samuele] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA USA.
   [Salloum, Fadi N.; Van Tassell, Benjamin W.; Abbate, Antonio] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Sinagra, Gianfranco] Univ Trieste, Cardiovasc Dept, I-34127 Trieste, Italy.
   [Finato, Nicoletta] Univ Udine, Dept Med & Morphol Res, I-33100 Udine, Italy.
   [Nicklin, Martin J.] Univ Sheffield, Sir Henry Wellcome Labs Med Res, Div Genom Med, Sheffield S10 2TN, S Yorkshire, England.
RP Dobrina, A (corresponding author), Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
EM dobrina@units.it
RI Sinagra, Gianfranco/AAE-3943-2020; sinagra, gianfranco gs/P-7643-2014;
   Abbate, Antonio/G-8805-2016; Abbate, Antonio/E-3405-2014; Crovella,
   Sergio/K-5050-2016; Salloum, Fadi N/C-2391-2008
OI Abbate, Antonio/0000-0002-1930-785X; Crovella,
   Sergio/0000-0001-8493-1168; SINAGRA, GIANFRANCO/0000-0003-2700-8478;
   Salloum, Fadi/0000-0002-8947-9315; Dobrina, Aldo/0000-0002-8393-1796;
   Nicklin, Martin/0000-0002-0127-1131
FU Italian Ministero dell'Universita e della RicercaMinistry of Education,
   Universities and Research (MIUR); American Heart AssociationAmerican
   Heart Association;  [KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [KL2TR000057, KL2TR000057,
   KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [KL2RR031989, KL2RR031989] Funding Source: NIH RePORTER
FX This work was supported by funds of the Italian Ministero
   dell'Universita e della Ricerca and by an American Heart Association
   Beginning Grant-in-Aid (Mid-Atlantic Affiliate) to AA. FNS is supported
   by an American Heart Association Scientist Development Grant. BWVT is
   supported by an institutional KL2RR031989-01. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbate A, 2005, EUR HEART J, V26, P2039, DOI 10.1093/eurheartj/ehi419
   Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233
   Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923
   Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865
   AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453
   Banda NK, 2005, J IMMUNOL, V174, P3608, DOI 10.4049/jimmunol.174.6.3608
   Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079
   Boniotto M, 2003, EUR J HISTOCHEM, V47, P177
   Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263
   de Moissac D, 2000, J MOL CELL CARDIOL, V32, P53, DOI 10.1006/jmcc.1999.1057
   Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901
   Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417
   Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014
   Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785
   Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8
   Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594
   Ekhterae D, 1999, CIRC RES, V85, pE70
   Gabay C, 1997, J IMMUNOL, V159, P5905
   Gabay C, 1999, CYTOKINE, V11, P561, DOI 10.1006/cyto.1998.0451
   Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497
   Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C
   Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303
   Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603
   Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53
   Patti G, 2004, J AM COLL CARDIOL, V43, P35, DOI 10.1016/j.jacc.2003.07.032
   Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017
   Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568
   Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Suzuki K, 2001, CIRCULATION, V104, pI308
   Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X
   Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101
   Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549
NR 39
TC 12
Z9 12
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2013
VL 8
IS 1
AR e53265
DI 10.1371/journal.pone.0053265
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 069IY
UT WOS:000313429800035
PM 23308180
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Vuch, J
   Siori, MS
   Bigatti, MP
   Segat, L
   De Fabrizio, G
   Crovella, S
AF Vuch, J.
   Siori, M. S.
   Bigatti, M. P.
   Segat, L.
   De Fabrizio, G.
   Crovella, S.
TI Analysis of the beta-globin gene in DNA of suspected thalassemic great
   apes
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Ancient DNA; beta-globin gene; beta-thalassemia; Mutation; Pan
   troglodytes; Pongo pygmaeus
ID CRIBRA ORBITALIA; EXTRACTION; SKELETAL; CHIMPANZEES
AB DNA was recovered from teeth of 2 great ape skeletons, Pan troglodytes (Ptr) and Pongo pygmaeus (Ppy), belonging to a 19thcentury zoological collection. The skeletons presented morphological alterations possibly associated with beta-thalassemia: Ptr had deformation of the calvaria and oro-maxillo-facial bones with porotic hyperostosis and extended osteoporotic lesions of the skeleton, while Ppy showed a general marked widening of the calvarial diploe but moderate osteoporotic signs on the post-cranial skeleton. We screened Ptr and Ppy for mutations in the beta-globin gene (exons 1, 2, and 3) because we suspected thalassemia. Ptr beta-globin sequences showed the highest degree of similarity with the human ones (99.8%), while those of Ppy were slightly different (98.2%). The results were consistent with the phylogenetic relationships between their beta-globin gene sequences. We did not find any mutation in the beta-globin gene of Ptr and Ppy; therefore, we conclude that, in spite of skeletal alterations, the 2 subjects analyzed were not affected by beta-thalassemia.
C1 [Vuch, J.; Segat, L.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Siori, M. S.; Bigatti, M. P.] Univ Turin, Dept Human & Anim Biol, Turin, Italy.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [De Fabrizio, G.] Univ Trieste, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
EM crovelser@gmail.com
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485; Siori, Maria Stella/0000-0003-0291-4271
CR CHOPRA S. R. K., 1957, PROC ZOOL SOC LONDON, V128, P67
   Cray J, 2008, AM J PHYS ANTHROPOL, V136, P394, DOI 10.1002/ajpa.20821
   De Mattia D, 1996, Minerva Pediatr, V48, P11
   Degusta D, 2010, INT J OSTEOARCHAEOL, V20, P597, DOI 10.1002/oa.1081
   Domrongkitchaiporn S, 2003, J BONE MINER RES, V18, P1682, DOI 10.1359/jbmr.2003.18.9.1682
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Hershkovitz I, 1997, AM J PHYS ANTHROPOL, V104, P213, DOI 10.1002/(SICI)1096-8644(199710)104:2<213::AID-AJPA8>3.0.CO;2-Z
   HES J, 1990, ORAL SURG ORAL MED O, V69, P185, DOI 10.1016/0030-4220(90)90326-N
   Hollar MA, 2001, RADIOLOGY, V221, P347, DOI 10.1148/radiol.2212991231
   Holly SB, 1994, YEARB PHYS ANTHROPOL, V37, P177, DOI DOI 10.1002/AJPA.1330370608
   Lagia A, 2007, INT J OSTEOARCHAEOL, V17, P269, DOI 10.1002/oa.881
   Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446
   MOSELEY JE, 1965, AMER J ROENTGENOL RA, V95, P135, DOI 10.2214/ajr.95.1.135
   MOSELEY JE, 1974, SEMIN ROENTGENOL, V9, P169, DOI 10.1016/0037-198X(74)90015-7
   NATHAN H, 1966, AM J PHYS ANTHROPOL, V24, P351, DOI 10.1002/ajpa.1330240307
   Rascol VL, 2007, CURR OPIN IMMUNOL, V19, P542, DOI 10.1016/j.coi.2007.06.009
   Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05
   Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247
   Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383
   ROY MS, 1994, EXPERIENTIA, V50, P551, DOI 10.1007/BF01921724
   Schultz A. H., 1956, P965
   SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x
   STUARTMACADAM P, 1987, AM J PHYS ANTHROPOL, V74, P511, DOI 10.1002/ajpa.1330740409
   Swindler D.R., 2002, PRIMATE DENTITION
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813
   Winkler LA, 1996, AM J PHYS ANTHROPOL, V99, P191
   Zihlman AL, 2007, J ZOOL, V273, P63, DOI 10.1111/j.1469-7998.2007.00301.x
NR 28
TC 0
Z9 1
U1 0
U2 3
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2013
VL 12
IS 2
BP 1731
EP 1739
DI 10.4238/2013.May.21.4
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 159FI
UT WOS:000320030100086
PM 23765979
OA Bronze
DA 2020-12-08
ER

PT J
AU Celsi, F
   Catamo, E
   Kleiner, G
   Tricarico, PM
   Vuch, J
   Crovella, S
AF Celsi, Fulvio
   Catamo, Eulalia
   Kleiner, Giulio
   Tricarico, Paola Maura
   Vuch, Josef
   Crovella, Sergio
TI HLA-G/C, miRNAs, and Their Role in HIV Infection and Replication
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID CELL-SURFACE EXPRESSION; LEUKOCYTE ANTIGEN-G; RNA INTERFERENCE; HUMAN
   CYTOMEGALOVIRUS; MICRORNA EXPRESSION; MAJOR DETERMINANTS; CYTOPLASMIC
   TAIL; T-LYMPHOCYTES; C EXPRESSION; HOST CONTROL
AB In recent years, a number of different mechanisms regulating gene expressions, either in normal or in pathological conditions, have been discovered. This review aims to highlight some of the regulatory pathways involved during the HIV-1 infection and disease progression, focusing on the novel discovered microRNAs (miRNAs) and their relation with immune system's agents. Human leukocyte antigen (HLA) family of proteins plays a key role because it is a crucial modulator of the immune response; here we will examine recent findings, centering especially on HLA-C and -G, novel players lately discovered to engage in modulation of immune system. We hope to provide novel perspectives useful to find out original therapeutic roads against HIV-1 infection and AIDS progression.
C1 [Celsi, Fulvio; Kleiner, Giulio; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Catamo, Eulalia; Tricarico, Paola Maura; Vuch, Josef; Crovella, Sergio] Univ Trieste, I-34128 Trieste, Italy.
RP Celsi, F (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
EM celsi@burlo.trieste.it
RI Celsi, Fulvio/H-2775-2019; Crovella, Sergio/K-5050-2016; tricarico,
   paola/AAB-8972-2019; Catamo, Eulalia/K-9399-2016
OI Celsi, Fulvio/0000-0002-9760-8463; Crovella, Sergio/0000-0001-8493-1168;
   tricarico, paola/0000-0002-1954-4126; Catamo,
   Eulalia/0000-0002-4701-9134; Kleiner, Giulio/0000-0002-1830-3961
CR Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x
   Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117
   Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8
   Alkhouly N, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0460-8
   Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138
   Antoniou AN, 2003, CURR OPIN IMMUNOL, V15, P75, DOI 10.1016/S0952-7915(02)00010-9
   Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685
   Barcova M, 1998, J INFECT DIS, V177, P905, DOI 10.1086/515230
   Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010
   Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003
   Buranapraditkun S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023603
   Carosella ED, 2000, IMMUNOL TODAY, V21, P532, DOI 10.1016/S0167-5699(00)01707-2
   Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028
   Castro MJ, 2000, HUM IMMUNOL, V61, P1164, DOI 10.1016/S0198-8859(00)00189-0
   Chang ST, 2013, MBIO, V4, DOI 10.1128/mBio.00549-12
   Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016
   Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390
   Cirulli V, 2006, DIABETES, V55, P1214, DOI 10.2337/db05-0731
   Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5
   Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929
   COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000
   Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10
   Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2
   Derrien M, 2004, J GEN VIROL, V85, P1945, DOI 10.1099/vir.0.79867-0
   Donaghy L, 2007, CLIN EXP IMMUNOL, V147, P236, DOI 10.1111/j.1365-2249.2006.03268.x
   Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363
   Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767
   Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791
   Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1
   Gatignol A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-65
   Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777
   Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x
   Hayes AM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-36
   Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006
   Hill AVS, 1996, PARASITOLOGY, V112, pS75, DOI 10.1017/S003118200007668X
   Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118
   Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639
   Karn J., 2012, COLD SPRING HARBOR P, V2, P2012
   Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003
   Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670
   Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18
   Krakauer DC, 1999, P ROY SOC B-BIOL SCI, V266, P1069, DOI 10.1098/rspb.1999.0745
   Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914
   Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825
   Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924
   Le Discorde M, 2005, BIOL REPROD, V73, P280, DOI 10.1095/biolreprod.104.037986
   Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000
   Lenfant F, 2003, J GEN VIROL, V84, P307, DOI 10.1099/vir.0.18735-0
   Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07
   Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395
   Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008
   Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101
   Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803
   Murdaca G, 2009, CLIN IMMUNOL, V133, P238, DOI 10.1016/j.clim.2009.08.002
   Nattermann J, 2005, ANTIVIR THER, V10, P95
   NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522
   Neisig A, 1998, J IMMUNOL, V160, P171
   Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0
   Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44
   Onno M, 2000, J IMMUNOL, V164, P6426, DOI 10.4049/jimmunol.164.12.6426
   Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X
   Piguet V, 2000, NAT CELL BIOL, V2, P163
   Pizzato N, 2004, HUM IMMUNOL, V65, P1389, DOI 10.1016/j.humimm.2004.07.239
   Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106
   Rebmann V, 2003, HUM IMMUNOL, V64, P1017, DOI 10.1016/j.humimm.2003.08.354
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249
   Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338
   Segat L, 2010, AIDS, V24, P1961, DOI 10.1097/QAD.0b013e32833c3324
   Sisk JM, 2012, VIRUSES-BASEL, V4, P1844, DOI 10.3390/v4101844
   SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816
   Specht A, 2010, J VIROL, V84, P7300, DOI 10.1128/JVI.00619-10
   Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961
   Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263
   Swaminathan S, 2009, BLOOD, V113, P5029, DOI 10.1182/blood-2009-01-196741
   Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486
   Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327
   Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76
   Trachtenberg E, 2009, GENES IMMUN, V10, P673, DOI 10.1038/gene.2009.58
   Turk WJR, 2013, AIDS, V27, P7, DOI 10.1097/QAD.0b013e32835ab1f2
   Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000
   Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13
   Williams M, 2002, J VIROL, V76, P12173, DOI 10.1128/JVI.76.23.12173-12184.2002
   Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5
   Wright Mathew W., 2011, Human Genomics, V5, P90
   Yan Wei-Hua, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P76
   Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707
   Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81
   Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002
NR 90
TC 10
Z9 13
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 693643
DI 10.1155/2013/693643
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 170AL
UT WOS:000320821800001
PM 23841087
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Bianco, AM
   Girardelli, M
   Tommasini, A
   Martelossi, S
   Monasta, L
   Crovella, S
AF Marcuzzi, Annalisa
   Bianco, Anna Monica
   Girardelli, Martina
   Tommasini, Alberto
   Martelossi, Stefano
   Monasta, Lorenzo
   Crovella, Sergio
TI Genetic and Functional Profiling of Crohn's Disease: Autophagy Mechanism
   and Susceptibility to Infectious Diseases
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; ILEAL MUCOSA;
   ESCHERICHIA-COLI; COMMON VARIANTS; GUT MICROBIOTA; NOD2; DIVERSITY;
   INNATE; IRGM
AB Crohn's disease is a complex disease in which genome, microbiome, and environment interact to produce the immunological background of the disease. Disease in childhood is more extensive and characterized by a rapid progression, leading to severe repercussions in the course of the disorder. Several genetic variations have been associated with an increased risk of developing the disease and most of these are also implicated in other autoimmune disorders. The gut has many tiers of defense against incursion by luminal microbes, including the epithelial barrier and the innate and adaptive immune responses. Moreover, recent evidence shows that bacterial and viral infections, as well as inflammasome genes and genes involved in the autophagy process, are implicated in Crohn's disease pathogenesis. The aim of this review is to establish how much the diagnostic system can improve, thus increasing the success of Crohn's disease diagnosis. The major expectation for the near future is to be able to anticipate the possible consequences of the disease already in childhood, thus preventing associated complications, and to choose the best treatment for each patient.
C1 [Marcuzzi, Annalisa; Bianco, Anna Monica; Girardelli, Martina; Tommasini, Alberto; Martelossi, Stefano; Monasta, Lorenzo; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo T, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo T, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Monasta, Lorenzo/B-1388-2012; Crovella, Sergio/K-5050-2016; BIANCO, ANNA
   MONICA/D-3098-2014; Tommasini, Alberto/AAE-3882-2020; Marcuzzi,
   Annalisa/AAA-6038-2020; Girardelli, Martina/K-7199-2016
OI Monasta, Lorenzo/0000-0001-7774-548X; Crovella,
   Sergio/0000-0001-8493-1168; BIANCO, ANNA MONICA/0000-0001-8101-9659;
   Tommasini, Alberto/0000-0002-6943-7927; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Girardelli, Martina/0000-0003-1186-4907
CR Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647
   Achkar JP, 2008, CURR OPIN GASTROEN, V24, P429, DOI 10.1097/MOG.0b013e3283009c92
   Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2
   Ayling RM, 2012, ANN CLIN BIOCHEM, V49, P44, DOI 10.1258/acb.2011.011150
   Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504
   Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X
   Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9
   Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52
   Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019
   Bianco AM, 2012, MED HYPOTHESES, V78, P520, DOI 10.1016/j.mehy.2012.01.023
   Biank V, 2007, INFLAMM BOWEL DIS, V13, P1430, DOI 10.1002/ibd.20213
   Bickston Stephen J, 2003, Curr Gastroenterol Rep, V5, P518, DOI 10.1007/s11894-003-0043-5
   Bodmer W, 2010, CURR OPIN GENET DEV, V20, P262, DOI 10.1016/j.gde.2010.04.016
   Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045
   Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667
   Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762
   Cadwell K, 2010, GASTROENTEROLOGY, V139, P1448, DOI 10.1053/j.gastro.2010.09.023
   Cannioto Z, 2009, EUR J PEDIATR, V168, P149, DOI 10.1007/s00431-008-0721-2
   Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069
   Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002
   Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8
   de Ridder L, 2007, INFLAMM BOWEL DIS, V13, P1083, DOI 10.1002/ibd.20171
   Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003
   Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115
   Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022
   Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1
   Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Glubb DM, 2011, WORLD J GASTROENTERO, V17, P2829, DOI 10.3748/wjg.v17.i23.2829
   Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414
   Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06
   Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686
   Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422
   Gutierrez A., 2013, GUT
   Haglund S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056989
   Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954
   Helbig KL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-14
   Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006
   Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190
   Huett A, 2010, INFLAMM BOWEL DIS, V16, P152, DOI 10.1002/ibd.20991
   Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102
   Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489
   Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263
   Kanaan ZM, 2012, J NEGAT RESULTS BIOM, V11, DOI 10.1186/1477-5751-11-7
   Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517
   Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013
   Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330
   Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391
   Kunz C, 2009, ADV EXP MED BIOL, V639, P67, DOI 10.1007/978-1-4020-8749-3_6
   Lacher M, 2007, BIOCHEM BIOPH RES CO, V363, P701, DOI 10.1016/j.bbrc.2007.09.020
   Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679
   Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432
   Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161
   Lewis JD, 2009, CLIN GASTROENTEROL H, V7, P1195, DOI 10.1016/j.cgh.2009.07.019
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284
   Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Marcuzzi A, 2012, GENE, V493, P282, DOI 10.1016/j.gene.2011.11.043
   Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997
   Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027
   McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215
   Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474
   Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875
   Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053
   Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403
   Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242
   Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061
   Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106
   Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017
   Podolsky DK, 2002, BEST PRACT RES CL GA, V16, P933, DOI 10.1053/bega.2002.0354
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Radford-Smith G, 2006, WORLD J GASTROENTERO, V12, P7097, DOI 10.3748/wjg.v12.i44.7097
   Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49
   REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856
   Rosenstiel P, 2008, CELL MOL LIFE SCI, V65, P1361, DOI 10.1007/s00018-008-7502-y
   Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119
   Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b
   Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230
   Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788
   Tommasini A, 2010, SCAND J GASTROENTERO, V45, P1141, DOI 10.3109/00365521.2010.492529
   Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823
   van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8
   Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013
   van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369
   Verstraelen H, 2008, Verh K Acad Geneeskd Belg, V70, P147
   Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231
   von Kampen O, 2010, J BIOL CHEM, V285, P19921, DOI 10.1074/jbc.M110.127480
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310
   Yuk JM, 2012, EXP MOL MED, V44, P99, DOI 10.3858/emm.2012.44.2.032
   Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112
   Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002
NR 104
TC 9
Z9 11
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 297501
DI 10.1155/2013/297501
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 147BF
UT WOS:000319139500001
PM 23738324
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Piscianz, E
   Kleiner, G
   Tommasini, A
   Severini, GM
   Monasta, L
   Crovella, S
AF Marcuzzi, Annalisa
   Piscianz, Elisa
   Kleiner, Giulio
   Tommasini, Alberto
   Severini, Giovanni Maria
   Monasta, Lorenzo
   Crovella, Sergio
TI Clinical Genetic Testing of Periodic Fever Syndromes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID FAMILIAL MEDITERRANEAN FEVER; COLD AUTOINFLAMMATORY SYNDROME;
   HYPERIMMUNOGLOBULINEMIA-D; PFAPA SYNDROME; INDUCED APOPTOSIS; DIAGNOSTIC
   SCORE; TNF RECEPTOR; MUTATIONS; CRYOPYRIN; DISEASES
AB Periodic fever syndromes (PFSs) are a wide group of autoinflammatory diseases. Due to some clinical overlap between different PFSs, differential diagnosis can be a difficult challenge. Nowadays, there are no universally agreed recommendations for most PFSs, and near half of patients may remain without a genetic diagnosis even after performing multiple-gene analyses. Molecular analysis of periodic fevers' causative genes can improve patient quality of life by providing early and accurate diagnosis and allowing the administration of appropriate treatment. In this paper we focus our discussion on effective usefulness of genetic diagnosis of PFSs. The aim of this paper is to establish how much can the diagnostic system improve, in order to increase the success of PFS diagnosis. The mayor expectation in the near future will be addressed to the so-called next generation sequencing approach. Although the application of bioinformatics to high-throughput genetic analysis could allow the identification of complex genotypes, the complexity of this definition will hardly result in a clear contribution for the physician. In our opinion, however, to obtain the best from this new development a rule should always be kept well in mind: use genetics only to answer specific clinical questions.
C1 [Marcuzzi, Annalisa; Piscianz, Elisa; Kleiner, Giulio; Tommasini, Alberto; Severini, Giovanni Maria; Monasta, Lorenzo; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Immunopathol Lab, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Med Sci, I-34100 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Immunopathol Lab, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Tommasini, Alberto/AAE-3882-2020; Monasta, Lorenzo/B-1388-2012;
   Marcuzzi, Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016
OI Tommasini, Alberto/0000-0002-6943-7927; Monasta,
   Lorenzo/0000-0001-7774-548X; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Crovella, Sergio/0000-0001-8493-1168; Piscianz,
   Elisa/0000-0001-7374-1684; Kleiner, Giulio/0000-0002-1830-3961
CR Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z
   Anton-Martin P, 2011, EUR J PEDIATR, V170, P1563, DOI 10.1007/s00431-011-1479-5
   Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7
   Ben-Chetrit E, 2009, ARTHRIT CARE RES, V61, P1447, DOI 10.1002/art.24458
   Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170
   Bortot B, 2011, DIAGN MOL PATHOL, V20, P175, DOI 10.1097/PDM.0b013e31820b34fb
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   Cantarini L, 2011, INT J IMMUNOPATH PH, V24, P827, DOI 10.1177/039463201102400402
   Cantarini L, 2011, INT J IMMUNOPATH PH, V24, P695, DOI 10.1177/039463201102400315
   Caorsi R, 2012, AUTOIMMUN REV, V12, P81, DOI 10.1016/j.autrev.2012.07.027
   D'Osualdo A, 2006, ARTHRITIS RHEUM-US, V54, P998, DOI 10.1002/art.21657
   D'Osualdo A, 2005, EUR J HUM GENET, V13, P314, DOI 10.1038/sj.ejhg.5201323
   DERBES VJ, 1972, ANN ALLERGY, V30, P335
   Dickie Laura J, 2010, F1000 Med Rep, V2, DOI 10.3410/M2-3
   Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544
   DOEGLAS HMG, 1974, ARCH DERMATOL, V110, P382, DOI 10.1001/archderm.110.3.382
   DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   Federici L, 2006, ANN RHEUM DIS, V65, P1427, DOI 10.1136/ard.2006.054304
   Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357
   Garavello W, 2009, J PEDIATR-US, V155, P250, DOI 10.1016/j.jpeds.2009.02.038
   Gattorno M, 2008, ARTHRITIS RHEUM-US, V58, P1823, DOI 10.1002/art.23474
   Gattorno M, 2009, PEDIATRICS, V124, pE721, DOI 10.1542/peds.2009-0088
   Guz G, 2009, CURR OPIN INFECT DIS, V22, P309, DOI 10.1097/QCO.0b013e328329d15e
   Hashkes PJ, 2012, PEDIATR CLIN N AM, V59, P447, DOI 10.1016/j.pcl.2012.03.005
   Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790
   Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756
   Hull KM, 2002, MEDICINE, V81, P349, DOI 10.1097/00005792-200209000-00002
   Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105
   Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90
   Kolly L., J ALLERGY C IN PRESS
   Kothiyal P., 2009, CURRENT PROTOCOLS HU, P17
   Krause K, 2012, ALLERGY, V67, P1465, DOI 10.1111/all.12030
   La Regina M, 2003, EUR J HUM GENET, V11, P50, DOI 10.1038/sj.ejhg.5200916
   Lachmann HJ, 2011, CLIN EXP IMMUNOL, V165, P301, DOI 10.1111/j.1365-2249.2011.04438.x
   Lainka E, 2012, EUR J PEDIATR, V171, P1775, DOI 10.1007/s00431-012-1803-8
   Lidar M, 2004, SEMIN ARTHRITIS RHEU, V33, P273, DOI 10.1053/S0049-0172(03)00137-9
   Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851
   Marcuzzi A, 2012, CURR PHARM DESIGN, V18, P5746, DOI 10.2174/138161212803530835
   Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   MARSHALL GS, 1987, J PEDIATR-US, V110, P43, DOI 10.1016/S0022-3476(87)80285-8
   Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627
   McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7
   Muscari I, 2012, AUTOIMMUN REV, V12, P10, DOI 10.1016/j.autrev.2012.07.015
   Padeh S, 2005, PEDIATR CLIN N AM, V52, P577, DOI 10.1016/j.pcl.2005.01.005
   Peridis S, 2010, INT J PEDIATR OTORHI, V74, P1203, DOI 10.1016/j.ijporl.2010.08.014
   Piram M, 2011, ANN RHEUM DIS, V70, P309, DOI 10.1136/ard.2010.132613
   Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201
   Savic S, 2012, BEST PRACT RES CL RH, V26, P505, DOI 10.1016/j.berh.2012.07.009
   Sayarlioglu M, 2005, INT J CLIN PRACT, V59, P202, DOI 10.1111/j.1368-5031.2004.00294.x
   Soriano A, 2012, AUTOIMMUN REV, V12, P31, DOI 10.1016/j.autrev.2012.07.019
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Tchernitchko D, 2005, ARTHRITIS RHEUM-US, V52, P3603, DOI 10.1002/art.21408
   Thomas KT, 1999, J PEDIATR-US, V135, P15, DOI 10.1016/S0022-3476(99)70321-5
   Thompson R, 2012, ADV PROTEIN CHEM STR, V89, P27, DOI 10.1016/B978-0-12-394287-6.00002-1
   Toplak N, 2012, ANN RHEUM DIS, V71, P1177, DOI 10.1136/annrheumdis-2011-200549
   Toro JR, 2000, ARCH DERMATOL, V136, P1487, DOI 10.1001/archderm.136.12.1487
   Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507
   Touitou I, 2008, BEST PRACT RES CL RH, V22, P811, DOI 10.1016/j.berh.2008.08.009
   van der Hilst JCH, 2005, CLIN EXP MED, V5, P87, DOI 10.1007/s10238-005-0071-6
   van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7
   VANDERMEER JWM, 1984, LANCET, V1, P1087
   Vigo G, 2012, AUTOIMMUN REV, V12, P52, DOI 10.1016/j.autrev.2012.07.021
   Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200
   WILLIAMSON LM, 1982, Q J MED, V51, P469
   Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734
   Zanin V, 2012, INFLAMM RES, V61, P1363, DOI 10.1007/s00011-012-0537-4
   Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006
NR 68
TC 9
Z9 9
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 501305
DI 10.1155/2013/501305
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 089YL
UT WOS:000314945800001
PM 23484126
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Kleiner, G
   Piscianz, E
   Zanin, V
   Monasta, L
   Crovella, S
   Marcuzzi, A
AF Tricarico, Paola Maura
   Kleiner, Giulio
   Piscianz, Elisa
   Zanin, Valentina
   Monasta, Lorenzo
   Crovella, Sergio
   Marcuzzi, Annalisa
TI Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex
   Vivo Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID NATURAL ISOPRENOIDS; PERIODIC FEVER; HYPER-IGD; PYROPTOSIS; CYTOKINES;
   INHIBITION; ANAKINRA; MODEL
AB Mevalonate Kinase Deficiency (MKD) is a rare autosomal recessive inborn disorder of cholesterol biosynthesis caused by mutations in the mevalonate kinase (MK) gene, leading to MK enzyme decreased activity. The consequent shortage of mevalonate-derived isoprenoid compounds results in an inflammatory phenotype, caused by the activation of the NALP3 inflammasome that determines an increased caspase-1 activation and IL-1 beta release. In MKD, febrile temperature can further decrease the residual MK activity, leading to mevalonate pathway modulation and to possible disease worsening. We previously demonstrated that the administration of exogenous isoprenoids such as geraniol or the modulation of the enzymatic pathway with drugs, such as Tipifarnib, partially rescues the inflammatory phenotype associated with the defective mevalonic pathway. However, it has not been investigated yet how temperature can affect the success of these treatments. Thus, we investigated the effect of temperature on primary human monocytes from MKD patients. Furthermore the ability of geraniol and Tipifarnib to reduce the abnormal inflammatory response, already described at physiological temperature in MKD, was studied in a febrile condition. We evidenced the role of temperature in the modulation of the inflammatory events and suggested strongly considering this variable in future researches aimed at finding a treatment for MKD.
C1 [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy.
   [Kleiner, Giulio; Piscianz, Elisa; Zanin, Valentina; Monasta, Lorenzo; Crovella, Sergio; Marcuzzi, Annalisa] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Marcuzzi, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI tricarico, paola/AAB-8972-2019; Marcuzzi, Annalisa/AAA-6038-2020;
   Monasta, Lorenzo/B-1388-2012; Crovella, Sergio/K-5050-2016
OI tricarico, paola/0000-0002-1954-4126; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Monasta, Lorenzo/0000-0001-7774-548X;
   Crovella, Sergio/0000-0001-8493-1168; Piscianz,
   Elisa/0000-0001-7374-1684; Kleiner, Giulio/0000-0002-1830-3961
CR Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bodar EJ, 2005, NETH J MED, V63, P260
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   Gattorno M, 2008, ARTHRITIS RHEUM-US, V58, P1823, DOI 10.1002/art.23474
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Houten SM, 2002, HUM MOL GENET, V11, P3115, DOI 10.1093/hmg/11.25.3115
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Lira SA, 2012, IMMUNOL RES, V54, P111, DOI 10.1007/s12026-012-8313-7
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065
   O'Meara SJ, 2005, BIOCHEM J, V386, P177, DOI 10.1042/BJ20041290
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Toplak N, 2012, ANN RHEUM DIS, V71, P1177, DOI 10.1136/annrheumdis-2011-200549
   Tricarico PM, 2012, AMYLOID, V19, P163, DOI 10.3109/13506129.2012.689266
   van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7
   Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976
NR 26
TC 2
Z9 2
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 715465
DI 10.1155/2013/715465
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 218EG
UT WOS:000324415000001
PM 24073415
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Zanin, V
   Monasta, L
   Martelossi, S
   Marcuzzi, A
   Crovella, S
AF Bianco, Anna Monica
   Zanin, Valentina
   Monasta, Lorenzo
   Martelossi, Stefano
   Marcuzzi, Annalisa
   Crovella, Sergio
TI Family history in early-onset inflammatory bowel disease
SO JOURNAL OF GASTROENTEROLOGY
LA English
DT Letter
ID CROHNS-DISEASE
C1 [Bianco, Anna Monica; Zanin, Valentina; Monasta, Lorenzo; Martelossi, Stefano; Marcuzzi, Annalisa; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Bianco, AM (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
EM bianco@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; BIANCO, ANNA MONICA/D-3098-2014;
   Crovella, Sergio/K-5050-2016; Monasta, Lorenzo/B-1388-2012
OI Marcuzzi, Annalisa/0000-0003-3427-618X; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Crovella, Sergio/0000-0001-8493-1168;
   Monasta, Lorenzo/0000-0001-7774-548X
CR Bianco AM, 2012, MED HYPOTHESES, V78, P520, DOI 10.1016/j.mehy.2012.01.023
   Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231
   Kuwahara E, 2012, J GASTROENTEROL, V47, P961, DOI 10.1007/s00535-012-0558-3
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   Marcuzzi A, 2012, GENE, V493, P282, DOI 10.1016/j.gene.2011.11.043
   Tsianos EV, 2012, WORLD J GASTROENTERO, V18, P105, DOI 10.3748/wjg.v18.i2.105
NR 6
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0944-1174
J9 J GASTROENTEROL
JI J. Gastroenterol.
PD JAN
PY 2013
VL 48
IS 1
BP 144
EP 144
DI 10.1007/s00535-012-0654-4
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 068LW
UT WOS:000313369200014
PM 22886482
OA Bronze
DA 2020-12-08
ER

PT J
AU Vuch, J
   Marcuzzi, A
   Bianco, AM
   Tommasini, A
   Zanin, V
   Crovella, S
AF Vuch, J.
   Marcuzzi, A.
   Bianco, A. M.
   Tommasini, A.
   Zanin, V.
   Crovella, S.
TI Evolutionary hypothesis of the Mevalonate Kinase Deficiency
SO MEDICAL HYPOTHESES
LA English
DT Article
ID PERIODIC FEVER SYNDROME; HYPERIMMUNOGLOBULINEMIA-D; HYPER-IGD;
   CHOLESTEROL
AB Mevalonate Kinase Deficiency (MKD) is an autosomal-recessively inherited disorder of cholesterol biosynthesis with higher prevalence in the Netherlands and other North European countries. MKD is due to mutations in the second enzyme of mevalonate pathway (mevalonate kinase, MK/MVK) which results in reduced enzymatic activity and in the consequent shortage of downstream compounds. In most severe cases the deregulation of mevalonate pathway is associated with a decrease in serum cholesterol.
   More than 100 pathological mutations have been described in the MVK gene so far, and a founder effect has been hypothesized as responsible for the diffusion of the most frequent disease-associated mutations.
   In the acute phase of disease, patients affected with MKD present low cholesterol levels comparable to their basal physiologic conditions, already characterized by lower cholesterol levels when compared to healthy individuals. Low cholesterol levels are widely known to correlate with the reduction of cardiovascular events.
   We hypothesize a selective advantage for heterozygote carriers of the most frequent MVK mutations in those countries where the diet is characterized by high consumption of saturated animal fats rich in cholesterol. This could explain the maintenance in North European population of the main mutations leading to MKD and the distribution world-wide of these mutations that followed the migrations of North European populations. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Vuch, J.; Marcuzzi, A.; Bianco, A. M.; Tommasini, A.; Zanin, V.; Crovella, S.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Crovella, S.] Univ Trieste, Univ Dept Clin Med Sci Surg & Hlth, I-34127 Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI BIANCO, ANNA MONICA/D-3098-2014; Tommasini, Alberto/AAE-3882-2020;
   Marcuzzi, Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016
OI BIANCO, ANNA MONICA/0000-0001-8101-9659; Tommasini,
   Alberto/0000-0002-6943-7927; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Crovella, Sergio/0000-0001-8493-1168
CR Caspari R, 2011, SCI AM, V305, P44, DOI 10.1038/scientificamerican0811-44
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Houten SM, 2003, EUR J HUM GENET, V11, P196, DOI 10.1038/sj.ejhg.5200933
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Mandey SHL, 2006, HUM MUTAT, V27, P796, DOI 10.1002/humu.20361
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   Simon A, 2004, J INTERN MED, V256, P247, DOI 10.1111/j.1365-2796.2004.01359.x
   Simon A, 2003, AM J MED, V114, P148, DOI 10.1016/S0002-9343(02)01429-8
   Steinberg D, 2005, J LIPID RES, V46, P2037, DOI 10.1194/jlr.R500010-JLR200
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Zeegers MPA, 2004, EUR J HUM GENET, V12, P591, DOI 10.1038/sj.ejhg.5201151
NR 11
TC 7
Z9 7
U1 0
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JAN
PY 2013
VL 80
IS 1
BP 67
EP 69
DI 10.1016/j.mehy.2012.10.016
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 071QO
UT WOS:000313609500017
PM 23168296
DA 2020-12-08
ER

PT J
AU Segat, L
   Padovan, L
   Doc, D
   Petix, V
   Morgutti, M
   Crovella, S
   Ricci, G
AF Segat, Ludovica
   Padovan, Lara
   Doc, Darja
   Petix, Vincenzo
   Morgutti, Marcello
   Crovella, Sergio
   Ricci, Giuseppe
TI A Real-Time Polymerase Chain Reaction-Based Protocol for
   Low/Medium-Throughput Y-Chromosome Microdeletions Analysis
SO GENETIC TESTING AND MOLECULAR BIOMARKERS
LA English
DT Article
ID OF-THE-ART; MOLECULAR DIAGNOSIS; MALE-INFERTILITY; SPERMATOGENESIS;
   GUIDELINES; REGION
AB Purpose: We describe a real-time polymerase chain reaction (PCR) protocol based on the fluorescent molecule SYBR Green chemistry, for a low-to medium-throughput analysis of Y-chromosome microdeletions, optimized according to the European guidelines and aimed at making the protocol faster, avoiding post-PCR processing, and simplifying the results interpretation. Methods: We screened 156 men from the Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Institute for Maternal and Child Health IRCCS Burlo Garofolo (Trieste, Italy), 150 not presenting Y-chromosome microdeletion, and 6 with microdeletions in different azoospermic factor (AZF) regions. For each sample, the Zinc finger Y-chromosomal protein (ZFY), sex-determining region Y (SRY), sY84, sY86, sY127, sY134, sY254, and sY255 loci were analyzed by performing one reaction for each locus. Results: AZF microdeletions were successfully detected in six individuals, confirming the results obtained with commercial kits. Conclusion: Our real-time PCR protocol proved to be a rapid, safe, and relatively cheap method that was suitable for a low-to medium-throughput diagnosis of Y-chromosome microdeletion, which allows an analysis of approximately 10 samples (with the addition of positive and negative controls) in a 96-well plate format, or approximately 46 samples in a 384-well plate for all markers simultaneously, in less than 2 h without the need of post-PCR manipulation.
C1 [Segat, Ludovica; Padovan, Lara; Doc, Darja; Petix, Vincenzo; Morgutti, Marcello; Crovella, Sergio; Ricci, Giuseppe] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34100 Trieste, Italy.
   [Crovella, Sergio; Ricci, Giuseppe] Univ Trieste, Trieste, Italy.
RP Segat, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34100 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485; RICCI, GIUSEPPE/0000-0002-8031-1102
FU TALENTS Program (7th R&D Framework Program, Specific Program:
   PEOPLE-Marie Curie Actions-COFUND)
FX SC is the recipient of a grant from the TALENTS Program (7th R&D
   Framework Program, Specific Program: PEOPLE-Marie Curie Actions-COFUND).
CR Ali S, 2003, GENE, V321, P25, DOI 10.1016/j.gene.2003.08.006
   Buch B, 2003, FERTIL STERIL, V80, P907, DOI 10.1016/S0015-0282(03)01155-5
   Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226
   Kozina V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023174
   Krausz C, 2006, FRONT BIOSCI-LANDMRK, V11, P3049, DOI 10.2741/2032
   Simoni M, 1999, INT J ANDROL, V22, P292
   Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x
   Simoni M, 2001, HUM REPROD, V16, P402, DOI 10.1093/humrep/16.3.402
   SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0
   Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722
   TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879
   Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933
NR 12
TC 2
Z9 3
U1 0
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1945-0265
J9 GENET TEST MOL BIOMA
JI Genet. Test. Mol. Biomark.
PD DEC
PY 2012
VL 16
IS 12
BP 1349
EP 1355
DI 10.1089/gtmb.2012.0220
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 047IE
UT WOS:000311832300002
PM 23101560
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Crovella, S
   Monasta, L
   Brumatti, LV
   Gattorno, M
   Frenkel, J
AF Marcuzzi, Annalisa
   Crovella, Sergio
   Monasta, Lorenzo
   Brumatti, Liza Vecchi
   Gattorno, Marco
   Frenkel, Joost
TI Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway
   Modulation in Inflammation
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Mevalonate; statin; aminobisphosphonate; inflammation; cholesterol
ID PERIODIC FEVER SYNDROME; KAPPA-B ACTIVATION; HYPER-IGD SYNDROME;
   CELL-DEATH; FARNESYLTRANSFERASE INHIBITORS; HYPERIMMUNOGLOBULINEMIA-D;
   IN-VITRO; HISTIDINE-DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; CASPASE
   ACTIVATION
AB Inflammation is a highly regulated process involved both in the response to pathogens as well as in tissue homeostasis. In recent years, a complex network of proteins in charge of inflammation control has been revealed by the study of hereditary periodic fever syndromes. Most of these proteins belong to a few families and share the capability of sensing pathogen-associated and damage-associated molecular patterns. By interacting with each other, these proteins participate in the assembly of molecular platforms, called inflammasomes, which ultimately lead to the activation of cytokines, to the transcription of inflammatory genes or to the induction of cell apoptosis. Among hereditary periodic fever syndromes, mevalonate kinase deficiency (MKD) is the sole in which the phenotype did not directly associate with a deficiency of these proteins, but with a metabolic defect of the mevalonate pathway, highlighting the importance of this metabolic pathway in the inflammation control. Noteworthy, drugs acting on this pathway can greatly influence the inflammatory response. The modulation of inflammation by mevalonate pathway is of interest, since it may involve mechanisms not directly referable to inflammasomes. MKD provides a model to study these mechanisms and possibly to develop new classes of anti-inflammatory drugs.
C1 [Frenkel, Joost] Univ Med Ctr Utrecht, Dept Pediat, NL-3508 AB Utrecht, Netherlands.
   [Marcuzzi, Annalisa; Crovella, Sergio; Monasta, Lorenzo; Brumatti, Liza Vecchi] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Gattorno, Marco] Sci Inst G Gaslini, UO Pediat 2, Genoa, Italy.
RP Frenkel, J (corresponding author), Univ Med Ctr Utrecht, Dept Pediat, NL-3508 AB Utrecht, Netherlands.
EM J.Frenkel@umcutrecht.nl
RI Gattorno, Marco/AAL-2974-2020; Crovella, Sergio/K-5050-2016; Monasta,
   Lorenzo/B-1388-2012; Vecchi Brumatti, Liza/J-4968-2016; Marcuzzi,
   Annalisa/AAA-6038-2020
OI Crovella, Sergio/0000-0001-8493-1168; Monasta,
   Lorenzo/0000-0001-7774-548X; Vecchi Brumatti, Liza/0000-0001-8149-1873;
   Marcuzzi, Annalisa/0000-0003-3427-618X; Gattorno,
   Marco/0000-0003-0704-1916
FU Institute for Maternal and Child Health - IRCCS "Burlo Garofolo" [RC
   42/11]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health - IRCCS "Burlo Garofolo" (RC 42/11).
CR Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565
   Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004
   Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Biasucci LM, 2010, CLIN CHEM LAB MED, V48, P1685, DOI 10.1515/CCLM.2010.277
   Bodar EJ, 2005, NETH J MED, V63, P260
   Braun T, 2008, BRIT J HAEMATOL, V141, P576, DOI 10.1111/j.1365-2141.2008.07099.x
   Brucknerova I, 2009, NEUROENDOCRINOL LETT, V30, P29
   Brunner TB, 2003, CANCER RES, V63, P5656
   Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002
   Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702
   Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   Case Christopher L., 2011, Yale Journal of Biology and Medicine, V84, P333
   Chang FY, 2009, J CHIN MED ASSOC, V72, P294, DOI 10.1016/S1726-4901(09)70375-2
   Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107
   Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200
   Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284
   CRICK DC, 1995, BIOCHEM BIOPH RES CO, V211, P590, DOI 10.1006/bbrc.1995.1854
   Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614
   Deng X, 2007, INT IMMUNOPHARMACOL, V7, P152, DOI 10.1016/j.intimp.2006.09.009
   Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005
   Diaz-Borjon A, 2006, JCR-J CLIN RHEUMATOL, V12, P131, DOI 10.1097/01.rhu.0000221796.06383.4e
   Drenth JPH, 2001, J PHARMACOL EXP THER, V298, P1221
   Drenth JPH, 2001, NEW ENGL J MED, V345, P1748, DOI 10.1056/NEJMra010200
   Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326
   Endres M, 2006, ATHEROSCLEROSIS SUPP, V7, P31, DOI 10.1016/j.atherosclerosissup.2006.01.005
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Frenkel J, 2001, RHEUMATOLOGY, V40, P579, DOI 10.1093/rheumatology/40.5.579
   Manuele MG, 2009, PHYTOTHER RES, V23, P1011, DOI 10.1002/ptr.2743
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9
   He L, 1997, J NUTR, V127, P668
   Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Houten SM, 1999, NAT GENET, V22, P175
   Houten SM, 2002, HUM MOL GENET, V11, P3115, DOI 10.1093/hmg/11.25.3115
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245
   Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160
   Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1
   KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3
   Menge T, 2005, NAT REV NEUROSCI, V6, P325, DOI 10.1038/nrn1652
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028
   Na HJ, 2004, J IMMUNOL, V173, P1276, DOI 10.4049/jimmunol.173.2.1276
   Nagata S, 2007, IMMUNOL REV, V220, P237, DOI 10.1111/j.1600-065X.2007.00571.x
   Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874
   Neven B, 2007, NEW ENGL J MED, V356, P2700, DOI 10.1056/NEJMoa070715
   Paoletti R, 2002, ATHEROSCLEROSIS SUPP, V3, P35, DOI 10.1016/S1567-5688(02)00002-8
   Park EJ, 2009, J CLIN BIOCHEM NUTR, V44, P125, DOI 10.3164/jcbn.08-201
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Prendergast GC, 2001, EXPERT OPIN INV DRUG, V10, P2105, DOI 10.1517/13543784.10.12.2105
   Rabi Thangaiyan, 2009, J Carcinog, V8, P9, DOI 10.4103/1477-3163.51368
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086
   Rios SE, 2001, BBA-MOL CELL BIOL L, V1531, P165, DOI 10.1016/S1388-1981(01)00105-6
   Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022
   Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520
   Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x
   Schneiders MS, 2006, ARTHRITIS RHEUM, V54, P2306, DOI 10.1002/art.21960
   Simon A, 2004, NEUROLOGY, V62, P994, DOI 10.1212/01.WNL.0000115390.33405.F7
   Stoffels M, 2011, CURR OPIN RHEUMATOL, V23, P419, DOI 10.1097/BOR.0b013e328349c3b1
   Takada Y, 2004, J BIOL CHEM, V279, P26287, DOI 10.1074/jbc.M400963200
   Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353
   van der Hilst Jeroen C H, 2010, Curr Rheumatol Rep, V12, P101, DOI 10.1007/s11926-010-0086-1
   Vigushin DM, 1998, CANCER CHEMOTH PHARM, V42, P111, DOI 10.1007/s002800050793
   Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976
   Yoon WJ, 2010, J OLEO SCI, V59, P415, DOI 10.5650/jos.59.415
NR 84
TC 9
Z9 9
U1 1
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD DEC
PY 2012
VL 18
IS 35
BP 5746
EP 5752
DI 10.2174/138161212803530835
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 022OK
UT WOS:000309968500017
PM 22726114
DA 2020-12-08
ER

PT J
AU Zanin, V
   Marcuzzi, A
   Piscianz, E
   Vuch, J
   Bianco, AM
   Monasta, L
   Decorti, G
   Crovella, S
AF Zanin, Valentina
   Marcuzzi, Annalisa
   Piscianz, Elisa
   Vuch, Josef
   Bianco, Anna Monica
   Monasta, Lorenzo
   Decorti, Giuliana
   Crovella, Sergio
TI The effect of clodronate on a mevalonate kinase deficiency cellular
   model
SO INFLAMMATION RESEARCH
LA English
DT Article
DE Mevalonate kinase deficiency; Clodronate; Apoptosis; Nitric oxide
ID HYPERIMMUNOGLOBULINEMIA-D SYNDROME; CELLS IN-VITRO; NATURAL ISOPRENOIDS;
   NITRIC-OXIDE; BISPHOSPHONATES; MACROPHAGES; ALENDRONATE; ANAKINRA
AB A potential anti-inflammatory effect of clodronate-an aminobisphosphonate-was described to antagonize the pro-inflammatory effects of the block in the mevalonate pathway, the main feature of a rare auto-inflammatory disease called mevalonate kinase deficiency (MKD).
   In this study we evaluated the potential anti-inflammatory effect of clodronate in MKD-a still orphan drug pediatric disease.
   We studied some biological parameters, nitric oxide production using Griess reagents and programmed cell death by flow cytometry, as common inflammatory parameters in MKD, in the presence of different doses of clodronate (1, 10 and 100 mu M).
   In our cellular model and in monocytes from patients with MKD, clodronate induced an increase in programed cell death and nitric oxide production in comparison with non-treated cells.
   Our findings suggest that clodronate does not have an anti-inflammatory effect as previously reported but that it increases the epiphenomena of this pediatric disease.
C1 [Zanin, Valentina; Marcuzzi, Annalisa; Piscianz, Elisa; Vuch, Josef; Bianco, Anna Monica; Monasta, Lorenzo; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Decorti, Giuliana; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Monasta, Lorenzo/B-1388-2012; BIANCO, ANNA
   MONICA/D-3098-2014; Marcuzzi, Annalisa/AAA-6038-2020
OI Crovella, Sergio/0000-0001-8493-1168; Monasta,
   Lorenzo/0000-0001-7774-548X; BIANCO, ANNA MONICA/0000-0001-8101-9659;
   Marcuzzi, Annalisa/0000-0003-3427-618X; Piscianz,
   Elisa/0000-0001-7374-1684; Decorti, Giuliana/0000-0002-9714-6246
FU European Project "Talents for an International House" within the 7th
   Research & Development Framework Programme PEOPLE-Marie Curie
   Actions-COFUND; Institute for Maternal and Child Health-IRCCS "Burlo
   Garofolo", TS, Italy [RC 42/2011]
FX S.C. is recipient of a fellowship grant from the European Project
   "Talents for an International House" within the 7th Research &
   Development Framework Programme PEOPLE-Marie Curie Actions-COFUND
   (Co-Funding of Regional, National and International Programmes). This
   work was supported by a grant from the Institute for Maternal and Child
   Health-IRCCS "Burlo Garofolo", TS, Italy (RC 42/2011).
CR Bodar EJ, 2005, NETH J MED, V63, P260
   Cailliez M, 2006, J INHERIT METAB DIS, V29, P763, DOI 10.1007/s10545-006-0408-7
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Frith JC, 2003, J BONE MINER RES, V18, P204, DOI 10.1359/jbmr.2003.18.2.204
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Makkonen N, 1996, J PHARMACOL EXP THER, V277, P1097
   Makkonen N, 1999, EUR J PHARM SCI, V8, P109, DOI 10.1016/S0928-0987(98)00065-7
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031
   Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022
   Shikama Y, 2010, TOXICOL LETT, V199, P123, DOI 10.1016/j.toxlet.2010.08.013
   van der Hilst JCH, 2008, MEDICINE, V87, P301, DOI 10.1097/MD.0b013e318190cfb7
NR 15
TC 3
Z9 4
U1 0
U2 2
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1023-3830
J9 INFLAMM RES
JI Inflamm. Res.
PD DEC
PY 2012
VL 61
IS 12
BP 1363
EP 1367
DI 10.1007/s00011-012-0537-4
PG 5
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA 035ZZ
UT WOS:000310995500009
PM 22851203
DA 2020-12-08
ER

PT J
AU Franca, R
   Rebora, P
   Basso, G
   Biondi, A
   Cazzaniga, G
   Crovella, S
   Decorti, G
   Fagioli, F
   Giarin, E
   Locatelli, F
   Poggi, V
   Valsecchi, MG
   Rausin, M
AF Franca, Raffaella
   Rebora, Paola
   Basso, Giuseppe
   Biondi, Andrea
   Cazzaniga, Giovanni
   Crovella, Sergio
   Decorti, Guiliana
   Fagioli, Franca
   Giarin, Emanuela
   Locatelli, Franco
   Poggi, Vincenzo
   Valsecchi, Maria Grazia
   Rausin, Marco
TI Glutathione S-transferase homozygous deletions and relapse in childhood
   acute lymphoblastic leukemia: a novel study design in a large Italian
   AIEOP cohort
SO PHARMACOGENOMICS
LA English
DT Article
DE acute lymphoblastic leukemia; glutathione S-transferase; polymorphisms;
   prognostic genetic factors; relapse; risk-adapted polychemotherapy;
   two-phase design
ID INITIAL RESPONSE; DRUG-RESISTANCE; GSTT1 DELETION; T-CELL;
   POLYMORPHISMS; GSTM1; GENOTYPES; CHILDREN; ENZYMES; GENES
AB Aim: In the AIEOP-BFM 2000 trial, 15% of pediatric patients treated according to risk-adapted polychemotherapeutic regimens relapsed. The present study aimed to investigate the influence of GST-M1 and GST-T1 deletions on clinical outcome of children with acute lymphoblastic leukemia treated according to the AIEOP-BFM ALL 2000 study protocol. Materials & methods: A novel-design, two-phase study was applied to select a subsample of 614 children to be genotyped for the deletions of GST genes. Cumulative incidence of relapse was then estimated by weighted Kaplan-Meier analysis, and the Cox model was applied to evaluate the effect of GST-M1 and GST-T1 isoenzyme deletions on relapse. Results: No overall effect was found, but the GST-M1 deletion was associated with better clinical outcome within prednisone poor-responder patients (hazard ratio [HR]: 0.45; 95% Cl: 0.23-0.91; p = 0.026), whereas the GST-T1 deletion was associated with worse outcome in the standard-risk group (HR: 4.62; 95% Cl: 1.04-20.6; p = 0.045) and within prednisone good responders (HR: 1.62; 95% Cl: 1.02-2.58; p = 0.041). Conclusion: Our results show that GST-M1 and GST-T1 homozygous deletions have opposite correlation with relapse, the former being protective and the latter unfavourable in specific subsets of acute lymphoblastic leukemia patients.
C1 [Franca, Raffaella; Rausin, Marco] UO Pediat Hematooncol, IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Rebora, Paola] Univ Milano Bicocca, Dept Clin Med & Prevent, Ctr Biostat Clin Epidemiol, I-20052 Milan, Italy.
   [Basso, Giuseppe; Giarin, Emanuela] Univ Padua, Pediat Clin, I-35128 Padua, Italy.
   [Biondi, Andrea; Cazzaniga, Giovanni] Univ Milano Bicocca, Ctr M Tettamanti, I-20052 Milan, Italy.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   [Decorti, Guiliana] Univ Trieste, Dept Life Sci, Trieste, Italy.
   [Fagioli, Franca] Regina Margherita Childrens Hosp, Stem Cell Transplantat & Cellular Therapy Div, Turin, Italy.
   [Locatelli, Franco] Univ Pavia, IRCCS Osped Pediat Bambino Gesu, Dept Pediat Hematol Oncol, I-27100 Pavia, Italy.
   [Poggi, Vincenzo] Pausilipon Hosp, Dept Pediat Oncol, I-80123 Naples, Italy.
   [Valsecchi, Maria Grazia] Univ Milano Bicocca, Dept Clin Med & Prevent, Ctr Biostat Clin Epidemiol, I-20052 Milan, Italy.
RP Decorti, G (corresponding author), Univ Trieste, Dept Life Sci, Via Fleming 22, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; Biondi, Andrea/AAX-1865-2020; Valsecchi,
   Maria Grazia/K-8891-2016; Biondi, Andrea/K-9997-2016; Rebora,
   Paola/M-9098-2016; Cazzaniga, Giovanni/K-6338-2016
OI Crovella, Sergio/0000-0001-8493-1168; Biondi,
   Andrea/0000-0002-6757-6173; Valsecchi, Maria Grazia/0000-0001-5574-3504;
   Rebora, Paola/0000-0003-0606-5852; Franca,
   Raffaella/0000-0001-8569-2023; Decorti, Giuliana/0000-0002-9714-6246;
   FAGIOLI, FRANCA/0000-0002-9257-900X; Cazzaniga,
   Giovanni/0000-0003-2955-4528; BASSO, GIUSEPPE/0000-0002-2634-9302
FU IRCCS Burlo Garofolo, Trieste; FIRC (Fondazione Italiana per la Ricerca
   sul Cancro)Associazione Italiana per la Ricerca sul Cancro (AIRC);
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [FP7-HEALTH-F2-2011 261474]; European Project 'Talents for an
   International House'; AIRC (Associazione Italiana per la Ricerca sul
   Cancro)Associazione Italiana per la Ricerca sul Cancro (AIRC)
FX R Franca is recipient of a postdoctoral fellowship from IRCCS Burlo
   Garofolo, Trieste. P Rebora was partially supported by a studentship
   from FIRC (Fondazione Italiana per la Ricerca sul Cancro). This research
   was partially supported by a grant from the European Commission
   (FP7-HEALTH-F2-2011 261474). S Crovella is recipient of a fellowship
   grant from European Project 'Talents for an International House' within
   the framework of the 7th Research & Development Framework Programme
   PEOPLE Marie Curie Actions - COFUND (Co-Funding of Regional. National
   and International Programmes). This study was partly supported by the
   special grant '5 per mile' of AIRC (Associazione Italiana per la Ricerca
   sul Cancro) to Franco Locatelli and Andrea Biondi. Giovanni Cazzaniga is
   supported by AIRC (Associazione Italiana per la Ricerca sul Cancro). The
   authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Anderer G, 2000, PHARMACOGENETICS, V10, P715, DOI 10.1097/00008571-200011000-00006
   BLACK SM, 1990, BIOCHEM J, V268, P309, DOI 10.1042/bj2680309
   Borst L, 2012, J PEDIAT HEMATOL ONC, V34, P38, DOI 10.1097/MPH.0b013e3182346cdd
   Breslow NE, 2008, SCAND J STAT, V35, P186, DOI 10.1111/j.1467-9469.2007.00574.x
   Bruhn C, 1998, BIOCHEM PHARMACOL, V56, P1189, DOI 10.1016/S0006-2952(98)00191-9
   Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030
   Chen CL, 1997, BLOOD, V89, P1701, DOI 10.1182/blood.V89.5.1701.1701_1701_1707
   Conter V, 2000, LEUKEMIA, V14, P2196, DOI 10.1038/sj.leu.2401963
   Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146
   Davies SM, 2002, BLOOD, V100, P67, DOI 10.1182/blood.V100.1.67
   DIRVEN HAAM, 1995, CHEM RES TOXICOL, V8, P979, DOI 10.1021/tx00049a012
   Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5
   Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239
   Gaynon Paul S, 2007, Curr Hematol Malig Rep, V2, P193, DOI 10.1007/s11899-007-0026-y
   Goasguen JE, 1996, LEUKEMIA LYMPHOMA, V23, P567, DOI 10.3109/10428199609054866
   HALL AG, 1992, BLOOD REV, V6, P163, DOI 10.1016/0268-960X(92)90028-O
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396
   Hosono N, 2010, CANCER SCI, V101, P767, DOI 10.1111/j.1349-7006.2009.01432.x
   Innocenti F, 2011, SEMIN ONCOL, V38, P186, DOI 10.1053/j.seminoncol.2011.01.005
   Josephy PD, 2010, HUM GENOMICS PROTEOM, V2012
   Krajinovic M, 2002, CLIN CANCER RES, V8, P802
   Lumley T, 2010, COMPLEX SURVEYS GUID
   Meissner B, 2004, LEUKEMIA, V18, P1920, DOI 10.1038/sj.leu.2403521
   NAKAGAWA K, 1990, J BIOL CHEM, V265, P4296
   ODWYER PJ, 1995, HEMATOL ONCOL CLIN N, V9, P383
   Paugh SW, CLIN PHARM THER, V90, P461
   PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271
   Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943
   Reilly M, 1996, AM J EPIDEMIOL, V143, P92
   Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544
   Sala A, 2003, LEUKEMIA, V17, P981, DOI 10.1038/sj.leu.2402888
   Scheike TH, 2004, BIOSTATISTICS, V5, P193, DOI 10.1093/biostatistics/5.2.193
   Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707
   Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009
   Stanulla M, 2000, BLOOD, V95, P1222, DOI 10.1182/blood.V95.4.1222.004k20_1222_1228
   Takanashi M, 2003, HAEMATOLOGICA, V88, P1238
   TEW KD, 1994, CANCER RES, V54, P4313
   Thorn CF, 2012, PHARMACOGENET GENOM, V22, P646, DOI 10.1097/FPC.0b013e3283527c02
   Timofeeva M, 2009, CLIN BIOCHEM, V42, P500, DOI 10.1016/j.clinbiochem.2008.12.011
   Townsend Danyelle, 2003, Am J Pharmacogenomics, V3, P157, DOI 10.2165/00129785-200303030-00002
   Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940
   YUAN ZM, 1991, DRUG METAB DISPOS, V19, P625
NR 43
TC 12
Z9 12
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1462-2416
EI 1744-8042
J9 PHARMACOGENOMICS
JI Pharmacogenomics
PD DEC
PY 2012
VL 13
IS 16
BP 1905
EP 1916
DI 10.2217/PGS.12.169
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 047CZ
UT WOS:000311816600010
PM 23215883
OA Green Published
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Segat, L
   Zanin, V
   Arraes, LC
   Crovella, S
AF da Silva, Ronaldo Celerino
   Segat, Ludovica
   Zanin, Valentina
   Arraes, Luiz Claudio
   Crovella, Sergio
TI Polymorphisms in DC-SIGN and L-SIGN genes are associated with HIV-1
   vertical transmission in a Northeastern Brazilian population
SO HUMAN IMMUNOLOGY
LA English
DT Article
ID ADHESION MOLECULE-3-GRABBING NONINTEGRIN; DENDRITIC CELLS; INFECTION;
   VARIANTS; MOLECULE; PROMOTER; PROTEIN; RISK
AB DC-SIGN and L-SIGN are receptors expressed on specialized macrophages in decidua, (Hofbauer and placental capillary endothelial cells), known to interact with several pathogens, including HIV-1.
   To disclose the possible involvement of these molecules in the susceptibility to HIV vertical transmission, we analyzed DC-SIGN and L-SIGN gene single nucleotide polymorphisms (SNPs) in 192 HIV-1 positive children and 58 HIV-1 negative children all born to HIV-1 positive mothers, as well as 96 healthy uninfected children not exposed to HIV-1, all from Northeast Brazil.
   The frequency of three SNPs in the DC-SIGN promoter (-139G > A, -201G > T and -336A > G) were significantly different when comparing HIV positive children with HIV-1 exposed uninfected children, indicating an association with susceptibility to HIV-1 vertical transmission.
   This genetic association suggests that DC-SIGN molecule may play a role in susceptibility to HIV-1 infection through vertical transmission. (C) 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Segat, Ludovica; Zanin, Valentina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [da Silva, Ronaldo Celerino; Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [da Silva, Ronaldo Celerino] Fed Univ Pernambuco UFPE, Lab lmmunopathol Keizo Asami LIKA, Recife, PE, Brazil.
   [Arraes, Luiz Claudio] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq); IRCCS Burlo Garofolo (Trieste Italy) [RC07/08];
   project APQ from the TALENTS Programme [APQ-0757-2.02/10,
   APQ-0020-4.01/08]
FX The authors wish to thank the Laboratory of Immunopathology Keizo Asami,
   the Department of Genetics, Federal University of Pernambuco, the
   Graduate Program in Genetics for supporting physical and scientific, as
   well as FACEPE and CNPq, for financial support. This work has been
   supported by the RC07/08 project from IRCCS Burlo Garofolo (Trieste
   Italy) and by the project APQ APQ-0757-2.02/10 and APQ-0020-4.01/08 from
   FACEPE (Recife, Pernambuco, Brazil). SC is recipient of a grant from the
   TALENTS Programme (7th R&D Framework Programme, Specific Programme:
   PEOPLE - Marie Curie Actions - COFUND).
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975
   Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613
   Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671
   Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002
   Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211
   Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005
   da Silva GK, 2011, AIDS, V25, P411, DOI 10.1097/QAD.0b013e328342fef1
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Geijtenbeek TBH, 2003, APIMIS, V11, P698
   Gramberg T, 2006, VIROLOGY, V347, P354, DOI 10.1016/j.virol.2005.11.033
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225
   Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020
   Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7
   Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209
   Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820
   Luzuriaga Katherine, 2007, Curr Infect Dis Rep, V9, P511, DOI 10.1007/s11908-007-0076-2
   Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004
   Ortiz M, 2008, GENES IMMUN, V9, P483, DOI 10.1038/gene.2008.40
   Rathore A, 2008, J CLIN IMMUNOL, V28, P50, DOI 10.1007/s10875-007-9131-x
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Selvaraj P, 2009, INFECT GENET EVOL, V9, P256, DOI 10.1016/j.meegid.2008.12.003
   Soilleux EJ, 2003, INT J BIOCHEM CELL B, V35, P283, DOI 10.1016/S1357-2725(02)00132-2
   Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092
   Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026
   Unaids, 2010, REPORT ON THE GLOBAL
   van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3
   Wichukchinda N, 2007, AIDS RES HUM RETROV, V23, P686, DOI 10.1089/aid.2006.0212
   Xu LJ, 2010, J CLIN IMMUNOL, V30, P402, DOI 10.1007/s10875-010-9376-7
   Zhang J, 2008, J INFECT DIS, V198, P68, DOI 10.1086/588710
NR 33
TC 7
Z9 7
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD NOV
PY 2012
VL 73
IS 11
BP 1159
EP 1165
DI 10.1016/j.humimm.2012.07.338
PG 7
WC Immunology
SC Immunology
GA 032KO
UT WOS:000310717500016
PM 22902397
DA 2020-12-08
ER

PT J
AU Girardelli, M
   Maestri, I
   Rinaldi, RR
   Tognon, M
   Boldorini, R
   Bovenzi, M
   Crovella, S
   Comar, M
AF Girardelli, Martina
   Maestri, Iva
   Rinaldi, Rosa R.
   Tognon, Mauro
   Boldorini, Renzo
   Bovenzi, Massimo
   Crovella, Sergio
   Comar, Manola
TI NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
SO INFECTIOUS AGENTS AND CANCER
LA English
DT Article
DE Mesothelioma; Asbestos; Inflammasome; NLRP1; NLRP3
ID MALIGNANT PLEURAL MESOTHELIOMA; NALP3 INFLAMMASOME; CELLS;
   CARCINOGENESIS; TRANSFORMATION; DISEASE; GENE; SV40; PREDISPOSITION;
   ACTIVATION
AB Background: An increasing incidence of malignant mesothelioma (MM) cases in patients with low levels of asbestos exposure suggests the interference of alternative cofactors. SV40 infection was detected, as co-morbidity factor, only in 22% of asbestos-MM patients from a North-Eastern Italy area. An additional mechanism of injury related to asbestos exposure in MM development has been recently associated to inflammatory responses, principally driven by interleukin (IL)-1 beta (beta) activated within the inflammasome complex. NLRP3 inflammosome has been described as the intracellular sensor for asbestos able to induce inflammasome activation and IL-1 beta secretion while NLRP1 is expressed in lung epithelial cells and alveolar macrophages and contributes to the immune response and to survival/apoptosis balance. This study proposes to evaluate the impact of known NLRP3 and NLRP1 polymorphisms in the individual susceptibility to asbestos-induced mesothelioma in subjects from a hyperendemic area for MM.
   Methods: 134 Italian patients with diagnosis of mesothelioma due (MMAE, n=69) or not (MMAF, n=65) to asbestos, 256 healthy Italian blood donors and 101 Italian healthy subjects exposed to asbestos (HCAE) were genotyped for NLRP1 (rs2670660 and rs12150220) and NLRP3 (rs35829419 and rs10754558) polymorphisms.
   Results: While NLRP3 SNPs were not associated to mesothelioma, the NLRP1 rs12150220 allele T was significantly more frequent in MMAE (0.55) than in HCAE (0.41) (p=0.011; OR=1.79) suggesting a predisponent effect of this allele on the development of mesothelioma. This effect was amplified when the NLRP1 rs2670660 allele was combined with the NLRP1 rs12150220 allele (p=0.004; OR=0.52).
   Conclusion: Although NLRP3 SNPs was not involved in mesothelioma predisposition, these data proposed NLRP1 as a novel factor possibly involved in the development of mesothelioma.
C1 [Girardelli, Martina] Inst Maternal & Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
   [Crovella, Sergio; Comar, Manola] Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Health, Trieste, Italy.
   [Maestri, Iva] Univ Ferrara, Dept Expt & Diagnost Med, Pathol Unit Pathol Anat Histol & Cytol, I-44100 Ferrara, Italy.
   [Rinaldi, Rosa R.] St Anna Univ Hosp Ferrara, Dept Lab Med, Operat Unit Anat Pathol, Ferrara, Italy.
   [Tognon, Mauro] Univ Ferrara, Sch Med & Surg, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy.
   [Boldorini, Renzo] Univ Piemonte Orientale, Fac Med, Dept Med Sci, Novara, Italy.
   [Bovenzi, Massimo] Univ Trieste, Clin Unit Occupat Med, Trieste, Italy.
RP Comar, M (corresponding author), Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Health, Trieste, Italy.
EM comar@burlo.trieste.it
RI Boldorini, Renzo/J-5330-2016; Crovella, Sergio/K-5050-2016; Comar,
   Manola/K-4613-2016; COMAR, Manola/K-4613-2016; Girardelli,
   Martina/K-7199-2016
OI Boldorini, Renzo/0000-0003-1183-2737; Crovella,
   Sergio/0000-0001-8493-1168; Comar, Manola/0000-0001-6310-3320; maestri,
   iva/0000-0002-3485-4640; COMAR, Manola/0000-0002-9487-861X; Girardelli,
   Martina/0000-0003-1186-4907; BOVENZI, MASSIMO/0000-0002-6001-5218
FU IRCCS 'Burlo Garofolo" [R.C. 11/11]; Friuli Venezia Giulia RegionRegione
   Friuli Venezia Giulia [969/APREV]; TALENTS Programme (7th R&D Framework
   Programme, Specific Programme: PEOPLE - Marie Curie Actions -
   COFUND)European Union (EU)
FX This study was supported, in part, by grants R.C. 11/11 from IRCCS
   'Burlo Garofolo" and from Friuli Venezia Giulia Region (969/APREV dd
   27.09.2010). S. C. is recipient of a grant from the TALENTS Programme
   (7th R&D Framework Programme, Specific Programme: PEOPLE - Marie Curie
   Actions - COFUND).
CR Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301
   Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045
   Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259
   Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724
   Comar M, 2012, TUMORI J, V98, P210, DOI 10.1700/1088.11931
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Dogan AU, 2006, CANCER RES, V66, P5063, DOI 10.1158/0008-5472.CAN-05-4642
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Foddis R, 2002, ONCOGENE, V21, P1434, DOI 10.1038/sj.onc.1205203
   Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028
   Goodman JE, 2009, CANCER CAUSE CONTROL, V20, P1237, DOI 10.1007/s10552-009-9357-4
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kastbom A, 2010, ANN RHEUM DIS, V69, P723, DOI 10.1136/ard.2008.106989
   Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907
   Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Pontillo A, 2011, ALZ DIS ASSOC DIS, V26, P277
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Qi F, 2011, EXPERT REV RESP MED, V5, P683, DOI [10.1586/ERS.11.51, 10.1586/ers.11.51]
   Robinson C, 2006, CANCER RES, V66, P10786, DOI 10.1158/0008-5472.CAN-05-4668
   Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286
   Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285
   Wang YH, 2004, INT J ONCOL, V25, P173
   Weiner SJ, 2009, J CANCER RES CLIN, V135, P15, DOI 10.1007/s00432-008-0444-9
   Yang HN, 2008, CURR TREAT OPTION ON, V9, P147, DOI 10.1007/s11864-008-0067-z
NR 33
TC 24
Z9 25
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-9378
J9 INFECT AGENTS CANCER
JI Infect. Agents Cancer
PD OCT 2
PY 2012
VL 7
AR 25
DI 10.1186/1750-9378-7-25
PG 7
WC Oncology; Immunology
SC Oncology; Immunology
GA 241GU
UT WOS:000326155200001
PM 23031505
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Secchiero, P
   Crovella, S
   Zauli, G
AF Marcuzzi, Annalisa
   Secchiero, Paola
   Crovella, Sergio
   Zauli, Giorgio
TI TRAIL administration down-modulated the acute systemic inflammatory
   response induced in a mouse model by muramyldipeptide or
   lipopolysaccharide
SO CYTOKINE
LA English
DT Article
DE TRAIL; MOP; LPS; Acute inflammatory response
ID LIGAND TRAIL; APOPTOSIS; METASTASIS; PATHWAY; CANCER
AB The potent inducer of apoptosis TRAIL/Apo2 ligand is now under considerations in clinical trials for the treatment of different types of cancer. Since the natural history of cancer is often characterized by microbial infections, we have investigated the effect of recombinant human TRAIL in a mouse model of systemic acute inflammation of microbial origin represented by BALB/c mice treated with either bacterial muramyldipeptide (MDP) or lipopolysaccharide (LPS). When administered intraperitoneally (i.p.), these inflammatory bacterial compounds triggered a severe systemic inflammatory response within 2 h, represented by body temperature elevation, increase of circulating serum amyloid-A (SAA) and of the number of leukocytes in the peritoneal cavity. Moreover, both MDP and LPS induced a significant elevation of the circulating levels of several inflammatory cytokines and chemokines. Noteworthy, pre-treatment with recombinant human TRAIL 48 and 72 h before administration of either MOP or LPS, significantly counteracted all acute inflammatory responses, including the elevation of key pro-inflammatory cytokines/chemokines such as IL-1a, IL-6, G-CSF, MCP-1. These data demonstrate for the first time that TRAIL has a potent anti-inflammatory activity, which might be beneficial for the anti-tumoral activity of TRAIL. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Marcuzzi, Annalisa; Crovella, Sergio; Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34100 Trieste, Italy.
   [Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.
   [Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy.
RP Zauli, G (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34100 Trieste, Italy.
EM zauli@burlo.trieste.it
RI secchiero, paola/G-9689-2015; Zauli, Giorgio/ABE-8001-2020; Crovella,
   Sergio/K-5050-2016; Marcuzzi, Annalisa/AAA-6038-2020
OI secchiero, paola/0000-0003-4101-7987; Crovella,
   Sergio/0000-0001-8493-1168; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Zauli, Giorgio/0000-0002-3750-8698
FU European Project "Talents for an International House" within the
   framework of the 7th Research & Development Framework Programme PEOPLE -
   Marie Curie Actions - COFUND (Co-Funding of Regional, National and
   International Programmes)European Union (EU); Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo", Italy; AIRC grantAssociazione
   Italiana per la Ricerca sul Cancro (AIRC); MIUR (to Paola
   Secchiero)Ministry of Education, Universities and Research (MIUR)
FX Sergio Crovella is recipient of a fellowship grant from European Project
   "Talents for an International House" within the framework of the 7th
   Research & Development Framework Programme PEOPLE - Marie Curie Actions
   - COFUND (Co-Funding of Regional, National and International
   Programmes). This work was supported by a grant from the Institute for
   Maternal and Child Health IRCCS "Burlo Garofolo", Italy, by an AIRC
   grant (to Giorgio Zauli) and by a FIRB grant from MIUR (to Paola
   Secchiero).
CR Anel A, 2011, RECENT PATENTS INFLA, V5, P184, DOI 10.2174/187221311797264883
   Campioni D, 2005, AM J PATHOL, V166, P557, DOI 10.1016/S0002-9440(10)62277-8
   Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x
   Cziupka K, 2010, CRIT CARE MED, V38, P2169, DOI 10.1097/CCM.0b013e3181eedaa8
   Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099
   DINARELLO CA, 1978, J INFECT DIS, V138, P760, DOI 10.1093/infdis/138.6.760
   Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061
   Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173
   Lub-de Hooge MN, 2004, SHOCK, V22, P186, DOI 10.1097/01.shk.0000132486.82177.ec
   Malin D, 2011, CLIN CANCER RES, V17, P5005, DOI 10.1158/1078-0432.CCR-11-0099
   McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062
   Raoult D, 2011, CLIN MICROBIOL INFEC, V17, P1123, DOI 10.1111/j.1469-0691.2011.03583.x
   Rummel C, 2011, CYTOKINE, V56, P739, DOI 10.1016/j.cyto.2011.09.022
   Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6
   Secchiero P, 2007, CURR DRUG METAB, V8, P395, DOI 10.2174/138920007780655432
NR 15
TC 10
Z9 11
U1 0
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD OCT
PY 2012
VL 60
IS 1
BP 43
EP 46
DI 10.1016/j.cyto.2012.06.001
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 024FL
UT WOS:000310095000008
PM 22727903
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Zanin, V
   Piscianz, E
   Tricarico, PM
   Vuch, J
   Girardelli, M
   Monasta, L
   Bianco, AM
   Crovella, S
AF Marcuzzi, Annalisa
   Zanin, Valentina
   Piscianz, Elisa
   Tricarico, Paola Maura
   Vuch, Josef
   Girardelli, Martina
   Monasta, Lorenzo
   Bianco, Anna Monica
   Crovella, Sergio
TI Lovastatin-induced apoptosis is modulated by geranylgeraniol in a
   neuroblastoma cell line
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
LA English
DT Article
DE Mevalonate kinase deficiency; Geranylgeraniol; Neuronal apoptosis;
   Lovastatin; Isoprenoids
ID HMG-COA REDUCTASE; MEVALONIC ACIDURIA; CHOLESTEROL; STATINS; DEATH;
   PATHWAY; INHIBITION; ACTIVATION; BRAIN
AB Mevalonic aciduria (MA), the most severe form of mevalonate kinase deficiency (MKD), is still an orphan drug disease and the pathogenetic mechanisms underlying neuronal dysfunction is still poorly understood. In our study we have investigated the apoptotic mechanism mediated by the exposure of the cultured neuroblastoma cell line, SH-SY5Y, to lovastatin in absence or in presence of the isoprenoid, geranylgeraniol, with the aim of unraveling the pathogenesis of MA. Lovastatin, blocks the mevalonate pathway inhibiting the 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CR), an enzyme of the mevalonate pathway upstream the mevalonate kinase enzyme, reproducing biochemical features similar to those found in MKD.
   We demonstrate that apoptosis in neuronal lovastatin treated-cells is induced by the mitochondrial pathway, with caspase-9 as the initiator and caspase-3 as the effector caspase. The presence of geranylgeraniol modulates both the caspase-9 and caspase-3 activity in a dose-dependent way, confirming that this isoprenoid enters the mevalonate pathway, is metabolized and finally is able to by-pass the statin biochemical block reconstituting the mevalonate pathway. According to our findings, it should not be the time course adopted that modulates the apoptotic response but rather the isoprenoid itself.
   Being aware that our results have been obtained using a biochemical model of MKD, and not cells from patients with the disease, we believe our findings increase the knowledge of MA pathogenesis, and may possibly contribute to the development of novel therapeutic strategies. (C) 2012 ISDN. Published by Elsevier Ltd. All rights reserved.
C1 [Marcuzzi, Annalisa; Zanin, Valentina; Piscianz, Elisa; Vuch, Josef; Girardelli, Martina; Monasta, Lorenzo; Bianco, Anna Monica; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Marcuzzi, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Monasta, Lorenzo/B-1388-2012; Crovella, Sergio/K-5050-2016; tricarico,
   paola/AAB-8972-2019; Marcuzzi, Annalisa/AAA-6038-2020; BIANCO, ANNA
   MONICA/D-3098-2014; Girardelli, Martina/K-7199-2016
OI Monasta, Lorenzo/0000-0001-7774-548X; Crovella,
   Sergio/0000-0001-8493-1168; tricarico, paola/0000-0002-1954-4126;
   Marcuzzi, Annalisa/0000-0003-3427-618X; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Girardelli, Martina/0000-0003-1186-4907;
   Piscianz, Elisa/0000-0001-7374-1684
FU Institute for Maternal and Child Health, IRCCS "Burlo Garofolo",
   Trieste, Italy [RC 42/2011]; European Project "Talents for an
   International House" within the 7th Research & Development Framework
   Programme PEOPLE - Marie Curie Actions - COFUND (co-funding of Regional,
   National and International Programmes)
FX This study was supported by a grant from the Institute for Maternal and
   Child Health, IRCCS "Burlo Garofolo", Trieste, Italy (RC 42/2011).;
   Crovella S. is recipient of a fellowship grant from the European Project
   "Talents for an International House" within the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND
   (co-funding of Regional, National and International Programmes).
CR Arnold DE, 2010, MOL CELL BIOCHEM, V345, P1, DOI 10.1007/s11010-010-0553-z
   Bodar EJ, 2005, NETH J MED, V63, P260
   Campia I, 2009, BRIT J PHARMACOL, V158, P1777, DOI 10.1111/j.1476-5381.2009.00465.x
   Celec P, 2008, MED HYPOTHESES, V70, P938, DOI 10.1016/j.mehy.2007.08.030
   Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9
   CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5
   D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Herrero-Martin G, 2008, FEBS LETT, V582, P2589, DOI 10.1016/j.febslet.2008.06.034
   Hooff G.P., 2010, MOL NEUROBIOL, V41, P341
   Huang ZL, 2006, J NEUROCHEM, V97, P280, DOI 10.1111/j.1471-4159.2006.03733.x
   Mailman T, 2011, J NEUROCHEM, V119, P1002, DOI 10.1111/j.1471-4159.2011.07474.x
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2011, APOPTOSIS, V16, P882, DOI 10.1007/s10495-011-0621-1
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5
   Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195
   Roensch J, 2007, NEUROCHEM INT, V50, P800, DOI 10.1016/j.neuint.2007.02.001
   Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x
   Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179
   Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476
NR 26
TC 29
Z9 29
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0736-5748
EI 1873-474X
J9 INT J DEV NEUROSCI
JI Int. J. Dev. Neurosci.
PD OCT
PY 2012
VL 30
IS 6
BP 451
EP 456
DI 10.1016/j.ijdevneu.2012.06.002
PG 6
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 015ZN
UT WOS:000309487000007
PM 22759742
DA 2020-12-08
ER

PT J
AU Zanin, V
   Delbue, S
   Marcuzzi, A
   Tavazzi, E
   Del Savio, R
   Crovella, S
   Marchioni, E
   Ferrante, P
   Comar, M
AF Zanin, Valentina
   Delbue, Serena
   Marcuzzi, Annalisa
   Tavazzi, Eleonora
   Del Savio, Rossella
   Crovella, Sergio
   Marchioni, Enrico
   Ferrante, Pasquale
   Comar, Manola
TI Specific protein profile in cerebrospinal fluid from HIV-1-positive
   cART-treated patients affected by neurological disorders
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Cytokines; HIV-1; Leukoencephalopathies; cART
ID NECROSIS-FACTOR-ALPHA; GLIAL-CELLS; BRAIN; INFECTION;
   LEUKOENCEPHALOPATHY; LYMPHOCYTES; CYTOKINES; HIV-1; TH17
AB Cytokines/chemokines are involved in the immune response of infections, including HIV-1. We defined the profile of 48 cytokines/chemokines in cerebrospinal fluid from 18 cART patients with chronic HIV-1 infection by Luminex technology. Nine patients were affected with leukoencephalopathies: five with John Cunningham virus (JCV) + progressive multifocal leukoencephalopathy (PML) and four with JCV-not determined leukoencephalopathy (NDLE). In addition, nine HIV-1-positive patients with no neurological signs (NND) and five HIV-1-negative patients affected with acute disseminated encephalomyelitis (ADEM) were enrolled. Ten cytokines (IL-15, IL-3, IL-16, IL-18, CTACK, GRO1, SCF, MCP-1, MIF, SDF) were highly expressed in HIV-1-positive patients while IL-1Ra and IL-17 were present at a lower level. In addition, the levels of IL-17, IL-9, FGF-basic, MIP-1 beta, and MCP-1 were significantly higher (p < 0.05) in patients with neurological diseases (PML, NDLE, ADEM) with respect to NND. Focusing the attention to the cytokine profile in JCV + PML patients with respect to JCV-NDLE patients, only TNF-beta was significantly downregulated (p < 0.05) in JCV + PML patients. This pilot study emphasized the role of immunoregulation in HIV-1-related neurological disorders during cART treatment.
C1 [Zanin, Valentina; Marcuzzi, Annalisa; Del Savio, Rossella; Crovella, Sergio; Comar, Manola] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Delbue, Serena] Fdn Ettore Sansavini, Hlth Sci Fdn, Lugo, RA, Italy.
   [Tavazzi, Eleonora; Marchioni, Enrico] IRCCS Natl Neurol Inst C Mondino Fdn, Dept Gen Neurol, Pavia, Italy.
   [Crovella, Sergio; Comar, Manola] Univ Trieste, I-34137 Trieste, Italy.
   [Ferrante, Pasquale] Univ Milan, Dept Publ Hlth Microbiol Virol, Milan, Italy.
   [Ferrante, Pasquale] Ist Clin Citta Studi, Milan, Italy.
   [Comar, Manola] Univ Trieste, Dept Med Sci, Trieste, Italy.
RP Comar, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via dell Istria 65-1, I-34137 Trieste, Italy.
EM comar@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Marcuzzi, Annalisa/AAA-6038-2020; Comar,
   Manola/K-4613-2016; delbue, serena/A-1145-2010; Marchioni,
   Enrico/AAC-2749-2019; COMAR, Manola/K-4613-2016
OI Crovella, Sergio/0000-0001-8493-1168; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Comar, Manola/0000-0001-6310-3320; Delbue,
   Serena/0000-0002-3199-9369; Marchioni, Enrico/0000-0003-0414-8128;
   Ferrante, Pasquale/0000-0001-7040-7293; COMAR,
   Manola/0000-0002-9487-861X
FU grants Ricerca Corrente from IRCCS 'Burlo Garofolo' [11/11]; NIMHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [MH072528]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [R01MH072528, R01MH072528,
   R01MH072528, R01MH072528, R01MH072528] Funding Source: NIH RePORTER
FX This study was supported by grants Ricerca Corrente no.11/11 from IRCCS
   'Burlo Garofolo' awarded to Manola Comar and by NIMH grant no. MH072528
   awarded to Pasquale Ferrante.
CR Barqasho B, 2009, HIV MED, V10, P94, DOI 10.1111/j.1468-1293.2008.00657.x
   BENVENISTE EN, 1994, RES P ARNMD, V72, P71
   BROOKS BR, 1984, NEUROL CLIN, V2, P299, DOI 10.1016/S0733-8619(18)31105-8
   Christo PP, 2009, J NEUROL SCI, V287, P79, DOI 10.1016/j.jns.2009.09.002
   Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x
   Delbue S, 2005, J NEUROVIROL, V11, P51, DOI 10.1080/13550280590900382
   Delbue S, 2012, J CELL PHYSIOL, V227, P3511, DOI 10.1002/jcp.24051
   Haddow LJ, 2011, AIDS, V25, P1163, DOI 10.1097/QAD.0b013e3283477d67
   ISRAEL N, 1989, J IMMUNOL, V143, P3956
   KAUL R, 1995, CLIN IMMUNOL IMMUNOP, V74, P271, DOI 10.1006/clin.1995.1039
   Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133
   Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008
   Letendre SL, 2011, J NEUROVIROL, V17, P63, DOI 10.1007/s13365-010-0013-2
   Maek-A-Nantawat W, 2007, VIRAL IMMUNOL, V20, P66, DOI 10.1089/vim.2006.0063
   MAJOR EO, 1990, J NEUROSCI RES, V27, P461, DOI 10.1002/jnr.490270405
   Meeker RB, 2011, J NEUROVIROL, V17, P258, DOI 10.1007/s13365-011-0034-5
   Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996
   OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336
   Rackstraw S, 2011, PSYCHOL HEALTH MED, V16, P548, DOI 10.1080/13548506.2011.579992
   TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991
   TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402
   Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013
   YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004
NR 23
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2012
VL 18
IS 5
BP 416
EP 422
DI 10.1007/s13365-012-0109-y
PG 7
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA 018LQ
UT WOS:000309662500008
PM 22581428
DA 2020-12-08
ER

PT J
AU Catamo, E
   Segat, L
   Lenarduzzi, S
   Petix, V
   Morgutti, M
   Crovella, S
AF Catamo, E.
   Segat, L.
   Lenarduzzi, S.
   Petix, V.
   Morgutti, M.
   Crovella, S.
TI CD14 polymorphisms correlate with an augmented risk for celiac disease
   in Italian patients
SO GENES AND IMMUNITY
LA English
DT Article
DE Celiac Disease; CD14; SNPs; HLA; immune response; inflammation
ID SINGLE NUCLEOTIDE POLYMORPHISM; TYPE-1 DIABETES-MELLITUS; TOLL-LIKE
   RECEPTORS; PROMOTER POLYMORPHISMS; LINKAGE ANALYSIS; INNATE IMMUNITY;
   GENE; DISORDER; REGION; HLA
AB Celiac disease (CD) is a T-cell-mediated chronic inflammatory disease characterized by autoimmune, immunological and environmental components, where genetic factors in addition to the main known risk factors (gliadin and human leukocyte antigen (HLA)-DQ haplotypes) are supposed to be involved. CD14 is a multifunctional receptor involved in the bacterial lipopolysaccharides-dependent signal transduction. The CD14 gene maps on the long arm of chromosome 5 (5q22-q32), a 'hotbed' region for CD; promoter polymorphisms are known to influence its expression. In this study we analyzed three CD14 promoter polymorphisms (c.-1359G > T, c.-1145A > G and c.-159C > T,) in 938 CD Italian patients and 533 healthy controls, with known HLA-DQ haplotypes, with the aim of evaluating their possible association with the disease. The c.-1145A > G G and c.-159C > T T alleles (as well as the combination of the two alleles in the GT haplotype), were identified as susceptibility factors for CD development, being significantly more frequent in CD patients than in healthy controls. This association was also confirmed when the analysis was restricted to only those subjects characterized by HLA-DQ risk haplotypes. Our results indicate the involvement of CD14 gene polymorphisms in the susceptibility to CD.
C1 [Catamo, E.; Segat, L.; Lenarduzzi, S.; Petix, V.; Morgutti, M.; Crovella, S.] Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
RP Segat, L (corresponding author), Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Catamo, Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Catamo,
   Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo, Trieste (Italy) [RC03/04]; European Project
   "Talents for an International House" within the framework of the 7th
   Research and Development Framework Program PEOPLE - Marie Curie Actions
   - COFUND (Co-Funding of Regional, National and International Programmes)
FX This study has been supported by a grant (RC03/04) from the IRCCS Burlo
   Garofolo, Trieste (Italy). SC is recipient of a fellowship grant from
   European Project "Talents for an International House" within the
   framework of the 7th Research and Development Framework Program PEOPLE -
   Marie Curie Actions - COFUND (Co-Funding of Regional, National and
   International Programmes).
CR Adamovic S, 2008, TISSUE ANTIGENS, V71, P27, DOI 10.1111/j.1399-0039.2007.00955.x
   Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011
   Amundsen SS, 2007, EUR J HUM GENET, V15, P980, DOI 10.1038/sj.ejhg.5201870
   Babron MC, 2003, EUR J HUM GENET, V11, P828, DOI 10.1038/sj.ejhg.5201051
   Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494
   Boniotto M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.9.e108
   Brandao LC, 2010, HUM IMMUNOL, V71, P277, DOI 10.1016/j.humimm.2009.12.008
   Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001
   Dezsofi A, 2008, J PEDIATR GASTR NUTR, V47, P283, DOI 10.1097/MPG.0b013e31816de885
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fernandes APM, 2004, SCAND J IMMUNOL, V59, P305, DOI 10.1111/j.0300-9475.2004.01386.x
   Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754
   Gu W, 2008, CRIT CARE MED, V36, P2274, DOI 10.1097/CCM.0b013e318180b1ed
   Holla LI, 2002, J MED GENET, V39, P844, DOI 10.1136/jmg.39.11.844
   Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218
   Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8
   Jarvinen TT, 2004, SCAND J GASTROENTERO, V39, P428, DOI 10.1080/00365520310008773
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320
   Koskinen LLE, 2009, TISSUE ANTIGENS, V74, P408, DOI 10.1111/j.1399-0039.2009.01359.x
   Koskinen L, 2009, IMMUNOGENETICS, V61, P247, DOI 10.1007/s00251-009-0361-3
   LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241
   Latiano A, 2007, J PEDIATR GASTR NUTR, V45, P180, DOI 10.1097/MPG.0b013e3180616bd2
   LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838
   Litonjua AA, 2005, J ALLERGY CLIN IMMUN, V115, P1056, DOI 10.1016/j.jaci.2005.02.006
   Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453
   Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506
   Mertens J, 2009, J MOL MED, V87, P815, DOI 10.1007/s00109-009-0479-7
   Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270
   Munthe-Kaas MC, 2010, J ALLERGY CLIN IMMUN, V125, P1361, DOI 10.1016/j.jaci.2010.02.010
   Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752
   Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004
   Reif S, 2004, AUTOIMMUN REV, V3, P40, DOI 10.1016/S1568-9972(03)00065-X
   Robins G, 2005, CURR OPIN GASTROEN, V21, P152, DOI 10.1097/01.mog.0000153312.05457.8d
   Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129
   Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100
   van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001
   Vatta S, 2011, HUM IMMUNOL, V72, P499, DOI 10.1016/j.humimm.2011.03.008
   Vercelli D, 2001, INT ARCH ALLERGY IMM, V124, P20, DOI 10.1159/000053658
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329
NR 45
TC 2
Z9 2
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
EI 1476-5470
J9 GENES IMMUN
JI Genes Immun.
PD SEP
PY 2012
VL 13
IS 6
BP 489
EP 495
DI 10.1038/gene.2012.23
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 001IV
UT WOS:000308455000008
PM 22648004
OA Bronze
DA 2020-12-08
ER

PT J
AU Tricarico, PM
   Marcuzzi, A
   Zanin, V
   Kleiner, G
   Bianco, AM
   Crovella, S
AF Tricarico, Paola Maura
   Marcuzzi, Annalisa
   Zanin, Valentina
   Kleiner, Giulio
   Bianco, Anna Monica
   Crovella, Sergio
TI Serum amyloid A and cholesterol: a pivotal role on inflammation
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Letter
ID PHASE; PROTEIN
C1 [Marcuzzi, Annalisa; Zanin, Valentina; Kleiner, Giulio; Bianco, Anna Monica; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34134 Trieste, Italy.
   [Tricarico, Paola Maura; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Marcuzzi, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34134 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; BIANCO, ANNA MONICA/D-3098-2014;
   Crovella, Sergio/K-5050-2016; tricarico, paola/AAB-8972-2019
OI Marcuzzi, Annalisa/0000-0003-3427-618X; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Crovella, Sergio/0000-0001-8493-1168;
   tricarico, paola/0000-0002-1954-4126; Kleiner,
   Giulio/0000-0002-1830-3961
CR De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489
   Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   Okamoto H, 2008, J RHEUMATOL, V35, P752
   Tam SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003867
   Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200
NR 9
TC 1
Z9 1
U1 0
U2 4
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1350-6129
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD SEP
PY 2012
VL 19
IS 3
BP 163
EP 164
DI 10.3109/13506129.2012.689266
PG 2
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 990MS
UT WOS:000307635600009
PM 22624603
DA 2020-12-08
ER

PT J
AU Filho, CB
   Rodrigues, FF
   Segat, L
   Fonseca, AM
   Araujo, J
   Arahata, C
   Pontes, L
   Vilar, L
   de Lima Filho, JL
   Crovella, S
AF Filho, C. B.
   Rodrigues, F. F.
   Segat, L.
   Fonseca, A. M.
   Araujo, J.
   Arahata, C.
   Pontes, L.
   Vilar, L.
   de Lima Filho, J. L.
   Crovella, S.
TI Association of MBL2 gene exon 1 variants with autoimmune thyroid disease
   in Brazilian patients
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID MANNOSE-BINDING LECTIN; POLYMORPHISMS; DEFICIENCY
AB We investigated the association between MBL2 gene exon 1 functional polymorphisms and autoimmune thyroid disease (AITD) in 163 Brazilian patients (87 with Hashimoto thyroiditis, HT; 76 with Graves disease) and 214 healthy controls. Individuals carrying MBL2 O allele are at higher risk of developing AITD (OR = 1.58, 95% CI: 1.112.26; P-value = 0.009) and HT (OR = 1.67, 95% CI: 1.092.55; P-value = 0.013) as suggesting a possible role for mannose-binding lectin in influencing disease susceptibility.
C1 [Segat, L.; Crovella, S.] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Filho, C. B.] Otavio de Freitass Hosp, Internal Med Unit, Recife, PE, Brazil.
   [Filho, C. B.; Vilar, L.] Pernambucos Diabet & Endocrinol Ctr, Recife, PE, Brazil.
   [Rodrigues, F. F.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Rodrigues, F. F.; Fonseca, A. M.; de Lima Filho, J. L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Araujo, J.; Arahata, C.; Pontes, L.; Vilar, L.] Univ Fed Pernambuco, Pediat Endocrinol Unit, Clin Hosp, Recife, PE, Brazil.
   [Araujo, J.; Arahata, C.; Pontes, L.] Prof Fernando Figueira Integral Med Inst IMIP, Recife, PE, Brazil.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trie-ste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC0304, RC07/08]; TALENTS
FX This study has been supported by the RC0304 grant from IRCCS Burlo
   Garofolo. LS is recipient of a fellowship grant (RC07/08) from IRCCS
   Burlo Garofolo. SC is recipient of a grant from the TALENTS Programme
   (7th R&D Framework Programme, Specific Programme: PEOPLE - Marie Curie
   Actions - CO-FUND).
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Araujo J, 2009, CLIN IMMUNOL, V131, P254, DOI 10.1016/j.clim.2008.12.010
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032
   Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a
   Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   HAMBURGER JI, 1986, ANN INTERN MED, V104, P219, DOI 10.7326/0003-4819-104-2-219
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Klecha AJ, 2008, NEUROIMMUNOMODULAT, V15, P68, DOI 10.1159/000135626
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Melo FM, 2009, INT J IMMUNOGENET, V36, P377, DOI 10.1111/j.1744-313X.2009.00871.x
   Muller S, 2010, GUT, V59, P1493, DOI 10.1136/gut.2010.208348
   Potlukova E, 2010, CLIN IMMUNOL, V136, P123, DOI 10.1016/j.clim.2010.02.015
   Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605
   Sandrin-Garcia P, 2011, HUM IMMUNOL, V72, P516, DOI 10.1016/j.humimm.2011.03.007
   Schoepfer AM, 2009, AM J GASTROENTEROL, V104, P2508, DOI 10.1038/ajg.2009.315
   Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030
NR 19
TC 2
Z9 2
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD AUG
PY 2012
VL 39
IS 4
BP 357
EP 361
DI 10.1111/j.1744-313X.2012.01102.x
PG 5
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 969SK
UT WOS:000306078300013
PM 22360648
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Zanin, V
   Girardelli, M
   Magnolato, A
   Martelossi, S
   Tommasini, A
   Marcuzzi, A
   Crovella, S
AF Bianco, Anna Monica
   Zanin, Valentina
   Girardelli, Martina
   Magnolato, Andrea
   Martelossi, Stefano
   Tommasini, Alberto
   Marcuzzi, Annalisa
   Crovella, Sergio
TI A common genetic background could explain Early-Onset Crohn's disease
   (vol 78, pg 520, 2012)
SO MEDICAL HYPOTHESES
LA English
DT Correction
C1 [Bianco, Anna Monica; Zanin, Valentina; Girardelli, Martina; Magnolato, Andrea; Martelossi, Stefano; Tommasini, Alberto; Marcuzzi, Annalisa; Crovella, Sergio] Univ Trieste, Inst Maternal & Child Hth IRCCS Burlo Garofolo, I-34134 Trieste, Italy.
RP Bianco, AM (corresponding author), Univ Trieste, Inst Maternal & Child Hth IRCCS Burlo Garofolo, Via Istria 65-1, I-34134 Trieste, Italy.
EM bianco@burlo.trieste.it
RI BIANCO, ANNA MONICA/D-3098-2014; Crovella, Sergio/K-5050-2016; Marcuzzi,
   Annalisa/AAA-6038-2020; Tommasini, Alberto/AAE-3882-2020
OI BIANCO, ANNA MONICA/0000-0001-8101-9659; Crovella,
   Sergio/0000-0001-8493-1168; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Tommasini, Alberto/0000-0002-6943-7927; Magnolato,
   Andrea/0000-0002-5099-6526
CR Bianco AM, 2012, MED HYPOTHESES, V78, P520, DOI 10.1016/j.mehy.2012.01.023
NR 1
TC 0
Z9 0
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD AUG
PY 2012
VL 79
IS 2
BP 285
EP 285
DI 10.1016/j.mehy.2012.04.040
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 978UG
UT WOS:000306770700045
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Catamo, E
   Arosio, B
   Mari, D
   Crovella, S
AF Pontillo, Alessandra
   Catamo, Eulalia
   Arosio, Beatrice
   Mari, Daniela
   Crovella, Sergio
TI NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease
SO ALZHEIMER DISEASE & ASSOCIATED DISORDERS
LA English
DT Article
DE Alzheimer disease; inflammasome; NALP1/NLRP1; polymorphism
ID DEMENTIA; INFLAMMASOMES; EXPRESSION; NALP-1; SCALE
AB Alzheimer disease (AD) is a complex neurodegenerative disease. Genetic and molecular studies have confirmed that in the human brain, amyloid-beta fibrils can induce, through the activation of NALP1 inflammosome, inflammatory and apoptotic responses involved in the pathogenesis of AD. Considering that AD pathogenesis is multifactorial, we hypothesized that NALP1/NLRP1 could be a susceptibility gene involved in the devolvement of the disease. The possible association between 9 selected polymorphisms in the NALP1/NLRP1 gene and AD was evaluated by comparing their frequency distribution in an Italian cohort of AD patients (AD, n = 276) and in a group of Italian sex-matched and age-matched healthy controls without dementia (HC, n = 266). Our study, evidences the association of 4 nonsynonymous polymorphisms in the NLRP1 gene (rs2137722, rs34733791, rs11657747, rs11651595) with AD. The major alleles of all 4 single nucleotide polymorphisms and the corresponding homozygote genotypes were more frequent in AD patients than in healthy controls, suggesting an association of these variants in the predisposition versus the development of the disease. These findings seem to support the previously reported role of NALP1 in neuronal damage, and provide evidence of an association between single nucleotide variations in the NLRP1 gene and AD.
C1 [Pontillo, Alessandra] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   [Catamo, Eulalia] Univ Trieste, Dept Med Sci Surg & Hlth, I-34137 Trieste, Italy.
   [Arosio, Beatrice; Mari, Daniela] Univ Milan, Geriatr Unit, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy.
RP Pontillo, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Crovella, Sergio/K-5050-2016;
   Pontillo, Alessandra/AAD-4790-2019; Mari, Daniela/K-5663-2016; Pontillo,
   ALESSANDRA/D-4352-2012; Catamo, Eulalia/K-9399-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Mari, Daniela/0000-0002-6950-0789; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Catamo, Eulalia/0000-0002-4701-9134;
   Arosio, Beatrice/0000-0002-0615-3580
FU IRCCS Burlo Garofolo [RC05/09]
FX This study was supported by funds from IRCCS Burlo Garofolo (RC05/09).
   The study did not receive any funds from the following organizations:
   National Institutes of Health, Wellcome Trust, and Howard Hughes Medical
   Institute.
CR Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491
   Appollonio I, 2005, INT J GERIATR PSYCH, V20, P1138, DOI 10.1002/gps.1406
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bianchi A, 2008, NEUROL SCI, V29, P209, DOI 10.1007/s10072-008-0970-x
   Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905
   Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158
   Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147
   Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S
   Daum I, 1996, J CLIN EXP NEUROPSYC, V18, P648, DOI 10.1080/01688639608408289
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x
   LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9
   Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x
   SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x
   Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46
   Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
NR 23
TC 48
Z9 49
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0893-0341
J9 ALZ DIS ASSOC DIS
JI Alzheimer Dis. Assoc. Dis.
PD JUL-SEP
PY 2012
VL 26
IS 3
BP 277
EP 281
DI 10.1097/WAD.0b013e318231a8ac
PG 5
WC Clinical Neurology; Pathology
SC Neurosciences & Neurology; Pathology
GA 997SR
UT WOS:000308186900013
PM 21946017
DA 2020-12-08
ER

PT J
AU Segat, L
   Crovella, S
AF Segat, L.
   Crovella, S.
TI HLA-G 14bp del/ins genetic variation: association with susceptibility to
   human immunodeficiency virus-1 vertical transmission but not with human
   immunodeficiency virus-1 infection through horizontal transmission
SO TISSUE ANTIGENS
LA English
DT Letter
DE genetic polymorphisms; human immunodeficiency virus-1 infection; human
   leukocyte antigen-G; vertical transmission
ID LEUKOCYTE ANTIGEN-G; HIV-INFECTION; RISK; POLYMORPHISM; EXPRESSION;
   MOLECULE
C1 [Segat, L.; Crovella, S.] Inst Maternal & Child Health IRCCS, Trieste, Italy.
   [Crovella, S.] Univ Trieste, Dept Clin Med Sci Surg & Hlth, Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
CR Aghafar MZKA, 2012, TISSUE ANTIGENS, V79, P367, DOI 10.1111/j.1399-0039.2012.01843.x
   Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28
   An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002
   Derrien M, 2004, J GEN VIROL, V85, P1945, DOI 10.1099/vir.0.79867-0
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Fainardi E, 2011, CELL MOL LIFE SCI, V68, P433, DOI 10.1007/s00018-010-0584-3
   Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Lajoie J, 2006, J INFECT DIS, V193, P298, DOI 10.1086/498877
   Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007
   Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008
   Matte C, 2002, AIDS, V16, P2491, DOI 10.1097/00002030-200212060-00021
   MCMASTER MT, 1995, J IMMUNOL, V154, P3771
   Moodley S, 2011, PLACENTA, V32, P778, DOI 10.1016/j.placenta.2011.07.012
   Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]
   Segat L, 2010, AIDS, V24, P1961, DOI 10.1097/QAD.0b013e32833c3324
   Segat L, 2009, AIDS, V23, P1916, DOI 10.1097/QAD.0b013e32832f8104
   Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001
   Tripathi P, 2007, AIDS, V21, P1395, DOI 10.1097/QAD.0b013e32810c8bbc
NR 21
TC 7
Z9 8
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-2815
EI 1399-0039
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD JUL
PY 2012
VL 80
IS 1
BP 12
EP 13
DI 10.1111/j.1399-0039.2012.01874.x
PG 2
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 952BA
UT WOS:000304763500002
PM 22512775
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Girardelli, M
   Kamada, AJ
   Pancotto, JAT
   Donadi, EA
   Crovella, S
   Sandrin-Garcia, P
AF Pontillo, Alessandra
   Girardelli, Martina
   Kamada, Anselmo J.
   Pancotto, Joao A. T.
   Donadi, Eduardo A.
   Crovella, Sergio
   Sandrin-Garcia, Paula
TI Polimorphisms in Inflammasome Genes Are Involved in the Predisposition
   to Systemic Lupus Erythematosus
SO AUTOIMMUNITY
LA English
DT Article
DE Genetic polymorphisms; SLE; inflammasome; IL-1 beta; NLRP1
ID CELIAC-DISEASE; POLYMORPHISMS; AUTOIMMUNE; ASSOCIATION; POPULATION;
   INTERLEUKIN-1; HAPLOTYPE; NALP1; MAPS
AB Recent findings provide evidence of inflammasome critical role in the predisposition to autoimmune disorders. The involvement of inflammasome in the pathogenesis of systemic lupus erythematosus (SLE) has been hypothesized even if no significant association within inflammasome genes mutations or polymorphisms and lupus has been reported yet. We analyzed 14 single nucleotide polymorphisms (SNPs) within 7 inflammasome genes (NLRP1, NLRP3, NLRC4, AIM2, CARD8, CASP1, IL1B) in 144 patients affected by systemic lupus erythematosus and in 158 healthy controls from Southern Brazilian (state of Sao Paulo) with the aim of disclosing the possible role of inflammasome genes in the susceptibility of SLE. Our results demonstrated that NLRP1 rs2670660 SNP and the NLRP1 rs12150220-rs2670660 A-G haplotype were associated with SLE in our study population, and in particular with the development of nephritis, rash and arthritis. These findings are concordant with previously reported association of NLRP1 with vitiligo and type-1 diabetes underlining once more the involvement of NALP1 inflammasome in the pathogenesis of autoimmune disorders.
C1 [Pontillo, Alessandra] Univ Sao Paulo, Fac Med, LIM 56, Lab Med Invest Dermatol & Immunodeficiency, BR-05403000 Sao Paulo, Brazil.
   [Pontillo, Alessandra; Kamada, Anselmo J.; Crovella, Sergio; Sandrin-Garcia, Paula] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Girardelli, Martina] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Pancotto, Joao A. T.; Donadi, Eduardo A.] Univ Sao Paulo, Div Clin Immunol, Dept Med, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Fac Med, LIM 56, Lab Med Invest Dermatol & Immunodeficiency, Av Dr Eneas de Caravalho Aguiar 500, BR-05403000 Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Pontillo, Alessandra/ABC-6266-2020; Kamada, Anselmo Jiro/H-3006-2012;
   Pontillo, ALESSANDRA/D-4352-2012; donadi, eduardo A/H-7080-2013;
   Pontillo, Alessandra/AAD-4790-2019; Crovella, Sergio/K-5050-2016;
   Girardelli, Martina/K-7199-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Kamada, Anselmo
   Jiro/0000-0002-0437-0151; Pontillo, ALESSANDRA/0000-0002-7883-0640;
   donadi, eduardo A/0000-0002-9457-9601; Pontillo,
   Alessandra/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Girardelli, Martina/0000-0003-1186-4907
FU Sao Paulo Research foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [09/53575-5]; Brazilian Ministry of
   Science, Technology and Innovation/CNPq (APQ); Pernambuco Research
   foundation (FACEPE) [BFP-0046-2.02/11]; TALENTS
FX The authors declare no competing financial interests. This work was
   supported by the Sao Paulo Research foundation (FAPESP) (09/53575-5) and
   by the Brazilian Ministry of Science, Technology and Innovation/CNPq
   (APQ).; A.P. is recipient of a fellowship grant from Pernambuco Research
   foundation (FACEPE) (BFP-0046-2.02/11). S. C. is recipient of a grant
   from the TALENTS Programme (7th R&D Framework Programme, Specific
   Programme: PEOPLE - Marie Curie Actions - COFUND). The authors are
   responsible for the content and the writing of this article.
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214
   Camargo JF, 2004, GENES IMMUN, V5, P609, DOI 10.1038/sj.gene.6364133
   Contreras G, 2002, CLIN NEPHROL, V57, P95
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096
   Glinsky GV, 2008, CELL CYCLE, V7, P3680, DOI 10.4161/cc.7.23.7153
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865
   Huang CM, 2002, RHEUMATOL INT, V21, P173, DOI 10.1007/s00296-001-0164-9
   Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Manson Jessica J, 2006, Expert Rev Clin Immunol, V2, P377, DOI 10.1586/1744666X.2.3.377
   Muraki Y, 2004, J RHEUMATOL, V31, P720
   Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470
   Parks CG, 2004, ANN RHEUM DIS, V63, P91, DOI 10.1136/ard.2003.007336
   Parks CG, 2004, HUM IMMUNOL, V65, P622, DOI 10.1016/j.humimm.2004.03.001
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schiff MH, 2000, ANN RHEUM DIS, V59, P103, DOI 10.1136/ard.59.suppl_1.i103
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
NR 27
TC 105
Z9 105
U1 0
U2 12
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0891-6934
J9 AUTOIMMUNITY
JI Autoimmunity
PD JUN
PY 2012
VL 45
IS 4
BP 271
EP 278
DI 10.3109/08916934.2011.637532
PG 8
WC Immunology
SC Immunology
GA 926ZL
UT WOS:000302873600001
PM 22235789
DA 2020-12-08
ER

PT J
AU Sandrin-Garcia, P
   Brandao, LAC
   Guimaraes, RL
   Pancoto, JAT
   Donadi, EA
   de Lima, JL
   Segat, L
   Crovella, S
AF Sandrin-Garcia, P.
   Brandao, L. A. C.
   Guimaraes, R. L.
   Pancoto, J. A. T.
   Donadi, E. A.
   de Lima-Filho, J. L.
   Segat, L.
   Crovella, S.
TI Functional single-nucleotide polymorphisms in the DEFB1 gene are
   associated with systemic lupus erythematosus in Southern Brazilians
SO LUPUS
LA English
DT Article
DE Systemic lupus erythematosus; SNPs; DEFB1; genetic polymorphisms;
   defensins
ID HUMAN BETA-DEFENSIN-1 GENE; BETA-DEFENSIN; ATOPIC-DERMATITIS; HIV-1
   INFECTION; HAPLOTYPE; EXPRESSION; PEPTIDES; SNPS
AB Systemic lupus erythematosus (SLE) is an autoimmune disease that results in inflammation and tissue damage. The etiology of SLE remains unknown, but recent studies have shown that the innate immune system may have a role in SLE pathogenesis through the secretion of small cationic peptides named defensins. The aim of the study was to determine the possible involvement in SLE of three functional single nucleotide polymorphisms (SNPs) (c.-52G>A, c.-44C>G and c.-20G>A) in the 5'UTR region of DEFB1 gene, by analyzing them in a population of 139 SLE patients and 288 healthy controls. The c.-52G>A SNP showed significant differences in allele and genotype frequency distribution between SLE patients and controls (p = 0.01 and p = 0.02 respectively) indicating protection against SLE (A allele, OR = 0.68, AA genotype OR = 0.51). Significant differences were also observed for c.-44C>G SNP, the C/G genotype being associated with susceptibility to SLE (OR = 1.60, p = 0.04). Moreover, statistically significant differences between patients and controls were found for two DEFB1 haplotypes (GCA and GGG, p = 0.01 and p = 0.02 respectively). When considering DEFB1 SNPs and SLE clinical and laboratory manifestations, significant association was found with neuropsychiatric disorders, immunological alterations and anti-DNA antibodies. In conclusion, our results evidence a possible role for the c.-52G>A and c.-44C>G DEFB1 polymorphisms in SLE pathogenesis, that can be considered as possible risk factors for development of disease and disease-related clinical manifestations. Additional studies are needed, to corroborate these results as well as functional studies to understand the biological role of these SNPs in the pathogenesis of SLE. Lupus (2012) 21, 625-631.
C1 [Segat, L.] IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Sandrin-Garcia, P.; Brandao, L. A. C.; Guimaraes, R. L.; de Lima-Filho, J. L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Sandrin-Garcia, P.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Pancoto, J. A. T.; Donadi, E. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Med, BR-05508 Sao Paulo, Brazil.
   [Crovella, S.] Univ Trieste, IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34127 Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; donadi, eduardo
   A/H-7080-2013; Crovella, Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; donadi, eduardo
   A/0000-0002-9457-9601; Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE/CNPqNational Council for Scientific and Technological Development
   (CNPq); FACEPE [APQ-0020-4.01/08]; European Project 'Talents for an
   International House'
FX We acknowledge the financial support of FACEPE/CNPq. LS is recipient of
   a fellowship grant (APQ-0020-4.01/08) from FACEPE. SC is recipient of a
   fellowship grant from European Project 'Talents for an International
   House' within the framework of the 7th Research & Development Framework
   Programme PEOPLE - Marie Curie Actions COFUND (Co-Funding of Regional,
   National and International Programmes).
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553
   BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543
   Carroll MC, 2004, NAT REV IMMUNOL, V4, P825, DOI 10.1038/nri1456
   de Oca EPM, 2007, INT ARCH ALLERGY IMM, V142, P211, DOI 10.1159/000097023
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Froy O, 2009, ANN NY ACAD SCI, V1173, P365, DOI 10.1111/j.1749-6632.2009.04622.x
   Guimaraes RL, 2009, AUTOIMMUNITY, V42, P406, DOI 10.1080/08916930902882756
   Harder J, 1997, GENOMICS, V46, P472, DOI 10.1006/geno.1997.5074
   Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020
   Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Kalus AA, 2009, BMC ORAL HEALTH, V27, P9
   Kim E, 2009, J DERMATOL SCI, V54, P25, DOI 10.1016/j.jdermsci.2008.12.005
   Kreuter A, 2011, J AM ACAD DERMATOL, V65, P125, DOI 10.1016/j.jaad.2010.12.012
   Leung TF, 2006, GENES IMMUN, V7, P59, DOI 10.1038/sj.gene.6364279
   Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   Naslavsky MS, 2010, IMMUNOL LETT, V129, P53, DOI 10.1016/j.imlet.2009.12.024
   Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297
   Segat L, 2010, INT J DERMATOL, V49, P653, DOI 10.1111/j.1365-4632.2009.04343.x
   Sthoeger ZM, 2009, IMMUNOLOGY, V127, P116, DOI 10.1111/j.1365-2567.2008.02997.x
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Tamiya H, 2006, RHEUMATOL INT, V27, P147, DOI 10.1007/s00296-006-0173-9
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Vordenbaumen S, 2010, LUPUS, V19, P1648, DOI 10.1177/0961203310377089
NR 30
TC 10
Z9 10
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD MAY
PY 2012
VL 21
IS 6
BP 625
EP 631
DI 10.1177/0961203312436858
PG 7
WC Rheumatology
SC Rheumatology
GA 927NR
UT WOS:000302915200007
PM 22323338
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Vuch, J
   Girardelli, M
   Zanin, V
   Marcuzzi, A
   Crovella, S
AF Bianco, A. M.
   Vuch, J.
   Girardelli, M.
   Zanin, V.
   Marcuzzi, A.
   Crovella, S.
TI Letter: inflammatory bowel disease, complementary and alternative
   medicine, and genetics
SO ALIMENTARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Letter
C1 [Bianco, A. M.; Vuch, J.; Girardelli, M.; Zanin, V.; Marcuzzi, A.; Crovella, S.] Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
RP Bianco, AM (corresponding author), Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016; BIANCO,
   ANNA MONICA/D-3098-2014; Girardelli, Martina/K-7199-2016
OI Marcuzzi, Annalisa/0000-0003-3427-618X; Crovella,
   Sergio/0000-0001-8493-1168; BIANCO, ANNA MONICA/0000-0001-8101-9659;
   Girardelli, Martina/0000-0003-1186-4907
CR Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690
   Buehler BA, 2007, AM J MED GENET A, V143A, P2889, DOI 10.1002/ajmg.a.32031
   Kromhout D, 2002, CIRCULATION, V105, P893, DOI 10.1161/hc0702.103728
   Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9
   Weizman AV, 2012, ALIMENT PHARM THER, V35, P342, DOI 10.1111/j.1365-2036.2011.04956.x
NR 5
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0269-2813
J9 ALIMENT PHARM THER
JI Aliment. Pharmacol. Ther.
PD MAY
PY 2012
VL 35
IS 9
BP 1110
EP 1111
DI 10.1111/j.1365-2036.2012.05065.x
PG 3
WC Gastroenterology & Hepatology; Pharmacology & Pharmacy
SC Gastroenterology & Hepatology; Pharmacology & Pharmacy
GA 927HP
UT WOS:000302898400018
PM 25099779
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Zanin, V
   Girardelli, M
   Magnolato, A
   Martellossi, S
   Tommasini, A
   Marcuzzi, A
   Crovella, S
AF Bianco, Anna Monica
   Zanin, Valentina
   Girardelli, Martina
   Magnolato, Andrea
   Martellossi, Stefano
   Tommasini, Alberto
   Marcuzzi, Annalisa
   Crovella, Sergio
TI A common genetic background could explain early-onset Crohn's disease
SO MEDICAL HYPOTHESES
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY
   LOCI; NOD2; CHILDREN; PATHOGENESIS; RISK; SNPS; AGE; IBD
AB Crohn's disease (CD) is a multifactorial disease, in which environmental, microbial and genetic factors play important roles. CD is characterized by a chronic granulomatous inflammation by necrotic scarring with aspects of full-thickness wall.
   In spite of affecting mainly young adults, sometimes, CD can be present in the first year of life (early onset Crohn disease, EOCD) showing an unpredictable course and being often more severe than at older ages.
   In this paper we propose the hypothesis that EOCD patients should be analyzed using a Mendelian approach with family studies aimed to identify new loci directly involved in the early onset Crohn's disease. So we will leave the classic association study approach used until now for the identification of genes responsible for susceptibility to CD and propose linkage family analysis as alternative and powerful tool for the identification of new genetic variants associated with familiar cases of EOCD. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Bianco, Anna Monica; Zanin, Valentina; Magnolato, Andrea; Crovella, Sergio] Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34134 Trieste, Italy.
RP Bianco, AM (corresponding author), Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34134 Trieste, Italy.
EM bianco@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; Tommasini, Alberto/AAE-3882-2020;
   Crovella, Sergio/K-5050-2016; BIANCO, ANNA MONICA/D-3098-2014;
   Girardelli, Martina/K-7199-2016
OI Marcuzzi, Annalisa/0000-0003-3427-618X; Tommasini,
   Alberto/0000-0002-6943-7927; Crovella, Sergio/0000-0001-8493-1168;
   BIANCO, ANNA MONICA/0000-0001-8101-9659; Magnolato,
   Andrea/0000-0002-5099-6526; Girardelli, Martina/0000-0003-1186-4907
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Italy
   [RC 13/2008]
FX This work was supported by a Grant from the Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo", Italy (RC 13/2008).
CR Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2
   Aspberg S, 2006, ACTA PAEDIATR, V95, P1001, DOI 10.1080/08035250600573151
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Cannioto Z, 2009, EUR J PEDIATR, V168, P149, DOI 10.1007/s00431-008-0721-2
   Cohen R, 2008, INFLAMM BOWEL DIS, V14, P738, DOI 10.1002/ibd.20406
   Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231
   Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245
   Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954
   Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   Kim SC, 2004, GASTROENTEROLOGY, V126, P1550, DOI 10.1053/j.gastro.2004.03.022
   Lacher M, 2010, J PEDIATR SURG, V45, P1591, DOI 10.1016/j.jpedsurg.2009.10.046
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   Levine A, 2007, INFLAMM BOWEL DIS, V13, P1509, DOI 10.1002/ibd.20244
   Marcuzzi A, 2012, GENE, V493, P282, DOI 10.1016/j.gene.2011.11.043
   Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831
   Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032
   Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747
   Van Limbergen J, 2007, INFLAMM BOWEL DIS, V13, P338, DOI 10.1002/ibd.20096
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
NR 22
TC 16
Z9 17
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD APR
PY 2012
VL 78
IS 4
BP 520
EP 522
DI 10.1016/j.mehy.2012.01.023
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 920ZT
UT WOS:000302448500028
PM 22309886
DA 2020-12-08
ER

PT J
AU Vuch, J
   Marcuzzi, A
   Zanin, V
   Crovella, S
AF Vuch, Josef
   Marcuzzi, Annalisa
   Zanin, Valentina
   Crovella, Sergio
TI Comments to the Editor Concerning the Paper Entitled "Pre-clinical renal
   cancer chemopreventive efficacy of geraniol by modulation of multiple
   molecular pathways" Shiekh Tanveer Ahmad et al.
SO TOXICOLOGY
LA English
DT Letter
ID MEVALONATE KINASE-DEFICIENCY; ISOPRENOIDS; FARNESOL; MODEL
C1 [Vuch, Josef; Marcuzzi, Annalisa; Zanin, Valentina; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34134 Trieste, Italy.
   [Zanin, Valentina] Univ Trieste, I-34127 Trieste, Italy.
RP Vuch, J (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Via Istria 65-1, I-34134 Trieste, Italy.
EM josef.vuch@alice.it
RI Marcuzzi, Annalisa/AAA-6038-2020; Crovella, Sergio/K-5050-2016
OI Marcuzzi, Annalisa/0000-0003-3427-618X; Crovella,
   Sergio/0000-0001-8493-1168
CR Ahmad ST, 2011, TOXICOLOGY, V290, P69, DOI 10.1016/j.tox.2011.08.020
   Cardozo MT, 2011, J NUTR BIOCHEM, V22, P130, DOI 10.1016/j.jnutbio.2009.12.007
   Carnesecchi S, 2004, CANCER LETT, V215, P53, DOI 10.1016/j.canlet.2004.06.019
   Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083
   Kim SH, 2011, BIOCHEM BIOPH RES CO, V407, P129, DOI 10.1016/j.bbrc.2011.02.124
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, PEDIATR RES, V70, P78, DOI 10.1203/PDR.0b013e31821b581c
   Ong TP, 2006, CARCINOGENESIS, V27, P1194, DOI 10.1093/carcin/bgi291
   Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666
   YU SG, 1995, J NUTR, V125, P2763
NR 10
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD MAR 11
PY 2012
VL 293
IS 1-3
BP 123
EP 124
DI 10.1016/j.tox.2011.12.008
PG 2
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 910HI
UT WOS:000301627400013
PM 22210290
DA 2020-12-08
ER

PT J
AU Comar, M
   Zanotta, N
   Pesel, G
   Visconti, P
   Maestri, I
   Rinaldi, R
   Crovella, S
   Cortale, M
   De Zotti, R
   Bovenzi, M
AF Comar, Manola
   Zanotta, Nunzia
   Pesel, Giuliano
   Visconti, Patrizia
   Maestri, Iva
   Rinaldi, Rosa
   Crovella, Sergio
   Cortale, Maurizio
   De Zotti, Renata
   Bovenzi, Massimo
TI Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic
   area of north-eastern Italy
SO TUMORI J
LA English
DT Article
DE environmental exposure; epidemiologic study; occupational exposure;
   polyomavirus
ID SIMIAN-VIRUS-40; PATHOGENESIS; INFECTION; DISEASES; CHILDREN; GROWTH;
   RISK
AB Aims and background. Malignant mesothelioma is a fatal cancer of increasing incidence in north-eastern Italy. Together with asbestos, the polyomavirus SV40 was hypothesized to contribute to the onset of malignant mesothelioma. To investigate the putative role of SV40 in the individual susceptibility to asbestos-induced malignant mesothelioma, we conducted a molecular epidemiological study on a series of malignant mesothelioma patients from an area in north-eastern Italy hyperendemic for malignant pleural mesothelioma.
   Methods and study design. We collected 63 mesothelioma samples from incidence cases of patients diagnosed with malignant pleural mesothelioma in the period 2009-2010. DNA was extracted from patients' tissue biopsies using the BioRobot EZ1 Qiagen workstation. SV40 sequence detection and quantification was performed by specific real time PCR. The 74.6% of the 63 enrolled patients had a history of asbestos exposure. The epithelioid histotype was more prevalent in males (64.0%) and the mixed in females (61.5%) who showed significantly higher cancer co-morbidity (46.1% vs 12%, P = 0.005). SV40 was detected in 22% of MM tumors, with a low viral load. In SV40-positive patients, a threefold increased risk of asbestos exposure was observed, more evident in females (OR 4.32) than in males (OR 1.20).
   Conclusions. Our findings indicate that a high prevalence of SV40 was present in malignant mesothelioma incident cases from an area hyperendemic for malignant mesothelioma in north-eastern Italy. Although asbestos is considered the main risk factor in malignant mesothelioma onset, a role for SV40 could be hypothesized.
C1 [Comar, Manola] Univ Trieste, Dept Med Sci, Inst Maternal & Child Hlth, IRCCS Bur Garofolo, I-34137 Trieste, Italy.
   [Pesel, Giuliano; De Zotti, Renata; Bovenzi, Massimo] Univ Trieste, Dept Med Sci, Clin Unit Occupat Med, Trieste, Italy.
   [Maestri, Iva] Univ Ferrara, Unit Pathol Anat Histol & Cytol, Dept Expt & Diagnost Med Pathol, I-44100 Ferrara, Italy.
   [Rinaldi, Rosa] St Anna Univ, Hosp Ferrara, Operat Unit Anat Pathol, Dept Lab Med, Ferrara, Italy.
   [Cortale, Maurizio] Cattinara Hosp, Unit Thorac Surg, Dept Gen Surg, Trieste, Italy.
RP Comar, M (corresponding author), Univ Trieste, Dept Med Sci, Inst Maternal & Child Hlth, IRCCS Bur Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM comar@burlo.trieste.it
RI Zanotta, Nunzia/K-4539-2016; Comar, Manola/K-4613-2016; Crovella,
   Sergio/K-5050-2016; COMAR, Manola/K-4613-2016
OI Zanotta, Nunzia/0000-0002-6458-1946; Comar, Manola/0000-0001-6310-3320;
   Crovella, Sergio/0000-0001-8493-1168; maestri, iva/0000-0002-3485-4640;
   COMAR, Manola/0000-0002-9487-861X; BOVENZI, MASSIMO/0000-0002-6001-5218
FU IRCCS "Burlo Garofolo" [RC 23/09]; Friuli Venezia Giulia RegionRegione
   Friuli Venezia Giulia [969/APREV dd 27.09.2010]
FX This study was supported, in part, by grants RC 23/09 from IRCCS "Burlo
   Garofolo" and from Friuli Venezia Giulia Region (969/APREV dd
   27.09.2010).
CR Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004
   Bertazzi PA, 2005, MED LAVORO, V96, P238
   Bocchetta M, 2003, ONCOGENE, V22, P81, DOI 10.1038/sj.onc.1206097
   Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203
   Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301
   Campello C, 2010, J MED VIROL, V82, P1197, DOI 10.1002/jmv.21798
   Carbone M, 2008, CANCER RES, V68, P9488, DOI 10.1158/0008-5472.CAN-08-2332
   CICALA C, 1993, AM J PATHOL, V142, P1524
   Comar M, 2004, TRANSPLANTATION, V78, P544, DOI 10.1097/01.TP.0000136257.02830.29
   Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232
   Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786
   Comba P, 2005, INT J OCCUP ENV HEAL, V11, P36, DOI 10.1179/oeh.2005.11.1.36
   Cristaudo A, 2005, CANCER RES, V65, P3049, DOI 10.1158/0008-5472.CAN-04-2219
   De Zotti R, 2010, 3 ISPESL, P248
   Dogan AU, 2006, CANCER RES, V66, P5063, DOI 10.1158/0008-5472.CAN-05-4642
   Foddis R, 2002, ONCOGENE, V21, P1434, DOI 10.1038/sj.onc.1205203
   Goodman JE, 2009, CANCER CAUSE CONTROL, V20, P1237, DOI 10.1007/s10552-009-9357-4
   Hmeljak J, 2010, TUMORI J, V96, P667
   Marinaccio A, 2005, INT J CANCER, V115, P142, DOI 10.1002/ijc.20820
   McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018
   Merler E, 2009, MED LAV, V100, P120
   Merler E, 1999, Epidemiol Prev, V23, P316
   Moore S, 2005, EUR J CANCER CARE, V19, P458
   Nesti M, 2003, LINEE GUIDA RILEVAZI
   Pancaldi C, 2009, J INFECTION, V58, P53, DOI 10.1016/j.jinf.2008.10.014
   Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105
   Robinson C, 2006, CANCER RES, V66, P10786, DOI 10.1158/0008-5472.CAN-05-4668
   Vilchez RA, 2004, CLIN MICROBIOL REV, V17, P495, DOI 10.1128/cmr.17.3.495-508.2004
   Weiner SJ, 2009, J CANCER RES CLIN, V135, P15, DOI 10.1007/s00432-008-0444-9
NR 29
TC 9
Z9 9
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0300-8916
EI 2038-2529
J9 TUMORI J
JI Tumori J.
PD MAR-APR
PY 2012
VL 98
IS 2
BP 210
EP 214
PG 5
WC Oncology
SC Oncology
GA 962LM
UT WOS:000305546600005
PM 22677986
DA 2020-12-08
ER

PT J
AU Bianco, AM
   Zanin, V
   Marcuzzi, A
   Crovella, S
AF Bianco, Anna Monica
   Zanin, Valentina
   Marcuzzi, Annalisa
   Crovella, Sergio
TI Letter to the Editor
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Letter
DE simvastatin; geraniol; mevalonate; cholesterol; isoprenoids
ID NATURAL ISOPRENOIDS; INFLAMMATION
C1 [Bianco, Anna Monica; Marcuzzi, Annalisa] Inst Maternal & Child Hlth Burlo Garofolo, I-34137 Trieste, Italy.
   [Zanin, Valentina; Crovella, Sergio] Univ Trieste, Trieste, Italy.
RP Bianco, AM (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM bianco@burlo.trieste.it
RI BIANCO, ANNA MONICA/D-3098-2014; Crovella, Sergio/K-5050-2016; Marcuzzi,
   Annalisa/AAA-6038-2020
OI BIANCO, ANNA MONICA/0000-0001-8101-9659; Crovella,
   Sergio/0000-0001-8493-1168; Marcuzzi, Annalisa/0000-0003-3427-618X
CR Houten SM, 2003, CELL MOL LIFE SCI, V60, P1118, DOI 10.1007/s00018-003-2296-4
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Polo MP, 2011, CELL BIOCHEM FUNCT, V29, P452, DOI 10.1002/cbf.1772
   Simon A, 2004, CLIN PHARMACOL THER, V75, P476, DOI 10.1016/j.clpt.2004.01.012
NR 5
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0263-6484
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD MAR
PY 2012
VL 30
IS 2
BP 176
EP 176
DI 10.1002/cbf.2798
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 903KT
UT WOS:000301116100014
PM 22275121
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Girardelli, M
   Bianco, AM
   Martelossi, S
   Magnolato, A
   Tommasini, A
   Crovella, S
AF Marcuzzi, Annalisa
   Girardelli, Martina
   Bianco, Anna Monica
   Martelossi, Stefano
   Magnolato, Andrea
   Tommasini, Alberto
   Crovella, Sergio
TI Inflammation profile of four early onset Crohn patients
SO GENE
LA English
DT Article
DE Crohn disease; Inflammatory bowel disease; Polymorphism analysis;
   Cytokines
ID BOWEL-DISEASE; SUSCEPTIBILITY; INTERLEUKIN-10; VARIANTS; IL-10; NOD2;
   ASSOCIATION; CYTOKINES; CHILDREN; IBD
AB Crohn disease (CD) is a multifactorial disorder affecting mainly young adults. Sometimes, however, it can present in the first year of life (Early onset Crohn disease (EOCD)) showing an unpredictable course and can often be more severe than at older ages. Some cases have been associated to an underlying primary immunodeficiency such as IL10R deficiency. We studied the functional response to IL-10 and the genotype of IL-10 receptor in four patients with early onset crohn-like colitis. We found an IL10R variant, which may be associated with a decreased response to the cytokine in one patient. Further studies to determine its pathogenic effect should be performed. In addition IL-10 mediated inhibition of LPS-induced TNF alpha expression was measured in patient's monocytes. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Marcuzzi, Annalisa; Girardelli, Martina; Bianco, Anna Monica; Martelossi, Stefano; Magnolato, Andrea; Tommasini, Alberto; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofalo, I-34134 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, I-34127 Trieste, Italy.
RP Bianco, AM (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofalo, Via Istria 65-1, I-34134 Trieste, Italy.
EM bianco@burlo.trieste.it
RI Marcuzzi, Annalisa/AAA-6038-2020; BIANCO, ANNA MONICA/D-3098-2014;
   Crovella, Sergio/K-5050-2016; Tommasini, Alberto/AAE-3882-2020;
   Girardelli, Martina/K-7199-2016
OI Marcuzzi, Annalisa/0000-0003-3427-618X; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Crovella, Sergio/0000-0001-8493-1168;
   Tommasini, Alberto/0000-0002-6943-7927; Magnolato,
   Andrea/0000-0002-5099-6526; Girardelli, Martina/0000-0003-1186-4907
CR Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Cannioto Z, 2009, EUR J PEDIATR, V168, P149, DOI 10.1007/s00431-008-0721-2
   Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231
   Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x
   Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1
   Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x
   Frodsham AJ, 2006, P NATL ACAD SCI USA, V103, P9148, DOI 10.1073/pnas.0602800103
   Gasche C, 2003, J IMMUNOL, V170, P5578, DOI 10.4049/jimmunol.170.11.5578
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   Kim SC, 2004, GASTROENTEROLOGY, V126, P1550, DOI 10.1053/j.gastro.2004.03.022
   Lacher M, 2010, J PEDIATR SURG, V45, P1591, DOI 10.1016/j.jpedsurg.2009.10.046
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   Levine A, 2007, INFLAMM BOWEL DIS, V13, P1509, DOI 10.1002/ibd.20244
   Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622
   Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794
   Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z
NR 19
TC 11
Z9 11
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD FEB 10
PY 2012
VL 493
IS 2
BP 282
EP 285
DI 10.1016/j.gene.2011.11.043
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 895DM
UT WOS:000300476400016
PM 22155628
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Oshiro, TM
   Girardelli, M
   Kamada, AJ
   Crovella, S
   Duarte, AJS
AF Pontillo, Alessandra
   Oshiro, Telma M.
   Girardelli, Martina
   Kamada, Anselmo J.
   Crovella, Sergio
   Duarte, Alberto J. S.
TI Polymorphisms in Inflammasome' Genes and Susceptibility to HIV-1
   Infection
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE genetics; HIV-1; inflammasome; IL-1 beta; innate immunity; NALP3/NLRP3;
   polymorphisms
ID DISEASE; IMMUNITY; CCL3L1
AB The involvement of inflammasome genes in the susceptibility to HIV-1 infection was investigated. Twelve single nucleotide polymorphisms within NLRP1, NLRP3, NLRC4, CARD8, CASP1, and IL1B genes were analyzed in 150 HIV-1-infected Brazilian subjects and 158 healthy controls. The 2 polymorphisms rs10754558 in NLRP3 and rs1143634 in IL1B were significantly associated to the HIV-1 infection. These findings supported the previously hypothesized involvement of NALP3-inflammasome in HIV-1 pathogenesis, underlining once more the key role of inflammation and innate immunity in the susceptibility to HIV-1 infection.
C1 [Pontillo, Alessandra] Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, LIM 56, BR-05403000 Sao Paulo, Brazil.
   [Girardelli, Martina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Kamada, Anselmo J.; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Fac Med, Lab Med Invest Dermatol & Immunodeficiency, LIM 56, Av Dr Eneas de Caravalho Aguiar 500, BR-05403000 Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Pontillo, Alessandra/AAD-4790-2019; Pontillo, ALESSANDRA/D-4352-2012;
   Oshiro, Telma M/C-7152-2012; Pontillo, Alessandra/ABC-6266-2020; Kamada,
   Anselmo Jiro/H-3006-2012; Crovella, Sergio/K-5050-2016; Duarte, Alberto
   J S/D-4382-2012; Girardelli, Martina/K-7199-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Oshiro, Telma M/0000-0002-8791-9233;
   Pontillo, Alessandra/0000-0002-7883-0640; Kamada, Anselmo
   Jiro/0000-0002-0437-0151; Crovella, Sergio/0000-0001-8493-1168;
   Girardelli, Martina/0000-0003-1186-4907
FU Sao Paulo Research foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [09/53575-5]; Pernambuco Research
   foundation (FACEPE) [APQ-0757-2.02/10]; IRCCS "Burlo Garofolo", Trieste,
   Italy [RC 07/08]; TALENTS Program (7th R&D Framework Program, Specific
   Program: PEOPLE-Marie Curie Actions-COFUND)
FX Supported by the Sao Paulo Research foundation (FAPESP) (09/53575-5), by
   the Pernambuco Research foundation (FACEPE) (APQ-0757-2.02/10) and by a
   grant RC 07/08 from IRCCS "Burlo Garofolo", Trieste, Italy. A.P. was
   recipient of a visiting researcher grant from FAPESP. S. C. is recipient
   of a grant from the TALENTS Program (7th R&D Framework Program, Specific
   Program: PEOPLE-Marie Curie Actions-COFUND).
CR Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004
   Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087
   Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146
   Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11
   Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
NR 21
TC 50
Z9 51
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD FEB 1
PY 2012
VL 59
IS 2
BP 121
EP 125
DI 10.1097/QAI.0b013e3182392ebe
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 885OX
UT WOS:000299789600008
PM 22227487
OA Green Published
DA 2020-12-08
ER

PT J
AU Ferraroni, NR
   Segat, L
   Guimaraes, RL
   Brandao, LAC
   Crovella, S
   Constantino-Silva, RN
   Loja, C
   Duarte, AJD
   Grumach, AS
AF Ferraroni, N. R.
   Segat, L.
   Guimaraes, R. L.
   Brandao, L. A. C.
   Crovella, S.
   Constantino-Silva, R. N.
   Loja, C.
   da Silva Duarte, A. J.
   Grumach, A. S.
TI Mannose-binding lectin and MBL-associated serine protease-2 gene
   polymorphisms in a Brazilian population from Rio de Janeiro
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID INNATE IMMUNE-SYSTEM; COMPLEMENT PATHWAY; CORONAVIRUS INFECTION; PROTEIN
   LEVELS; SUSCEPTIBILITY; CHILDREN; MASP2; DEFICIENCY; MUTATIONS;
   GENOTYPES
AB Mannose-binding lectin (MBL) is a protein able to bind to carbohydrate patterns on pathogen membranes; upon MBL binding, its associated serine protease MBL-associated serine protease type 2 (MASP2) is autoactivated, promoting the activation of complement via the lectin pathway. For both MBL2 and MASP2 genes, the frequencies of polymorphisms are extremely variable between different ethnicities, and this aspect has to be carefully considered when performing genetic studies. While polymorphisms in the MBL-encoding gene (MBL2) have been associated, depending upon ethnicity, with several diseases in different populations, little is known about the distribution of MASP2 gene polymorphisms in human populations. The aim of our study was thus to determine the frequencies of MBL2 (exon 1 and promoter) and MASP2 (p.D371Y) polymorphisms in a Brazilian population from Rio de Janeiro. A total of 294 blood donor samples were genotyped for 27 polymorphisms in the MBL2 gene by direct sequencing of a region spanning from the promoter polymorphism H/L rs11003125 to the rs1800451 polymorphism (at codon 57 in the first exon of the gene). Genotyping for MASP2 p.D371Y was carried out using fluorogenic probes. To our knowledge, this is the first study reporting the prevalence of the MASP2 p.D371Y polymorphism in a Brazilian population. The C allele frequency 39% is something intermediate between the reported 14% in Europeans and 90% in Sub-Saharan Africans. MBL2 polymorphisms frequencies were quite comparable to those previously reported for admixed Brazilians. Both MBL2 and MASP2 polymorphisms frequencies reported in our study for the admixed Brazilian population are somehow intermediate between those reported in Europeans and Africans, reflecting the ethnic composition of the southern Brazilian population, estimated to derive from an admixture of Caucasian (31%), African (34%) and Native American (33%) populations. In conclusion, our population genetic study describes the frequencies of MBL2 and MASP2 functional SNPs in a population from Rio de Janeiro, with the aim of adding new information concerning the distribution of these SNPs in a previously unanalysed Brazilian population, thus providing a new genetic tool for the evaluation of the association of MBL2 and MASP2 functional SNPs with diseases in Brazil, with particular emphasis on the state of Rio de Janeiro.
C1 [Segat, L.] IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Ferraroni, N. R.; Constantino-Silva, R. N.; da Silva Duarte, A. J.; Grumach, A. S.] Univ Sao Paulo, Fac Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil.
   [Guimaraes, R. L.; Brandao, L. A. C.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Loja, C.] Hosp Servidores Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Grumach, A. S.] Fac Med ABC, Sao Paulo, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI da Silva, Rosemeire Navickas Constantino/Y-1427-2019; Brandao, Lucas
   Andre Cavalcanti/G-8333-2012; Grumach, Anete S/I-3430-2014; Duarte,
   Alberto J S/D-4382-2012; Crovella, Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; Grumach, Anete/0000-0002-9803-0309; Segat,
   Ludovica/0000-0002-6024-1485
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/59666-4]; FACEPE
   (Fundacao de Amparo a Pesquisa do Estado de Pernambuco)
   [APQ-0020-4.01/08]
FX This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) process 06/59666-4. LS is recipient of a fellowship
   grant (APQ-0020-4.01/08) from FACEPE (Fundacao de Amparo a Pesquisa do
   Estado de Pernambuco). SC is recipient of a fellowship grant from
   European Project 'Talents for an International House' within the
   framework of the 7th Research & Development Framework Programme PEOPLE -
   Marie Curie Actions - CO-FUND (Co-Funding of Regional, National and
   International Programmes). We also would like to thank Dr. Izabel Maria
   de Siqueira, Head of Blood Bank, who kindly collaborated with sample
   collection (Hospital dos Servidores do Estado do Rio de Janeiro).
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Araujo J, 2007, HUM IMMUNOL, V68, P739, DOI 10.1016/j.humimm.2007.05.007
   Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009
   Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Brandao LAC, 2008, HUM IMMUNOL, V69, P577, DOI 10.1016/j.humimm.2008.07.007
   Brandao LAC, 2008, ARCH DERMATOL, V144, P412, DOI 10.1001/archderm.144.3.412
   Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537
   Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x
   Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800
   Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283
   HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8
   Horcajada JP, 2009, CURR HIV RES, V7, P218, DOI 10.2174/157016209787581382
   Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007
   Jack DL, 2003, BIOCHEM SOC T, V31, P753, DOI 10.1042/BST0310753
   Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036
   LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Matsushita M, 1998, ARCH VIROL, V143, P645, DOI 10.1007/s007050050320
   MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497
   MILLER ME, 1968, LANCET, V2, P60
   Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x
   Ramasawmy R, 2008, CLIN VACCINE IMMUNOL, V15, P932, DOI 10.1128/CVI.00324-07
   Ramos-Casals M, 2009, RHEUMATOLOGY, V48, P65, DOI 10.1093/rheumatology/ken411
   Reason IJM, 2006, HUM IMMUNOL, V67, P991, DOI 10.1016/j.humimm.2006.08.296
   Schafranski MD, 2008, MOL IMMUNOL, V45, P3827, DOI 10.1016/j.molimm.2008.05.013
   Segat L, 2008, J VIRAL HEPATITIS, V15, P387, DOI [10.1111/j.1365-2893.2008.00965.x, 10.1111/j.1365-2893.2007.00965.x]
   Skalnikova H, 2004, J IMMUNOL METHODS, V295, P139, DOI 10.1016/j.jim.2004.10.007
   Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8
   Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836
   Stover CM, 1999, CYTOGENET CELL GENET, V84, P148, DOI 10.1159/000015243
   Sullivan KE, 1996, ARTHRITIS RHEUM, V39, P2046, DOI 10.1002/art.1780391214
   SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9
   SUPER M, 1989, LANCET, V2, P1236
   Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373
   Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018
   THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x
   Thiel S, 2009, J IMMUNOL, V182, P2939, DOI 10.4049/jimmunol.0802053
   Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x
   Wang Y, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-51
   Ytting H, 2011, SCAND J IMMUNOL, V73, P122, DOI 10.1111/j.1365-3083.2010.02480.x
   Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479
NR 47
TC 4
Z9 5
U1 1
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1744-3121
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD FEB
PY 2012
VL 39
IS 1
BP 32
EP 38
DI 10.1111/j.1744-313X.2011.01052.x
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 872EJ
UT WOS:000298791300006
PM 22035380
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Silva, LT
   Oshiro, TM
   Finazzo, C
   Crovella, S
   Duarte, AJS
AF Pontillo, Alessandra
   Silva, Lais T.
   Oshiro, Telma M.
   Finazzo, Claudia
   Crovella, Sergio
   Duarte, Alberto J. S.
TI HIV-1 induces NALP3-inflammasome expression and interleukin-1 beta
   secretion in dendritic cells from healthy individuals but not from
   HIV-positive patients
SO AIDS
LA English
DT Article
DE dendritic cells; HIV-1; immunotherapy; inflammasome; interleukin-1 beta;
   NALP3; vaccine
ID NLRP3 GENE; ACTIVATION; VACCINE; DISEASE
AB Objective: NALP3-inflammasome is an innate mechanism, alternative to type-1 interferon, which is able to recognize nucleic acids and viruses in the cytoplasm and to induce pro-inflammatory response. Here, we hypothesized the involvement of inflammasome in the early defense against HIV-1 and in the full maturation of dendritic cells: for this, we evaluated the response of dendritic cells pulsed with HIV-1 in terms of inflammasome activation in healthy donors. Moreover, inflammasome response to HIV was evaluated in HIV-infected individuals.
   Design and methods: Monocyte-derived dendritic cells isolated from 20 healthy individuals (HC-DC) and 20 HIV-1-infected patients (HIV-DC) were pulsed with alditrithiol-2-inactivated HIV-1. We then analyzed inflammasome genes expression and interleukin-1 beta (IL-1 beta) secretion.
   Results: In HC-DC, HIV-1 induced higher NLRP3/NALP3 mRNA expression compared with other inflammasome genes such as NALP1/NLRP1 or IPAF/NLRC4 (P < 0.001). This augmented expression was accompanied by CASP1-increased and IL1B-increased mRNA levels and by a significant increment of IL-1b secretion (P < 0.05). Otherwise, HIV-1 failed to activate inflammasome and cytokine production in HIV-DC. HIV-DC showed an increased NLRP3/NALP3 basal expression, suggesting a chronic inflammatory profile of patients' immune cells.
   Conclusion: HIV-1 was able to induce a NALP3-inflammasome response in healthy individuals, indicating that this inflammasome could play a role in the first steps of HIV-1 infection; the consequent inflammatory process may be important for directing host immune response against the virus and/or disease progression. HIV-DC seemed to be chronically activated, but unresponsive against pathogens. Our findings could be of interest considering the ongoing research about dendritic cell manipulation and therapeutic strategies for AIDS involving dendritic cell-based immune-vaccines. (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
C1 [Pontillo, Alessandra; Silva, Lais T.; Oshiro, Telma M.; Finazzo, Claudia; Duarte, Alberto J. S.] Univ Sao Paulo, Fac Med, Lab Med Investigat Dermatol & Immunodeficiency, BR-05403000 Sao Paulo, Brazil.
   [Crovella, Sergio] Univ Trieste, Trieste, Italy.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Pontillo, A (corresponding author), Univ Sao Paulo, Fac Med, Lab Med Investigat Dermatol & Immunodeficiency, LIM 56,Av Dr Eneas Caravalho Aguiar 500, BR-05403000 Sao Paulo, Brazil.
EM pontillo.a@gmail.com
RI Crovella, Sergio/K-5050-2016; Oshiro, Telma M/C-7152-2012; Duarte,
   Alberto J S/D-4382-2012; Pontillo, ALESSANDRA/D-4352-2012; Pontillo,
   Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020
OI Crovella, Sergio/0000-0001-8493-1168; Oshiro, Telma
   M/0000-0002-8791-9233; Pontillo, ALESSANDRA/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640
FU Sao Paulo Research foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [09/53575-5]; IRCCS 'Burlo Garofolo'
   (Trieste, Italy) [RC 07/08]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); TALENTS Programme
FX This work was supported by the Sao Paulo Research foundation (FAPESP)
   (09/53575-5) and by a grant RC 07/08 from IRCCS 'Burlo Garofolo'
   (Trieste, Italy).; A. P. is recipient of a visiting researcher grant
   from FAPESP. S. C. is recipient of a grant from the TALENTS Programme
   (7th R&D Framework Programme, Specific Programme: PEOPLE - Marie Curie
   Actions - COFUND).
CR Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276
   Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122
   Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851
   Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117
   Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147
   Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337
   McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674
   Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54
   Newman PA, 2010, AIDS, V24, P1749, DOI 10.1097/QAD.0b013e32833adbe8
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794
NR 16
TC 43
Z9 44
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JAN 2
PY 2012
VL 26
IS 1
BP 11
EP 18
DI 10.1097/QAD.0b013e32834d697f
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 863BA
UT WOS:000298136600002
PM 21971358
OA Green Published
DA 2020-12-08
ER

PT J
AU Kido, EA
   Neto, JRCF
   Silva, RLD
   Pandolfi, V
   Guimaraes, ACR
   Veiga, DT
   Chabregas, SM
   Crovella, S
   Benko-Iseppon, AM
AF Kido, Ederson Akio
   Costa Ferreira Neto, Jose Ribamar
   de Oliveira Silva, Roberta Lane
   Pandolfi, Valesca
   Ribeiro Guimaraes, Ana Carolina
   Veiga, Daniela Truffi
   Chabregas, Sabrina Moutinho
   Crovella, Sergio
   Benko-Iseppon, Ana Maria
TI New Insights in the Sugarcane Transcriptome Responding to Drought Stress
   as Revealed by Supersage
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID AMINO-ACID AMINOTRANSFERASE; GENE-EXPRESSION ANALYSIS; GLYCINE-RICH
   PROTEINS; ABSCISIC-ACID; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; RESPONSIVE
   TRANSCRIPTOME; PHOTORESPIRATORY PATHWAY; SALT-STRESS; KEY ENZYME;
   ARABIDOPSIS
AB In the scope of the present work, four SuperSAGE libraries have been generated, using bulked root tissues from four drought-tolerant accessions as compared with four bulked sensitive genotypes, aiming to generate a panel of differentially expressed stress-responsive genes. Both groups were submitted to 24 hours of water deficit stress. The SuperSAGE libraries produced 8,787,315 tags (26 bp) that, after exclusion of singlets, allowed the identification of 205,975 unitags. Most relevant BlastN matches comprised 567,420 tags, regarding 75,404 unitags with 164,860 different ESTs. To optimize the annotation efficiency, the Gene Ontology (GO) categorization was carried out for 186,191 ESTs (BlastN against Uniprot-SwissProt), permitting the categorization of 118,208 ESTs (63.5%). In an attempt to elect a group of the best tags to be validated by RTqPCR, the GO categorization of the tag-related ESTs allowed the in silico identification of 213 upregulated unitags responding basically to abiotic stresses, from which 145 presented no hits after BlastN analysis, probably concerning new genes still uncovered in previous studies. The present report analyzes the sugarcane transcriptome under drought stress, using a combination of high-throughput transcriptome profiling by SuperSAGE with the Solexa sequencing technology, allowing the identification of potential target genes during the stress response.
C1 [Kido, Ederson Akio; Costa Ferreira Neto, Jose Ribamar; de Oliveira Silva, Roberta Lane; Pandolfi, Valesca; Crovella, Sergio; Benko-Iseppon, Ana Maria] Fed Univ Pernambuco UFPE, Dept Genet, BR-50670901 Recife, PE, Brazil.
   [Ribeiro Guimaraes, Ana Carolina; Veiga, Daniela Truffi; Chabregas, Sabrina Moutinho] Sugarcane Technol Ctr CTC, Div Biotechnol, BR-13400970 Piracicaba, SP, Brazil.
RP Kido, EA (corresponding author), Fed Univ Pernambuco UFPE, Dept Genet, BR-50670901 Recife, PE, Brazil.
EM kido.ufpe@gmail.com; ana.iseppon@gmail.com
RI Kido, Ederson A/E-2489-2016; Iseppon, Ana Maria Benko/M-5527-2019;
   Guimaraes, Ana Carolina/D-9513-2013; Kido, Ederson Akio/P-9932-2019;
   Crovella, Sergio/K-5050-2016; Herbario Virtual, Inct/J-8725-2013;
   Pandolfi, Valesca/L-1637-2016
OI Kido, Ederson A/0000-0001-5484-993X; Iseppon, Ana Maria
   Benko/0000-0002-0575-3197; Kido, Ederson Akio/0000-0001-5484-993X;
   Crovella, Sergio/0000-0001-8493-1168; Pandolfi,
   Valesca/0000-0003-2283-5669
FU Financiadora de Estudos e Projetos (FINEP)Ciencia Tecnologia e Inovacao
   (FINEP); Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors thank Professor Gunter Kahl (Frankfurt University, Germany).
   This work has been funded by Brazilian institutions: Financiadora de
   Estudos e Projetos (FINEP), Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE), and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq).
CR Ahn JC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-253
   Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anjum SA, 2011, J AGRON CROP SCI, V197, P296, DOI 10.1111/j.1439-037X.2011.00468.x
   Asif MA, 2011, MOL BIOTECHNOL, V49, P250, DOI 10.1007/s12033-011-9399-1
   Belin C, 2008, PLANT SIGNAL BEHAV, V3, P478, DOI 10.4161/psb.3.7.5679
   Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x
   Bray E., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2
   Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251
   Campbell MA, 2001, PLANT PHYSIOL BIOCH, V39, P855, DOI 10.1016/S0981-9428(01)01306-7
   Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004
   Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006
   Coemans B, 2005, THEOR APPL GENET, V111, P1118, DOI 10.1007/s00122-005-0039-7
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3
   D'Hont Angelique, 2008, V1, P483
   Devaiah KM, 2007, PLANT GROWTH REGUL, V52, P249, DOI 10.1007/s10725-007-9195-x
   Diebold R, 2002, PLANT PHYSIOL, V129, P540, DOI 10.1104/pp.001602
   Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012
   Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063
   Durantini D, 2008, HEREDITY, V101, P465, DOI 10.1038/hdy.2008.29
   Edwards R, 2000, HERBICIDES THEIR MEC, V8, P38
   FAOSTAT Food and Agriculture Organization of the Unite Nations, 2010, FAO STAT DAT
   Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145
   Galante PAF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r40
   Galle A, 2009, J PLANT PHYSIOL, V166, P1878, DOI 10.1016/j.jplph.2009.05.016
   Gao F, 2009, PLANTA, V230, P611, DOI 10.1007/s00425-009-0973-8
   George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004
   Gilardoni PA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-66
   Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016
   Godoy AV, 2000, PLANT SCI, V152, P123, DOI 10.1016/S0168-9452(99)00211-3
   Goldemberg J, 2007, SCIENCE, V315, P808, DOI 10.1126/science.1137013
   Gowda M, 2004, PLANT PHYSIOL, V134, P890, DOI 10.1104/pp.103.034496
   Gubis J, 2007, S AFR J BOT, V73, P505, DOI 10.1016/j.sajb.2007.03.011
   Hamada H, 2008, J GEN PLANT PATHOL, V74, P313, DOI 10.1007/s10327-008-0106-4
   Hassanein R. A., 2009, Australian Journal of Basic and Applied Sciences, V3, P904
   Iskandar HM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-12
   Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x
   Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x
   KAMALAY JC, 1980, CELL, V19, P935, DOI 10.1016/0092-8674(80)90085-9
   Kido EA, 2010, CURR PROTEIN PEPT SC, V11, P220, DOI 10.2174/138920310791112110
   KIPER M, 1979, NUCLEIC ACIDS RES, V6, P1961, DOI 10.1093/nar/6.5.1961
   Kishor PBK, 2005, CURR SCI INDIA, V88, P424
   Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943
   Kultz D, 2001, AM ZOOL, V41, P743, DOI 10.1668/0003-1569(2001)041[0743:EOOMKS]2.0.CO;2
   Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002
   Malatrasi M, 2006, THEOR APPL GENET, V113, P965, DOI 10.1007/s00122-006-0339-6
   Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336
   Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100
   Matsumura H, 2008, CURR PHARM BIOTECHNO, V9, P368, DOI 10.2174/138920108785915157
   Matsumura H, 2006, NAT METHODS, V3, P469, DOI 10.1038/NMETH882
   MCCARTY DR, 1995, ANNU REV PLANT PHYS, V46, P71, DOI 10.1146/annurev.pp.46.060195.000443
   McClung CR, 2000, PLANT PHYSIOL, V123, P381, DOI 10.1104/pp.123.1.381
   Menossi M, 2008, Int J Plant Genomics, V2008, P458732, DOI 10.1155/2008/458732
   Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815
   Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230
   Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x
   Molina C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-31
   Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553
   Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x
   Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x
   Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x
   Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458
   Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839
   Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580
   PADAN E, 1993, J BIOENERG BIOMEMBR, V25, P647
   Patade VY, 2011, PROTOPLASMA, V248, P613, DOI 10.1007/s00709-010-0207-8
   Razavizadeh R., 2009, Biological Letters, V46, P63, DOI 10.2478/v10120-009-0002-4
   Riechmann JL, 1998, BIOL CHEM, V379, P633
   Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105
   Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6
   Rock CD, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P33, DOI 10.1007/978-90-481-3112-9_3
   Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007
   Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6
   Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299
   Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x
   Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872
   Sharma AD, 2003, CURR SCI INDIA, V84, P911
   Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196
   Shimkets R. A., 2004, GENE EXPRESSION PROF, P1
   Taiz L., 2004, FISIOLOGIA VEGETAL
   Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163
   Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235
   Terauchi R., 2008, HDB PLANT FUNCTIONAL, P37
   Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960
   Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002
   UNICA Uniao da industria de Cana-de-acucar, 2009, STAT SUG SECT 2009
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x
   Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026
   Wang SC, 2011, PLANT MOL BIOL REP, V29, P125, DOI 10.1007/s11105-010-0221-1
   Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5
   Xu K, 2009, J PLANT BIOL, V52, P453, DOI 10.1007/s12374-009-9058-2
   Xu ZS, 2009, J INTEGR PLANT BIOL, V51, P58, DOI 10.1111/j.1744-7909.2008.00776.x
   Yamada M, 2005, J EXP BOT, V56, P1975, DOI 10.1093/jxb/eri195
   Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313
   Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214
   Zhu BC, 1998, PLANT SCI, V139, P41, DOI 10.1016/S0168-9452(98)00175-7
NR 98
TC 22
Z9 25
U1 0
U2 24
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2012
AR 821062
DI 10.1100/2012/821062
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 964ZD
UT WOS:000305734400001
PM 22629208
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zanin, V
   Segat, L
   Bianco, AM
   Padovan, L
   Tavares, NDC
   Crovella, S
AF Zanin, Valentina
   Segat, Ludovica
   Bianco, Anna Monica
   Padovan, Lara
   Cunha Tavares, Nathalia de Alencar
   Crovella, Sergio
TI DEFB1 gene 5 ' untranslated region (UTR) polymorphisms in inflammatory
   bowel diseases
SO CLINICS
LA English
DT Article
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1; CROHNS-DISEASE;
   ULCERATIVE-COLITIS; BETA-DEFENSINS; EXPRESSION; ASSOCIATION;
   NEUTROPHILS; IMMUNITY; INNATE
C1 [Zanin, Valentina; Crovella, Sergio] Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Segat, Ludovica; Bianco, Anna Monica; Padovan, Lara] Inst Maternal & Child Hlth IRCCS Burlo Garofolo T, Trieste, Italy.
   [Cunha Tavares, Nathalia de Alencar] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami LIKA, Recife, PE, Brazil.
RP Zanin, V (corresponding author), Univ Trieste, Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
EM crovella@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; BIANCO, ANNA MONICA/D-3098-2014
OI Crovella, Sergio/0000-0001-8493-1168; BIANCO, ANNA
   MONICA/0000-0001-8101-9659; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC03/04]; FACEPE, Recife, Brazil
   [APQ-1130-2.02/08]; European Project "Talents for an International
   House"
FX Grants RC03/04 from IRCCS Burlo Garofolo Trieste (Italy) and
   APQ-1130-2.02/08 (FACEPE, Recife, Brazil) supported this study. SC is
   the recipient of a fellowship grant from the European Project "Talents
   for an International House'' within the framework of the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND
   (Co-Funding of Regional, National and International Programmes).
CR Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984
   Bajaj-Elliott M, 2002, GUT, V51, P356, DOI 10.1136/gut.51.3.356
   Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x
   Chande N, 2009, AM J GASTROENTEROL, V104, P235, DOI 10.1038/ajg.2008.16
   Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935
   de Oca EPM, 2007, INT ARCH ALLERGY IMM, V142, P211, DOI 10.1159/000097023
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008
   Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x
   Papp M, 2007, WORLD J GASTROENTERO, V13, P2028, DOI 10.3748/wjg.v13.i14.2028
   Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x
   Sartor RB, 2007, J CLIN GASTROENTEROL, V41, pS37
   Sherman H, 2006, MOL IMMUNOL, V43, P1617, DOI 10.1016/j.molimm.2005.09.013
   Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004
   Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001
   Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
NR 27
TC 8
Z9 9
U1 0
U2 2
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2012
VL 67
IS 4
BP 395
EP 398
DI 10.6061/clinics/2012(04)14
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 931EV
UT WOS:000303199300014
PM 22522766
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, MFPTB
   Guimaraes, V
   Silva, MAR
   do Amaral, CMM
   Becak, W
   Stocco, RC
   Freitas, AC
   Crovella, S
AF Baldez da Silva, M. F. P. T.
   Guimaraes, V.
   Silva, M. A. R.
   Medeiros do Amaral, C. M.
   Becak, W.
   Stocco, R. C.
   Freitas, A. C.
   Crovella, S.
TI Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of
   cervical lesions in gynecological patients from Recife, Brazil
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Human papillomavirus; Cervical lesions; Cervical cancer
ID CANCER; WOMEN; VACCINATION; INFECTION
AB Human papilloma virus (HPV) is a well-established cause of cervical cancer. While many studies have been performed so far on HPV viral biology, mode of infection and prevention measures, scanty information is available on lesion sites of infected women and the incidence of viral types at specific locations. We looked for a possible relationship between the most common viral types (HPVs 16, 18, 31, 33) found in Recife, PE, Brazil, and lesion sites. We examined 396 HPV-positive women at the Gynecological Unit of the IMIP at Recife; 288 women were positive for HPV 16, 18, 31, or 33, present as a single-virus type or as co-infection. HPV 16 was the most frequent virus type found in the vulva, vagina, uterine cervix-vagina, and uterine cervix. HPV 31 was the second prevalent virus type in vulva, vagina, uterine cervix-vagina, uterine cervix, and mole. HPVs 18 and 33 were present with similar frequencies in the mole-vulva region. Among the co-infections, HPV 16/18 and HPV16/31 were the most frequent in our study group, followed by HPV 16/33.
C1 [Baldez da Silva, M. F. P. T.] Univ Estadual Maringa, Lab Citogenet, Maringa, PR, Brazil.
   [Guimaraes, V.] Inst Materno Infantil Prof Fernando Figueira, Unidade Ginecol, Recife, PE, Brazil.
   [Silva, M. A. R.; Medeiros do Amaral, C. M.; Freitas, A. C.; Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Becak, W.; Stocco, R. C.] Inst Butantan, Genet Lab, Sao Paulo, Brazil.
   [Crovella, S.] Univ Trieste, Genet Serv IRCCS Burlo Garofolo Dept Reprod & Dev, Trieste, Italy.
RP da Silva, MFPTB (corresponding author), Univ Estadual Maringa, Lab Citogenet, Maringa, PR, Brazil.
EM mfbaldez@hotmail.com
RI Freitas, Antonio/G-1843-2012; de Cassia RC Stocco, Rita/F-2445-2012;
   Crovella, Sergio/K-5050-2016
OI Freitas, Antonio/0000-0002-4957-9549; de Cassia RC Stocco,
   Rita/0000-0002-2375-5567; Crovella, Sergio/0000-0001-8493-1168; Silva,
   Maria Angelica Ramos/0000-0002-7363-988X
CR AULT KA, 2006, INFECT DIS OBSTET GY, P1
   Broomall EM, 2010, POSTGRAD MED, V122, P121, DOI 10.3810/pgm.2010.03.2129
   Castro Therezita M. Peixoto Patury Galvão, 2009, Rev. Bras. Otorrinolaringol., V75, P167, DOI 10.1590/S0034-72992009000200002
   Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016
   DASILVA MFB, 2009, GENET MOL RES, V8, P1437, DOI DOI 10.4238/VOL8-4GMR677
   GIULIANO A, 2009, 25 INT PAP C CLIN ED
   Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996
   Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x
   Derchain SFM, 2007, REV BRAS GINECOL OBS, V29, P281, DOI 10.1590/S0100-72032007000600001
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Park RB, 2002, J VIROL, V76, P11359, DOI 10.1128/JVI.76.22.11359-11364.2002
   Rama C, 2008, REV SAUDE PUBL, V42, P411, DOI 10.1590/S0034-89102008000300004
   Rama CH, 2008, REV SAUDE PUBL, V42, P123, DOI [10.1590/S0034-89102008000100016, 10.1590/s0034-89102008000100016]
   Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948
NR 14
TC 12
Z9 12
U1 0
U2 3
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA HUDSON 655, JARDIM CANADA, RIBEIRAO PRETO, SP, BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2012
VL 11
IS 1
BP 462
EP 466
DI 10.4238/2012.March.1.3
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 914BK
UT WOS:000301923500051
PM 22427039
OA Bronze
DA 2020-12-08
ER

PT J
AU Schreiber, R
   Campos-Coelho, AV
   Brandao, L
   Guimaraes, RL
   Kamada, AJ
   Ferreira-Sae, MC
   Matos-Souza, JR
   Cipolli, JA
   de Lima, JL
   Crovella, S
   Nadruz, W
AF Schreiber, R.
   Campos-Coelho, A. V.
   Brandao, L.
   Guimaraes, R. L.
   Kamada, A. J.
   Ferreira-Sae, M. C.
   Matos-Souza, J. R.
   Cipolli, J. A.
   de Lima-Filho, J. L.
   Crovella, S.
   Nadruz, W., Jr.
TI Mannose-binding lectin (MBL2) polymorphisms and inflammation in
   hypertensive patients
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID DEFICIENCY
AB We investigated the possible role of Mannose binding lectin 2 (MBL2) functional polymorphisms in the prevalence of hypertension and hypertensive end-organ damage in 300 hypertensive patients and 313 normotensive individuals from Southern Brazil. Hypertensive subjects with MBL2 AO/OO genotypes presented lower C-reactive protein levels than AA individuals and consequently lower inflammatory status.
C1 [Schreiber, R.; Ferreira-Sae, M. C.; Matos-Souza, J. R.; Cipolli, J. A.; Nadruz, W., Jr.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.
   [Campos-Coelho, A. V.; Brandao, L.; Guimaraes, R. L.; Kamada, A. J.; de Lima-Filho, J. L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovelser@gmail.com
RI Crovella, Sergio/K-5050-2016; Filho, Jose Luiz Lima/M-8076-2019; Junior,
   Wilson Nadruz/I-3643-2013; Brandao, Lucas Andre Cavalcanti/G-8333-2012;
   Coelho, Antonio Victor C/E-6795-2015; Schreiber, Roberto/G-4995-2013;
   Kamada, Anselmo Jiro/H-3006-2012
OI Crovella, Sergio/0000-0001-8493-1168; Junior, Wilson
   Nadruz/0000-0002-0003-5102; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Coelho, Antonio Victor
   C/0000-0003-2143-9701; Kamada, Anselmo Jiro/0000-0002-0437-0151
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [05/56986-5]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico, BrazilNational Council for
   Scientific and Technological Development (CNPq) [304329/06-1,
   474206/07-6]
FX This study was sponsored by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (Proc. 05/56986-5) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (Proc. 304329/06-1 and
   474206/07-6), Brazil.
CR Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433
   Collard CD, 2007, CIRCULATION, V116, pI106, DOI 10.1161/CIRCULATIONAHA.106.679530
   Dahl M, 2004, J EXP MED, V199, P1391, DOI 10.1084/jem.20040111
   Hansen TK, 2010, DIABETOLOGIA, V53, P1517, DOI 10.1007/s00125-010-1742-8
   Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006
   Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e
   Rugonfalvi-Kiss S, 2005, STROKE, V36, P944, DOI 10.1161/01.STR.0000160752.67422.18
   Sales ML, 2010, AM J HYPERTENS, V23, P649, DOI 10.1038/ajh.2010.24
   Sales ML, 2010, CLIN CHIM ACTA, V411, P744, DOI 10.1016/j.cca.2010.02.006
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
NR 12
TC 1
Z9 1
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1744-3121
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD DEC
PY 2011
VL 38
IS 6
BP 525
EP 527
DI 10.1111/j.1744-313X.2011.01036.x
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 851HA
UT WOS:000297257800009
PM 21895981
DA 2020-12-08
ER

PT J
AU Kido, EA
   Barbosa, PKD
   Neto, JRCF
   Pandolfi, V
   Houllou-Kido, LM
   Crovella, S
   Molina, C
   Kahl, G
   Benko-Iseppon, AM
AF Kido, Ederson Akio
   de Araujo Barbosa, Pedranne Kelle
   Costa Ferreira Neto, Jose Ribamar
   Pandolfi, Valesca
   Houllou-Kido, Laureen Michelle
   Crovella, Sergio
   Molina, Carlos
   Kahl, Guenter
   Benko-Iseppon, Ana Maria
TI Identification of Plant Protein Kinases in Response to Abiotic and
   Biotic Stresses Using SuperSAGE
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Cowpea; salinity; potyvirus infection; plant signaling
ID NUCLEOSIDE DIPHOSPHATE KINASE; GENE-EXPRESSION; SERIAL ANALYSIS;
   PHOSPHATIDYLCHOLINE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; REVEAL CHANGES;
   SAGE ANALYSIS; ORYZA-SATIVA; SALT STRESS; CELL-DEATH
AB Plants are sessile organisms subjected to many environmental adversities. For their survival they must sense and respond to biotic and abiotic stresses efficiently. During this process, protein kinases are essential in the perception of environmental stimuli, triggering signaling cascades. Kinases are among the largest and most important gene families for biotechnological purposes, bringing many challenges to the bioinformaticians due to the combination of conserved domains besides diversified regions. Cowpea [Vigna unguiculata (L.) Walp.] is an important legume that is adapted to different agroclimatic conditions, including drought, humidity and a range of temperatures. For this crop, the association of the SuperSAGE method with high-throughput sequencing technology would generate reliable transcriptome profiles with millions of tags counted and statistically analyzed. An approach evaluating biotic and abiotic stresses was carried out generating over 13 million cowpea SuperSAGE tags available from leaves/ roots of plants under abiotic (mechanical injury and salinity) or biotic (CABMV, Cowpea aphid born mosaic virus) stresses. The annotation and identification of tags linked by BlastN to previously well described ESTs, allowed the posterior identification of kinases. The annotation efficiency depended on the database used, with the KEGG figuring as a good source for annotated ESTs especially when complemented by an independent Gene Ontology categorization, as well as the Gene Index using selected species. The use of different approaches allowed the identification of 1,350 kinase candidates considering biotic libraries and 2,268 regarding abiotic libraries, based on a combination of both, adequate descriptions and GO terms. Additional searches in kinase specific databases allowed the identification of a relatively low number of additional kinases, uncovering the lack of kinase databases for non-model organisms, especially plants. Concerning the kinase families, a total of 713 potential kinases were classified into 13 families of the CMGC and STE groups. Concerning the differentially expressed kinases, 169 of the 713 potential kinases were identified (p < 0.05), 100 up-and 69 down-regulated when comparing distinct libraries, allowing the generation of a comprehensive panel of the differentially expressed kinases under biotic and abiotic stresses in a non-model plant as cowpea.
C1 [Kido, Ederson Akio; de Araujo Barbosa, Pedranne Kelle; Costa Ferreira Neto, Jose Ribamar; Pandolfi, Valesca; Houllou-Kido, Laureen Michelle; Crovella, Sergio; Benko-Iseppon, Ana Maria] Univ Fed Pernambuco, Ctr Biol Sci, Dept Genet, BR-50670420 Recife, PE, Brazil.
   [Molina, Carlos; Kahl, Guenter] Goethe Univ Frankfurt, Bioctr, D-60439 Frankfurt, Germany.
RP Benko-Iseppon, AM (corresponding author), Univ Fed Pernambuco, Ctr Biol Sci, Dept Genet, Av Prof Moraes Rego 1235, BR-50670420 Recife, PE, Brazil.
EM ana.benko.iseppon@pq.cnpq.br
RI Kido, Ederson Akio/P-9932-2019; Crovella, Sergio/K-5050-2016; Pandolfi,
   Valesca/L-1637-2016; Iseppon, Ana Maria Benko/M-5527-2019; Kido, Ederson
   A/E-2489-2016
OI Kido, Ederson Akio/0000-0001-5484-993X; Crovella,
   Sergio/0000-0001-8493-1168; Pandolfi, Valesca/0000-0003-2283-5669;
   Iseppon, Ana Maria Benko/0000-0002-0575-3197; Kido, Ederson
   A/0000-0001-5484-993X
FU Banco do Nordeste do Brasil (BNB); Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco (FACEPE); Financiadora de Estudos e
   Projetos (FINEP)Ciencia Tecnologia e Inovacao (FINEP); Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; DAAD (German
   Academic Exchange Service, Germany)Deutscher Akademischer Austausch
   Dienst (DAAD)
FX The authors thank Dr. Bjorn Rotter, Ruth Jungmann and Dr. Peter Winter
   (GenXPro GmbH) for scientific and technical advices. This work has been
   funded by brazilian intitutions: Banco do Nordeste do Brasil (BNB),
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE), Financiadora de Estudos e Projetos (FINEP), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq) e Fundacao
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). EAK
   also thanks to DAAD (German Academic Exchange Service, Germany) for
   travel fellowship.
CR Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2010, KINASE SEQUENCE DATA
   [Anonymous], 2010, SOYBEAN PHYTOZOME V5
   [Anonymous], KYOTO ENCY GENES GEN
   [Anonymous], 2010, REFERENCE SEQUENCE D
   [Anonymous], 2010, KINASE SUBSTRATE DAT
   [Anonymous], 2010, RICE KINASE DATABASE
   [Anonymous], 2010, KINASE PATHWAY DATAB
   Arisz SA, 2009, BBA-MOL CELL BIOL L, V1791, P869, DOI 10.1016/j.bbalip.2009.04.006
   Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487
   Calsa T, 2007, PLANT MOL BIOL, V63, P745, DOI 10.1007/s11103-006-9121-z
   Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9
   Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259
   Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410
   Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645
   Chiasson D, 2005, PLANT MOL BIOL, V58, P887, DOI 10.1007/s11103-005-8395-x
   Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005
   Cho SM, 2004, MOL CELLS, V18, P390
   Coemans B, 2005, THEOR APPL GENET, V111, P1118, DOI 10.1007/s00122-005-0039-7
   Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7
   De Carvalho MCDG, 2008, TREE PHYSIOL, V28, P905, DOI 10.1093/treephys/28.6.905
   Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270
   Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958
   Eckardt NA, 2009, PLANT CELL, V21, P2545, DOI 10.1105/tpc.109.210913
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ekman DR, 2003, PLANT PHYSIOL, V133, P1397, DOI 10.1104/pp.103.028019
   Etheridge Naomi, 2005, Briefings in Functional Genomics & Proteomics, V3, P372, DOI 10.1093/bfgp/3.4.372
   Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014
   Functional Genomics of Plant Phosphorylation, 2010, FUNCTIONAL GENOMICS
   Galvis MLE, 2001, PLANT PHYSIOL, V126, P69, DOI 10.1104/pp.126.1.69
   Gilardoni PA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-66
   Hamada H, 2008, J GEN PLANT PATHOL, V74, P313, DOI 10.1007/s10327-008-0106-4
   HANKS SK, 1995, FASEB J, V9, P576
   HARRIS N, 1994, PLANT MOL BIOL, V25, P739, DOI 10.1007/BF00029611
   Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921
   Irian S, 2007, MOL PLANT MICROBE IN, V20, P1477, DOI 10.1094/MPMI-20-12-1477
   Jung SH, 2003, PLANT MOL BIOL, V52, P553, DOI 10.1023/A:1024866716987
   Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7
   KINNEY AJ, 1987, BIOCHEM J, V242, P755, DOI 10.1042/bj2420755
   Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884
   Koike A, 2003, GENOME RES, V13, P1231, DOI 10.1101/gr.835903
   Lee JY, 2003, PLANT PHYSIOL, V132, P517, DOI 10.1104/pp.103.020511
   Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008
   Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2
   Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018
   Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x
   Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100
   Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x
   Matsumura H, 2006, NAT METHODS, V3, P469, DOI 10.1038/NMETH882
   McIntosh S, 2007, PLANT BIOTECHNOL J, V5, P69, DOI 10.1111/j.1467-7652.2006.00218.x
   Mitsuya Y, 2009, J PLANT PHYSIOL, V166, P626, DOI 10.1016/j.jplph.2008.08.006
   Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553
   Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899
   Nasir KHB, 2005, PLANT J, V43, P491, DOI 10.1111/j.1365-313X.2005.02472.x
   Nielsen KL, 2005, PLANT BIOTECHNOL J, V3, P175, DOI 10.1111/j.1467-7652.2005.00115.x
   Nose M., 2010, FOR PATH, P1
   Novikova GV, 1999, PLANTA, V208, P239, DOI 10.1007/s004250050555
   Oktem H. A., 2008, GENES GENOMES GENOMI, V2, P14
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134
   Peck SC, 2003, CURR OPIN PLANT BIOL, V6, P334, DOI 10.1016/S1369-5266(03)00056-6
   Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232
   Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008
   Poole RL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-475
   Poroyko V, 2005, PLANT PHYSIOL, V138, P1700, DOI 10.1104/pp.104.057638
   Resource for Plant Comparative Genomics, 2010, RESOURCE PLANT COMP
   Robinson SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-434
   Milla MA, 2006, PLANT MOL BIOL, V61, P13, DOI 10.1007/s11103-005-5798-7
   Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X
   Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013
   Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x
   SIKORSKA E, 1980, PHYSIOL PLANTARUM, V48, P201, DOI 10.1111/j.1399-3054.1980.tb03242.x
   Song GS, 2010, MOL PLANT, V3, P1012, DOI 10.1093/mp/ssq046
   Song SH, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-49
   Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257
   Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015
   Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002
   Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369
   Tzeng TY, 2009, PLANT CELL PHYSIOL, V50, P1695, DOI 10.1093/pcp/pcp114
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Universal Protein Resource - UniProt, 2010, UN PROT RES
   Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Venkatachalam P., 2010, INT J PLANT BIOL, V1, P33, DOI DOI 10.4081/pb.2010.e7
   Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3
   White J, 2006, PLANT BIOTECHNOL J, V4, P289, DOI 10.1111/j.1467-7652.2006.00181.x
   White J, 2008, PLANT SCI, V175, P858, DOI 10.1016/j.plantsci.2008.08.008
   Xing T, 2002, TRENDS PLANT SCI, V7, P224, DOI 10.1016/S1360-1385(02)02255-0
   Xing T, 2001, MOL PLANT MICROBE IN, V14, P1261, DOI 10.1094/MPMI.2001.14.10.1261
   Zimmermann S, 1999, J BIOL CHEM, V274, P17017, DOI 10.1074/jbc.274.24.17017
   GENE INDEX PROJECT
NR 96
TC 10
Z9 11
U1 1
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD NOV
PY 2011
VL 12
IS 7
BP 643
EP 656
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 882LD
UT WOS:000299564300007
PM 21827428
DA 2020-12-08
ER

PT J
AU Segat, L
   Crovella, S
AF Segat, Ludovica
   Crovella, Sergio
TI MBL1 gene in nonhuman primates
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE MBL1; Evolution; Nonhuman primates; Pseudogene; Sequencing; Synteny
ID MANNOSE-BINDING PROTEIN; SEQUENCE ALIGNMENT; LECTIN; REVEALS;
   CHROMOSOME-10; EVOLUTION; INFECTION
AB With the aim of investigating the evolution of MBL1P1 (MBL1) gene, we analyzed the MBL1 coding region sequences in several specimens of two species of great apes, two species of Hylobatidae, four species of Cercopithecidae, and one Platyrrhine species, and in human beings. An indication for a progressive silencing of the molecule has been found. We found a similar to 300 bp insertion in the first intron of MBL1 in the Cercopithecidae that could explain the different splicing between primates species and possibly why Macaca mulatta is able to produce a complete protein, whereas in human beings the protein product is truncated. Based on our genetic findings, we could speculate that all the Cercopithecidae (presenting the 300-bp insertion) may express MBL1 mature protein like the M mulatta, whereas the lesser and great apes, which lack this insertion as do human beings, may have only the truncated pseudogene. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Segat, Ludovica] IRCCS Burio Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burio Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo (Trieste, Italy) [RC03/04]; FACEPE (Recife,
   Pernambuco, Brazil) [APQ APQ-0757-2.02/10]; FACEPE [APQ-0020-4.01/08];
   TALENTS Programme (7th R&D Framework Programme, Specific Programme:
   PEOPLE Marie Curie Actions-COFUND)
FX The authors thank dr. Mario Ventura for his support in cytogenetic
   analysis. This study has been supported by a grant (RC03/04) from IRCCS
   Burlo Garofolo (Trieste, Italy) and by the project APQ APQ-0757-2.02/10
   from FACEPE (Recife, Pernambuco, Brazil). IS is recipient of a
   fellowship grant (APQ-0020-4.01/08) from FACEPE. S.C. is recipient of a
   grant from the TALENTS Programme (7th R&D Framework Programme, Specific
   Programme: PEOPLE Marie Curie Actions-COFUND).
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
   Guo N, 1998, MAMM GENOME, V9, P246, DOI 10.1007/s003359900735
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634
   Mogues T, 1996, GLYCOBIOLOGY, V6, P543, DOI 10.1093/glycob/6.5.543
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175
   SASTRY K, 1991, J IMMUNOL, V147, P692
   SASTRY R, 1995, MAMM GENOME, V6, P103, DOI 10.1007/BF00303252
   SENALDI G, 1995, J INFECTION, V31, P145, DOI 10.1016/S0163-4453(95)92185-0
   Seyfarth J, 2005, HUM MOL GENET, V14, P2859, DOI 10.1093/hmg/ddi318
   SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9
   Turner M W, 2000, Rev Immunogenet, V2, P305
   Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   WHITE RA, 1994, MAMM GENOME, V5, P807, DOI 10.1007/BF00292020
NR 22
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD NOV
PY 2011
VL 72
IS 11
BP 1084
EP 1090
DI 10.1016/j.humimm.2011.08.009
PG 7
WC Immunology
SC Immunology
GA 841WO
UT WOS:000296546100017
PM 21889966
DA 2020-12-08
ER

PT J
AU Chagas, BS
   Batista, MVA
   Guimaraes, V
   Balbino, VQ
   Crovella, S
   Freitas, AC
AF Chagas, Barbara S.
   Batista, Marcus V. A.
   Guimaraes, Vilma
   Balbino, Valdir Q.
   Crovella, Sergio
   Freitas, Antonio C.
TI New variants of E6 and E7 oncogenes of human papillomavirus type 31
   identified in Northeastern Brazil
SO GYNECOLOGIC ONCOLOGY
LA English
DT Article
DE Human papillomavirus variants; Genetic diversity; Cervical cancer
ID CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS-16 E6; SEQUENCE
   VARIANTS; BINDING-SITES; RISK; PREDICTION; LESIONS; CANCER; GENE;
   POLYMORPHISM
AB Objective. We sought to characterize E6 and E7 oncogenes genetic variability of HPV-31 isolated from cervical scraping samples of Northeastern Brazilian women.
   Methods. E6 and E7 were amplified with specific primers, cloned and sequenced. The sequences obtained were aligned with the GenBank reference sequences with the aim of evaluating the possible genetic variants.
   Results. We identified several genetic variants in E6 and E7 sequences from HPV-31 positive women. Three nucleotide changes in E6 were described for the first time in this study. Some nucleotide changes were non-synonymous substitutions.
   Conclusion. The knowledge of region/country HPV specific genetic variations is relevant to understand the epidemiology and the development of effective vaccines. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Chagas, Barbara S.; Batista, Marcus V. A.; Balbino, Valdir Q.; Crovella, Sergio; Freitas, Antonio C.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Guimaraes, Vilma] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Crovella, Sergio; Freitas, Antonio C.] Univ Fed Pernambuco, Lab Immunopathol Keizo Azami, Recife, PE, Brazil.
   [Crovella, Sergio] Genet Serv IRCCS Burlo Garofolo, Trieste, Italy.
RP Freitas, AC (corresponding author), Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM antonio.freitas@pq.cnpq.br
RI Batista, Marcus VA/E-3223-2013; Freitas, Antonio/G-1843-2012; Crovella,
   Sergio/K-5050-2016; Chagas, Barbara/M-9327-2019; Balbino, Valdir de
   Queiroz/H-6877-2014
OI Batista, Marcus VA/0000-0003-4745-8919; Freitas,
   Antonio/0000-0002-4957-9549; Crovella, Sergio/0000-0001-8493-1168; Simas
   Chagas, Barbara/0000-0003-3917-9055; Balbino, Valdir de
   Queiroz/0000-0002-4319-3952
FU Brazilian Institute CNPq; FACEPE; European Project "Talents for an
   International House" within the framework of the 7th Research &
   Development Framework Programme PEOPLE - Marie Curie Actions - COFUND;
   Regional, National and International Programmes
FX We would like to thank the Brazilian Institute CNPq and FACEPE for
   providing Research Fellowship for M.V.A.B and B.S.C. Doctoral Degree,
   respectively. The authors also thank the Program for Technological
   Development in Tools for Health-PDTISFIOCRUZ for the use of its
   facilities. SC is recipient of a fellowship grant from European Project
   "Talents for an International House" within the framework of the 7th
   Research & Development Framework Programme PEOPLE - Marie Curie Actions
   - COFUND (Co-Funding of Regional, National and International
   Programmes).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677
   Bernard HU, 2002, ANTIVIR THER, V7, P219
   Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-X
   BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
   Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005
   CLIFFORD GM, 2006, VACCINE
   de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037
   de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
   Hu XR, 2001, J PATHOL, V195, P307, DOI 10.1002/path.944
   Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024
   KAST WM, 1994, J IMMUNOL, V152, P3904
   Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003
   Londesborough P, 1996, INT J CANCER, V69, P364
   Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x
   Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Raiol T, 2009, J MED VIROL, V81, P685, DOI 10.1002/jmv.21432
   Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197
   Sichero L, 2006, BRAZ J MED BIOL RES, V39, P707, DOI 10.1590/S0100-879X2006000600002
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Song YS, 1997, GYNECOL ONCOL, V66, P275, DOI 10.1006/gyno.1997.4756
   Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361
   Swofford D.L., 2002, PAUP PHYLOGENETIC AN
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054
   Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796
   Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520
   Zehbe I, 1998, CANCER RES, V58, P829
   Zehbe I, 2001, CANCER RES, V61, P608
NR 31
TC 13
Z9 13
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0090-8258
EI 1095-6859
J9 GYNECOL ONCOL
JI Gynecol. Oncol.
PD NOV
PY 2011
VL 123
IS 2
BP 284
EP 288
DI 10.1016/j.ygyno.2011.07.008
PG 5
WC Oncology; Obstetrics & Gynecology
SC Oncology; Obstetrics & Gynecology
GA 839ZJ
UT WOS:000296407700020
PM 21802716
DA 2020-12-08
ER

PT J
AU Barkokebas, A
   Carvalho, ADT
   de Souza, PRE
   Gomez, RS
   Xavier, GM
   Ribeiro, CMB
   Crovella, S
   Porter, SR
   Leao, JC
AF Barkokebas, Andreza
   Carvalho, Alessandra de Albuquerque T.
   Eleuterio de Souza, Paulo Roberto
   Gomez, Ricardo Santiago
   Xavier, Guilherme Machado
   Beder Ribeiro, Camila Maria
   Crovella, Sergio
   Porter, Stephen Ross
   Leao, Jair Carneiro
TI Mannose-binding lectin gene (MBL-2) polymorphism in oral lichen planus
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Oral lichen planus; Polymorphism; Mannose-binding lectin
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR;
   RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA; FACTOR-ALPHA; SUSCEPTIBILITY;
   DISEASE; INTERLEUKIN-1-BETA; ASSOCIATION; PROGRESSION
AB TNF-alpha may be associated with the etiopathogenesis of oral lichen planus (OLP), and it has been suggested that polymorphism of mannose-binding lectin (MBL) increases the in vitro production of TNF-alpha. The aim of the present study was to assess the relevance of genetic diversity of MBL in OLP. The study sample comprised 90 individuals, 45 OLP patients and 45 healthy volunteers. MBL-2 gene was amplified using real-time PCR. Frequency of A/A genotype was 55.6% in OLP and 53.3% in healthy volunteers. Likewise, A/0 heterozygote genotype was found in 42.2% and 35.6%; 2.2% and 11.1%, had the recessive 0/0 genotype respectively. Frequencies of the "A" and "0" alleles were 77% and 23% in the OLP group and 71.2% in control group. There were no statistically significant differences regarding genotype frequency (p=0.546) or allele frequency (p=0.497). In conclusion, no significant association was found between polymorphism of MBL-2 gene and OLP.
C1 [Carvalho, Alessandra de Albuquerque T.; Beder Ribeiro, Camila Maria; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Barkokebas, Andreza] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Eleuterio de Souza, Paulo Roberto] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Gomez, Ricardo Santiago; Xavier, Guilherme Machado] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Belo Horizonte, MG, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
   [Porter, Stephen Ross] Eastman Dent Inst, Oral Med Unit, Div Maxillofacial Diagnost Surg & Med Sci, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Crovella, Sergio/K-5050-2016; Gomez, Ricardo Santiago/G-1976-2012; Leao,
   Jair Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Crovella, Sergio/0000-0001-8493-1168; Gomez, Ricardo
   Santiago/0000-0001-8770-8009; Leao, Jair Carneiro/0000-0001-8303-2291;
   Souza, Paulo/0000-0002-9186-9849; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079; Porter, Stephen/0000-0002-3328-2759
CR Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Bidarra M, 2008, J ORAL PATHOL MED, V37, P582, DOI 10.1111/j.1600-0714.2008.00703.x
   Boniotto M, 2005, J MOL MED, V83, P308, DOI 10.1007/s00109-004-0623-3
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Carrozzo M, 2004, J INVEST DERMATOL, V122, P87, DOI 10.1046/j.0022-202X.2003.22108.x
   Chainani-Wu N, 2001, J AM DENT ASSOC, V132, P901, DOI 10.14219/jada.archive.2001.0302
   Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x
   Fayyazi A, 1999, ARCH DERMATOL RES, V291, P485, DOI 10.1007/s004030050442
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Garred P, 2000, J RHEUMATOL, V27, P26
   Graudal NA, 1998, J RHEUMATOL, V25, P629
   Grossmann SMC, 2006, ARQUIVOS ODONTOLOGIA, V42, P1
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
   Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.0.CO;2-D
   Ismail Sumairi B, 2007, J Oral Sci, V49, P89
   Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   KARAGOUNI EE, 1994, J ORAL PATHOL MED, V23, P28, DOI 10.1111/j.1600-0714.1994.tb00250.x
   Leao J C, 1999, Rev Assoc Med Bras (1992), V45, P55, DOI 10.1590/S0104-42301999000100011
   Lee YH, 2005, ARTHRITIS RHEUM-US, V52, P3966, DOI 10.1002/art.21484
   Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9
   Manolache L, 2008, J EUR ACAD DERMATOL, V22, P437, DOI 10.1111/j.1468-3083.2007.02458.x
   Mendonca RMH, 2006, 14 C BRAS EST NAT RN, P279
   Messias-Reason I, 2008, CLIN EXP DERMATOL, V33, P495, DOI 10.1111/j.1365-2230.2008.02743.x
   Mullighan CG, 2000, ARTHRITIS RHEUM, V43, P2851, DOI 10.1002/1529-0131(200012)43:12<2851::AID-ANR28>3.0.CO;2-W
   Navas-Alfaro SE, 2003, J BRAS PATOL MED LAB, V39, P4
   Papapanou Panos N, 2002, Ann Periodontol, V7, P54, DOI 10.1902/annals.2002.7.1.54
   Pezelj-Ribaric S, 2004, MEDIAT INFLAMM, V13, P131, DOI 10.1080/09629350410001688530
   POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x
   Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
   Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x
   Worthley DL, 2006, WORLD J GASTROENTERO, V12, P6420, DOI 10.3748/wjg.v12.i40.6420
   Xavier GM, 2007, J ORAL PATHOL MED, V36, P476, DOI 10.1111/j.1600-0714.2007.00560.x
NR 43
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD OCT
PY 2011
VL 15
IS 5
BP 699
EP 704
DI 10.1007/s00784-010-0428-4
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 846HU
UT WOS:000296888600014
PM 20499118
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Piscianz, E
   Girardelli, M
   Crovella, S
   Pontillo, A
AF Marcuzzi, Annalisa
   Piscianz, Elisa
   Girardelli, Martina
   Crovella, Sergio
   Pontillo, Alessandra
TI Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine
   monocytes
SO APOPTOSIS
LA English
DT Article
DE Pyroptosis; Apoptosis; Caspase; Mevalonate
ID KINASE-DEFICIENCY; NATURAL ISOPRENOIDS; PROTEIN PRENYLATION; CINCA
   SYNDROME; APOPTOSIS; INHIBITION; CELLS; ANAKINRA; GERANYLGERANYLATION;
   INFLAMMATION
AB The inhibition of mevalonate pathway by the aminobisphosphonate alendronate (ALD) has been previously associated with an augmented lipopolysaccharide-induced interleukin-1beta (IL-1 beta) secretion in monocytes, as demonstrated in an auto-inflammatory disease known as mevalonate kinase deficiency (MKD). In this study we investigated the effect of ALD + LPS on monocyte cell line (Raw 264.7) death. ALD strongly augmented LPS-induced programmed cell death (PCD) as well as IL-1 beta secretion in Raw murine monocytes, whereas necrosis was rather unaffected. ALD + LPS induced caspase-3 activation. Inhibition of IL-1 beta stimulation partially restored cell viability. These findings suggest that the inhibition of mevalonate pathway, together with a bacterial stimulus, induce a PCD partly sustained by the caspase-3-related apoptosis and partly by caspase-1-associated pyroptosis. The involvement of pyroptosis is a novel hit in our cell model and opens discussions about its role in inflammatory cells with chemical or genetic inhibition of mevalonate pathway.
C1 [Marcuzzi, Annalisa; Girardelli, Martina; Crovella, Sergio; Pontillo, Alessandra] Inst Maternal & Child Hlth Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   [Piscianz, Elisa] Univ Trieste, Dept Reprod & Dev Sci & Publ Hlth Care, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-740530 Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Pontillo, ALESSANDRA/D-4352-2012;
   Pontillo, Alessandra/AAD-4790-2019; Marcuzzi, Annalisa/AAA-6038-2020;
   Crovella, Sergio/K-5050-2016; Girardelli, Martina/K-7199-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Marcuzzi, Annalisa/0000-0003-3427-618X;
   Crovella, Sergio/0000-0001-8493-1168; Girardelli,
   Martina/0000-0003-1186-4907; Piscianz, Elisa/0000-0001-7374-1684
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo" [RC
   13/08]; European Project "Talents for an International House" within the
   framework of the 7th Research & Development Framework Programme
   PEOPLE-Marie Curie Actions-COFUND
FX The authors are grateful to Dr. A. Tommasini (Paediatric Division, IRCCS
   "Burlo Garofolo") for providing Kineret (R). This work was supported by
   a grant from the Institute for Maternal and Child Health IRCCS "Burlo
   Garofolo" (RC 13/08). SC is recipient of a fellowship grant from
   European Project "Talents for an International House" within the
   framework of the 7th Research & Development Framework Programme
   PEOPLE-Marie Curie Actions-COFUND (Co-Funding of Regional National and
   International Programmes).
CR Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Braun T, 2008, BRIT J HAEMATOL, V141, P576, DOI 10.1111/j.1365-2141.2008.07099.x
   Callejas JL, 2007, CLIN RHEUMATOL, V26, P576, DOI 10.1007/s10067-005-0168-z
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Dunford JE, 2006, J BONE MINER RES, V21, P684, DOI 10.1359/JBMR.060118
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   Granel B, 2005, RHEUMATOLOGY, V44, P689, DOI 10.1093/rheumatology/keh547
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033
   Hirota R, 2010, J FOOD SCI, V75, pH87, DOI 10.1111/j.1750-3841.2010.01541.x
   Kastelan M, 2009, ACTA DERMATOVENER CR, V17, P182
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Mo HB, 2004, EXP BIOL MED, V229, P567
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moss JE, 1999, INT REV CYTOL, V187, P203, DOI 10.1016/S0074-7696(08)62419-5
   Nagashima T, 2006, ARTHRITIS RHEUM-US, V54, P579, DOI 10.1002/art.21564
   Nevyjel M, 2007, PEDIATRICS, V119, pE523, DOI 10.1542/peds.2006-2015
   Pontillo A, 2010, EUR J HUM GENET, V18, P844, DOI 10.1038/ejhg.2010.9
   Rung E, 2006, MOL REPROD DEV, V73, P1277, DOI 10.1002/mrd.20551
   Toyras A, 2003, EUR J PHARM SCI, V19, P223, DOI 10.1016/S0928-0987(03)00108-8
NR 25
TC 18
Z9 18
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1360-8185
J9 APOPTOSIS
JI Apoptosis
PD SEP
PY 2011
VL 16
IS 9
BP 882
EP 888
DI 10.1007/s10495-011-0621-1
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 805CT
UT WOS:000293704700002
PM 21667041
DA 2020-12-08
ER

PT J
AU Comar, M
   Segat, L
   Crovella, S
   Bovenzi, M
   Cortini, E
   Tognon, M
AF Comar, Manola
   Segat, Luclovica
   Crovella, Sergio
   Bovenzi, Massimo
   Cortini, Enzo
   Tognon, Mauro
TI The significance of mannose-binding lectin gene polymorphisms on the
   risk of BK virus coinfection in women with human papillomavirus-positive
   cervical lesions
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE HPV; BKV; HSIL; LSIL; MBL2; Mannose-binding lectin
ID CLINICAL-IMPLICATIONS; PROSTATE-CANCER; DNA VIRUSES; T-ANTIGEN; MBL2
   GENE; INFECTION; SIMIAN-VIRUS-40; TRANSPLANTATION; DEFICIENCY; CHILDREN
AB The simultaneous detection of oncogenic human papillomavirus (HPV) and BK virus (BIN) has been recently reported in cervical cancers, suggesting that these viruses may act together in the process of cell transformation; host genetic polymorphisms may also influence virus persistence/reactivation. To disclose a possible role of the gene encoding for the mannose-binding lectin, MBL2, in susceptibility to BIN infection, we analyzed functional polymorphisms in the first exon of MBL2 in women stratified for the presence/absence of BIN and affected by different grades of HPV-induced cervical precancerous lesions. All BIN-positive samples were also HPV positive (HPV 16), and all presented with high-grade squamous intraepithelial lesions. The MBL2 A allele was significantly more frequent in BKV-negative patients than in BKV-positive patients. These data indicate a possible role for the A allele in conferring protection to BKV infection in high-risk HPV-positive women (odds ratio 0.40, 95% confidence interval 0.20-0.85, p = 0.01). (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Segat, Luclovica; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   [Bovenzi, Massimo] Univ Trieste, Dept Reprod Dev & Publ Hlth Sci, Clin Unit Occupat Med, Trieste, Italy.
   [Comar, Manola; Cortini, Enzo] IRCCS Burlo Garofolo, Clin Unit Hyg & Prevent Med, Trieste, Italy.
   [Tognon, Mauro] Univ Ferrara, Dept Morphol & Embryol, Sect Cell Biol & Mol Genet, I-44100 Ferrara, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Comar, Manola/K-4613-2016; COMAR,
   Manola/K-4613-2016
OI Crovella, Sergio/0000-0001-8493-1168; Comar, Manola/0000-0001-6310-3320;
   COMAR, Manola/0000-0002-9487-861X; BOVENZI, MASSIMO/0000-0002-6001-5218;
   Segat, Ludovica/0000-0002-6024-1485
FU Ministries of Research, Italy [IRCCS - Burlo Garofolo RC 13/09];
   Universities of Trieste and Ferrara, Italy; Fondazione Cassa di
   Risparmio di FerraraFondazione Carife; Fondazione Cassa di Risparmio di
   Cento, Italy
FX The technical assistance of Miss Sara Morassut is gratefully
   acknowledged. This study was funded by: IRCCS - Burlo Garofolo RC 13/09
   grant by Ministries of Research, Italy; Universities of Trieste and
   Ferrara, Italy; Fondazione Cassa di Risparmio di Ferrara and Fondazione
   Cassa di Risparmio di Cento, Italy.
CR Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004
   Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Balis V, 2007, INT J BIOL MARKER, V22, P245
   Boothpur R, 2010, J CLIN VIROL, V47, P306, DOI 10.1016/j.jcv.2009.12.006
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Comar M, 2004, TRANSPLANTATION, V78, P544, DOI 10.1097/01.TP.0000136257.02830.29
   Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232
   Comar M, 2010, J MED VIROL, V82, P1236, DOI 10.1002/jmv.21786
   Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07
   Galani E, 2009, CLIN MICROBIOL INFEC, V15, P977, DOI 10.1111/j.1469-0691.2009.03032.x
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   GENDELMAN HE, 1986, P NATL ACAD SCI USA, V83, P9759, DOI 10.1073/pnas.83.24.9759
   Giuliani L, 2007, LUNG CANCER, V57, P273, DOI 10.1016/j.lungcan.2007.02.019
   Giuliani L, 2008, ANTICANCER RES, V28, P1405
   Guimaraes V, 2008, HUM IMMUNOL, V69, P273, DOI 10.1016/j.humimm.2008.03.002
   Hara K, 1998, J VIROL, V72, P5335, DOI 10.1128/JVI.72.7.5335-5342.1998
   Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266
   Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5
   Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]
   Martini F, 2004, CANCER INVEST, V22, P697, DOI 10.1081/CNV-200032937
   Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506
   Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011
   Segat L, 2009, HUM IMMUNOL, V70, P436, DOI 10.1016/j.humimm.2009.03.006
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x
NR 27
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD AUG
PY 2011
VL 72
IS 8
BP 663
EP 666
DI 10.1016/j.humimm.2011.04.002
PG 4
WC Immunology
SC Immunology
GA 801KU
UT WOS:000293438400009
PM 21536088
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   De Leo, L
   Decorti, G
   Crovella, S
   Tommasini, A
   Pontillo, A
AF Marcuzzi, Annalisa
   De Leo, Luigina
   Decorti, Giuliana
   Crovella, Sergio
   Tommasini, Alberto
   Pontillo, Alessandra
TI The Farnesyltransferase Inhibitors Tipifarnib and Lonafarnib Inhibit
   Cytokines Secretion in a Cellular Model of Mevalonate Kinase Deficiency
SO PEDIATRIC RESEARCH
LA English
DT Article
ID INTERLEUKIN-1-BETA SECRETION; HYPERIMMUNOGLOBULINEMIA-D; NATURAL
   ISOPRENOIDS; PATHWAY; CELLS; FARNESYLATION; MACROPHAGES; ACTIVATION;
   MONOCYTES; SCH66336
AB The shortage of geranylgeranyl-pyrophosphate (GGPP) was associated to an increased IL-1 beta release in the autoinflammatory syndrome mevalonate kinase deficiency (MKD), a rare inherited disease that has no specific therapy. Farnesyltransferase inhibitors (FTIs) act at the end of mevalonate pathway. Two FT Is, Tipifarnib (Tip) and Lonafarnib (Lon), were therefore evaluated as possible therapeutical choices for the treatment of MKD. FTIs could lead to a redirection of the limited available number of mevalonate intermediates preferentially to GGPP synthesis, eventually preventing the uncontrolled inflammatory response. The effect of Tip and Lon on intracellular cholesterol level (ICL) and on proinflammatory cytokines secretion was evaluated in a cellular model of MKD, chemically obtained treating RAW 264.7 cells with lovastatin (Lova) and alendronate (Ald). The combination of FTIs with the isoprenoid geraniol (GOH) was also tested both in this model and in monocytes isolated from MKD patients. Tip and Lon proved to revert the ICL lowering and to significantly reduce the lipopolysaccharide-induced cytokines secretion in Ald-Lova -RAW 264.7 cells. This anti-inflammatory effect was amplified combining the use of GOH with Fits. The effect of GOH and Tip was successfully replicated in MKD patients' monocytes. Tip and Lon showed a dramatic anti-inflammatory effect in monocytes where mevalonate pathway was chemically or genetically impaired. (Pediatr Res 70: 78-82, 2011)
C1 [Marcuzzi, Annalisa; Crovella, Sergio; Pontillo, Alessandra] Inst Maternal & Child Hlth Burlo Garofolo, Med Genet Serv, I-34134 Trieste, Italy.
   [Tommasini, Alberto] Inst Maternal & Child Hlth Burlo Garofolo, Immunopathol Lab, I-34134 Trieste, Italy.
   [De Leo, Luigina] Univ Trieste, Dept Reprod & Dev Sci & Publ Hlth Care, I-34137 Trieste, Italy.
   [Decorti, Giuliana] Univ Trieste, Dept Life Sci, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-50740530 Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34134 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016;
   Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   Tommasini, Alberto/AAE-3882-2020; Marcuzzi, Annalisa/AAA-6038-2020; De
   Leo, Luigina/K-9513-2016
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Tommasini,
   Alberto/0000-0002-6943-7927; Marcuzzi, Annalisa/0000-0003-3427-618X; De
   Leo, Luigina/0000-0003-4013-1630; Decorti, Giuliana/0000-0002-9714-6246
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo," Italy
   [RC 13/2008]
FX Supported by a grant from the Institute for Maternal and Child Health
   IRCCS "Burlo Garofolo," Italy (RC 13/2008).
CR Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565
   Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200
   Baulch-Brown C, 2007, LEUKEMIA RES, V31, P341, DOI 10.1016/j.leukres.2006.07.018
   Braun T, 2008, BRIT J HAEMATOL, V141, P576, DOI 10.1111/j.1365-2141.2008.07099.x
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Deng X, 2007, INT IMMUNOPHARMACOL, V7, P152, DOI 10.1016/j.intimp.2006.09.009
   Desrosiers RR, 2005, INT J CANCER, V114, P702, DOI 10.1002/ijc.20807
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey
   Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13
   Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397
   Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9
   Iftakhar-E-Khuda I, 2009, CLIN EXP IMMUNOL, V155, P552, DOI 10.1111/j.1365-2249.2008.03779.x
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Meara SJ, 2005, BIOCHEM J, V386, P177, DOI 10.1042/BJ20041290
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005
   Venkatasubbarao K, 2005, CANCER RES, V65, P2861, DOI 10.1158/0008-5472.CAN-04-2396
   Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976
NR 24
TC 16
Z9 16
U1 1
U2 4
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 W CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD JUL
PY 2011
VL 70
IS 1
BP 78
EP 82
DI 10.1203/PDR.0b013e31821b581c
PG 5
WC Pediatrics
SC Pediatrics
GA 782MZ
UT WOS:000292015100015
PM 21430599
OA Bronze
DA 2020-12-08
ER

PT J
AU Vatta, S
   Fabris, A
   Segat, L
   Not, T
   Crovella, S
AF Vatta, Serena
   Fabris, Annalisa
   Segat, Ludovica
   Not, Tarcisio
   Crovella, Sergio
TI Tag-single nucleotide polymorphism-based human leukocyte antigen
   genotyping in celiac disease patients from northeastern Italy
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Celiac disease; HLA; Tag-SNPs; Genotyping; Genetic susceptibility;
   Real-time PCR
ID GENETICS; ALLELES; HLA
AB We genotyped celiac disease (CD) associated haplotypes DQ2.5, DQ8, DQ2.2, and DQ7 in 1005 CD patients from North Eastern Italy using a Tag single nucleotide polymorphism (SNPs) approach and real time PCR platform, checking the accuracy and reliability of the method and comparing it to traditional PCR-SSP. Only 14 of 2010 chromosomes analyzed (0.7%) showed discrepancies between the Tag-SNPs real-time polymerase chain reaction (PCR) method and the PCR single-strand polymorphism (SSP) technique, indicating a high sensitivity and specificity (ranging from 0.987 to 1 and from 0.998 to 0.999, respectively) for tagging with respect to corresponding human leukocyte antigen (HLA) alleles identified by PCR-SSP. Moreover, the overall cost of the Tag-SNPs HLA typing method was low (3 to 4 (sic)/sample instead of 35 to 70 /sample with commercial kits), making it suitable for mass screenings. Hence, we believe that the Tag-SNPs HLA typing could be used to complement or replace classic HLA typing in at high-risk groups, for research purposes and eventually in population screening programs. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Fabris, Annalisa; Segat, Ludovica; Crovella, Sergio] Ist Ricovero & Cura Carattere Sci Burlo Garofalo, Genet Serv, Trieste, Italy.
   [Vatta, Serena; Not, Tarcisio] Ist Ricovero & Cura Carattere Sci Burlo Garofalo, Immunopathol Lab, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), Ist Ricovero & Cura Carattere Sci Burlo Garofalo, Genet Serv, Trieste, Italy.
EM segat@burlo.trieste.it
RI Not, Tarcisio/K-2616-2018; Crovella, Sergio/K-5050-2016
OI Not, Tarcisio/0000-0003-1059-3009; Crovella, Sergio/0000-0001-8493-1168;
   Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo (Trieste, Italy) [RC 03/04]; European Project
   "Talents for an International House"
FX This work was supported by the Research project RC 03/04 from IRCCS
   Burlo Garofolo (Trieste, Italy). S.C. is the recipient of a fellowship
   grant from European Project "Talents for an International House" within
   the framework of the 7th Research and Development Framework Programme
   PEOPLE-Marie Curie Actions-COFUND (Co-Funding of Regional, National and
   International Programmes).
CR Brandao LC, 2010, HUM IMMUNOL, V71, P277, DOI 10.1016/j.humimm.2009.12.008
   CUCCA F, 1994, HUM IMMUNOL, V40, P143, DOI 10.1016/0198-8859(94)90060-4
   de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101
   Koskinen L, 2009, IMMUNOGENETICS, V61, P247, DOI 10.1007/s00251-009-0361-3
   Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x
   Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687
   Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270
   Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53
   van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001
NR 11
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUN
PY 2011
VL 72
IS 6
BP 499
EP 502
DI 10.1016/j.humimm.2011.03.008
PG 4
WC Immunology
SC Immunology
GA 771EB
UT WOS:000291138900006
PM 21513759
DA 2020-12-08
ER

PT J
AU Sandrin-Garcia, P
   Brandao, LAC
   Coelho, AVC
   Guimaraes, RL
   Pancoto, JAT
   Segat, L
   Donadi, EA
   de Lima, JL
   Crovella, S
AF Sandrin-Garcia, Paula
   Cavalcanti Brandao, Lucas Andre
   Campos Coelho, Antonio Victor
   Guimaraes, Rafael Lima
   Tres Pancoto, Joao Alexandre
   Segat, Ludovica
   Donadi, Eduardo Antonio
   de Lima-Filho, Jose Luiz
   Crovella, Sergio
TI Mannose binding lectin gene (MBL2) functional polymorphisms are
   associated with systemic lupus erythematosus in southern Brazilians
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Systemic lupus erythematosus; Mannose binding lectin; MBL2 gene
   polymorphisms; Nephritic disorders; Antiphospholipid syndrome
ID RHEUMATOID-ARTHRITIS; VARIANT ALLELES; DISEASE; INFECTION; FREQUENCY;
   PROMOTER; COHORT; RISK; SLE
AB Susceptibility to systemic lupus erythematosus (SLE) has been associated with immunologic, environmental, and genetic factors. To uncover a possible association between MBL2 gene polymorphisms and SLE, we analyzed functional polymorphisms in the promoter and first exon of the MBL2 gene in 134 Brazilian SLE patients and 101 healthy controls. Genotype and allele frequencies of MBL2 A/O polymorphism were significantly different between patients and controls, and the 0 allele was associated with an increased risk of SLE. An association between low mannose binding lectin (MBL) producer combined genotypes and increased risk for SLE was also reported. Furthermore, when stratifying SLE patients according to clinical and laboratory data, an association between the A/O genotype and nephritic disorders and between the X/Y genotype and antiphospholipid syndrome was evident. Combined genotypes responsible for low MBL production were more frequently observed in SLE patients with nephritis. Our results indicate MBL2 polymorphisms as possible risk factors for SLE development and disease-related clinical manifestations. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Segat, Ludovica; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   [Sandrin-Garcia, Paula; Cavalcanti Brandao, Lucas Andre; Campos Coelho, Antonio Victor; Guimaraes, Rafael Lima; de Lima-Filho, Jose Luiz] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Recife, PE, Brazil.
   [Sandrin-Garcia, Paula; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Tres Pancoto, Joao Alexandre; Donadi, Eduardo Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Med, Sao Paulo, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
EM segat@burlo.trieste.it
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Crovella,
   Sergio/K-5050-2016; Filho, Jose Luiz Lima/M-8076-2019; donadi, eduardo
   A/H-7080-2013; Coelho, Antonio Victor C/E-6795-2015
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; donadi, eduardo A/0000-0002-9457-9601;
   Coelho, Antonio Victor C/0000-0003-2143-9701; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE [APQ-1098-4.01/08, APQ-0020-4.01/08]; FACEPE/CNPqNational Council
   for Scientific and Technological Development (CNPq) [(DCR-0089-2.02/08];
   European Project "Talents for an International House"
FX We acknowledge the financial support of FACEPE (APQ-1098-4.01/08) and
   FACEPE/CNPq (DCR-0089-2.02/08). LS is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE. SC is recipient of a fellowship grant
   from European Project "Talents for an International House" within the
   framework of the 7th Research and Development Framework Programme PEOPLE
   - Marie Curie Actions-COFUND (Co-Funding of Regional, National and
   International Programmes).
CR Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Calvo-Alen J, 2006, ARTHRITIS RHEUM-US, V54, P1940, DOI 10.1002/art.21787
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Font J, 2007, RHEUMATOLOGY, V46, P76, DOI 10.1093/rheumatology/kel199
   Garred P, 2001, GENES IMMUN, V2, P442, DOI 10.1038/sj.gene.6363804
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   GARRED P, 1995, LANCET, V346, P941, DOI 10.1016/S0140-6736(95)91559-1
   Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944
   Horiuchi T, 2000, GENES IMMUN, V1, P464, DOI 10.1038/sj.gene.6363710
   Jakab L, 2007, CLIN IMMUNOL, V125, P230, DOI 10.1016/j.clim.2007.08.020
   Lee YH, 2005, ARTHRITIS RHEUM-US, V52, P3966, DOI 10.1002/art.21484
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Momot T, 2006, ANN RHEUM DIS, V65, P278, DOI 10.1136/ard.2005.042929
   Monticielo OA, 2010, LUPUS, V19, P280, DOI 10.1177/0961203309351895
   Monticielo OA, 2008, CLIN RHEUMATOL, V27, P413, DOI 10.1007/s10067-008-0838-8
   Ohlenschlaeger T, 2004, NEW ENGL J MED, V351, P260, DOI 10.1056/NEJMoa033122
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sandrin-Garcia P, 2009, ANN NY ACAD SCI, V1173, P493, DOI 10.1111/j.1749-6632.2009.04636.x
   Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229
   Takahashi R, 2005, ANN RHEUM DIS, V64, P311, DOI 10.1136/ard.2003.020172
   TORRESSALIDO M, 2009, RHEUMATOL INT, V23, P1
   Troelsen LN, 2007, ARTHRITIS RHEUM, V56, P21, DOI 10.1002/art.22302
   Tsutsumi A, 2005, AUTOIMMUN REV, V4, P364, DOI 10.1016/j.autrev.2005.02.004
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
NR 31
TC 19
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUN
PY 2011
VL 72
IS 6
BP 516
EP 521
DI 10.1016/j.humimm.2011.03.007
PG 6
WC Immunology
SC Immunology
GA 771EB
UT WOS:000291138900009
PM 21510992
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Zanin, V
   Vuch, J
   Pontillo, A
   Crovella, S
AF Marcuzzi, Annalisa
   Zanin, Valentina
   Vuch, Josef
   Pontillo, Alessandra
   Crovella, Sergio
TI Acute Effects of Intravenous Administration of Pamidronate in Patients
   with Osteoporosis
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Letter
ID CYTOKINE PROFILES; IN-VITRO; BISPHOSPHONATES; SECRETION
C1 [Marcuzzi, Annalisa; Pontillo, Alessandra; Crovella, Sergio] Inst Maternal & Child Hlth Burlo Garofolo, Med Genet Serv, Trieste, Italy.
   [Zanin, Valentina; Vuch, Josef] Univ Trieste, Dept Reprod & Dev Sci & Publ Hlth Care, I-34127 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-50740530 Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), Dept Reprod & Dev Sci, Via Istria 65-1, I-34134 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Marcuzzi, Annalisa/AAA-6038-2020;
   Pontillo, ALESSANDRA/D-4352-2012; Pontillo, Alessandra/AAD-4790-2019;
   Pontillo, Alessandra/ABC-6266-2020
OI Crovella, Sergio/0000-0001-8493-1168; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Pontillo, ALESSANDRA/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640
CR Carbone LD, 2006, CLIN EXP IMMUNOL, V146, P371, DOI 10.1111/j.1365-2249.2006.03216.x
   CECCHINI MG, 1990, J BONE MINER RES, V5, P1019
   Lim MJ, 2010, J KOREAN MED SCI, V25, P1277, DOI 10.3346/jkms.2010.25.9.1277
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2011, IN VIVO, V25, P87
   PENNANEN N, 1995, PHARMACEUT RES, V12, P916, DOI 10.1023/A:1016281608773
   Slobodin G, 2009, CLIN RHEUMATOL, V28, P1359, DOI 10.1007/s10067-009-1256-2
   Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353
   Van Offel JF, 2001, CLIN EXP RHEUMATOL, V19, P13
NR 9
TC 0
Z9 0
U1 0
U2 4
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD JUN
PY 2011
VL 26
IS 6
BP 848
EP 849
DI 10.3346/jkms.2011.26.6.848
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA 774CF
UT WOS:000291358200025
PM 21655077
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Zanin, V
   Crovella, S
   Pontillo, A
AF Marcuzzi, Annalisa
   Zanin, Valentina
   Crovella, Sergio
   Pontillo, Alessandra
TI Comments on "Geranylgeraniol - A new potential therapeutic approach to
   bisphosphonate associated osteonecrosis of the jaw"
SO ORAL ONCOLOGY
LA English
DT Letter
ID MEVALONATE KINASE-DEFICIENCY; NATURAL ISOPRENOIDS; INFLAMMATION;
   PATHWAY; CELLS
C1 [Marcuzzi, Annalisa; Zanin, Valentina; Crovella, Sergio; Pontillo, Alessandra] IRCCS Burlo Garofolo, Inst Child Hlth, Med Genet Serv, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-50740530 Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), IRCCS Burlo Garofolo, Inst Child Hlth, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Marcuzzi, Annalisa/AAA-6038-2020;
   Pontillo, Alessandra/AAD-4790-2019; Pontillo, ALESSANDRA/D-4352-2012;
   Pontillo, Alessandra/ABC-6266-2020
OI Crovella, Sergio/0000-0001-8493-1168; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, ALESSANDRA/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640
CR DELEO L, 2010, PHARM RES, V10, P639
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2011, IN VIVO, V25, P87
   Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008
   Shipman CM, 1998, CANCER RES, V58, P5294
   Virtanen SS, 2002, CANCER RES, V62, P2708
   Ziebart T, 2011, ORAL ONCOL, V47, P195, DOI 10.1016/j.oraloncology.2010.12.003
NR 7
TC 3
Z9 3
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
J9 ORAL ONCOL
JI Oral Oncol.
PD MAY
PY 2011
VL 47
IS 5
BP 436
EP 437
DI 10.1016/j.oraloncology.2011.02.017
PG 2
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA 765QF
UT WOS:000290723000024
PM 21411362
DA 2020-12-08
ER

PT J
AU Bezzerri, V
   d'Adamo, P
   Rimessi, A
   Lanzara, C
   Crovella, S
   Nicolis, E
   Tamanini, A
   Athanasakis, E
   Tebon, M
   Bisoffi, G
   Drumm, ML
   Knowles, MR
   Pinton, P
   Gasparini, P
   Berton, G
   Cabrini, G
AF Bezzerri, Valentino
   d'Adamo, Pio
   Rimessi, Alessandro
   Lanzara, Carmen
   Crovella, Sergio
   Nicolis, Elena
   Tamanini, Anna
   Athanasakis, Emmanouil
   Tebon, Maela
   Bisoffi, Giulia
   Drumm, Mitchell L.
   Knowles, Michael R.
   Pinton, Paolo
   Gasparini, Paolo
   Berton, Giorgio
   Cabrini, Giulio
TI Phospholipase C-beta 3 Is a Key Modulator of IL-8 Expression in Cystic
   Fibrosis Bronchial Epithelial Cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID TOLL-LIKE RECEPTOR-5; PROTEIN-KINASE-C; LUNG-DISEASE;
   PSEUDOMONAS-AERUGINOSA; AIRWAY EPITHELIA; FLAGELLIN; CALCIUM;
   PHOSPHORYLATION; INFLAMMATION; CHEMOTAXIS
AB Respiratory insufficiency is the major cause of morbidity and mortality in patients affected by cystic fibrosis (CF). An excessive neutrophilic inflammation, mainly orchestrated by the release of IL-8 from bronchial epithelial cells and amplified by chronic bacterial infection with Pseudomonas aeruginosa, leads to progressive tissue destruction. The anti-inflammatory drugs presently used in CF patients have several limitations, indicating the need for identifying novel molecular targets. To address this issue, we preliminarily studied the association of 721 single nucleotide polymorphisms from 135 genes potentially involved in signal transduction implicated in neutrophil recruitment in a cohort of F508del homozygous CF patients with either severe or mild progression of lung disease. The top ranking association was found for a nonsynonymous polymorphism of the phospholipase C-beta 3 (PLCB3) gene. Studies in bronchial epithelial cells exposed to P. aeruginosa revealed that PLCB3 is implicated in extracellular nucleotide-dependent intracellular calcium signaling, leading to activation of the protein kinase C alpha and C beta and of the nuclear transcription factor NF-kappa B p65. The proinflammatory pathway regulated by PLCB3 acts by potentiating the Toll-like Receptors' signaling cascade and represents an interesting molecular target to attenuate the excessive recruitment of neutrophils without completely abolishing the inflammatory response. The Journal of Immunology, 2011, 186: 4946-4958.
C1 [Cabrini, Giulio] Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, I-37126 Verona, Italy.
   [d'Adamo, Pio; Lanzara, Carmen; Crovella, Sergio; Athanasakis, Emmanouil; Gasparini, Paolo] Univ Trieste, Med Genet Lab, Dept Reprod & Dev Sci, I-34137 Trieste, Italy.
   [Rimessi, Alessandro; Pinton, Paolo] Univ Ferrara, Signal Transduct Lab, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
   [Bisoffi, Giulia] Univ Hosp Verona, Biostat Unit, I-37126 Verona, Italy.
   [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.
   [Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Sch Med, Chapel Hill, NC 27599 USA.
   [Berton, Giorgio] Univ Verona, Sect Gen Pathol, Dept Pathol & Diagnost, I-37134 Verona, Italy.
RP Cabrini, G (corresponding author), Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, Piazzale Stefani 1, I-37126 Verona, Italy.
EM giulio.cabrini@univr.it
RI Gasparini, Paolo/B-6173-2014; Rimessi, Alessandro/K-5420-2016; Cabrini,
   Giulio/K-4761-2016; ATHANASAKIS, EMMANOUIL/G-8205-2011; d'Adamo, Adamo
   Pio/G-4064-2011; rimessi, alessandro/O-3335-2019; Crovella,
   Sergio/K-5050-2016; Bezzerri, Valentino/K-8132-2016; Athanasakis,
   Emmanouil/K-1326-2018; Pinton, Paolo/J-8025-2012
OI Rimessi, Alessandro/0000-0001-7091-5765; Cabrini,
   Giulio/0000-0003-2720-0742; d'Adamo, Adamo Pio/0000-0001-9367-4909;
   rimessi, alessandro/0000-0001-7091-5765; Crovella,
   Sergio/0000-0001-8493-1168; Bezzerri, Valentino/0000-0002-6849-4487;
   NICOLIS, ELENA/0000-0001-7810-3307; Gasparini,
   Paolo/0000-0002-0859-0856; Athanasakis, Emmanouil/0000-0002-7707-2665;
   Pinton, Paolo/0000-0001-7108-6508
FU Italian Cystic Fibrosis FoundationMinistry of Health, ItalyItalian
   Cystic Fibrosis Research Foundation [3/2008, 8/2009, 13/2009, 18/2009,
   2/2010]; Italian Association for Cancer Research TelethonAssociazione
   Italiana per la Ricerca sul Cancro (AIRC)Fondazione Telethon [GGP09128];
   University of Ferrara; Itaian Ministry of Education, University, and
   Research; Italian Ministry of HealthMinistry of Health, Italy; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HL68890, DK27651];
   American Cystic Fibrosis Foundation [DRUMM00A0, KNOWLES00A0, RDPR026];
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL068890, R01HL068890,
   R01HL068890, R01HL068890, R01HL068890, R01HL068890, R01HL068890,
   R01HL068890, R01HL068890, R01HL068890, R01HL068890, R01HL068890,
   R01HL068890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651, P30DK027651, P30DK027651,
   P30DK027651, P30DK027651, P30DK027651] Funding Source: NIH RePORTER
FX This work was supported by the Italian Cystic Fibrosis Foundation
   (Grants 3/2008, 8/2009, 13/2009, 18/2009, and 2/2010; to P. G., G. C.
   and P. P.), the Italian Association for Cancer Research Telethon (Grant
   GGP09128), local funds from the University of Ferrara, the Itaian
   Ministry of Education, University, and Research and the Italian Ministry
   of Health (to P. P.), National Institutes of Health Grants HL68890 and
   DK27651, and American Cystic Fibrosis Foundation Grants DRUMM00A0,
   KNOWLES00A0, and RDPR026 (to M.L.D. and M.R.K.). V.B. is a fellow of the
   Italian Cystic Fibrosis Research Foundation, and E.N. is a fellow of the
   Azienda Ospedaliera Universitaria Integrata di Verona.
CR Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC
   Ashlock MA, 2009, SEMIN RESP CRIT CARE, V30, P611, DOI 10.1055/s-0029-1238919
   Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223
   Bezzerri V, 2008, AM J RESP CELL MOL, V39, P86, DOI 10.1165/rcmb.2007-0176OC
   BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783
   Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518
   CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247
   Chun J, 2009, J LEUKOCYTE BIOL, V86, P1135, DOI 10.1189/jlb.0209072
   Clunes MT, 2008, CURR OPIN PHARMACOL, V8, P292, DOI 10.1016/j.coph.2008.04.006
   Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469
   Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631
   Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006
   Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861
   Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811
   Hillian AD, 2008, GENES IMMUN, V9, P501, DOI 10.1038/gene.2008.42
   Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075
   LAGERCRANTZ J, 1995, GENOMICS, V26, P467, DOI 10.1016/0888-7543(95)80164-H
   Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046
   McNamara N, 2006, AM J RESP CELL MOL, V34, P653, DOI 10.1165/rcmb.2005-0441OC
   McNamara N, 2001, P NATL ACAD SCI USA, V98, P9086, DOI 10.1073/pnas.161290898
   Muhlebach MS, 2004, PEDIATR PULM, V37, P393, DOI 10.1002/ppul.20010
   Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626
   Nichols DP, 2008, CLIN REV ALLERG IMMU, V35, P135, DOI 10.1007/s12016-008-8081-2
   Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638
   Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4
   Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF
   Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200
   Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200
   Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200
   Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011
   Strassheim D, 2000, J BIOL CHEM, V275, P39767, DOI 10.1074/jbc.M007775200
   Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415
   Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435
   Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139
   Welsh M, 2001, METABOLIC MOL BASES, P5121
   Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005
   Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002
   ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313
NR 40
TC 24
Z9 24
U1 0
U2 7
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD APR 15
PY 2011
VL 186
IS 8
BP 4946
EP 4958
DI 10.4049/jimmunol.1003535
PG 13
WC Immunology
SC Immunology
GA 744FY
UT WOS:000289081500046
PM 21411730
OA Green Accepted, Bronze
DA 2020-12-08
ER

PT J
AU da Silva, RC
   Segat, L
   Crovella, S
AF da Silva, Ronald Celerino
   Segat, Ludovica
   Crovella, Sergio
TI Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE HIV-1; Vertical transmission; DC-SIGN; L-SIGN
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS;
   HEPATITIS-C VIRUS; BREAST-MILK MACROPHAGES; HUMAN DENDRITIC CELLS;
   T-CELLS; ENDOTHELIAL-CELLS; LECTIN RECEPTORS; TYPE-1 INFECTION;
   TRANS-INFECTION
AB The innate immune system acts in the first line of host defense against pathogens. One of the mechanisms used involves the early recognition and uptake of microbes by host professional phagocytes, through pattern recognition receptors (PRRs). These PRRs bind to conserved microbial ligands expressed by pathogens and initiate both innate and adaptative immune responses. Some PRRs located on the surface of dendritic cells (DCs) and other cells seem to play an important role in human immunodeficiency virus type 1 (HIV-1) transmission. Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin, CD209 (DC-SIGN) and its homolog, DC-SIGN-related (DC-SIGNR or L-SIGN) receptors are PPRs able to bind the HIV-1 gp120 envelope protein and, because alterations in their expression patterns also occur, they might play a role in both horizontal and vertical transmission as well as in disseminating the virus within the host. This review aims to explore the involvement of the DC-SIGN and L-SIGN receptors in HIV-1 transmission from mother to child. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Segat, Ludovica; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   [da Silva, Ronald Celerino; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [da Silva, Ronald Celerino] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU FACEPE [APQ-0020-4.01/08]; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX We thank the Laboratory of Immunopathology Keizo Asami, the Department
   of Genetics, Federal University of Pernambuco, the Graduate Program in
   Genetics and Molecular Biology for supporting physical and scientific,
   as well as FACEPE and CNPq, for financial support. S.L. is recipient of
   a fellowship grant (APQ-0020-4.01/08) from FACEPE
CR Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002
   Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975
   Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671
   Ben-Ali M, 2007, HUM IMMUNOL, V68, P908, DOI 10.1016/j.humimm.2007.09.003
   Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061
   Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002
   Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211
   Borggren M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-28
   Caparros E, 2005, IMMUNOBIOLOGY, V210, P185, DOI 10.1016/j.imbio.2005.05.013
   Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005
   Cormier EG, 2004, P NATL ACAD SCI USA, V101, P14067, DOI 10.1073/pnas.0405695101
   Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Figdor CG, 2003, PATHOL BIOL, V51, P61, DOI 10.1016/S0369-8114(03)00097-X
   Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   GEIJTENBEEK TBH, TROPHOBLAST RES, V15, pS19
   GEIJTENBEEK TBH, PLACENTA SA, V22, pS19
   Gramberg T, 2006, VIROLOGY, V347, P354, DOI 10.1016/j.virol.2005.11.033
   Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003
   Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8
   Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89
   Hong P, 2009, BRIT J NUTR, V101, P482, DOI 10.1017/S0007114508025804
   Ichikawa M, 2003, IMMUNOLOGY, V108, P189, DOI 10.1046/j.1365-2567.2003.01572.x
   Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006
   KOOYK YV, 2008, BIOCHEM SOC T, V36, P1478
   Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003
   Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001
   Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409
   Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200
   Luzuriaga Katherine, 2007, Curr Infect Dis Rep, V9, P511, DOI 10.1007/s11908-007-0076-2
   Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004
   Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004
   Moussa M, 1999, AM J REPROD IMMUNOL, V41, P312
   Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200
   Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105
   Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06
   Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004
   Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003
   Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398
   Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070
   Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025
   Satomi M, 2005, J INFECT DIS, V191, P174, DOI 10.1086/426829
   Selvaraj P, 2009, INFECT GENET EVOL, V9, P256, DOI 10.1016/j.meegid.2008.12.003
   Sewell AK, 2001, TRENDS IMMUNOL, V22, P173, DOI 10.1016/S1471-4906(01)01866-X
   SHEN R, 2010, J LEUKOCYTE BIOL, V87, P1
   Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219
   Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005
   Soilleux EJ, 2003, INT J BIOCHEM CELL B, V35, P283, DOI 10.1016/S1357-2725(02)00132-2
   Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092
   Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026
   Steinman RM, 2000, CELL, V100, P491, DOI 10.1016/S0092-8674(00)80684-4
   Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   *UNAIDS, REP GLOB AIDS EP 200
   Velilla PA, 2008, CLIN IMMUNOL, V126, P243, DOI 10.1016/j.clim.2007.11.004
   Wichukchinda N, 2007, AIDS RES HUM RETROV, V23, P686, DOI 10.1089/aid.2006.0212
   Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960
   Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004
   Zhu DY, 2010, BIOCHEM BIOPH RES CO, V393, P598, DOI 10.1016/j.bbrc.2010.02.021
NR 63
TC 23
Z9 24
U1 0
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD APR
PY 2011
VL 72
IS 4
BP 305
EP 311
DI 10.1016/j.humimm.2011.01.012
PG 7
WC Immunology
SC Immunology
GA 743MT
UT WOS:000289023100002
PM 21277928
OA Green Published
DA 2020-12-08
ER

PT J
AU Segat, L
   Crovella, S
AF Segat, L.
   Crovella, S.
TI MBL2 polymorphisms and the choice of controls for association studies:
   just another story?
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Letter
ID MANNOSE-BINDING LECTIN; HUMAN-PAPILLOMAVIRUS INFECTION; HIV-1 VERTICAL
   TRANSMISSION; GENE POLYMORPHISMS; AIDS PROGRESSION; RISK; CHILDREN; PCR
C1 [Segat, L.; Crovella, S.] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Segat, L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
CR Araujo J, 2009, CLIN IMMUNOL, V131, P254, DOI 10.1016/j.clim.2008.12.010
   Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Guimaraes V, 2008, HUM IMMUNOL, V69, P273, DOI 10.1016/j.humimm.2008.03.002
   Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4
   Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498
   Melo FM, 2009, INT J IMMUNOGENET, V36, P377, DOI 10.1111/j.1744-313X.2009.00871.x
   Segat L, 2008, J VIRAL HEPATITIS, V15, P387, DOI [10.1111/j.1365-2893.2008.00965.x, 10.1111/j.1365-2893.2007.00965.x]
   Segat L, 2007, CLIN IMMUNOL, V124, P13, DOI 10.1016/j.clim.2007.04.006
   Segat L, 2009, HUM IMMUNOL, V70, P436, DOI 10.1016/j.humimm.2009.03.006
   Skalnikova H, 2004, J IMMUNOL METHODS, V295, P139, DOI 10.1016/j.jim.2004.10.007
   Steffensen R, 2003, J IMMUNOL METHODS, V278, P191, DOI 10.1016/S0022-1759(03)00190-X
   Tan YJ, 2009, MOL IMMUNOL, V47, P632, DOI 10.1016/j.molimm.2009.08.020
   Vallinoto ACR, 2009, HUM IMMUNOL, V70, P754, DOI 10.1016/j.humimm.2009.06.014
NR 16
TC 3
Z9 3
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1744-3121
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD APR
PY 2011
VL 38
IS 2
BP 101
EP 104
DI 10.1111/j.1744-313X.2010.00981.x
PG 4
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 728CT
UT WOS:000287852400002
PM 21362144
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Vendramin, A
   Catamo, E
   Fabris, A
   Crovella, S
AF Pontillo, Alessandra
   Vendramin, Anna
   Catamo, Eulalia
   Fabris, Annalisa
   Crovella, Sergio
TI The Missense Variation Q705K in CIAS1/NALP3/NLRP3 Gene and an NLRP1
   Haplotype Are Associated With Celiac Disease
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
ID RISK VARIANTS; INFLAMMASOME; CRYOPYRINOPATHIES; IDENTIFICATION;
   POPULATION; NALP1; CELLS; CIAS1
AB OBJECTIVES: Celiac disease (CD) is a multifactorial common disorder with several susceptibility loci. Variations in the NALP1/NLRP1 and NALP3/NLRP3 genes have been reported to confer risk for several autoimmune conditions. We hypothesized that polymorphisms in these genes, due to their role in innate immunity and inflammatory processes, may affect susceptibility to CD.
   METHODS: Two single-nucleotide polymorphisms (SNPs) in NLRP1 (rs12150220, rs2670660) and two SNPs (rs10754558, rs35829419) in NLRP3 genes were genotyped in 504 CD Italian patients and 256 healthy controls.
   RESULTS: The minor A allele of NLRP3 rs35829419 (Q705K) polymorphism appeared to exert a protective role against the development of CD (P = 0.029; odds ratio (OR) = 0.56). Moreover, a particular NLRP1 haplotype was associated with predisposition to CD (P = 0.003; OR = 1.38), even more when present in combination with the rs35829419 major C allele (P = 0.002; OR = 1.42).
   CONCLUSIONS: We hypothesized that the deregulation of CIAS1/NALP3/NLRP3 and NALP1/NLRP1 inflammasomes could have a role in CD pathogenesis
C1 [Pontillo, Alessandra; Vendramin, Anna; Catamo, Eulalia; Fabris, Annalisa; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Med Genet Serv, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Med Genet Serv, Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016;
   Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   Catamo, Eulalia/K-9399-2016
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Catamo,
   Eulalia/0000-0002-4701-9134
FU Italian Ministry of HealthMinistry of Health, Italy [RC05/09, RC03/04];
   Institute of Child Health IRCCS Burlo Garofolo, Trieste, Italy [RC05/09]
FX The Italian Ministry of Health supported the study with two grants:
   "Progetti di Ricerca Corrente IRCCS Burlo Garofolo" RC05/09 and
   RC03/04.; This is work was supported by the Institute of Child Health
   IRCCS Burlo Garofolo, Trieste, Italy (grant no. RC05/09).
CR Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Brandao LC, 2010, HUM IMMUNOL, V71, P277, DOI 10.1016/j.humimm.2009.12.008
   Caroli F, 2007, RHEUMATOLOGY, V46, P473, DOI 10.1093/rheumatology/kel269
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Heap GA, 2009, SEMIN IMMUNOL, V21, P346, DOI 10.1016/j.smim.2009.04.001
   Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044
   Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x
   Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Koskinen L, 2009, IMMUNOGENETICS, V61, P247, DOI 10.1007/s00251-009-0361-3
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871
   Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166
   Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270
   Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874
   O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shaker Marcus, 2007, Pediatr Rheumatol Online J, V5, P12, DOI 10.1186/1546-0096-5-12
   Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616
   van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058
   Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286
   Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
NR 27
TC 71
Z9 72
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD MAR
PY 2011
VL 106
IS 3
BP 539
EP 544
DI 10.1038/ajg.2010.474
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 730VT
UT WOS:000288064200022
PM 21245836
DA 2020-12-08
ER

PT J
AU Padovan, L
   Segat, L
   Crovella, S
AF Padovan, Lara
   Segat, Ludovica
   Crovella, Sergio
TI A polymorphism in PRF1 gene is associated with HIV-1 vertical
   transmission in Brazilian children
SO AIDS
LA English
DT Article
ID CD8 T-CELLS; PERFORIN; INFECTION; EXPRESSION; RESPONSES
AB We investigated the possible association between PRF1 gene polymorphisms and HIV-1 vertical transmission in Brazilian children by analyzing PRF1 gene coding and untranslated regions in 173 perinatally infected children (HIV+), 51 exposed uninfected (HIV-), and 171 HIV-unexposed uninfected children. Seven single nucleotide polymorphisms were identified in our samples. The rs885822 C allele and CC genotype were significantly more frequent in HIV-negative than in HIV-positive patients and associated with a protective effect toward HIV vertical transmission.
C1 [Padovan, Lara; Segat, Ludovica; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Padovan, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485
FU Ministerio da Saude, Secretaria de Vigilancia em Saude - SVS
   Departamento de DST, Aids e Hepatites Virais [401635/2009-0]; IRCCS
   Burlo Garofolo [RC 77/08]; FACEPE [APQ-0020-4.01/08]
FX The present work has been supported by a 401635/2009-0 CNPq grant from
   the 'Ministerio da Saude, Secretaria de Vigilancia em Saude - SVS
   Departamento de DST, Aids e Hepatites Virais', and by a RC 77/08 grant
   from IRCCS Burlo Garofolo. L.S. is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE.
CR Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660
   Haridas V, 2003, AIDS, V17, P2313, DOI 10.1097/00002030-200311070-00005
   Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006
   Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917
   LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0
   LOWIN B, 1995, CURR TOP MICROBIOL I, V198, P1
   MCLLROY D, 2006, INT J IMMUNOGENET, V33, P73
   Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845
   Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419
   Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911
   Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791
NR 11
TC 4
Z9 4
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD FEB 20
PY 2011
VL 25
IS 4
BP 535
EP 537
DI 10.1097/QAD.0b013e3283428b7c
PG 3
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 716LN
UT WOS:000286970300017
PM 21157294
DA 2020-12-08
ER

PT J
AU da Silva, GK
   Guimaraes, R
   Mattevi, VS
   Lazzaretti, RK
   Sprinz, E
   Kuhmmer, R
   Brandao, L
   Crovella, S
   Chies, JAB
AF da Silva, Gabriela Kniphoff
   Guimaraes, Rafael
   Mattevi, Vanessa Sune
   Lazzaretti, Rosmeri Kuhmmer
   Sprinz, Eduardo
   Kuhmmer, Regina
   Brandao, Lucas
   Crovella, Sergio
   Bogo Chies, Jose Artur
TI The role of mannose-binding lectin gene polymorphisms in susceptibility
   to HIV-1 infection in Southern Brazilian patients
SO AIDS
LA English
DT Article
DE ethnicity; HIV; immunogenetics; MBL; polymorphisms
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; MBL2 GENE; CLINICAL-IMPLICATIONS; AIDS
   PROGRESSION; VARIANT ALLELES; INNATE IMMUNITY; PROTEIN GENE;
   ASSOCIATION; CHILDREN; DISEASE
AB Objective: This study investigates the role of mannose-binding lectin (MBL) in the susceptibility to HIV-1 infection analyzing polymorphisms located at the MBL2 promoter and exon 1 regions.
   Materials and methods: The prevalence of MBL2 variant alleles was investigated in 410 HIV-1-infected patients from the South Brazilian HIV cohort and in 345 unexposed uninfected healthy individuals. The promoter variants were genotyped using polymerase chain reaction with sequence-specific primers (PCR-SSP) and exon 1 variants were analyzed by real-time PCR using a melting temperature assay and were confirmed by PCR-restriction fragment length polymorphism (RFLP). MBL2 genotypic and allelic frequencies were compared between HIV-1-infected patients and controls using the chi-squared tests.
   Results: The analyses were performed subdividing the individuals according to their ethnic origin. Among Euro-derived individuals a higher frequency of the LX/LX genotype was observed in patients when compared to controls (P < 0.001). The haplotypic analysis also showed a higher frequency of the haplotypes associated with lower MBL levels among HIV-1-infected patients (P = 0.0001). Among Afro-derived individuals the frequencies of LY/LY and HY/HY genotypes were higher in patients when compared to controls (P = 0.009 and P = 0.02).
   Conclusions: An increased frequency of MBL2 genotypes associated with low MBL levels was observed in Euro-derived patients, suggesting a potential role for MBL in the susceptibility to HIV-1 infection in Euro-derived individuals. (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
C1 [Bogo Chies, Jose Artur] Univ Fed Rio Grande do Sul, Immunogenet Lab, Inst Biosci, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil.
   [Guimaraes, Rafael; Brandao, Lucas; Crovella, Sergio] Univ Fed Pernambuco, Porto Alegre, RS, Brazil.
   [Mattevi, Vanessa Sune] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil.
   [Lazzaretti, Rosmeri Kuhmmer; Sprinz, Eduardo; Kuhmmer, Regina] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
RP Chies, JAB (corresponding author), Univ Fed Rio Grande do Sul, Immunogenet Lab, Inst Biosci, Dept Genet, Av Bento Goncalves 9500,POB 15053,Campus Vale, BR-91501970 Porto Alegre, RS, Brazil.
EM jabchies@terra.com.br
RI Chies, Jose Artur Bogo/K-9664-2015; Mattevi, Vanessa S./B-3915-2014;
   Crovella, Sergio/K-5050-2016; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; sprinz, eduardo/V-7961-2019
OI Chies, Jose Artur Bogo/0000-0001-7025-0660; Mattevi, Vanessa
   S./0000-0002-2697-4909; Crovella, Sergio/0000-0001-8493-1168; Brandao,
   Lucas Andre Cavalcanti/0000-0002-8588-4559; sprinz,
   eduardo/0000-0003-4343-8304
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [479438/2009-9, 302105/2008-5, 564988/2008-1]
FX The work was funded by CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) 479438/2009-9. J.A.B.C. received a CNPq grant
   302105/2008-5. G.K. daS. received a CNPq grant 564988/2008-1.
CR Alagarasu K, 2007, TUBERCULOSIS, V87, P535, DOI 10.1016/j.tube.2007.07.007
   Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Apetrei C, 2007, J VIROL, V81, P7913, DOI 10.1128/JVI.00281-07
   Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030
   Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712
   Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706
   Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164
   Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x
   Dzwonek A, 2006, ANTIVIR THER, V11, P499
   Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746
   Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767
   Fiane AE, 2005, EUR HEART J, V26, P1660, DOI 10.1093/eurheartj/ehi198
   Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008
   Garred P, 1997, SCAND J IMMUNOL, V46, P204, DOI 10.1046/j.1365-3083.1997.d01-111.x
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x
   Hart ML, 2003, J GEN VIROL, V84, P353, DOI 10.1099/vir.0.18734-0
   Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352
   Heggelund L, 2005, EUR J CLIN INVEST, V35, P765, DOI 10.1111/j.1365-2362.2005.01579.x
   Ip WK, 2004, SCAND J IMMUNOL, V59, P310, DOI 10.1111/j.0300-9475.2004.01392.x
   Kuhn L, 2006, AM J CLIN NUTR, V84, P610
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4
   Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498
   Marzi A, 2007, VIROLOGY, V368, P322, DOI 10.1016/j.virol.2007.07.004
   Maury CPJ, 2007, J INTERN MED, V262, P466, DOI 10.1111/j.1365-2796.2007.01838.x
   Mindel A, 2001, BRIT MED J, V322, P1290, DOI 10.1136/bmj.322.7297.1290
   Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979
   Monticielo OA, 2010, LUPUS, V19, P280, DOI 10.1177/0961203309351895
   Monticielo OA, 2008, CLIN RHEUMATOL, V27, P413, DOI 10.1007/s10067-008-0838-8
   Mueller S, 2007, PEDIATR ALLERGY IMMU, V18, P665, DOI 10.1111/j.1399-3038.2007.00573.x
   Neonato MG, 1999, EUR J HUM GENET, V7, P679, DOI 10.1038/sj.ejhg.5200360
   Parrella P, 2007, EUR J EPIDEMIOL, V22, P159, DOI 10.1007/s10654-007-9111-8
   Santos IKFD, 2001, INFECT IMMUN, V69, P5212
   Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159
   Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982
   Singh KK, 2008, J ALLERGY CLIN IMMUN, V122, P173, DOI 10.1016/j.jaci.2008.05.025
   Tan YJ, 2009, MOL IMMUNOL, V47, P632, DOI 10.1016/j.molimm.2009.08.020
   Terai I, 2003, EUR J IMMUNOL, V33, P2755, DOI 10.1002/eji.200323955
   Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005
   Turner M W, 2000, Rev Immunogenet, V2, P305
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   *UNAIDS WHO, 2007, AIDS EP UPD DEC 2007
   Vallinoto ACR, 2006, MOL IMMUNOL, V43, P1358, DOI 10.1016/j.molimm.2005.09.001
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
   Vianna P, 2010, AM J REPROD IMMUNOL, V64, P359, DOI 10.1111/j.1600-0897.2010.00846.x
   Wang X, 2007, CLIN EXP ALLERGY, V37, P1334, DOI 10.1111/j.1365-2222.2007.02761.x
   Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031
   Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x
NR 56
TC 15
Z9 15
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD FEB 20
PY 2011
VL 25
IS 4
BP 411
EP 418
DI 10.1097/QAD.0b013e328342fef1
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 716LN
UT WOS:000286970300002
PM 21192229
OA Green Published
DA 2020-12-08
ER

PT J
AU da Cruz, HLA
   Montenegro, RD
   Lima, JFD
   Poroca, DD
   Lima, JFD
   Montenegro, LML
   Crovella, S
   Schindler, HC
AF Alves da Cruz, Heidi Lacerda
   Montenegro, Rosana de Albuquerque
   de Araujo Lima, Juliana Falcao
   Poroca, Diogo da Rocha
   da Costa Lima, Juliana Figueiredo
   Lapa Montenegro, Lilian Maria
   Crovella, Sergio
   Schindler, Haiana Charifker
TI EVALUATION OF A NESTED-PCR FOR MYCOBACTERIUM TUBERCULOSIS DETECTION IN
   BLOOD AND URINE SAMPLES
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Mycobacterium tuberculosis; nested-PCR; blood; urine; molecular
   diagnosis; IS6110 insertion sequence
ID POLYMERASE-CHAIN-REACTION; PULMONARY TUBERCULOSIS; CLINICAL-SAMPLES;
   EXTRAPULMONARY TUBERCULOSIS; RAPID DIAGNOSIS; DNA; IDENTIFICATION;
   AMPLIFICATION; COMPLEX
AB The polymerase chain reaction (PCR) and its variations, such as the nested-PCR, have been described as promising techniques for rapid diagnosis of tuberculosis (TB). With the aim of evaluating the usefulness of a nested-PCR method on samples of blood and urine of patients suspected of tuberculosis we analyzed 192 clinical samples, using as a molecular target the insertion element IS6110 specific of M. tuberculosis genome. Nested-PCR method showed higher sensitivity in patients with extrapulmonary tuberculosis (47.8% and 52% in blood and urine) when compared to patients with the pulmonary form of the disease (sensitivity of 29% and 26.9% in blood and urine), regardless of the type of biological sample used. The nested-PCR is a rapid technique that, even if not showing a good sensitivity, should be considered as a helpful tool especially in the extrapulmonary cases or in cases where confirmatory diagnosis is quite difficult to be achieved by routine methods. The performance of PCR-based techniques should be considered and tested in future works on other types of biological specimens besides sputum, like blood and urine, readily obtainable in most cases. The improving of M. tuberculosis nested-PCR detection in TB affected patients will give the possibility of an earlier detection of bacilli thus interrupting the transmission chain of the disease.
C1 [Poroca, Diogo da Rocha; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Alves da Cruz, Heidi Lacerda; Montenegro, Rosana de Albuquerque; de Araujo Lima, Juliana Falcao; da Costa Lima, Juliana Figueiredo; Lapa Montenegro, Lilian Maria; Schindler, Haiana Charifker] Fundacao Oswaldo Cruz, Dept Imunol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Genet Serv IRCCS Burlo Garofolo, I-34127 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
EM crovelser@gmail.com
RI Mitchell, Ellen/H-5475-2013; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Figueiredo da Costa Lima,
   Juliana/0000-0002-9087-358X
FU FACEPE; PDTIS
FX The authors thank the doctors and health professionals from HC-UFPE that
   collaborated with the research. We thank the staff of Laboratory
   Imunoepidemiologia of CPqAM/FIOCRUZ that assisted in carrying out the
   techniques. This work was supported by FACEPE and PDTIS.
CR Ahmed N, 1998, J CLIN MICROBIOL, V36, P3094, DOI 10.1128/JCM.36.10.3094-3095.1998
   Assis Nelma Cristina Sousa de, 2007, J. Bras. Patol. Med. Lab., V43, P1, DOI 10.1590/S1676-24442007000100003
   BACH AH, 2003, THESIS U FEDERAL PER
   Boddinghaus B, 2001, J CLIN MICROBIOL, V39, P3750, DOI 10.1128/JCM.39.10.3750-3752.2001
   Bollela VR, 1999, REV SAUDE PUBL, V33, P281, DOI 10.1590/S0034-89101999000300009
   Butcher PD, 1996, J APPL BACTERIOL, V81, pS53, DOI 10.1111/j.1365-2672.1996.tb04599.x
   COBERLY JS, 2001, INFECT DIS EPIDEMIOL
   Ferreira Aurigena Antunes de Araújo, 2005, Rev. bras. epidemiol., V8, P142, DOI 10.1590/S1415-790X2005000200006
   Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113
   Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003
   Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240
   Huggett JF, 2003, INT J BIOCHEM CELL B, V35, P1407, DOI 10.1016/S1357-2725(03)00102-X
   Kafwabulula M, 2002, INT J TUBERC LUNG D, V6, P732
   Khan Mumtaz Ahmad, 2006, J Ayub Med Coll Abbottabad, V18, P25
   KOX LFF, 1994, J CLIN MICROBIOL, V32, P672, DOI 10.1128/JCM.32.3.672-678.1994
   Marchi AM, 2008, BRAZ J MICROBIOL, V39, P613, DOI 10.1590/S1517-83822008000400003
   *MIN HLTH, 2009, HLTH SURV SECR NAT P
   MIYAZAKI Y, 1993, J CLIN MICROBIOL, V31, P2228, DOI 10.1128/JCM.31.8.2228-2232.1993
   Ogusku MM, 2003, BRAZ J MICROBIOL, V34, P165, DOI 10.1590/S1517-83822003000200015
   Ogusku MM, 2004, J BRAS PNEUMOL, V30, P433, DOI DOI 10.1590/S1806-37132004000400008
   Portillo-Gomez L, 2000, INT J TUBERC LUNG D, V4, P361
   Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018
   Ritis K, 2000, J INTERN MED, V248, P415, DOI 10.1046/j.1365-2796.2000.00750.x
   Rodriguez JC, 1997, APMIS, V105, P612, DOI 10.1111/j.1699-0463.1997.tb05061.x
   Rossetti MLR, 1997, J MICROBIOL METH, V28, P139, DOI 10.1016/S0167-7012(97)00978-0
   SCHUGER NW, 1995, LANCET, V344, P232
   Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119
   *SINAN, 2006, NAT SYST HLTH SURV P
   Smith KC, 1996, PEDIATRICS, V97, P155
   Taci N, 2003, RESP MED, V97, P676, DOI 10.1053/rmed.2003.1500
   Torrea G, 2005, J MED MICROBIOL, V54, P39, DOI 10.1099/jmm.0.45688-0
   WHO, 2007, GLOB TUB CONTR
   ZAMBARDI G, 1995, MOL CELL PROBE, V9, P91, DOI 10.1016/S0890-8508(95)80033-6
NR 33
TC 15
Z9 16
U1 0
U2 3
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JAN-MAR
PY 2011
VL 42
IS 1
BP 321
EP 329
DI 10.1590/S1517-83822011000100041
PG 9
WC Microbiology
SC Microbiology
GA 707WF
UT WOS:000286320600041
PM 24031638
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Fabris, A
   Segat, L
   Catamo, E
   Morgutti, M
   Vendramin, A
   Crovella, S
AF Fabris, Annalisa
   Segat, Ludovica
   Catamo, Eulalia
   Morgutti, Marcello
   Vendramin, Anna
   Crovella, Sergio
TI HLA-G 14 bp Deletion/Insertion Polymorphism in Celiac Disease
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
ID G MESSENGER-RNA; INTERFERON-GAMMA; G GENE; SUSCEPTIBILITY; ASSOCIATION;
   EXPRESSION; RISK; DQ; LYMPHOCYTES; MECHANISMS
AB OBJECTIVES: Nonclassical major histocompatibility class I HLA-G antigen is a tolerogenic molecule that inhibits lytic activity of natural killer (NK) cells and cytotoxic T lymphocytes. Because of its immunomodulatory and tolerogenic properties, HLA-G molecules may have a role in celiac disease (CD). We analyzed the HLA-G 14 bp deletion/insertion polymorphism, known to have a functional effect on mRNA stability, in a group of 522 CD patients, stratified for the presence of HLA-DQ2 genotype, and 400 healthy individuals to evaluate the possible effect of the polymorphism on the risk to develop the disease.
   METHODS: HLA-G 14 bp deletion/insertion polymorphism (rs1704) was detected by polymerase chain reaction and double-checked by direct sequencing.
   RESULTS: The 14bp inserted (I) allele and the homozygous I/I genotype were significantly more frequent in CD patients than in healthy controls. The presence of I allele was associated with an increased risk of CD (OR 1.35) and the effect of I allele was consistent with a recessive genetic model (P<0.001).
   CONCLUSIONS: Our results also indicate that the effect of the HLA-G D/I polymorphism is restricted for HLA-DQ2, and not simply due to the presence of linkage disequilibrium with the major known risk factor; moreover we found that the presence of the I allele confers an increased risk of CD in addition to the risk conferred by HLA-DQ2 alone and that subjects that carry both DQ2 and HLA-G I alleles have an increased risk of CD than subjects that carry DQ2 but not the I allele.
C1 [Fabris, Annalisa; Segat, Ludovica; Catamo, Eulalia; Morgutti, Marcello; Vendramin, Anna; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Segat, Ludovica] Univ Fed Pernambuco, Lab Imunopatol Keizo Azami, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Catamo, Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Catamo,
   Eulalia/0000-0002-4701-9134; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC03/04]; FACEPE
   [APQ-0020-4.01/08]
FX This work was supported by a grant RC03/04 from IRCCS Burlo Garofolo
   Trieste (Italy). SL is a recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE.
CR Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28
   Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X
   Bolognesi E, 2003, TISSUE ANTIGENS, V61, P308, DOI 10.1034/j.1399-0039.2003.00028.x
   Brandao LC, 2010, HUM IMMUNOL, V71, P277, DOI 10.1016/j.humimm.2009.12.008
   Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300
   Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Hviid TVF, 2005, HUM IMMUNOL, V66, P688, DOI 10.1016/j.humimm.2005.03.003
   Jarvinen TT, 2004, SCAND J GASTROENTERO, V39, P428, DOI 10.1080/00365520310008773
   Karell K, 2002, SCAND J GASTROENTERO, V37, P56, DOI 10.1080/003655202753387365
   Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320
   Koskinen L, 2009, IMMUNOGENETICS, V61, P247, DOI 10.1007/s00251-009-0361-3
   Lefebvre S, 1999, J REPROD IMMUNOL, V43, P213, DOI 10.1016/S0165-0378(99)00035-2
   LeMaoult J, 2005, AUTOIMMUN REV, V4, P503, DOI 10.1016/j.autrev.2005.04.006
   Lin A, 2007, TISSUE ANTIGENS, V70, P427, DOI 10.1111/j.1399-0039.2007.00926.x
   Louka AS, 2003, IMMUNOGENETICS, V55, P339, DOI 10.1007/s00251-003-0586-5
   Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687
   Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x
   MAZZILLI MC, 1992, HUM IMMUNOL, V33, P133, DOI 10.1016/0198-8859(92)90064-T
   Megiorni F, 2008, AM J GASTROENTEROL, V103, P997, DOI 10.1111/j.1572-0241.2007.01716.x
   Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3
   Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680
   Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270
   Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9
   Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006
   Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004
   Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X
   SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V
   SPURKLAND A, 1992, HUM IMMUNOL, V35, P188, DOI 10.1016/0198-8859(92)90104-U
   Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011
   Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021
   Torres MI, 2007, WORLD J GASTROENTERO, V13, P1156, DOI 10.3748/wjg.v13.i8.1156
   Torres MI, 2006, INT IMMUNOL, V18, P713, DOI 10.1093/intimm/dxl008
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Wapenaar MC, 2004, J AUTOIMMUN, V23, P183, DOI 10.1016/j.jaut.2004.05.004
   Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059
NR 40
TC 15
Z9 16
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD JAN
PY 2011
VL 106
IS 1
BP 139
EP 144
DI 10.1038/ajg.2010.340
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 717CS
UT WOS:000287021200020
PM 20823837
DA 2020-12-08
ER

PT J
AU Crovella, S
   Segat, L
   Amato, A
   Athanasakis, E
   Bezzerri, V
   Braggion, C
   Casciaro, R
   Castaldo, G
   Colombo, C
   Covone, AE
   De Rose, V
   Gagliardini, R
   Lanzara, C
   Minicucci, L
   Morgutti, M
   Nicolis, E
   Pardo, F
   Quattrucci, S
   Raia, V
   Ravazzolo, R
   Seia, M
   Stanzial, V
   Termini, L
   Zazzeron, L
   Cabrini, G
   Gasparini, P
AF Crovella, Sergio
   Segat, Ludovica
   Amato, Annalisa
   Athanasakis, Emmanouil
   Bezzerri, Valentino
   Braggion, Cesare
   Casciaro, Rosaria
   Castaldo, Giuseppe
   Colombo, Carla
   Covone, Angela Elvira
   De Rose, Virginia
   Gagliardini, Rolando
   Lanzara, Carmen
   Minicucci, Laura
   Morgutti, Marcello
   Nicolis, Elena
   Pardo, Francesca
   Quattrucci, Serena
   Raia, Valeria
   Ravazzolo, Roberto
   Seia, Manuela
   Stanzial, Valentino
   Termini, Lisa
   Zazzeron, Laura
   Cabrini, Giulio
   Gasparini, Paolo
TI A polymorphism in the 5 ' UTR of the DEFB1 gene is associated with the
   lung phenotype in F508del homozygous Italian cystic fibrosis patients
SO CLINICAL CHEMISTRY AND LABORATORY MEDICINE
LA English
DT Article
DE cystic fibrosis; DEFB1; functional SNPs; innate immunity; lung
   phenotype; modifier genes
ID HUMAN BETA-DEFENSIN-1 GENE; BETA-DEFENSINS; PSEUDOMONAS-AERUGINOSA;
   ADAPTIVE IMMUNITY; EXPRESSION; PEPTIDES; TRANSCRIPTION; INDUCTION;
   INNATE; CELLS
AB Background: The identification of cystic fibrosis (CF) patients who are at greater risk of lung damage could be clinically valuable. Thus, we attempted to replicate previous findings and verify the possible association between three single nucleotide polymorphisms (SNPs c.-52G > A, c.-44C > G and c.-20G > A) in the 5' untranslated region (5' UTR) of the beta defensin 1 (DEFB1) gene and the CF pulmonary phenotype.
   Methods: Genomic DNA from 92 Italian CF patients enrolled in different regional CF centres was extracted from peripheral blood and genotyped for DEFB1 SNPs using TaqMan (R) allele specific probes. In order to avoid genetic confounding causes that can account for CF phenotype variability, all patients were homozygous for the F508del CFTR mutation, and were then classified on the basis of clinical and functional data as mild lung phenotype (Mp, n = 50) or severe lung phenotype patients (Sp, n = 42).
   Results: For the c.-20G > A SNP, the frequency of the A allele, as well as the AA genotype, were significantly more frequent in Mp than in Sp patients, and thus this was associated with a protective effect against severe pulmonary disease (OR = 0.48 and 0.28, respectively). The effect of the c.-20G > A A allele is consistent with a recessive model, and the protective effect against Sp is exerted only when it is present in homozygosis. For the other two SNPs, no differences were observed as allelic and genotypic frequency in the two subgroups of CF patients.
   Conclusions: Our results, although necessary to be confirmed in larger and multiethnic populations, reinforce DEFB1 as a candidate modifier gene of the CF pulmonary phenotype.
C1 [Crovella, Sergio; Segat, Ludovica; Athanasakis, Emmanouil; Lanzara, Carmen; Morgutti, Marcello; Gasparini, Paolo] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Amato, Annalisa; Quattrucci, Serena] Univ Rome, Dept Pediat, CF Reg Ctr Rome, Rome, Italy.
   [Bezzerri, Valentino; Nicolis, Elena; Stanzial, Valentino; Cabrini, Giulio] Univ Hosp Verona, Lab Mol Pathol, Verona, Italy.
   [Braggion, Cesare] A Meyer Childrens Hosp, CF Ctr, Florence, Italy.
   [Casciaro, Rosaria; Minicucci, Laura] Ist Giannina Gaslini, CF Ctr, Pediat Clin, I-16148 Genoa, Italy.
   [Castaldo, Giuseppe] CEINGE Biotecnol Avanzate, Naples, Italy.
   [Colombo, Carla; Zazzeron, Laura] Univ Milan, Cyst Fibrosis CF Ctr, Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Milan, Italy.
   [Covone, Angela Elvira; Ravazzolo, Roberto] Ist Giannina Gaslini, Mol Genet Lab, I-16148 Genoa, Italy.
   [De Rose, Virginia] Univ Turin, CF Ctr, SCDU Malattie Apparato Resp, Turin, Italy.
   [Gagliardini, Rolando] Salesi Childrens Hosp, CF Ctr, Ancona, Italy.
   [Pardo, Francesca; Termini, Lisa] Childrens Hosp, CF Ctr, Palermo, Italy.
   [Raia, Valeria] Univ Naples Federico II, Dept Paediat, CF Ctr, Naples, Italy.
   [Ravazzolo, Roberto] Univ Genoa, Dept Pediat Sci, Genoa, Italy.
   [Ravazzolo, Roberto] Univ Genoa, CEBR, Genoa, Italy.
   [Seia, Manuela] Univ Milan, Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Mol Lab, Milan, Italy.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI ATHANASAKIS, EMMANOUIL/G-8205-2011; Bezzerri, Valentino/K-8132-2016;
   Gasparini, Paolo/B-6173-2014; Crovella, Sergio/K-5050-2016; Cabrini,
   Giulio/K-4761-2016; Covone, Angela/AAA-7859-2020; Athanasakis,
   Emmanouil/K-1326-2018
OI Bezzerri, Valentino/0000-0002-6849-4487; Crovella,
   Sergio/0000-0001-8493-1168; Cabrini, Giulio/0000-0003-2720-0742; Covone,
   Angela/0000-0002-7669-5270; Segat, Ludovica/0000-0002-6024-1485;
   NICOLIS, ELENA/0000-0001-7810-3307; Gasparini,
   Paolo/0000-0002-0859-0856; Athanasakis, Emmanouil/0000-0002-7707-2665;
   Castaldo, Giuseppe/0000-0002-4036-0874
FU Fondazione Italiana per la Fibrosi Cistica (FFC) [22/2006, 3/2008]; FVG
   (Trieste, Italy); IRCCS Burlo Garofolo (Trieste, Italy) [RC37/07]
FX This work has been supported by a research grant from "Fondazione
   Italiana per la Fibrosi Cistica'' (FFC project #22/2006 and #3/2008 to
   PG and GC), by a FVG 2008 grant (Trieste, Italy) and by a RC37/07 grant
   from IRCCS Burlo Garofolo (Trieste, Italy).
CR Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9
   Intrieri M, 2010, CLIN CHEM LAB MED, V48, P489, DOI 10.1515/CCLM.2010.098
   Jia HP, 2001, GENE, V263, P211
   Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749
   Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433
   Malik AN, 2007, BIOCHEM BIOPH RES CO, V353, P318, DOI 10.1016/j.bbrc.2006.12.037
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461
   SANTIS G, 1992, PEDIATR PULM, V8, P239
   Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1
   Sherman H, 2006, MOL IMMUNOL, V43, P1617, DOI 10.1016/j.molimm.2005.09.013
   Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900
   Tesse R, 2008, GENES IMMUN, V9, P57, DOI 10.1038/sj.gene.6364440
   Vankeerberghen A, 2005, GENOMICS, V85, P574, DOI 10.1016/j.ygeno.2005.02.003
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
NR 24
TC 9
Z9 9
U1 0
U2 5
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1434-6621
J9 CLIN CHEM LAB MED
JI Clin. Chem. Lab. Med.
PD JAN
PY 2011
VL 49
IS 1
BP 49
EP 54
DI 10.1515/CCLM.2011.023
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 709DT
UT WOS:000286418300007
PM 21077791
DA 2020-12-08
ER

PT J
AU Castro-Antunes, MM
   Crovella, S
   Brandao, LAC
   Guimaraes, RL
   Motta, MEFA
   da Silva, GAP
AF Castro-Antunes, Margarida Maria
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
   Guimaraes, Rafael Lima
   Farias Almeida Motta, Maria Eugenia
   Pontes da Silva, Giselia Alves
TI Fequency distribution of HLA DQ2 and DQ8 in celiac patients and
   first-degree relatives in Recife, northeastern Brazil
SO CLINICS
LA English
DT Article
DE Celiac disease; HLA; Relatives; Genotyping; Diagnosis
ID DISEASE; PREVALENCE; RISK; POPULATION; DIAGNOSIS
AB AIMS : The aim of this study was to evaluate the frequencies of the HLA genotypes DQ2 and DQ8 and the alleles A1(star)05, A1(star) 0201, B1(star)0201 and B1(star)0302 in individuals with celiac disease in Recife, northeastern Brazil.
   METHODS: HLA DQ2 and DQ8 genotyping was performed for 73 individuals with celiac disease and 126 first-degree relatives with negative transglutaminase serology. The alleles DQA1(star)05, DQA1(star)0201, DQB1(star)02 and DQB1(star)0302 were identified by sequencing using specific primers and the EU-DQ kit from the Eurospital Laboratory, Trieste, Italy and double-checked by the All Set SPP kit (Dynal).
   RESULTS: Among the 73 cases, 50 (68.5%) had the genotype DQ2, 13 (17.8%) had DQ8, 5 (6.8%) had DQ2 and DQ8, and 5 did not have any of these genotypes. Among the 5 negative individuals, four had the B1(star)02 allele and one did not have any of the alleles studied. B1(star)02 was the most frequent allele in both groups (94% in the patients and 89% in the control relatives).
   CONCLUSIONS: In this study, celiac disease was associated with the genotypes DQ2 and DQ8. DQ2 predominated, but the distribution of the frequencies was different from what has been found in European populations and was closer to what has been found in the Americas. The high frequencies of the HLA genotypes DQ2 and DQ8 that were found in first-degree relatives would make it difficult to use these HLA genotypes for routine diagnosis of celiac disease in this group.
C1 [Castro-Antunes, Margarida Maria; Farias Almeida Motta, Maria Eugenia] Fed Univ Pernambuco UFPE, Hlth Sci Ctr, Dept Postgrad Studies Children & Adolescents Hlth, Recife, PE, Brazil.
   [Crovella, Sergio; Cavalcanti Brandao, Lucas Andre; Guimaraes, Rafael Lima; Pontes da Silva, Giselia Alves] Keiso Asami Immunopathol Lab LIKA, Recife, PE, Brazil.
   [Castro-Antunes, Margarida Maria] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   Children Hosp Burlo Garofolo Trieste, Genet Serv, Trieste, Italy.
RP Castro-Antunes, MM (corresponding author), Fed Univ Pernambuco UFPE, Hlth Sci Ctr, Dept Postgrad Studies Children & Adolescents Hlth, Recife, PE, Brazil.
EM margarida.mmcastro@gmail.com
RI Crovella, Sergio/K-5050-2016; Antunes, Margarida/AAO-1732-2020; Brandao,
   Lucas Andre Cavalcanti/G-8333-2012
OI Crovella, Sergio/0000-0001-8493-1168; Antunes,
   Margarida/0000-0001-5785-9906; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559
FU Brazilian National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [475120 / 2006-1]
FX This study was funded by the Brazilian National Counsel of Technological
   and Scientific Development (CNPq) (Case No. 475120 / 2006-1).
CR Accomando S, 2004, DIGEST LIVER DIS, V36, P492, DOI 10.1016/j.dld.2004.01.026
   Araya M, 2000, J PEDIATR GASTR NUTR, V31, P381, DOI 10.1097/00005176-200010000-00010
   Bevan S, 1999, J MED GENET, V36, P687
   Bonamico M, 2006, J PEDIATR GASTR NUTR, V42, P150, DOI 10.1097/01.mpg.0000189337.08139.83
   Butterworth JR, 2005, EUR J GASTROEN HEPAT, V17, P541, DOI 10.1097/00042737-200505000-00011
   Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931
   CATASSI C, 2006, J PEDIAT GASTROENTER, V40, P279, DOI DOI 10.1097/01.MPG.0000151650.03929.D5
   Chang M, 2009, J CLIN GASTROENTEROL, V43, P43, DOI 10.1097/MCG.0b013e318187311d
   Cintado A, 2006, HUM IMMUNOL, V67, P639, DOI 10.1016/j.humimm.2006.04.009
   Esteve M, 2006, GUT, V55, P1739, DOI 10.1136/gut.2006.095299
   Farre C, 1999, DIGEST DIS SCI, V44, P2344, DOI 10.1023/A:1026685527228
   Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286
   Gandolfi L, 2000, AM J GASTROENTEROL, V95, P689, DOI 10.1111/j.1572-0241.2000.01847.x
   HEDRICK PW, 1983, GENETICS, V104, P449
   Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001
   Hunt KA, 2009, GUT, V58, P473, DOI 10.1136/gut.2008.155879
   Johnson TC, 2004, CLIN GASTROENTEROL H, V2, P888, DOI 10.1016/S1542-3565(04)00390-8
   Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187
   Nigam P, 2004, TISSUE ANTIGENS, V64, P204, DOI 10.1111/j.1399-0039.2004.00264.x
   Oliveira RP, 2007, EUR J GASTROEN HEPAT, V19, P43, DOI 10.1097/01.meg.0000250586.61232.a3
   Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100
   Polvi A, 1998, HUM IMMUNOL, V59, P169, DOI 10.1016/S0198-8859(98)00008-1
   Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040
   Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242
   Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
NR 28
TC 14
Z9 15
U1 0
U2 3
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2011
VL 66
IS 2
BP 227
EP 231
DI 10.1590/S1807-59322011000200008
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 748BO
UT WOS:000289365200008
PM 21484038
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Crovella, S
   Biller, L
   Santos, S
   Salustiano, A
   Brandao, L
   Guimaraes, R
   Segat, L
   de Lima, JL
   Arraes, LC
AF Crovella, Sergio
   Biller, Lara
   Santos, Sergio
   Salustiano, Ana
   Brandao, Lucas
   Guimaraes, Rafael
   Segat, Ludovica
   de Lima Filho, Jose Luiz
   Arraes, Luiz Claudio
TI Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected
   patients and controls from northeastern Brazil
SO CLINICS
LA English
DT Article
ID HLA-B-ASTERISK-5701; HYPERSENSITIVITY; PHARMACOGENETICS
C1 [Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   [Santos, Sergio; Salustiano, Ana] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Biller, Lara; Brandao, Lucas; Guimaraes, Rafael; Segat, Ludovica; de Lima Filho, Jose Luiz] Fed Univ Pernambuco Recife, LIKA, Recife, PE, Brazil.
   Lab Cent Saude Publ Dr Milton Bezerra Sobral LACE, Recife, PE, Brazil.
   [Arraes, Luiz Claudio] Inst Med Integrada Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
EM crovelser@gmail.com
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Filho, Jose Luiz
   Lima/M-8076-2019; Crovella, Sergio/K-5050-2016
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo (Trieste Italy) [RC07/08]; Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [APQ
   APQ-0757-2.02/10, APQ-0020-4.01/08]; TALENTS Programme (7th R&D
   Framework Programme, Specific Programme: PEOPLE Marie Curie Actions)
FX This work has been supported by the RC07/08 project from IRCCS Burlo
   Garofolo (Trieste Italy) and by the project APQ APQ-0757-2.02/10 from
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE). LS is a recipient of a fellowship grant (APQ-0020-4.01/08)
   from FACEPE. SC is recipient of a grant from the TALENTS Programme (7th
   R&D Framework Programme, Specific Programme: PEOPLE Marie Curie Actions
   - COFUND).
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Arrizabalaga J, 2009, HIV CLIN TRIALS, V10, P48, DOI [10.1310/hct1001-048, 10.1310/hct1001-48]
   Dawood S, 2009, CANCER INVEST, V27, P482, DOI 10.1080/07357900802574660
   Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6
   Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135
   Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x
   Poggi H, 2010, BRAZ J INFECT DIS, V14, P510, DOI 10.1590/S1413-86702010000500015
   Roca Bernardino, 2008, Recent Pat Antiinfect Drug Discov, V3, P132, DOI 10.2174/157489108784746650
   Rodriguez-Novoa S, 2008, PHARMACOGENOMICS, V9, P1531, DOI 10.2217/14622416.9.10.1531
   Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382
   Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001
   Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002
   Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187
NR 13
TC 10
Z9 11
U1 0
U2 5
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2011
VL 66
IS 8
BP 1485
EP 1487
DI 10.1590/S1807-59322011000800030
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA 819KC
UT WOS:000294822800030
PM 21915505
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Crovella, S
   Pontillo, A
AF Marcuzzi, Annalisa
   Crovella, Sergio
   Pontillo, Alessandra
TI Geraniol Rescues Inflammation in Cellular and Animal Models of
   Mevalonate Kinase Deficiency
SO IN VIVO
LA English
DT Article
DE Pamidronate; geraniol; inflammation; mevalonate kinase deficiency
ID NITROGEN-CONTAINING BISPHOSPHONATES; CELLS IN-VITRO; INTERLEUKIN-1-BETA
   SECRETION; CYTOKINE PROFILES; BONE-RESORPTION; MECHANISMS; VIVO;
   PAMIDRONATE; ALENDRONATE; INHIBITION
AB Background/Aim: The inhibition of the mevalonate pathway through genetic defects such as mevalonate kinase deficiency (MKD) or pharmacological drugs such as aminobisphosphonates causes a shortage of intermediate compounds, in particular geranylgeranyl-pyrophosphate (GGPP), which is associated with the consequent augmented IL-1 beta release in monocytes. Considering that, due to its biochemical structure, isoprenoid geraniol enters the mevalonate pathway and may revert the genetic or pharmacological inhibition, the present study tested isoprenoid geraniol in cellular and animal MKD models obtained through the use of aminobisphosphonate pamidronate. Materials and Methods: The effect of natural isoprenoid geraniol on bacterial induced-inflammation was evaluated in a monocytic cell line (Raw 264.7) and in Balb/c mice treated with pamidronate. Results: Geraniol diminished the levels of inflammatory markers induced by pamidronate stimuli in vitro and in vivo. Conclusion: Geraniol may be proposed as a novel therapeutic approach for the orphan disease MKD, and may also be considered for the evaluation of possible inflammatory side-effects of aminobisphosphonates.
C1 [Marcuzzi, Annalisa; Crovella, Sergio; Pontillo, Alessandra] Inst Maternal & Child Hlth IRCCS Burlo Garofolo T, Med Genet Serv, I-34134 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo T, Med Genet Serv, Via Istria 65-1, I-34134 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Marcuzzi, Annalisa/AAA-6038-2020;
   Pontillo, Alessandra/AAD-4790-2019; Pontillo, ALESSANDRA/D-4352-2012;
   Crovella, Sergio/K-5050-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168
FU Institute for Maternal and Child Health IRCCS 'Burlo Garofolo' [RC
   13/08]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS 'Burlo Garofolo' (RC 13/08).
CR Carbone LD, 2006, CLIN EXP IMMUNOL, V146, P371, DOI 10.1111/j.1365-2249.2006.03216.x
   CECCHINI MG, 1990, J BONE MINER RES, V5, P1019
   De Leo L, 2010, PHARMACOL RES, V61, P506, DOI 10.1016/j.phrs.2010.02.012
   Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005
   Diaz-Borjon A, 2006, JCR-J CLIN RHEUMATOL, V12, P131, DOI 10.1097/01.rhu.0000221796.06383.4e
   Dombrecht EJ, 2007, CLIN EXP RHEUMATOL, V25, P817
   Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9
   Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   MARCUZZI A, 2010, INT IMMUNOPHARMACOL, V61, P506
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Marcuzzi A, 2010, INFLAMM RES, V59, P335, DOI 10.1007/s00011-010-0168-6
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PENNANEN N, 1995, PHARMACEUT RES, V12, P916, DOI 10.1023/A:1016281608773
   Reinholz GG, 2002, BREAST CANCER RES TR, V71, P257, DOI 10.1023/A:1014418017382
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   Slobodin G, 2009, CLIN RHEUMATOL, V28, P1359, DOI 10.1007/s10067-009-1256-2
   Suri S, 2001, BONE, V29, P336, DOI 10.1016/S8756-3282(01)00589-0
   Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353
   van Beek ER, 2003, BONE, V33, P805, DOI 10.1016/j.bone.2003.07.007
   Van Offel JF, 2001, CLIN EXP RHEUMATOL, V19, P13
NR 24
TC 25
Z9 25
U1 0
U2 5
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
J9 IN VIVO
JI In Vivo
PD JAN-FEB
PY 2011
VL 25
IS 1
BP 87
EP 92
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 720RC
UT WOS:000287296800012
PM 21282739
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Brandao, L
   Guimaraes, R
   Segat, L
   Araujo, J
   Crovella, S
AF Pontillo, A.
   Brandao, L.
   Guimaraes, R.
   Segat, L.
   Araujo, J.
   Crovella, S.
TI Two SNPs in NLRP3 gene are involved in the predisposition to type-1
   diabetes and celiac disease in a pediatric population from northeast
   Brazil
SO AUTOIMMUNITY
LA English
DT Article
DE NLRP1; NLRP3; type-1 diabetes; celiac disease; atopic dermatitis
ID POLYMORPHISMS; NALP1; CIAS1; IDENTIFICATION; INFLAMMASOME; ASSOCIATION;
   EXPRESSION; MUTATIONS; HAPLOTYPE; VARIANTS
AB Recent findings provide evidence of the critical role of innate immunity NALP1/NLRP1 and NALP3/NLRP3/CIAS1 genes in inflammatory diseases, and also in the predisposition to autoimmune disorders.
   We evaluated the possible association of five single nucleotide polymorphisms (SNPs), two in NLRP1 gene and three in NLRP3 gene, in pediatric patients from the north eastern region of Brazil affected by type-1 diabetes (T1D, n = 196), celiac disease (CD, n = 59), and atopic dermatitis (AD, n = 165), and in healthy individuals (n = 192).
   Our results demonstrated that NLRP3 rs10754558 SNP was associated specifically to T1D (p = 4exp-3) and NLRP3 rs358294199 SNP to CD (p = 5exp-4) in the Brazilian population. Despite its strong association with T1D in Norwegian population, NLRP1 was not associated with T1D, in the Brazilian population. According to previous studies in Caucasoid cohorts, NLRP1 and NLRP3 seemed not to be associated to AD.
   Since it has been reported that IL-1beta has a systemic effect in the lost of the immunologic tolerance and that NALP3 inflammasome is directly involved in the production of this pro-inflammatory cytokine, we hypothesized that variations in NLRP3 could belong to a predisposing genetic background that contribute to the development of autoimmune diseases.
C1 [Pontillo, A.; Segat, L.; Crovella, S.] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Trieste, Italy.
   [Brandao, L.; Guimaraes, R.; Segat, L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Araujo, J.] Univ Fed Pernambuco, Hosp Clin, Serv Endocrinol, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, ALESSANDRA/D-4352-2012; Pontillo, Alessandra/ABC-6266-2020;
   Crovella, Sergio/K-5050-2016; Pontillo, Alessandra/AAD-4790-2019;
   Brandao, Lucas Andre Cavalcanti/G-8333-2012
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Pontillo, Alessandra/0000-0002-7883-0640; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Segat, Ludovica/0000-0002-6024-1485
CR Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Caroli F, 2007, RHEUMATOLOGY, V46, P473, DOI 10.1093/rheumatology/kel269
   Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738
   Garner CP, 2007, GENES IMMUN, V8, P108, DOI 10.1038/sj.gene.6364361
   HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
   Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044
   Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x
   Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   KASTBOM A, 2009, ANN RHEUM DIS   0513
   Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006
   Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720
   Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166
   O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278
   Omi T, 2006, EUR J HUM GENET, V14, P1295, DOI 10.1038/sj.ejhg.5201698
   Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072
   Shaker Marcus, 2007, Pediatr Rheumatol Online J, V5, P12, DOI 10.1186/1546-0096-5-12
   STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298
   van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058
   Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286
   Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285
NR 26
TC 89
Z9 93
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0891-6934
EI 1607-842X
J9 AUTOIMMUNITY
JI Autoimmunity
PD DEC
PY 2010
VL 43
IS 8
BP 583
EP 589
DI 10.3109/08916930903540432
PG 7
WC Immunology
SC Immunology
GA 678LC
UT WOS:000284074300002
PM 20370570
DA 2020-12-08
ER

PT J
AU Bulla, R
   De Seta, F
   Radillo, O
   Agostinis, C
   Durigutto, P
   Pellis, V
   De Santo, D
   Crovella, S
   Tedesco, F
AF Bulla, R.
   De Seta, F.
   Radillo, O.
   Agostinis, C.
   Durigutto, P.
   Pellis, V.
   De Santo, D.
   Crovella, S.
   Tedesco, F.
TI Mannose-binding lectin is produced by vaginal epithelial cells and its
   level in the vaginal fluid is influenced by progesterone
SO MOLECULAR IMMUNOLOGY
LA English
DT Article
DE MBL; Complement; Vagina; Menstrual cycle; Female reproductive tract;
   Mucosal immunity
ID COMPLEMENT COMPONENTS; EXPRESSION; PATHWAY; PROTEIN; GENE; PREGNANCY;
   HEALTH; TRACT; WOMEN; C3
AB Mannose-binding lectin (MBL) is a recognition molecule of the complement (C) system and binds to carbohydrate ligands present on a wide range of pathogenic bacteria viruses fungi and parasites
   MBL has been detected in the cervico-vaginal cavity where it can provide a first-line defence against infectious agents colonizing the lower tract of the reproductive system
   Analysis of the cervico-vaginal lavage (CVL) obtained from 11 normal cycling women at different phases of the menstrual cycle revealed increased levels of MBL in the secretive phase Part of this MBL derives from the circulation as indicated by the presence of transferrin in CVL tested as a marker of vascular and tissue permeability The local synthesis of MBL is suggested by the finding that its level is substantially higher than that of transferrin in the secretive phase The contribution of endometrium is negligible since the MBL level did not change before and after hysterectomy RT-PCR and in situ RT-PCR analysis showed that the vaginal tissue and in particular the basal layer of the epithelium is a source of MBL which binds to the basal membrane and to cells of the outer layers of the epithelium
   In conclusion we have shown that MBL detected in CVL derives both from plasma as result of transudation and from local synthesis and its level is progesterone dependent increasing in the secretive phase of the menstrual cycle (C) 2010 Elsevier Ltd All rights reserved
C1 [Agostinis, C.; Durigutto, P.; Tedesco, F.] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [De Seta, F.; Agostinis, C.; De Santo, D.] Univ Trieste, Dept Reprod & Dev Sci, IRCCS Burlo Garofolo, I-34127 Trieste, Italy.
   [De Seta, F.] Des Moines Univ, Des Moines, IA USA.
   [Radillo, O.; Pellis, V.] IRCCS Burlo Garofolo, Serv Pathol & Lab Med, Trieste, Italy.
   [Crovella, S.] Univ Trieste, IRCCS Burlo Garofolo, Genet Serv, I-34127 Trieste, Italy.
   [Crovella, S.] Univ Trieste, IRCCS Burlo Garofolo, Dept Dev & Reprod Sci, I-34127 Trieste, Italy.
RP Tedesco, F (corresponding author), Univ Trieste, Dept Life Sci, Via Valerio 28, I-34127 Trieste, Italy.
RI Bulla, Roberta/F-9957-2015; Tedesco, Francesco/F-1929-2011; Crovella,
   Sergio/K-5050-2016
OI Bulla, Roberta/0000-0003-1737-5776; Crovella,
   Sergio/0000-0001-8493-1168; Durigutto, Paolo/0000-0003-3862-4970; De
   Seta, Francesco/0000-0003-1611-0813; Agostinis,
   Chiara/0000-0002-8315-2258
FU Minister dell Istruzione Universita e Ricerca (MIUR)Ministry of
   Education, Universities and Research (MIUR) [LSHN-CT-2004-512040];
   Associazione Italiana per la Ricerca sul CancroAssociazione Italiana per
   la Ricerca sul Cancro (AIRC) Funding Source: Custom
FX We thank Erika Bianchini Silvia Smiroldo and Francesca Colombo of the
   Department of Reproductive and Developmental Sciences for providing
   biological samples This work was supported by the European NoE EMBIC
   within FP6 (contract number LSHN-CT-2004-512040) AIRC and COFIN 2007
   provided by Minister dell Istruzione Universita e Ricerca (MIUR)
CR Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007
   Babula O, 2003, CLIN INFECT DIS, V37, P733, DOI 10.1086/377234
   Boniotto M, 2003, EUR J HISTOCHEM, V47, P177
   Bulla R, 2008, MOL IMMUNOL, V45, P2629, DOI 10.1016/j.molimm.2007.12.025
   Christiansen OB, 1999, SCAND J IMMUNOL, V49, P193
   Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x
   Downing I, 2003, IMMUNOLOGY, V109, P360, DOI 10.1046/j.1365-2567.2003.01675.x
   Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005
   Gerritsma JSJ, 1997, CYTOKINE, V9, P276, DOI 10.1006/cyto.1996.0164
   Giraldi A., 2006, WOMENS SEXUAL FUNCTI
   HASTY LA, 1994, AM J OBSTET GYNECOL, V170, P168
   HOMANN C, 1995, LIVER, V15, P39
   Jack DL, 2003, BIOCHEM SOC T, V31, P753, DOI 10.1042/BST0310753
   Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631
   Kilpatrick DC, 1999, HUM REPROD, V14, P2379, DOI 10.1093/humrep/14.9.2379
   Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316
   Kruse C, 2002, AM J OBSTET GYNECOL, V187, P1313, DOI 10.1067/mob.2002.126846
   Kuipers S, 2003, FEMS IMMUNOL MED MIC, V36, P33, DOI 10.1016/S0928-8244(03)00032-4
   Morio H, 1997, EUR J BIOCHEM, V243, P770, DOI 10.1111/j.1432-1033.1997.00770.x
   Patton DL, 2000, AM J OBSTET GYNECOL, V183, P967, DOI 10.1067/mob.2000.108857
   Pellis V, 2005, CLIN EXP IMMUNOL, V139, P120, DOI 10.1111/j.1365-2249.2005.02660.x
   Petersen SV, 2001, MOL IMMUNOL, V38, P133
   Sayegh RA, 1996, J CLIN ENDOCR METAB, V81, P1641, DOI 10.1210/jc.81.4.1641
   SCHUMACHER G F B, 1973, P201
   Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982
   Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229
   Tang LJ, 2007, J PROTEOME RES, V6, P2874, DOI 10.1021/pr0700899
   Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Uemura K, 2002, J IMMUNOL, V169, P6945, DOI 10.4049/jimmunol.169.12.6945
   van de Geijn FE, 2007, HUM REPROD, V22, P362, DOI 10.1093/humrep/del392
   VANDERPUYE OA, 1992, AM J REPROD IMMUNOL, V27, P145, DOI 10.1111/j.1600-0897.1992.tb00742.x
   WAGNER GL, 1978, HUMAN VAGINA
   Wagner S, 2003, J IMMUNOL, V170, P1462, DOI 10.4049/jimmunol.170.3.1462
   Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4
   Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x
NR 38
TC 23
Z9 24
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD NOV-DEC
PY 2010
VL 48
IS 1-3
BP 281
EP 286
DI 10.1016/j.molimm.2010.07.016
PG 6
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 701GI
UT WOS:000285806000031
PM 20728220
DA 2020-12-08
ER

PT J
AU Tommasini, A
   Pirrone, A
   Palla, G
   Taddio, A
   Martelossi, S
   Crovella, S
   Ventura, A
AF Tommasini, Alberto
   Pirrone, Angela
   Palla, Gabriella
   Taddio, Andrea
   Martelossi, Stefano
   Crovella, Sergio
   Ventura, Alessandro
TI The universe of immune deficiencies in Crohn's disease: a new viewpoint
   for an old disease?
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Crohn's disease; genetics; phagocytes; primary immunodeficiency; therapy
ID CHRONIC GRANULOMATOUS-DISEASE; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL
   EPITHELIAL BARRIER; COLONY-STIMULATING FACTOR; NEUTROPHIL DYSFUNCTION;
   AUTOPHAGY GENES; TWIN COHORT; NOD2; SUSCEPTIBILITY; ASSOCIATION
AB Crohn's disease (CD) is generally considered a multifactorial disorder, since different genetic and environmental factors are thought to play a role in its pathogenesis. Recently, genome wide linkage studies allowed to identify the association of several loci with the increased risk of CD, although it is still unclear how they interact with environmental factors in causing the disease. The fact that many CD-risk-related genes are involved in the function of phagocytes seems in agreement with the well known role of these cells in CD histopathology. Functional defects in cytokine production or in clearance of bacteria in CD patients have recently been reported. Growing evidence that CD could arise from primary phagocyte immunodeficiency is also coming from the study of cases with early onset in infancy. We review such evidences starting from selected cases and discuss the clinical implications of these findings.
C1 [Tommasini, Alberto; Pirrone, Angela; Taddio, Andrea; Martelossi, Stefano; Crovella, Sergio; Ventura, Alessandro] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Tommasini, Alberto; Pirrone, Angela; Taddio, Andrea; Martelossi, Stefano; Crovella, Sergio; Ventura, Alessandro] Univ Trieste, I-34137 Trieste, Italy.
   [Palla, Gabriella] Univ Pisa, Dept Procreat & Dev Med, Pisa, Italy.
RP Tommasini, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM Tommasini@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Tommasini, Alberto/AAE-3882-2020
OI Crovella, Sergio/0000-0001-8493-1168; Tommasini,
   Alberto/0000-0002-6943-7927; Taddio, Andrea/0000-0001-6817-4953;
   Ventura, Alessandro/0000-0002-4657-1760
FU IRCCS Burlo Garofolo research [RC26/08, RC03/09]
FX The work was funded by IRCCS Burlo Garofolo research grant # RC26/08 and
   RC03/09.
CR Agarwal S, 2010, INFLAMM BOWEL DIS, V16, P703, DOI 10.1002/ibd.21040
   Ahlin A, 1995, ACTA PAEDIATR, V84, P1386, DOI 10.1111/j.1651-2227.1995.tb13575.x
   Ahmed FE, 2006, EXPERT REV MOL DIAGN, V6, P345, DOI 10.1586/14737159.6.3.345
   Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259
   Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587
   BARREAU F, 2009, GUT
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Beattie RM, 1998, NUTRITION, V14, P345
   Becker Mara L, 2005, Curr Rheumatol Rep, V7, P427, DOI 10.1007/s11926-005-0046-3
   Bernasconi E, 2010, INFLAMM BOWEL DIS, V16, P428, DOI 10.1002/ibd.21072
   BOLTON PM, 1973, BRIT J SURG, V60, P319
   Cadwell K, 2009, CURR TOP MICROBIOL, V335, P141, DOI 10.1007/978-3-642-00302-8_7
   Cannioto Z, 2009, EUR J PEDIATR, V168, P149, DOI 10.1007/s00431-008-0721-2
   Canto E, 2009, INFLAMM BOWEL DIS, V15, P1686, DOI 10.1002/ibd.21013
   Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683
   Cassinotti A, 2008, GUT, V57, P211, DOI 10.1136/gut.2007.128694
   Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069
   COUPER R, 1991, GASTROENTEROLOGY, V100, P549, DOI 10.1016/0016-5085(91)90229-E
   CROHN BB, 1952, AM J MED, V13, P583, DOI 10.1016/0002-9343(52)90025-9
   DAgata ID, 1996, GUT, V39, P605, DOI 10.1136/gut.39.4.605
   Dieckgraefe BK, 2002, LANCET, V360, P1478, DOI 10.1016/S0140-6736(02)11437-1
   Fata F, 1997, J CLIN GASTROENTEROL, V24, P253, DOI 10.1097/00004836-199706000-00015
   Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x
   Folwaczny C, 2003, EUR J GASTROEN HEPAT, V15, P621, DOI 10.1097/00042737-200306000-00007
   Freudenberg F, 2010, J ALLERGY CLIN IMMUN, V125, P943, DOI 10.1016/j.jaci.2010.01.035
   Garty BZ, 1996, ISRAEL J MED SCI, V32, P1276
   Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1
   Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206
   Granzotto M, 2007, WORLD J GASTROENTERO, V13, P6191, DOI 10.3748/wjg.13.6191
   Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8
   Halfvarson J, 2007, INFLAMM BOWEL DIS, V13, P1536, DOI 10.1002/ibd.20242
   Hoover EG, 1996, J PEDIATR GASTR NUTR, V22, P346, DOI 10.1097/00005176-199605000-00002
   HUANG J, 2009, COLORECTAL DIS
   Huang JS, 2004, CLIN GASTROENTEROL H, V2, P690, DOI 10.1016/S1542-3565(04)00292-7
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   ISAACS D, 1985, J PEDIATR GASTR NUTR, V4, P498, DOI 10.1097/00005176-198506000-00030
   Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972
   Keita AC, 2008, J PATHOL, V215, P135, DOI 10.1002/path.2337
   Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911
   LAMPORT RD, 1992, AM J GASTROENTEROL, V87, P1638
   Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616
   LEWISK K, 2009, INFLAMM BOWEL DIS
   Lionetti P, 2005, JPEN-PARENTER ENTER, V29, pS173, DOI 10.1177/01486071050290S4S173
   Liu S, 2008, INFLAMM BOWEL DIS, V14, P727, DOI 10.1002/ibd.20331
   Ma TY, 1997, P SOC EXP BIOL MED, V214, P318
   Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338
   Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72
   Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2
   MAZLAM MZ, 1992, GUT, V33, P773, DOI 10.1136/gut.33.6.773
   McDermott MF, 2002, CURR OPIN ALLERGY CL, V2, P511, DOI 10.1097/00130832-200212000-00006
   McGonagle D, 2009, PEDIATR RES, V65, p38R, DOI 10.1203/PDR.0b013e31819dbd0a
   Moss Alan C, 2005, Gastroenterology, V129, P2115, DOI 10.1053/j.gastro.2005.09.059
   Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2
   Myrup B, 1998, GUT, V42, P127, DOI 10.1136/gut.42.1.127
   Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010
   Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722
   Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114
   Palmer CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007787
   Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034
   PRESS RD, 2001, MOL DIAGN, V6, P347
   Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739
   ROE TF, 1992, NEW ENGL J MED, V326, P1666, DOI 10.1056/NEJM199206183262504
   Salh B, 1998, IMMUNOLOGY, V95, P473, DOI 10.1046/j.1365-2567.1998.00614.x
   Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840
   Schappi MG, 2001, ARCH DIS CHILD, V84, P147, DOI 10.1136/adc.84.2.147
   SEGAL AW, 1976, LANCET, V2, P219
   Sewell GW, 2009, CURR OPIN IMMUNOL, V21, P506, DOI 10.1016/j.coi.2009.06.003
   Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282
   Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233
   Spehlmann ME, 2008, INFLAMM BOWEL DIS, V14, P968, DOI 10.1002/ibd.20380
   STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378
   STEVENS C, 1991, J CLIN GASTROENTEROL, V13, P328, DOI 10.1097/00004836-199106000-00016
   Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823
   VANNIER JP, 1982, ARCH FR PEDIATR, V39, P367
   Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726
   Visser G, 2002, J INHERIT METAB DIS, V25, P261, DOI 10.1023/A:1016572706488
   Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543
   Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707
   Wilk Jacque N, 2002, Curr Opin Investig Drugs, V3, P1291
   Wirtz S, 2003, GENE THER, V10, P854, DOI 10.1038/sj.gt.3302013
   Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41
   Xavier RJ, 2008, GUT, V57, P717, DOI 10.1136/gut.2007.134254
   Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P736, DOI 10.1002/ibd.21144
   YOGMAN MW, 1974, NEW ENGL J MED, V290, P228
   Zhang HF, 2009, HUM GENET, V125, P627, DOI 10.1007/s00439-009-0660-7
NR 85
TC 13
Z9 14
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5521
EI 1502-7708
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD OCT
PY 2010
VL 45
IS 10
BP 1141
EP 1149
DI 10.3109/00365521.2010.492529
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 654EO
UT WOS:000282151500002
PM 20497046
DA 2020-12-08
ER

PT J
AU Barkokebas, A
   Carvalho, AAT
   Souza, PRE
   Gomez, RS
   Xavier, GM
   Ribeiro, CMB
   Crovella, S
   Porter, SR
   Leao, JC
AF Barkokebas, A.
   Carvalho, A. A. T.
   Souza, P. R. E.
   Gomez, R. S.
   Xavier, G. M.
   Ribeiro, C. M. B.
   Crovella, S.
   Porter, S. R.
   Leao, J. C.
TI Mannose binding lectin gene (MBL-2) polymorphism in oral lichen planus
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Barkokebas, A.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Carvalho, A. A. T.; Ribeiro, C. M. B.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Souza, P. R. E.] Univ Fed Rural de Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Gomez, R. S.; Xavier, G. M.] Univ Fed Minas Gerais, Dept Clin Patologica & Cirurgia Odontologica, Belo Horizonte, MG, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
   [Porter, S. R.] Univ London, Eastman Dent Inst, Div Maxillofacial Diagnost Surg & Med Sci, Oral Med unit, London, England.
RI Crovella, Sergio/K-5050-2016; Leao, Jair Carneiro/AAL-6154-2020; Gomez,
   Ricardo Santiago/G-1976-2012
OI Crovella, Sergio/0000-0001-8493-1168; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gomez, Ricardo
   Santiago/0000-0001-8770-8009; Porter, Stephen/0000-0002-3328-2759
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2010
VL 16
IS 6
BP 524
EP 524
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 643HZ
UT WOS:000281287500047
DA 2020-12-08
ER

PT J
AU Segat, L
   Catamo, E
   Fabris, A
   Morgutti, M
   D'Agaro, P
   Campello, C
   Crovella, S
AF Segat, Ludovica
   Catamo, Eulalia
   Fabris, Annalisa
   Morgutti, Marcello
   D'Agaro, Pierlanfranco
   Campello, Cesare
   Crovella, Sergio
TI HLA-G*0105N allele is associated with augmented risk for HIV infection
   in white female patients
SO AIDS
LA English
DT Article
ID HLA-G POLYMORPHISMS; LEUKOCYTE ANTIGEN-G; EXPRESSION; PROGRESSION;
   POPULATION; MOLECULE; CELLS; SUSCEPTIBILITY; TRANSMISSION; SURVIVAL
AB We analyzed HLA-G 3777G>C, HLA-G 14 bp deletion/insertion and HLA-G*0105N polymorphisms in HIV-positive white adult participants, infected through horizontal heterosexual transmission, and unexposed uninfected individuals, all from north eastern Italy. We report a new association between the HLA-G*0105N allele and HIV infection in adult white female participants, being HLA-G*0105N null allele correlated with an augmented risk (odds rati = 4.35, 95% confidence interval = 1.38-18.07, P = 0.005) for HIV infection.
C1 [Segat, Ludovica; Catamo, Eulalia; Fabris, Annalisa; Morgutti, Marcello; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.
   [Segat, Ludovica] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [D'Agaro, Pierlanfranco; Campello, Cesare] Univ Trieste, Dept Publ Med Sci, UCO Hyg & Prevent Med, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Inst Maternal & Child Hlth, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Catamo, Eulalia/K-9399-2016
OI Crovella, Sergio/0000-0001-8493-1168; Segat,
   Ludovica/0000-0002-6024-1485; Catamo, Eulalia/0000-0002-4701-9134
FU Brazilian Research Ministry, CNPqNational Council for Scientific and
   Technological Development (CNPq) [401635/2009-0]; IRCCS Burlo Garofolo
   (Trieste, Italy) [RC 77/08]; Fundacao de Amparo a Ciencia e Tecnologia
   do Estado de Pernambuco (FACEPE) [APQ-0020-4.01/08]
FX The present work has been supported by a 401635/2009-0 CNPq grant from
   the Brazilian Research Ministry and by a RC 77/08 grant from IRCCS Burlo
   Garofolo (Trieste, Italy). L. S. is recipient of a fellowship grant
   (APQ-0020-4.01/08) from Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE).
CR Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28
   An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002
   Castro MJ, 2000, TISSUE ANTIGENS, V56, P232, DOI 10.1034/j.1399-0039.2000.560305.x
   Derrien M, 2004, J GEN VIROL, V85, P1945, DOI 10.1099/vir.0.79867-0
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100
   Gomez-Casado E, 1999, CELL MOL LIFE SCI, V56, P356, DOI 10.1007/s000180050436
   Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x
   Lajoie J, 2006, J INFECT DIS, V193, P298, DOI 10.1086/498877
   Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007
   Lajoie J, 2009, AIDS, V23, P1437, DOI 10.1097/QAD.0b013e32832d0825
   Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52
   Le Discorde M, 2005, BIOL REPROD, V73, P280, DOI 10.1095/biolreprod.104.037986
   LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101
   Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46
   Lin A, 2007, TISSUE ANTIGENS, V70, P427, DOI 10.1111/j.1399-0039.2007.00926.x
   Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005
   Matte C, 2004, AIDS, V18, P427, DOI 10.1097/00002030-200402200-00008
   Matte C, 2000, HUM IMMUNOL, V61, P1150, DOI 10.1016/S0198-8859(00)00200-7
   Mothe B, 2009, DIS MARKERS, V27, P105, DOI [10.1155/2009/360362, 10.3233/DMA-2009-0655]
   Ober C, 1998, PLACENTA, V19, P127, DOI 10.1016/S0143-4004(98)90000-5
   Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X
   Singh P, 2008, VACCINE, V26, P2966, DOI 10.1016/j.vaccine.2008.01.012
   Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001
   van der Ven K, 1998, HUM IMMUNOL, V59, P302, DOI 10.1016/S0198-8859(98)00021-4
NR 25
TC 13
Z9 15
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JUL 31
PY 2010
VL 24
IS 12
BP 1961
EP 1964
DI 10.1097/QAD.0b013e32833c3324
PG 4
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 622WT
UT WOS:000279697400021
PM 20588159
DA 2020-12-08
ER

PT J
AU Carrera, MC
   Moura, P
   Crovella, S
   de Souza, PRE
   de Alencar, LCA
   Sarinho, E
AF Carrera, Matilde Campos
   Moura, Patricia
   Crovella, Sergio
   Eleuterio de Souza, Paulo Roberto
   Arraes de Alencar, Luiz Claudio
   Sarinho, Emanuel
TI High polymorphism of the MBL2 gene in patients with atopic dermatitis
SO ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
LA English
DT Article
ID MANNOSE-BINDING LECTIN; STAPHYLOCOCCUS-AUREUS; APOPTOTIC CELLS; DISEASE;
   SKIN
AB Background: Low serum levels of mannose-binding lectin (MBL) are determined mainly by variant alleles of the MBL2 gene and it has been suggested that MBL may play a role in the susceptibility to atopic dermatitis (AD).
   Objective: The aim was to investigate the difference of the frequency of MBL2 variant alleles in AD patients and in a group of individuals without AD, and associate the MBL2 alleles with AD severity.
   Methods: MBL2 variant allele's frequency was investigated in 131 children with AD and 165 healthy children/adolescents matched by convenience. The severity of disease was graded according to the SCORing Atopic Dermatitis (SCORAD) index. The first exon variants were called "O" and the wild type "A". The variants in the promoter were H/L at -550 and X/Y at -221, determined by Real Time PCR.
   Results: Children with AD had higher frequency of allele O and the genotypes related to low or deficient levels of MBL, when compared to the healthy group (p = 0.0012 and p < 0.001, respectively), but not with AD severity.
   Conclusion: Low or deficient MBL serum levels determined genetically may contribute to the predisposition for AD, but not for disease severity. Ann Allergy Asthma Immunol. 2010; 105: 39-42.
C1 [Carrera, Matilde Campos; Arraes de Alencar, Luiz Claudio] Inst Materno Infantil de Pernambuco, Dept Dermatol, Recife, PE, Brazil.
   [Moura, Patricia] Univ Pernambuco, Inst Biol Sci, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
   [Eleuterio de Souza, Paulo Roberto] Rural Fed Univ Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Arraes de Alencar, Luiz Claudio] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [Sarinho, Emanuel] Univ Fed Pernambuco, Dept Paediat, Recife, PE, Brazil.
RP Sarinho, E (corresponding author), Pernambuco, Ave Parnamirim 327,Apto 202, Recife, PE, Brazil.
EM emanuel.sarinho@gmail.com
RI Moura, Patricia M M F/H-7233-2018; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Moura,
   Patricia/0000-0003-4259-388X; Souza, Paulo/0000-0002-9186-9849
CR Akdis CA, 2004, CURR OPIN IMMUNOL, V16, P717, DOI 10.1016/j.coi.2004.09.004
   Brandao LAC, 2008, ARCH DERMATOL, V144, P412, DOI 10.1001/archderm.144.3.412
   Brandrup F, 1999, BRIT J DERMATOL, V140, P180
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   Gong JQ, 2006, BRIT J DERMATOL, V155, P680, DOI 10.1111/j.1365-2133.2006.07410.x
   Hashimoto S, 2006, J DERMATOL SCI, V44, P93, DOI 10.1016/j.jdermsci.2006.08.004
   Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
   Lokitz ML, 2005, J INVEST DERMATOL, V125, P166, DOI 10.1111/j.0022-202X.2005.23794.x
   McGirt LY, 2006, J ALLERGY CLIN IMMUN, V118, P202, DOI 10.1016/j.jaci.2006.04.033
   Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781
   Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517
   Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223
   STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298
   Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x
NR 14
TC 9
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1081-1206
EI 1534-4436
J9 ANN ALLERG ASTHMA IM
JI Ann. Allergy Asthma Immunol.
PD JUL
PY 2010
VL 105
IS 1
BP 39
EP 42
DI 10.1016/j.anai.2010.03.017
PG 4
WC Allergy; Immunology
SC Allergy; Immunology
GA 701PE
UT WOS:000285832100008
PM 20642202
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Paoluzzi, E
   Crovella, S
AF Pontillo, Alessandra
   Paoluzzi, Elisa
   Crovella, Sergio
TI The inhibition of mevalonate pathway induces upregulation of NALP3
   expression: new insight in the pathogenesis of mevalonate kinase
   deficiency
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE mevalonate kinase deficiency; inflammasome; NALP3; caspase-1
ID CELLS; ACTIVATION; CASPASE-1; MUTATIONS; SECRETION; RELEASE; DISEASE;
   CIAS1
AB Mevalonate kinase deficiency (MKD) is a rare hereditary auto-inflammatory syndrome due to mutations in mevalonate kinase, the second enzyme of mevalonate pathway of cholesterol, and nonsterol-isoprenoids biosynthesis. The shortage of mevalonate-derived intermediates, and in particular of geranylgeranyl pyrophosphate (GGPP), has been linked with the activation of caspase-1 and thereby with the production of IL-1 beta, but the true concatenation of these two events has not been clarified yet. We hypothesized that inflammasomes could mediate the activation of caspase-1 due to the shortage of GGPP. We monitored the expression of the principal proteins (NALP1, NALP3 and IPAF) of the three known inflammasomes, first in a cellular model of MKD and then in two MKD patients, after bacterial lipopolysaccharide (LPS) stimulation. In healthy subjects, alendronate alone induced the expression of NALP1 and NALP3, and then together with LPS it induced a dramatic increase in NALP3 expression. In MKD patients, NALP3 expression was higher than in untreated healthy controls. Our results, although preliminary, showed that the inhibition of the mevalonate pathway led to a hyper-expression of NALP3, suggesting a possible involvement of NALP3-inflammasome in the activation of caspase-1 consequent to GGPP decrement. This is the first time that the involvement of the inflammasome complexes was shown in MKD pathogenesis. European Journal of Human Genetics (2010) 18, 844-847; doi: 10.1038/ejhg.2010.9; published online 24 February 2010
C1 [Pontillo, Alessandra; Paoluzzi, Elisa; Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Med Genet Serv, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Pontillo, Alessandra/AAD-4790-2019;
   Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168
FU Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo',
   Trieste, Italy [RC 13/08]
FX We acknowledge the participation of the patients, control subjects and
   family members. This work was funded by the Institute for Maternal and
   Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy (RC 13/08).
CR Bodar EJ, 2007, BLOOD, V109, P2416, DOI 10.1182/blood-2005-10-039578
   Deng X, 2009, TOXICOL APPL PHARM, V235, P97, DOI 10.1016/j.taap.2008.11.005
   Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357
   Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874
   O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329
   Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577
   Toyras A, 2003, EUR J PHARM SCI, V19, P223, DOI 10.1016/S0928-0987(03)00108-8
NR 14
TC 39
Z9 40
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUL
PY 2010
VL 18
IS 7
BP 844
EP 847
DI 10.1038/ejhg.2010.9
PG 4
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 611RM
UT WOS:000278838800018
PM 20179743
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Pontillo, A
   Brandao, LA
   Guimaraes, RL
   Segat, L
   Athanasakis, E
   Crovella, S
AF Pontillo, Alessandra
   Brandao, Lucas A.
   Guimaraes, Rafael L.
   Segat, Ludovica
   Athanasakis, Emmanouil
   Crovella, Sergio
TI A 3 ' UTR SNP in NLRP3 Gene is Associated With Susceptibility to HIV-1
   Infection
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE genetics; HIV-1; inflammasome; IL-1beta; innate immunity;
   NALP3/NLRP3/CIAS1; NALP1/NLRP1; polymorphisms
ID NALP3 INFLAMMASOME; DISEASE; IMMUNITY; CCL3L1
AB Objectives: Innate immunity genes polymorphisms are known to be involved in the multifactorial susceptibility to HIV-1 infection. Recently it has been hypothesized that inflammasomes could play an important role in the host response to viruses. The aim of our study is to verify if single-nucleotide polymorphisms (SNPs) in genes encoding for NALPs-innate immune receptors that form molecular complexes leading to the production of IL-1beta and the activation of immune response-could influence the individual susceptibility to HIV-1.
   Design: We performed an association study analyzing 2 NLRP1 and NLRP3 SNPs in HIV-1 vertically infected Brazilian children (n = 135), HIV-1-infected Brazilain adults (n = 192) and HIV-1-positive Italian seropositive subjects (n = 192).
   Results: The 3'UTR NLRP3 rs10754558 SNP was associated with HIV-1 infection in all the studied groups. The frequency of rs10754558 G allele was differently distributed within seropositive subjects (HIV+) and controls, and in particular the GG genotype was less frequent in HIV+.
   Conclusions: susceptibility to HIV-1 infection is associated with a 3'UTR NLRP3 polymorphism. This is the first report linking SNPs in the NALPs with HIV-1 infection, and further epidemiologic and functional studies are needed to deeper investigate the role of inflammasome in the susceptibility to HIV-1 infection.
C1 [Pontillo, Alessandra; Segat, Ludovica; Athanasakis, Emmanouil; Crovella, Sergio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   [Brandao, Lucas A.; Guimaraes, Rafael L.; Segat, Ludovica] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; ATHANASAKIS, EMMANOUIL/G-8205-2011;
   Crovella, Sergio/K-5050-2016; Pontillo, ALESSANDRA/D-4352-2012;
   Pontillo, Alessandra/AAD-4790-2019; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Athanasakis, Emmanouil/K-1326-2018
OI Pontillo, Alessandra/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, ALESSANDRA/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Athanasakis,
   Emmanouil/0000-0002-7707-2665; Segat, Ludovica/0000-0002-6024-1485
FU Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste,
   Italy [RC 13/08, RC07/08, RC03/04]; CNPqNational Council for Scientific
   and Technological Development (CNPq) [474566/2008-0]
FX Supported by funding by the Institute for Maternal and Child
   Health-IRCCS "Burlo Garofolo", Trieste, Italy (RC 13/08; RC07/08;
   RC03/04) and by the CNPq (474566/2008-0).; The authors declare that they
   have no disclosure of funding received for this work from any of the
   following organizations: National Institutes of Health; Wellcome Trust;
   and Howard Hughes Medical Institute.
CR Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   BEDNARIK DP, 1990, EMBO J, V9, P1157, DOI 10.1002/j.1460-2075.1990.tb08222.x
   Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004
   Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592
   Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087
   Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85
   Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968
   Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006
   Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286
NR 22
TC 58
Z9 63
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD JUL 1
PY 2010
VL 54
IS 3
BP 236
EP 240
DI 10.1097/QAI.0b013e3181dd17d4
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 613YV
UT WOS:000279022300002
PM 20502346
DA 2020-12-08
ER

PT J
AU Padovan, L
   Segat, L
   Pontillo, A
   Antcheva, N
   Tossi, A
   Crovella, S
AF Padovan, Lara
   Segat, Ludovica
   Pontillo, Alessandra
   Antcheva, Nikolinka
   Tossi, Alessandro
   Crovella, Sergio
TI Histatins In Non-Human Primates: Gene Variations and Functional Effects
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE antimicrobial peptide; histatins; innate immunity; molecular evolution
ID HISTIDINE-RICH POLYPEPTIDES; HUMAN SALIVARY HISTATINS; CANDIDA-ALBICANS;
   ANTIMICROBIAL PEPTIDES; ANTICANDIDAL ACTIVITY; FUNGICIDAL ACTIVITY;
   MINERALIZED TISSUE; PAROTID SECRETION; PROTEINS; FAMILY
AB Human histatins are histidine-rich, low molecular weight salivary proteins that contribute to the immune system of the oral cavity. In this work, nucleotide sequences of the HIS1 (coding for histatin 1) and HIS2 (coding for histatin 3) genes, homologous to the human ones, have been sequenced and analysed in five primates species including Great Ape, Hylobatidae and Cercopithecidae. In HIS1, the region corresponding to the putative mature peptide shows a premature stop codon in Macaca and Cercopithecus, while HIS2 a six codon insertion in the Cercopithecidae. Histatin 5, a 24-residue peptide derived from histatin 3, is the most antimicrobially active among human histatins, thus macaque and nomascus orthologues of histatin 5 were selected for chemical synthesis and functional characterization, in comparison to the human peptide. All synthesized histatins are predicted to be poorly amphipathic, depending on the charged state of His residues and assume partially alpha-helical conformations only in lipophilic conditions. Antimicrobial assays against Candida and Criptococcus spp. indicate somewhat different spectra of in vitro activity against the tested fungi.
   We have described HIS1 and HIS2 gene variations in primates and have analysed their functional effects on selected Hst5 orthologues. The human antimicrobial peptide has been proposed to represent an important lead for new generation of antimicrobial compounds for the treatment of oral mycoses, thus the information from the non-human primates histatins studied may aid strategies for drugs design.
C1 [Segat, Ludovica; Pontillo, Alessandra; Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Segat, Ludovica; Pontillo, Alessandra; Crovella, Sergio] Univ Trieste, IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Padovan, Lara; Antcheva, Nikolinka; Tossi, Alessandro] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Segat, Ludovica] Univ Fed Pernambuco, LIKA, BR-50670901 Recife, PE, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, BR-50670901 Recife, PE, Brazil.
RP Segat, L (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Pontillo, Alessandra/AAD-4790-2019; Tossi, Alessandro/U-2474-2017;
   Tossi, Alessandro/ABC-9061-2020; Pontillo, Alessandra/ABC-6266-2020;
   Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Tossi,
   Alessandro/0000-0001-9087-5764; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Segat, Ludovica/0000-0002-6024-1485
FU FVGRegione Friuli Venezia Giulia [R3A2]; PRINMinistry of Education,
   Universities and Research (MIUR)Research Projects of National Relevance
   (PRIN) [2005051341_005]; EUEuropean Union (EU) [COOP-CT-2005-018191];
   "Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco"
   (FACEPE) [APQ-0020-4.01/08]
FX This work was carried out within FVG regional project R3A2 and PRIN.
   Project (2005051341_005). N. Antcheva gratefully acknowledges support
   from the EU 6th framework project ET-PA (COOP-CT-2005-018191). L. Segat
   is recipient of a fellowship grant (APQ-0020-4.01/08) from "Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco" (FACEPE)
CR Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200
   Bartie KL, 2008, INT ENDOD J, V41, P586, DOI 10.1111/j.1365-2591.2008.01404.x
   Cabras T, 2007, BIOCHEM BIOPH RES CO, V358, P277, DOI 10.1016/j.bbrc.2007.04.121
   Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   DICKINSON DP, 1987, BIOCHEM BIOPH RES CO, V149, P784, DOI 10.1016/0006-291X(87)90436-0
   Dong J, 2003, J DENT RES, V82, P748, DOI 10.1177/154405910308200917
   Edgerton M, 2000, Adv Dent Res, V14, P16
   Edgerton M, 2000, ANTIMICROB AGENTS CH, V44, P3310, DOI 10.1128/AAC.44.12.3310-3316.2000
   Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009
   Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100
   Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200
   Lupetti A, 2008, EUR J CLIN MICROBIOL, V27, P1125, DOI 10.1007/s10096-008-0553-z
   MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984
   Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981
   OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472
   Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003
   PETERS EH, 1977, BIOCHEM GENET, V15, P925, DOI 10.1007/BF00483989
   POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984
   Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y
   RAJ PA, 1990, J BIOL CHEM, V265, P3893
   Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081
   Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x
   SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1
   SABATINI LM, 1993, MOL BIOL EVOL, V10, P497
   SANTARPIA RP, 1988, ARCH ORAL BIOL, V33, P567, DOI 10.1016/0003-9969(88)90131-8
   Sugimoto Jun, 2006, Gerodontology, V23, P164, DOI 10.1111/j.1741-2358.2006.00120.x
   Torres SR, 2009, MYCOSES, V52, P11, DOI 10.1111/j.1439-0507.2008.01602.x
   TROXLER RF, 1990, J DENT RES, V69, P2, DOI 10.1177/00220345900690010101
   Vylkova S, 2006, ANTIMICROB AGENTS CH, V50, P324, DOI 10.1128/AAC.50.1.324-331.2006
   WADDELL WJ, 1956, J LAB CLIN MED, V48, P311
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Welling MM, 2007, ANTIMICROB AGENTS CH, V51, P3416, DOI 10.1128/AAC.00196-07
   WOLFHEIM JH, 1983, PRIMATES COMP ANATOM
   XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991
   XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
NR 37
TC 7
Z9 7
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD JUL
PY 2010
VL 17
IS 7
BP 909
EP 918
DI 10.2174/092986610791306715
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 599KL
UT WOS:000277910800014
PM 20423320
DA 2020-12-08
ER

PT J
AU Marcuzzi, A
   Tommasini, A
   Crovella, S
   Pontillo, A
AF Marcuzzi, Annalisa
   Tommasini, Alberto
   Crovella, Sergio
   Pontillo, Alessandra
TI Natural isoprenoids inhibit LPS-induced-production of cytokines and
   nitric oxide in aminobisphosphonate-treated monocytes
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Inflammation; MKD; Periodic fever; Isoprenoid
ID MEVALONATE KINASE; IL-1-BETA RELEASE; CELLS; DEFICIENCY; ACTIVATION;
   CASPASE-1; GROWTH
AB The inhibition of mevalonate pathway through genetic defects (mevalonate kinase deficiency. MKD) or pharmacologic drugs (aminobisphosphonates) causes a shortage of intermediate compounds and, in particular, of geranylgeranyl-pyrophosphate (GGPP) associated to the activation of caspase-1 and IL-1 beta release. Geraniol (GOH), farnesol (FOH),geranylgeraniol (GGOH) and menthol (MOH), due to their isoprenoid structure, are supposed to enter the mevalonate pathway and to by-pass the biochemical block, reconstituting the pathway. Considering the already known side effects of aminobisphosphonates, and the lack of a specific treatment for MKD, we evaluated the impact of these natural isoprenoids compounds in a RAW cell lines chemically treated with the aminobisphosphonate alendronate, and in monocytes isolated from 2 patients affected by MKD. GOH, FOH, GGOH and MOH were all capable to diminish inflammatory marker levels induced by LPS. These natural isoprenoids could be proposed as novel therapeutic approach for the still orphan drug MKD, but also considered for the evaluation of possible inflammatory side effects of aminobisphosphonates. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Marcuzzi, Annalisa; Tommasini, Alberto] Univ Trieste, Dept Reprod & Dev Sci, I-34134 Trieste, Italy.
   [Tommasini, Alberto] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Lab Immunopathol, Trieste, Italy.
   [Crovella, Sergio; Pontillo, Alessandra] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Marcuzzi, A (corresponding author), Univ Trieste, Dept Reprod & Dev Sci, Via Istria 65-1, I-34134 Trieste, Italy.
EM marcuzzi@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Pontillo, Alessandra/AAD-4790-2019;
   Tommasini, Alberto/AAE-3882-2020; Crovella, Sergio/K-5050-2016;
   Marcuzzi, Annalisa/AAA-6038-2020; Pontillo, ALESSANDRA/D-4352-2012
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Tommasini, Alberto/0000-0002-6943-7927;
   Crovella, Sergio/0000-0001-8493-1168; Marcuzzi,
   Annalisa/0000-0003-3427-618X; Pontillo, ALESSANDRA/0000-0002-7883-0640
FU Institute for Maternal and Child Health IRCCS "Burlo Garofolo" [RC
   13/08]
FX This work was supported by a grant from the Institute for Maternal and
   Child Health IRCCS "Burlo Garofolo" (RC 13/08).
CR Chang FY, 2009, J CHIN MED ASSOC, V72, P294, DOI 10.1016/S1726-4901(09)70375-2
   He L, 1997, J NUTR, V127, P668
   Houten SM, 2003, J BIOL CHEM, V278, P5736, DOI 10.1074/jbc.M206564200
   Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9
   Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Merat S, 2010, DIGEST DIS SCI, V55, P1385, DOI 10.1007/s10620-009-0854-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Park EJ, 2009, J CLIN BIOCHEM NUTR, V44, P125, DOI 10.3164/jcbn.08-201
   Polo MP, 2006, BIOCHEM CELL BIOL, V84, P102, DOI 10.1139/O05-160
   Reszka Alfred A, 2003, Curr Osteoporos Rep, V1, P45, DOI 10.1007/s11914-003-0008-5
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
NR 13
TC 33
Z9 34
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-5769
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD JUN
PY 2010
VL 10
IS 6
BP 639
EP 642
DI 10.1016/j.intimp.2010.03.008
PG 4
WC Immunology; Pharmacology & Pharmacy
SC Immunology; Pharmacology & Pharmacy
GA 612HR
UT WOS:000278888000001
PM 20304105
DA 2020-12-08
ER

PT J
AU Segat, L
   Guimaraes, RL
   Brandao, LAC
   Rocha, CRC
   Zanin, V
   Trevisiol, C
   Filho, JLD
   Crovella, S
AF Segat, Ludovica
   Guimaraes, Rafael L.
   Brandao, Lucas A. C.
   Rocha, Cintia R. C.
   Zanin, Valentina
   Trevisiol, Chiara
   de Lima Filho, Jose Luiz
   Crovella, Sergio
TI Beta defensin-1 gene (DEFB1) polymorphisms are not associated with
   atopic dermatitis in children and adolescents from northeast Brazil
   (Recife, Pernambuco)
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1 GENE; INNATE
AB Background
   Atopic dermatitis (AD) is a common inflammatory skin disease resulting from the interplay between environmental, immunological and genetic factors. In our study, we investigated the role of three single nucleotide polymorphisms (SNPs) at 5'-UTR of DEFB1 gene, encoding for the human beta defensin-1, on the susceptibility to develop AD in a group of Brazilian children and adolescents.
   Methods
   Three SNPs, -20 G/A (rs11362), -44 C/G (rs1800972), and -52 G/A (rs1799946) at 5'-UTR of DEFB1 gene were genotyped in two groups of children and adolescents, one affected by AD (96 subjects), the other healthy (191 individuals), from northeast Brazil.
   Results
   -44 C/G frequencies were comparable between the two groups. The -20 GG genotype was more frequent in AD subjects than in healthy controls; the -52 GG, conversely, was more frequent in healthy controls than in AD. However, both these differences did not reach statistical significance. Also, association between SNPs and AD severity has been shown. The analysis of DEFB1 haplotypes did not highlight any association of the three SNPs with AD development or disease severity.
   Conclusions
   Our results seem to exclude a role for the -44 C/G DEFB1 SNPs on the pathogenesis and severity of AD, while for the -20 C/G and -52 G/A, even if not statistically significant, we evidenced a slight trend for susceptibility (-20 GG) and protection (-52 GG) for the development of AD. However, as controversial findings have been reported in the literature, the role of DEFB1 in the development of AD and in the severity of the phenotype deserves further investigation.
C1 [Segat, Ludovica; Zanin, Valentina; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Segat, Ludovica; Guimaraes, Rafael L.; Brandao, Lucas A. C.; Rocha, Cintia R. C.; de Lima Filho, Jose Luiz] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Segat, Ludovica; Zanin, Valentina; Crovella, Sergio] Univ Trieste, I-34137 Trieste, Italy.
   [Trevisiol, Chiara] San Polo Hosp, Pediat Unit, Monfalcone, Gorizia, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Brandao, Lucas Andre
   Cavalcanti/G-8333-2012; Filho, Jose Luiz Lima/M-8076-2019
OI Crovella, Sergio/0000-0001-8493-1168; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC03/04]; FACEPE [APQ-1130-2.02/08,
   APQ-0020-4.01/08]
FX This study was supported by a grant RC03/04 from IRCCS Burlo Garofolo
   and APQ-1130-2.02/08 from FACEPE. LS is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE.
CR Allaker RP, 2008, T ROY SOC TROP MED H, V102, P3, DOI 10.1016/j.trstmh.2007.07.005
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   [Anonymous], 1993, DERMATOLOGY, V186, P23
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P257, DOI 10.1002/ajhb.10020
   Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x
   de Oca EPM, 2007, INT ARCH ALLERGY IMM, V142, P211, DOI 10.1159/000097023
   Dhaliwal W, 2009, CLIN EXP IMMUNOL, V156, P263, DOI 10.1111/j.1365-2249.2008.03808.x
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
   Howell MD, 2007, CURR OPIN ALLERGY CL, V7, P413, DOI 10.1097/ACI.0b013e3282a64343
   INEGI Instituto Nacional de Estadistica y Geografia, 2000, 12 CENS GEN POBL VIV
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Kim E, 2009, J DERMATOL SCI, V54, P25, DOI 10.1016/j.jdermsci.2008.12.005
   Kiyohara Chikako, 2008, Allergol Int, V57, P39, DOI 10.2332/allergolint.R-07-150
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   O'Regan GM, 2008, CURR OPIN ALLERGY CL, V8, P406, DOI 10.1097/ACI.0b013e32830e6fb2
   Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
NR 20
TC 10
Z9 10
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0011-9059
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD JUN
PY 2010
VL 49
IS 6
BP 653
EP 657
DI 10.1111/j.1365-4632.2009.04343.x
PG 5
WC Dermatology
SC Dermatology
GA 604WF
UT WOS:000278308500008
PM 20618470
DA 2020-12-08
ER

PT J
AU Segat, L
   Morgutti, M
   Athanasakis, E
   Trevisiol, C
   Amaddeo, A
   Poli, F
   Crovella, S
AF Segat, L.
   Morgutti, M.
   Athanasakis, E.
   Trevisiol, C.
   Amaddeo, A.
   Poli, F.
   Crovella, S.
TI Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from
   North-Eastern Italy
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
ID MODIFIER GENES; HUMAN BETA-DEFENSIN-1; BETA-DEFENSINS; POLYMORPHISMS;
   EXPRESSION; PEPTIDES; GENOTYPE; POPULATIONS; ASSOCIATION; IMMUNITY
AB P>Cystic fibrosis (CF) transmembrane regulator protein (CFTR) gene is undoubtedly the main genetic factor involved in the modulation of CF phenotype. However, other factors such as human defensins and the genes encoding for these antimicrobial peptides have been hypothesized as possible modifiers influencing airways infection in CF patients, but their role in the pathogenesis of lung disease is still debated. Since DEFB1 gene encoding for human beta-defensin 1 displays features such as antimicrobial or chemotactic activity playing a role in inflammation, it has been considered as a possible candidate CF modifier gene. We analysed three single nucleotide polymorphisms (SNPs) in the 5'-untranslated region of the DEFB1 gene (namely g-52G > A, g-44C > G and g-20G > A) in a group of 62 CF patients from North Eastern Italy, and in 130 healthy controls, with the aim of verifying the possible association of these functional SNPs with the pulmonary phenotype of CF patients. DEFB1 SNPs have been genotyped by using Taqman allele-specific fluorescent probes and a real-time PCR platform. No significant differences were found for allele, genotype and haplotype frequencies of DEFB1 g-52G > A, g-44C > G and g-20G > A SNPs in CF patients stratified for Pseudomonas aeruginosa infection, as well as in patients with a severe and mild clinical phenotype or in patients stratified for CFTR genotypes. DEFB1 allele, genotype and haplotype frequencies of CF patients globally considered were similar to those of healthy controls. Our findings are discordant with respect to another recent study performed on CF patients coming from Southern Italy, probably due to different ethnicity of the patients.
C1 [Segat, L.; Morgutti, M.; Athanasakis, E.; Crovella, S.] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Trevisiol, C.] San Polo Hosp, Pediat Unit, I-34074 Monfalcone, GO, Italy.
   [Amaddeo, A.; Poli, F.] IRCCS Burlo Garofolo, Pediat Unit, I-34137 Trieste, Italy.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; ATHANASAKIS, EMMANOUIL/G-8205-2011;
   Athanasakis, Emmanouil/K-1326-2018
OI Crovella, Sergio/0000-0001-8493-1168; Athanasakis,
   Emmanouil/0000-0002-7707-2665; AMADDEO, Alessandro/0000-0003-2117-0781;
   Segat, Ludovica/0000-0002-6024-1485
FU 'Fondazione Italiana per la Fibrosi Cistica' (Trieste, Italy) [FVG
   2008]; IRCCS Burlo Garofolo (Trieste, Italy) [RC03/04]
FX This work has been supported by a research grant from 'Fondazione
   Italiana per la Fibrosi Cistica' by a FVG 2008 grant (Trieste, Italy)
   and by a RC03/04 grant from IRCCS Burlo Garofolo (Trieste, Italy).
CR Accurso FJ, 2003, AM J RESP CRIT CARE, V167, P289, DOI 10.1164/rccm.2210006
   Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x
   Davies JC, 2005, PEDIATR PULM, V39, P383, DOI 10.1002/ppul.20198
   Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9
   Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749
   Kulczycki LL, 2003, AM J MED GENET A, V116A, P262, DOI 10.1002/ajmg.a.10886
   Leung TF, 2006, GENES IMMUN, V7, P59, DOI 10.1038/sj.gene.6364279
   Malik AN, 2007, BIOCHEM BIOPH RES CO, V353, P318, DOI 10.1016/j.bbrc.2006.12.037
   McKone EF, 2006, CHEST, V130, P1441, DOI 10.1378/chest.130.5.1441
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Polgar G, 1971, PULMONARY FUNCTION T
   Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461
   Sherman H, 2006, MOL IMMUNOL, V43, P1617, DOI 10.1016/j.molimm.2005.09.013
   Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900
   Tesse R, 2008, GENES IMMUN, V9, P57, DOI 10.1038/sj.gene.6364440
   Vankeerberghen A, 2005, GENOMICS, V85, P574, DOI 10.1016/j.ygeno.2005.02.003
   Wallace AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-76
NR 24
TC 6
Z9 7
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1744-3121
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD JUN
PY 2010
VL 37
IS 3
BP 169
EP 175
DI 10.1111/j.1744-313X.2010.00907.x
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 599MD
UT WOS:000277916100003
PM 20193032
DA 2020-12-08
ER

PT J
AU Trevisiol, C
   Crovella, S
AF Trevisiol, C.
   Crovella, S.
TI MBL2 GENETIC VARIANTS ARE ASSOCIATED WITH INCREASED RISK FOR DEVELOPING
   CELIAC DISEASE IN ITALIAN PATIENTS
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Meeting Abstract
ID MANNOSE-BINDING LECTIN; ALLELES
C1 [Trevisiol, C.] San Polo Hosp, Monfalcone, Italy.
   [Crovella, S.] Children Hosp Burlo Garofolo, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR Boniotto M, 2005, J MOL MED, V83, P308, DOI 10.1007/s00109-004-0623-3
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Iltanen S, 2003, AM J GASTROENTEROL, V98, P2808
NR 3
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-2116
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD JUN
PY 2010
VL 50
SU 2
BP E93
EP E94
PG 2
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA 608AJ
UT WOS:000278550100189
DA 2020-12-08
ER

PT J
AU Trevisiol, C
   Zanin, V
   Crovella, S
AF Trevisiol, C.
   Zanin, V.
   Crovella, S.
TI DEFB1 GENE 5' UNTRANSLATED REGION (UTR) POLYMORPHISMS IN INFLAMMATORY
   BOWEL DISEASES
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Meeting Abstract
C1 [Trevisiol, C.] San Polo Hosp, Monfalcone, Italy.
   [Zanin, V.; Crovella, S.] Children Hosp Burlo Garofolo, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-2116
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD JUN
PY 2010
VL 50
SU 2
BP E99
EP E99
PG 1
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA 608AJ
UT WOS:000278550100200
DA 2020-12-08
ER

PT J
AU De Leo, L
   Marcuzzi, A
   Decorti, G
   Tommasini, A
   Crovella, S
   Pontillo, A
AF De Leo, Luigina
   Marcuzzi, Annalisa
   Decorti, Giuliana
   Tommasini, Alberto
   Crovella, Sergio
   Pontillo, Alessandra
TI Targeting farnesyl-transferase as a novel therapeutic strategy for
   mevalonate kinase deficiency: In vitro and in vivo approaches
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Auto-inflammatory syndromes; Hereditary periodic fevers; Mevalonate
   kinase deficiency; Farnesyl-transferase inhibitors; Isoprenoids;
   Geraniol; Geranylgeraniol; Farnesol; Manumycin A
ID PERIODIC FEVER SYNDROME; INTERLEUKIN-1-BETA SECRETION;
   HYPERIMMUNOGLOBULINEMIA-D; CELLS; FARNESYLTRANSFERASE; INHIBITOR;
   PROTEIN; CHOLESTEROL
AB Mevalonate kinase deficiency (MKD) is a rare inborn auto-inflammatory disease due to the impairment of the pathway for the biosynthesis of cholesterol and non-sterol isoprenoids. The shortage of isoprenoids compounds and in particular of geranylgeranylpyrophosphate (GGPP) was recently associated to the MKD characteristic inflammatory attacks.
   The aim of this study is to demonstrate that the normalization of the mevalonate pathway intermediates levels and in particular of GGPP, through the specific inhibition of farnesyl-transferase (FT) with Manumycin A could ameliorate the inflammatory phenotype of MKD patients.
   The effect of Manumycin A was first evaluated in MKD mouse and cellular models, chemically obtained using the aminobisphosphonate alendronate (ALD), and then in monocytes isolated from 2 MKD patients. Our findings were compared to those obtained by using natural exogenous isoprenoids (NEIs).
   Manumycin A was able to significantly reduce the inflammatory marker serum amyloid A in ALD-treated Balb/c mice, as well as 1L-1 beta secretion in ALD-monocytes and in MKD patients. These results clearly showed that, through the inhibition of FT, an increased number of mevalonate pathway intermediates could be redirected towards the synthesis of GGPP diminishing the inflammatory response. The importance in limiting the shortage of GGPP was emphasized by the anti-inflammatory effect of NEIs that, due to their biochemical structure, can enter the MKD pathway.
   In conclusion, manumycin A, as well as NEIs, showed anti-inflammatory effect in MKD models and especially in MKD-monocytes, suggesting novel approaches in the treatment of MKD, an orphan disease without any efficacious treatment currently available. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Crovella, Sergio; Pontillo, Alessandra] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   [Decorti, Giuliana] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [De Leo, Luigina; Marcuzzi, Annalisa; Tommasini, Alberto] Univ Trieste, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Pontillo, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM pontillo@burlo.trieste.it
RI Pontillo, ALESSANDRA/D-4352-2012; Pontillo, Alessandra/AAD-4790-2019;
   Pontillo, Alessandra/ABC-6266-2020; De Leo, Luigina/K-9513-2016;
   Marcuzzi, Annalisa/AAA-6038-2020; Tommasini, Alberto/AAE-3882-2020;
   Crovella, Sergio/K-5050-2016
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; De Leo, Luigina/0000-0003-4013-1630;
   Marcuzzi, Annalisa/0000-0003-3427-618X; Tommasini,
   Alberto/0000-0002-6943-7927; Crovella, Sergio/0000-0001-8493-1168;
   Decorti, Giuliana/0000-0002-9714-6246
FU Institute of Maternal and Child Health [RC 13/08]
FX This study was supported by the Institute of Maternal and Child Health
   IRCCS "Burlo Garofolo", grant (RC 13/08).
CR Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200
   Braun T, 2008, BRIT J HAEMATOL, V141, P576, DOI 10.1111/j.1365-2141.2008.07099.x
   CRICK DC, 1995, BIOCHEM BIOPH RES CO, V211, P590, DOI 10.1006/bbrc.1995.1854
   DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002
   Drenth JPH, 1996, J IMMUNOL, V157, P400
   FEARS R, 1981, BIOCHEM J, V199, P1
   Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550
   Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9
   Kouchi H, 1999, BIOCHEM BIOPH RES CO, V264, P915, DOI 10.1006/bbrc.1999.1546
   Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008
   Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194
   Marcuzzi A, 2008, PEDIATR RES, V64, P177, DOI 10.1203/PDR.0b013e3181761870
   Xue XH, 2006, J PHARMACOL EXP THER, V317, P53, DOI 10.1124/jpet.105.095976
NR 13
TC 17
Z9 17
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD JUN
PY 2010
VL 61
IS 6
BP 506
EP 510
DI 10.1016/j.phrs.2010.02.012
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 599AV
UT WOS:000277883200005
PM 20206266
DA 2020-12-08
ER

PT J
AU Crovella, S
AF Crovella, Sergio
TI Antimicrobial Plant Peptides Isolated from Native and Crop Species in
   Brazil: Development of New Drugs
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Editorial Material
C1 Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Crovella, S (corresponding author), Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD MAY
PY 2010
VL 11
IS 3
BP 180
EP 180
DI 10.2174/138920310791112057
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 589NI
UT WOS:000277156600001
PM 20408807
DA 2020-12-08
ER

PT J
AU Benko-Iseppon, AM
   Galdino, SL
   Calsa, T
   Kido, EA
   Tossi, A
   Belarmino, LC
   Crovella, S
AF Benko-Iseppon, Ana Maria
   Galdino, Suely Lins
   Calsa, Tercilio, Jr.
   Kido, Ederson Akio
   Tossi, Alessandro
   Belarmino, Luis Carlos
   Crovella, Sergio
TI Overview on Plant Antimicrobial Peptides
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Pathogenesis related (PR) protein; defensin; thionin; lipid transfer
   protein (LTP); hevein-like protein; knotin-type protein; snakin;
   cyclotide
ID LIPID TRANSFER PROTEIN; ANTIFUNGAL PROTEINS; HOST-DEFENSE; GENE FAMILY;
   MACADAMIA-INTEGRIFOLIA; IMPATIENS-BALSAMINA; SEQUENCE HOMOLOGY; KNOTTED
   PROTEINS; REGULATED GENE; RICH DOMAIN
AB Mechanisms related to biotic interactions, such as pathogen attack, herbivory and symbiosis are important challenges to higher plants and have been widely studied especially for breeding purposes. The present review focuses on a special category of defense molecules, the plant antimicrobial peptides, providing an overview of their main molecular features and structures.
C1 [Benko-Iseppon, Ana Maria] Univ Fed Pernambuco, Ctr Biol Sci, Dept Genet, UFPE CCB Genet, BR-50670420 Recife, PE, Brazil.
   [Benko-Iseppon, Ana Maria; Galdino, Suely Lins; Calsa, Tercilio, Jr.; Kido, Ederson Akio; Belarmino, Luis Carlos; Crovella, Sergio] Univ Fed Pernambuco, Ctr Biol Sci, Antibiot Dept, BR-50670420 Recife, PE, Brazil.
   [Tossi, Alessandro] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Genet Serv, IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
RP Benko-Iseppon, AM (corresponding author), Univ Fed Pernambuco, Ctr Biol Sci, Dept Genet, UFPE CCB Genet, Av Prof Moraes Rego 1235, BR-50670420 Recife, PE, Brazil.
EM ana.benko.iseppon@pq.cnpq.br
RI Iseppon, Ana Maria Benko/M-5527-2019; Kido, Ederson A/E-2489-2016;
   Tossi, Alessandro/U-2474-2017; Junior, Tercilio Calsa/H-3780-2012; Kido,
   Ederson Akio/P-9932-2019; Crovella, Sergio/K-5050-2016; Tossi,
   Alessandro/ABC-9061-2020
OI Iseppon, Ana Maria Benko/0000-0002-0575-3197; Kido, Ederson
   A/0000-0001-5484-993X; Tossi, Alessandro/0000-0001-9087-5764; Junior,
   Tercilio Calsa/0000-0002-8302-2031; Kido, Ederson
   Akio/0000-0001-5484-993X; Crovella, Sergio/0000-0001-8493-1168; 
FU FVG (2008) region (Italy).; CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brazil)National Council for Scientific and
   Technological Development (CNPq)
FX This study has been partly supported by the R3A2 grant from FVG (2008)
   region (Italy). The authors also thank CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Brazil) for the concession of
   fellowships.
CR Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011
   BenNissan G, 1996, PLANT MOL BIOL, V32, P1067, DOI 10.1007/BF00041390
   Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685
   Bloch C, 1998, PROTEINS, V32, P334, DOI 10.1002/(SICI)1097-0134(19980815)32:3<334::AID-PROT9>3.0.CO;2-H
   BLOCHET JE, 1993, FEBS LETT, V329, P336, DOI 10.1016/0014-5793(93)80249-T
   Bonas U, 1999, CURR OPIN MICROBIOL, V2, P94, DOI 10.1016/S1369-5274(99)80016-2
   BROEKAERT WF, 1989, SCIENCE, V245, P1100, DOI 10.1126/science.245.4922.1100
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023
   Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148
   Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8
   CAMMUE BPA, 1992, J BIOL CHEM, V267, P2228
   Cammue Bruno Philippe Angelo, 1995, Plant Physiology (Rockville), V109, P445, DOI 10.1104/pp.109.2.445
   Carvalho AD, 2004, PHYSIOL PLANTARUM, V122, P328, DOI 10.1111/j.1399-3054.2004.00413.x
   Carvalho AD, 2007, PEPTIDES, V28, P1144, DOI 10.1016/j.peptides.2007.03.004
   Castro MS, 2003, J CHROMATOGR B, V794, P109, DOI 10.1016/S1570-0232(03)00423-9
   Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13
   Chen KC, 2002, J AGR FOOD CHEM, V50, P7258, DOI 10.1021/jf020527q
   Chester KS, 1933, Q REV PHYTOPATHOL, V42, P185
   CHIANG CC, 1991, MOL PLANT MICROBE IN, V4, P324, DOI 10.1094/MPMI-4-324
   Choi Y, 2008, BIOCHEM BIOPH RES CO, V375, P230, DOI 10.1016/j.bbrc.2008.08.001
   Craik DJ, 2009, TRENDS PLANT SCI, V14, P328, DOI 10.1016/j.tplants.2009.03.003
   Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383
   Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161
   DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952
   Diz MSS, 2006, BBA-GEN SUBJECTS, V1760, P1323, DOI 10.1016/j.bbagen.2006.04.010
   Douliez JP, 2001, EUR J BIOCHEM, V268, P1400, DOI 10.1046/j.1432-1327.2001.02007.x
   Dubreil L, 1998, PLANT SCI, V138, P121, DOI 10.1016/S0168-9452(98)00121-6
   DUVICK JP, 1992, J BIOL CHEM, V267, P18814
   Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509
   Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767
   Farrokhi N, 2008, PLANT BIOTECHNOL J, V6, P105, DOI 10.1111/j.1467-7652.2007.00315.x
   Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007
   GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197
   Gonorazky AG, 2005, J PLANT PHYSIOL, V162, P618, DOI 10.1016/j.jplph.2004.10.006
   Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   HERZOG M, 1995, PLANT MOL BIOL, V27, P743, DOI 10.1007/BF00020227
   Iwai T, 2002, MOL PLANT MICROBE IN, V15, P515, DOI 10.1094/MPMI.2002.15.6.515
   Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o
   Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898
   Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627
   KADER JC, 1975, BIOCHIM BIOPHYS ACTA, V380, P31, DOI 10.1016/0005-2760(75)90042-9
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005
   Kotilainen M, 1999, PLANT CELL, V11, P1093, DOI 10.1105/tpc.11.6.1093
   Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575
   Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626
   Lin P, 2007, PEPTIDES, V28, P1514, DOI 10.1016/j.peptides.2007.06.028
   Liu YJ, 2002, BIOCHEM BIOPH RES CO, V294, P535, DOI 10.1016/S0006-291X(02)00509-0
   Marcus JP, 1997, EUR J BIOCHEM, V244, P743, DOI 10.1111/j.1432-1033.1997.00743.x
   McManus AM, 1999, J MOL BIOL, V293, P629, DOI 10.1006/jmbi.1999.3163
   Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615
   MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9
   MORENO M, 1994, EUR J BIOCHEM, V223, P135, DOI 10.1111/j.1432-1033.1994.tb18974.x
   OHTANI S, 1977, J BIOCHEM-TOKYO, V82, P753
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W
   Padovan L, 2010, PROTEIN PEPTIDE LETT, V17, P297, DOI 10.2174/092986610790780350
   Padovan L, 2009, PROTEIN PEPTIDE LETT, V16, P430, DOI 10.2174/092986609787848027
   Patel SU, 1998, BIOCHEMISTRY-US, V37, P983, DOI 10.1021/bi971747d
   Pelegrini PB, 2009, CURR MICROBIOL, V59, P400, DOI 10.1007/s00284-009-9451-6
   PYEE J, 1994, ARCH BIOCHEM BIOPHYS, V311, P460, DOI 10.1006/abbi.1994.1263
   Salvaudon L, 2005, EVOLUTION, V59, P2518, DOI 10.1111/j.0014-3820.2005.tb00965.x
   SCHRADERFISCHER G, 1994, MOL GEN GENET, V245, P380, DOI 10.1007/BF00290119
   Segura A, 1998, FEBS LETT, V435, P159, DOI 10.1016/S0014-5793(98)01060-6
   Segura A, 1999, MOL PLANT MICROBE IN, V12, P16, DOI 10.1094/MPMI.1999.12.1.16
   SEGURA A, 1993, FEBS LETT, V332, P243, DOI 10.1016/0014-5793(93)80641-7
   Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001
   Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Sharma P, 1996, PLANT MOL BIOL, V31, P707, DOI 10.1007/BF00042244
   SHI LF, 1992, PLANT J, V2, P153
   Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678
   Slusarenko AJ, 2000, MECH RESISTANCE PLAN
   Staskawicz B, 2009, MOL PLANT PATHOL, V10, P719, DOI 10.1111/j.1364-3703.2009.00584.x
   Tailor RH, 1997, J BIOL CHEM, V272, P24480, DOI 10.1074/jbc.272.39.24480
   Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591
   Tavares LS, 2008, PEPTIDES, V29, P1842, DOI 10.1016/j.peptides.2008.06.003
   TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F
   TERRAS FRG, 1992, J BIOL CHEM, V267, P15301
   TERRAS FRG, 1992, PLANT PHYSIOL, V100, P1055, DOI 10.1104/pp.100.2.1055
   TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573
   THOMA S, 1993, PLANT J, V3, P427, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x
   Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475
   TSUBOI S, 1992, J BIOCHEM-TOKYO, V111, P500, DOI 10.1093/oxfordjournals.jbchem.a123787
   van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425
   van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072
   Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866
   Wong JH, 2006, PEPTIDES, V27, P2075, DOI 10.1016/j.peptides.2006.03.020
   Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9
   Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004
NR 95
TC 61
Z9 66
U1 1
U2 52
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD MAY
PY 2010
VL 11
IS 3
BP 181
EP 188
DI 10.2174/138920310791112075
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 589NI
UT WOS:000277156600002
PM 20088772
DA 2020-12-08
ER

PT J
AU Benko-Iseppon, AM
   Crovella, S
AF Benko-Iseppon, Ana Maria
   Crovella, Sergio
TI Ethnobotanical Bioprospection of Candidates for Potential Antimicrobial
   Drugs from Brazilian Plants: State of Art and Perspectives
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Antimicrobial uses; Angiosperms; Pteridophytes; Woody tropical species
ID TRANSCRIPTOME; DEFENSIN; GENES
AB Despite of the high biological diversity and traditional use of medicinal plants in Brazil, no comprehensive ethnobotanic review of plants with potential antimicrobial effects is available. In the present work own field information is aggregated with a literature review, identifying 433 Brazilian plant species potentially useful for identification of antimicrobial peptides. They included mainly woody species, distributed on 100 plant families (93 angiosperms and 7 pteridophytes) and 266 genera, covering all Brazilian regions and ecosystems. Main plant parts and indications for their use are presented and discussed, revealing the high potential that these plants present for the future planning strategies regarding the future development of antimicrobial drugs.
C1 [Benko-Iseppon, Ana Maria] Univ Fed Pernambuco, Dept Genet, UFPE CCB Genet, BR-50670420 Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Crovella, Sergio] Univ Trieste, Genet Serv, IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
RP Benko-Iseppon, AM (corresponding author), Univ Fed Pernambuco, Dept Genet, UFPE CCB Genet, Av Prof Moraes Rego 1235, BR-50670420 Recife, PE, Brazil.
EM ana.benko.iseppon@pq.cnpq.br
RI Iseppon, Ana Maria Benko/M-5527-2019; Crovella, Sergio/K-5050-2016
OI Iseppon, Ana Maria Benko/0000-0002-0575-3197; Crovella,
   Sergio/0000-0001-8493-1168
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX We thank the local communities that kindly accepted to share their
   knowledge with us and with the scientific world. This study was
   supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico), Brazil.
CR Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021
   Bagalkotkar G, 2006, J PHARM PHARMACOL, V58, P1559, DOI 10.1211/jpp.58.12.0001
   Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011
   Barros I.C.L., 1997, PTERIDOFITAS MED SAM
   Benko-Iseppon A. M., 2000, B SOC ARGENT BOT, V35, P269
   Benko-Iseppon AM, 2002, BOT J LINN SOC, V138, P245, DOI 10.1046/j.1095-8339.2002.138002245.x
   BENKOISEPPON AM, 2007, NEW TRENDS ETHNOBOTA, P9
   Boufleuer N.T., 2004, THESIS U FEDERAL ACR
   Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507
   CHANG SC, 2005, THESIS U ESTADUAL PE
   Correa M. P., 1984, DICIONARIO PLANTAS U
   CUNICO MM, 2002, BRAZ J PHARM, V12, P69
   Gitai J, 2005, PLANT SYST EVOL, V253, P65, DOI 10.1007/s00606-005-0306-8
   GIULIETTI A.N., 2005, MEGADIVERSIDADE, V1, P52, DOI DOI 10.1371/J0URNAL.PGEN.1001015
   Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016
   Guidon N., 1994, B SOC PREHISTORIQUE, V91, P246
   Johri R. K., 1997, Journal of Medicinal and Aromatic Plant Sciences, V19, P744
   MARCELLI MP, 1998, LICHENOLOGY LATIN AM
   Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001
   Morawetz W., 2003, MONOGRAPH SERIES NEW, V88, P36
   Naik A D, 2003, Indian J Med Sci, V57, P387
   Padovan L, 2010, PROTEIN PEPTIDE LETT, V17, P297, DOI 10.2174/092986610790780350
   Padovan L, 2009, PROTEIN PEPTIDE LETT, V16, P430, DOI 10.2174/092986609787848027
   Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325
   Prithiviraj B., 2006, ENCY PLANT CROP SCI, V1, P1
   Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a
   Ribeiro C., 2008, THESIS U FEDERAL PAR
   Salatino A, 2007, J BRAZIL CHEM SOC, V18, P11, DOI 10.1590/S0103-50532007000100002
   SILVA RZ, 2002, VISAO ACAD, V3, P59
   Souza MGC, 2004, BOT J LINN SOC, V144, P181, DOI 10.1111/j.1095-8339.2003.00230.x
   Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866
NR 31
TC 8
Z9 8
U1 0
U2 13
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD MAY
PY 2010
VL 11
IS 3
BP 189
EP 194
DI 10.2174/138920310791112129
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 589NI
UT WOS:000277156600003
PM 20353382
DA 2020-12-08
ER

PT J
AU Padovan, L
   Crovella, S
   Tossi, A
   Segat, L
AF Padovan, Lara
   Crovella, Sergio
   Tossi, Alessandro
   Segat, Ludovica
TI Techniques for Plant Defensin Production
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Plant defensins; peptide production; heterologous expression; chemical
   synthesis
ID ANTIMICROBIAL PEPTIDES; NICOTIANA-BENTHAMIANA; ANTIFUNGAL ACTIVITY;
   EXPRESSION SYSTEM; ESCHERICHIA-COLI; PICHIA-PASTORIS; ARABIDOPSIS;
   PROTEINS; SEEDS
AB To defend themselves from attack by pathogens, plants can rely only on their innate defense systems. Defensins are antimicrobial peptides that contribute to plant immunity by displaying a direct cidal activity against various pathogens, some of which are responsible for plant diseases. These determine a significant decrease in the quality and safety of agricultural products, especially among food crops, and cause significant economic losses. There is consequently an increasing interest for antimicrobial compounds such as the defensins, which might be applied in different ways to protect important food or bio-fuel crops. In this review we analyze the techniques that have been reported in the literature for the production of isolated plant defensins of adequate quality and sufficient quantity for potential use in plant protection.
   For research purposes, defensins have been heterologously expressed in diverse hosts, such as bacteria, yeasts, fungi and plants. Chemical synthesis is instead not commonly used for their production, due to structural characteristics that make it difficult to obtain the correct protein folding. To consider the possibility of producing plant defensins in a large scale, cost-effective methods guaranteeing high quality product are required. Future studies may thus focus on the development of more stable compounds, as well as decreasing production costs by improving preparative syntheses or biotechnological procedures such as using transgenic crops as plant factories.
C1 [Padovan, Lara; Crovella, Sergio; Segat, Ludovica] Univ Trieste, Genet Serv, IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
   [Padovan, Lara; Crovella, Sergio; Segat, Ludovica] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Padovan, Lara; Tossi, Alessandro] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Genet, BR-50670901 Recife, PE, Brazil.
   [Segat, Ludovica] Univ Fed Pernambuco, LIKA, BR-50670901 Recife, PE, Brazil.
RP Padovan, L (corresponding author), Univ Trieste, Genet Serv, IRCCS Burlo Garofolo, Via Istria 65-1, I-34137 Trieste, Italy.
EM padovan@burlo.trieste.it
RI Tossi, Alessandro/U-2474-2017; Crovella, Sergio/K-5050-2016; Tossi,
   Alessandro/ABC-9061-2020
OI Tossi, Alessandro/0000-0001-9087-5764; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
FU FVGRegione Friuli Venezia Giulia [LR26]; FACEPE [APQ-0020-4.01/08]
FX A. T. is recipient in the FVG LR26 Phytovet grant. L.S. is recipient of
   a fellowship grant (APQ-0020-4.01/08) from FACEPE. None of the authors
   has any potential financial conflict of interest related to this
   manuscript.
CR Aerts AM, 2007, PLANT CELL REP, V26, P1391, DOI 10.1007/s00299-007-0329-4
   Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252
   Antcheva N, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P55, DOI 10.1016/B978-012369442-3/50014-3
   Bruckdorfer T, 2004, CURR PHARM BIOTECHNO, V5, P29, DOI 10.2174/1389201043489620
   Cabral KMS, 2003, PROTEIN EXPRES PURIF, V31, P115, DOI 10.1016/S1046-5928(03)00136-0
   Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018
   DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233
   DEMEDEIROS LN, 2009, BIOCHIM BIOPHYS ACTA, V1798, P105
   DeSamblanx GW, 1996, PEPTIDE RES, V9, P262
   Donini M, 2005, APPL ENVIRON MICROB, V71, P6360, DOI 10.1128/AEM.71.10.6360-6367.2005
   Francois IEJA, 2002, PLANT PHYSIOL, V128, P1346, DOI 10.1104/pp.010794
   Games PD, 2008, PEPTIDES, V29, P2090, DOI 10.1016/j.peptides.2008.08.008
   Gil F, 2001, FEBS LETT, V488, P13, DOI 10.1016/S0014-5793(00)02405-4
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Huang GJ, 2008, J AGR FOOD CHEM, V56, P2989, DOI 10.1021/jf072994j
   Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o
   Kant P, 2009, PEPTIDES, V30, P1593, DOI 10.1016/j.peptides.2009.05.024
   Kovaleva V, 2009, PEPTIDES, V30, P2136, DOI 10.1016/j.peptides.2009.08.007
   Kovalskaya N, 2009, PROTEIN EXPRES PURIF, V63, P12, DOI 10.1016/j.pep.2008.08.013
   Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575
   Lin P, 2010, BIOSCIENCE REP, V30, P101, DOI 10.1042/BSR20090004
   Liu YJ, 2006, PROTEINS, V63, P777, DOI 10.1002/prot.20962
   Marques L, 2009, J APPL MICROBIOL, V106, P1640, DOI 10.1111/j.1365-2672.2008.04131.x
   Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x
   Odintsova TI, 2008, BIOCHIMIE, V90, P939, DOI 10.1016/j.biochi.2008.02.023
   OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W
   PADOVAN L, 2010, PROTEIN PEP IN PRESS
   Padovan L, 2009, PROTEIN PEPTIDE LETT, V16, P430, DOI 10.2174/092986609787848027
   Pelegrini PB, 2008, PROTEINS, V73, P719, DOI 10.1002/prot.22086
   Saitoh H, 2001, MOL PLANT MICROBE IN, V14, P111, DOI 10.1094/MPMI.2001.14.2.111
   Scholthof HB, 1996, ANNU REV PHYTOPATHOL, V34, P299, DOI 10.1146/annurev.phyto.34.1.299
   Sels J, 2007, TRANSGENIC RES, V16, P531, DOI 10.1007/s11248-006-9057-8
   Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6
   TERRAS FRG, 1992, J BIOL CHEM, V267, P15301
   Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016
   Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475
   Vijayan S, 2008, APPL MICROBIOL BIOT, V80, P1023, DOI 10.1007/s00253-008-1648-2
   Wang SY, 2009, APPL MICROBIOL BIOT, V82, P79, DOI 10.1007/s00253-008-1729-2
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 39
TC 6
Z9 7
U1 0
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD MAY
PY 2010
VL 11
IS 3
BP 231
EP 235
DI 10.2174/138920310791112101
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 589NI
UT WOS:000277156600008
PM 20088770
DA 2020-12-08
ER

PT J
AU Belarmino, LC
   Capriles, PVSZ
   Crovella, S
   Dardenne, LE
   Benko-Iseppon, AM
AF Belarmino, L. C.
   Capriles, P. V. S. Z.
   Crovella, S.
   Dardenne, L. E.
   Benko-Iseppon, A. M.
TI EST-Database Search of Plant Defensins - An Example Using Sugarcane, a
   Large and Complex Genome
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Data mining; EST-database; comparative modeling; defense system; crop
   evolution; drug discovery
ID ANTISENSE TRANSCRIPTS; IDENTIFICATION; PREDICTION; MICRORNAS; ALIGNMENT
AB EST (Expressed Sequence Tags) databases are increasing in number and size, especially regarding cultivated plants. Sugarcane is one of the most important tropical and subtropical crops, presenting a complex polyploid genome of hybrid origin, bearing a challenge for the understanding of genetic processes in higher plants. In the present work a general search was carried out on the largest Sugarcane EST Database (SUCEST) that includes 237,954 ESTs aiming to identify defensin antimicrobial peptides - a class of small, basic, cysteine-rich peptides distributed throughout the kingdoms. Using a computational approach 17 new defensin isoforms could be identified. Main steps for the search, characterization and evaluation of the defensin expression profile are presented. Prevalent expression tissues were leaf roll, lateral bark, root apex, base of inflorescence, developing seed, and calli. Bioinformatics and phylogenetic analysis of the primary structure of the sugarcane defensin candidates as well as the 3D structures obtained by comparative modeling support their role as antimicrobials.
C1 [Benko-Iseppon, A. M.] Univ Fed Pernambuco, Dept Genet, UFPE CCB Genet, BR-50670420 Recife, PE, Brazil.
   [Capriles, P. V. S. Z.; Dardenne, L. E.] Natl Lab Sci Comp LNCC MCT, GMMSB, Rio De Janeiro, Brazil.
RP Benko-Iseppon, AM (corresponding author), Univ Fed Pernambuco, Dept Genet, UFPE CCB Genet, Av Prof Moraes Rego 1235, BR-50670420 Recife, PE, Brazil.
EM ana.benko.iseppon@pq.cnpq.br
RI Crovella, Sergio/K-5050-2016; CAPRILES, PRISCILA/G-4768-2012; Iseppon,
   Ana Maria Benko/M-5527-2019; Capriles, Priscila/AAN-2039-2020
OI Crovella, Sergio/0000-0001-8493-1168; Iseppon, Ana Maria
   Benko/0000-0002-0575-3197; Capriles, Priscila/0000-0001-9780-4328
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, Brazil)CAPES; FACEPE (Fundacao de Amparo a Pesquisa do Estado
   de Pernambuco, Brazil)
FX The authors thank CNPq (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Brazil), CAPES (Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior, Brazil) and FACEPE (Fundacao de Amparo a Pesquisa do
   Estado de Pernambuco, Brazil) for the concession of fellowships. None of
   the authors has any potential financial conflict of interest related to
   this manuscript.
CR Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   BRAUN W, 1985, J MOL BIOL, V186, P611, DOI 10.1016/0022-2836(85)90134-2
   Butterfield M., 2001, P SOC AFR SUGARCANE, V75, P1
   Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266
   Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785
   D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378
   D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556
   Durbin R, 1998, BIOL SEQUENCE ANAL P
   Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   GIULIETTI A.N., 2005, MEGADIVERSIDADE, V1, P52, DOI DOI 10.1371/J0URNAL.PGEN.1001015
   Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0
   Hiller K, 2003, NUCLEIC ACIDS RES, V31, P3862, DOI 10.1093/nar/gkg536
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   KIDO EA, 2010, CURR PROTEI IN PRESS
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22
   Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
   Menossi M, 2008, Int J Plant Genomics, V2008, P458732, DOI 10.1155/2008/458732
   Ming R, 2006, PL BRED RE, V27, P15
   Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553
   Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051
   Padovan L, 2009, PROTEIN PEPTIDE LETT, V16, P430, DOI 10.2174/092986609787848027
   Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213
   Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006
   Vettore AL, 2001, GENET MOL BIOL, V24, P1, DOI 10.1590/S1415-47572001000100002
   Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92
   Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30
   Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101
   Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063
   Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302
NR 40
TC 6
Z9 7
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD MAY
PY 2010
VL 11
IS 3
BP 248
EP 254
DI 10.2174/138920310791112048
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 589NI
UT WOS:000277156600010
PM 20088773
DA 2020-12-08
ER

PT J
AU Naslavsky, MS
   Crovella, S
   Lima, JL
   Rocha, CRC
AF Naslavsky, M. S.
   Crovella, S.
   Lima Filho, J. L.
   Rocha, C. R. C.
TI The sound of silence: Human beta-defensin-1 gene untranslated SNPs
   change the predicted mRNA secondary structure in a length-dependent
   manner
SO IMMUNOLOGY LETTERS
LA English
DT Letter
DE DEFB1; Alternative transcription initiation; RNA secondary structure;
   Regulation of gene expression
ID HOST-DEFENSE; POLYMORPHISMS; DEFB1; TRANSLATION; CHILDREN
AB This study investigated how 5'-UTR of DEFB1 gene (encoding for the human beta-defensin-1) affects mRNA secondary structure and its correlation with translation efficiency in the susceptibility of diseases. It was possible to determine DEFB1 mRNA folding under the influence of 5'-UTR SNPs haplotypes and putative alternative transcript lengths. Different DEFB1 mRNAs that fold in a pattern that is haplotype and length-dependent are potentially able to drive changes in peptide expression dynamics. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Naslavsky, M. S.; Crovella, S.; Lima Filho, J. L.; Rocha, C. R. C.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Lima Filho, J. L.; Rocha, C. R. C.] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil.
RP Rocha, CRC (corresponding author), Univ Fed Pernambuco, LIKA, Av Prof Moraes Rego,S-N,Cidade Univ, Recife, PE, Brazil.
EM cintiarcrocha@uol.com.br
RI Naslavsky, Michel/U-6595-2019; Naslavsky, Michel/L-1772-2015; Filho,
   Jose Luiz Lima/M-8076-2019; Crovella, Sergio/K-5050-2016
OI Naslavsky, Michel/0000-0002-9068-1713; Crovella,
   Sergio/0000-0001-8493-1168
CR Baroncelli S, 2008, AIDS, V22, P1515, DOI 10.1097/QAD.0b013e3282fd6e0c
   Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026
   Cagliani R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r143
   Chen QX, 2007, GENES IMMUN, V8, P439, DOI 10.1038/sj.gene.6364401
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362
   Jia HP, 2001, J PEDIATR-US, V138, P109, DOI 10.1067/mpd.2001.109375
   Kalus Andrea A, 2009, BMC Oral Health, V9, P21, DOI 10.1186/1472-6831-9-21
   KOCSIS AK, 2008, SCAND J GASTROENTERO, P1
   Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412
   Leung TF, 2006, GENES IMMUN, V7, P59, DOI 10.1038/sj.gene.6364279
   Milanese M, 2007, CANCER RES, V67, P5997, DOI 10.1158/0008-5472.CAN-06-3544
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   NASLAVSKY MS, 2009, GENETICS EVOLUTION
   PANTELIS A, 2008, ORAL ONCOLOGY
   Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006
   de Oca EPM, 2009, INFECT GENET EVOL, V9, P617, DOI 10.1016/j.meegid.2009.03.006
   RICCI E, 1999, J ACQ IMMUN DEF SYND, V51, P13
   Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294
   Tesse R, 2008, GENES IMMUN, V9, P57, DOI 10.1038/sj.gene.6364440
   Vylkova S, 2007, ANTIMICROB AGENTS CH, V51, P154, DOI 10.1128/AAC.00478-06
   Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603
NR 23
TC 13
Z9 14
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD MAR 10
PY 2010
VL 129
IS 1
BP 53
EP 55
DI 10.1016/j.imlet.2009.12.024
PG 3
WC Immunology
SC Immunology
GA 580ED
UT WOS:000276429100009
PM 20060856
DA 2020-12-08
ER

PT J
AU Segat, L
   Brandao, LAC
   Guimares, RL
   Pontillo, A
   Athanasakis, E
   de Oliveira, RM
   Arraes, LC
   de Lima, JL
   Crovella, S
AF Segat, Ludovica
   Brandao, Lucas A. C.
   Guimares, Rafael L.
   Pontillo, Alessandra
   Athanasakis, Emmanouil
   de Oliveira, Rafael Martins
   Arraes, Luiz C.
   de Lima Filho, Jose Luiz
   Crovella, Sergio
TI Polymorphisms in innate immunity genes and patients response to
   dendritic cell-based HIV immuno-treatment
SO VACCINE
LA English
DT Article
DE Dendritic cell immunotherapy; Innate immunity; HIV infection
ID MANNOSE-BINDING LECTIN; NITRIC-OXIDE; MONOCYTES; INFECTION; VACCINE;
   DISEASE; MBL
AB Dendritic cells (DCs)-based vaccine was demonstrated to increase HIV specific cellular immune response; however, in some HIV-infected patients, the response to the vaccine resulted to be not effective. In order to understand if the outcome of the vaccination may be influenced by the host's genome and natural immunity, we studied the innate immune genome of HIV-infected patients previously vaccinated with DCs. We identified 15 SNPs potentially associated with the response to the immuno-treatment and two SNPs significantly associated with the modulation of the response to the DC vaccine: MBL2 rs10824792 and NOS1 rs693534. These two SNPs were also studied in different ethnic groups (Brazilians, African and Caucasian) of HIV-infected, exposed uninfected and unexposed uninfected subjects. The HIV positive Caucasian patients were also characterized by different disease progressions. Our findings suggest that, independently and/or in addition to other variables. the host's genome could significantly contribute to the modulation of the response to the DC vaccine. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Segat, Ludovica; Pontillo, Alessandra; Athanasakis, Emmanouil; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Segat, Ludovica; Pontillo, Alessandra; Athanasakis, Emmanouil; Crovella, Sergio] Univ Trieste, I-34137 Trieste, Italy.
   [Segat, Ludovica; Brandao, Lucas A. C.; Guimares, Rafael L.; de Lima Filho, Jose Luiz] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [de Oliveira, Rafael Martins] Univ Sao Paulo, Lab Invest Med Dermatol & Imunodeficiencias LIM56, BR-05508 Sao Paulo, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Arraes, Luiz C.] Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
RP Segat, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Pontillo, Alessandra/ABC-6266-2020; Pontillo, ALESSANDRA/D-4352-2012;
   Crovella, Sergio/K-5050-2016; Pontillo, Alessandra/AAD-4790-2019; Filho,
   Jose Luiz Lima/M-8076-2019; Brandao, Lucas Andre Cavalcanti/G-8333-2012;
   ATHANASAKIS, EMMANOUIL/G-8205-2011; Athanasakis, Emmanouil/K-1326-2018
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Pontillo, Alessandra/0000-0002-7883-0640; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Athanasakis,
   Emmanouil/0000-0002-7707-2665; Segat, Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo [RC03/04, RC07/08]; FACEPE [APQ-1130-2.02/08,
   APQ-0020-4.01/08]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [474566/2008-0]
FX This work was supported by grants RC03/04 and RC07/08 from IRCCS Burlo
   Garofolo by a grant APQ-1130-2.02/08 from FACEPE and by a grant no.
   474566/2008-0 from CNPq. SL is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE. The authors wish to thank dr. Alfredo
   Garzino-Demo and dr. Louise Kuhn for kindly providing DNA samples of HIV
   positive subjects.
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Andrieu JM, 2007, J INTERN MED, V261, P123, DOI 10.1111/j.1365-2796.2006.01738.x
   Bernig T, 2005, HUM GENET, V118, P404, DOI 10.1007/s00439-005-0053-5
   Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009
   BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735
   Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712
   Duan JY, 2008, P NATL ACAD SCI USA, V105, P5183, DOI 10.1073/pnas.0800974105
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fernandez-Ruiz V, 2004, IMMUNOL LETT, V93, P87, DOI 10.1016/j.imlet.2004.03.002
   Garcia M, 2001, IMMUNOL INVEST, V30, P267, DOI 10.1081/IMM-100108163
   Gonzalez-Nicolas J, 2001, EUR CYTOKINE NETW, V12, P437
   Heggelund L, 2005, EUR J CLIN INVEST, V35, P765, DOI 10.1111/j.1365-2362.2005.01579.x
   Heggelund L, 2003, JAIDS-J ACQ IMM DEF, V32, P354, DOI 10.1097/00126334-200304010-00002
   Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147
   MacDonald SL, 2008, BIOCHEM SOC T, V36, P1497, DOI 10.1042/BST0361497
   Piras IS, 2009, EXP MOL PATHOL, V86, P136, DOI 10.1016/j.yexmp.2008.11.007
   Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x
   Sherry B, 2000, MOL MED, V6, P542, DOI 10.1007/BF03401793
   Turner MW, 1998, IMMUNOBIOLOGY, V199, P327, DOI 10.1016/S0171-2985(98)80037-5
NR 19
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 2
PY 2010
VL 28
IS 10
BP 2201
EP 2206
DI 10.1016/j.vaccine.2009.12.056
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 573RZ
UT WOS:000275933600008
PM 20056178
DA 2020-12-08
ER

PT J
AU Brandao, LC
   Vatta, S
   Guimaraes, R
   Segat, L
   Araujo, J
   De Lima, JL
   Arraes, LC
   Not, T
   Crovella, S
AF Brandao, Lucas C.
   Vatta, Serena
   Guimaraes, Rafael
   Segat, Ludovica
   Araujo, Jaqueline
   De Lima Filho, Jose L.
   Arraes, Luiz C.
   Not, Tarcisio
   Crovella, Sergio
TI Rapid genetic screening for major human leukocyte antigen risk
   haplotypes in patients with type 1 diabetes from Northeastern Brazil
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Type 1 diabetes; HLA haplotypes; Tag-SNPs; Real-time PCR; Fluorogenic
   probes
ID SINGLE NUCLEOTIDE POLYMORPHISMS; CELIAC-DISEASE; MELLITUS; HLA;
   SUSCEPTIBILITY; HETEROZYGOTES; POPULATION; IDDM; ASSOCIATION; CAUCASIANS
AB The aim of this study was to identify in the Brazilian population the frequency of human leukocyte antigen (HILA) DQ2.5 and DQ8 haplotypes conferring risk for type 1 diabetes (T1D), and to validate a new genotyping method aimed at cost reduction and automation. A total of 184 children and adolescents with T1D and 184 healthy individuals from Recife (northeastern Brazil) were analyzed using the conventional polymerase chain reaction-sequence-specific primers HLA genotyping and a newly described Tag-single-nucleotide polymorphism real-time polymerase chain reaction. The Tag-single-nucleotide polymorphism-based HLA genotyping method was successfully validated, proved to be robust, with limited cost and thus could be successfully used for the identification of genetic susceptibility for T1D in areas with limited financial resources. Our findings report for the first time the distribution of DQ2.5 and DQ8 HLA risk haplotypes associated with T1D in northeastern Brazil and evidence a major risk for developing T1D when the heterozygous DQ2.5/DQ8 or the homozygous DQ2.5/DQ2.5 haplotypes are present. (c) 2010 American Society for Histocompatibility, and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Brandao, Lucas C.; Guimaraes, Rafael; Segat, Ludovica; De Lima Filho, Jose L.] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   [Vatta, Serena; Not, Tarcisio] IRCCS Burto Garofolo, Immunopathol Lab, Trieste, Italy.
   [Segat, Ludovica; Crovella, Sergio] IRCCS Burto Garofolo, Genet Serv, Trieste, Italy.
   [Araujo, Jaqueline] Univ Fed Pernambuco, Clin Hosp, Pediat Endocrinol Unit, Recife, PE, Brazil.
   [Arraes, Luiz C.] Intistuto Med Integrada Prof Fernando Figueira, Recife, PE, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
EM segat@burlo.trieste.it
RI Brandao, Lucas Andre Cavalcanti/G-8333-2012; Filho, Jose Luiz
   Lima/M-8076-2019; Crovella, Sergio/K-5050-2016; Not,
   Tarcisio/K-2616-2018
OI Brandao, Lucas Andre Cavalcanti/0000-0002-8588-4559; Crovella,
   Sergio/0000-0001-8493-1168; Not, Tarcisio/0000-0003-1059-3009; Segat,
   Ludovica/0000-0002-6024-1485
FU IRCCS Burlo Garofolo Trieste (Italy) [RC03/04]; FACEPE (Recife, Brazil)
   [APQ-1130-2.02/08]; FACEPE [APQ-0020-4.01/08]
FX This work has been supported by a grant RC03/04 from IRCCS Burlo
   Garofolo Trieste (Italy) and by a grant APQ-1130-2.02/08 from FACEPE
   (Recife, Brazil). S.L. is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE. None of the authors has any potential
   financial conflict of interest related to this manuscript.
CR Abiru N, 2002, DIABETES-METAB RES, V18, P357, DOI 10.1002/dmrr.323
   Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340
   Alves Crésio, 2006, Arq Bras Endocrinol Metab, V50, P436, DOI 10.1590/S0004-27302006000300005
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Anaya JM, 2006, J AUTOIMMUN, V26, P208, DOI 10.1016/j.jaut.2006.01.001
   Araya M, 2000, J PEDIATR GASTR NUTR, V31, P381, DOI 10.1097/00005176-200010000-00010
   Azam A, 2004, EXPERT OPIN BIOL TH, V4, P1569, DOI 10.1517/14712598.4.10.1569
   Barker JM, 2008, DIABETES, V57, P3152, DOI 10.2337/db08-0605
   DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0
   de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885
   FERREIRA SRG, 1993, DIABETES CARE, V16, P701, DOI 10.2337/diacare.16.5.701
   Koskinen L, 2009, IMMUNOGENETICS, V61, P247, DOI 10.1007/s00251-009-0361-3
   Lisboa HRK, 1998, BRAZ J MED BIOL RES, V31, P1553, DOI 10.1590/S0100-879X1998001200007
   LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958
   Marques SBD, 1998, BRAZ J MED BIOL RES, V31, P365, DOI 10.1590/S0100-879X1998000300005
   Moghaddam PH, 1998, DIABETES, V47, P263, DOI 10.2337/diab.47.2.263
   Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270
   NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114
   Noble JA, 1996, AM J HUM GENET, V59, P1134
   PUGLIESE A, 2007, P 13 INT HIST WORKSH, V1, P788
   Romanos J., 2008, DIABETES, V58, pe1, DOI [10.2337/db08-131219114716, DOI 10.2337/DB08-131219114716]
   RONNINGEN KS, 1989, HUM IMMUNOL, V24, P165, DOI 10.1016/0198-8859(89)90057-8
   ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169
   Steenkiste A, 2007, TISSUE ANTIGENS, V69, P214, DOI 10.1111/j.1399-0039.2006.00772.x
   THOMSON G, 1988, AM J HUM GENET, V43, P799
   THOMSON G, 2005, TISSUE ANTIGENS, V65, P115
   TUOMILEHTO J, 1995, INT J EPIDEMIOL, V24, P984, DOI 10.1093/ije/24.5.984
   Valdes AM, 2005, DIABETOLOGIA, V48, P2540, DOI 10.1007/s00125-005-0011-8
   Volpini WMG, 2001, HUM IMMUNOL, V62, P1226, DOI 10.1016/S0198-8859(01)00323-8
   Zavattari P, 2001, HUM MOL GENET, V10, P881, DOI 10.1093/hmg/10.8.881
NR 30
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD MAR
PY 2010
VL 71
IS 3
BP 277
EP 280
DI 10.1016/j.humimm.2009.12.008
PG 4
WC Immunology
SC Immunology
GA 567ZJ
UT WOS:000275488500008
PM 20035815
DA 2020-12-08
ER

PT J
AU Padovan, L
   Segat, L
   Tossi, A
   Calsa, T
   Ederson, AK
   Brandao, L
   Guimaraes, RL
   Pandolfi, V
   Pestana-Calsa, MC
   Belarmino, LC
   Benko-Iseppon, AM
   Crovella, S
AF Padovan, Lara
   Segat, Ludovica
   Tossi, Alessandro
   Calsa, Tercilio, Jr.
   Ederson, Akio Kido
   Brandao, Lucas
   Guimaraes, Rafael L.
   Pandolfi, Valesca
   Pestana-Calsa, Maria Clara
   Belarmino, Luis Carlos
   Benko-Iseppon, Ana Maria
   Crovella, Sergio
TI Characterization of a New Defensin from Cowpea (Vigna unguiculata (L.)
   Walp.)
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Antimicrobial peptides; cowpea mosaic virus; evolution; plant defensin;
   protein function; Vigna unguiculata
ID PLANT-DEFENSIN; GAMMA-THIONIN; PEPTIDES; EXPRESSION; PROTEIN; CDNA;
   GENE; INHIBITORS; SEQUENCE; INSIGHTS
AB Using Phaseoleae defensins available in databases, a putative defensin gene was isolated in cowpea (Vigna unguiculata (L.) Walp.) and cloned from genomic cowpea DNA. The putative mature defensin sequence displays the characteristic defensins residues arrangement, secondary and tertiary structures were predicted and splicing analysis was performed. Using RT-PCR, defensin expression and differences in response to biotic stimuli between infected and non infected plants were tested.
C1 [Padovan, Lara; Segat, Ludovica; Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   [Padovan, Lara; Segat, Ludovica; Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Padovan, Lara; Tossi, Alessandro] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Segat, Ludovica; Brandao, Lucas; Guimaraes, Rafael L.] Univ Fed Pernambuco, LIKA, BR-50670901 Recife, PE, Brazil.
   [Calsa, Tercilio, Jr.; Ederson, Akio Kido; Pandolfi, Valesca; Pestana-Calsa, Maria Clara; Belarmino, Luis Carlos; Benko-Iseppon, Ana Maria; Crovella, Sergio] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Genet, BR-50670901 Recife, PE, Brazil.
RP Padovan, L (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM padovan@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Tossi, Alessandro/U-2474-2017; Brandao,
   Lucas Andre Cavalcanti/G-8333-2012; Tossi, Alessandro/ABC-9061-2020;
   Kido, Ederson A/E-2489-2016; Iseppon, Ana Maria Benko/M-5527-2019; Kido,
   Ederson Akio/P-9932-2019; Junior, Tercilio Calsa/H-3780-2012; Pandolfi,
   Valesca/L-1637-2016
OI Crovella, Sergio/0000-0001-8493-1168; Tossi,
   Alessandro/0000-0001-9087-5764; Brandao, Lucas Andre
   Cavalcanti/0000-0002-8588-4559; Kido, Ederson A/0000-0001-5484-993X;
   Iseppon, Ana Maria Benko/0000-0002-0575-3197; Kido, Ederson
   Akio/0000-0001-5484-993X; Junior, Tercilio Calsa/0000-0002-8302-2031;
   Pandolfi, Valesca/0000-0003-2283-5669; Segat,
   Ludovica/0000-0002-6024-1485
CR Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824
   Antcheva N, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P55, DOI 10.1016/B978-012369442-3/50014-3
   Azevedo H., 2007, REV BRASILEIRA BIOCI, V5, P528
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   Carvalho AO, 2006, PROTEIN PEPTIDE LETT, V13, P1029, DOI 10.2174/092986606778777515
   Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13
   Chang S., 1993, PLANT MOL BIOL REP, V11, P113, DOI [10.1007/BF02670468, DOI 10.1007/BF02670468]
   DIMARCQ JL, 1990, EMBO J, V9, P2507, DOI 10.1002/j.1460-2075.1990.tb07430.x
   Do HM, 2004, PLANT SCI, V166, P1297, DOI 10.1016/j.plantsci.2004.01.008
   Ehlers JD, 1997, FIELD CROP RES, V53, P187, DOI 10.1016/S0378-4290(97)00031-2
   Franco OL, 2006, FEBS J, V273, P3489, DOI 10.1111/j.1742-4658.2006.05349.x
   Games PD, 2008, PEPTIDES, V29, P2090, DOI 10.1016/j.peptides.2008.08.008
   Houlne G, 1998, MOL GEN GENET, V259, P504, DOI 10.1007/s004380050841
   ISHIBASHI N, 1990, PLANT MOL BIOL, V15, P59, DOI 10.1007/BF00017724
   Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o
   KARUNANANDAA B, 1994, PLANT MOL BIOL, V26, P459, DOI 10.1007/BF00039555
   Liu YJ, 2006, PROTEINS, V63, P777, DOI 10.1002/prot.20962
   Melo FR, 2002, PROTEINS, V48, P311, DOI 10.1002/prot.10142
   MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x
   Ngai PHK, 2005, BIOCHEM CELL BIOL, V83, P212, DOI 10.1139/O05-037
   Padovan L, 2009, PROTEIN PEPTIDE LETT, V16, P430, DOI 10.2174/092986609787848027
   Pelegrini PB, 2008, PROTEINS, V73, P719, DOI 10.1002/prot.22086
   PIORIBEIRO G, 2001, CADERNO OMEGA, V12, P44
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Weising Kurt, 2005, P1
   Zhang Y, 1997, FEMS MICROBIOL LETT, V149, P59, DOI 10.1111/j.1574-6968.1997.tb10308.x
   Zhu S, 2007, IMMUNOGENETICS, V59, P949, DOI 10.1007/s00251-007-0259-x
   Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354
NR 30
TC 16
Z9 16
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD MAR
PY 2010
VL 17
IS 3
BP 297
EP 304
DI 10.2174/092986610790780350
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 554KD
UT WOS:000274433000003
PM 20236084
DA 2020-12-08
ER

PT J
AU Segat, L
   Milanese, M
   Arosio, B
   Vergani, C
   Crovella, S
AF Segat, Ludovica
   Milanese, Michele
   Arosio, Beatrice
   Vergani, Carlo
   Crovella, Sergio
TI Lack of association between Interleukin-18 gene promoter polymorphisms
   and onset of Alzheimer's disease
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Alzheimer; IL18; Polymorphisms
AB In our case-control study we analyzed two functional IL18 gene promoter polymorphisms (-137 G/C and -607 C/A) and an additional polymorphism at position -656 (G/T) in Alzheimer patients and healthy controls in order to verify the involvement of these genetic variations in the onset of Alzheimer disease.
   No significant differences were detected for the three IL18 SNPs between AD patients and controls. The haplotypes distribution also did not show any difference within AD subjects and controls. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Segat, Ludovica; Milanese, Michele; Crovella, Sergio] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   [Arosio, Beatrice; Vergani, Carlo] Univ Milan, Dept Internal Med, Geriatr Unit, Osped Maggiore Policlin,Fdn IRCCS Milan, I-20122 Milan, Italy.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
RP Segat, L (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Arosio,
   Beatrice/0000-0002-0615-3580; Segat, Ludovica/0000-0002-6024-1485
FU AIRC (Italian Association for Cancer Research)Associazione Italiana per
   la Ricerca sul Cancro (AIRC) [2004]; IRCCS Burlo Garofolo [RC03/04]
FX This work was supported by a AIRC (Italian Association for Cancer
   Research) regional grant 2004 and by funds from IRCCS Burlo Garofolo
   (RC03/04).
NR 0
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD JAN
PY 2010
VL 31
IS 1
BP 162
EP 164
DI 10.1016/j.neurobiolaging.2008.03.005
PG 3
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 525KA
UT WOS:000272213500017
PM 18433937
DA 2020-12-08
ER

PT J
AU Palumbo, V
   Segat, L
   Padovan, L
   Amoroso, A
   Trimarco, B
   Izzo, R
   Lembo, G
   Zagrosek, VR
   Knoll, R
   Brancaccio, M
   Tarone, G
   Crovella, S
AF Palumbo, Valeria
   Segat, Ludovica
   Padovan, Lara
   Amoroso, Antonio
   Trimarco, Bruno
   Izzo, Raffaele
   Lembo, Giuseppe
   Zagrosek, Vera Regiz
   Knoll, Ralph
   Brancaccio, Mara
   Tarone, Guido
   Crovella, Sergio
TI Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and
   cardiopathic patients
SO BMC MEDICAL GENETICS
LA English
DT Article
ID HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY;
   CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; PROTEIN; MUTATIONS; SPECTRUM;
   NONSENSE
AB Background: Melusin is a muscle specific signaling protein, required for compensatory hypertrophy response in pressure-overloaded heart. The role of Melusin in heart function has been established both by loss and gain of function experiments in murine models. With the aim of verifying the hypothesis of a potential role of the Melusin encoding gene, ITGB1BP2, in the modification of the clinical phenotype of human cardiomyopathies, we screened the ITGB1BP2 gene looking for genetic variations possibly associated to the pathological phenotype in three selected groups of patients affected by hypertension and dilated or hypertrophic cardiomyopathy
   Methods: We analyzed ITGB1BP2 by direct sequencing of the 11 coding exons and intron flanking sequences in 928 subjects, including 656 hypertensive or cardiopathic patients and 272 healthy individuals.
   Results: Only three nucleotide variations were found in patients of three distinct families: a C>T missense substitution at position 37 of exon 1 causing an amino acid change from His-13 to Tyr in the protein primary sequence, a duplication (IVS6+12_18dupTTTTGAG) near the 5' donor splice site of intron 6, and a silent 843C>T substitution in exon 11.
   Conclusions: The three variations of the ITGB1BP2 gene have been detected in families of patients affected either by hypertension or primary hypertrophic cardiomyopathy; however, a clear genotype/phenotype correlation was not evident. Preliminary functional results and bioinformatic analysis seem to exclude a role for IVS6+12_18dupTTTTGAG and 843C>T in affecting splicing mechanism.
   Our analysis revealed an extremely low number of variations in the ITGB1BP2 gene in nearly 1000 hypertensive/cardiopathic and healthy individuals, thus suggesting a high degree of conservation of the melusin gene within the populations analyzed.
C1 [Amoroso, Antonio; Brancaccio, Mara; Tarone, Guido] Univ Turin, Dipartimento Genet Biol & Biochim, I-10126 Turin, Italy.
   [Palumbo, Valeria; Segat, Ludovica; Padovan, Lara; Crovella, Sergio] IRCCS Burlo Garofolo, Serv Genet, I-34100 Trieste, Italy.
   [Segat, Ludovica] Univ Fed Pernambuco, LIKA, BR-50732970 Recife, PE, Brazil.
   [Trimarco, Bruno; Izzo, Raffaele] Univ Naples Federico 2, Dipartimento Med Clin & Sci Cardiovasc & Immunol, I-80131 Naples, Italy.
   [Lembo, Giuseppe] IRCCS Neuromed, Dipartimento Angiocardio Neurol, I-86077 Pozzilli, IS, Italy.
   [Zagrosek, Vera Regiz] Charite, Berlin Inst Gender Med, D-10115 Berlin, Germany.
   [Zagrosek, Vera Regiz] Charite, Cardiovasc Res Ctr, D-10115 Berlin, Germany.
   [Knoll, Ralph] Univ Gottingen, Ctr Heart, D-37075 Gottingen, Germany.
   [Brancaccio, Mara; Tarone, Guido] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy.
RP Tarone, G (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Via Santena 19, I-10126 Turin, Italy.
EM valeria.palumbo@uniroma1.it; segat@burlo.trieste.it;
   padovan@burlo.trieste.it; antonio.amoroso@unito.it;
   bruno.trimarco@unina.it; raffaele.izzo@unina.it; lembo@neuromed.it;
   Vera.Regitz-Zagrosek@charite.de; r.knoell@imperial.ac.uk;
   mara.brancaccio@unito.it; guido.tarone@unito.it;
   crovella@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020; Izzo, Raffaele/G-4892-2011; Ralph,
   Knoell/AAE-5990-2020; Lembo, Giuseppe/AAE-8096-2020; Trimarco, Bruno
   BT/K-7851-2016
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Izzo, Raffaele/0000-0002-0308-2836; Ralph,
   Knoell/0000-0001-8871-112X; Lembo, Giuseppe/0000-0002-3510-223X;
   Trimarco, Bruno BT/0000-0002-0701-6449; Segat,
   Ludovica/0000-0002-6024-1485; Palumbo, Valeria/0000-0002-7758-9891;
   Brancaccio, Mara/0000-0003-2327-6846; Tarone, Guido/0000-0003-4805-086X
FU TelethonFondazione Telethon; European community FPVI "EugeneHeart";
   Ministry of University and Research and Regione Piemonte [CIPE 2006];
   IRCCS Burlo Garofolo [RC 03/04]; FACEPE [APQ-0020-4.01/08]
FX This work was supported by grants from Telethon and from the European
   community FPVI "EugeneHeart" to GT, and from the Ministry of University
   and Research and Regione Piemonte (CIPE 2006 and Progetto Ricerca
   Sanitaria Finalizzata) to MB. RC 03/04 from IRCCS Burlo Garofolo also
   supported the study. LS is recipient of a fellowship grant
   (APQ-0020-4.01/08) from FACEPE.
CR Barki-Harrington L, 2003, NAT MED, V9, P19, DOI 10.1038/nm0103-19
   Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282
   Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805
   Brancaccio M, 2006, CARDIOVASC RES, V70, P422, DOI 10.1016/j.cardiores.2005.12.015
   Brokat S, 2007, EUR J HEART FAIL, V9, P568, DOI 10.1016/j.ejheart.2007.02.009
   Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
   Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4
   De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0
   Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178
   Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x
   Erdmann J, 2001, J AM COLL CARDIOL, V38, P322, DOI 10.1016/S0735-1097(01)01387-0
   Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774
   Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983
   Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649
   Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095
NR 15
TC 8
Z9 9
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD DEC 17
PY 2009
VL 10
AR 140
DI 10.1186/1471-2350-10-140
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 540XX
UT WOS:000273375500001
PM 20017903
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Segat, L
   Pontillo, A
   Milanese, M
   Tossi, A
   Crovella, S
AF Segat, Ludovica
   Pontillo, Alessandra
   Milanese, Michele
   Tossi, Alessandro
   Crovella, Sergio
TI Evolution of the hepcidin gene in primates
SO BMC GENOMICS
LA English
DT Article
ID ANTIMICROBIAL PEPTIDE HEPCIDIN; IRON OVERLOAD; HEMOCHROMATOSIS;
   EXPRESSION; SELECTION; LIKELIHOOD; CLONING; LIVER; HAMP
AB Background: Hepcidin/LEAP-1 is an iron regulatory hormone originally identified as an antimicrobial peptide. As part of a systematic analysis of the evolution of host defense peptides in primates, we have sequenced the orthologous gene from 14 species of non-human primates.
   Results: The sequence of the mature peptide is highly conserved amongst all the analyzed species, being identical to the human one in great apes and gibbons, with a single residue conservative variation in Old-World monkeys and with few substitutions in New-World monkeys.
   Conclusion: Our analysis indicates that hepcidin's role as a regulatory hormone, which involves interaction with a conserved receptor (ferroportin), may result in conservation over most of its sequence, with the exception of the stretch between residues 15 and 18, which in New-World monkeys (as well as in other mammals) shows a significant variation, possibly indicating that this structural region is involved in other functions.
C1 [Segat, Ludovica; Pontillo, Alessandra; Milanese, Michele; Crovella, Sergio] Univ Trieste, Genet Unit, IRCCS Burlo Garofolo, Trieste, Italy.
   [Segat, Ludovica; Pontillo, Alessandra; Milanese, Michele; Crovella, Sergio] Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
   [Tossi, Alessandro] Univ Trieste, Dept Biochem Biophys & Macromol Chem, Trieste, Italy.
   [Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
RP Segat, L (corresponding author), Univ Trieste, Genet Unit, IRCCS Burlo Garofolo, Trieste, Italy.
EM segat@burlo.trieste.it; pontillo@burlo.trieste.it;
   michele.milanese@gmail.com; atossi@units.it; crovella@burlo.trieste.it
RI Tossi, Alessandro/ABC-9061-2020; Tossi, Alessandro/U-2474-2017;
   Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   Pontillo, ALESSANDRA/D-4352-2012
OI Tossi, Alessandro/0000-0001-9087-5764; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Segat, Ludovica/0000-0002-6024-1485
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528
   Crovella S, 2005, CURR PROTEIN PEPT SC, V6, P7, DOI 10.2174/1389203053027593
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Donovan A, 2000, NATURE, V403, P776
   Fry MM, 2004, VET CLIN PATH, V33, P223, DOI 10.1111/j.1939-165X.2004.tb00377.x
   Fu YM, 2007, MOL CELL BIOCHEM, V305, P191, DOI 10.1007/s11010-007-9543-1
   Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005
   Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802
   Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014
   Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200
   Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7
   Matthes T, 2004, BLOOD, V104, P2181, DOI 10.1182/blood-2004-01-0332
   Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225
   Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049
   Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686
   Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498
   Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200
   Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200
   Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053
   Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31
   Shi JS, 2006, DEV COMP IMMUNOL, V30, P746, DOI 10.1016/j.dci.2005.10.009
   Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475
   Vergili Z, 2005, OFIOLITI, V30, P37
   Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200
NR 30
TC 14
Z9 14
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD MAR 5
PY 2008
VL 9
AR 120
DI 10.1186/1471-2164-9-120
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 298RQ
UT WOS:000255705200001
PM 18321376
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Milanese, M
   Segat, L
   Pontillo, A
   Arraes, LC
   de Lima, JL
   Crovella, S
AF Milanese, Michele
   Segat, Ludovica
   Pontillo, Alessandra
   Arraes, Luiz Claudio
   de Lima Filho, Jos Luiz
   Crovella, Sergio
TI DEFB1 gene polymorphisms and increased risk of HIV-1 infection in
   Brazilian children
SO AIDS
LA English
DT Article
ID DEFENSINS
AB In our study we analysed three single nucleotide polymorphisms (SNPs) in the 5' untranslated region (UTR) of the DEFB1 gene, namely -52(G/A) -44(C/G) and -20(G/A), in three groups of north-eastern Brazilian children in order to assess their role in HIV-1 infection. Our results allowed us to hypothesize that the SNPs located in the 5'UTR of the DEFB1 gene can be employed as a marker of risk for HIV-1 infection.
C1 Univ Trieste, Dept Dev & Reprod Sci, Trieste, Italy.
   Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   Univ Fed Pernambuco, Lab Imunopatol Keizo Azami, Recife, PE, Brazil.
RP Milanese, M (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Trieste, Italy.
RI Pontillo, Alessandra/ABC-6266-2020; Pontillo, Alessandra/AAD-4790-2019;
   Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Pontillo,
   ALESSANDRA/0000-0002-7883-0640; Crovella, Sergio/0000-0001-8493-1168;
   Segat, Ludovica/0000-0002-6024-1485
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787
   KAGAN BL, 1994, TOXICOLOGY, V87, P131, DOI 10.1016/0300-483X(94)90158-9
   Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
   Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005
NR 8
TC 56
Z9 62
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD AUG 1
PY 2006
VL 20
IS 12
BP 1673
EP 1675
DI 10.1097/01.aids.0000238417.05819.40
PG 3
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 076VI
UT WOS:000239985800016
PM 16868452
DA 2020-12-08
ER

PT J
AU Zelezetsky, I
   Pontillo, A
   Puzzi, L
   Antcheva, N
   Segat, L
   Pacor, S
   Crovella, S
   Tossi, A
AF Zelezetsky, Igor
   Pontillo, Alessandra
   Puzzi, Luca
   Antcheva, Nikolinka
   Segat, Ludovica
   Pacor, Sabrina
   Crovella, Sergio
   Tossi, Alessandro
TI Evolution of the primate cathelicidin - Correlation between structural
   variations and antimicrobial activity
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PEPTIDE LL-37; LYTIC PEPTIDES; IDENTIFICATION; NEUTROPHILS; LIKELIHOOD;
   MEMBRANES; SELECTION; RECEPTOR; DEFENSE; FAMILY
AB Cathelicidin genes homologous to the human CAMP gene, coding for the host defense peptide LL-37, have been sequenced and analyzed in 20 primate species, including Great Apes, hylobatidae, cercopithecidae, callithricidae, and cebidae. The region corresponding to the putative mature antimicrobial peptide is subject to a strong selective pressure for variation, with evidence for positive selection throughout the phylogenetic tree relating the peptides, which favors alterations in the charge while little affecting overall hydrophobicity or amphipathicity. Selected peptides were chemically synthesized and characterized, and two distinct types of behavior were observed. Macaque and leaf-eating monkey RL- 37 peptides, like other helical antimicrobial peptides found in insect, frog, and mammalian species, were unstructured in bulk solution and had a potent, salt and medium independent antimicrobial activity in vitro, which may be the principal function also in vivo. Human LL-37 and the orangutan, hylobates, and callithrix homologues instead showed a salt-dependent structuring and likely aggregation in bulk solution that affected antimicrobial activity and its medium dependence. The two types of peptides differ also in their interaction with host cells. The evolution of these peptides has thus resulted in distinct mechanisms of action that affect the direct antimicrobial activity and may also modulate accessory antimicrobial functions due to interactions with host cells.
C1 Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   Univ Trieste, Dept Biomed Sci, I-34127 Trieste, Italy.
RP Tossi, A (corresponding author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
EM tossi@bbcm.units.it
RI Pontillo, ALESSANDRA/D-4352-2012; Crovella, Sergio/K-5050-2016; Tossi,
   Alessandro/ABC-9061-2020; Pontillo, Alessandra/ABC-6266-2020; Pontillo,
   Alessandra/AAD-4790-2019; Tossi, Alessandro/U-2474-2017
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Crovella,
   Sergio/0000-0001-8493-1168; Pontillo, Alessandra/0000-0002-7883-0640;
   Pontillo, Alessandra/0000-0002-7883-0640; Tossi,
   Alessandro/0000-0001-9087-5764; Puzzi, Luca/0000-0001-9296-2263; PACOR,
   SABRINA/0000-0001-8043-6725; Segat, Ludovica/0000-0002-6024-1485
CR Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004
   Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9
   Bals R, 2001, CLIN DIAGN LAB IMMUN, V8, P370, DOI 10.1128/CDLI.8.2.370-375.2001
   Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528
   Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987
   Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
   Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x
   Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020
   Hill W. C. O., 1970, PRIMATES COMP ANATOM
   Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718
   Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005
   Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545
   Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070
   Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951
   Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114
   Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520
   Tossi A, 1997, EUR J BIOCHEM, V250, P549, DOI 10.1111/j.1432-1033.1997.0549a.x
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   Tossi A, 1997, Methods Mol Biol, V78, P133
   Tossi A, 2002, PEPTIDES 2002, V27, P416
   Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Wang YQ, 2004, ANTIMICROB AGENTS CH, V48, P2097, DOI 10.1128/AAC.48.6.2097-2100.2004
   Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115
   Wolfheim J. H., 1983, PRIMATES WORLD DISTR
   Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957
   Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x
   ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
   Zelezetsky I, 2005, BIOCHEM J, V390, P177, DOI 10.1042/BJ20042138
   Zelezetsky I, 2005, ARCH BIOCHEM BIOPHYS, V434, P358, DOI 10.1016/j.abb.2004.11.006
   Zhao CQ, 2001, ANTIMICROB AGENTS CH, V45, P2695, DOI 10.1128/AAC.45.10.2695-2702.2001
NR 43
TC 82
Z9 99
U1 0
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 21
PY 2006
VL 281
IS 29
BP 19861
EP 19871
DI 10.1074/jbc.M511108200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 063RV
UT WOS:000239038200009
PM 16720578
OA Bronze
DA 2020-12-08
ER

PT J
AU Arraes, LC
   de Souza, PR
   Bruneska, D
   Castelo, A
   Cavada, BD
   de Lima, JL
   Crovella, S
AF Arraes, L. C.
   de Souza, P. R.
   Bruneska, D.
   Castelo Filho, A.
   de Souza Cavada, B.
   de Lima Filho, J. L.
   Crovella, S.
TI A cost-effective melting temperature assay for the detection of
   single-nucleotide polymorphism in the MBL2 gene of HIV-1-infected
   children
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE melting temperature assay; real time PCR; MBL2; polymorphisms;
   HIV-1-positive children
ID HIV-INFECTION; PROGRESSION; AIDS
AB We report a fast (less than 3 h) and cost-effective melting temperature assay method for the detection of single-nucleotide polymorphisms in the MBL2 gene. The protocol, which is based on the Corbett Rotor Gene real time PCR platform and SYBR Green I chemistry, yielded, in the cohorts studied, sensitive (100%) and specific (100%) PCR amplification without the use of costly fluorophore-labeled probes or post-PCR manipulation. At the end of the PCR, the dissociation protocol included a slow heating from 60 degrees to 95 degrees C in 0.2 degrees C steps, with an 8-s interval between steps. Melting curve profiles were obtained using the dissociation software of the Rotor Gene-3000 apparatus. Samples were analyzed in duplicate and in different PCR runs to test the reproducibility of this technique. No supplementary data handling is required to determine the MBL2 genotype. MBL2 genotyping performed on a cohort of 164 HIV-1-positive Brazilian children and 150 healthy controls, matched for age and sex and ethnic origin, yielded reproducible results confirmed by direct sequencing of the amplicon performed in blind. The three MBL2 variants (Arg52Cys, Gly54Asp, Gly57Glu) were grouped together and called allele 0, while the combination of three wild-type alleles was called allele A. The frequency of the A/A homozygotes was significantly higher among healthy controls (0.68) than in HIV-infected children (0.55; P = 0.0234) and the frequency of MBL2 0/0 homozygotes was higher among HIV-1-infected children than healthy controls (P = 0.0296). The 0 allele was significantly more frequent among the 164 HIV-1-infected children (0.29) than among the 150 healthy controls (0.18; P = 0.0032). Our data confirm the association between the presence of the mutated MBL2 allele (allele 0) and HIV-1 infection in perinatally exposed children. Our results are in agreement with the literature data which indicate that the presence of the allele 0 confers a relative risk of 1.37 for HIV-1 infection through vertical transmission.
C1 Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
   Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   Inst Materno Infant Pernambuco, Recife, PE, Brazil.
   Univ Fed Sao Paulo, Disciplina Gastroenterol, Sao Paulo, Brazil.
   Univ Fed Ceara, Dept Bioquim & Biol Mol, Fortaleza, Ceara, Brazil.
RP Crovella, S (corresponding author), Univ Trieste, Dept Dev & Reprod Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Filho, Jose Luiz Lima/M-8076-2019
OI Crovella, Sergio/0000-0001-8493-1168; Souza, Paulo/0000-0002-9186-9849;
   Cavada, Benildo/0000-0002-5791-6170
CR Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Flavell AJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng113
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Lee LG, 1999, BIOTECHNIQUES, V27, P342, DOI 10.2144/99272rr01
   Lipsky RH, 2001, CLIN CHEM, V47, P635
   Meyer K, 2004, CLIN CHEM, V50, P391, DOI 10.1373/clinchem.2003.026799
   Ou-Yang H, 2004, J CLIN PATHOL, V57, P159, DOI 10.1136/jcp.2003.011130
   Pirulli D, 2001, CLIN EXP MED, V1, P99, DOI 10.1007/s10238-001-8019-y
   Pirulli D, 2000, CLIN CHEM, V46, P129
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49
NR 14
TC 18
Z9 19
U1 0
U2 3
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN
PY 2006
VL 39
IS 6
BP 719
EP 723
DI 10.1590/S0100-879X2006000600003
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 053KY
UT WOS:000238305200003
PM 16751976
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Segat, L
   Bevilacqua, D
   Boniotto, M
   Arraes, LC
   de Souza, PR
   de Lima, JL
   Crovella, S
AF Segat, L
   Bevilacqua, D
   Boniotto, M
   Arraes, LC
   de Souza, PR
   de Lima, JL
   Crovella, S
TI IL-18 gene promoter polymorphism is involved in HIV-1 infection in a
   Brazilian pediatric population
SO IMMUNOGENETICS
LA English
DT Article
DE IL-18; HIV-1 infection; Brazilian children; promoter polymorphism;
   single-tube allele-specific PCR
ID T-CELL LINE; HIV-1-INFECTED PATIENTS; DISEASE PROGRESSION;
   INTERLEUKIN-18; PATHOGENESIS
AB In our study, we identified a polymorphism (C-607A) in the promoter region of the IL-18 gene that shows different frequencies between human immunodeficiency virus (HIV)-1-infected children and healthy controls in a pediatric Brazilian population. The presence of the -607 C allele correlates to HIV-1 infection and confers an increased risk of infection in subjects carrying the single nucleotide polymorphism.
C1 Univ Trieste, Dept Reprod & Dev Sci, I-34137 Trieste, Italy.
   Childrens Hosp Burlo Garofolo, Genet Serv, Trieste, Italy.
   Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   Univ Fed Pernambuco, Lab Imunopatol Keizo Azami, Recife, PE, Brazil.
RP Segat, L (corresponding author), Univ Trieste, Dept Reprod & Dev Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM segat@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; Crovella, Sergio/K-5050-2016; Filho, Jose
   Luiz Lima/M-8076-2019; Boniotto, Michele/AAB-4302-2020
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; Souza, Paulo/0000-0002-9186-9849; Segat,
   Ludovica/0000-0002-6024-1485
CR Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002
   Boniotto M, 2005, J IMMUNOL METHODS, V304, P184, DOI 10.1016/j.jim.2005.06.016
   Choi HJ, 2001, J INFECT DIS, V184, P560, DOI 10.1086/322805
   Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   Hoshino T, 2001, J IMMUNOL, V166, P7014, DOI 10.4049/jimmunol.166.12.7014
   Klein SA, 2000, EUR CYTOKINE NETW, V11, P47
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Pirhonen J, 1999, J IMMUNOL, V162, P7322
   Pugliese A, 2002, CELL BIOCHEM FUNCT, V20, P333, DOI 10.1002/cbf.981
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schneider S, 2000, ARLEQUIN SOFTWARE PO
   Shapiro GG, 1998, IMMUNOL ALLERGY CLIN, V18, P1, DOI 10.1016/S0889-8561(05)70343-X
   Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x
   Sugiura T, 2002, GENES IMMUN, V3, P394, DOI 10.1038/sj.gene.6363922
   Tanaka J, 1999, Dent Mater J, V18, P11
   Wiercinska-Drapalo A, 2004, MICROBES INFECT, V6, P1273, DOI 10.1016/j.micinf.2004.07.009
NR 17
TC 25
Z9 26
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PD JUN
PY 2006
VL 58
IS 5-6
BP 471
EP 473
DI 10.1007/s00251-006-0104-7
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 049KK
UT WOS:000238014900016
PM 16738942
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Berti, I
   Santon, D
   Ventura, A
   Crovella, S
AF Boniotto, M
   Berti, I
   Santon, D
   Ventura, A
   Crovella, S
TI Absence of maternal microchimerism in very early onset inflammatory
   bowel disease R1
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Letter
C1 Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
   IRCCS Burlo Garofolo, Pediat Unit, Trieste, Italy.
   IRCCS Burlo Garofolo, Genet Unit, Trieste, Italy.
RP Boniotto, M (corresponding author), Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
RI Boniotto, Michele/AAB-4302-2020; Crovella, Sergio/K-5050-2016; Boniotto,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; Boniotto,
   Michele/0000-0002-9548-2254; Ventura, Alessandro/0000-0002-4657-1760
CR Artlett CM, 2000, LANCET, V356, P2155, DOI 10.1016/S0140-6736(00)03499-1
   Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0
   Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5
   Srivatsa B, 2003, J PEDIATR-US, V142, P31, DOI 10.1067/mpd.2003.mpd0327
   Stevens AM, 2003, LANCET, V362, P1617, DOI 10.1016/S0140-6736(03)14795-2
NR 5
TC 3
Z9 3
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0815-9319
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD JUN
PY 2006
VL 21
IS 6
BP 1082
EP 1084
DI 10.1111/j.1440-1746.2006.04126.x
PG 4
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 045KD
UT WOS:000237740100033
PM 16725006
DA 2020-12-08
ER

PT J
AU Crovella, S
   Pontillo, A
   Tossi, A
   Amoroso, A
AF Crovella, S.
   Pontillo, A.
   Tossi, A.
   Amoroso, A.
TI Molecular evolution of the primate cathelicidin
SO TISSUE ANTIGENS
LA English
DT Meeting Abstract
CT 20th European Immunogenetics and Histocompatibility Conference
CY JUN 08-11, 2006
CL Oslo, NORWAY
SP European Federat Immunogenet
C1 Univ Trieste, BBCM, Trieste, Italy.
   Univ Turin, I-10124 Turin, Italy.
RI Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD JUN
PY 2006
VL 67
IS 6
MA P-035
BP 473
EP 473
PG 1
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 048LW
UT WOS:000237949600085
DA 2020-12-08
ER

PT J
AU Crovella, S
   Segat, L
   Milanese, M
   Amoroso, A
AF Crovella, S.
   Segat, L.
   Milanese, M.
   Amoroso, A.
TI Evolution of the mannose binding lectin pseudogene (MBL1P1) in primates
SO TISSUE ANTIGENS
LA English
DT Meeting Abstract
CT 20th European Immunogenetics and Histocompatibility Conference
CY JUN 08-11, 2006
CL Oslo, NORWAY
SP European Federat Immunogenet
C1 Univ Trieste, Trieste, Italy.
   Univ Turin, Turin, Italy.
RI amoroso, antonio/AAL-1475-2020; Crovella, Sergio/K-5050-2016; AMOROSO,
   ANTONIO/AAN-3884-2020
OI amoroso, antonio/0000-0002-9437-9407; Crovella,
   Sergio/0000-0001-8493-1168; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD JUN
PY 2006
VL 67
IS 6
MA P-037
BP 474
EP 474
PG 1
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 048LW
UT WOS:000237949600087
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Jordan, WJ
   Eskdale, J
   Tossi, A
   Antcheva, N
   Crovella, S
   Connell, ND
   Gallagher, G
AF Boniotto, M
   Jordan, WJ
   Eskdale, J
   Tossi, A
   Antcheva, N
   Crovella, S
   Connell, ND
   Gallagher, G
TI Human beta-defensin 2 induces a vigorous cytokine response in peripheral
   blood mononuclear cells
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID BETA-DEFENSIN 2; ANTIMICROBIAL PEPTIDES; ADAPTIVE IMMUNITY; DENDRITIC
   CELLS; INNATE; GENE; DISCOVERY; SEARCH
AB beta-Defensins are a family of small cationic peptides involved in the innate response to microbial infection. Although their role in microbial killing is well established, the mechanisms through which this occurs remain largely undefined. Here, using protein array technology, we describe a role for human beta-defensins in the induction of an inflammatory cytokine response by human peripheral blood mononuclear cells (PBMCs). Human beta-defensins 1, 2, and 3 were examined for induction of an array of cytokines and chemokines. Some cytokines, such as interleukin 8 (IL-8) and monocyte chemoattractant protein 1, were up-regulated by all three defensins, while others, such as IL-6 and IL-10, were induced more selectively. It was notable that each defensin induced a unique pattern of cytokines. This report documents, for the first time, an analysis of the composite cytokine response of human PBMCs to beta-defensins. The induction or up-regulation of a number of cytokines involved in the adaptive immune response suggests a possible role for these defensins in linking innate and acquired immunity.
C1 Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.
   IRCCS, Genet Serv, I-34137 Trieste, Italy.
   Univ Trieste, Dept Biochem, I-34100 Trieste, Italy.
   Univ Med & Dent New Jersey, Dept Med, Newark, NJ 07103 USA.
RP Boniotto, M (corresponding author), Univ Med & Dent New Jersey, Dept Oral Biol, MSB,Rm C-636,185 S Orange Ave, Newark, NJ 07103 USA.
EM boniotto@bbcm.units.it; Grant.Gallagher@gmail.com
RI Tossi, Alessandro/ABC-9061-2020; Boniotto, Michele/F-1857-2010;
   Gallagher, Grant/AAL-7952-2020; Tossi, Alessandro/U-2474-2017; Boniotto,
   Michele/AAB-4302-2020; Crovella, Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Tossi,
   Alessandro/0000-0001-9087-5764; Crovella, Sergio/0000-0001-8493-1168
FU NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R21DE014997, R21DE014997, R21DE014997] Funding Source: NIH RePORTER;
   NIDCR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [R21 DE014997, R1DE14997A] Funding Source:
   Medline
CR Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004
   Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410
   BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565
   Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644
   Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   Brogden KA, 2003, ORAL MICROBIOL IMMUN, V18, P95, DOI 10.1034/j.1399-302X.2003.00047.x
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239
   Jia HP, 2001, GENE, V263, P211
   Jordan WJ, 2004, BLOOD, V103, P717, DOI 10.1182/blood-2003-01-0192
   Jordan WJ, 2002, J IMMUNOL METHODS, V260, P1, DOI 10.1016/S0022-1759(01)00490-2
   Kao CY, 2003, AM J RESP CELL MOL, V29, P71, DOI 10.1165/rcmb.2002-0205OC
   Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651
   Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x
   Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p
   Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   van Wetering S, 2005, J LEUKOCYTE BIOL, V77, P444, DOI 10.1189/jlb.0604367
   van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282
   Vedrine C, 2004, CYTOM PART B-CLIN CY, V60B, P14, DOI 10.1002/cyto.b.20012
   Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515
   WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902
   Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
NR 34
TC 65
Z9 74
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD APR
PY 2006
VL 50
IS 4
BP 1433
EP 1441
DI 10.1128/AAC.50.4.1433-1441.2006
PG 9
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 031EA
UT WOS:000236685700044
PM 16569862
OA Other Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Souza, PR
   Arraes, LC
   de Lima, JL
   Bruneska, D
   Milanese, M
   Crovella, S
AF de Souza, PR
   Arraes, LC
   de Lima, JL
   Bruneska, D
   Milanese, M
   Crovella, S
TI CCR5 promoter polymorphisms and HIV-1 perinatal transmission in
   Brazilian children
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE CCR5; promoter; polymorphisms; HIV-1; vertical transmission
ID IMMUNODEFICIENCY-VIRUS TYPE-1; AIDS PROGRESSION; GENE; HAPLOTYPES;
   INFECTION; RECEPTOR; IDENTIFICATION; ASSOCIATION; EXPRESSION; COFACTOR
AB The frequencies of four CCR5 promoter polymorphisms, and of the Delta 32 deletion, have been evaluated in Brazilian HIV-1 positive (HIV+) and HIV-1 negative (HIV-) children, both born from HIV-1 positive mothers and healthy controls (HC), with the aim of investigating whether CCR5 polyrnorphisms could be associated to vertical transmission of HIV-1. One hundred and six HIV-1 positive children and 70 HIV-1 negative children were enrolled from impoverished areas of Recife (Brazil). We recruited also as healthy controls 104 uninfected children from the same ethnic background, matched for age and known to be not at risk for HIV-1 infection. CCR5 polymorphisms were detected by PCR amplification and direct sequencing. Although no significative divergence was found for CCR5 Delta 32, CCR5-59356-C/T and CCR5-59653 C/T polymorphisms, the frequency of CCR5-59353-T/C and CCR5-59402-A/G genotypes differed among HIV+, HIV- and HC children. The presence of the CCR5-59353-TT genotype indicated a trend for increased risk of vertical transmission of HIV-1 infection in Brazilian children, while the presence of the CCR5-59402-AA genotype is suggestive for a protective effect against HIV-1 vertical transmission. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
   IMIP, Recife, PE, Brazil.
   Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Fed Pernambuco, LIKA, Recife, PE, Brazil.
EM crovella@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Filho, Jose Luiz Lima/M-8076-2019
OI Crovella, Sergio/0000-0001-8493-1168; Souza, Paulo/0000-0002-9186-9849
CR Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   An P, 2000, AIDS, V14, P2117, DOI 10.1097/00002030-200009290-00007
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Contopoulos-Ioannidis DG, 2003, JAIDS-J ACQ IMM DEF, V32, P70, DOI 10.1097/00126334-200301010-00010
   Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749
   John GC, 2001, J INFECT DIS, V184, P89, DOI 10.1086/321006
   Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999
   Li C, 2005, INT J IMMUNOGENET, V32, P99, DOI 10.1111/j.I744-313X.2005.00498.x
   Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907
   Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100
   *R DEV COR TEAM A, 2004, R LANG ENV STAT COMP
   Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5
   Shieh B, 2000, INT IMMUNOL, V12, P1311, DOI 10.1093/intimm/12.9.1311
   Winkler CA, 2004, JAIDS-J ACQ IMM DEF, V37, P1534, DOI 10.1097/01.qai.0000127353.01578.63
NR 19
TC 12
Z9 12
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD FEB
PY 2006
VL 69
IS 1
BP 77
EP 84
DI 10.1016/j.jri.2005.09.001
PG 8
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 013KC
UT WOS:000235407200009
PM 16233918
DA 2020-12-08
ER

PT J
AU Segat, L
   Milanese, M
   Boniotto, M
   Crovella, S
   Bernardon, M
   Costantini, M
   Alberico, S
AF Segat, L
   Milanese, M
   Boniotto, M
   Crovella, S
   Bernardon, M
   Costantini, M
   Alberico, S
CA Italian Grp SIGO HIV Obstetrics
TI DEFB-1 genetic polymorphism screening in HIV-1 positive pregnant women
   and their children
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE genetic polymorphisms; DEFB-1; HIV-1; innate immunity; maternal-fetal
   transmission
ID ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-1; DEFENSINS; INNATE;
   INFECTION; IMMUNITY
AB Objective. In our study we evaluated the frequency of three SNPs (-52 G/A, 744 C/G; 720 G/A) in the 50 UTR of DEFB-1 gene, in a cohort of 130 HIV-1 infected mothers and their children, collected by the Italian group SIGO in Obstetrics and Gynecology.
   Methods. The three SNPs (752 G/A, 744 C/G; 720 G/A) in the 50 UTR of DEFB-1 gene were genotyped by direct sequencing of PCR products.
   Results. The C allele at position 744 was shown to be significantly different in both HIV-1 positive mothers and their children when compared to the healthy controls. The odds ratio for -44 C allele in children born to HIV-1 infected mothers is 7.09 (confidence interval 3.38-15.3) while the odds ratio for this allele in HIV-1 infected mothers is 6.42 (confidence interval 3.14-13.4).
   Conclusions. Our results evidence a high frequency of the 744 degrees C allele in HIV-1 infected mothers and their children with augmented potential risk of maternal fetal transmission. This potential vertical transmission risk has been successfully prevented by antiretroviral drug treatment and cesarian section of the HIV-1 positive mothers.
C1 Univ Trieste, Dept Dev & Reprod Sci, Trieste, Italy.
   Childrens Hosp, Genet Serv, Trieste, Italy.
   Childrens Hosp, Gynecol & Obstet, Trieste, Italy.
   Univ Trieste, Dept Dev & Reprod Sci, Gynecol Unit, Trieste, Italy.
RP Crovella, S (corresponding author), IRCCS, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; Boniotto, Michele/AAB-4302-2020;
   Crovella, Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485;
   Bernardon, Maria/0000-0002-6250-0807
CR Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb
   Crovella S, 2005, CURR PROTEIN PEPT SC, V6, P7, DOI 10.2174/1389203053027593
   Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   Levy JA, 2001, TRENDS IMMUNOL, V22, P312, DOI 10.1016/S1471-4906(01)01925-1
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
NR 8
TC 23
Z9 25
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JAN
PY 2006
VL 19
IS 1
BP 13
EP 16
DI 10.1080/14767050500381123
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 023MF
UT WOS:000236130100003
PM 16572527
DA 2020-12-08
ER

PT J
AU Puppo, F
   Musso, M
   Pirulli, D
   Griseri, P
   Bachetti, T
   Crovella, S
   Patrone, G
   Ceccherini, I
   Ravazzolo, R
AF Puppo, F
   Musso, M
   Pirulli, D
   Griseri, P
   Bachetti, T
   Crovella, S
   Patrone, G
   Ceccherini, I
   Ravazzolo, R
TI Comparative genomic sequence analysis coupled to chromatin
   immunoprecipitation: a screening procedure applied to search for
   regulatory elements at the RET locus
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE Hirschsprung disease; comparative sequence analysis; histone
   acetylation; real-time quantitative PCR; transcriptional regulation
ID HIRSCHSPRUNG-DISEASE; C-RET; PROTOONCOGENE; EXPRESSION; ENHANCER;
   REGION; PROMOTER; HAPLOTYPE; MUTATION; RECEPTOR
AB Comparative genomic sequence analysis coupled to chromatin immunoprecipitation: a screening procedure applied to search for regulatory elements at the RET locus. Physiol Genomics 23: 269-274, 2005. First published September 6, 2005; doi: 10.1152/physiolgenomics. 00036.2005.-RET gene expression is characterized by high tissue and stage specificity during the development of neural crest derivatives and in the pathogenesis of inherited cancer syndromes and Hirschsprung disease. Identifying all elements contributing to its transcriptional regulation might provide new clues to clarify both developmental and pathogenic mechanisms. We previously demonstrated that chromatin acetylation affects RET transcription; therefore, we have set up a strategy based on analysis of sequences conserved among species at the RET locus, combined with the characterization of their chromatin structure, to identify new potential regulatory elements. The histone acetylation level was evaluated by the chromatin immunoprecipitation method applied to cells displaying different degrees of endogenous RET expression. Realtime quantitative PCR of immunoprecipitated DNA-protein complexes and transfection experiments, with constructs expressing a reporter gene in which the putative regulatory regions are inserted, indicate a correlation between histone acetylation and endogenous RET expression and highlight conserved sequences with potential regulatory roles. This paper presents a reliable screening procedure to unearth elements able to affect gene regulation at the transcriptional level in a large genomic region.
C1 G Gaslini Inst Children, Genet Mol Lab, I-16147 Genoa, Italy.
   Univ Genoa, Dept Pediat, Genoa, Italy.
   Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy.
   Inst Burlo Garofolo, Dept Genet, Trieste, Italy.
RP Ravazzolo, R (corresponding author), G Gaslini Inst Children, Genet Mol Lab, Largo G Gaslini 5, I-16147 Genoa, Italy.
EM rravazzo@unige.it
RI Ceccherini, Isabella/P-8195-2014; griseri, paola/AAJ-4823-2020;
   Crovella, Sergio/K-5050-2016
OI Ceccherini, Isabella/0000-0001-8732-1955; Crovella,
   Sergio/0000-0001-8493-1168; Puppo, Francesca/0000-0002-9823-0810
FU TelethonFondazione Telethon [GGP04257] Funding Source: Medline
CR Andrew SD, 2000, GENE, V256, P283, DOI 10.1016/S0378-1119(00)00302-4
   Attie-Bitach T, 1998, AM J MED GENET, V80, P481, DOI 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO;2-6
   Burzynski GM, 2005, AM J HUM GENET, V76, P850, DOI 10.1086/429589
   Burzynski GM, 2004, EUR J HUM GENET, V12, P604, DOI 10.1038/sj.ejhg.5201199
   Chakravarti A., 2001, METABOLIC MOL BASES, P6231
   Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467
   Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210
   Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135
   Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598
   Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959
   Honda T, 1999, J CHEM NEUROANAT, V17, P163, DOI 10.1016/S0891-0618(99)00036-8
   Ichihara M, 2004, CANCER LETT, V204, P197, DOI 10.1016/S0304-3835(03)00456-7
   Kawakami T, 2003, NEUROUROL URODYNAM, V22, P83, DOI 10.1002/nau.10074
   Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107
   Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828
   Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520
   MarcosGutierrez CV, 1997, ONCOGENE, V14, P879, DOI 10.1038/sj.onc.1201048
   Miller W, 2000, NAT BIOTECHNOL, V18, P148, DOI 10.1038/72588
   Munnes M, 1998, ONCOGENE, V17, P2573, DOI 10.1038/sj.onc.1202165
   Natarajan D, 2002, DEVELOPMENT, V129, P5151
   Patrone G, 1997, FEBS LETT, V419, P76, DOI 10.1016/S0014-5793(97)01435-X
   PATRONE G, 2000, GENE FUNCT DIS, V3, P145
   Puppo F, 2002, FEBS LETT, V523, P123, DOI 10.1016/S0014-5793(02)02957-5
   Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714
   Schuchardt A, 1996, DEVELOPMENT, V122, P1919
   Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801
NR 26
TC 6
Z9 6
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD NOV 17
PY 2005
VL 23
IS 3
BP 269
EP 274
DI 10.1152/physiolgenomics.00036.2005
PG 6
WC Cell Biology; Genetics & Heredity; Physiology
SC Cell Biology; Genetics & Heredity; Physiology
GA 995FN
UT WOS:000234086300002
PM 16144862
DA 2020-12-08
ER

PT J
AU Chantson, JT
   Falzacappa, MVV
   Crovella, S
   Metzler-Nolte, N
AF Chantson, JT
   Falzacappa, MVV
   Crovella, S
   Metzler-Nolte, N
TI Antibacterial activities of ferrocenoyl- and cobaltocenium-peptide
   bioconjugates
SO JOURNAL OF ORGANOMETALLIC CHEMISTRY
LA English
DT Article
DE antibacterial agents; bioorganometallic chemistry; cobaltocenium;
   ferrocene; peptides; solid phase synthesis
ID RECEPTOR MODULATORS SERMS; ACTIVITY IN-VITRO; ANTIMALARIAL ACTIVITY;
   BIOLOGICAL-ACTIVITY; BIOORGANOMETALLIC CHEMISTRY; SEMISYNTHETIC
   ANTIBIOTICS; ELECTRONIC DETECTION; BREAST-CANCER; ANALOGS; CHLOROQUINE
AB The peptide and metallocene-peptide bioconjugates R-Arg-Arg-Phe-NH2, R-Phe-Arg-Phe-NH2 where R = H, Fe(Cp)(C5H4-CO), CO(Cp)(C5H4-CO)(+) and R'-Gly-Trp-Arg-Arg-Phe-NH2, R'-Trp-Arg-Arg-Phe-NH2, where R' = n-C5H11 CO, Fe(CPK5H4- CO), CO(CP)(C5H4-CO)(+), and Arg = L-arginine, Gly = L-glycine, Phe = L-phenylalanine, Trp = L-tryptophan were prepared by solid phase peptide synthesis (SPPS). The compounds were purified by RP-HPLC and characterized by ESI-MS and NMR spectroscopy. Antibacterial properties of the compounds were determined by minimum inhibitory concentration (MIC) tests against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Pretoria, Dept Chem, ZA-0002 Pretoria, South Africa.
   Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany.
   Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
RP Chantson, JT (corresponding author), Univ Pretoria, Dept Chem, ZA-0002 Pretoria, South Africa.
EM janine.chantson@up.ac.za; nils.metzler-nolte@urz.uni-heidelberg.de
RI Crovella, Sergio/K-5050-2016; Metzler-Nolte, Nils/H-7626-2014
OI Crovella, Sergio/0000-0001-8493-1168; Metzler-Nolte,
   Nils/0000-0001-8111-9959
CR Beilstein AE, 2001, J ORGANOMET CHEM, V637, P398, DOI 10.1016/S0022-328X(01)00943-3
   Biot C, 1997, J MED CHEM, V40, P3715, DOI 10.1021/jm970401y
   Biot C, 1999, BIOORGAN MED CHEM, V7, P2843, DOI 10.1016/S0968-0896(99)00224-2
   Biot C, 1999, J ORGANOMET CHEM, V589, P59, DOI 10.1016/S0022-328X(99)00302-2
   Biot C, 2005, MOL PHARMACEUT, V2, P185, DOI 10.1021/mp0500061
   Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o
   BRUNET JC, 1981, J ORGANOMET CHEM, V216, P73, DOI 10.1016/S0022-328X(00)84002-4
   CHANTSON JT, UNPUB
   CUINGNET E, 1982, EUR J MED CHEM, V17, P203
   CUINGNET E, 1980, J ORGANOMET CHEM, V195, P325, DOI 10.1016/S0022-328X(00)93315-1
   de Hatten X, 2004, J ORGANOMET CHEM, V689, P4856, DOI 10.1016/j.jorganchem.2004.10.002
   Delhaes L, 2002, CHEMBIOCHEM, V3, P418, DOI 10.1002/1439-7633(20020503)3:5<418::AID-CBIC418>3.0.CO;2-P
   EDWARDS EI, 1975, J ORGANOMET CHEM, V85, pC23, DOI 10.1016/S0022-328X(00)80708-1
   EDWARDS EI, 1976, J ORGANOMET CHEM, V107, P351, DOI 10.1016/S0022-328X(00)91527-4
   Fish RH, 2003, ORGANOMETALLICS, V22, P2166, DOI 10.1021/om0300777
   HUBLAU P, 1983, EUR J MED CHEM, V18, P131
   Jaouen C, 2000, CR ACAD SCI II C, V3, P89
   Jaouen G, 2004, CURR MED CHEM, V11, P2505, DOI 10.2174/0929867043364487
   Kang JH, 1996, INT J PEPT PROT RES, V48, P357
   Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005
   Long YT, 2003, J AM CHEM SOC, V125, P8724, DOI 10.1021/ja034684x
   Noor F, 2005, ANGEW CHEM INT EDIT, V44, P2429, DOI 10.1002/anie.200462519
   RICOUART A, 1988, INT J PEPT PROT RES, V32, P56
   SHEATS JE, 1970, J ORG CHEM, V35, P3245, DOI 10.1021/jo00835a014
   Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039
   Top S, 2003, CHEM-EUR J, V9, P5223, DOI 10.1002/chem.200305024
   Umek RM, 2001, J MOL DIAGN, V3, P74, DOI 10.1016/S1525-1578(10)60655-1
   van Staveren DR, 2002, CHEM COMMUN, P1406, DOI 10.1039/b203128k
   van Staveren DR, 2004, CHEM REV, V104, P5931, DOI 10.1021/cr0101510
   Walsh C, 2005, CHEM REV, V105, P391, DOI 10.1021/cr030100y
   Yu CJ, 2001, J AM CHEM SOC, V123, P11155, DOI 10.1021/ja010045f
   Zatsepin T. S., 2003, RUSS CHEM REV, V72, P537, DOI DOI 10.1070/RC2003V072N06ABEH000807
   2004, J ORGANOMET CHEM, P689
NR 33
TC 78
Z9 79
U1 1
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0022-328X
EI 1872-8561
J9 J ORGANOMET CHEM
JI J. Organomet. Chem.
PD NOV 1
PY 2005
VL 690
IS 21-22
BP 4564
EP 4572
DI 10.1016/j.jorganchem.2005.07.007
PG 9
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic
SC Chemistry
GA 981BX
UT WOS:000233063200005
DA 2020-12-08
ER

PT J
AU Annoni, G
   Segat, L
   Arosio, B
   Galimberti, L
   Clerici, M
   Vergani, C
   Crovella, S
AF Annoni, G
   Segat, L
   Arosio, B
   Galimberti, L
   Clerici, M
   Vergani, C
   Crovella, S
TI Polymorphisms in the promoter region of PIN1 gene are associated with
   Alzheimer's disease
SO GERONTOLOGIST
LA English
DT Meeting Abstract
C1 Univ Milano Bicocca, Monza, Milan, Italy.
   Univ Trieste, Genet Sect, Dept Reprod & Dev Sci, Trieste, Italy.
   Univ Milan, Osped Maggiore Policlin, Dept Internal Med, Fdn IRCCS, Milan, Italy.
   Univ Milan, DISP, LITA, VIALBA, Milan, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 0016-9013
J9 GERONTOLOGIST
JI Gerontologist
PD OCT
PY 2005
VL 45
SI 2
BP 600
EP 601
PG 2
WC Gerontology
SC Geriatrics & Gerontology
GA 988QF
UT WOS:000233615001695
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Segat, L
   Milanese, M
   Crovella, S
AF Boniotto, M
   Segat, L
   Milanese, M
   Crovella, S
TI Detection of two functional polymorphisms in the promoter region of the
   IL-18 gene by single-tube allele specific PCR and melting temperature
   analysis
SO JOURNAL OF IMMUNOLOGICAL METHODS
LA English
DT Article
DE IL-18; melting analysis; SNP genotyping; SYBR green I; association
   studies
ID INTERLEUKIN-18
AB IL-18 is an important cytokine in both innate and acquired immunity. IL-18 promoter polymorphisms have been investigated in several autoimmune and infectious diseases. Here we present two assays for a medium to a high throughput genotyping of C-607A and G-137C IL-18 SNPs. Using these protocols we have been able to rapidly genotype a cohort of 131 healthy Italian individuals. The assays, based on a multiplex allele-specific PCR and the melting temperature analysis of the PCR product, are rapid, easily automated, inexpensive and well suited to case-control association studies. (c) 2005 Elsevier B.V. All rights reserved.
C1 IRCCS, Genet Serv, I-34100 Trieste, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, I-34100 Trieste, Italy.
RP Crovella, S (corresponding author), IRCCS, Genet Serv, Via Istria 65-1, I-34100 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010;
   Crovella, Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; Segat, Ludovica/0000-0002-6024-1485
CR Germer S, 1999, GENOME RES, V9, P72
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   GRACIE JA, 2005, GENES IMMUN
   Hoshino T, 2001, J IMMUNOL, V166, P7014, DOI 10.4049/jimmunol.166.12.7014
   Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164
   Kretowski A, 2002, DIABETES, V51, P3347, DOI 10.2337/diabetes.51.11.3347
   Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0
   NEWTON CR, 1989, LANCET, V2, P1481
   Reddy P, 2004, CURR OPIN HEMATOL, V11, P405, DOI 10.1097/01.moh.0000141926.95319.42
   Sivalingam SP, 2003, TISSUE ANTIGENS, V62, P498, DOI 10.1046/j.1399-0039.2003.00137.x
NR 10
TC 6
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-1759
EI 1872-7905
J9 J IMMUNOL METHODS
JI J. Immunol. Methods
PD SEP
PY 2005
VL 304
IS 1-2
BP 184
EP 188
DI 10.1016/j.jim.2005.06.016
PG 5
WC Biochemical Research Methods; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 968OG
UT WOS:000232171200017
PM 16111697
DA 2020-12-08
ER

PT J
AU Miorin, E
   Ciana, G
   Crovella, S
   Colonna, F
AF Miorin, E
   Ciana, G
   Crovella, S
   Colonna, F
TI Novel compound heterozygous mutations in SGLT2 gene are responsible for
   autosomal recessive renal glucosuria.
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT 46th Annual Meeting of the European-Society-for-Pediatric-Research
CY AUG 31-SEP 03, 2005
CL Siena, ITALY
SP European Soc Pediat Res
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
NR 0
TC 0
Z9 1
U1 0
U2 1
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD AUG
PY 2005
VL 58
IS 2
MA 250
BP 397
EP 397
DI 10.1203/00006450-200508000-00279
PG 1
WC Pediatrics
SC Pediatrics
GA 952HV
UT WOS:000230995500280
OA Bronze
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Arbustini, E
   de Gasperis, MR
   Crovella, S
AF Marziliano, N
   Arbustini, E
   de Gasperis, MR
   Crovella, S
TI Detection of Epstein Barr virus in formalin-fixed paraffin tissues by
   fluorescent direct in situ polymerase chain reaction
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE EBV; lymph node; salivary glands; in situ hybridization; in situ PCR;
   quantitative PCR
ID MAEDI-VISNA VIRUS; INFECTION; PCR; EBV; HYBRIDIZATION; ASSOCIATION;
   CARCINOMAS; HEPATITIS; SECTIONS
AB Specific viral laboratory diagnosis of primary Epstein-Barr Virus (EBV) infection is usually based on antibody-detection assays. However, molecular detection is also considered the reference standard assay for diagnosis of central nervous system infections and of most cases of nasopharyngeal carcinoma (NPC). One-step or nested polymerase chain reaction (PCR) has rapidly replaced immunological assays based on virus-specific Ig antibodies for the laboratory diagnosis of Herpesvirus infections, even if serological methods are considered an additional tool for defining clinical diagnosis. In this article, we will present a rapid, sensitive and robust molecular tool for the viral detection of EBV (EBNA-1) within tissue specimens by making use of in situ PCR (IS-PCR).
C1 IRCCS, Policlin S Matteo, Mol Diagnost Cardiovasc & Transplant Pathol Lab, Transplant Res Area, I-27100 Pavia, Italy.
   Pediat Hosp Bambino Gesu, Serv Microbiol & Virol, Rome, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
RP Marziliano, N (corresponding author), IRCCS, Policlin S Matteo, Mol Diagnost Cardiovasc & Transplant Pathol Lab, Transplant Res Area, Piazzale Golgi 1, I-27100 Pavia, Italy.
EM n.marziliano@smatteo.pv.it
RI Crovella, Sergio/K-5050-2016; Arbustini, Eloisa/K-8174-2016
OI Crovella, Sergio/0000-0001-8493-1168; Arbustini,
   Eloisa/0000-0003-2948-7994
CR Barkholt L, 1998, TRANSPLANT INT, V11, P336, DOI 10.1007/s001470050155
   Benkoel L, 2004, EUR J HISTOCHEM, V48, P185
   Chang FJ, 2000, ANTICANCER RES, V20, P3935
   Fares F, 1998, J VIROL METHODS, V71, P211, DOI 10.1016/S0166-0934(98)00002-0
   Kobayashi R, 1998, ARCH VIROL, V143, P803, DOI 10.1007/s007050050332
   KOFFA M, 1995, INT J CANCER, V63, P58, DOI 10.1002/ijc.2910630112
   Mancuso T, 1997, INT J ONCOL, V11, P527
   Preziuso S, 2003, EUR J HISTOCHEM, V47, P373
   Preziuso S, 2003, EUR J HISTOCHEM, V47, P151
   Takeuchi H, 1997, ARCH VIROL, V142, P1743, DOI 10.1007/s007050050194
   Temple GK, 2004, GENE CHROMOSOME CANC, V41, P405, DOI 10.1002/gcc.20091
NR 11
TC 3
Z9 3
U1 0
U2 0
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PD JUL-SEP
PY 2005
VL 49
IS 3
BP 309
EP 312
PG 4
WC Cell Biology
SC Cell Biology
GA 018WP
UT WOS:000235795800009
PM 16216817
DA 2020-12-08
ER

PT J
AU Mladinic, M
   Wintzer, M
   Del Bel, E
   Casseler, C
   Lazarevic, D
   Crovella, S
   Gustincich, S
   Cattaneo, A
   Nicholls, J
AF Mladinic, M
   Wintzer, M
   Del Bel, E
   Casseler, C
   Lazarevic, D
   Crovella, S
   Gustincich, S
   Cattaneo, A
   Nicholls, J
TI Differential expression of genes at stages when regeneration can and
   cannot occur after injury to immature mammalian spinal cord
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE spinal cord injury; trophic molecules; inhibitory molecules; gene
   expression; Monodelphis domestica; development; opossum
ID MYELIN BASIC-PROTEIN; MONODELPHIS-DOMESTICA; IDENTIFYING GENES; NEWBORN
   OPOSSUM; SCHWANN-CELLS; RECOVERY; REPAIR; BRAIN; GROWTH; TISSUE
AB 1. Comprehensive screens were made for genes that change their expression during a brief critical period in development when neonatal mammalian central nervous system (CNS) loses its capacity to regenerate.
   2. In newly born opossums older than 12 days regeneration ceases to occur in the cervical spinal cord. It continues for 5 more days in lumbar regions. The mRNA's expressed in cords that do and do not regenerate were analyzed by polymerase chain reaction-based subtractive hybridization. The mRNAs extracted from cervical cords of animals aged 9 and 12 days were subtracted reciprocally, old from young and young from old.
   3. Additional subtractions were made between lumbar regions of 12 day-old cords (which can regenerate) and cervical regions (which cannot). Mini libraries of approximately 2000 opossum cDNA clones resulted from each subtraction. Many sequences were novel. Others that were expressed differentially were related to cell growth, proliferation, differentiation, motility, adhesion, cytoskeleton and extracellular matrix.
   4. A major task was to narrow the search and to eliminate genes that were not associated with regeneration. Clones from different subtractions were cross-hybridized. After those common to regenerating and nonregenerating cords were rejected, approximately 284 sequences of interest remained. Our results revealed novel sequences, as well as genes involved in transcription, cell signaling, myelin formation, growth cone motility, liver regeneration, and nucleic acid and protein management as the candidates important for neuroregeneration.
   5. For selected genes of potential interest for regeneration (for example cadherin, catenin, myelin basic protein), their temporal and spatial distributions and levels of expression in the CNS were measured by Northern blots, semiquantitative and real-time RT-PCR, and in situ hybridization.
   Our experiments set the stage for testing the efficacy of candidate genes in turning on or off the capacity for spinal cord regeneration. Opossum spinal cords in vitro provide a reliable and rapid assay for axon outgrowth and synapse formation.
C1 SISSA, Neurobiol Sector, I-34014 Trieste, Italy.
   Univ Sao Paulo, Dept Fisiol, BR-14049 Ribeirao Preto, Brazil.
   Childrnes Hosp Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   Karolinska Inst, Dept Neurosci, Stockholm, Sweden.
RP Nicholls, J (corresponding author), SISSA, Neurobiol Sector, I-34014 Trieste, Italy.
EM nicholls@sissa.it
RI Pejatovic, Miranda/V-3554-2019; Del Bel, Elaine A/E-2308-2012; Cattaneo,
   Antonino/AAA-7252-2019; Crovella, Sergio/K-5050-2016; Lazarevic,
   Dejan/AAN-1861-2020; CATTANEO, ANTONINO/K-4471-2016; Del Bel,
   Elaine/E-2308-2012
OI Del Bel, Elaine A/0000-0002-4158-7376; Crovella,
   Sergio/0000-0001-8493-1168; CATTANEO, ANTONINO/0000-0002-6975-8923;
   lazarevic, dejan/0000-0003-4527-290X; Del Bel,
   Elaine/0000-0003-3483-8074
CR Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x
   Bregman BS, 2002, PROG BRAIN RES, V137, P257
   Calegari F, 2004, DIFFERENTIATION, V72, P92, DOI 10.1111/j.1432-0436.2004.07202002.x
   Del-Bel EA, 2002, NEUROSCI LETT, V332, P123, DOI 10.1016/S0304-3940(02)00933-3
   Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025
   DiCicco-Bloom E, 2004, DEV BIOL, V271, P161, DOI 10.1016/j.ydbio.2004.03.028
   Fernandez J, 1998, J COMP NEUROL, V396, P338
   Fox MA, 2003, MOL CELL NEUROSCI, V23, P507, DOI 10.1016/S1044-7431(03)00073-3
   Hatoko M, 2001, ANN PLAS SURG, V47, P322, DOI 10.1097/00000637-200109000-00017
   Ito J, 2001, EXP NEUROL, V169, P30, DOI 10.1006/exnr.1999.7300
   Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004
   Kawaguchi S, 2004, PROG BRAIN RES, V143, P155, DOI 10.1016/S0079-6123(03)43015-X
   Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8
   Lepre M, 1998, EUR J NEUROSCI, V10, P2500, DOI 10.1046/j.1460-9568.1998.t01-1-00263.x
   Maes T, 2002, GENOMICS, V80, P21, DOI 10.1006/geno.2002.6799
   McBride CB, 2003, MOL CELL NEUROSCI, V23, P383, DOI 10.1016/S1044-7431(03)00063-0
   MIKOSHIBA K, 1991, COMP BIOCHEM PHYS C, V98, P51
   Mladinic M, 1999, P ROY SOC B-BIOL SCI, V266, P1207, DOI 10.1098/rspb.1999.0764
   Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7
   Nicholls J., 2001, NEURON BRAIN
   NICHOLLS JG, 1990, J EXP BIOL, V152, P1
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   Properzi F, 2004, NEWS PHYSIOL SCI, V19, P33, DOI 10.1152/nips.01449.2003
   SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060
   Sambrook J., 2001, MOL CLONING LAB MANU
   Saunders NR, 1998, J NEUROSCI, V18, P339
   SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146
   Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004
   Shibuya Y, 1996, J NEUROCYTOL, V25, P615, DOI 10.1007/BF02284828
   Terman JR, 2000, BRAIN RES BULL, V53, P845, DOI 10.1016/S0361-9230(00)00431-7
   VARGA ZM, 1995, EUR J NEUROSCI, V7, P2119, DOI 10.1111/j.1460-9568.1995.tb00634.x
   VONBERNHARDI R, 1995, J NEUROBIOL, V27, P353, DOI 10.1002/neu.480270308
   Wintzer M, 2004, J ANAT, V204, P3, DOI 10.1111/j.1469-7580.2004.00258.x
   YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N
NR 34
TC 14
Z9 15
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD APR
PY 2005
VL 25
IS 2
BP 407
EP 426
DI 10.1007/s10571-005-3150-z
PG 20
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 927SO
UT WOS:000229221000012
PM 16047549
DA 2020-12-08
ER

PT J
AU Crovella, S
   Bernardon, M
   Braida, L
   Boniotto, M
   Guaschino, S
   Ferrazzi, E
   Martinelli, P
AF Crovella, S
   Bernardon, M
   Braida, L
   Boniotto, M
   Guaschino, S
   Ferrazzi, E
   Martinelli, P
CA Italian Grp SIGO HIV Obstet Gyneco
TI Italian multicentric pilot study on MBL2 genetic polymorphisms in HIV
   positive pregnant women and their children
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE HIV; pregnancy; genetic polymorphisms; beta defensins; MBL2; innate
   immunity
ID VERTICAL TRANSMISSION; AIDS PROGRESSION; INFECTION
AB Objective. We investigated genetic polymorphisms of MBL2 gene, in a cohort of 90 italian HIV-1 pregnant seropositive women and their children in order to understand whether the MBL2 genotype of HIV-1 positive mothers might be related to their ability to transmit the virus to their children.
   Materials and methods. DNA was extracted from Iso Code Stix cards, and MBL2 genoptyping was performed by Melting Temperature Assay.
   Results. The frequency of the MBL2 0/0 homozygotes was higher in HIV-1 positive mothers than in healthy controls, the MBL2 0/0 genotype was more frequent in children born from HIV positive mothers than healthy subjects.
   Conclusions. We have confirmed the association of polymorphisms involving a gene of the innate immunity with an increased risk of being infected by HIV. These polymorphisms were also evidenced in children born from HIV + mothers, but the risk of infection was strongly reduced by cesarean delivery and by antiretroviral treatment.
C1 Children Hosp Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   Univ Trieste, Dept Dev & Reprod Sci, Genet Unit, I-34127 Trieste, Italy.
   Children Hosp Burlo Garofolo, Gynecol & Obstet Serv, Trieste, Italy.
   Univ Trieste, Dept Dev & Reprod Sci, Gynecol Unit, I-34127 Trieste, Italy.
   Luigi Sacco Hosp, Dept Obstet & Gynecol, Milan, Italy.
   Federico II Univ Hosp, Dept Obstet & Gynecol, Naples, Italy.
RP Crovella, S (corresponding author), Children Hosp Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; Boniotto, Michele/AAB-4302-2020;
   Crovella, Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; Bernardon, Maria/0000-0002-6250-0807
CR Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Thorne C, 2001, AIDS, V15, P761, DOI 10.1097/00002030-200104130-00012
   Turner M W, 2000, Rev Immunogenet, V2, P305
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
NR 8
TC 5
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1476-7058
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD APR
PY 2005
VL 17
IS 4
BP 253
EP 256
DI 10.1080/14767050500072599
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 947SP
UT WOS:000230667000003
PM 16152689
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Braida, L
   Baldas, V
   Not, T
   Ventura, A
   Vatta, S
   Radillo, O
   Tedesco, F
   Percopo, S
   Montico, M
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Braida, L
   Baldas, V
   Not, T
   Ventura, A
   Vatta, S
   Radillo, O
   Tedesco, F
   Percopo, S
   Montico, M
   Amoroso, A
   Crovella, S
TI Evidence of a correlation between mannose binding lectin and celiac
   disease: a model for other autoimmune diseases
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Article
DE celiac disease; mannose binding lectin; polymorphisms; autoimmunity;
   apoptosis
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; TISSUE TRANSGLUTAMINASE;
   RHEUMATOID-ARTHRITIS; POLYMORPHISMS; GENE; ALLELES; CELLS; HLA;
   SUSCEPTIBILITY; ASSOCIATION
AB Celiac disease is a multifactorial disorder caused, in genetically susceptible patients, by the ingestion of dietary gluten. Very little is known about the genetic factors, but there is a strong association of two HLA haplotypes (DQ2 or alpha 1*05, beta 1*02 and DQ8 or alpha 1*0301, beta 1*0302) with the disease. We investigated the relationship between polymorphisms in the first exon of the MBL2 gene, which encodes for mannose binding lectin (MBL) and celiac disease. Moreover we studied the MBL role by immunohistochemistry and TUNEL. Results were confirmed by clinical findings. We enrolled 149 Italian celiac patients; 116 were characterized by the presence of DQ2 or DQ8. The HLA haplotype was established by allelic specific PCR while the MBL2 genotype was resolved by melting temperature assay. Immunohistochemistry and TUNEL assays were performed on serial sections of biopsy specimens from celiac patients and healthy controls. MBL2 allele and genotype frequencies varied significantly between celiac patients and healthy controls. The frequencies of the 0 allele were 28% in DQ2 or DQ8 celiac patients, 36% in HLA atypical celiac patients, and 22% in healthy controls. Interestingly, the MBL2 0/0 genotype was present in 7 of 33 HLA atypical celiac patients (21%) and in 13 of 116 HLA typical celiac patients (13%) but in only 7 of 147 healthy controls (5%). Furthermore, we found that MBL2 genotype is strongly associated with the occurrence of secondary autoimmune diseases. Immunohistochemistry and TUNEL findings support a role of MBL2 in the clearance of apoptotic cells. In conclusion, MBL2 variants, responsible for lower MBL levels, are associated with celiac disease and higher risk of developing autoimmune diseases. Here we propose a role for MBL in the disease which could be easily applied to other autoimmune disorders.
C1 Children Hosp Burlo Garofolo, Genet Serv, I-34100 Trieste, Italy.
   Univ Trieste, Dept Sci Reprod & Dev, Genet Unit, I-34100 Trieste, Italy.
   Univ Triestand, Children Hosp Burlo Garofolo, Dept Sci Reprod & Dev, Pediat Unit, I-34100 Trieste, Italy.
   Children Hosp Burlo Garofolo, Clin Anal Lab, I-34100 Trieste, Italy.
   Univ Trieste, Dept Physiol & Pathol, I-34100 Trieste, Italy.
   Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy.
   Children Hosp Burlo Garofolo, Epidemiol Unit, I-34100 Trieste, Italy.
RP Crovella, S (corresponding author), Children Hosp Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34100 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; Montico, Marcella/B-5290-2013; Not,
   Tarcisio/K-2616-2018; Boniotto, Michele/AAB-4302-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Tedesco, Francesco/F-1929-2011; amoroso,
   antonio/AAL-1475-2020; Crovella, Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Montico,
   Marcella/0000-0003-0377-8232; Not, Tarcisio/0000-0003-1059-3009;
   amoroso, antonio/0000-0002-9437-9407; Crovella,
   Sergio/0000-0001-8493-1168; Ventura, Alessandro/0000-0002-4657-1760
CR Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603
   Bolognesi E, 2003, TISSUE ANTIGENS, V61, P308, DOI 10.1034/j.1399-0039.2003.00028.x
   Boniotto M, 2003, EUR J HISTOCHEM, V47, P177
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200
   Ciccocioppo R, 2001, AM J CLIN PATHOL, V115, P494
   Crosdale DJ, 2000, EUR J IMMUNOGENET, V27, P111, DOI 10.1046/j.1365-2370.2000.00211.x
   Dieterich W, 2003, INT ARCH ALLERGY IMM, V132, P98, DOI 10.1159/000073710
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954
   Huang YF, 2003, EUR J IMMUNOGENET, V30, P121, DOI 10.1046/j.1365-2370.2003.00370.x
   Iltanen S, 2003, AM J GASTROENTEROL, V98, P2808
   Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.0.CO;2-D
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2
   KELLY J, 1987, J IMMUNOL METHODS, V96, P127, DOI 10.1016/0022-1759(87)90376-0
   Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200
   Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x
   Louka AS, 2003, HUM IMMUNOL, V64, P350, DOI 10.1016/S0198-8859(02)00822-4
   Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2
   Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888
   Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781
   Rector A, 2001, GENES IMMUN, V2, P323, DOI 10.1038/sj.gene.6363784
   Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957
   TOPIC E, 1991, EUR J CLIN CHEM CLIN, V29, P327
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Turner M W, 2000, Rev Immunogenet, V2, P305
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
   Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x
NR 32
TC 39
Z9 40
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0946-2716
EI 1432-1440
J9 J MOL MED
JI J. Mol. Med.
PD APR
PY 2005
VL 83
IS 4
BP 308
EP 315
DI 10.1007/s00109-004-0623-3
PG 8
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 919SS
UT WOS:000228638500008
PM 15645196
DA 2020-12-08
ER

PT J
AU Crovella, S
   Antcheva, N
   Zelezetsky, I
   Boniotto, M
   Pacor, S
   Falzacappa, MVV
   Tossi, A
AF Crovella, S
   Antcheva, N
   Zelezetsky, I
   Boniotto, M
   Pacor, S
   Falzacappa, MVV
   Tossi, A
TI Primate beta-defensins - Structure, function and evolution
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE beta-defensin; antimicrobial peptide; host defense; innate immunity;
   molecular evolution
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HELICAL ANTIMICROBIAL PEPTIDES; HUMAN
   BETA-DEFENSIN-1; INNATE IMMUNITY; MAST-CELLS; ANTIBACTERIAL ACTIVITIES;
   MAMMALIAN DEFENSINS; ADAPTIVE IMMUNITY; ATOPIC-DERMATITIS;
   ALPHA-DEFENSINS
AB Host defense peptides (HDPs) are endogenous antibiotics that play a multifunctional role in the innate immunity of mammals. Among these, beta-defensins contribute to mucosal and epithelial defense, also acting as signal molecules for cellular components of innate and adaptive immunity. Numerous members of this family have been identified in mammalian and avian species, and genomic studies in human and mouse indicate a considerable complexity in their gene organization. Recent reports on the evolution of primate and rodent members of this family indicate quite a complex pattern of variation. In this review we briefly discuss the evolution of mammalian beta-defensins in relation to other types of defensins, and then concentrate on the evolution of beta-defensins 1 to 4 in primates. In particular, the surprisingly varied patterns of evolution, which range from neutral or weakly purifying, to positive selection to a high level of conservation are analyzed in terms of possible genetics, structural or functional implications, as well as to observed variations on the antimicrobial activity in vitro. The role of polymorphisms in the genes encoding for these host defense peptides in determining susceptibility to human diseases are also briefly considered.
C1 Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   Univ Trieste, Dept Biomed Sci, I-34127 Trieste, Italy.
RP Tossi, A (corresponding author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, Via Giorgieri 1, I-34127 Trieste, Italy.
EM tossi@bbcm.units.it
RI Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; Tossi,
   Alessandro/U-2474-2017; Tossi, Alessandro/ABC-9061-2020; BONIOTTO,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; Tossi,
   Alessandro/0000-0001-9087-5764; PACOR, SABRINA/0000-0001-8043-6725;
   BONIOTTO, Michele/0000-0002-9548-2254
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   AMICHE M, 1994, J BIOL CHEM, V269, P17847
   Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004
   Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401
   Befus AD, 1999, J IMMUNOL, V163, P947
   BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   Bevins CL, 1996, GENOMICS, V31, P95, DOI 10.1006/geno.1996.0014
   Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565
   Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   BONIOTTO M, IN PRESS GENETIC TES
   BRAIDA L, IN PRESS AIDS
   Carbone L, 2002, CHROMOSOMA, V111, P267, DOI 10.1007/s00412-002-0205-5
   Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808
   Cole AM, 2003, CURR PHARM DESIGN, V9, P1463, DOI 10.2174/1381612033454667
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008
   Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje
   Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
   Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4
   Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355
   Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   Harris RH, 2004, J BIOL CHEM, V279, P20250, DOI 10.1074/jbc.M400499200
   HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2
   Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157
   Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200
   Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200
   Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003
   Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200
   Hughes AL, 1997, J MOL EVOL, V44, P675, DOI 10.1007/PL00006191
   Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   Huttner KM, 1998, GENE, V206, P85, DOI 10.1016/S0378-1119(97)00569-6
   Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200
   Jia HP, 2001, GENE, V263, P211
   Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779
   Kao CY, 2003, AM J RESP CELL MOL, V29, P71, DOI 10.1165/rcmb.2002-0205OC
   KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0
   LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13
   Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461
   LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0
   Linzmeier R, 1999, GENE, V233, P205, DOI 10.1016/S0378-1119(99)00136-5
   Liu LD, 1997, GENOMICS, V43, P316, DOI 10.1006/geno.1997.4801
   Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3
   Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x
   Matsushita I, 2002, BIOCHEM BIOPH RES CO, V291, P17, DOI 10.1006/bbrc.2002.6395
   Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p
   Maxwell AI, 2003, MOL IMMUNOL, V40, P413, DOI 10.1016/S0161-5890(03)00160-3
   Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002
   Morrison GM, 2003, MOL BIOL EVOL, V20, P460, DOI 10.1093/molbev/msg060
   Morrison GM, 2002, MAMM GENOME, V13, P445, DOI 10.1007/s00335-002-3014-5
   Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002
   Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Nes IF, 2000, BIOPOLYMERS, V55, P50, DOI 10.1002/1097-0282(2000)55:1<50::AID-BIP50>3.0.CO;2-3
   Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023
   Nicastro G, 2003, EUR J BIOCHEM, V270, P1969, DOI 10.1046/j.1432-1033.2003.03563.x
   Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017
   Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x
   Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421
   Niyonsaba F, 2001, EUR J IMMUNOL, V31, P1066, DOI 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#
   Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262
   Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   OUELLETTE AJ, 1989, GENOMICS, V5, P233, DOI 10.1016/0888-7543(89)90051-7
   Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
   Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003
   Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520
   Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31
   SIMMACO M, 1994, J BIOL CHEM, V269, P11956
   Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931
   Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498
   Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045
   Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200
   Thouzeau C, 2003, J BIOL CHEM, V278, P51053, DOI 10.1074/jbc.M306839200
   Tossi A, 1997, EUR J BIOCHEM, V250, P549, DOI 10.1111/j.1432-1033.1997.0549a.x
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475
   Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x
   Vatta S, 2000, Hum Mutat, V15, P582
   Ventura M, 2004, EUR J HISTOCHEM, V48, P195
   Vouille V, 1997, FEBS LETT, V414, P27, DOI 10.1016/S0014-5793(97)00972-1
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
   Zhao CQ, 2001, INFECT IMMUN, V69, P2684, DOI 10.1128/IAI.69.4.2684-2691.2001
   ZIMMERMANN GR, 1995, BIOCHEMISTRY-US, V34, P13663, DOI 10.1021/bi00041a048
   Zucht H D, 1998, Eur J Med Res, V3, P315
NR 102
TC 46
Z9 56
U1 0
U2 14
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD FEB
PY 2005
VL 6
IS 1
BP 7
EP 21
DI 10.2174/1389203053027593
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 893KT
UT WOS:000226718500003
PM 15638765
DA 2020-12-08
ER

PT J
AU Pennesi, M
   Marchetti, F
   Crovella, S
   Boaretto, F
   Travan, L
   Lazzerini, M
   Neri, E
   Ventura, A
AF Pennesi, M
   Marchetti, F
   Crovella, S
   Boaretto, F
   Travan, L
   Lazzerini, M
   Neri, E
   Ventura, A
TI A new mutation in two siblings with cystinosis presenting with Bartter
   syndrome
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE nephropathic cystinosis; Bartter syndrome; renal failure; genetic
   evaluation
ID NEPHROPATHIC CYSTINOSIS; GENE CTNS; DELETION
AB Nephropathic cystinosis is a severe autosomal recessive inherited metabolic disease characterized by accumulation of free cystine in lysosomes. Cystinosis can lead to renal failure and multiorgan impairment. Only five cases of cystinosis with associated Bartter syndrome are reported in the literature, and no genetic evaluation has been reported. We describe two siblings with nephropathic cystinosis presenting with features of Bartter syndrome and their genetic pattern.
C1 Univ Trieste, IRCCS Burlo Garofolo, Dept Pediat, Pediat Clin, Trieste, Italy.
   Univ Trieste, Dept Child Hlth & Human Dev, Dept Genet, Trieste, Italy.
RP Pennesi, M (corresponding author), Univ Trieste, IRCCS Burlo Garofolo, Dept Pediat, Pediat Clin, Via Istria 65-1, Trieste, Italy.
EM pennesi@burlo.trieste.it
RI boaretto, francesca/K-9811-2016; Crovella, Sergio/K-5050-2016
OI boaretto, francesca/0000-0003-2015-929X; Crovella,
   Sergio/0000-0001-8493-1168; Pennesi, Marco/0000-0001-5207-6232; Laura,
   Travan/0000-0001-9861-0832; Marchetti, Federico/0000-0002-1257-7312;
   Ventura, Alessandro/0000-0002-4657-1760
CR Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790
   BERIO A, 1978, MINERVA PEDIATR, V30, P1825
   Broyer M, 1997, Rev Prat, V47, P1550
   Forestier L, 1999, AM J HUM GENET, V65, P353, DOI 10.1086/302509
   Gahl W A, 1997, Pediatr Rev, V18, P302, DOI 10.1542/pir.18-9-302
   Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552
   LEBEL M, 1977, SYNDROME BARTTER ASS, P5
   LEMIRE J, 1984, AM J NEPHROL, V4, P81, DOI 10.1159/000166782
   MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246
   O'Regan S, 1980, ACTA PEDIAT BELG, V44, P638
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shaer AJ, 2001, AM J MED SCI, V322, P316, DOI 10.1097/00000441-200112000-00004
   Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165
   Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319
   Van't Hoff WG, 2000, ARCH DIS CHILD, V83, P189, DOI 10.1136/adc.83.3.189
   WHYTE MP, 1985, CLIN PEDIATR, V24, P447, DOI 10.1177/000992288502400806
NR 16
TC 13
Z9 13
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0931-041X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD FEB
PY 2005
VL 20
IS 2
BP 217
EP 219
DI 10.1007/s00467-004-1702-y
PG 3
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA 891AT
UT WOS:000226554400019
PM 15583946
DA 2020-12-08
ER

PT J
AU Pellis, V
   De Seta, F
   Crovella, S
   Bossi, F
   Bulla, R
   Guaschino, S
   Radillo, O
   Garred, P
   Tedesco, F
AF Pellis, V
   De Seta, F
   Crovella, S
   Bossi, F
   Bulla, R
   Guaschino, S
   Radillo, O
   Garred, P
   Tedesco, F
TI Mannose binding lectin and C3 act as recognition molecules for
   infectious agents in the vagina
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE Candida albicans; clue cells; C1q; MBL; C3
ID MUCOSAL IMMUNE-SYSTEM; CANDIDA-ALBICANS; ACTIVATION; ALLELES
AB In our study we examined the early complement components in patients with bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and in healthy controls. The levels of C1q, mannose-binding lectin (MBL) and C3 were measured by ELISA in the cervicovaginal lavage (CVL) from gynaecological patients and controls. No significant differences were observed in the levels of these proteins in the three study groups. Immunofluorescence analysis of the clue cells and Candida hyphae from BV and VVC patients for surface-bound complement components showed the presence of C3, while C1q was undetectable. MBL was revealed on clue cells but not on Candida. Binding of MBL to Candida, grown or cytocentrifuged from the CVL of VVC patients, was found to be pH dependent and occurred between pH 4.5 and pH 5.5. In conclusion, we demonstrated that MBL and C3 present in the vaginal cavity act as recognition molecules for infectious agents that colonize the cervicovaginal mucosa. Our finding that MBL, but not C1q, binds to bacteria and fungi in vagina suggests that the lectin and classical pathways of complement activation may play a different role in immune defence in the female genital tract.
C1 Univ Trieste, Dept Physiol & Pathol, Trieste, Italy.
   Univ Trieste, Dept Obstet & Gynaecol, IRCCS, Trieste, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
   Rigshosp, Dept Clin Immunol, Tissue Typing Lab, DK-2100 Copenhagen, Denmark.
RP Tedesco, F (corresponding author), Univ Trieste, Dept Physiol & Pathol, Via Fleming 22, Trieste, Italy.
EM tedesco@units.it
RI Bulla, Roberta/F-9957-2015; Crovella, Sergio/K-5050-2016; Tedesco,
   Francesco/F-1929-2011
OI Bulla, Roberta/0000-0003-1737-5776; Crovella,
   Sergio/0000-0001-8493-1168; De Seta, Francesco/0000-0003-1611-0813;
   Garred, Peter/0000-0002-2876-8586
CR AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9
   Babula O, 2003, CLIN INFECT DIS, V37, P733, DOI 10.1086/377234
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003
   Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505
   EDWARDS JE, 1986, J IMMUNOL, V137, P3577
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   HEIDENREICH F, 1985, INFECT IMMUN, V50, P598, DOI 10.1128/IAI.50.2.598-600.1985
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x
   Kozel TR, 1996, CLIN MICROBIOL REV, V9, P34, DOI 10.1128/CMR.9.1.34
   KOZEL TR, 1987, INFECT IMMUN, V55, P1890, DOI 10.1128/IAI.55.8.1890-1894.1987
   Langeggen H, 2000, CLIN EXP IMMUNOL, V121, P69, DOI 10.1046/j.1365-2249.2000.01238.x
   Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200
   Mestecky J, 1999, J INFECT DIS, V179, pS470, DOI 10.1086/314806
   POULAIN D, 1978, ANN INST PASTEUR MIC, VA129, P141
   Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999
   SAMBOROK J, 1989, MOL CLONING LAB MANU
   TEDESCO F, 1990, J CLIN INVEST, V86, P884, DOI 10.1172/JCI114789
   Volanakis J.E., 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3
   1979, MORB MORTAL WKLY REP, V28, P61
NR 21
TC 47
Z9 50
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD JAN
PY 2005
VL 139
IS 1
BP 120
EP 126
DI 10.1111/j.1365-2249.2005.02660.x
PG 7
WC Immunology
SC Immunology
GA 879YF
UT WOS:000225754600016
PM 15606621
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Ventura, M
   Boniotto, M
   Montemurro, G
   Segat, L
   Marziliano, N
   Crovella, S
AF Ventura, M
   Boniotto, M
   Montemurro, G
   Segat, L
   Marziliano, N
   Crovella, S
TI Comparative localization of the mannose-binding lectin-2 (MBL2)gene in
   non-human primates
SO CYTOGENETIC AND GENOME RESEARCH
LA English
DT Article
C1 Univ Trieste, Reprod & Dev Sci Dept, IT-34137 Trieste, Italy.
   Univ Bari, DAPEG Genet Sect, Bari, Italy.
   Childrens Hosp Burlo Garofolo, Genet Serv, Trieste, Italy.
   Cardiovasc & Transplant Pathol Lab, Transplant Res Area, Pavia, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Reprod & Dev Sci Dept, Via Istria 65-1, IT-34137 Trieste, Italy.
EM crovella@burio.trieste.it
RI Ventura, Mario/E-6420-2011; Boniotto, Michele/AAB-4302-2020; Crovella,
   Sergio/K-5050-2016; BONIOTTO, Michele/F-1857-2010
OI Ventura, Mario/0000-0001-7762-8777; Crovella,
   Sergio/0000-0001-8493-1168; BONIOTTO, Michele/0000-0002-9548-2254;
   Segat, Ludovica/0000-0002-6024-1485
CR Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379
   Falzacappa MVV, 2004, GENES IMMUN, V5, P653, DOI 10.1038/sj.gene.6364140
   Kilpatrick DC, 2002, TRANSFUSION MED, V12, P335, DOI 10.1046/j.1365-3148.2002.00408.x
   LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
NR 5
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1424-8581
EI 1424-859X
J9 CYTOGENET GENOME RES
JI Cytogenet. Genome Res.
PY 2005
VL 111
IS 2
BP 186A
EP U5
DI 10.1159/000086392
PG 2
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 962JU
UT WOS:000231728500017
DA 2020-12-08
ER

PT J
AU Falzacappa, MVV
   Segat, L
   Puppini, B
   Amoroso, A
   Crovella, S
AF Falzacappa, MVV
   Segat, L
   Puppini, B
   Amoroso, A
   Crovella, S
TI Evolution of the mannose-binding lectin gene in primates
SO GENES AND IMMUNITY
LA English
DT Article
DE MBL2; innate immunity; primates evolution; nucleotide and amino-acid
   sequences; sequence alignment and comparison
ID PROTEIN; SERUM; POLYMORPHISMS; SEQUENCE; SUSCEPTIBILITY; ACTIVATION;
   MUTATIONS; INFECTION; SELECTION; REVEALS
AB The mannose-binding lectin MBL2 plays an important role in the innate immune system. It binds carbohydrates surface, acts as an opsonin and activates the complement system. With the aim of studying the evolution of the MBL2 gene in primates, we sequenced its coding region in 12 non-human primate species and compared them with the human sequence. We demonstrated that nucleotide and amino-acidic sequences of the MBL2 among primates are highly homologous, underlining the importance of this molecule in the defense system against pathogen invasions. In particular, in the collagen-like domain that confers the characteristic structure to MBL2 protein, the identity among primates is really high. In the carbohydrate recognition domain, we evidenced some primates' group-specific amino-acidic mutations not resulting in changes of the structure or function of this MBL2 domain. Phylogenetic analysis did not evidence any positive selective pressure in MBL2 gene among non-human primates. Our findings indicate that MBL2 is well conserved in agreement with its important role in the immune system: in non-human primates, we did not observe the same 'plasticity' of the MBL2 human gene, where a frequency of more than 1% of nucleotide variations was described in the coding and promoter regions.
C1 Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany.
   Univ Trieste, Dept Reprod & Dev Sci, Genet Sect, Trieste, Italy.
   Childrens Hosp Burlo Garofolo, Genet Serv, Trieste, Italy.
RP Falzacappa, MVV (corresponding author), Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, Neuenheimer Feld 156, D-69120 Heidelberg, Germany.
EM MaVi.Verga-Falzacappa@med.uni-heidelberg.de
RI Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Segat, Ludovica/0000-0002-6024-1485
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044
   GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4
   GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x
   Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100
   Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147
   HOLMSKOV U, 1993, GLYCOBIOLOGY, V3, P147, DOI 10.1093/glycob/3.2.147
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0
   Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316
   KOZUTSUMI Y, 1980, BIOCHEM BIOPH RES CO, V95, P658, DOI 10.1016/0006-291X(80)90836-0
   KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   KURATA H, 1994, J BIOCHEM-TOKYO, V115, P1148, DOI 10.1093/oxfordjournals.jbchem.a124471
   Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200
   Laursen SB, 1998, IMMUNOLOGY, V93, P421, DOI 10.1046/j.1365-2567.1998.00446.x
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Nair SV, 2000, COMP BIOCHEM PHYS B, V125, P279, DOI 10.1016/S0305-0491(99)00180-7
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   OKA S, 1988, ARCH BIOCHEM BIOPHYS, V260, P257, DOI 10.1016/0003-9861(88)90448-1
   Petersen SV, 2001, MOL IMMUNOL, V38, P133
   SASTRY K, 1991, J IMMUNOL, V147, P692
   Storgaard P, 1996, SCAND J IMMUNOL, V43, P289, DOI 10.1046/j.1365-3083.1996.d01-39.x
   Turner M W, 2000, Rev Immunogenet, V2, P305
   Vitved L, 2000, IMMUNOGENETICS, V51, P955, DOI 10.1007/s002510000232
   Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200
NR 33
TC 14
Z9 22
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
J9 GENES IMMUN
JI Genes Immun.
PD DEC
PY 2004
VL 5
IS 8
BP 653
EP 661
DI 10.1038/sj.gene.6364140
PG 9
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 875JD
UT WOS:000225415400008
PM 15483660
OA Bronze
DA 2020-12-08
ER

PT J
AU Badolato, R
   Fontana, S
   Barcella, L
   Moratto, D
   D'ippolito, C
   Crovella, S
   Notarangelo, LD
   Duse, M
AF Badolato, R
   Fontana, S
   Barcella, L
   Moratto, D
   D'ippolito, C
   Crovella, S
   Notarangelo, LD
   Duse, M
TI Toll-like receptor-4 genotype in children with respiratory infections
SO ALLERGY
LA English
DT Editorial Material
DE pneumonia; toll-like receptors; mannose; polymorphism; children
ID MUTATIONS
C1 Univ Brescia, Spedali Civili, Dept Pediat, I-25125 Brescia, Italy.
RP Badolato, R (corresponding author), Univ Brescia, Spedali Civili, Dept Pediat, I-25125 Brescia, Italy.
EM badolato@med.unibs.it
RI Badolato, Raffaele/A-8081-2010; Crovella, Sergio/K-5050-2016;
   Notarangelo, Luigi D/F-9718-2016
OI Badolato, Raffaele/0000-0001-7375-5410; Crovella,
   Sergio/0000-0001-8493-1168; Notarangelo, Luigi D/0000-0002-8335-0262;
   Fontana, Stefania/0000-0003-0415-3410
CR Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048
   Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078
   Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673
   Seitz M, 2003, ALLERGY, V58, P1247, DOI 10.1046/j.1398-9995.2003.00225.x
NR 4
TC 4
Z9 4
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0105-4538
J9 ALLERGY
JI Allergy
PD SEP
PY 2004
VL 59
IS 9
BP 1018
EP 1019
DI 10.1111/j.1398-9995.2004.00523.x
PG 3
WC Allergy; Immunology
SC Allergy; Immunology
GA 843DX
UT WOS:000223057200025
PM 15291919
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Ventura, M
   Eskdale, J
   Crovella, S
   Gallagher, G
AF Boniotto, M
   Ventura, M
   Eskdale, J
   Crovella, S
   Gallagher, G
TI Evidence for duplication of the human defensin gene DEFB4 in chromosomal
   region 8p22-23 and implications for the analysis of SNP allele
   distribution
SO GENETIC TESTING
LA English
DT Article
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1; ANTIMICROBIAL
   PEPTIDES; DISCOVERY
AB Defensins constitute a primary mechanism in the innate immune system of humans and all mammals. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. In humans, four beta-defensins have been described so far, corresponding to the products of the genes DEFB1 (hBD1, NM_005218), DEFB4 (hBD2, NM_004942.2), DEFB103 (hBD3, NM_018661), and DEFB104 (hBD4, NM_080389), respectively. All these genes have been mapped to chromosome 8p22-23. Much interest has been shown in genetic variation in the population at defensin loci to understand individual differences in disease susceptibility and severity. In this study, we have used an electronic search and then fluorescence in situ hybridization (FISH) on elongated chromosomes to demonstrate that the region containing the DEFB4 gene is duplicated on human chromosome 8p, making difficult the discovery of new SNPs in this gene and compromising the assessment of their allelic distribution in various ethnic populations for disease association studies.
C1 Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Oral Biol, Newark, NJ 07103 USA.
   Univ Bari, DAPEG, Genet Sect, I-70126 Bari, Italy.
   Univ Trieste, Reprod & Dev Sci Dept, I-34137 Trieste, Italy.
RP Gallagher, G (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Oral Biol, 185 S Orange Ave, Newark, NJ 07103 USA.
EM gallaggr@umdnj.edu
RI Boniotto, Michele/AAB-4302-2020; Crovella, Sergio/K-5050-2016; Ventura,
   Mario/E-6420-2011; Boniotto, Michele/F-1857-2010; Gallagher,
   Grant/AAL-7952-2020
OI Crovella, Sergio/0000-0001-8493-1168; Ventura,
   Mario/0000-0001-7762-8777; Boniotto, Michele/0000-0002-9548-2254; 
CR Fellermann K, 2003, NEW ENGL J MED, V348, P361
   Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4
   IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030
   Jia HP, 2001, GENE, V263, P211
   Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Mars WM, 1995, J BIOL CHEM, V270, P30371, DOI 10.1074/jbc.270.51.30371
   Matsushita I, 2002, BIOCHEM BIOPH RES CO, V291, P17, DOI 10.1006/bbrc.2002.6395
   Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31
   Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931
   Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914
NR 13
TC 7
Z9 9
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1090-6576
J9 GENET TEST
JI Genet. Test.
PD FAL
PY 2004
VL 8
IS 3
BP 325
EP 327
DI 10.1089/gte.2004.8.325
PG 3
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 875QR
UT WOS:000225437300017
PM 15727258
DA 2020-12-08
ER

PT J
AU Trevisiol, C
   Brandt, TG
   Silva, GAP
   Crovella, S
   Ventura, A
AF Trevisiol, C
   Brandt, TG
   Silva, GAP
   Crovella, S
   Ventura, A
TI High prevalence of unrecognized celiac disease in an unselected hospital
   population in north-eastern Brasil (Recife, Pernambuco)
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Letter
C1 Univ Trieste, Trieste, Italy.
   Univ Fed Pernambuco, Recife, PE, Brazil.
RP Trevisiol, C (corresponding author), Univ Trieste, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Ventura,
   Alessandro/0000-0002-4657-1760
CR CATASSI C, 1995, ACTA PAEDIATR, V84, P672, DOI 10.1111/j.1651-2227.1995.tb13725.x
   de Freitas IN, 2002, J CLIN GASTROENTEROL, V34, P430, DOI 10.1097/00004836-200204000-00009
   Gandolfi L, 2000, AM J GASTROENTEROL, V95, P689, DOI 10.1111/j.1572-0241.2000.01847.x
   Guandalini S, 2000, J PEDIATR GASTR NUTR, V31, P362, DOI 10.1097/00005176-200010000-00005
   Trevisiol C, 2002, SCAND J GASTROENTERO, V37, P679, DOI 10.1080/00365520212513
NR 5
TC 5
Z9 11
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0277-2116
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD AUG
PY 2004
VL 39
IS 2
BP 214
EP 215
DI 10.1097/00005176-200408000-00022
PG 2
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA 842AF
UT WOS:000222973900021
PM 15269636
DA 2020-12-08
ER

PT J
AU Braida, L
   Boniotto, M
   Pontillo, A
   Tovo, PA
   Amoroso, A
   Crovella, S
AF Braida, L
   Boniotto, M
   Pontillo, A
   Tovo, PA
   Amoroso, A
   Crovella, S
TI A single-nucleotide polymorphism in the human beta-defensin 1 gene is
   associated with HIV-1 infection in Italian children
SO AIDS
LA English
DT Article
ID ANTIMICROBIAL PEPTIDES; INNATE; IMMUNITY
AB In this study we show a significant correlation between a single-nucleotide polymorphism in the 5'-untranslated region of the DEFB1 gene, which probably regulates the gene expression of human beta defensin 1 (hBD-1) and the risk of HIV-1 infection in an Italian paediatric population (97 HIV-1 perinatally infected children), pointing to the importance of innate immunity in HIV-1 infection.
C1 Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, I-34127 Trieste, Italy.
   Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.
   Childrens Hosp Burlo Garofolo, Genet Serv, Trieste, Italy.
   Childrens Hosp Regina Margherita, Dept Pediat, Turin, Italy.
RP Braida, L (corresponding author), Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, I-34127 Trieste, Italy.
RI Pontillo, Alessandra/AAD-4790-2019; Pontillo, Alessandra/ABC-6266-2020;
   AMOROSO, ANTONIO/AAN-3884-2020; Boniotto, Michele/F-1857-2010; Crovella,
   Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; Boniotto,
   Michele/AAB-4302-2020; Pontillo, ALESSANDRA/D-4352-2012
OI Pontillo, Alessandra/0000-0002-7883-0640; Pontillo,
   Alessandra/0000-0002-7883-0640; Boniotto, Michele/0000-0002-9548-2254;
   Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Pontillo, ALESSANDRA/0000-0002-7883-0640;
   Tovo, Pier Angelo/0000-0002-0192-3240
CR Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7
   Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0
   Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157
   Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003
   Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222
   Levy JA, 2001, TRENDS IMMUNOL, V22, P312, DOI 10.1016/S1471-4906(01)01925-1
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
NR 8
TC 111
Z9 121
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD JUL 23
PY 2004
VL 18
IS 11
BP 1598
EP 1600
DI 10.1097/01.aids.0000131363.82951.fb
PG 3
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 841MN
UT WOS:000222934500016
PM 15238780
DA 2020-12-08
ER

PT J
AU Tommasini, A
   Not, T
   Kiren, V
   Baldas, V
   Santon, D
   Trevisiol, C
   Berti, I
   Neri, E
   Gerarduzzi, T
   Bruno, I
   Lenhardt, A
   Zamuner, E
   Spano, A
   Crovella, S
   Martellossi, S
   Torre, G
   Sblattero, D
   Marzari, R
   Bradbury, A
   Tamburlini, G
   Ventura, A
AF Tommasini, A
   Not, T
   Kiren, V
   Baldas, V
   Santon, D
   Trevisiol, C
   Berti, I
   Neri, E
   Gerarduzzi, T
   Bruno, I
   Lenhardt, A
   Zamuner, E
   Spano, A
   Crovella, S
   Martellossi, S
   Torre, G
   Sblattero, D
   Marzari, R
   Bradbury, A
   Tamburlini, G
   Ventura, A
TI Mass screening for coeliac disease using antihuman transglutaminase
   antibody assay
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
ID TISSUE TRANSGLUTAMINASE; PREVALENCE; CHILDREN; ADOLESCENTS; DIAGNOSIS
AB Aims: To determine coeliac disease prevalence by an anti-transglutaminase antibody assay in a large paediatric population; to evaluate acceptance of the screening programme, dietary compliance, and long term health effects.
   Methods: Cross-sectional survey of 3188 schoolchildren ( aged 6 - 12) and prospective follow up of diagnosed cases. Main outcome measures were: prevalence of coeliac disease defined by intestinal biopsy or positivity to both human tissue transglutaminase and anti-endomysium antibodies in HLA DQ2-8 positive subjects; percentage of children whose families accepted screening; dietary compliance as defined by negativity for anti-transglutaminase antibodies; and presence of clinical or laboratory abnormalities at 24 month follow up.
   Results: The families of 3188/3665 children gave their consent (87%). Thirty biopsy proven coeliacs were identified ( prevalence 1: 106). Three other children testing positive for both coeliac related autoantibodies and HLA DQ2-8 but refusing biopsy were considered as having coeliac disease ( prevalence 1: 96). Of 33 cases, 12 had coeliac related symptoms. The 30 biopsy proven coeliacs followed a gluten-free diet. Of 28 subjects completing 18 - 24 months follow up, 20 (71.4%) were negative for anti-transglutaminase antibodies, while eight were slightly positive; symptoms resolved in all 12 symptomatic children.
   Conclusions: Prevalence of coeliac disease is high in Italian schoolchildren. Two thirds of cases were asymptomatic. Acceptance of the programme was good, as was dietary compliance. Given the high prevalence and possible complications of untreated coeliac disease, the availability of a valid screening method, and evidence of willingness to comply with dietary treatment population mass screening deserves careful consideration.
C1 Univ Trieste, Dept Reprod & Dev Scil, I-34127 Trieste, Italy.
   IRCCS Burlo Garofolo, Unit Hlth Serv Res & Int Hlth, Trieste, Italy.
   Univ Trieste, Dept Biol, I-34127 Trieste, Italy.
   Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.
RP Not, T (corresponding author), Ist Infanzia Burlo Garofolo, Pediat Clin, Via Istria 65-1, I-34100 Trieste, Italy.
EM not@burlo.trieste.it
RI Tommasini, Alberto/AAE-3882-2020; Crovella, Sergio/K-5050-2016; Not,
   Tarcisio/K-2616-2018
OI Tommasini, Alberto/0000-0002-6943-7927; Crovella,
   Sergio/0000-0001-8493-1168; Not, Tarcisio/0000-0003-1059-3009; bruno,
   irene/0000-0002-2437-6198; Ventura, Alessandro/0000-0002-4657-1760;
   Berti, Irene/0000-0001-6063-2737
FU TelethonFondazione Telethon [E.1141] Funding Source: Medline
CR Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362
   Clemente MG, 2000, GUT, V47, P520, DOI 10.1136/gut.47.4.520
   CORRAO G, 2001, LANCET, V47, P306
   DIAZ AR, 2002, PEDIATRIKA, V22, P311
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2
   Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852
   Grech V, 2002, BRIT MED J, V324, P1010, DOI 10.1136/bmj.324.7344.1010
   Greco L, 1996, ACTA PAEDIATR, V85, P25, DOI 10.1111/j.1651-2227.1996.tb14243.x
   Guidetti CS, 2001, GUT, V49, P502, DOI 10.1136/gut.49.4.502
   Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164
   Holmes GKT, 2002, DIGEST LIVER DIS, V34, P229, DOI 10.1016/S1590-8658(02)80198-0
   Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008
   Mustalahti Kirsi, 2002, Eff Clin Pract, V5, P105
   Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019
   Picarelli A, 2000, PEDIATR RES, V48, P590, DOI 10.1203/00006450-200011000-00006
   Rutz R, 2002, SWISS MED WKLY, V132, P43
   SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005
   Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253
   Trevisiol C, 2002, SCAND J GASTROENTERO, V37, P679, DOI 10.1080/00365520212513
   Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297
   Ventura A, 2001, CLIN PEDIATR, V40, P575, DOI 10.1177/000992280104001008
   Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
NR 24
TC 155
Z9 159
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD JUN 1
PY 2004
VL 89
IS 6
BP 512
EP 515
DI 10.1136/adc.2003.029603
PG 4
WC Pediatrics
SC Pediatrics
GA 823CM
UT WOS:000221587300007
PM 15155392
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Ventura, M
   Boniotto, M
   Pazienza, M
   Palumbo, V
   Cardone, MF
   Rocchi, M
   Tossi, A
   Amoroso, A
   Crovella, S
AF Ventura, M
   Boniotto, M
   Pazienza, M
   Palumbo, V
   Cardone, MF
   Rocchi, M
   Tossi, A
   Amoroso, A
   Crovella, S
TI Localization of beta-defensin genes in non human primates
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Letter
DE innate immunity; molecular evolution; FISH; homology
ID IN-SITU HYBRIDIZATION; HUMAN BETA-DEFENSIN-2; EPITHELIAL-CELLS;
   CHROMOSOMES; HOMOLOGIES; EXPRESSION; MONKEY; INFLAMMATION; GLANDS;
   PLASMA
AB Defensins are a family of host defence peptides that play an important role in the innate immunity of mammalian and avian species. In humans, four beta-defensins have been isolated so far, corresponding to the products of the genes DEFB1 (h-BD1, GenBank accession number NM_005218); DEFB4 (h-Bd2, NM_004942.2), DEFB103 (h-BD3, NM_018661); and DEFB104 (hBD4, NM_080389) mapping on chromosome 8p23.22. We have localized beta-defensin genes on metaphasic chromosomes of great apes and several non-human primate species to determine their physical mapping. Using fluorescent in situ hybridization and BAC probes containing the four beta-defensin genes, we have mapped the homologous regions to the beta-defensin genes on chromosome 8p23-p.22 in non-human primates, while no signals were detected on prosimians chromosomes.
C1 Univ Trieste, Reprod & Dev Sci Dept, I-34137 Trieste, Italy.
   Univ Bari, DAPEG Genet Sect, Bari, Italy.
   Children Hosp Burlo Garofolo, Genet Serv, Trieste, Italy.
   Univ Trieste, Dept Biochem Biophys & Chem Macromol, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Reprod & Dev Sci Dept, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; Tossi, Alessandro/ABC-9061-2020; amoroso,
   antonio/AAL-1475-2020; Boniotto, Michele/AAB-4302-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Ventura, Mario/E-6420-2011; Cardone, Maria
   Francesca/G-8818-2012; Tossi, Alessandro/U-2474-2017; BONIOTTO,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Ventura, Mario/0000-0001-7762-8777;
   Cardone, Maria Francesca/0000-0002-7597-7313; Tossi,
   Alessandro/0000-0001-9087-5764; Rocchi, Mariano/0000-0002-9451-5616;
   BONIOTTO, Michele/0000-0002-9548-2254; Palumbo,
   Valeria/0000-0002-7758-9891
CR BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   Bigoni F, 1997, AM J PRIMATOL, V42, P289, DOI 10.1002/(SICI)1098-2345(1997)42:4<289::AID-AJP4>3.0.CO;2-T
   Carbone L, 2002, CHROMOSOMA, V111, P267, DOI 10.1007/s00412-002-0205-5
   Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156
   Finelli P, 1999, MAMM GENOME, V10, P713, DOI 10.1007/s003359901077
   Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje
   Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   Harder J, 1997, GENOMICS, V46, P472, DOI 10.1006/geno.1997.5074
   Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239
   LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0
   Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6
   Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999
   SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   SEMPLE CA, 2003, GENOME BIOL R, V31, P4
   Sherlock JK, 1996, GENOMICS, V33, P214, DOI 10.1006/geno.1996.0186
   Stanyon R, 2000, AM J PRIMATOL, V50, P95, DOI 10.1002/(SICI)1098-2345(200002)50:2<95::AID-AJP1>3.0.CO;2-8
   WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004
   Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9
   YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861
   Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4
NR 24
TC 2
Z9 2
U1 0
U2 2
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1121-760X
EI 2038-8306
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PD APR-JUN
PY 2004
VL 48
IS 2
BP 195
EP 199
PG 5
WC Cell Biology
SC Cell Biology
GA 824OH
UT WOS:000221695400015
PM 15208090
DA 2020-12-08
ER

PT J
AU Antcheva, N
   Boniotto, M
   Zelezetsky, I
   Pacor, S
   Falzacappa, MVV
   Crovella, S
   Tossi, A
AF Antcheva, N
   Boniotto, M
   Zelezetsky, I
   Pacor, S
   Falzacappa, MVV
   Crovella, S
   Tossi, A
TI Effects of positively selected sequence variations in human and Macaca
   fascicularis beta-defensins 2 on antimicrobial activity
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID BETA-DEFENSINS; PRIMATES; EPITHELIA; CHEMOKINE; PEPTIDES; ALPHA; GENE
AB The evolution of orthologous genes coding for beta-defensin 2 (BD2) in primates has been subject to positive selection during the divergence of the platyrrhines from the catarrhines and of the Cercopithecidae from the Hylobatidae, great apes, and humans. Three peptides have been selected for a functional analysis of the effects of sequence variations on the direct antimicrobial activity: human BD2 (hBD2), Macaca fascicularis BD2 (mfaBD2), and a variant of the human peptide lacking Asp(4), (-D)hBD2, which is characteristic only of the human/great ape peptides. hBD2 and mfaBD2 showed a significant difference in specificity, the former being more active towards Escherichia coli and the later towards Staphylococcus aureus and Candida albicans. Asp(4) in the human peptide appears to be important, as (-D)hBD2 was less structured and had a markedly lower antimicrobial activity. The evolution of beta-defensin 2 in primates may thus have been driven, at least in part, by different environmental pressures so as to modulate antimicrobial activity.
C1 Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   Univ Trieste, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   Univ Trieste, Dept Biomed Sci, I-34127 Trieste, Italy.
RP Tossi, A (corresponding author), Univ Trieste, Dept Biochem Biophys & Macromol Chem, Via Giorgieri 1, I-34127 Trieste, Italy.
EM tossi@bbcm.units.it
RI Tossi, Alessandro/U-2474-2017; Boniotto, Michele/F-1857-2010; Tossi,
   Alessandro/ABC-9061-2020; Boniotto, Michele/AAB-4302-2020; Crovella,
   Sergio/K-5050-2016
OI Tossi, Alessandro/0000-0001-9087-5764; Boniotto,
   Michele/0000-0002-9548-2254; Crovella, Sergio/0000-0001-8493-1168;
   PACOR, SABRINA/0000-0001-8043-6725
CR Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
   Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x
   Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   HENGSTEN.W, 1969, CARBOHYD RES, V10, P463, DOI 10.1016/S0008-6215(00)80909-X
   Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200
   Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200
   Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x
   Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200
   Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961
   Tossi A, 1997, EUR J BIOCHEM, V250, P549, DOI 10.1111/j.1432-1033.1997.0549a.x
   Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9
NR 15
TC 42
Z9 43
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2004
VL 48
IS 2
BP 685
EP 688
DI 10.1128/AAC.48.2.685-688.2004
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 768WC
UT WOS:000188592200058
PM 14742239
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Antcheva, N
   Zelezetsky, I
   Boniotto, M
   Pacor, S
   Crovella, S
   Tossi, A
AF Antcheva, N.
   Zelezetsky, I.
   Boniotto, M.
   Pacor, S.
   Crovella, S.
   Tossi, A.
TI EVOLUTION OF PRIMATE beta-DEFENSINS: EFFECT OF STRUCTURAL VARIATIONS IN
   MODULATING ANTIMICROBIAL AND SIGNALLING ACTIVITIES
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Meeting Abstract
C1 [Antcheva, N.; Zelezetsky, I.; Tossi, A.] Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
   [Boniotto, M.; Crovella, S.] Univ Trieste, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   [Pacor, S.] Univ Trieste, Dept Biomed Sci, I-34127 Trieste, Italy.
RI Boniotto, Michele/AAB-4302-2020; Crovella, Sergio/K-5050-2016; Tossi,
   Alessandro/ABC-9061-2020
OI Crovella, Sergio/0000-0001-8493-1168; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1075-2617
J9 J PEPT SCI
JI J. Pept. Sci.
PY 2004
VL 10
BP 184
EP 184
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA V05MV
UT WOS:000207131001137
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Pirulli, D
   Falzacappa, MVV
   Trevisiol, C
   Gerarduzzi, T
   Crovella, S
AF Boniotto, M
   Pirulli, D
   Falzacappa, MVV
   Trevisiol, C
   Gerarduzzi, T
   Crovella, S
TI Localization and expression of two human beta-defensins (HBD-1 and
   HBD-2) in intestinal biopsies of celiac patients
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Letter
DE celiac disease; defensins; innate immunity; RT in situ PCR
ID DISEASE
C1 Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Unita Genet, Sez Genet, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet, Trieste, Italy.
   IRCCS Burlo Garofolo, UO Pediat, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Unita Genet, Sez Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; BONIOTTO,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; BONIOTTO,
   Michele/0000-0002-9548-2254
CR Boniotto M, 2003, EUR J HISTOCHEM, V47, P177
   GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7
   Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200
   Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X
   Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3
   O'Neil DA, 1999, J IMMUNOL, V163, P6718
   Oppenheim JJ, 2002, ARTHRITIS RES THER, V4, pS183, DOI 10.1186/ar574
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006
NR 9
TC 2
Z9 2
U1 0
U2 0
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PD OCT-DEC
PY 2003
VL 47
IS 4
BP 389
EP 391
PG 3
WC Cell Biology
SC Cell Biology
GA 760LJ
UT WOS:000187834800014
PM 14706937
DA 2020-12-08
ER

PT J
AU Leone, V
   Presani, G
   Perticarari, S
   Tommasini, A
   Crovella, S
   Lenhardt, A
   Picco, P
   Lepore, L
AF Leone, V
   Presani, G
   Perticarari, S
   Tommasini, A
   Crovella, S
   Lenhardt, A
   Picco, P
   Lepore, L
TI Chronic infantile neurological cutaneous articular syndrome: CD10
   over-expression in neutrophils is a possible key to the pathogenesis of
   the disease
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE chronic; infantile; neurological; cutaneous and articular syndrome
   (CINCA) neonatal onset multisystem inflammatory disease (NOMID);
   CD10/neutral endopeptidase; neutrophil activation markers
ID MULTISYSTEM INFLAMMATORY DISEASE; PROTEIN ASC; KAPPA-B; ACTIVATION;
   PYRIN; ARTHROPATHY; MUTATIONS; FAMILY; CIAS1; RASH
AB Chronic, Infantile, Neurological, Cutaneous and Articular Syndrome (CINCA) or Neonatal/Infantile Onset Multisystem Inflammatory Disease (NOMID/IOMID) is a rare, multisystem inflammatory disease characterised by neonatal onset of urticarial symptoms, persistent rash, ocular inflammatory lesions, progressive articular and neurological involvement and associated with characteristic overgrowth of the ossification nucleus of the patella. The tissues involved are extensively infiltrated by inflammatory cells, mostly neutrophils. This paper describes the clinical features of three new cases as well as a study of activation markers in neutrophils and search for mutations of the CIAS1gene in these patients. Clinical records of three cases of CINCA are reported. For genetic analysis, exon 3 of the CIAS1gene was amplified and sequenced. Immunophenotype, oxidative burst and phagocytosis were analysed in neutrophils obtained from all the three CINCA patients as well as from eight juvenile idiopathic arthritis (JIA) patients and eight healthy controls. Functional assays in neutrophils were normal in all three patients with CINCA syndrome and did not differ from those of JIA patients and healthy controls. The surface density of CD10 was significantly higher on neutrophils from CINCA patients as compared to those of JIA and controls ( P <0.0005). In one subject a new missense mutation in the CIAS1gene was identified. Conclusion: the hyper expression of the activation antigen CD10/NEP in neutrophils from these three cases of CINCA, as compared to JIA patients and healthy controls, irrespective of the presence of mutations in CIAS1, could be a marker of the inflammatory disorder typical of some patients with CINCA syndrome.
C1 IRCCS Burlo Garofolo, Pediat Clin, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Immunol Lab, Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Unita Genet, Trieste, Italy.
   IRCCS G Gaslini, Div Pediat 2, Genoa, Italy.
RP Lepore, L (corresponding author), IRCCS Burlo Garofolo, Pediat Clin, Via Istria 65-1, I-34137 Trieste, Italy.
EM leporel@burlo.trieste.it
RI Tommasini, Alberto/AAE-3882-2020; Crovella, Sergio/K-5050-2016
OI Tommasini, Alberto/0000-0002-6943-7927; Crovella,
   Sergio/0000-0001-8493-1168; Presani, Eleonora/0000-0001-6254-9603
CR Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688
   DeCunto CL, 1997, J PEDIATR-US, V130, P551, DOI 10.1016/S0022-3476(97)70238-5
   Eksioglu-Demiralp E, 2001, CLIN EXP RHEUMATOL, V19, pS19
   Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357
   Hashkes PJ, 1997, J PEDIATR-US, V130, P513
   HASSINK SG, 1983, ARTHRITIS RHEUM, V26, P668, DOI 10.1002/art.1780260515
   HUTTENLOCHER A, 1995, J RHEUMATOL, V22, P1171
   KAUFMAN RA, 1986, RADIOLOGY, V160, P741, DOI 10.1148/radiology.160.3.3737913
   LACHAUX A, 1987, ARCH FR PEDIATR, V44, P125
   LAMPERT F, 1986, EUR J PEDIATR, V144, P593, DOI 10.1007/BF00496045
   Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200
   PERTICARARI S, 1994, J IMMUNOL METHODS, V170, P117, DOI 10.1016/0022-1759(94)90251-8
   Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57
   Prieur AM, 2001, CLIN EXP RHEUMATOL, V19, P103
   PRIEUR AM, 1981, J PEDIATR-US, V99, P79, DOI 10.1016/S0022-3476(81)80961-4
   Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200
   Ruchon AF, 2000, J BONE MINER RES, V15, P1266, DOI 10.1359/jbmr.2000.15.7.1266
   Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552
   YAROM A, 1985, J PEDIATR-US, V106, P390, DOI 10.1016/S0022-3476(85)80662-4
NR 19
TC 10
Z9 11
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD OCT
PY 2003
VL 162
IS 10
BP 669
EP 673
DI 10.1007/s00431-003-1284-x
PG 5
WC Pediatrics
SC Pediatrics
GA 719WV
UT WOS:000185228800003
PM 12928894
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Antcheva, N
   Zelezetsky, I
   Tossi, A
   Palumbo, V
   Falzacappa, MVV
   Sgubin, S
   Braida, L
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Antcheva, N
   Zelezetsky, I
   Tossi, A
   Palumbo, V
   Falzacappa, MVV
   Sgubin, S
   Braida, L
   Amoroso, A
   Crovella, S
TI A study of host defence peptide beta-defensin 3 in primates
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE anti-bacterial; anti-microbial peptide; innate immunity
ID INDUCIBLE PEPTIDE; GENE; DISCOVERY; SPECTRUM
AB We have investigated the molecular evolution of the gene coding for beta-defensin 3 (DEFB103) in 17 primate species including humans. Unlike the DEFB4 genes (coding for beta-defensin 2) [Boniotto, Tossi, Del Pero, Sgubin, Antcheva, Santon and Masters (2003) Genes Immun. 4, 251-257], DEFB103 shows a marked degree of conservation in humans, Great Apes and New and Old World monkeys. Only the Hylobates concolor defensin hcBD3 showed an amino acid variation Arg(17)-->Trp(17) that could have a functional implication, as it disrupts an intramolecular salt bridge with Glu(27), which locally decreases the charge and may favour dimerization in the human congener hBD3. This is thought to involve the formation of an intermolecular salt bridge between Glu(28) and Lys(32) on another monomer [Schibli, Hunter, Aseyev, Starner, Wiencek, McCray, Tack and Vogel (2002) J. Biol. Chem. 277, 8279-8289]. To test the role of dimerization in mediating biological activity, we synthesized hBD3, hcBD3 and an artificial peptide in which the Lys(26)-Glu(27)-Glu(28) stretch was replaced by the equivalent Phe-Thr-Lys stretch from human beta-defensin 1 and we characterized their structure and anti-microbial activity. Although the structuring and dimerization of these peptides were found to differ significantly, this did not appear to affect markedly the anti-microbial potency, the broad spectrum of activity or the insensitivity of the anti-microbial action to the salinity of the medium.
C1 Univ Trieste, Dept Reprod & Dev Sci, I-34137 Trieste, Italy.
   Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dept Reprod & Dev Sci, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/F-1857-2010; AMOROSO, ANTONIO/AAN-3884-2020; Tossi,
   Alessandro/U-2474-2017; amoroso, antonio/AAL-1475-2020; Boniotto,
   Michele/AAB-4302-2020; Tossi, Alessandro/ABC-9061-2020; Crovella,
   Sergio/K-5050-2016
OI Boniotto, Michele/0000-0002-9548-2254; Tossi,
   Alessandro/0000-0001-9087-5764; amoroso, antonio/0000-0002-9437-9407;
   Crovella, Sergio/0000-0001-8493-1168
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401
   Boniotto M, 2003, GENES IMMUN, V4, P251, DOI 10.1038/sj.gene.6363958
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197
   Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje
   Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   Jia HP, 2001, GENE, V263, P211
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200
   Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
   Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31
   Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114
   Tossi A, 1997, EUR J BIOCHEM, V250, P549, DOI 10.1111/j.1432-1033.1997.0549a.x
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   TOSSI A, 2002, P 27 EUR PEPT S BEN, P302
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
NR 23
TC 63
Z9 64
U1 0
U2 4
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD SEP 14
PY 2003
VL 374
BP 707
EP 714
DI 10.1042/BJ20030528
PN 3
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 725MK
UT WOS:000185546800013
PM 12795637
OA Green Published
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Braida, L
   Ventura, A
   Percopo, S
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Braida, L
   Ventura, A
   Percopo, S
   Amoroso, A
   Crovella, S
TI Promoter polymorphisms of the CD14 gene in Italian patients with coeliac
   disease
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID MONOCYTE DIFFERENTIATION ANTIGEN; CELLS IN-VIVO; APOPTOTIC CELLS;
   AUTOIMMUNE DISORDERS; LINKAGE ANALYSIS; RECEPTOR GENE; RISK; BINDING;
   RECOGNITION; MACROPHAGES
C1 Univ Trieste, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   Univ Naples Federico II, Dipartimento Pediat, I-80131 Naples, Italy.
   IRCCS Burlo Garofolo, Serv Genet, I-34137 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; Boniotto,
   Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010; AMOROSO,
   ANTONIO/AAN-3884-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Boniotto, Michele/0000-0002-9548-2254;
   Ventura, Alessandro/0000-0002-4657-1760
CR Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893
   Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183
   Amano S, 1997, J CELL PHYSIOL, V173, P301, DOI 10.1002/(SICI)1097-4652(199712)173:3<301::AID-JCP1>3.0.CO;2-R
   Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494
   BALDINI M, AM THOR SOC M TOR
   Bevan S, 1999, J MED GENET, V36, P687
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996
   Devitt A, 1998, NATURE, V392, P505
   Fadok VA, 1998, J IMMUNOL, V161, P6250
   GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876
   Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624
   Greco L, 2001, ANN HUM GENET, V65, P35, DOI 10.1046/j.1469-1809.2001.6510035.x
   Grunwald U, 1996, J IMMUNOL, V157, P4119
   HAZIOT A, 1988, J IMMUNOL, V141, P547
   Holla LI, 2002, J MED GENET, V39, P844, DOI 10.1136/jmg.39.11.844
   Klein W, 2002, SCAND J GASTROENTERO, V37, P189, DOI 10.1080/003655202753416867
   Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008
   LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838
   Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453
   Louka AS, 2002, TISSUE ANTIGENS, V59, P70, DOI 10.1034/j.1399-0039.2002.590117.x
   Meloni G, 1999, LANCET, V353, P37, DOI 10.1016/S0140-6736(05)74871-6
   Moffatt OD, 1999, J IMMUNOL, V162, P6800
   Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752
   Nores JER, 1999, EUR J IMMUNOL, V29, P265, DOI 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.3.CO;2-7
   Not T, 2001, DIABETOLOGIA, V44, P151, DOI 10.1007/s001250051593
   Obana N, 2002, SCAND J GASTROENTERO, V37, P699, DOI 10.1080/00365520212504
   Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781
   Petronzelli F, 1997, ANN HUM GENET, V61, P307
   RISCH N, 1987, AM J HUM GENET, V40, P1
   Ronchetti A, 1999, J IMMUNOL, V163, P130
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schlegel RA, 1999, CELL DEATH DIFFER, V6, P583, DOI 10.1038/sj.cdd.4400529
   Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359
   ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253
   Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297
   Vercelli D, 2001, INT ARCH ALLERGY IMM, V124, P20, DOI 10.1159/000053658
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Yoshida A, 1997, INFECT IMMUN, V65, P1953, DOI 10.1128/IAI.65.5.1953-1955.1997
NR 40
TC 7
Z9 10
U1 0
U2 1
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
J9 J MED GENET
JI J. Med. Genet.
PD SEP 1
PY 2003
VL 40
IS 9
AR e108
DI 10.1136/jmg.40.9.e108
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 718ZP
UT WOS:000185177700017
PM 12960224
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Radillo, O
   Not, T
   Amoroso, A
   Ventura, A
   Tedesco, F
   Crovella, S
AF Boniotto, M
   Radillo, O
   Not, T
   Amoroso, A
   Ventura, A
   Tedesco, F
   Crovella, S
TI MBL gene expression in intestinal biopsies of celiac patients
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 9th European Meeting on Complement in Human Disease
CY SEP 06-09, 2003
CL TRIESTE, ITALY
DE MBL; celiac disease
C1 Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy.
   IRCCS, Dept Lab Med, Burlo Garofolo, Italy.
   Univ Trieste, Dept Physiol & Pathol, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; Tedesco,
   Francesco/F-1929-2011
OI Crovella, Sergio/0000-0001-8493-1168; 
NR 0
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD SEP
PY 2003
VL 40
IS 2-4
BP 220
EP 221
PG 2
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 715MJ
UT WOS:000184975900119
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Tossi, A
   DelPero, M
   Sgubin, S
   Antcheva, N
   Santon, D
   Masters, J
   Crovella, S
AF Boniotto, M
   Tossi, A
   DelPero, M
   Sgubin, S
   Antcheva, N
   Santon, D
   Masters, J
   Crovella, S
TI Evolution of the beta defensin 2 gene in primates
SO GENES AND IMMUNITY
LA English
DT Article
DE antimicrobial peptides; beta defensins; innate immunity; primates;
   nucleotide sequences; amino-acid sequences
ID POSITIVE DARWINIAN SELECTION; HUMAN BETA-DEFENSIN-2; EPITHELIA;
   CHEMOKINE; CCR6
AB With the aim of further investigating the molecular evolution of beta defensin genes, after having analysed beta defensin 1 (DEFB1) in humans and several nonhuman primate species, we have studied the evolution of the beta defensin 2 gene (DEFB2), which codifies for a peptide with antimicrobial and chemoattractant activity, in humans and 16 primate species. We have found evidence of positive selection during the evolution of orthologous DEFB2 genes at two points on a phylogenetic tree relating these primates: during the divergence of the platyrrhines from the catarrhines and during the divergence of the Cercopithecidae from the Hylobatidae, Great Apes and humans. Furthermore, amino acid variations in Old World Monkeys seem to centre either on residues that are involved in oligomerisation in the human molecule, or that are conserved (40-80%) in beta-defensins in general. It is thus likely that these variations affect the biological function of the molecules and suggest that their synthesis and functional analysis might reveal interesting new information as to their role in innate immunity.
C1 Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, I-34100 Trieste, Italy.
   Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy.
   Univ Turin, Dipartimento Biol Anim & Uomo, Turin, Italy.
   Natal Museum, Pietermaritzburg, South Africa.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Via Istria 65-1, I-34100 Trieste, Italy.
RI Tossi, Alessandro/U-2474-2017; Boniotto, Michele/AAB-4302-2020;
   Boniotto, Michele/F-1857-2010; Crovella, Sergio/K-5050-2016; Tossi,
   Alessandro/ABC-9061-2020
OI Tossi, Alessandro/0000-0001-9087-5764; Boniotto,
   Michele/0000-0002-9548-2254; Crovella, Sergio/0000-0001-8493-1168; 
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401
   Del Pero M, 2002, IMMUNOGENETICS, V53, P907, DOI 10.1007/s00251-001-0412-x
   EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115
   Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x
   Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200
   Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200
   HUGHES AL, 1990, MOL BIOL EVOL, V7, P515
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200
   PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078
   Sambrook J, 1989, MOL CLONING LAB MANU
   Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961
   TANAKA T, 1989, MOL BIOL EVOL, V6, P447
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708
NR 21
TC 39
Z9 41
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
J9 GENES IMMUN
JI Genes Immun.
PD JUN
PY 2003
VL 4
IS 4
BP 251
EP 257
DI 10.1038/sj.gene.6363958
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 683EZ
UT WOS:000183136100002
PM 12761560
OA Bronze
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Radillo, O
   Braida, L
   Pirulli, D
   Citta, A
   Not, T
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Radillo, O
   Braida, L
   Pirulli, D
   Citta, A
   Not, T
   Amoroso, A
   Crovella, S
TI Detection of MBL-2 gene expression in intestinal biopsies of celiac
   patients by in situ reverse transcription polymerase chain reaction
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Letter
DE celiac disease; MBL2; MBP; RT in situ PCR; apoptosis; autoimmunity
ID MANNOSE-BINDING LECTIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
   RHEUMATOID-ARTHRITIS; SJOGRENS-SYNDROME; POLYMORPHISMS; DISEASE;
   SUSCEPTIBILITY
C1 Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Unita Genet, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Unitat Pediat, Trieste, Italy.
   IRCCS Burlo Garofolo, Lab Anal, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Unita Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI Boniotto, Michele/F-1857-2010; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020; Not, Tarcisio/K-2616-2018; Boniotto,
   Michele/AAB-4302-2020; AMOROSO, ANTONIO/AAN-3884-2020
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407; Not,
   Tarcisio/0000-0003-1059-3009; 
CR Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   NIELSEN SL, 1995, CLIN EXP IMMUNOL, V100, P219
   Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781
   Rector A, 2001, GENES IMMUN, V2, P323, DOI 10.1038/sj.gene.6363784
   Saevarsdottir S, 2001, J RHEUMATOL, V28, P728
   SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4
   SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Wang ZY, 2001, ANN RHEUM DIS, V60, P483, DOI 10.1136/ard.60.5.483
NR 14
TC 15
Z9 15
U1 0
U2 1
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PD APR-JUN
PY 2003
VL 47
IS 2
BP 177
EP 180
PG 4
WC Cell Biology
SC Cell Biology
GA 685CM
UT WOS:000183243300013
PM 12777216
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Braida, L
   Pirulli, D
   Arraes, L
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Braida, L
   Pirulli, D
   Arraes, L
   Amoroso, A
   Crovella, S
TI MBL2 polymorphisms are involved in HIV-1 infection in Brazilian
   perinatally infected children
SO AIDS
LA English
DT Letter
ID MANNOSE-BINDING LECTIN; VARIANT; AIDS
C1 Univ Trieste, Dept Reprod & Dev Sci, I-34137 Trieste, Italy.
   Inst Materno Infantil Pernambuco, Unitad Virol, Recife, PE, Brazil.
   IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
RP Boniotto, M (corresponding author), Univ Trieste, Dept Reprod & Dev Sci, Via Istria 65-1, I-34137 Trieste, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; Boniotto,
   Michele/AAB-4302-2020; amoroso, antonio/AAL-1475-2020; BONIOTTO,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; BONIOTTO, Michele/0000-0002-9548-2254
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Mass J, 1998, AIDS, V12, P2275
   Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949
   Sambrook J., 1989, MOL CLONING LAB MANU
   SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
NR 13
TC 30
Z9 31
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD MAR 28
PY 2003
VL 17
IS 5
BP 779
EP 780
DI 10.1097/00002030-200303280-00025
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 673EF
UT WOS:000182566700025
PM 12646810
DA 2020-12-08
ER

PT J
AU Pascolo, L
   Fernetti, C
   Pirulli, D
   Crovella, S
   Amoroso, A
   Tiribelli, C
AF Pascolo, L
   Fernetti, C
   Pirulli, D
   Crovella, S
   Amoroso, A
   Tiribelli, C
TI Effects of maturation on RNA transcription and protein expression of
   four MRP genes in human placenta and in BeWo cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE MRP proteins; placenta; gene expression; BeWo; maturation; polarization;
   real-time PCR
ID MELTING TEMPERATURE ASSAY; UNCONJUGATED BILIRUBIN; TRANSPORT; MEMBRANE;
   LINE; MONOLAYERS; MUTATIONS; EFFLUX; FAMILY
AB The placenta is a multifunctional organ that protects the fetus from toxic compounds and the MRPs contribute to this function. The expression of MRP1, MRP2, MRP3, and MRP5 was compared in human placenta] tissue and in BeWo cells by real-time RTPCR analysis; protein expression was assessed by Western blot. MRP1 and MRP3 were the most abundantly expressed genes in placenta but only MRP1 was highly expressed in the BeWo cells. Expression of MRP1 increased 4-fold in the third as compared with first trimester placental samples, and increased 20-fold with polarization of BeWo cells. MRP2, MRP3, and MRP5 were weakly expressed both in placenta and BeWo cells. Protein expression followed mRNA quantification for MRP1 and MRP5 but not for MRP2 and MRP3. These data indicated that MRP1 and MRP5 increase with trophoblast maturation, suggesting a particular role for these proteins in the organ functional development. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Ctr Studi Fegato, I-34127 Trieste, Italy.
   Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, I-34127 Trieste, Italy.
   IRCCS, Genet Serv, Trieste, Italy.
RP Pascolo, L (corresponding author), Ctr Studi Fegato, AREA Sci Pk, I-34127 Trieste, Italy.
EM lorella.pascolo@csf.units.it
RI AMOROSO, ANTONIO/AAN-3884-2020; amoroso, antonio/AAL-1475-2020; Pascolo,
   Lorella/AAB-5207-2020; Crovella, Sergio/K-5050-2016; Tiribelli,
   Claudio/A-4716-2014
OI amoroso, antonio/0000-0002-9437-9407; Pascolo,
   Lorella/0000-0003-1044-7263; Crovella, Sergio/0000-0001-8493-1168;
   Tiribelli, Claudio/0000-0001-6596-7595
CR Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055
   Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4
   BRAVO P, 1993, AM J PHYSIOL, V265, pG242
   CERNEUS DP, 1991, J CELL BIOL, V114, P1149, DOI 10.1083/jcb.114.6.1149
   CERNEUS DP, 1993, J CELL BIOL, V122, P1223, DOI 10.1083/jcb.122.6.1223
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   FALLER DP, 1995, AM J PHYSIOL-CELL PH, V269, pC148
   Fernetti C, 2001, BIOCHEM BIOPH RES CO, V288, P1064, DOI 10.1006/bbrc.2001.5885
   Grant CE, 1997, GENOMICS, V45, P368, DOI 10.1006/geno.1997.4950
   Harris ED, 1998, AM J CLIN NUTR, V67, p988S, DOI 10.1093/ajcn/67.5.988S
   Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588
   Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200
   KEETING PE, 1991, J BONE MINER RES, V6, P827
   KELLEY LK, 1983, BIOCHIM BIOPHYS ACTA, V734, P91, DOI 10.1016/0005-2736(83)90079-2
   Keppler D, 2000, SEMIN LIVER DIS, V20, P265, DOI 10.1055/s-2000-9391
   Keppler D, 1997, BIOL CHEM, V378, P787
   Kiuchi Y, 1998, FEBS LETT, V433, P149, DOI 10.1016/S0014-5793(98)00899-0
   Kool M, 1997, CANCER RES, V57, P3537
   LEE K, 1986, BILE PIGMENTS JAUNDI, P373
   Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1
   Liu F, 1997, AM J PHYSIOL-CELL PH, V273, pC1596
   Marziliano N, 2000, HAEMATOLOGICA, V85, P990
   MOE AJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1321
   MOE AJ, 1994, PLACENTA, V15, P797, DOI 10.1016/S0143-4004(05)80182-1
   Novak DA, 1997, PLACENTA, V18, P379, DOI 10.1016/S0143-4004(97)80037-9
   Pascolo L, 2001, FEBS LETT, V495, P94, DOI 10.1016/S0014-5793(01)02357-2
   PATTILLO RA, 1968, CANCER RES, V28, P1231
   Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126
   Pirulli D, 2000, CLIN CHEM, V46, P1842
   RINGLER GE, 1990, ENDOCR REV, V11, P105, DOI 10.1210/edrv-11-1-105
   Scheffer GL, 2002, LAB INVEST, V82, P193, DOI 10.1038/labinvest.3780411
   SCHNEIDER H, 1991, REPROD FERT DEVELOP, V3, P345, DOI 10.1071/RD9910345
   Serrano MA, 2002, PLACENTA, V23, P527, DOI 10.1053/plac.2002.0838
   St-Pierre MV, 2000, AM J PHYSIOL-REG I, V279, pR1495
   Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164
   Walgren RA, 2000, J PHARMACOL EXP THER, V294, P830
NR 36
TC 73
Z9 76
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 28
PY 2003
VL 303
IS 1
BP 259
EP 265
DI 10.1016/S0006-291X(03)00327-9
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 665LK
UT WOS:000182122000040
PM 12646196
DA 2020-12-08
ER

PT J
AU Romanello, M
   Bicego, M
   Pirulli, D
   Crovella, S
   Moro, L
   D'Andrea, P
AF Romanello, M
   Bicego, M
   Pirulli, D
   Crovella, S
   Moro, L
   D'Andrea, P
TI Extracellular NAD(+): a novel autocrine/paracrine signal in osteoblast
   physiology
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE NAD(+); osteoblasts; calcium; mechanical loading; local factors
ID CYCLIC ADP-RIBOSE; RELEASE; BONE; CELLS; DIFFERENTIATION; HEMICHANNELS;
   CD38
AB Intercellular communication allows co-ordination of cell metabolism and sensitivity to extracellular stimuli. In bone cells, paracrine stimulation and cell-to-cell coupling through gap junctions induce the formation of complex intercellular networks, which favours the intercellular exchange of nutrients and second messengers, ultimately controlling the process of bone remodelling. The importance of local factors in bone remodelling is known since many years. Bone cells secrete and respond to a variety signals, among which include prostaglandins, cytokines, growth factors, and ATP. We here report evidence that extracellular NAD+ is a novel extracellular signal stimulating osteoblast differentiation. We found that HOBIT human osteoblastic cells, which are known to express ADP-ribosyl cyclase/CD38 activity, respond to micromolar concentrations of extracellular NAD(+) with oscillatory increases of the cytosolic Ca2+ concentration. The initial Ca2+ response was followed by a time-dependent inhibition of cell growth, the appearance of an epithelial morphology, and by an increase of alkaline phosphatase and osteocalcin expression. Under resting condition HOBIT cells release NAD+ in the extracellular medium and the release is significantly potentiated by mechanical stimulation. Taken together these results point to NAD(+) as a novel autocrine/paracrine factor involved in stimulation and maintenance of the osteoblast differentiated phenotype. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, I-34137 Trieste, Italy.
RP D'Andrea, P (corresponding author), Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, Via Licio Giorgieri 1, I-34127 Trieste, Italy.
EM dandrea@bbcm.univ.trieste.it
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621
   Bowler WB, 2001, BONE, V28, P507, DOI 10.1016/S8756-3282(01)00430-6
   Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x
   Bruzzone S, 2001, FASEB J, V15, P10
   *COMM ENZ SOC FRAN, 1982, ANN BIOL CLIN, V40, P291
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   Franco L, 1998, FASEB J, V12, P1507
   GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457
   Genever PG, 2001, FASEB J, V15, P1586, DOI 10.1096/fj.00-0594fje
   Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546
   Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200
   Horowitz Mark C., 1996, P687
   HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624
   John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236
   Jorgensen NR, 2000, J BONE MINER RES, V15, P1024, DOI 10.1359/jbmr.2000.15.6.1024
   KEETING PE, 1992, J BONE MINER RES, V7, P127
   KIM UH, 1993, ARCH BIOCHEM BIOPHYS, V305, P147, DOI 10.1006/abbi.1993.1404
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348
   Lee HC, 1997, PHYSIOL REV, V77, P1133
   Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pilbeam Carol C., 1996, P715
   Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124
   Romanello M, 2001, BIOCHEM BIOPH RES CO, V285, P1226, DOI 10.1006/bbrc.2001.5325
   Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465
   Romanello M, 2001, BIOCHEM BIOPH RES CO, V282, P1138, DOI 10.1006/bbrc.2001.4710
   Siggelkow H, 1999, CALCIFIED TISSUE INT, V64, P414, DOI 10.1007/PL00005823
   Stein Gary S., 1996, P69
   Sun L, 1999, J CELL BIOL, V146, P1161, DOI 10.1083/jcb.146.5.1161
   Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com
   TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005
   Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x
   Yoneda Toshiyuki, 1996, P729
   ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9
   Zocchi E, 1999, FASEB J, V13, P273
NR 36
TC 15
Z9 15
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 6
PY 2002
VL 299
IS 3
BP 424
EP 431
AR PII S0006-291X(02)02665-7
DI 10.1016/S0006-291X(02)02665-7
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 625LM
UT WOS:000179818000015
PM 12445818
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Braida, L
   Spano, A
   Pirulli, D
   Baldas, V
   Trevisiol, C
   Not, T
   Tommasini, A
   Amoroso, A
   Crovella, S
AF Boniotto, M
   Braida, L
   Spano, A
   Pirulli, D
   Baldas, V
   Trevisiol, C
   Not, T
   Tommasini, A
   Amoroso, A
   Crovella, S
TI Variant mannose-binding lectin alleles are associated with celiac
   disease
SO IMMUNOGENETICS
LA English
DT Article
DE MBL2 polymorphisms; celiac disease; autoimmunity; apoptosis
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; POLYMORPHISMS; GENE;
   SUSCEPTIBILITY; IDENTIFICATION; CALRETICULIN; INFECTIONS; GLIADIN
AB In this study, we investigated the role of mannose-binding lectin (MBL) in celiac disease, by performing genotype analysis for the three point mutations in the first exon of the gene in 117 Italian celiac patients (characterized by flat biopsy and positive for anti-endomysium antibody and human transglutaminase antibodies) and 130 pan-ethnic healthy controls. The frequency of homozygous mutant 0/0 was significantly higher in the 117 Italian celiac patients (0.13) than in the 130 pan-ethnic healthy controls (0.05; P=0.0405). An increased frequency of homozygous 0/0 allele was found among patients with celiac disease compared with controls. These results suggest an involvement of MBL in the pathophysiology of celiac disease.
C1 Univ Trieste, Dipartimento Sci Reprod & Sviluppo, Genet Sect, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Reprod & Sviluppo, Pediat Unit, I-34137 Trieste, Italy.
   Burlo Garofolo Childrens Hosp, I-34137 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Reprod & Sviluppo, Genet Sect, Via Istria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI AMOROSO, ANTONIO/AAN-3884-2020; amoroso, antonio/AAL-1475-2020;
   Tommasini, Alberto/AAE-3882-2020; Boniotto, Michele/AAB-4302-2020;
   Crovella, Sergio/K-5050-2016; Not, Tarcisio/K-2616-2018; Boniotto,
   Michele/F-1857-2010
OI amoroso, antonio/0000-0002-9437-9407; Tommasini,
   Alberto/0000-0002-6943-7927; Crovella, Sergio/0000-0001-8493-1168; Not,
   Tarcisio/0000-0003-1059-3009; Boniotto, Michele/0000-0002-9548-2254
CR Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   Kelly P, 2000, GASTROENTEROLOGY, V119, P1236, DOI 10.1053/gast.2000.19573
   Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316
   Krupickova S, 1999, GUT, V44, P168, DOI 10.1136/gut.44.2.168
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Muto S, 1999, BIOL PHARM BULL, V22, P347
   Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781
   Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3
   Rector A, 2001, GENES IMMUN, V2, P323, DOI 10.1038/sj.gene.6363784
   Saevarsdottir S, 2001, J RHEUMATOL, V28, P728
   Sambrook J., 1989, MOL CLONING LAB MANU
   SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Wang ZY, 2001, ANN RHEUM DIS, V60, P483, DOI 10.1136/ard.60.5.483
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
NR 23
TC 16
Z9 17
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0093-7711
EI 1432-1211
J9 IMMUNOGENETICS
JI Immunogenetics
PD NOV
PY 2002
VL 54
IS 8
BP 596
EP 598
DI 10.1007/s00251-002-0504-2
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 624DJ
UT WOS:000179744800009
PM 12439623
DA 2020-12-08
ER

PT J
AU Boaretto, F
   Savoldi, S
   Santon, D
   Crovella, S
   Martone, M
   Artero, M
   Pennesi, M
   Panzetta, G
   Amoroso, A
AF Boaretto, F
   Savoldi, S
   Santon, D
   Crovella, S
   Martone, M
   Artero, M
   Pennesi, M
   Panzetta, G
   Amoroso, A
TI Genetic heterogeneity in autosomal dominant alports syndrome (ADAS).
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
CT 52nd Annual Meeting of the American-Society-of-Human-Genetics
CY OCT 15-19, 2002
CL BALTIMORE, MARYLAND
SP Amer Soc Human Genet, NICHHD, NCI, NIMH, Affymetrix Inc, Gentra Syst, NIDCD
C1 Cattinara Hosp, Nephrol & Dialysis Serv, Trieste, TS, Italy.
   IRCCS Burlo Garofolo, Trieste, TS, Italy.
   Univ Trieste, Trieste, Italy.
RI boaretto, francesca/K-9811-2016; AMOROSO, ANTONIO/AAN-3884-2020;
   Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020
OI boaretto, francesca/0000-0003-2015-929X; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT
PY 2002
VL 71
IS 4
SU S
MA 1560
BP 437
EP 437
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA 594AC
UT WOS:000178025801556
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Ventura, M
   Cardone, MF
   Boaretto, F
   Archidiacono, N
   Rocchi, M
   Crovella, S
AF Boniotto, M
   Ventura, M
   Cardone, MF
   Boaretto, F
   Archidiacono, N
   Rocchi, M
   Crovella, S
TI Localization of a new highly repeated DNA sequence of Lemur catta
   (Lemuridae, Strepsirhini)
SO GENOME
LA English
DT Article
DE highly repeated DNA; FISH; chromosome rearrangements; heterochromatin;
   Malagasy lemurs
ID PHYLOGENETIC-RELATIONSHIPS; EULEMUR; FAMILY; PATTERNS; GENE
AB We have isolated and cloned an 800-bp highly repeated DNA (HRDNA) sequence from Lemur catta (LCA) and described its localization on LCA chromosomes. Lemur catta HRDNA sequences were localized by performing FISH experiments on standard and elongated metaphasic chromosomes using an LCA HRDNA probe (LCASAT). A complex hybridization pattern was detected. A strong pericentromeric hybridization signal was observed on most LCA chromosomes. Chromosomes 7 and 13 were lit in pericentromeric regions, as well as in the interspersed heterochromatin. Chromosomes 1, 3, 4, 17, 19, X, and microchromosomes (20, 25, 26, and 27) showed no signals in the pericentromeric region, but chromosomes 3 and 4 showed a positive hybridization in heterochromatic regions. The 800-bp L. catta HRDNA was species specific. We performed FISH experiments with the LCASAT probe on Eutemur macaco macaco (EMA) and Eulemur fulvus fulvus (EFU) metaphases and no positive signal of hybridization was detected. These findings were also confirmed by Southern blot analysis and PCR.
C1 Univ Trieste, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   Univ Bari, Dipartimento Anat Patol & Genet, Sez Genet, I-70126 Bari, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; boaretto, francesca/K-9811-2016; Cardone,
   Maria Francesca/G-8818-2012; Ventura, Mario/E-6420-2011; Boniotto,
   Michele/AAB-4302-2020; BONIOTTO, Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; boaretto,
   francesca/0000-0003-2015-929X; Cardone, Maria
   Francesca/0000-0002-7597-7313; Ventura, Mario/0000-0001-7762-8777;
   BONIOTTO, Michele/0000-0002-9548-2254; archidiacono,
   nicoletta/0000-0002-1439-9521
CR CROVELLA S, 1993, PRIMATES, V34, P61, DOI 10.1007/BF02381281
   Delpero M, 2001, ZOOL J LINN SOC-LOND, V133, P83, DOI 10.1111/j.1096-3642.2001.tb00624.x
   IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592
   MONTAGNON D, 1993, CYTOGENET CELL GENET, V63, P131, DOI 10.1159/000133518
   Pastorini J, 2000, MOL PHYLOGENET EVOL, V16, P418, DOI 10.1006/mpev.2000.0796
   Sambrook J, 1989, MOL CLONING LAB MANU
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TATTERSALL I, 1993, SCI AM, V268, P110, DOI 10.1038/scientificamerican0193-110
   Ventura M, 2001, GENE, V275, P305, DOI 10.1016/S0378-1119(01)00653-9
   WILLARD HF, 1985, AM J HUM GENET, V37, P524
   Wyner Y, 1999, BIOL J LINN SOC, V66, P39, DOI 10.1006/bijl.1998.0258
   Wyner Y, 2000, MOL PHYLOGENET EVOL, V15, P124, DOI 10.1006/mpev.1999.0723
   Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122
NR 15
TC 0
Z9 0
U1 0
U2 2
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0831-2796
J9 GENOME
JI Genome
PD OCT
PY 2002
VL 45
IS 5
BP 973
EP 976
DI 10.1139/G02-048
PG 4
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 609BE
UT WOS:000178882100023
PM 12416631
DA 2020-12-08
ER

PT J
AU Hladnik, U
   Braida, L
   Boniotto, M
   Pirulli, D
   Gerin, F
   Amoroso, A
   Crovella, S
AF Hladnik, U
   Braida, L
   Boniotto, M
   Pirulli, D
   Gerin, F
   Amoroso, A
   Crovella, S
TI Single-tube genotyping of MBL-2 polymorphisms using melting temperature
   analysis
SO CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE MBL-2; polymorphisms; melting temperature analysis; automatic allele
   calling
ID MANNOSE-BINDING LECTIN; HIV-INFECTION; PROGRESSION; VARIANT; AIDS
AB Recently several authors correlated MBL-2 gene polymorphisms with different pathologies and there is a growing interest for MBL-2 genotyping in a large number of individuals. We have developed a single-tube, rapid, economic, and fully automated melting temperature analysis screening method, based on ABI 7700 Sequence Detection System technology and SYBR Green I chemistry, for the detection of three polymorphisms (exon 1, codons 52, 54, 57) in the MBL-2 gene. We also developed an electronic sheet for the automatic calling of different genotypes, based on the analysis of the first derivative of ABI 7700 raw data.
C1 Univ Trieste, Sez Genet, Dipartimento Sci Riprod & Sviluppo, I-34100 Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet, I-34100 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Sez Genet, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34100 Trieste, Italy.
EM crovella@burlo.trieste.it
RI Boniotto, Michele/AAB-4302-2020; AMOROSO, ANTONIO/AAN-3884-2020;
   Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; Boniotto,
   Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Boniotto, Michele/0000-0002-9548-2254;
   Hladnik, Uros/0000-0002-0867-059X
CR Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861
   Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   Marziliano N, 2000, CLIN CHEM, V46, P423
   Neth O, 2001, LANCET, V358, P614, DOI 10.1016/S0140-6736(01)05776-2
   Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
NR 10
TC 35
Z9 35
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1591-8890
EI 1591-9528
J9 CLIN EXP MED
JI Clin. Exper. Med.
PD JUL
PY 2002
VL 2
IS 2
BP 105
EP 108
DI 10.1007/s102380200014
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 573CV
UT WOS:000176812500007
PM 12141527
DA 2020-12-08
ER

PT J
AU Trevisiol, C
   Ventura, A
   Baldas, V
   Tommasini, A
   Santon, D
   Martelossi, S
   Torre, G
   Berti, I
   Spano, A
   Crovella, S
   Amoroso, A
   Sblattero, D
   Marzari, R
   Bradbury, A
   Not, T
AF Trevisiol, C
   Ventura, A
   Baldas, V
   Tommasini, A
   Santon, D
   Martelossi, S
   Torre, G
   Berti, I
   Spano, A
   Crovella, S
   Amoroso, A
   Sblattero, D
   Marzari, R
   Bradbury, A
   Not, T
TI A reliable screening procedure for coeliac disease in clinical practice
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE anti-endomysium antibody; coeliac disease; human-recombinant
   anti-transglutaminase; antibodies; HLA DQ2 and DQ8
ID TISSUE TRANSGLUTAMINASE ELISA; AUTOIMMUNE DISORDERS; ANTIENDOMYSIUM;
   ANTIBODIES; ASSAY; SENSITIVITY; DIAGNOSIS; CHILDREN; GLUTEN; RISK
AB Background: The main autoantigen recognized by the sera of patients with coeliac disease (CD) is tissue transglutaminase (tTG). A human-recombinant form of tTG was used to develop an ELISA to measure anti-tTG serum antibodies for the diagnosis of CD. Preliminary retrospective reports suggest that the human tTG-based ELISA could identify coeliac patients missed by the IgA-anti-endomysium antibody test (AEA). Whether the human recombinant tTG ELISA is sufficiently accurate to become the main diagnostic CD tool in everyday clinical practice is unknown. The objective was to determine, in a prospective study, the sensitivity and specificity of an ELISA test based on the use of human tTG compared with AEA, to analyse the discordant cases for HLA DQ2-8 and for clinical and intestinal biopsy characteristics. Methods: 1106 patients referred to a gastrointestinal outpatient clinic for symptoms attributable to CD, 52 first-degree relatives of CD patients and 200 healthy controls were tested for both anti-human tTG and AEA antibodies. Results: Out of 1158 subjects, 146 were tested positive for anti-tTG antibodies and 140 were biopsy-proven coeliacs. The AEA test identified 126/1158 coeliacs who also tested positive for anti-tTG antibodies. The 14 patients missed by the AEA test carried the typical HLA-DQ for CD; they had normal levels of total serum IgA and had milder pathology than those with both anti-tTG and AEA positivity (P < 0001). Conclusions: These results prove that human tTG-based ELISA is an excellent diagnostic tool for CD, for mass screening by both the specialist and the general clinic.
C1 Univ Trieste, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, I-34127 Trieste, Italy.
   Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.
   Univ Trieste, Dept Biol, I-34127 Trieste, Italy.
RP Not, T (corresponding author), Ist Infanzia Burlo Garofolo, Pediat Clin, Via Istrai 65-1, IT-34100 Trieste, Italy.
EM not@burlo.trieste.it
RI AMOROSO, ANTONIO/AAN-3884-2020; Tommasini, Alberto/AAE-3882-2020; Not,
   Tarcisio/K-2616-2018; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020
OI Tommasini, Alberto/0000-0002-6943-7927; Not,
   Tarcisio/0000-0003-1059-3009; Crovella, Sergio/0000-0001-8493-1168;
   amoroso, antonio/0000-0002-9437-9407; Ventura,
   Alessandro/0000-0002-4657-1760; Berti, Irene/0000-0001-6063-2737
CR Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   GENTILE V, 1991, J BIOL CHEM, V266, P478
   Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x
   Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1
   Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164
   Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008
   Lampasona V, 1998, LANCET, V352, P1192, DOI 10.1016/S0140-6736(05)60530-2
   MAKI M, 1995, GUT, V36, P239, DOI 10.1136/gut.36.2.239
   Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170
   MAZURE R, 1994, AM J GASTROENTEROL, V89, P2130
   Meloni G, 1999, LANCET, V353, P37, DOI 10.1016/S0140-6736(05)74871-6
   Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713
   Murray JA, 2000, CLIN DIAGN LAB IMMUN, V7, P584, DOI 10.1128/CDLI.7.4.584-587.2000
   Not T, 1997, EUR J PEDIATR, V156, P616, DOI 10.1007/s004310050676
   Not T, 2001, DIABETOLOGIA, V44, P151, DOI 10.1007/s001250051593
   Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019
   Rostami K, 1999, AM J GASTROENTEROL, V94, P888
   Sardy M, 1999, CLIN CHEM, V45, P2142
   SATEGNAGUIDETTI C, 1993, J CLIN GASTROENTEROL, V17, P123, DOI 10.1097/00004836-199309000-00007
   SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005
   Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253
   Scott Helge, 1996, P237, DOI 10.1016/B978-044482383-0/50035-2
   Seissler J, 1999, HORM METAB RES, V31, P375, DOI 10.1055/s-2007-978758
   Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3
   Troncone R, 1999, J PEDIATR-US, V134, P166, DOI 10.1016/S0022-3476(99)70410-5
   Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
NR 27
TC 37
Z9 39
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5521
EI 1502-7708
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD JUN 1
PY 2002
VL 37
IS 6
BP 679
EP 684
DI 10.1080/00365520212513
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 564EH
UT WOS:000176301700011
PM 12126246
DA 2020-12-08
ER

PT J
AU Crovella, S
   Pirulli, D
   De Santo, D
   De Seta, F
   Boniotto, M
   Braida, L
   Boaretto, F
   Guaschino, S
   Amoroso, A
AF Crovella, S
   Pirulli, D
   De Santo, D
   De Seta, F
   Boniotto, M
   Braida, L
   Boaretto, F
   Guaschino, S
   Amoroso, A
TI Quantitative in situ detection of high-risk human papillomavirus in
   cytological specimens by SYBR Green I fluorescent labeling
SO CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE high-risk human papillomavirus; in situ quantitative PCR; cell smears;
   fluorescent detection
ID AMPLIFICATION; HYBRIDIZATION; CANCER; PCR
AB In this study we developed an in situ protocol for quantitative detection of high-risk human papillomavirus (HPV), based on direct in situ polymerase chain reaction (PCR) with SYBR Green I labeling and GeneAmp 5700 Sequence Detection System technology. This protocol was applied on cytological specimens of patients with cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC). We performed direct in situ quantitative PCR on cell smears, uninfected human skin fibroblasts, Hela and Caski cells. After in situ amplification, slides were counterstained with propidium iodide and analyzed under a fluorescent microscope in order to localize high-risk HPV and verify preservation of morphology. After PCR optimization, we obtained the following results. The Hela cells showed values ranging from 15 to 33 copies of high-risk HPV per cell, the Caski cell line from 220 to 300 high-risk HPV copies per cell and the cell smear (both CIN and SCC) around 20-35 copies of high-risk HPV per cell. No high-risk HPV amplification was detected in uninfected human fibroblasts, healthy controls, non-amplification control, and non-specific primer control. A positive intranuclear high-risk HPV amplification was detected in cell smears from 20 patients with CIN and 10 with SCC. In conclusion, our in situ quantitative protocol for high-risk HPV detection on cell smears combines both quantitative data and in situ localization of the target, with preservation of morphology. For this reason it could be used as a rapid screening tool when both morphological and quantitative results are requested on the same slide.
C1 Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Sez Genet, I-34100 Trieste, Italy.
   Univ Trieste, UCO Ostetr & Ginecol, Dipartimento Sci Riprod & Sviluppo, I-34100 Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet, I-34100 Trieste, Italy.
RP Amoroso, A (corresponding author), Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Sez Genet, Via Istria 65-1, I-34100 Trieste, Italy.
EM amoroso@burlo.trieste.it
RI AMOROSO, ANTONIO/AAN-3884-2020; boaretto, francesca/K-9811-2016;
   Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010;
   Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020
OI boaretto, francesca/0000-0003-2015-929X; Boniotto,
   Michele/0000-0002-9548-2254; Crovella, Sergio/0000-0001-8493-1168;
   amoroso, antonio/0000-0002-9437-9407; De Seta,
   Francesco/0000-0003-1611-0813
CR ALDER K, 1997, HISTOCHEM CELL BIOL, V108, P321
   Brennan MM, 2001, BRIT J BIOMED SCI, V58, P24
   BROKER TR, 1987, OBSTET GYN CLIN N AM, V14, P329
   Cannistra SA, 1996, NEW ENGL J MED, V334, P1030, DOI 10.1056/NEJM199604183341606
   Germer S, 1999, GENOME RES, V9, P72
   Hacker GW, 1998, EUR J HISTOCHEM, V42, P111
   Hove M. G. M., 2000, Central African Journal of Medicine, V46, P217
   Josefsson A, 1999, J CLIN MICROBIOL, V37, P490, DOI 10.1128/JCM.37.3.490-496.1999
   KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737
   Laimins LA, 1996, SEMIN VIROL, V7, P305, DOI 10.1006/smvy.1996.0038
   Mancuso T, 1997, INT J ONCOL, V11, P527
   Musiani M, 1997, J HISTOCHEM CYTOCHEM, V45, P729, DOI 10.1177/002215549704500511
   Nuovo GJ, 1999, J HISTOCHEM CYTOCHEM, V47, P273, DOI 10.1177/002215549904700301
   PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413
   Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507
   RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
   Syrjanen KJ, 1996, EUR J OBSTET GYN R B, V65, P45, DOI 10.1016/0028-2243(95)02303-A
   Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201
   Wiedorn KH, 1999, HISTOCHEM CELL BIOL, V111, P89, DOI 10.1007/s004180050338
   Zehbe I, 1997, AM J PATHOL, V150, P1553
NR 21
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1591-8890
EI 1591-9528
J9 CLIN EXP MED
JI Clin. Exper. Med.
PD MAY
PY 2002
VL 2
IS 1
BP 1
EP 6
DI 10.1007/s102380200000
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 554NP
UT WOS:000175742400001
PM 12049184
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Tossi, A
   Crovella, S
AF Boniotto, M
   Tossi, A
   Crovella, S
TI beta-defensin 2 in the rhesus monkey (Macaca mulatta) and the
   long-tailed macaque (M-fascicularis)
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Letter
ID ANTIMICROBIAL PEPTIDES; HOST-DEFENSE
C1 Univ Trieste, Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Trieste, Italy.
RI Tossi, Alessandro/U-2474-2017; Tossi, Alessandro/ABC-9061-2020;
   Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; BONIOTTO,
   Michele/F-1857-2010
OI Tossi, Alessandro/0000-0001-9087-5764; Crovella,
   Sergio/0000-0001-8493-1168; BONIOTTO, Michele/0000-0002-9548-2254
CR Bals R, 2001, CLIN DIAGN LAB IMMUN, V8, P370, DOI 10.1128/CDLI.8.2.370-375.2001
   BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7
   Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3
   Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999
   Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
NR 8
TC 4
Z9 4
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD MAR
PY 2002
VL 9
IS 2
BP 503
EP 503
DI 10.1128/CDLI.9.2.503-504.2002
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 532EA
UT WOS:000174457600051
PM 11874904
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Tresoldi, E
   Romiti, ML
   Boniotto, M
   Crovella, S
   Salvatori, F
   Palomba, E
   Pastore, A
   Cancrini, C
   de Martino, M
   Plebani, A
   Castelli, G
   Rossi, P
   Tovo, PA
   Amoroso, A
   Scarlatti, G
AF Tresoldi, E
   Romiti, ML
   Boniotto, M
   Crovella, S
   Salvatori, F
   Palomba, E
   Pastore, A
   Cancrini, C
   de Martino, M
   Plebani, A
   Castelli, G
   Rossi, P
   Tovo, PA
   Amoroso, A
   Scarlatti, G
CA European Shared Cost Project Grp
   Italian Register HIV Infection Chi
TI Prognostic value of the stromal cell-derived factor 1 3 ' A mutation in
   pediatric human immunodeficiency virus type 1 infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT Keystone Symposia
CY APR 04-10, 2000
CL KEYSTONE, COLORADO
ID DISEASE PROGRESSION; HIV-1 INFECTION; CCR5; TRANSMISSION; INDIVIDUALS;
   VARIANT; SDF-1
AB A mutation of the stromal cell-derived factor 1 gene (SDF-1 3'A) was shown to protect adults exposed to human immunodeficiency virus type 1 (HIV-1) from infection and to affect HIV disease progression in adults. The presence of this mutation in HIV-1-infected Kenyan children did not predict mother-to-child virus transmission. The SDF-1 3'A polymorphism was studied in 256 HIV-1-infected, 118 HIV-1-exposed but uninfected, and 170 unexposed and uninfected children of Italian origin, and the frequency of SDF-1 3'A heterozygosity and homozygosity in each of the 3 groups was similar. Of the 256 HIV-1-infected children, 194 were regularly followed up and were assigned to groups according to disease progression. The frequency of the SDF-1 3'A allele was substantially lower among children with long-term nonprogression than among children with rapid (P=.0329) or delayed (P=.0375) progression. We show that the presence of the SDF-1 3'A gene correlates with accelerated disease progression in HIV-1-infected children born to seropositive mothers but does not protect against mother-to-child HIV-1 transmission.
C1 San Raffaele Sci Inst, Dept Biotechnol, HIV Immunobiol Unit, I-20132 Milan, Italy.
   Univ Milan, Dept Pediat, Milan, Italy.
   Univ Roma Tor Vergata, Dept Pediat, Rome, Italy.
   Childrens Hosp Bambino Gesu, Div Infect Dis & Immunol, Rome, Italy.
   Univ Trieste, Childrens Hosp, Genet Serv, Trieste, Italy.
   Univ Florence, Dept Pediat, Florence, Italy.
   Univ Turin, Dept Pediat, I-10124 Turin, Italy.
RP Scarlatti, G (corresponding author), San Raffaele Sci Inst, Dept Biotechnol, HIV Immunobiol Unit, Via Olgettina 58, I-20132 Milan, Italy.
RI Boniotto, Michele/F-1857-2010; Crovella, Sergio/K-5050-2016; Rossi,
   Paolo/K-5746-2016; rossi, paolo/D-6504-2012; Boniotto,
   Michele/AAB-4302-2020; scarlatti, gabriella/H-1482-2018; amoroso,
   antonio/AAL-1475-2020; Plebani, Alessandro/C-8593-2011; AMOROSO,
   ANTONIO/AAN-3884-2020
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; Rossi, Paolo/0000-0003-2620-7918; scarlatti,
   gabriella/0000-0003-2316-2689; amoroso, antonio/0000-0002-9437-9407;
   cancrini, caterina/0000-0001-8410-9617; Tovo, Pier
   Angelo/0000-0002-0192-3240
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [HD 34337] Funding
   Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD
   HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R01HD034337, R01HD034337, R01HD034337, R01HD034337, R01HD034337]
   Funding Source: NIH RePORTER
CR [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650
   FANRIJ RP, 1998, AIDS, V12, pF85
   John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000
   Magierowska M, 1998, IMMUNOGENETICS, V48, P417, DOI 10.1007/s002510050454
   Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941
   Marechal V, 1999, J VIROL, V73, P3608
   Martin N, 1996, AIDS RES HUM RETROV, V12, P1565, DOI 10.1089/aid.1996.12.1565
   Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786
   OMETTO L, 1995, AIDS, V9, P427, DOI 10.1097/00002030-199509050-00003
   PIAZZA A, 1985, ANN HUM GENET, V49, P47, DOI 10.1111/j.1469-1809.1985.tb01675.x
   Romiti ML, 2000, MOL MED, V6, P28, DOI 10.1007/BF03401932
   Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259
   Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003
   Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389
NR 15
TC 28
Z9 28
U1 0
U2 2
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2002
VL 185
IS 5
BP 696
EP 700
DI 10.1086/339004
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 521YL
UT WOS:000173868900018
PM 11865429
OA Bronze
DA 2020-12-08
ER

PT J
AU Del Pero, M
   Boniotto, M
   Zuccon, D
   Cervella, P
   Spano, A
   Amoroso, A
   Crovella, S
AF Del Pero, M
   Boniotto, M
   Zuccon, D
   Cervella, P
   Spano, A
   Amoroso, A
   Crovella, S
TI beta-defensin 1 gene variability among non-human primates
SO IMMUNOGENETICS
LA English
DT Article
DE defensins; molecular evolution; molecular adaptation; innate immune
   system; antimicrobial peptide
ID TRACHEAL EPITHELIAL-CELLS; HUMAN BETA-DEFENSIN-1; ANTIMICROBIAL
   PEPTIDES; INNATE IMMUNITY; MAMMALIAN DEFENSINS; ALPHA-DEFENSINS;
   LIPOPOLYSACCHARIDE; INFLAMMATION; ANTIBIOTICS; EXPRESSION
AB Defensins are a recently described family,of peptides that play an important role in innate immunity. Recent studies have shown that defensins exhibit a broad spectrum of antimicrobial activities against bacteria and fungi. Three families have been identified so far in mammals, alpha-defensins, beta-defensins and theta-defensins, presumably derived from a common ancestral defensin. A long-term study on the evolution of these multigene families among primates has been undertaken to investigate: (1) the degree of interspecific differentiation; (2) the genetic mechanisms responsible for the variability of these molecules; and (3) the possible role of different environmental factors in their evolution. Nucleotide sequences have been obtained from great and lesser apes, several African and Asian catarrhine monkeys and one New World monkey. A comparison of rates of synonymous and nonsynonymous (amino-acid changing) nucleotide substitution indicates that the primate P-defensin I gene evolved under a pattern of random nucleotide substitution as predicted by the neutral theory of molecular evolution. These results are not consistent with the hypothesis that the primate P-defensin 1 gene has diversified in response to changes in the microbial species to which a given host is exposed. Analyses of interpecific variability have yielded some insights about the pattern of molecular evolution of the gene among primates. Humans and great apes present high levels of sequence similarity, differing in only one amino acid residue in the mature peptide. Compared with these taxa, hylobatids and cercopithecids exhibit 3-4 amino acid substitutions, some of which increase the net charge of the active molecule.
C1 Univ Trieste, Osped Infantile Burlo Garofolo, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   Univ Turin, Dipartimento Biol Anim & Uomo, I-10123 Turin, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Osped Infantile Burlo Garofolo, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34137 Trieste, Italy.
RI Zuccon, Dario/AAF-7055-2020; Boniotto, Michele/F-1857-2010; AMOROSO,
   ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; Boniotto,
   Michele/AAB-4302-2020; amoroso, antonio/AAL-1475-2020
OI Zuccon, Dario/0000-0001-8236-5924; Boniotto,
   Michele/0000-0002-9548-2254; Crovella, Sergio/0000-0001-8493-1168;
   amoroso, antonio/0000-0002-9437-9407; CERVELLA,
   Piero/0000-0002-0642-6059
CR Aiyar A, 2000, Methods Mol Biol, V132, P221
   ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994
   BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
   Brockus CW, 1998, ANIM GENET, V29, P283, DOI 10.1046/j.1365-2052.1998.00338.x
   BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1104/pp.108.4.1353
   Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156
   Dork T, 1998, MOL CELL PROBE, V12, P171, DOI 10.1006/mcpr.1998.0165
   GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7
   Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje
   Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293
   Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088
   Harder J, 1997, GENOMICS, V46, P472, DOI 10.1006/geno.1997.5074
   HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2
   Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hughes AL, 1997, J MOL EVOL, V44, P675, DOI 10.1007/PL00006191
   Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   Huttner KM, 1997, FEBS LETT, V413, P45, DOI 10.1016/S0014-5793(97)00875-2
   KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210
   KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0
   LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095
   Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6
   Liu LD, 1997, GENOMICS, V43, P316, DOI 10.1006/geno.1997.4801
   Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634
   Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994
   Russell JP, 1996, INFECT IMMUN, V64, P1565, DOI 10.1128/IAI.64.5.1565-1568.1996
   Sambrook J, 1989, MOL CLONING LAB MANU
   SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988
   SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453
   SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985
   SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984
   Stolzenberg ED, 1997, P NATL ACAD SCI USA, V94, P8686, DOI 10.1073/pnas.94.16.8686
   Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999
   Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
   Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525
   ZHAO C, 1996, FEBS LETT, V369, P319
NR 46
TC 33
Z9 48
U1 0
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0093-7711
J9 IMMUNOGENETICS
JI Immunogenetics
PD FEB
PY 2002
VL 53
IS 10-11
BP 907
EP 913
DI 10.1007/s00251-001-0412-x
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 535TR
UT WOS:000174662900011
PM 11862391
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Belgrano, A
   Pizzignach, M
   Spano, A
   Vatta, S
   Crovella, S
   Baldas, V
   Santon, D
   Trevisiol, C
   Tommasini, A
   Ventura, S
   Torre, G
   Not, T
   Amoroso, A
AF Boniotto, M
   Belgrano, A
   Pizzignach, M
   Spano, A
   Vatta, S
   Crovella, S
   Baldas, V
   Santon, D
   Trevisiol, C
   Tommasini, A
   Ventura, S
   Torre, G
   Not, T
   Amoroso, A
TI HLA association was not found in TTG+ and EMA- coeliac patients while
   SDF-1 association was evident only in young subjects
SO TISSUE ANTIGENS
LA English
DT Meeting Abstract
C1 Univ Trieste, IRCCS Burlo Garofolo, Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Boniotto, Michele/AAB-4302-2020; Tommasini,
   Alberto/AAE-3882-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Tommasini, Alberto/0000-0002-6943-7927
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PY 2002
VL 59
SU 2
BP 36
EP 36
PG 1
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 564JM
UT WOS:000176311300109
DA 2020-12-08
ER

PT J
AU Mase, G
   Ros, S
   Gemma, A
   Bonfigli, L
   Carraro, N
   Cazzato, G
   Rolfo, M
   Zanconati, F
   Sepcic, J
   Jurjevic, A
   Pirulli, D
   Boniotto, M
   Zezlina, S
   Crovella, S
   Amoroso, A
AF Mase, G
   Ros, S
   Gemma, A
   Bonfigli, L
   Carraro, N
   Cazzato, G
   Rolfo, M
   Zanconati, F
   Sepcic, J
   Jurjevic, A
   Pirulli, D
   Boniotto, M
   Zezlina, S
   Crovella, S
   Amoroso, A
TI ALS with variable phenotypes in a six-generation family caused by
   leu144phe mutation in the SOD1 gene
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 11th International Symposium on Amyotrophic Lateral Sclerosis/Motor
   Neuron Disease
CY DEC 04-06, 2000
CL AARHUS, DENMARK
DE ALS; Istro-Rumanian; SOD1 gene
ID AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE GENE; MOTOR-NEURON
   DISEASE; FRONTOTEMPORAL DEMENTIA; HYPERTHYROIDISM; LINKAGE
AB Background: amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder. The mutations of Cu/Zn superoxide dismutase gene (SOD1) are responsible for familial ALS. We investigated a large family of Istro-Rumanian origin characterized by an autosomal dominant ALS occurring in 18 cases (three of which are still alive) throughout six generations. Methods: clinical data were available for nine patients from the 2nd generation onward, among which one contained the neuropathological. details. The mean age at onset of the disease (SD) was 57.3 +/- 8.9 years (range 49-72), while the duration of the disease spanned over a length of time equal to 4.9 +/- 1.96 years (range 1.5-7). The analysis of the coding region of SOD1 was done by PCR and direct sequencing. The SOD1 activity was measured by using the red and mononuclear cells belonging to three of the patients. Results: the leul44phe mutation of SOD1 was identified in four patients while a normal sequence was found in five healthy related subjects. The molecular defect was responsible for a decrease in SOD1 activity. Most of patients in this family presented clinical manifestations of ALS (in particular, the lower limb onset variant) not as severe as typical ALS caused by other SOD1 mutations. However, one patient suffering from hyperthyroidism for 17 years, showed an early onset and a rapidly progressing ALS coupled with dementia. Conclusions: we described a large family with a relatively not severe phenotype of ALS (due to a leul44phe SOD1 mutation) that was compromised in one patient by a concomitant hyperthyroidism. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Trieste, Genet Serv, I-34137 Trieste, Italy.
   Burlo Garofolo Hosp, I-34137 Trieste, Italy.
   Univ Trieste, Dept Neurol, Trieste, Italy.
   Cattinara Hosp, Trieste, Italy.
   Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy.
   Univ Trieste, Dept Pathol, Trieste, Italy.
   Univ Rijeka, Dept Neurol, Rijeka, Croatia.
RP Amoroso, A (corresponding author), Univ Trieste, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM amoroso@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; sepcic, juraj/S-7687-2018; Boniotto,
   Michele/AAB-4302-2020; amoroso, antonio/AAL-1475-2020; Boniotto,
   Michele/F-1857-2010; AMOROSO, ANTONIO/AAN-3884-2020
OI Crovella, Sergio/0000-0001-8493-1168; sepcic, juraj/0000-0002-5669-7981;
   amoroso, antonio/0000-0002-9437-9407; Boniotto,
   Michele/0000-0002-9548-2254; ZANCONATI, FABRIZIO/0000-0001-5357-9579
CR Aguirre T, 1999, EUR J HUM GENET, V7, P599, DOI 10.1038/sj.ejhg.5200337
   ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61
   APPEL SH, 1986, ARCH NEUROL-CHICAGO, V43, P234, DOI 10.1001/archneur.1986.00520030026007
   BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0
   Ceroni M, 1999, NEUROLOGY, V53, P1064, DOI 10.1212/WNL.53.5.1064
   Chotmongkol Verajit, 1999, Journal of the Medical Association of Thailand, V82, P615
   DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519
   FISHER M, 1985, AM J MED, V78, P1041, DOI 10.1016/0002-9343(85)90231-1
   FRIDOVICH I, 1975, ADV ENZYMOLOGY RELAT, P61
   HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0
   Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664
   Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535
   JONES CT, 1993, LANCET, V342, P1050, DOI 10.1016/0140-6736(93)92905-9
   Juneja T, 1997, NEUROLOGY, V48, P55, DOI 10.1212/WNL.48.1.55
   KUSAKA H, 1993, CLIN NEUROPATHOL, V12, P164
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MCMENAMIN J, 1980, J NEUROL NEUROSUR PS, V43, P46, DOI 10.1136/jnnp.43.1.46
   Morita M, 1998, EUR J NEUROL, V5, P389, DOI 10.1046/j.1468-1331.1998.540389.x
   MOTTIER D, 1981, NOUV PRESSE MED, V10, P1665
   Moulard B, 1997, REV NEUROL-FRANCE, V153, P314
   Nakano I, 2000, NEUROPATHOLOGY, V20, P68, DOI 10.1046/j.1440-1789.2000.00272.x
   Neary D, 2000, J NEUROL SCI, V180, P15, DOI 10.1016/S0022-510X(00)00425-1
   Nestor P, 2000, SEMIN NEUROL, V20, P439, DOI 10.1055/s-2000-13176
   Orrell RW, 1997, J NEUROL SCI, V153, P46, DOI 10.1016/S0022-510X(97)00181-0
   Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1
   PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592
   Robberecht W, 2000, J NEUROL, V247, P2
   ROSATI G, 1980, ARCH NEUROL-CHICAGO, V37, P530, DOI 10.1001/archneur.1980.00500570078020
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207
   Sambrook J., 1999, MOL CLONING LAB MANU
   SERRADELL AP, 1990, REV NEUROL, V146, P219
   SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001
   Siddique T, 1996, CLIN NEUROSCI, V3, P338
   TANAKA M, 1993, J NEUROL SCI, V120, P22, DOI 10.1016/0022-510X(93)90019-U
   Vercelletto M, 1999, EUR J NEUROL, V6, P295, DOI 10.1046/j.1468-1331.1999.630295.x
   Weber M, 2000, BRAIN, V123, P1505, DOI 10.1093/brain/123.7.1505
   *WORDL MED ASS, 1991, BRIT MED J, V302, P1194
NR 38
TC 33
Z9 33
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2001
VL 191
IS 1-2
BP 11
EP 18
DI 10.1016/S0022-510X(01)00625-6
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 491JD
UT WOS:000172104500003
PM 11676987
DA 2020-12-08
ER

PT J
AU Crovella, S
   Boniotto, M
   Del Pero, M
   Amoroso, A
AF Crovella, S
   Boniotto, M
   Del Pero, M
   Amoroso, A
TI Beta-defensin 1 gene variability among non-human primates.
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
C1 Univ Trieste, Dept Sci Biol & Reprod, Mol Genet Unit, I-34127 Trieste, Italy.
   Univ Turin, Dept Anim Biol, Turin, Italy.
RI Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; amoroso,
   antonio/AAL-1475-2020; AMOROSO, ANTONIO/AAN-3884-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0002-9297
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT
PY 2001
VL 69
IS 4
SU 1
MA 1006
BP 355
EP 355
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA 483RD
UT WOS:000171648901006
DA 2020-12-08
ER

PT J
AU Amoroso, A
   Pirulli, D
   Florian, F
   Puzzer, D
   Boniotto, M
   Crovella, S
   Zezlina, S
   Spano, A
   Mazzola, G
   Savoldi, S
   Ferrettini, C
   Berutti, S
   Petrarulo, M
   Marangella, M
AF Amoroso, A
   Pirulli, D
   Florian, F
   Puzzer, D
   Boniotto, M
   Crovella, S
   Zezlina, S
   Spano, A
   Mazzola, G
   Savoldi, S
   Ferrettini, C
   Berutti, S
   Petrarulo, M
   Marangella, M
TI AGXT gene mutations and their influence on clinical heterogeneity of
   type 1 primary hyperoxaluria
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID ALANINE-GLYOXYLATE AMINOTRANSFERASE; CATALYTIC ACTIVITY; POINT MUTATION;
   SERINE; IDENTIFICATION; DIAGNOSIS; PHENOTYPE; DISEASE; INTRON
AB Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder that is caused by a deficiency of alanine: glyoxylate aminotransferase (AGT), which is encoded by a single copy gene (AGXT). Molecular diagnosis was used in conjunction with clinical, biochemical, and enzymological data to evaluate genotype-phenotype correlation. Twenty-three unrelated, Italian PH1 patients were studied, 20 of which were grouped according to severe form of PH1 (group A), adult form (group B), and mild to moderate decrease in renal function (group C). All 23 patients were analyzed by using the single-strand conformation polymorphism technique followed by the sequencing of the 11 AGXT exons. Relevant chemistries, including plasma, urine and dialyzate oxalate and glycolate assays, liver AGT activity, and pyridoxine responsiveness, were performed. Both mutant alleles were found in 21 out of 23 patients, and 13 different mutations were recognized in exons 1, 2, 4, and 10. Normalized AGT activity was lower in the severe form than in the adult form (P<0.05). Double heterozygous patients presented a lower age at the onset of the disease (P=0.025), and they were more frequent in group A (75%) than in the group B (14%; P=0.0406). The T444C mutation was more frequent in the severe form (P<0.05), and the opposite was observed for G630A (P<0.05). G630A mutation homozygotes had a higher AGT residual activity (P=0.00001). This study confirms the allelic heterogeneity of the AGXT, which could to some extent be responsible for the phenotypic heterogeneity in PH1.
C1 Univ Trieste, Dept Reprod & Dev Sci, Genet Sect, Trieste, Italy.
   IRCCS, Med Genet Serv, Trieste, Italy.
   Univ Trieste, Dept Biol, Trieste, Italy.
   Osped S Giovanni Battista Torino, Transplant Immunol Serv, Turin, Italy.
   Azienda Osped Triestina, Div Nephrol & Dialysis, Trieste, Italy.
   Osped Mauriziano Umberbo 1, Renal Stones Ctr, Turin, Italy.
RP Amoroso, A (corresponding author), IRCCS, Serv Genet, Via Istria 65-1, I-34137 Trieste, Italy.
EM amoroso@burlo.trieste.it
RI amoroso, antonio/AAL-1475-2020; AMOROSO, ANTONIO/AAN-3884-2020;
   Boniotto, Michele/F-1857-2010; Boniotto, Michele/AAB-4302-2020;
   Crovella, Sergio/K-5050-2016
OI amoroso, antonio/0000-0002-9437-9407; Boniotto,
   Michele/0000-0002-9548-2254; Crovella, Sergio/0000-0001-8493-1168
CR Basmaison O, 2000, Hum Mutat, V15, P577, DOI 10.1002/1098-1004(200006)15:6<577::AID-HUMU9>3.0.CO;2-#
   DANPURE CJ, 1993, BIOCHIMIE, V75, P309, DOI 10.1016/0300-9084(93)90091-6
   Danpure CJ, 1998, J NEPHROL, V11, P8
   DANPURE CJ, 1994, J INHERIT METAB DIS, V17, P487, DOI 10.1007/BF00711363
   DANPURE CJ, 1989, J INHERIT METAB DIS, V12, P210, DOI 10.1007/BF01800727
   DANPURE CJ, 1994, HUM GENET, V94, P55, DOI 10.1007/BF02272842
   DANPURE CJ, 1993, AM J HUM GENET, V53, P417
   DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4
   DANPURE CJ, 1995, CALCIUM OXALATE BIOL, P189
   DANPURE CJ, 1996, KIDNEY STONES MED SU, P859
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x
   DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317
   Ferrettini C, 1998, J NEPHROL, V11, P18
   Hoppe B, 1997, AM J KIDNEY DIS, V29, P36, DOI 10.1016/S0272-6386(97)90006-8
   KUO JL, 1993, GENOMICS, V16, P173, DOI 10.1006/geno.1993.1155
   Lhotta K, 1996, NEPHROL DIAL TRANSPL, V11, P2296, DOI 10.1093/oxfordjournals.ndt.a027152
   Maquat LE, 1996, AM J HUM GENET, V59, P279
   MARANGELLA M, 1992, J UROLOGY, V148, P986, DOI 10.1016/S0022-5347(17)36796-4
   MARANGELLA M, 1991, KIDNEY INT, V39, P149, DOI 10.1038/ki.1991.19
   MARANGELLA M, 1993, NEPHROL DIAL TRANSPL, V8, P1333
   MINATOGAWA Y, 1992, HUM MOL GENET, V1, P643, DOI 10.1093/hmg/1.8.643
   Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0
   NISHIYAMA K, 1991, BIOCHEM BIOPH RES CO, V176, P1093, DOI 10.1016/0006-291X(91)90396-O
   NISHIYAMA K, 1993, J CELL BIOL, V123, P1237, DOI 10.1083/jcb.123.5.1237
   Nogueira PK, 2000, HUM MUTAT, V15, P384, DOI 10.1002/(SICI)1098-1004(200004)15:4<384::AID-HUMU20>3.0.CO;2-J
   PETRARULO M, 1992, CLIN CHIM ACTA, V208, P183, DOI 10.1016/0009-8981(92)90075-2
   Petrarulo M, 1998, J NEPHROL, V11, P23
   Pirulli D, 1999, HUM GENET, V104, P523, DOI 10.1007/s004390050998
   PURDUE PE, 1991, HUM GENET, V87, P394
   PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900
   PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H
   PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341
   Rinat C, 1999, J AM SOC NEPHROL, V10, P2352
   Rumsby G, 1998, J NEPHROL, V11, P13
   SCHEINMAN JI, 1991, KIDNEY INT, V40, P389, DOI 10.1038/ki.1991.224
   SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193
   von Schnakenburg C, 1998, NEPHRON, V78, P485, DOI 10.1159/000044979
   von Schnakenburg C, 1998, J NEPHROL, V11, P15
   VonSchnakenburg C, 1997, ANN HUM GENET, V61, P365, DOI 10.1017/S0003480097006283
   vonSchnakenburg C, 1997, J MED GENET, V34, P489, DOI 10.1136/jmg.34.6.489
   WATTS RWE, 1998, J NEPHROL S1, V11, pS4
NR 41
TC 46
Z9 46
U1 0
U2 0
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD OCT
PY 2001
VL 12
IS 10
BP 2072
EP 2079
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 474JU
UT WOS:000171104000008
PM 11562405
DA 2020-12-08
ER

PT J
AU Ventura, M
   Boniotto, M
   Cardone, MF
   Fulizio, L
   Archidiacono, N
   Rocchi, M
   Crovella, S
AF Ventura, M
   Boniotto, M
   Cardone, MF
   Fulizio, L
   Archidiacono, N
   Rocchi, M
   Crovella, S
TI Characterization of a highly repeated DNA sequence family in five
   species of the genus Eulemur
SO GENE
LA English
DT Article
DE chromosome rearrangements; sequence alignment; malagasy lemurs;
   fluorescence in situ hybridization
ID CHROMOSOMAL EVOLUTION; LEMURIDAE; FULVUS; RESOLUTION; PHYLOGENY;
   PROSIMIANS; PRIMATES; PATTERNS
AB The karyotypes of Eulemur species exhibit a high degree of variation, as a consequence of the Robertsonian fusion and/or centromere fission. Centromeric and pericentromeric heterochromatin of eulemurs is constituted by highly repeated DNA sequences (including some telomeric TTAGGG repeats) which have so far been investigated and used for the study of the systematic relationships of the different species of the genus Eulemur. In our study, we have cloned a set of repetitive pericentromeric sequences of five Eulemur species: E. fulvus fulvus (EFU), E. mongoz (EMO), E. macaco (EMA), E. rubriventer (ERU), and E. coronatus (ECO). We have characterized these clones by sequence comparison and by comparative fluorescence in situ hybridization analysis in EMA and EFU. Our results showed a high degree of sequence similarity among Eulemur species, indicating a strong conservation, within the five species, of these pericentromeric highly repeated DNA sequences. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Trieste, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   Univ Bari, Dipartimento Biol, I-70126 Bari, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; Boniotto,
   Michele/F-1857-2010; archidiacono, nicoletta/B-8471-2011; Cardone, Maria
   Francesca/G-8818-2012; Ventura, Mario/E-6420-2011; Rocchi,
   Mariano/B-8451-2011
OI Crovella, Sergio/0000-0001-8493-1168; Boniotto,
   Michele/0000-0002-9548-2254; Cardone, Maria
   Francesca/0000-0002-7597-7313; Ventura, Mario/0000-0001-7762-8777;
   archidiacono, nicoletta/0000-0002-1439-9521
CR CROVELLA S, 1993, PRIMATES, V34, P61, DOI 10.1007/BF02381281
   DELSAL G, 1989, BIOTECHNIQUES, V7, P515
   DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830
   Garagna S, 1997, CHROMOSOME RES, V5, P487, DOI 10.1023/A:1018425215516
   Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171
   IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   KAY RF, 1978, AM J PHYS ANTHROPOL, V49, P119, DOI 10.1002/ajpa.1330490118
   LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592
   MONTAGNON D, 1993, CYTOGENET CELL GENET, V63, P131, DOI 10.1159/000133518
   Muller S, 1997, CYTOGENET CELL GENET, V78, P260, DOI 10.1159/000134669
   Pastorini J, 2000, MOL PHYLOGENET EVOL, V16, P418, DOI 10.1006/mpev.2000.0796
   RUMPLER Y, 1980, FOLIA PRIMATOL, V33, P253, DOI 10.1159/000155940
   RUMPLER Y, 1979, CYTOGENET CELL GENET, V24, P224, DOI 10.1159/000131384
   Sambrook J, 1989, MOL CLONING LAB MANU
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TATTERSALL I, 1993, SCI AM, V268, P110, DOI 10.1038/scientificamerican0193-110
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wyner Y, 1999, BIOL J LINN SOC, V66, P39, DOI 10.1006/bijl.1998.0258
   Wyner Y, 2000, MOL PHYLOGENET EVOL, V15, P124, DOI 10.1006/mpev.1999.0723
   Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122
   Yoder AD, 1999, CLADISTICS, V15, P351, DOI 10.1111/j.1096-0031.1999.tb00271.x
NR 22
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD SEP 19
PY 2001
VL 275
IS 2
BP 305
EP 310
DI 10.1016/S0378-1119(01)00653-9
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 485MX
UT WOS:000171759100013
PM 11587858
DA 2020-12-08
ER

PT J
AU Delpero, M
   Masters, JC
   Cervella, P
   Crovella, S
   Ardito, G
   Rumpler, Y
AF Delpero, M
   Masters, JC
   Cervella, P
   Crovella, S
   Ardito, G
   Rumpler, Y
TI Phylogenetic relationships among the Malagasy lemuriforms (Primates :
   Strepsirrhini) as indicated by mitochondrial sequence data from the 12S
   rRNA gene
SO ZOOLOGICAL JOURNAL OF THE LINNEAN SOCIETY
LA English
DT Review
DE evolution; maximum parsimony; maximum likelihood; neighbour joining;
   Madagascar; radiation
ID INDRIIDAE PRIMATES; CYTOCHROME-B; SUBUNIT RNA; AYE-AYE; DNA; EVOLUTION;
   SYSTEMATICS; LEMURIDAE; FAMILY; COMPILATION
AB Numerous phylogenetic hypotheses have been advanced for the Malagasy lemuriform radiation, drawing on data from morphology, physiology, behaviour and molecular genetics. Almost all possible relationships have been proposed, and most nodes have been contested. We present a phylogenetic analysis, using several analytical methods, of a partial sequence from the 12S rRNA mitochondrial gene. This gene codes for the small ribosomal subunit, and functional constraints require that the secondary structure of the molecule is strongly conserved, which in turn exerts constraints on the primary sequence structure. Although previous studies have suggested a very wide range of phylogenetic applicability for this molecule, our results indicate that it is most useful in strepsirrhine primates for estimating relationships among genera within families and among relatively recently diverged families (mean sequence divergence about 11%). Relationships among families separated by larger genetic distances (>12% divergence; e.g. Cheirogaleidae, Daubentoniidae, Megaladapidae) are difficult to resolve consistently. Our data show strong support for an Indridae-Lemuridae sister group and for monophyly of the Lemuridae with Varecia as the sister to all other lemurids. They also support, albeit less strongly, sister group relationships between Lemur and Hapalemur within the Lemuridae and between Propithecus and Avahi in the Indridae. (C) 2001 The Linnean Society of London.
C1 Natal Museum, ZA-3200 Pietermaritzburg, South Africa.
   Univ Turin, Dipartimento Biol Anim & Uomo, I-10123 Turin, Italy.
   Univ KwaZulu Natal, Sch Bot & Zool, ZA-3209 Scottsville, South Africa.
   Univ Trieste, Med Genet Lab, Dipartimento Sci Reprod & Sviluppo, I-34127 Trieste, Italy.
   Univ Florence, Ist Antropol, I-50122 Florence, Italy.
   Univ Strasbourg, Fac Med, Inst Embryol, F-67085 Strasbourg, France.
RP Masters, JC (corresponding author), Natal Museum, Private Bag 9070, ZA-3200 Pietermaritzburg, South Africa.
EM jmasters@nmsa.org.za
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; CERVELLA,
   Piero/0000-0002-0642-6059
CR ADKINS RM, 1994, J MOL EVOL, V38, P215
   ALLARD MW, 1992, P NATL ACAD SCI USA, V89, P3972, DOI 10.1073/pnas.89.9.3972
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   AnkelSimons F, 1996, AM J PRIMATOL, V39, P87, DOI 10.1002/(SICI)1098-2345(1996)39:2<87::AID-AJP1>3.0.CO;2-N
   BEARD KC, 1988, J HUM EVOL, V17, P71, DOI 10.1016/0047-2484(88)90050-4
   BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0
   Cartmill M., 1975, P313
   COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741
   CRONIN JE, 1978, RECENT ADV PRIMATOL, V3, P287
   CROVELLA S, 1993, PRIMATES, V34, P61, DOI 10.1007/BF02381281
   Crovella S., 1995, Human Evolution, V10, P35, DOI 10.1007/BF02437512
   DELPERO M, 1995, PRIMATES, V36, P431, DOI 10.1007/BF02382865
   DENE H, 1976, FOLIA PRIMATOL, V25, P35, DOI 10.1159/000155706
   DENE HT, 1976, MOL ANTHR, P171
   DUNONBLUTEAU D, 1986, FEBS LETT, V198, P333, DOI 10.1016/0014-5793(86)80431-8
   DUTRILLAUX B, 1988, FOLIA PRIMATOL, V50, P130, DOI 10.1159/000156337
   EAGLEN RH, 1983, INT J PRIMATOL, V4, P249, DOI 10.1007/BF02735549
   EAGLEN RH, 1980, THESIS DUKE U
   FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513
   FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Felsenstein J., 1993, PHYLIP PHYLOGENY INF
   Fleagle JG, 1988, PRIMATE ADAPTATION E
   Garbutt N., 1999, MAMMALS MADAGASCAR
   GATESY J, 1992, MOL BIOL EVOL, V9, P433
   GEBO DL, 1988, J HUM EVOL, V17, P135, DOI 10.1016/0047-2484(88)90052-8
   GEBO DL, 1985, AM J PHYS ANTHROPOL, V67, P269, DOI 10.1002/ajpa.1330670312
   GODFREY LR, IN PRESS PRIMATE FOS
   GODINOT M, 1992, NATURE, V357, P324, DOI 10.1038/357324a0
   Groves C.P., 1989, THEORY HUMAN PRIMATE
   GROVES CP, 1995, J HUM EVOL, V28, P427, DOI 10.1006/jhev.1995.1033
   GROVES CP, 1988, J HUM EVOL, V17, P513, DOI 10.1016/0047-2484(88)90040-1
   GROVES CP, 1974, PROSIMIAN BIOL, P449
   Hill W. C. O., 1953, PRIMATES COMP ANATOM
   HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338
   HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540
   HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190
   ISHAK B, 1988, AM J PRIMATOL, V15, P275, DOI 10.1002/ajp.1350150309
   ISHAK B, 1992, FOLIA PRIMATOL, V58, P121, DOI 10.1159/000156619
   Jenkins P., 1987, CATALOGUE PRIMATES 4
   JUKES TH, 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028
   KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196
   Kolnicki RL, 1999, SYMBIOSIS, V26, P123
   Lernould J.-M., 1988, P54
   Linnaeus C., 1758, SYSTEMA NATURAE
   LUCKETT WP, 1986, AM J PHYS ANTHROPOL, V69, P233
   MACEDONIA JM, 1994, FOLIA PRIMATOL, V63, P1, DOI 10.1159/000156787
   MADDISON WP, 1992, MACCLADE ANAL PHYLOG
   Martin R. D., 1990, PRIMATE ORIGINS EVOL
   Masters JC, 1995, CREATURES OF THE DARK, P31
   MASTERS JC, TANGLED THREADS CONF
   MINDELL DP, 1991, P NATL ACAD SCI USA, V88, P10322, DOI 10.1073/pnas.88.22.10322
   MINDELL DP, 1990, ANNU REV ECOL SYST, V21, P541, DOI 10.1146/annurev.es.21.110190.002545
   MITTERMEIER RA, 1994, LEMURS MADAGASCAR
   MIYAMOTO MM, 1990, P NATL ACAD SCI USA, V87, P6127, DOI 10.1073/pnas.87.16.6127
   NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025
   Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637
   OXNARD CE, 1981, AM J PHYS ANTHROPOL, V54, P1, DOI 10.1002/ajpa.1330540102
   OXNARD CE, 1981, AM J PHYS ANTHROPOL, V54, P421, DOI 10.1002/ajpa.1330540316
   OXNARD CE, 1981, AM J PHYS ANTHROPOL, V54, P481, DOI 10.1002/ajpa.1330540406
   Petter J.-J., 1979, P247
   PETTER JJ, 1977, FAUNE MADAGASCAR, V44
   PORTER CA, 1995, J MOL EVOL, V40, P30, DOI 10.1007/BF00166594
   Randria GFN, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P55
   Razafindraibe H, 1997, CR ACAD SCI III-VIE, V320, P469, DOI 10.1016/S0764-4469(97)81974-9
   Razafindraibe H, 2000, PRIMATES, V41, P189, DOI 10.1007/BF02557800
   Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047
   RUMPLER Y, 1990, CELL BIOL REV, V23, P1
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sarich V.M, 1976, P141
   SCHWARTZ J H, 1985, Anthropological Papers of the American Museum of Natural History, V60, P1
   SCHWARTZ JH, 1975, FOLIA PRIMATOL, V23, P290, DOI 10.1159/000155678
   SHEDD DH, 1991, FOLIA PRIMATOL, V57, P221, DOI 10.1159/000156589
   Simon C, 1996, MOL BIOL EVOL, V13, P923, DOI 10.1093/oxfordjournals.molbev.a025660
   SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651
   SIMONS EL, 1988, FOLIA PRIMATOL, V50, P143, DOI 10.1159/000156340
   SIMONS EL, 1995, QUATERNARY RES, V43, P249, DOI 10.1006/qres.1995.1025
   Simons EL, 1972, PRIMATE EVOLUTION
   Smuts B.B., 1987, PRIMATE SOC
   Soligo C, 1999, J HUM EVOL, V36, P97, DOI 10.1006/jhev.1998.0263
   Stanger-Hall K, 1998, MOL BIOL EVOL, V15, P1572, DOI 10.1093/oxfordjournals.molbev.a025885
   Stanger-Hall Kathrin F., 1997, Journal of Mammalian Evolution, V4, P163, DOI 10.1023/A:1027345624734
   Swofford DL, 1993, PHYLOGENETIC ANAL US
   SZALAY FS, 1973, FOLIA PRIMATOL, V19, P88, DOI 10.1159/000155535
   TATTERSALL I, 1991, ANTHROPOL PAP AM MUS, V69, P3
   Tattersall I., 1975, PHYLOGENY PRIMATES, P299, DOI [10.1007/978-1-4684-2166-8_13, DOI 10.1007/978-1-4684-2166-8_13]
   Tattersall I., 1982, PRIMATES MADAGASCAR
   Tattersall Ian, 1993, P163
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   VANDEPEER Y, 1994, NUCLEIC ACIDS RES, V22, P3488
   VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111
   Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z
   YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104
   Yoder AD, 1996, MOL BIOL EVOL, V13, P1339, DOI 10.1093/oxfordjournals.molbev.a025580
   Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122
   Yoder AD, 1999, CLADISTICS, V15, P351, DOI 10.1111/j.1096-0031.1999.tb00271.x
NR 101
TC 32
Z9 33
U1 0
U2 22
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0024-4082
EI 1096-3642
J9 ZOOL J LINN SOC-LOND
JI Zool. J. Linn. Soc.
PD SEP
PY 2001
VL 133
IS 1
BP 83
EP 103
DI 10.1111/j.1096-3642.2001.tb00624.x
PG 21
WC Zoology
SC Zoology
GA 461XR
UT WOS:000170389600005
OA Bronze
DA 2020-12-08
ER

PT J
AU Braida, L
   Crovella, S
   Boniotto, M
   Luchesi, A
   de Vonderweid, U
   Casetta, B
   Amoroso, A
AF Braida, L
   Crovella, S
   Boniotto, M
   Luchesi, A
   de Vonderweid, U
   Casetta, B
   Amoroso, A
TI A rapid and quantitative mass spectrometry method for determining the
   concentration of acylcarnitines and aminoacids in amniotic fluid
SO PRENATAL DIAGNOSIS
LA English
DT Article
DE amniotic fluid; aminoacids; acylcarnitines; mass spectrometry
ID BLOOD SPOTS; PRENATAL-DIAGNOSIS; ACIDS; NEWBORNS; MUTATION; PLASMA
AB We describe a quantitative. rapid, sensitive and reproducible tandem mass spectrometry (MSMS) method for the one-step detection of aminoacid (AAs) and acylcarnitine (ACs) concentrations in amniotic fluid. This technology is quicker and more sensitive than other methods used to date since it is possible to determine very low AA and AC concentrations in samples simultaneously in a single run. The high degree of automation allows a large number of pregnancies to be screened for metabolic defects in a very short time. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 IRCCS Burlo Garofolo, Serv Genet Med, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Unita Operat Neonatol, I-34137 Trieste, Italy.
   Univ Trieste, Dipartmento Sci Riproduz & Sviluppo, I-34137 Trieste, Italy.
   Appl Biosyst Inc, I-20052 Monza, MI, Italy.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Serv Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010;
   Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407
CR BOCK JL, 1994, CLIN CHEM, V40, P56
   Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057
   Chace DH, 1996, CLIN CHEM, V42, P349
   CHACE DH, 1995, CLIN CHEM, V41, P62
   CHACE DH, 1993, CLIN CHEM, V39, P66
   CONNE B, 1995, J INHERIT METAB DIS, V18, P577, DOI 10.1007/BF02436002
   Dawson EB, 1999, J REPROD MED, V44, P28
   GREGERSEN N, 1993, HUM HERED, V43, P342, DOI 10.1159/000154157
   Jauniaux E, 1999, HUM REPROD, V14, P1638, DOI 10.1093/humrep/14.6.1638
   Jauniaux E, 1998, EARLY HUM DEV, V51, P159, DOI 10.1016/S0378-3782(97)00107-2
   KAMOUN P, 1998, PRENAT DIAGN, V18, P947
   Rabier D, 1996, PRENATAL DIAG, V16, P623
   Van Hove JLK, 2000, J INHERIT METAB DIS, V23, P571, DOI 10.1023/A:1005673828469
   VANHOVE JLK, 1993, J INHERIT METAB DIS, V16, P361, DOI 10.1007/BF00710283
NR 14
TC 7
Z9 7
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0197-3851
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD JUL
PY 2001
VL 21
IS 7
BP 543
EP 546
DI 10.1002/pd.93
PG 4
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA 463LY
UT WOS:000170478700004
PM 11494287
DA 2020-12-08
ER

PT J
AU Pirulli, D
   Giordano, M
   Lessi, M
   Spano, A
   Puzzer, D
   Zezlina, S
   Boniotto, M
   Crovella, S
   Florian, F
   Marangella, M
   Momigliano-Richiardi, P
   Savoldi, S
   Amoroso, A
AF Pirulli, D
   Giordano, M
   Lessi, M
   Spano, A
   Puzzer, D
   Zezlina, S
   Boniotto, M
   Crovella, S
   Florian, F
   Marangella, M
   Momigliano-Richiardi, P
   Savoldi, S
   Amoroso, A
TI Detection of AGXT gene mutations by denaturing high-performance liquid
   chromatography for diagnosis of hyperoxaluria type 1
SO CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE hyperoxaluria type 1; AGXT; denaturing high-performance liquid
   chromatography; heteroduplex
ID AMINOTRANSFERASE CATALYTIC-ACTIVITY; GLYOXYLATE AMINOTRANSFERASE;
   CONFORMATION POLYMORPHISM; POINT MUTATION; ALANINE; IDENTIFICATION;
   SERINE; REGION
AB Primary hyperoxaluria type 1 is an autosomal recessive disorder of glyoxylate metabolism, caused by a deficiency of alanine:glyoxylate aminotransferase, which is encoded by a single copy gene (AGXT). The aim of this research was to standardize denaturing high-performance liquid chromatography, a new, sensitive, relatively inexpensive, and automated technique, for the detection of AGXT mutation. Denaturing high-performance liquid chromatography was used to analyze in blind the AGXT gene in 20 unrelated Italian patients with primary hyperoxaluria type I previously studied by other standard methods (single-strand conformation polymorphism analysis and direct sequencing) and 50 controls. Denaturing high-performance liquid chromatography allowed us to identify 13 mutations and the polymorphism at position 154 in exon I of the AGXT gene. Hence the method is more sensitive and less time consuming than single-strand conformation polymorphism analysis for the detection of AGXT mutations, thus representing a useful and reliable tool for detecting the mutations responsible for primary hyperoxaluria type 1. The new technology could also be helpful in the search for healthy carriers of AGXT mutations amongst family members and their partners, and p for screening of AGXT polymorphisms in patients with nephrolithiasis and healthy populations.
C1 IRCCS Burlo Garofolo, Med Genet Serv, I-34137 Trieste, Italy.
   Univ Trieste, Dept Sci Reprod & Dev, Trieste, Italy.
   Univ Piemonte Orientale Amedeo Avogadro, Dept Med Sci, Novara, Italy.
   Univ Trieste, Dept Biol, Trieste, Italy.
   Mauriziano Umberto I Hosp, Ctr Renal Calcolosis, Turin, Italy.
   Cattinara Hosp, Div Nephrol & Dialysis, Trieste, Italy.
RP Amoroso, A (corresponding author), IRCCS Burlo Garofolo, Med Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
EM amoroso@burlo.trieste.it
RI AMOROSO, ANTONIO/AAN-3884-2020; amoroso, antonio/AAL-1475-2020;
   Crovella, Sergio/K-5050-2016; Boniotto, Michele/AAB-4302-2020; BONIOTTO,
   Michele/F-1857-2010
OI amoroso, antonio/0000-0002-9437-9407; Crovella,
   Sergio/0000-0001-8493-1168; GIORDANO, Mara/0000-0001-6686-4600;
   BONIOTTO, Michele/0000-0002-9548-2254
CR Basmaison O, 2000, Hum Mutat, V15, P577, DOI 10.1002/1098-1004(200006)15:6<577::AID-HUMU9>3.0.CO;2-#
   DANPURE CJ, 1989, J INHERIT METAB DIS, V12, P210, DOI 10.1007/BF01800727
   DANPURE CJ, 1991, AM J KIDNEY DIS, V17, P366, DOI 10.1016/S0272-6386(12)80624-X
   DANPURE CJ, 1993, AM J HUM GENET, V53, P417
   DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4
   DANPURE CJ, 1995, CALCIUM OXALATE BIOL, P189
   Ferrettini C, 1998, J NEPHROL, V11, P18
   Giordano M, 1999, GENOMICS, V56, P247, DOI 10.1006/geno.1998.5715
   Jones AC, 1999, CLIN CHEM, V45, P1133
   Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396
   MINATOGAWA Y, 1992, HUM MOL GENET, V1, P643, DOI 10.1093/hmg/1.8.643
   NISHIYAMA K, 1991, BIOCHEM BIOPH RES CO, V176, P1093, DOI 10.1016/0006-291X(91)90396-O
   Nogueira PK, 2000, HUM MUTAT, V15, P384, DOI 10.1002/(SICI)1098-1004(200004)15:4<384::AID-HUMU20>3.0.CO;2-J
   O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411
   Pirulli D, 1999, HUM GENET, V104, P523, DOI 10.1007/s004390050998
   PURDUE PE, 1991, HUM GENET, V87, P394
   PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H
   PURDUE PE, 1991, GENOMICS, V10, P34, DOI 10.1016/0888-7543(91)90481-S
   PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341
   SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193
   TAKADA Y, 1990, BIOCHEM J, V268, P517, DOI 10.1042/bj2680517
   Tarn AC, 1997, J INHERIT METAB DIS, V20, P689, DOI 10.1023/A:1005326510239
   Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996
   von Schnakenburg C, 1998, J NEPHROL, V11, P15
   vonSchnakenburg C, 1997, J MED GENET, V34, P489, DOI 10.1136/jmg.34.6.489
NR 25
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1591-8890
EI 1591-9528
J9 CLIN EXP MED
JI Clin. Exper. Med.
PD JUN
PY 2001
VL 1
IS 2
BP 99
EP 104
DI 10.1007/s10238-001-8019-y
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 546XT
UT WOS:000175302200005
PM 11699734
DA 2020-12-08
ER

PT J
AU Pozzato, G
   Zorat, F
   Nascimben, F
   Gregorutti, M
   Comar, C
   Baracetti, S
   Vatta, S
   Bevilacqua, E
   Belgrano, A
   Crovella, S
   Amoroso, A
AF Pozzato, G
   Zorat, F
   Nascimben, F
   Gregorutti, M
   Comar, C
   Baracetti, S
   Vatta, S
   Bevilacqua, E
   Belgrano, A
   Crovella, S
   Amoroso, A
TI Haemochromatosis gene mutations in a clustered Italian population:
   evidence of high prevalence in people of Celtic ancestry
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE haemochromatosis; HFE mutations; Celtic people
ID POLYMERASE-CHAIN-REACTION; HEREDITARY HEMOCHROMATOSIS; HFE GENE;
   CYS282TYR MUTATION; H63D MUTATIONS; FREQUENCY; C282Y; ASSOCIATION;
   EXPRESSION; MIGRATION
AB Hereditary haemochromatosis is an inherited disorder characterised by an excessive iron absorption from the diet and is associated with several HFE gene mutations. One hypothesis is that these genetic mutations originated in the Celtic populations. The aim of this study is to determine the frequency of HFE gene mutations in a clustered Italian population of Celtic ancestry (Cimbri, Asiago plateau). One hundred and forty-nine consecutive unrelated blood donors (31 females and 178 males) were enrolled in this study. A family investigation was performed in each case to identify the ethnic origin of the individuals. The analysis of HFE gene mutations was performed by PCR amplification followed by digestion with Rsal and Dpnll restriction enzymes. At least one HFE gene mutation was identified in 49 individuals (32.9%) of the studied population. The allele frequencies of the C282Y and H63D were respectively 0.037 and 0.144. When we considered only the 103 individuals with relatives born in Asiago, the prevalence of the HFE mutations rose from 32.9 to 39.8%; the allele frequencies of the C282Y and H63D were respectively 0.048 and 0.174. The mean serum iron and ferritin levels were significantly higher in individuals with the HFE mutations than in normal cases. This study indicates that the prevalence of the HFE gene mutations is surprisingly high in Italians with Celtic ancestry. This could suggest the need to perform large mass studies in selected areas of the country to detect the affected patients and prevent the disease in homozygous individuals.
C1 Ist Infanzia, Serv Genet, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento Med Clin & Neurol, Unita Operat Med Clin, Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Sez Genet, Trieste, Italy.
RP Amoroso, A (corresponding author), Ist Infanzia, Serv Genet, Via dellIstria 65-1, I-34137 Trieste, Italy.
EM amoroso@burlo.trieste.it
RI Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407
CR BASSETT ML, 1984, SEMIN LIVER DIS, V4, P217, DOI 10.1055/s-2008-1041772
   BELLOLI S, 1999, P BIOIR SORR IT MAY, P244
   Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027
   Bodmer JG, 1997, NAT GENET, V15, P234, DOI 10.1038/ng0397-234c
   Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172
   Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830
   CASSANELLI S, 1999, P BIOIR SORR IT MAY, P249
   Chang JG, 1997, BLOOD, V89, P3492, DOI 10.1182/blood.V89.9.3492
   CharvetProtat S, 1997, REV EPIDEMIOL SANTE, V45, P315
   Cogswell ME, 1999, AM J PREV MED, V16, P134, DOI 10.1016/S0749-3797(98)00141-X
   Conte D, 1998, ANN INTERN MED, V128, P370, DOI 10.7326/0003-4819-128-5-199803010-00005
   CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630
   DEMARCO F, 1999, P BIOIR SORR IT MAY, P246
   EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411
   EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103
   Fabrega E, 1999, MED CLIN-BARCELONA, V112, P451
   Fargion S, 1996, J HEPATOL, V24, P564, DOI 10.1016/S0168-8278(96)80141-3
   Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399
   GOMEZ A, 1999, P BIOIR SORR IT MAY, P238
   HALLBERG L, 1989, J INTERN MED, V225, P249, DOI 10.1111/j.1365-2796.1989.tb00074.x
   JONSSON JJ, 1991, J CLIN EPIDEMIOL, V44, P1289, DOI 10.1016/0895-4356(91)90090-V
   Jouanolle AM, 1998, ANN GENET-PARIS, V41, P195
   KARLSSON M, 1988, ACTA MED SCAND, V224, P385
   LASKER GW, 1978, HUM BIOL, V50, P235
   LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x
   Marziliano N, 2000, HAEMATOLOGICA, V85, P990
   NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
   Nielsen P, 1998, BRIT J HAEMATOL, V103, P842
   Orlandi E, 1999, HAEMATOLOGICA, V84, P181
   Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198
   PHATAK PD, 1994, ARCH INTERN MED, V154, P769, DOI 10.1001/archinte.154.7.769
   PIAZZA A, 1987, NATURE, V329, P714, DOI 10.1038/329714a0
   Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003
   Piperno A, 1996, HEPATOLOGY, V24, P43, DOI 10.1002/hep.510240109
   PIPERNO A, 1992, J HEPATOL, V16, P364, DOI 10.1016/S0168-8278(05)80671-3
   Roberts AG, 1997, LANCET, V349, P321, DOI 10.1016/S0140-6736(96)09436-6
   Simon M, 1980, Prog Med Genet, V4, P135
   Smith BN, 1997, HEPATOLOGY, V25, P1439, DOI 10.1002/hep.510250622
   Sohda T, 1999, BIOCHEM GENET, V37, P63, DOI 10.1023/A:1018718101579
   Steffensen R, 1998, TISSUE ANTIGENS, V52, P230, DOI 10.1111/j.1399-0039.1998.tb03037.x
   VELATI C, 1990, HAEMATOLOGICA, V74, P525
   VELATI C, 1999, P BIOIR SORR IT MAY, P237
   Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384
   WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968
   WIGGERS P, 1991, J INTERN MED, V230, P265, DOI 10.1111/j.1365-2796.1991.tb00441.x
   YASUDA N, 1974, THEOR POPUL BIOL, V5, P123, DOI 10.1016/0040-5809(74)90054-9
   ZEI G, 1983, ANN HUM GENET, V47, P329, DOI 10.1111/j.1469-1809.1983.tb01003.x
   ZEI G, 1986, ANN HUM GENET, V50, P169, DOI 10.1111/j.1469-1809.1986.tb01036.x
NR 48
TC 21
Z9 22
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD JUN
PY 2001
VL 9
IS 6
BP 445
EP 451
DI 10.1038/sj.ejhg.5200643
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 446PU
UT WOS:000169522300008
PM 11436126
OA Bronze
DA 2020-12-08
ER

PT J
AU Romanello, M
   Moro, L
   Pirulli, D
   Crovella, S
   D'Andrea, P
AF Romanello, M
   Moro, L
   Pirulli, D
   Crovella, S
   D'Andrea, P
TI Effects of cAMP on intercellular coupling and osteoblast differentiation
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE osteoblasts; gap junctions; cAMP; alkaline phosphatase; osteocalcin
ID ARTICULAR CHONDROCYTES; GENE-EXPRESSION; CYCLIC-AMP; CELLS; CONNEXIN43;
   PHOSPHORYLATION; PERMEABILITY; STIMULATION; MECHANISM; CHANNELS
AB Bone-forming cells are organized in a multicellular network interconnected by gap junctions. Direct intercellular communication via gap junctions is an important component of bone homeostasis, coordinating cellular responses to external signals and promoting osteoblast differentiation. The cAMP pathway, a major intercellular signal transduction mechanism, regulates osteoblastic function and metabolism, We investigated the effects of this second messenger on junctional communication and on the expression of differentiation markers in human HOBIT osteoblastic cells, Increased levels of cAMP induce posttranslational modifications (i.e., phosphorylations) of connexin43 and enhancement of gap junction assembly, resulting in an increased junctional permeance to Lucifer yellow and to a positive modulation of intercellular Ca2+ wares. Increased intercellular communication, however, was accompanied by a parallel decrease of alkaline phosphatase activity and by an increase of osteocalcin expression, cAMP-dependent stimulation of cell-to-cell coupling induces a complex modulation of bone differentiation markers. (C) 2001 Academic Press.
C1 Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riprod & Sviluyppo, I-34137 Trieste, Italy.
RP D'Andrea, P (corresponding author), Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, Via Licio Giorgieri 1, I-34127 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR ATKINSON MM, 1995, J CELL SCI, V108, P3079
   Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x
   Civitelli R, 1998, J CELL BIOCHEM, V68, P8, DOI 10.1002/(SICI)1097-4644(19980101)68:1<8::AID-JCB2>3.0.CO;2-#
   Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805
   Grandolfo M, 1998, J BONE MINER RES, V13, P443, DOI 10.1359/jbmr.1998.13.3.443
   HANSEN M, 1993, J CELL SCI, V106, P995
   Jorgensen NR, 1997, J CELL BIOL, V139, P497, DOI 10.1083/jcb.139.2.497
   Jorgensen NR, 2000, J BONE MINER RES, V15, P1024, DOI 10.1359/jbmr.2000.15.6.1024
   KEETING PE, 1992, J BONE MINER RES, V7, P127
   Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249
   Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   METHA PP, 1992, MOL BIOL CELL, V3, P839
   MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357
   MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077
   Paulson AF, 2000, J CELL SCI, V113, P3037
   ROMANELLO M, 2001, IN PRESS J BONE MIN
   Schiller PC, 2001, BONE, V28, P38, DOI 10.1016/S8756-3282(00)00412-9
   Schiller PC, 1997, J BONE MINER RES, V12, P2005, DOI 10.1359/jbmr.1997.12.12.2005
   STEINBERG TH, 1994, EMBO J, V13, P744, DOI 10.1002/j.1460-2075.1994.tb06316.x
   Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875
   Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669
   VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165
   WANG YJ, 1995, J CELL SCI, V108, P3501
NR 27
TC 28
Z9 30
U1 0
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 20
PY 2001
VL 282
IS 5
BP 1138
EP 1144
DI 10.1006/bbrc.2001.4710
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 427YQ
UT WOS:000168434700012
PM 11302734
DA 2020-12-08
ER

PT J
AU Pirulli, D
   Boniotto, M
   Vatta, L
   Crovella, S
   Spano, A
   Morgutti, M
   Zezlina, S
   Bertola, L
   Roccatello, D
   Scolari, F
   Peruzzi, L
   Savoldi, S
   Amoroso, A
AF Pirulli, D
   Boniotto, M
   Vatta, L
   Crovella, S
   Spano, A
   Morgutti, M
   Zezlina, S
   Bertola, L
   Roccatello, D
   Scolari, F
   Peruzzi, L
   Savoldi, S
   Amoroso, A
TI Polymorphisms in the promoter region and at codon 54 of the MBL2 gene
   are not associated with IgA nephropathy
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE DNA; genetics; TgA nephropathy; MBL2; polymorphisms; susceptibility
ID MANNAN-BINDING PROTEIN; COMPLEMENT ACTIVATION; GLOMERULAR DEPOSITION;
   LECTIN; GLOMERULONEPHRITIS; MECHANISM; ANTIGEN
AB Background. IgA nephropathy (IgAN) occurs sporadically in unrelated individuals. Several different polymorphic genes have been investigated in recent years in order to demonstrate their possible association with IgAN. Three recent, different studies with conflicting conclusions have discussed the role of the mannose binding lectin (MBL), a serum lectin involved in natural immunity, in the IgAN pathogenesis by examination of MBL deposits in biopsies. In the present study we investigated several polymorphisms of the MBL gene located in the promoter region and in the first exon.
   Methods. MBL polymorphism detection was performed in 12. Italian patients with familial IgA nephropathy and in 138 Italian patients with the sporadic form of the disease. The polymorphisms in the MBL2 promoter region and in the exon 1 were investigated, respectively, by direct sequencing and by amplification refractory mutation system-polymerase chain reaction on genomic DNA collected from peripheral blood. Seventy-four unrelated healthy subjects matched for ethnic origin were used as controls.
   Results. Allelic and genotypic frequencies of the polymorphisms at position -550, -328, -221 and at codon 54 did not show any differences between patients and controls. Similar frequency distributions of these polymorphisms were also found in the subgroups of IgAN patients subdivided according to the clinical manifestations and the progression of the disease.
   Conclusions. This study indicates that the analysed polymorphisms of the MBL gene do not appear to be primarily involved in the susceptibility and severity of IgAN.
C1 IRCCS Burlo Garofolo, Serv Genet, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Trieste, Italy.
   Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.
   L Einaudi Hosp, Multidisciplinary Ctr Immunopathol, Turin, Italy.
   Univ Brescia, Dept Nephrol, Brescia, Italy.
   Spedali Civil Brescia, I-25125 Brescia, Italy.
   Regina Margherita Childrens Hosp, Dept Nephrol, Turin, Italy.
   Osped Maggiore Trieste, Div Nephrol, Trieste, Italy.
RP Amoroso, A (corresponding author), IRCCS Burlo Garofolo, Serv Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI Boniotto, Michele/AAB-4302-2020; Coppo, Rosanna/AAD-7959-2020; Crovella,
   Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020; Boniotto, Michele/F-1857-2010
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Boniotto, Michele/0000-0002-9548-2254
CR COPPO R, 1986, NEW ENGL J MED, V315, P1167
   DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004
   DEMAINE AG, 1988, J CLIN INVEST, V81, P611, DOI 10.1172/JCI113361
   Egido J, 1987, Nephrol Dial Transplant, V2, P134
   Endo M, 1998, NEPHROL DIAL TRANSPL, V13, P1984, DOI 10.1093/ndt/13.8.1984
   Endo M, 2000, AM J KIDNEY DIS, V35, P401, DOI 10.1016/S0272-6386(00)70192-2
   FAUCHET R, 1980, NEW ENGL J MED, V302, P1033
   GALLA JH, 1984, LANCET, V2, P522
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   GREGORY MC, 1988, LANCET, V1, P11
   JENNETTE JC, 1985, KIDNEY INT, V28, P944, DOI 10.1038/ki.1985.222
   JULIAN BA, 1987, SEMIN NEPHROL, V7, P306
   JULIAN BA, 1985, NEW ENGL J MED, V312, P202, DOI 10.1056/NEJM198501243120403
   KASHIWABARA H, 1982, KIDNEY INT, V22, P377, DOI 10.1038/ki.1982.185
   LAI KN, 1988, CLIN NEPHROL, V29, P229
   Lhotta K, 1999, NEPHROL DIAL TRANSPL, V14, P881, DOI 10.1093/ndt/14.4.881
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   Matsuda M, 1998, NEPHRON, V80, P408, DOI 10.1159/000045212
   MONTOLIU J, 1980, ARCH INTERN MED, V140, P1374, DOI 10.1001/archinte.140.10.1374
   MOORE RH, 1990, KIDNEY INT, V37, P991, DOI 10.1038/ki.1990.75
   Naito H, 1999, J BIOCHEM-TOKYO, V126, P1004, DOI 10.1093/oxfordjournals.jbchem.a022543
   OCONNELL PJ, 1986, KIDNEY INT, V30, P627
   RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208
   Sambrook J., 1989, MOL CLONING LAB MANU
   Scolari F, 1999, AM J KIDNEY DIS, V33, P857, DOI 10.1016/S0272-6386(99)70417-8
   SCOLARI F, 1992, NEPHROL DIAL TRANSPL, V7, P587, DOI 10.1093/ndt/7.7.587
   SMITH SM, 1985, HUM PATHOL, V16, P181, DOI 10.1016/S0046-8177(85)80067-8
   SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8
   TOLKOFFRUBIN NE, 1978, TRANSPLANTATION, V26, P430, DOI 10.1097/00007890-197812000-00014
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
NR 31
TC 10
Z9 13
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
EI 1460-2385
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD APR
PY 2001
VL 16
IS 4
BP 759
EP 764
DI 10.1093/ndt/16.4.759
PG 6
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA 416TC
UT WOS:000167795400012
PM 11274270
OA Bronze
DA 2020-12-08
ER

PT J
AU Pascolo, L
   Bogoni, S
   Spano, A
   Demori, E
   Amoroso, A
   Crovella, S
AF Pascolo, L
   Bogoni, S
   Spano, A
   Demori, E
   Amoroso, A
   Crovella, S
TI Fluorescent RT in situ PCR detection of MRP1 mRNA in human HCV infected
   liver
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Letter
ID HEPATOCELLULAR-CARCINOMA; P-GLYCOPROTEIN; CELL-LINES; RESISTANCE;
   OVEREXPRESSION; EXPRESSION; CMOAT; MDR1
C1 Univ Trieste, Serv Genet, IRCCS Burlo Garofolo, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento BBCM, CSF, I-34127 Trieste, Italy.
RP Crovella, S (corresponding author), Univ Trieste, Serv Genet, IRCCS Burlo Garofolo, Dipartimento Sci Riprod & Sviluppo, Via Istria 65-1, I-34137 Trieste, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020; Pascolo, Lorella/AAB-5207-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Pascolo, Lorella/0000-0003-1044-7263
CR Dunn SE, 1996, HEPATOLOGY, V23, P662, DOI 10.1002/hep.510230402
   Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6
   Hoofnagle JH, 1999, J HEPATOL, V31, P264, DOI 10.1016/S0168-8278(99)80414-0
   Kim YS, 1999, CLIN NUCL MED, V24, P874, DOI 10.1097/00003072-199911000-00011
   Legrand O, 1996, BRIT J HAEMATOL, V94, P23, DOI 10.1046/j.1365-2141.1996.d01-1776.x
   Matsunaga T, 1998, JPN J CANCER RES, V89, P1276, DOI 10.1111/j.1349-7006.1998.tb00524.x
   Minemura M, 1999, INT J ONCOL, V15, P559
   Takeuchi A, 1999, J GASTROENTEROL, V34, P351, DOI 10.1007/s005350050273
NR 8
TC 1
Z9 1
U1 0
U2 1
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 2001
VL 45
IS 1
BP 105
EP 108
PG 4
WC Cell Biology
SC Cell Biology
GA 412QW
UT WOS:000167566700013
PM 11411859
DA 2020-12-08
ER

PT J
AU Comar, M
   Spano, A
   Canova, S
   Bogoni, S
   Marziliano, N
   Cernigoi, E
   Boniotto, M
   Amoroso, A
   Parodi, S
   Campello, C
   Crovella, S
AF Comar, M
   Spano, A
   Canova, S
   Bogoni, S
   Marziliano, N
   Cernigoi, E
   Boniotto, M
   Amoroso, A
   Parodi, S
   Campello, C
   Crovella, S
TI Direct in situ PCR allows rapid and sensitive detection of high risk
   human papillomavirus in cytologic specimens and formalin-fixed paraffin
   tissues by fluorescent labelling
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE HPV; in situ PCR; in situ hybridization; fluorescein isothiocyanate;
   cell smears; paraffin-embedded tissues
ID POLYMERASE-CHAIN-REACTION; HYBRIDIZATION; AMPLIFICATION; BIOPSY; CELLS;
   DNA
AB We developed a rapid, sensitive and robust high risk human papillomavirus (HR HPV) detection protocol based on direct in situ PCR technology and fluorochrome-modified nucleotides on cytologic specimens (cell smears) and on HPV infected tissues (CIN III). Reproducible results on both cytologic specimens and paraffin-embedded tissues were obtained, providing a powerful tool for clinical investigation on HR HPV infection. Quantitative PCR performed on the same tissue sections adjacent to those used for in situ techniques allowed us to establish the sensitivity of our methods, able to detect rare copies (about 15 in our paraffin-embedded tissues) of HPV.
C1 Univ Genoa, Fac Med & Chirurg, Dipartimento Oncol Biol & Genet, Natl Inst Res Canc,Lab Expt Oncol,IST, I-16132 Genoa, Italy.
   Univ Trieste, Ist Igiene & Med Prevent, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet Med, Dipartimento Sci Riprod & Sviluppo, I-34137 Trieste, Italy.
   PE Biosyst, SDS Core Lab, I-20052 Monza, MI, Italy.
   Univ Trieste, Ist Anat & Istol Patol, I-34100 Trieste, Italy.
RP Parodi, S (corresponding author), Univ Genoa, Fac Med & Chirurg, Dipartimento Oncol Biol & Genet, Natl Inst Res Canc,Lab Expt Oncol,IST, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
EM parodis@hp380.ist.unige.it
RI Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010;
   Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Comar, Manola/K-4613-2016; COMAR,
   Manola/K-4613-2016
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407; Comar,
   Manola/0000-0001-6310-3320; COMAR, Manola/0000-0002-9487-861X
CR Adams V, 1996, J MED VIROL, V48, P161, DOI 10.1002/(SICI)1096-9071(199602)48:2<161::AID-JMV8>3.0.CO;2-7
   ALDER K, 1997, HISTOCHEM CELL BIOL, V108, P321
   Arends MJ, 1998, J CLIN PATHOL, V51, P96, DOI 10.1136/jcp.51.2.96
   BIBBO M, 1994, CELL VISION, V1, P290
   CHENG JD, 1994, J HISTOTECHNOL, V17, P247, DOI 10.1179/his.1994.17.3.247
   Clerico L, 2000, INT J ONCOL, V16, P241
   Hacker GW, 1998, EUR J HISTOCHEM, V42, P111
   Laimins LA, 1996, SEMIN VIROL, V7, P305, DOI 10.1006/smvy.1996.0038
   LONG AA, 1993, HISTOCHEMISTRY, V99, P151, DOI 10.1007/BF00571876
   Mancuso T, 1997, INT J ONCOL, V11, P527
   MARTINEZ A, 1995, ENDOCRINOLOGY, V136, P4099, DOI 10.1210/en.136.9.4099
   Musiani M, 1997, J HISTOCHEM CYTOCHEM, V45, P729, DOI 10.1177/002215549704500511
   Nuovo GJ, 1999, J HISTOCHEM CYTOCHEM, V47, P273, DOI 10.1177/002215549904700301
   Patterson BK, 1996, NUCLEIC ACIDS RES, V24, P3656, DOI 10.1093/nar/24.18.3656
   Syrjanen KJ, 1996, EUR J OBSTET GYN R B, V65, P45, DOI 10.1016/0028-2243(95)02303-A
   TEO IA, 1995, HISTOCHEM J, V27, P647
   Unger ER, 1998, J HISTOCHEM CYTOCHEM, V46, P535, DOI 10.1177/002215549804600414
   Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201
   Wiedorn KH, 1999, HISTOCHEM CELL BIOL, V111, P89, DOI 10.1007/s004180050338
   Zehbe I, 1997, AM J PATHOL, V150, P1553
NR 20
TC 2
Z9 2
U1 0
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1019-6439
EI 1791-2423
J9 INT J ONCOL
JI Int. J. Oncol.
PD JAN
PY 2001
VL 18
IS 1
BP 181
EP 185
PG 5
WC Oncology
SC Oncology
GA 383TM
UT WOS:000165899000026
PM 11115557
DA 2020-12-08
ER

PT J
AU Pirulli, D
   Boniotto, M
   Puzzer, D
   Spano, A
   Amoroso, A
   Crovella, S
AF Pirulli, D
   Boniotto, M
   Puzzer, D
   Spano, A
   Amoroso, A
   Crovella, S
TI Flexibility of melting temperature assay for rapid detection of
   insertions, deletions, and single-point mutations of the AGXT gene
   responsible for type 1 primary hyperoxaluria
SO CLINICAL CHEMISTRY
LA English
DT Article
ID GLYOXYLATE AMINOTRANSFERASE; ALANINE
C1 IRCCS, Serv Genet, I-34137 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riproduz & Sviluppo, Sez Genet Med, I-34137 Trieste, Italy.
RP Crovella, S (corresponding author), IRCCS, Serv Genet, Via dellIstria 65-1, I-34137 Trieste, Italy.
RI Boniotto, Michele/F-1857-2010; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; Boniotto,
   Michele/AAB-4302-2020
OI Boniotto, Michele/0000-0002-9548-2254; amoroso,
   antonio/0000-0002-9437-9407; Crovella, Sergio/0000-0001-8493-1168; 
CR Bernard PS, 1998, ANAL BIOCHEM, V255, P101, DOI 10.1006/abio.1997.2427
   DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4
   Germer S, 1999, GENOME RES, V9, P72
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Marziliano N, 2000, CLIN CHEM, V46, P423
   NISHIYAMA K, 1993, J CELL BIOL, V123, P1237, DOI 10.1083/jcb.123.5.1237
   Nogueira PK, 2000, HUM MUTAT, V15, P384, DOI 10.1002/(SICI)1098-1004(200004)15:4<384::AID-HUMU20>3.0.CO;2-J
   Pirulli D, 1999, HUM GENET, V104, P523, DOI 10.1007/s004390050998
   PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H
   RIRIE KM, 1997, ANAL BIOCHEM, V245, P1516
   vonSchnakenburg C, 1997, J MED GENET, V34, P489, DOI 10.1136/jmg.34.6.489
NR 11
TC 13
Z9 16
U1 0
U2 1
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
J9 CLIN CHEM
JI Clin. Chem.
PD NOV
PY 2000
VL 46
IS 11
BP 1842
EP 1844
PG 3
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 372HR
UT WOS:000165228700020
PM 11067824
DA 2020-12-08
ER

PT J
AU DelPero, M
   Masters, JC
   Zuccon, D
   Cervella, P
   Crovella, S
   Ardito, G
AF DelPero, M
   Masters, JC
   Zuccon, D
   Cervella, P
   Crovella, S
   Ardito, G
TI Mitochondrial sequences as indicators of generic classification in bush
   babies
SO INTERNATIONAL JOURNAL OF PRIMATOLOGY
LA English
DT Article
DE galago; bush baby; mitochondrial genes; phylogeny; systematics
ID 12S RIBOSOMAL-RNA; PHYLOGENETIC-RELATIONSHIPS; DNA-SEQUENCES; EVOLUTION;
   GALAGINAE; AMPLIFICATION; CONFIDENCE; POSITION; PRIMATES; PRIMERS
AB Systematic relationships among the African bush babies are nor well understood. Various generic designations are currently in use. Some authors refer all species to a single genus (Galago), while others recognize less than or equal to4 genera. Phylogenetic reconstructions based on morphology, karyology, allozymes and vocal repertoires have generated inconsistent hypotheses of relationship. We analyzed partial sequences of three mitochondrial genes (270 bp from cytochrome b, 387 bp from 12S rRNA, and 241 bp from 16S rRNA, total 898 bp) to resolve some uncertainties. We sampled taxa from each of three genera: Galagoides alleni, G. demidoff and G. zanzibaricus; Galago senegalensis, G. gallarum and G. moholi; and Otolemur crassicaudatus and O. garnettii. Outgroup taxa were Asian lorises: Nycticebus coucang and Loris tardigradus. We analyzed sequences separately and in combination, and modeled phylogenies using maximum parsimony, weighted parsimony, neighbor-joining and maximum-likelihood. We obtained some variation in phylogenetic inference depending on sequence and analytical method but the results also gave strong phylogenetic signals. The lesser bush babies invariably formed a clade, showing evidence of very recent radiation. The greater bush babies also formed a clade, marked by somewhat greater interspecific genetic distances, which was allied with Galagoides alleni in most instances. Galagoides demidoff and G. zanzibaricus are not closely related though both diverged early in the history of the group. A genus comprising Galagoides alleni, G. demidoff and G. zanzibaricus is not supported by our data. The most likely alliance for Galagoides alleni is within the genus Otolemur. Of the three partial sequences employed in the study, 16S rRNA gave the most consistent results, while cytochrome b was least informative.
C1 Natal Museum, ZA-3200 Pietermaritzburg, South Africa.
   Univ Turin, Dipartimento Biol Anim, I-10123 Turin, Italy.
   Univ Florence, Ist Antropol, I-50122 Florence, Italy.
RP Masters, JC (corresponding author), Natal Museum, Private Bag 9070, ZA-3200 Pietermaritzburg, South Africa.
RI Zuccon, Dario/AAF-7055-2020; Crovella, Sergio/K-5050-2016
OI Zuccon, Dario/0000-0001-8236-5924; Crovella, Sergio/0000-0001-8493-1168;
   CERVELLA, Piero/0000-0002-0642-6059
CR COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0
   CROVELLA S, 1994, AM J PRIMATOL, V32, P177, DOI 10.1002/ajp.1350320304
   DEBOER LEM, 1973, GENETICA, V44, P155, DOI 10.1007/BF00119104
   DELPERO M, 1995, PRIMATES, V36, P431, DOI 10.1007/BF02382865
   DELPERO M, IN PRESS ZOOL J LINN
   EAGLEN RH, 1980, THESIS DUKE U DURHAM
   FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513
   FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Felsenstein J., 1993, PHYLIP PHYLOGENY INF
   Hill W. C. O., 1953, PRIMATES COMP ANATOM
   HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338
   HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540
   KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196
   MASTERS J, 1988, BIOL J LINN SOC, V34, P149, DOI 10.1111/j.1095-8312.1988.tb01954.x
   Masters JC, 1998, FOLIA PRIMATOL, V69, P357, DOI 10.1159/000052724
   MASTERS JC, 1987, GENETICA, V75, P123, DOI 10.1007/BF00055256
   MASTERS JC, 1994, PRIMATES, V35, P177, DOI 10.1007/BF02382053
   Matschie P., 1893, SITZUNGS BERICHT GES, V4, P107
   McNiff BE, 1998, AM J PHYS ANTHROPOL, V107, P225, DOI 10.1002/(SICI)1096-8644(199811)107:3<225::AID-AJPA1>3.0.CO;2-N
   MEYER A, 1994, TRENDS ECOL EVOL, V9, P278, DOI 10.1016/0169-5347(94)90028-0
   MINDELL DP, 1990, ANNU REV ECOL SYST, V21, P541, DOI 10.1146/annurev.es.21.110190.002545
   NASH LT, 1989, INT J PRIMATOL, V10, P57, DOI 10.1007/BF02735704
   Olson TR, 1979, THESIS U LONDON LOND
   Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637
   Parker A, 1996, GENOME, V39, P793, DOI 10.1139/g96-099
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHWARTZ J H, 1985, Anthropological Papers of the American Museum of Natural History, V60, P1
   SCHWARZ ERNST, 1931, ANN AND MAG NAT HIST, V7, P41
   SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651
   Springer MS, 1996, J MOL EVOL, V43, P357
   Swofford DL, 1993, PHYLOGENETIC ANAL US
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wesselman HB, 1984, CONTRIB VERT EVOL, V7, P1
   YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104
   Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122
   ZIMMERMANN E, 1990, Z ZOOL SYST EVOL, V28, P217
NR 37
TC 20
Z9 20
U1 0
U2 8
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0164-0291
J9 INT J PRIMATOL
JI Int. J. Primatol.
PD OCT
PY 2000
VL 21
IS 5
BP 889
EP 904
DI 10.1023/A:1005502927658
PG 16
WC Zoology
SC Zoology
GA 374BD
UT WOS:000165323800008
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Bevilacqua, E
   Pirulli, D
   Spano, A
   Amoroso, A
   Crovella, S
AF Marziliano, N
   Bevilacqua, E
   Pirulli, D
   Spano, A
   Amoroso, A
   Crovella, S
TI Single tube melting temperature assay for rapid and sensitive detection
   of the most frequent hemocromatosis mutations, C282Y and H63D
SO HAEMATOLOGICA
LA English
DT Letter
DE hemochromatosis; HFE; mutation detection; melting temperature
AB We report the development of a single-tube assay for rapid genotyping of the two mutations C282Y and H63D of the HFE gene, commonly detected by PCR-RFLP and responsible for 80% of cases of hereditary hemochromatosis. The method, named T melting curve analysis, discriminates between amplification products by their melting temperatures.
C1 IRCCS Burlo Garofolo, Serv Genet, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Cattedra Genet, I-34137 Trieste, Italy.
   PE Europe BV, SDS GA Core Lab, Monza, Italy.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Serv Genet, Via dellIstria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407
CR Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002
   Germer S, 1999, GENOME RES, V9, P72
   Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916
NR 3
TC 6
Z9 6
U1 0
U2 1
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA STRADA NUOVA 134, 27100 PAVIA, ITALY
SN 0390-6078
J9 HAEMATOLOGICA
JI Haematologica
PD SEP
PY 2000
VL 85
IS 9
BP 990
EP 991
PG 2
WC Hematology
SC Hematology
GA 359AR
UT WOS:000089589800019
PM 10982501
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Pascolo, L
   Fernetti, C
   Pirulli, D
   Bogoni, S
   Garcia-Mediavilla, MV
   Spano, A
   Puzzer, D
   Tiribelli, C
   Amoroso, A
   Crovella, S
AF Pascolo, L
   Fernetti, C
   Pirulli, D
   Bogoni, S
   Garcia-Mediavilla, MV
   Spano, A
   Puzzer, D
   Tiribelli, C
   Amoroso, A
   Crovella, S
TI Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ
   RT-PCR
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE MRP1; in situ PCR; in situ hybridization; BeWo cells; Hep G2 cells;
   human placenta
ID MULTIDRUG-RESISTANCE PROTEIN; POLYMERASE CHAIN-REACTION; IN-SITU;
   LUNG-CANCER; HUMAN PAPILLOMAVIRUS; PERIPHERAL-BLOOD; P-GLYCOPROTEIN;
   EXPRESSION; GENE; HYBRIDIZATION
AB The detection of the multridrug resistance-associated proteins is becoming increasingly important in assessing tumor sensitivity to treatment. In this work we describe a new, rapid, sensitive, and robust method for the detection of MRP1 expression based on direct RT-in situ-PCR technology and fluorochrome-modified (dCTP(Cy3)) nucleotides. MRP1 expression was found in both placenta (BeWo) and liver (Hep Ga) derived tumor cell line as well as in small cell lung carcinoma. In liver-derived cells, MRP1 expression was detected by RT-in situ-PCR but not by in situ hybridization, suggesting a higher sensitivity of in situ amplification for the low level of expression in Hep G2 cells. RT solution PCR confirmed the presence of MRP1 in BeWo and Hep G2 cells, although the level of the gene expression was lower in liver cells. This method represents a viable alternative to conventional immunohistochemistry, and may be useful in the evaluation of MRP1 expression in different tissue or cell lines. (C) 2000 Academic Press.
C1 Univ Trieste, CSF Dept BBCM, I-34127 Trieste, Italy.
   Univ Trieste, Dipartimento Sci Riprod & Sviluppo, Servizio Genet Med, IRCCS Burlo Garofolo, I-34137 Trieste, Italy.
RP Pascolo, L (corresponding author), Univ Trieste, CSF Dept BBCM, Via Giorgeri 1, I-34127 Trieste, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Pascolo, Lorella/AAB-5207-2020;
   Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020;
   Garcia-Mediavilla, Victoria/F-9641-2015; Tiribelli, Claudio/A-4716-2014
OI Pascolo, Lorella/0000-0003-1044-7263; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407;
   Garcia-Mediavilla, Victoria/0000-0002-5722-7500; Tiribelli,
   Claudio/0000-0001-6596-7595
CR Arts HJG, 1999, CLIN CANCER RES, V5, P2798
   BHALLA K, 1985, CANCER RES, V45, P3657
   Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4
   Cantz T, 2000, AM J PHYSIOL-GASTR L, V278, pG522
   COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704
   DANO K, 1972, CANCER CHEMOTH REP 1, V56, P701
   Endo K, 1996, CANCER, V77, P1681
   Endo K, 1996, INT J CANCER, V68, P372, DOI 10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A
   Filipits M, 1999, ANTICANCER RES, V19, P5043
   Hacker GW, 1998, EUR J HISTOCHEM, V42, P111
   Hipfner DR, 1996, CANCER RES, V56, P3307
   Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6
   Kool M, 1997, CANCER RES, V57, P3537
   Legrand O, 1996, BRIT J HAEMATOL, V94, P23, DOI 10.1046/j.1365-2141.1996.d01-1776.x
   LONG AA, 1993, HISTOCHEMISTRY, V99, P151, DOI 10.1007/BF00571876
   MARTINEZ A, 1995, ENDOCRINOLOGY, V136, P4099, DOI 10.1210/en.136.9.4099
   Meijer GA, 1999, J CLIN PATHOL, V52, P450, DOI 10.1136/jcp.52.6.450
   MIRSKI SEL, 1987, CANCER RES, V47, P2594
   Musiani M, 1997, J HISTOCHEM CYTOCHEM, V45, P729, DOI 10.1177/002215549704500511
   NUOVO GJ, 1994, J ACQ IMMUN DEF SYND, V7, P916
   PATTILLO RA, 1968, CANCER RES, V28, P1231
   PESTANER JP, 1994, ACTA CYTOL, V38, P676
   RINGLER GE, 1990, ENDOCR REV, V11, P105, DOI 10.1210/edrv-11-1-105
   Roelofsen H, 1997, GASTROENTEROLOGY, V112, P511, DOI 10.1053/gast.1997.v112.pm9024305
   TEO IA, 1995, HISTOCHEM J, V27, P647
   UEDA K, 1987, J BIOL CHEM, V262, P17432
   Utoguchi N, 1999, J PHARM SCI, V88, P1288, DOI 10.1021/js990173q
   Way BA, 1998, PLACENTA, V19, P323, DOI 10.1016/S0143-4004(98)90065-0
   Young LC, 1999, CLIN CANCER RES, V5, P673
   Zehbe I, 1997, AM J PATHOL, V150, P1553
NR 30
TC 12
Z9 13
U1 0
U2 3
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 28
PY 2000
VL 275
IS 2
BP 466
EP 471
DI 10.1006/bbrc.2000.3339
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 349WZ
UT WOS:000089069700036
PM 10964688
DA 2020-12-08
ER

PT J
AU Boniotto, M
   Crovella, S
   Pirulli, D
   Scarlatti, G
   Spano, A
   Vatta, L
   Zezlina, S
   Tovo, PA
   Palomba, E
   Amoroso, A
AF Boniotto, M
   Crovella, S
   Pirulli, D
   Scarlatti, G
   Spano, A
   Vatta, L
   Zezlina, S
   Tovo, PA
   Palomba, E
   Amoroso, A
TI Polymorphisms in the MBL2 promoter correlated with risk of HIV-1
   vertical transmission and AIDS progression
SO GENES AND IMMUNITY
LA English
DT Article
DE MBL2; Mannose-binding protein; promoter region; HIV-1 infection; AIDS
   progression
ID BINDING PROTEIN; INFECTION; LECTIN
AB We investigated the polymorphisms of the promoter region of the MBL2 gene, which codifies for the Mannose-binding protein (MBP). The study population included 90 children with vertically acquired HIV-infection, further divided on the basis of the disease rate, 27 HIV exposed-uninfected children, and 74 healthy control subjects matched for ethnic origin to evaluate the MBP involvement in the risk of HIV-1 infection and to assess the role of the MBP promoter in AIDS progression. A region of 380 bp in the promoter of the MBL2 gene was analysed by PGR and direct sequencing of both DNA strands. We found that the polymorphism at position -550 influences the risk of HIV-infection and AIDS progression. Also a 6 bp deletion at position -328 was correlated with HIV-1 infection. This study indicates that the promoter of the MBL2 gene influences vertical transmission of HIV and the course of perinatal infection.
C1 IRCCS Burlo Garofolo, Genet Serv, I-34137 Trieste, Italy.
   Univ Trieste, Chair Genet, I-34137 Trieste, Italy.
   San Raffaele Sci Inst, DIBIT, Unit Immunol HIV, I-20132 Milan, Italy.
   Regina Margherita Childrens Hosp & Univ, Dept Pediat, I-10126 Turin, Italy.
RP Amoroso, A (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Via Istria 65-1, I-34137 Trieste, Italy.
RI Boniotto, Michele/F-1857-2010; Boniotto, Michele/AAB-4302-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020; scarlatti, gabriella/H-1482-2018
OI Boniotto, Michele/0000-0002-9548-2254; Crovella,
   Sergio/0000-0001-8493-1168; amoroso, antonio/0000-0002-9437-9407;
   scarlatti, gabriella/0000-0003-2316-2689; Tovo, Pier
   Angelo/0000-0002-0192-3240
CR Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   *CDCP, 1987, MMWR-MORBID MORTAL W, V36, P225
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Madsen HO, 1998, J IMMUNOL, V161, P3169
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   ROBINSON WE, 1990, VIROLOGY, V175, P600, DOI 10.1016/0042-6822(90)90449-2
   SAMBROOK J, 1989, MOL CLONING LAB MANU, P458
   SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
NR 9
TC 53
Z9 54
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND
SN 1466-4879
J9 GENES IMMUN
JI Genes Immun.
PD JUN
PY 2000
VL 1
IS 5
BP 346
EP 348
DI 10.1038/sj.gene.6363685
PG 3
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 342UB
UT WOS:000088662600009
PM 11196698
OA Bronze
DA 2020-12-08
ER

PT J
AU Clerico, L
   Mancuso, T
   Crovella, S
   Amoroso, A
   Morgutti, M
   Demori, E
   Parodi, S
AF Clerico, L
   Mancuso, T
   Crovella, S
   Amoroso, A
   Morgutti, M
   Demori, E
   Parodi, S
TI Detection of ornithine decarboxylase mRNA in human breast cancer MCF-7
   cells by in situ RT-PCR
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE ornithine decarboxylase; in situ hybridization; in situ RT-PCR; breast
   cancer; MCF-7 cells; c-Myc
ID POLYMERASE-CHAIN-REACTION; IN-SITU; C-MYC; GENE; EXPRESSION;
   AMPLIFICATION; TARGET; GROWTH
AB We have studied the expression of ornithine decarboxylase (ODC) mRNA by in situ hybridization and in situ RT-PCR in human breast cancer MCF-7 cell line. III sits RT-PCR demonstrated the overexpression of ODC mRNA, localized over the cytoplasm, while a very low signal was detected by in situ hybridization. Our findings indicate that in situ RT-PCR could represent a useful tool to study different levels of ODC expression in normal and tumor tissues. Since ODC expression is regulated by c-Myc oncoprotein, this model could be useful to monitor in vivo the effects of new antineoplastic molecules, specific inhibitors of c-Myc.
C1 Ist Nazl Ric Canc, Expt Oncol Lab, I-16132 Genoa, Italy.
   Univ Genoa, Dept Expt Oncol, I-16132 Genoa, Italy.
   Univ Trieste, Chair Genet, Fac Med, I-34100 Trieste, Italy.
   IRCCS, I-34100 Trieste, Italy.
RP Parodi, S (corresponding author), Ist Nazl Ric Canc, Expt Oncol Lab, Largo R Benzi 10, I-16132 Genoa, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407
CR AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0
   BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804
   CLERICO L, IN PRESS EUR J HISTO
   Giorello L, 1998, CANCER RES, V58, P3654
   KOMMINOTH P, 1993, VIRCHOWS ARCH B, V64, P67, DOI 10.1007/BF02915097
   Long AA, 1998, EUR J HISTOCHEM, V42, P101
   Longenecker B. M., 1993, VACCINE RES, V2, P151
   Mancuso T, 1997, INT J ONCOL, V11, P527
   Miller TL, 1996, J CELL BIOCHEM, V60, P560, DOI 10.1002/(SICI)1097-4644(19960315)60:4<560::AID-JCB12>3.0.CO;2-L
   MOSHIER JA, 1990, J BIOL CHEM, V265, P4884
   OLEARY JJ, 1994, HISTOCHEM J, V26, P337, DOI 10.1007/BF00157767
   PEGG AE, 1988, CANCER RES, V48, P759
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   TEO IA, 1995, HISTOCHEM J, V27, P660
   THOMAS T, 1991, BREAST CANCER RES TR, V19, P257, DOI 10.1007/BF01961162
   THOMAS T, 1989, CANCER RES, V49, P5852
   THOMPSON DF, 1995, ANN PHARMACOTHER, V29, P189, DOI 10.1177/106002809502900217
   WRIGHT PS, 1995, CELL GROWTH DIFFER, V6, P1097
NR 18
TC 4
Z9 5
U1 0
U2 0
PU PROFESSOR D A SPANDIDOS
PI ATHENS
PA 1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE
SN 1019-6439
J9 INT J ONCOL
JI Int. J. Oncol.
PD FEB
PY 2000
VL 16
IS 2
BP 241
EP 244
PG 4
WC Oncology
SC Oncology
GA 275FL
UT WOS:000084808700003
PM 10639565
DA 2020-12-08
ER

PT J
AU Bigatti, MP
   Ardito, G
   Lamberti, L
   Crovella, S
   Collell, M
   Giordanino, S
   Benso, L
AF Bigatti, MP
   Ardito, G
   Lamberti, L
   Crovella, S
   Collell, M
   Giordanino, S
   Benso, L
TI Chromosomal aberrations, sister chromatid exchanges and high frequency
   cells in young patients with neurofibromatosis 1 (NF1)
SO NEOPLASMA
LA English
DT Article
DE NF1; chromosomal aberrations; SCE; HFCs; bleomycin; mytomycin C
ID VONRECKLINGHAUSEN NEUROFIBROMATOSIS; LYMPHOCYTES; CANCER; INSTABILITY;
   BIOMARKERS
AB Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs) and high frequency cells (HFCs) have been assessed in peripheral blood lymphocytes of 10 neurofibromatosis (NF1) patients and 10 healthy controls.
   In both groups, the spontaneous rates and the induced (bleomycin for CA and MMC for SCE) frequencies were analyzed. No differences between cells from NF1 patients and controls were observed with respect to spontaneous or bleomycin induced CA. Spontaneous or MMC induced SCE frequencies were also similar in NF1 patients and controls. HFCs, on the contrary, were statistically lower in NF1 patients.
C1 Univ Turin, Dept Anim & Human Biol, I-10123 Turin, Italy.
   Univ Florence, Inst Anthropol, Florence, Italy.
   Univ Trieste, Sch Med, Chair Genet, I-34127 Trieste, Italy.
   Univ Turin, Dept Sci Children & Adolescents, Ctr Auxol, Turin, Italy.
RP Bigatti, MP (corresponding author), Univ Turin, Dept Anim & Human Biol, I-10123 Turin, Italy.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR BONASSI S, 1995, CANCER GENET CYTOGEN, V79, P133, DOI 10.1016/0165-4608(94)00131-T
   BROGGER A, 1979, HEREDITAS, V91, P135
   CHENG WS, 1979, INT J CANCER, V23, P8, DOI 10.1002/ijc.2910230103
   COLLINS FS, 1994, MAN, P1005
   Crowe FW, 1956, CLIN PATHOLOGICAL GE
   DELHANTY JDA, 1983, CANCER GENET CYTOGEN, V8, P27, DOI 10.1016/0165-4608(83)90063-8
   DIETRICH CU, 1990, CANCER GENET CYTOGEN, V45, P161, DOI 10.1016/0165-4608(90)90080-T
   GRANBERGOHMAN I, 1988, HEREDITAS, V108, P93, DOI 10.1111/j.1601-5223.1988.tb00686.x
   HAFEZ M, 1986, CANCER, V57, P1937, DOI 10.1002/1097-0142(19860515)57:10<1937::AID-CNCR2820571008>3.0.CO;2-W
   HAFEZ M, 1985, CANCER, V55, P2434, DOI 10.1002/1097-0142(19850515)55:10<2434::AID-CNCR2820551022>3.0.CO;2-A
   Hagmar L, 1998, CANCER RES, V58, P4117
   HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704
   Illeni MT, 1997, INT J BIOL MARKER, V12, P118
   KEHRER H, 1994, MUTAT RES, V306, P61, DOI 10.1016/0027-5107(94)90167-8
   LAZUTKA JR, 1995, MUTAT RES-FUND MOL M, V331, P229, DOI 10.1016/0027-5107(95)00071-P
   Liou SH, 1999, CANCER RES, V59, P1481
   MOORE DH, 1984, SISTER CHROMATID EXC, P469
   MUSILOVA J, 1993, NEOPLASMA, V40, P93
   *NIH, 1988, CONS DEV C STAT NEUR, V6
   PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0
   RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704
   Rodenhiser DI, 1997, MUTAT RES-FUND MOL M, V373, P185, DOI 10.1016/S0027-5107(96)00171-6
   Rossner P, 1998, TOXICOL LETT, V96-7, P137, DOI 10.1016/S0378-4274(98)00060-5
   SHIRAISHI Y, 1979, ONCOLOGY, V36, P76
   TROILO P, 1992, MUTAT RES, V283, P237, DOI 10.1016/0165-7992(92)90054-L
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SLOVAK ACADEMIC PRESS LTD
PI BRATISLAVA
PA PO BOX 57 NAM SLOBODY 6, 810 05 BRATISLAVA, SLOVAKIA
SN 0028-2685
J9 NEOPLASMA
JI Neoplasma
PY 2000
VL 47
IS 4
BP 234
EP 238
PG 5
WC Oncology
SC Oncology
GA 345PP
UT WOS:000088824600007
PM 11043828
DA 2020-12-08
ER

PT J
AU Crovella, S
   Del Pero, M
   Marziliano, N
   Garagna, S
   Pecile, V
   Morgutti, M
   Boniotto, M
   Amoroso, A
   Montagnon, D
   Campa, CC
   Lamberti, L
   Bigatti, MP
   Ardito, G
AF Crovella, S
   Del Pero, M
   Marziliano, N
   Garagna, S
   Pecile, V
   Morgutti, M
   Boniotto, M
   Amoroso, A
   Montagnon, D
   Campa, CC
   Lamberti, L
   Bigatti, MP
   Ardito, G
TI MFASAT: A new alphoid DNA sequence isolated from Macaca fascicularis
   (Cercopithecidae, Primates)
SO GENOME
LA English
DT Article
DE alphoid DNA; Macaca fascicularis; FISH; sequence alignment
ID SATELLITE DNA; HUMAN-CHROMOSOMES; GREAT APES; ORGANIZATION; EVOLUTION;
   CENTROMERES; SUBSET
AB A new highly repeated DNA fragment isolated from Macaca fascicularis (MFASAT) is described. Our findings obtained by sequencing, Southern blot analysis, and fluorescent in situ hybridization (FISH) on metaphasic chromosomes strongly suggest that MFASAT can be considered as a member of the alphoid DNA family characteristic of Old World monkeys. The chromosomal localization of MFASAT, obtained by FISH, showed that this alphoid DNA is present in the peri-centromeric area of all the chromosomes. MFASAT showed a high degree of conservation when compared, by sequence alignment, to other Macaca species and Papio papio as expected for species with considerable genome conservation. A low degree of homology has been found comparing M. fascicularis alphoid DNA with a more distantly related Cercopithecidae species such as Cercopithecus aethiops.
C1 IRCCS Burlo Garofolo, Cattedra Genet, I-34137 Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet, I-34137 Trieste, Italy.
   Univ Turin, Dipartimento Biol Anim, I-10124 Turin, Italy.
   Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
   Univ Florence, Ist Antropol, I-50121 Florence, Italy.
   Univ Strasbourg, Inst Embryol, Strasbourg, France.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Cattedra Genet, Via Ostria 65-1, I-34137 Trieste, Italy.
EM crovella@burlo.trieste.it
RI AMOROSO, ANTONIO/AAN-3884-2020; Boniotto, Michele/F-1857-2010; Boniotto,
   Michele/AAB-4302-2020; amoroso, antonio/AAL-1475-2020; Garagna,
   Silvia/AAP-9173-2020; Crovella, Sergio/K-5050-2016; Pecile,
   Vanna/K-6558-2016
OI Boniotto, Michele/0000-0002-9548-2254; amoroso,
   antonio/0000-0002-9437-9407; Crovella, Sergio/0000-0001-8493-1168;
   Pecile, Vanna/0000-0002-9045-3761
CR ALEXANDROV IA, 1988, CHROMOSOMA, V96, P443, DOI 10.1007/BF00303039
   ALEXANDROV IA, 1991, GENOMICS, V11, P15, DOI 10.1016/0888-7543(91)90097-X
   ALEXANDROV IA, 1993, NUCLEIC ACIDS RES, V21, P2209
   Alves G, 1998, MOL PHYLOGENET EVOL, V9, P220, DOI 10.1006/mpev.1997.0462
   ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q
   BALDINI A, 1991, CHROMOSOMA, V101, P109, DOI 10.1007/BF00357060
   Crovella S., 1994, Human Evolution, V9, P63, DOI 10.1007/BF02438140
   DONEHOVER LC, 1980, P NATL ACAD SCI USA, V79, P1497
   DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0
   FANNING TG, 1993, CHROMOSOMA, V102, P306, DOI 10.1007/BF00661273
   GREIG GM, 1993, J MOL EVOL, V37, P464, DOI 10.1007/BF00160427
   Haaf T, 1997, CHROMOSOMA, V106, P226, DOI 10.1007/s004120050243
   KURNIT DM, 1973, CHROMOSOMA, V42, P23, DOI 10.1007/BF00326328
   LUNDJORGENSEN A, 1992, P NATL ACAD SCI USA, V89, P3310
   MANUELIDIS L, 1978, NATURE, V276, P92, DOI 10.1038/276092a0
   MARZILIANO N, 1997, SPEPSIS 97 NESTED DE
   MONTAGNON D, 1993, CYTOGENET CELL GENET, V63, P131, DOI 10.1159/000133518
   MUSICH PR, 1980, CHROMOSOMA, V80, P331, DOI 10.1007/BF00292688
   PEARSON WR, 1990, METHOD ENZYMOL, V183, P63
   PIKE LM, 1986, J MOL EVOL, V23, P127, DOI 10.1007/BF02099907
   RUBIN CM, 1980, J MOL BIOL, V136, P151, DOI 10.1016/0022-2836(80)90310-1
   SAMBROOK J, 1989, MOL CLONIG LAB MANUA
   Samonte RV, 1997, GENETICA, V101, P97, DOI 10.1023/A:1018360026244
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Warburton PE, 1996, GENOMICS, V33, P220, DOI 10.1006/geno.1996.0187
   WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394
   WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0
   WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M
NR 29
TC 5
Z9 5
U1 0
U2 0
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0831-2796
EI 1480-3321
J9 GENOME
JI Genome
PD DEC
PY 1999
VL 42
IS 6
BP 1066
EP 1070
DI 10.1139/gen-42-6-1066
PG 5
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 266JU
UT WOS:000084297500005
PM 10659771
DA 2020-12-08
ER

PT J
AU Pirulli, D
   Puzzer, D
   Ferri, L
   Crovella, S
   Amoroso, A
   Ferrettini, C
   Marangella, M
   Mazzola, G
   Florian, F
AF Pirulli, D
   Puzzer, D
   Ferri, L
   Crovella, S
   Amoroso, A
   Ferrettini, C
   Marangella, M
   Mazzola, G
   Florian, F
TI Molecular analysis of hyperoxaluria type 1 in Italian patients reveals
   eight new mutations in the alanine: glyoxylate aminotransferase gene
SO HUMAN GENETICS
LA English
DT Article
AB Systematic screening using the SSCP technique followed by sequencing of bands with abnormal mobility derived from the AGXT exons of 15 unrelated Italian patients with primary hyperoxaluria type 1 (PH1) allowed us to characterize both the mutant alleles in each individual. Eight new mutations were identified: C155del, C156ins, G244T, C252T, GAG408ins, G468A, G588A and G1098del. This study demonstrates both the effectiveness of the screening strategy chosen to identify all the mutant alleles and the high degree of allelic heterogeneity in PHI.
C1 Univ Trieste, Dipartimento Biol, I-34127 Trieste, Italy.
   IRCCS Burlo Garofolo, Cattedra Genet Med, Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet Med, Trieste, Italy.
   Osped Mauriziano Umberto I, Lab Calcolosi Renale, Turin, Italy.
   Osped S Giovanni Batista, Serv Immunol Trapianti, Turin, Italy.
RP Amoroso, A (corresponding author), Inst Infanzia, Serv Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407
CR DANPURE CJ, 1994, J INHERIT METAB DIS, V17, P487, DOI 10.1007/BF00711363
   Ferrettini C, 1998, J NEPHROL, V11, P18
   Petrarulo M, 1998, J NEPHROL, V11, P23
   PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H
   SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193
   von Schnakenburg C, 1998, J NEPHROL, V11, P15
NR 6
TC 37
Z9 40
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0340-6717
J9 HUM GENET
JI Hum. Genet.
PD JUN
PY 1999
VL 104
IS 6
BP 523
EP 525
DI 10.1007/s004390050998
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA 223RL
UT WOS:000081854000014
PM 10453743
DA 2020-12-08
ER

PT J
AU Amoroso, A
   Berrino, M
   Boniotto, M
   Crovella, S
   Palomba, E
   Scarlatti, G
   Serra, C
   Tovo, PA
   Vatta, S
AF Amoroso, A
   Berrino, M
   Boniotto, M
   Crovella, S
   Palomba, E
   Scarlatti, G
   Serra, C
   Tovo, PA
   Vatta, S
TI Polymorphism at codon 54 of mannose-binding protein gene influences AIDS
   progression but not HIV infection in exposed children
SO AIDS
LA English
DT Letter
ID PATHOGENESIS; VARIANT; LECTIN
C1 IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
   Univ Trieste, I-34127 Trieste, Italy.
   Univ Turin, Dept Genet, Turin, Italy.
   Regina Margherita Childrens Hosp, Dept Pediat, Turin, Italy.
   Univ Turin, I-10124 Turin, Italy.
   San Raffaele Sci Inst, DIBIT, Unit Immunobiol HIV, I-20132 Milan, Italy.
RP Amoroso, A (corresponding author), IRCCS Burlo Garofolo, Genet Serv, Trieste, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Boniotto, Michele/AAB-4302-2020;
   Crovella, Sergio/K-5050-2016; scarlatti, gabriella/H-1482-2018;
   Boniotto, Michele/F-1857-2010; amoroso, antonio/AAL-1475-2020
OI Crovella, Sergio/0000-0001-8493-1168; scarlatti,
   gabriella/0000-0003-2316-2689; Boniotto, Michele/0000-0002-9548-2254;
   amoroso, antonio/0000-0002-9437-9407; Tovo, Pier
   Angelo/0000-0002-0192-3240
CR Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1
   Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389
NR 5
TC 36
Z9 36
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD MAY 7
PY 1999
VL 13
IS 7
BP 863
EP 864
DI 10.1097/00002030-199905070-00019
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 194CG
UT WOS:000080174100019
PM 10357389
DA 2020-12-08
ER

PT J
AU Amoroso, A
   Pirulli, D
   Puzzer, D
   Ferri, L
   Crovella, S
   Ferrettini, C
   Marangella, M
   Mazzola, G
   Florian, F
AF Amoroso, A
   Pirulli, D
   Puzzer, D
   Ferri, L
   Crovella, S
   Ferrettini, C
   Marangella, M
   Mazzola, G
   Florian, F
TI Gene symbol: AGXT - Disease: Primary hyperoxaluria type I
SO HUMAN GENETICS
LA English
DT Article
C1 Ist Infanzia Burlo Garofolo, Serv Genet Med, I-34137 Trieste, Italy.
RP Amoroso, A (corresponding author), Ist Infanzia Burlo Garofolo, Serv Genet Med, Via Istria 65-1, I-34137 Trieste, Italy.
RI Crovella, Sergio/K-5050-2016; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; 
NR 0
TC 1
Z9 2
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0340-6717
J9 HUM GENET
JI Hum. Genet.
PD MAY
PY 1999
VL 104
IS 5
BP 441
EP 441
DI 10.1007/s004390050984
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA 208MA
UT WOS:000080994100014
PM 10394939
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Crovella, S
   Audero, E
   Pecile, V
   Bussolino, F
   Amoroso, A
   Garagna, S
AF Marziliano, N
   Crovella, S
   Audero, E
   Pecile, V
   Bussolino, F
   Amoroso, A
   Garagna, S
TI Genetic mapping of the mouse homologue of the human angiopoitetin-1 gene
   (Agpt) to mouse chromosome 9E2 by in situ hybridization
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Article
ID MECHANISMS; CELLS; TEK
C1 Perkin Elmer, Appl Biosyst Div, Trieste, Italy.
   Univ Trieste, Cattedra Genet, Trieste, Italy.
   IRCCS, Serv Genet, Trieste, Italy.
   Univ Turin, Dipartimento Genet Biol & Biochim, I-10124 Turin, Italy.
   Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
RP Marziliano, N (corresponding author), PE Europe BV, Via Tiepolo 24, I-20052 Monza, MI, Italy.
RI AMOROSO, ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; amoroso,
   antonio/AAL-1475-2020; Garagna, Silvia/AAP-9173-2020; Bussolino,
   Federico/K-2500-2016
OI Crovella, Sergio/0000-0001-8493-1168; amoroso,
   antonio/0000-0002-9437-9407; Audero, Enrica/0000-0002-6138-244X;
   Bussolino, Federico/0000-0002-5348-1341
CR Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8
   Davies MK, 1996, CARDIOLOGY, V87, P1, DOI 10.1159/000177159
   DUMONT DJ, 1992, ONCOGENE, V7, P1471
   Grosios K, 1999, CYTOGENET CELL GENET, V84, P118, DOI 10.1159/000015235
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045
   Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1999
VL 87
IS 3-4
BP 199
EP 200
DI 10.1159/000015466
PG 2
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 288PT
UT WOS:000085572800010
PM 10702667
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Mancuso, T
   Comar, M
   Cernigoi, E
   Da Prato, L
   Garagna, S
   Boniotto, M
   Pirulli, D
   Puzzer, D
   Morgutti, M
   Amoroso, A
   Crovella, S
AF Marziliano, N
   Mancuso, T
   Comar, M
   Cernigoi, E
   Da Prato, L
   Garagna, S
   Boniotto, M
   Pirulli, D
   Puzzer, D
   Morgutti, M
   Amoroso, A
   Crovella, S
TI Fluorescent in situ PCR allows sensitive three hours detection of human
   papilloma virus in cells and tissues
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Letter
ID HYBRIDIZATION
C1 IRCCS, Cattedra Genet, Serv Genet, Trieste, Italy.
   Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
   Ist Nazl Tumori, I-20133 Milan, Italy.
   Univ Trieste, Ist Igiene, I-34127 Trieste, Italy.
   Univ Trieste, Ist Clin Ginecol, I-34127 Trieste, Italy.
   Perkin Elmer Appl Biosyst, Monza, Italy.
RP Crovella, S (corresponding author), IRCCS, Cattedra Genet, Serv Genet, Trieste, Italy.
RI Boniotto, Michele/F-1857-2010; Garagna, Silvia/AAP-9173-2020; Boniotto,
   Michele/AAB-4302-2020; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Comar, Manola/K-4613-2016; Crovella,
   Sergio/K-5050-2016; COMAR, Manola/K-4613-2016
OI Boniotto, Michele/0000-0002-9548-2254; amoroso,
   antonio/0000-0002-9437-9407; Comar, Manola/0000-0001-6310-3320;
   Crovella, Sergio/0000-0001-8493-1168; COMAR, Manola/0000-0002-9487-861X
CR Hacker GW, 1998, EUR J HISTOCHEM, V42, P111
   LONG AA, 1993, HISTOCHEMISTRY, V99, P151, DOI 10.1007/BF00571876
   Mancuso T, 1997, INT J ONCOL, V11, P527
   Musiani M, 1997, J HISTOCHEM CYTOCHEM, V45, P729, DOI 10.1177/002215549704500511
   ZEHBE I, 1997, AM J PATHOL, V150, P1533
NR 5
TC 1
Z9 1
U1 0
U2 2
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 1999
VL 43
IS 2
BP 155
EP 157
PG 3
WC Cell Biology
SC Cell Biology
GA 208JP
UT WOS:000080987500006
PM 10439218
DA 2020-12-08
ER

PT J
AU Clerico, L
   Mancuso, T
   Da Prato, L
   Marziliano, N
   Garagna, S
   Pecile, V
   Demori, E
   Morgutti, M
   Citta, A
   Parodi, S
   Amoroso, A
   Crovella, S
AF Clerico, L
   Mancuso, T
   Da Prato, L
   Marziliano, N
   Garagna, S
   Pecile, V
   Demori, E
   Morgutti, M
   Citta, A
   Parodi, S
   Amoroso, A
   Crovella, S
TI In situ RT-PCR allows the detection of ornithine decarboxylase mRNA in
   paraffin embedded archival human hyperplastic breast tissues
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE ornithine decarboxylase; mRNA expression; hyperplastic breast tissue; in
   situ PCR; archival tissues
ID CANCER; KINASE; TARGET; GROWTH
AB Expression of ornithine decarboxylase (ODC) is induced by c-Myc oncoprotein and is required for cell proliferation and tumour growth. We have studied the expression of ODC mRNA by in situ hybridisation and in situ RT-PCR in archival human hyperplastic breast tissues. A very low signal was detected by in situ hybridisation, while the in situ RT-PCR on human breast archival tissues demonstrated an over-expression of ODC mRNA in epithelial cells characterised by some degree of hyperplasia, maintaining the morphology of the archival tissue intact despite the multiple steps of fixation, permeabilization and thermal cycling.
C1 IRCCS Burlo Garofolo, Cattedra Genet, Trieste, Italy.
   IRCCS Burlo Garofolo, Serv Genet, Trieste, Italy.
   Univ Genoa, Dipartimento Oncol Sperimentale, I-16126 Genoa, Italy.
   Perkin Elmer Appl Biosyst Italia SpA, Milan, Italy.
   Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
RP Crovella, S (corresponding author), IRCCS Burlo Garofolo, Cattedra Genet, Trieste, Italy.
RI Garagna, Silvia/AAP-9173-2020; amoroso, antonio/AAL-1475-2020; AMOROSO,
   ANTONIO/AAN-3884-2020; Crovella, Sergio/K-5050-2016; Pecile,
   Vanna/K-6558-2016
OI amoroso, antonio/0000-0002-9437-9407; Crovella,
   Sergio/0000-0001-8493-1168; Pecile, Vanna/0000-0002-9045-3761
CR ASKEW D, 1992, ONCOGENE, V6, P1915
   AUVINEN M, 1995, MOL CELL BIOL, V15, P6513
   BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804
   HAYASHI S, 1995, BIOCHEM J, V302, P1
   Hoshino Y, 1994, Nihon Geka Gakkai Zasshi, V95, P743
   LEWIS FA, 1996, J CELL PATHOL, V1, P13
   MANNI A, 1995, CANCER LETT, V92, P49, DOI 10.1016/0304-3835(95)03763-M
   Manni A, 1997, INT J CANCER, V70, P175, DOI 10.1002/(SICI)1097-0215(19970117)70:2<175::AID-IJC7>3.3.CO;2-D
   MASAKI M, 1996, CANCER, V77, P1634
   OKUZUMI J, 1991, CANCER RES, V51, P1448
   PEGG AE, 1988, CANCER RES, V48, P759
   PERSSON L, 1989, CANCER LETT, V45, P83, DOI 10.1016/0304-3835(89)90140-7
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
NR 13
TC 2
Z9 2
U1 0
U2 0
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 1999
VL 43
IS 3
BP 179
EP 183
PG 5
WC Cell Biology
SC Cell Biology
GA 236RT
UT WOS:000082612900002
PM 10563250
DA 2020-12-08
ER

PT J
AU Amoroso, A
   Danek, G
   Vatta, S
   Crovella, S
   Berrino, M
   Guarrera, S
   Fasano, ME
   Mazzola, G
   Amore, A
   Gianoglio, B
   Peruzzi, L
   Coppo, R
AF Amoroso, A
   Danek, G
   Vatta, S
   Crovella, S
   Berrino, M
   Guarrera, S
   Fasano, ME
   Mazzola, G
   Amore, A
   Gianoglio, B
   Peruzzi, L
   Coppo, R
CA Italian Grp Renal Immunopathology
TI Polymorphisms in angiotensin-converting enzyme gene and severity of
   renal disease in Henoch-Schoenlein patients
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE ACE; DNA polymorphism; Henoch-Schoenlein purpura; PCR
ID INSERTION DELETION POLYMORPHISM; IGA NEPHROPATHY; SCHONLEIN PURPURA;
   HEART-DISEASE; GLOMERULONEPHRITIS; PROGRESSION; ASSOCIATION;
   HYPERTROPHY; NEPHRITIS; RISK
AB Background. The influence of angiotensin converting enzyme (ACE) gene polymorphism on the progression of primary IgA nephropathy (pIgAN) is still debated. Even though the allele frequency was reported to be similar to controls, in some studies D/D patients had a faster decline of renal function and need of dialysis. Since Henoch-Schoenlein purpura (HSP) nephritis is considered a systemic vasculitis with renal lesions indistinguishable from pIgAN, we investigated the effect of the ACE polymorphism on presentation and progression of HSP IgAN.
   Methods. We examined the insertion (I) and deletion (D) polymorphism in intron 16 of ACE gene by PCR amplification of genomic DNA of 82 patients (37 children), with biopsy-proven IgAN associated with HSP enrolled in a collaborative study.
   Results. No significant association with clinical presentation at onset or with final outcome was found (functional impairment at outcome in 31.8% D/D, 27.4% I/D and 44% I/I, heavy proteinuria in 36.3% D/D, 21.6% I/D, and 11.1% I/I). Patients homozygous for the D allele had a greater number of extrarenal relapses (P = 0.0028). No association was found between the ACE genotype and the presence of hypertension at onset and at the end of the follow-up. No difference was found between adults and children.
   Conclusions. In this cohort of HSP IgAN, no ACE I/D polymorphisms were found to be associated with progressive deterioration of renal function. Different genes possibly involved in vasculitis might more strictly modulate expression and evolution of HSP IgAN.
C1 IRCCS, Serv Genet, I-34137 Trieste, Italy.
   Univ Trieste, Chair Genet, Trieste, Italy.
   Univ Turin, Dept Genet Biol & Med Chem, I-10124 Turin, Italy.
   S Giovanni Hosp, Transplant Immunol Serv, Turin, Italy.
   Paediat Hosp Regina Margherita, Dept Nephrol, Turin, Italy.
RP Amoroso, A (corresponding author), IRCCS, Serv Genet, Via Istria 65-1, I-34137 Trieste, Italy.
RI Coppo, Rosanna/AAD-7959-2020; amoroso, antonio/AAL-1475-2020; Crovella,
   Sergio/K-5050-2016; AMOROSO, ANTONIO/AAN-3884-2020
OI amoroso, antonio/0000-0002-9437-9407; Crovella,
   Sergio/0000-0001-8493-1168; 
CR ABE J, 1993, NEPHRON, V65, P17, DOI 10.1159/000187434
   Amoroso A, 1997, EUR J IMMUNOGENET, V24, P323, DOI 10.1046/j.1365-2370.1997.d01-112.x
   ARBUSTINI E, 1995, BRIT HEART J, V74, P584
   BALIAH T, 1974, TRANSPLANTATION, V18, P343, DOI 10.1097/00007890-197410000-00007
   Burg M, 1997, CLIN NEPHROL, V48, P205
   CASTELLANO M, 1995, CIRCULATION, V91, P2721, DOI 10.1161/01.CIR.91.11.2721
   Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277
   DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267
   DZAU VJ, 1989, J HYPERTENS, V7, pS3, DOI 10.1097/00004872-198909007-00002
   ERDOS EG, 1987, LAB INVEST, V56, P345
   FUKUSHIMA T, 1995, LANCET, V346, P571
   GIBBONS GH, 1997, CLIN CARDIOL S2, V20, P1825
   HARDEN PN, 1995, LANCET, V345, P1540, DOI 10.1016/S0140-6736(95)91088-3
   Hunley TE, 1996, KIDNEY INT, V49, P571, DOI 10.1038/ki.1996.81
   Jin DK, 1996, NEPHRON, V73, P390
   Lindpaintner K, 1996, NEW ENGL J MED, V334, P1023, DOI 10.1056/NEJM199604183341604
   LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103
   LOFTERS WS, 1973, CAN MED ASSOC J, V109, P46
   MCLEAN RH, 1984, KIDNEY INT, V26, P855, DOI 10.1038/ki.1984.228
   MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114
   MONTOLIU J, 1990, NEPHRON, V54, P77, DOI 10.1159/000185813
   MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464
   RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W
   RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844
   RUIZ J, 1994, P NATL ACAD SCI USA, V91, P3662, DOI 10.1073/pnas.91.9.3662
   SCHMIDT S, 1995, AM J KIDNEY DIS, V26, P727, DOI 10.1016/0272-6386(95)90435-2
   SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302
   Task Force on Blood Pressure Control in Children, 1987, PEDIATRICS, V79, P1
   WOLF G, 1993, J AM SOC NEPHROL, V3, P1521
   YORIOKA T, 1995, CLIN NEPHROL, V44, P80
   YOSHIDA H, 1995, J CLIN INVEST, V96, P2162, DOI 10.1172/JCI118270
NR 31
TC 31
Z9 35
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD DEC
PY 1998
VL 13
IS 12
BP 3184
EP 3188
DI 10.1093/ndt/13.12.3184
PG 5
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA 147CW
UT WOS:000077471200040
PM 9870486
OA Bronze
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Crovella, S
   Da Prato, L
   Garagna, S
AF Marziliano, N
   Crovella, S
   Da Prato, L
   Garagna, S
TI Localization of repeated DNA sequences in Melagasy lemurs archival
   chromosome preparations by repeated primed in situ labelling (rPRINS)
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Meeting Abstract
C1 Perkin Elmer Italia, I-20052 Monza, Italy.
   Univ Trieste, Fac Med, Cattedra Genet, IRCCS Burlo Garofalo, I-34137 Trieste, Italy.
   Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
RI Garagna, Silvia/AAP-9173-2020; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1998
VL 81
IS 2
SU S
MA P101
BP 132
EP 132
PG 1
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 115GH
UT WOS:000075654800126
DA 2020-12-08
ER

PT J
AU Marziliano, N
   Crovella, S
   Zuccotti, M
   Garagna, S
AF Marziliano, N
   Crovella, S
   Zuccotti, M
   Garagna, S
TI Six-year-old archival chromosome preparations are still good biological
   reagents for repeated primed in situ labelling (rPRINS)
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE archival chromosome preparations; rPRINS; satellite DNA; Eulemur
   coronatus
ID REPETITIVE DNA-SEQUENCES; IN-SITU; OLIGONUCLEOTIDE; HYBRIDIZATION;
   ORGANIZATION; SATELLITE; INSITU
AB Six-year-old chromosome preparations of Eulemur coronatus were used for in situ localization of highly repetitive DNA sequences. The application of the repeated primed in situ labelling (rPRINS) technique allowed the detection of positive signals whereas conventional fluorescence in situ hybridization gave negative results on the same archival preparations. This paper reveals the possibility of rescuing archival chromosome preparations for both clinical and comparative cytogenetics. Moreover, the chromosomal localization of the ECOSAT 503 bp highly repetitive DNA sequences were found to localize in the pericentromeric region of every chromosome, with the exception of chromosome 9.
C1 Univ Pavia, Dipartimento Biol Anim, I-27100 Pavia, Italy.
   Perkin Elmer Italia SpA, I-20052 Monza, Milano, Italy.
   Univ Trieste, Fac Med, Cattedra Genet, I-34137 Trieste, Italy.
RP Garagna, S (corresponding author), Univ Pavia, Dipartimento Biol Anim, Piazza Botta 9-10, I-27100 Pavia, Italy.
RI Garagna, Silvia/AAP-9173-2020; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073
   GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378
   Garagna S, 1997, CHROMOSOME RES, V5, P487, DOI 10.1023/A:1018425215516
   GOSDEN J, 1991, CYTOGENET CELL GENET, V57, P100, DOI 10.1159/000133122
   GOSDEN J, 1993, BIOTECHNIQUES, V15, P78
   Gosden JR, 1996, CHROMOSOME RES, V4, P331, DOI 10.1007/BF02257267
   KIPLING D, 1994, CHROMOSOMA, V103, P46, DOI 10.1007/BF00364725
   KOCH JE, 1989, CHROMOSOMA, V98, P259, DOI 10.1007/BF00327311
   Marziliano N, 1997, EUR J HISTOCHEM, V41, P165
   MEZZANOTTE R, 1988, CYTOGENET CELL GENET, V48, P60, DOI 10.1159/000132588
   MITCHELL A, 1992, CHROMOSOMA, V101, P333, DOI 10.1007/BF00346012
   MONTAGNON D, 1993, CYTOGENET CELL GENET, V63, P131, DOI 10.1159/000133518
   PARDUE ML, 1985, NUCLEIC ACID HYBRIDI, P179
   PERETTI D, 1993, EUR J HISTOCHEM, V37, P303
   Ronchetti E, 1997, EUR J HISTOCHEM, V41, P79
   SOUTHERN EM, 1985, NUCLEI ACID HYBRIDIS, P1
   TERKELSEN C, 1993, CYTOGENET CELL GENET, V63, P235, DOI 10.1159/000133540
   Viegas-Pequignot E, 1992, IN SITU HYBRIDIZATIO, P137
   WARTER S, 1985, AM J PHYS ANTHROPOL, V67, P123, DOI 10.1002/ajpa.1330670207
NR 19
TC 0
Z9 0
U1 0
U2 0
PU LUIGI PONZIO E FIGLIO
PI PAVIA
PA VIA D DA CATALOGNA 1/3, 27100 PAVIA, ITALY
SN 1121-760X
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 1998
VL 42
IS 2
BP 151
EP 155
PG 5
WC Cell Biology
SC Cell Biology
GA ZV716
UT WOS:000074333900008
PM 9728293
DA 2020-12-08
ER

PT J
AU Garagna, S
   Ronchetti, E
   Mascheretti, S
   Crovella, S
   Formenti, D
   Rumpler, Y
   Romanini, MGM
AF Garagna, S
   Ronchetti, E
   Mascheretti, S
   Crovella, S
   Formenti, D
   Rumpler, Y
   Romanini, MGM
TI Non-telomeric chromosome localization of (TTAGGG)(n) repeats in the
   genus Eulemur
SO CHROMOSOME RESEARCH
LA English
DT Article
DE Eulemur; heterochromatin; telomeric sequence
ID ALPHA-SATELLITE DNA; REPETITIVE DNA; EVOLUTION; SEQUENCES; HYBRID; LEMUR
AB The chromosomal distribution of the (TTAGGG)(n) telomeric repetitive sequences was studied in the Malagasy species Eulemur fulvus fulvus (2n = 60), Eulemur rubriventer (2n = 50), Eulemur coronatus (2n = 46) and Eulemur macaco (2n = 44). These sequences hybridize to the telomeres of all chromosomes of the four species and also to the pericentromeres of all chromosomes of E. fulvus, E. coronatus and E. macaco, with the exception of the pericentromeres of E. coronatus and E. macaco chromosomes 9, the homeologous E. fulvus chromosomes 2 and E. macaco chromosomes 1. In E. rubriventer only a very weak signal was detected at the pericentromeres of a few chromosomes. In E. fulvus, E. coronatus and E. macaco, non-telomeric (TTAGGG)(n) sequences collocalize with constitutive heterochromatin. The interspecific differences of the hybridization pattern of (TTAGGG)(n) sequences at the pericentromeres suggest that E. rubriventer branched off the common trunk before amplification of endogenous (TTAGGG)(n) sequences occurred in pericentromeric regions.
C1 UNIV STRASBOURG 1,INST EMBRYOL,FAC MED,STRASBOURG,FRANCE.
RP Garagna, S (corresponding author), UNIV PAVIA,DIPARTIMENTO BIOL ANIM,PIAZZA BOTTA 9-10,I-27100 PAVIA,ITALY.
RI Garagna, Silvia/AAP-9173-2020; Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR ARNASON U, 1988, J MOL EVOL, V27, P217, DOI 10.1007/BF02100077
   BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Crovella S., 1995, Human Evolution, V10, P35, DOI 10.1007/BF02437512
   DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830
   ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073
   FANG G, 1995, TELOMERES, P69
   FANNING TG, 1987, J MOL BIOL, V197, P627, DOI 10.1016/0022-2836(87)90469-4
   FRY K, 1977, CELL, V12, P1069, DOI 10.1016/0092-8674(77)90170-2
   GARAGNA S, 1995, CHROMOSOMA, V103, P685, DOI 10.1007/BF00344229
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283
   MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   RONCHETTI E, 1993, CYTOGENET CELL GENET, V63, P1, DOI 10.1159/000133490
   RUMPLER Y, 1989, J HUM EVOL, V4, P157
   RUMPLER Y, 1990, CHROMOSOME EVOLUTION, V23
   SALVADORI S, 1995, CHROMOSOME RES, V3, P54, DOI 10.1007/BF00711162
   SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547
   SOUTHERN EM, 1970, NATURE, V227, P794, DOI 10.1038/227794a0
   SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7
   WARTER S, 1985, AM J PHYS ANTHROPOL, V67, P123, DOI 10.1002/ajpa.1330670207
   ZACHIAN VA, 1995, SCIENCE, V270, P1601
NR 22
TC 45
Z9 46
U1 0
U2 0
PU RAPID SCIENCE PUBLISHERS
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH
SN 0967-3849
J9 CHROMOSOME RES
JI Chromosome Res.
PD NOV
PY 1997
VL 5
IS 7
BP 487
EP 491
DI 10.1023/A:1018425215516
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA YK139
UT WOS:A1997YK13900009
PM 9421267
DA 2020-12-08
ER

PT J
AU Mancuso, T
   Crovella, S
   Casazza, S
   Pescarolo, MP
   Clerico, L
   Russo, P
   Parodi, S
AF Mancuso, T
   Crovella, S
   Casazza, S
   Pescarolo, MP
   Clerico, L
   Russo, P
   Parodi, S
TI A fast and simple in situ PCR method to detect human papilloma virus
   infection in archival paraffin-embedded tissues
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE human papilloma virus; in situ-PCR; in situ hybridization; archival
   samples; viral infection
ID POLYMERASE CHAIN-REACTION; GENITAL-TRACT LESIONS; INSITU HYBRIDIZATION;
   SOUTHERN BLOT; DNA; AMPLIFICATION; CELLS; CONDYLOMATA; NEOPLASIA
AB We describe a simple and fast method for the detection and localization of low copy numbers of HPV DNA in formalin-fixed and paraffin-embedded archival tissues. We have developed a protocol for direct bl situ-PCR in order to demonstrate its convenience in rapid and reproducible assessment of HPV infection in unknown biopsies. The morphological aspect of the tissues has been maintained, despite the multiple steps of fixation, permeabilization and thermal cycling, and positivity has been detected only in virus target cells.
C1 NATL INST CANC RES,DEPT EXPT ONCOL,I-16132 GENOA,ITALY.
   UNIV GENOA,DEPT CLIN & EXPT ONCOL,I-16132 GENOA,ITALY.
   PERKIN ELMER CORP,I-10044 PIANEZZA,TURIN,ITALY.
   OSPED GALLIERA,I-16128 GENOA,ITALY.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103
   BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472
   BERNARD C, 1994, MOL CELL PROBE, V8, P337, DOI 10.1006/mcpr.1994.1049
   BURNS J, 1987, J CLIN PATHOL, V40, P865
   CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991
   EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357
   GU J, 1995, SITU POLYMERASE CHAI
   GU J, 1994, CELL VISION, V1, P8
   HAASE AT, 1990, P NATL ACAD SCI USA, V87, P4971, DOI 10.1073/pnas.87.13.4971
   Komminoth P, 1992, Diagn Mol Pathol, V1, P85, DOI 10.1097/00019606-199203000-00014
   LEWIS F, 1996, APPROACH SITU PCR
   LEWIS FA, 1996, J CELL PATHOL, V1, P13
   LORINCZ AT, 1987, J NATL CANCER I, V79, P671
   NUOVO GJ, 1989, AM J SURG PATHOL, V13, P700, DOI 10.1097/00000478-198908000-00009
   NUOVO GJ, 1990, AM J SURG PATHOL, V14, P643, DOI 10.1097/00000478-199007000-00005
   NUOVO GJ, 1991, AM J PATHOL, V139, P1239
   NUOVO GJ, 1991, AM J PATHOL, V139, P847
   NUOVO GJ, 1991, AM J PATHOL, V138, P53
   NUOVO GJ, 1990, OBSTET GYNECOL, V75, P1006
   NUOVO GJ, 1990, AM J SURG PATHOL, V14, P829, DOI 10.1097/00000478-199009000-00004
   NUOVO GJ, 1989, OBSTET GYNECOL, V74, P673
   NUOVO GJ, 1995, PCR METH APPL, V4, P151
   NUOVO GJ, 1992, PCR IN SITU HYBRIDIZ
   TIEBEL O, 1995, LAB MED, V19, P167
   ZEHBE I, 1992, ANTICANCER RES, V12, P2165
   ZEHBE I, 1994, CELL VISION, V1, P163
NR 26
TC 6
Z9 6
U1 0
U2 1
PU INT JOURNAL ONCOLOGY
PI ATHENS
PA C/O PROFESSOR D A SPANDIDOS, EDITORIAL OFFICE, 1, S MERKOURI ST, ATHENS
   116 35, GREECE
SN 1019-6439
J9 INT J ONCOL
JI Int. J. Oncol.
PD SEP
PY 1997
VL 11
IS 3
BP 527
EP 531
PG 5
WC Oncology
SC Oncology
GA XP910
UT WOS:A1997XP91000013
PM 21528242
DA 2020-12-08
ER

PT J
AU BIGATTI, MP
   LAMBERT, L
   CROVELLA, S
   ARDITO, G
AF BIGATTI, MP
   LAMBERT, L
   CROVELLA, S
   ARDITO, G
TI BASE-LINE AND MITOMYCIN-C (MMC)-INDUCED SISTER-CHROMATID EXCHANGES IN XX
   AND XY CELLS OF CALLITHRIX-JACCHUS CHIMERIC TWINS
SO MUTATION RESEARCH LETTERS
LA English
DT Article
DE SISTER-CHROMATID EXCHANGE; CALLITHRIX JACCHUS; CHIMERA-LYMPHOCYTES
   CULTURE; MITOMYCIN C
ID PERIPHERAL-BLOOD LYMPHOCYTES; CHROMOSOME-ABERRATIONS; AGE; SEX;
   POPULATION; SMOKING; SCE
AB Lymphocytes from chimeric individuals of the species Callithrix jacchus (Primates) were examined to evaluate differences in the frequency of sister chromatid exchanges (SCE) between XX and XY cells. The aim was to discover whether SCE differ according to genetic sex and whether XX and XY cells show a different sensitivity to SCE inducing agents. This experimental model has enabled us to eliminate the possible differences caused by environmental factors. The results obtained do not reveal significant differences between male and female cells, in either the baseline SCE frequency or that induced by mitomycin C at concentrations of 0.01 and 0.03 mu g/ml. No significant differences were observed in the distribution of high SCE frequency cells (HFC), even if it is possible to observe a higher level of exchanges in XX cells in each trial. With regard to the phenotypic sex, there appears to be a trend towards slightly higher SCE rates in females, even if results are not statistically significant.
C1 UNIV FLORENCE,IST ANTROPOL,FLORENCE,ITALY.
RP BIGATTI, MP (corresponding author), UNIV TURIN,DIPARTIMENTO BIOL ANIM,ANTROPOL LAB,VIA ACCAD ALBERTINA 17,I-10123 TURIN,ITALY.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1
   BIGATTI P, 1992, MUTAT RES, V282, P19, DOI 10.1016/0165-7992(92)90068-S
   BROGGER A, 1979, HEREDITAS, V91, P135
   CARRANO AV, 1982, MUTAGENICITY NEW HOR, P267
   DEWDNEY RS, 1986, MUTAT RES, V171, P43, DOI 10.1016/0165-1218(86)90007-8
   DSOUZA D, 1988, HUM GENET, V79, P83, DOI 10.1007/BF00291717
   HEDNER K, 1982, HUM GENET, V62, P305, DOI 10.1007/BF00304544
   HIRSCH B, 1990, DNA DAMAGE REPAIR HU, P303
   HUSUM B, 1986, HEREDITAS, V105, P17, DOI 10.1111/j.1601-5223.1986.tb00635.x
   LAZUTKA JR, 1994, MUTAT RES, V306, P173, DOI 10.1016/0027-5107(94)90028-0
   MARGOLIN BH, 1985, ENVIRON MUTAGEN, V7, P63, DOI 10.1002/em.2860070810
   MOORE DH, 1984, BASIC LIFE SCI, V29, P149
   SHARMA T, 1986, MUTAT RES, V174, P27, DOI 10.1016/0165-7992(86)90073-4
   SOPER KA, 1984, MUTAT RES, V129, P77, DOI 10.1016/0027-5107(84)90126-X
   WAKSVIK H, 1981, CLIN GENET, V20, P449
   WULF HC, 1986, SCI TOTAL ENVIRON, V48, P81, DOI 10.1016/0048-9697(86)90155-5
   WULF HC, 1985, CYTOGENET CELL GENET, V30, P105
   1990, MUTAT RES, V241, P325
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-7992
J9 MUTAT RES LETT
JI Mutat. Res. Lett.
PD AUG
PY 1995
VL 347
IS 3-4
BP 157
EP 162
DI 10.1016/0165-7992(95)00035-6
PG 6
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA RV345
UT WOS:A1995RV34500009
PM 7565907
DA 2020-12-08
ER

PT J
AU DELPERO, M
   CROVELLA, S
   CERVELLA, P
   ARDITO, G
   RUMPLER, Y
AF DELPERO, M
   CROVELLA, S
   CERVELLA, P
   ARDITO, G
   RUMPLER, Y
TI PHYLOGENETIC-RELATIONSHIPS AMONG MALAGASY LEMURS AS REVEALED BY
   MITOCHONDRIAL-DNA SEQUENCE-ANALYSIS
SO PRIMATES
LA English
DT Article
DE MALAGASY LEMURS; LEMURIDAE; PHYLOGENETIC TREES; MITOCHONDRIAL DNA
ID CHROMOSOMAL EVOLUTION; MOLECULAR PHYLOGENY; SYSTEMATICS; PRIMATES;
   PROSIMII; EULEMUR; TREES; CATTA
AB Systematics and evolution of Malagasy lemurs has been analyzed using morphological characters, fossil evidence, ecological/ethological data, and chromosomal banding patterns. Recent developments in DNA technology have provided evolutionary biologists with additional and powerful tools for making phylogenetic inference. In the last years several studies concerning highly repeated DNA sequences (hrDNA) provided new insights about the systematic relationships among the differ ent species of Lemuridae and Cheirogaleidae.
   Here, a reconstruction of molecular phylogeny of extant Malagasy lemurs based on the comparison of cytochrome-b mitochondrial DNA sequences is presented. With the Polymerase Chain Reaction (PCR) and direct sequencing of amplified DNA fragments, both the phylogenetic range and resolving power of comparative analysis can be extended. These techniques allow to gather sequence data useful to evaluate the pattern of molecular evolution offering opportunities for phylogenetic purposes.
   A 290-bp fragment of cytochrome-b gene has been amplified and sequenced from the following species: Tupaia glis, Galago alleni, Daubentonia madagascariensis, Indri indri, Variegata variegata, Eulemur fulvus, Eulemur coronatus, Eulemur rubriventer, Eulemur mongoz, Eulemur macaco, Lemur catta, and Hapalemur griseus griseus.
   The phylogenetic trees obtained show the relationships among the Eulemur species and confirm the karyological and hrDNA results of a separated clade for L. catta/Hapalemur. The separation of Varecia variegata from the other genus of the family Lemuridae is discussed.
C1 UNIV FLORENCE,IST ANTROPOL,FLORENCE,ITALY.
   UNIV STRASBOURG 1,FAC MED,INST EMBRYOL,F-67085 STRASBOURG,FRANCE.
RP DELPERO, M (corresponding author), UNIV TURIN,DIPARTIMENTO BIOL ANIM,17 VIA ACCAD ALBERTINA,I-10123 TURIN,ITALY.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; CERVELLA,
   Piero/0000-0002-0642-6059
CR AFFOLTER M, 1938, B ACAD MALGACHE, V8, P77
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ANDREW RJ, 1964, EVOL GENET, V2, P227
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   CROVELLA S, 1993, PRIMATES, V34, P61, DOI 10.1007/BF02381281
   CROVELLA S, 1994, PRIMATES, V35, P519, DOI 10.1007/BF02381961
   Crovella S., 1992, Human Evolution, V7, P63, DOI 10.1007/BF02437454
   DISOTELL TR, 1992, MOL BIOL EVOL, V9, P1
   DUFFY LK, 1986, ANN NY ACAD SCI, P254
   DUNAIF A, 1991, FOLIA PRIMATOL, V57, P173, DOI 10.1159/000156582
   EAGLEN RH, 1983, INT J PRIMATOL, V4, P249, DOI 10.1007/BF02735549
   FEAGLE J, 1988, PRIMATE ADAPTATION E
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Felsenstein J., 1993, PHYLIP PHYLOGENY INF
   Garza JC, 1992, MOL PHYLOGENET EVOL, V1, P202, DOI 10.1016/1055-7903(92)90016-A
   GRAY JE, 1863, CITED INDIRECTLY
   Groves C.P., 1989, THEORY HUMAN PRIMATE
   GROVES CP, 1988, J HUM EVOL, V17, P513, DOI 10.1016/0047-2484(88)90040-1
   HAYASAKA K, 1988, MOL BIOL EVOL, V5, P626
   Hill W. C. O., 1953, PRIMATES COMP ANATOM
   HILL WCO, 1953, PRIMATES COMP ANATOM, V3
   HIXON JE, 1986, MOL BIOL EVOL, V3, P1
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196
   MADDISON WP, 1992, MACCLADE ANAL PHYLOG
   MONTAGNON D, 1993, CYTOGENET CELL GENET, V63, P131, DOI 10.1159/000133518
   Napier JR, 1967, HDB LIVING PRIMATES
   PAABO S, 1989, J BIOL CHEM, V264, P9709
   PETTER JJ, 1977, FAUNA MADAGASCAR, V44
   PETTER JJ, 1962, MEM MUS NAT HIST NAT, V27, P1
   Pocock R. I., 1918, P ZOOL SOC LOND, V55, P19
   Rumpler Y., 1975, P25
   RUMPLER Y, 1978, CYTOGENET CELL GENET, V21, P201, DOI 10.1159/000130897
   RUMPLER Y, 1968, CR SOC BIOL, V162, P1430
   RUMPLER Y, 1986, MAMMALIA, V50, P82
   RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570
   SAITOU N, 1991, AM J PHYS ANTHROPOL, V84, P75, DOI 10.1002/ajpa.1330840107
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sambrook J, 1989, MOL CLONING LABORATO
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHEDD DH, 1991, FOLIA PRIMATOL, V57, P221, DOI 10.1159/000156589
   Simons E.L., 1972, PRIMATE EVOLUTION
   SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547
   SWOFFORD DL, 1990, PAUP PHYLOGENETIC AN
   Szalay F.S., 1979, EVOLUTIONARY HIST PR
   TATTERSALL I, 1983, PRIMATES MADAGASCAR
   WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x
   YOEDER AD, 1994, AM J PHYS ANTHROPOL, V94, P25
NR 49
TC 29
Z9 30
U1 1
U2 19
PU JAPAN MONKEY CENTRE
PI INUYAMA AICHI
PA PRIMATES, EDITORIAL OFFICE, INUYAMA AICHI 484, JAPAN
SN 0032-8332
J9 PRIMATES
JI Primates
PD JUL
PY 1995
VL 36
IS 3
BP 431
EP 440
DI 10.1007/BF02382865
PG 10
WC Zoology
SC Zoology
GA RN792
UT WOS:A1995RN79200011
DA 2020-12-08
ER

PT J
AU RUMPLER, Y
   CROVELLA, S
   MONTAGNON, D
AF RUMPLER, Y
   CROVELLA, S
   MONTAGNON, D
TI SYSTEMATIC RELATIONSHIPS AMONG CHEIROGALEIDAE (PRIMATES, STREPSIRHINI)
   DETERMINED FROM ANALYSIS OF HIGHLY REPEATED DNA
SO FOLIA PRIMATOLOGICA
LA English
DT Note
DE CHEIROGALEIDAE; KARYOTYPE; HIGHLY REPEATED DNA; RESTRICTION ENZYMES;
   SOUTHERN BLOT; SYSTEMATICS; MICROCEBUS; CHEIROGALEUS; MIRZA; PHANER;
   ALLOCEBUS
RP RUMPLER, Y (corresponding author), UNIV STRASBOURG 1,FAC MED,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR CROVELLA S, 1993, PRIMATES, V34, P61, DOI 10.1007/BF02381281
   FELSENSTEIN J, 1987, PHYLIP PHYLOGENY INF
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   MANIATIS T, 1982, MOL CLONING
   RAKOTOSAMIMANAN.B, 1970, B ASSOC ANAT, V148, P493
   RUMPLER Y, 1971, CR SOC BIOL, V165, P436
   Rumpler Y, 1990, CHROMOSOMAL EVOLUTIO, V23
   SOUTHERN EM, 1975, J MOL BIOL, V38, P503
   TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0
NR 9
TC 11
Z9 11
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0015-5713
J9 FOLIA PRIMATOL
JI Folia Primatol.
PY 1994
VL 63
IS 3
BP 149
EP 155
DI 10.1159/000156809
PG 7
WC Zoology
SC Zoology
GA QY513
UT WOS:A1994QY51300004
PM 7750862
DA 2020-12-08
ER

PT J
AU RONCHETTI, E
   CROVELLA, S
   RUMPLER, Y
   PELLICCIARI, C
   ROMANINI, MGM
AF RONCHETTI, E
   CROVELLA, S
   RUMPLER, Y
   PELLICCIARI, C
   ROMANINI, MGM
TI GENOME SIZE AND QUALITATIVE AND QUANTITATIVE CHARACTERISTICS OF
   C-HETEROCHROMATIC DNA IN EULEMUR SPECIES AND IN A VIABLE HYBRID
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Article
ID CHROMOSOMAL EVOLUTION; MICROCEBUS; LEMUR
AB The amounts of nuclear DNA and the AT and GC content of four Eulemur (Prosimii, Lemuridae) species and of an E. coronatus x E. macaco hybrid were measured by flow cytometry in peripheral blood leukocytes, following propidium iodide, Hoechst 33258, and mithramycin staining. Hoechst 33258 and mithramycin were also used to evaluate the base composition of genomic DNA in the chromosomes. The amount of DNA resisting C-banding pretreatment (C-heterochromatic DNA) was measured in metaphase chromosomes by static fluorometry. The genome of E. coronatus was significantly larger than the genomes of all other species examined, due to a higher content of pericentromeric, mainly GC-rich, heterochromatic DNA. The restriction banding patterns produced by BamHI digestion and ethidium bromide staining on extracted DNA were studied in the hybrid and its parental species (E. coronatus and E. macaco). The restriction banding pattern of the sole E. coronatus individual showed two bands which were repeated in the restriction banding pattern of the hybrid. The qualitative and quantitative differences of C-heterochromatic DNA in E. coronatus confirm the ''splitting'' processes and the phylogenetic relationships in the genus Eulemur suggested by Jung et al. (1992) on the basis of the restriction banding patterns produced by endonuclease digestion.
C1 UNIV PAVIA,DIPARTIMENTO BIOL ANIM,PIAZZA BOTTA 10,I-27100 PAVIA,ITALY.
   UNIV PAVIA,CNR,CTR STUDIO ISTOCHIM,I-27100 PAVIA,ITALY.
   UNIV STRASBOURG 1,EMBRYOL LAB,F-67070 STRASBOURG,FRANCE.
RI Crovella, Sergio/K-5050-2016; Pellicciari, Carlo/Q-1481-2016
OI Crovella, Sergio/0000-0001-8493-1168; Pellicciari,
   Carlo/0000-0001-7684-0469
CR BACHMANN K, 1972, CHROMOSOMA, V37, P85, DOI 10.1007/BF00329560
   BARROS RMD, 1990, CHROMOSOMA, V99, P440, DOI 10.1007/BF01726697
   BENAZZI M, 1981, CARYOLOGIA, V34, P129, DOI 10.1080/00087114.1981.10796880
   CAPANNA E, 1971, CARYOLOGIA, V24, P471, DOI 10.1080/00087114.1971.10796455
   COUNCE SJ, 1973, CHROMOSOMA, V44, P231, DOI 10.1007/BF00329119
   DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830
   HAMILTON AE, 1977, THESIS DUKE U ANN AR
   JUNG KY, 1992, IN PRESS FOLIA PERIN, V232
   MANIATIS T, 1982, MOL CLONING
   MOSES MJ, 1977, CHROMOSOMES TODAY, V6, P72
   PELLICCIARI C, 1982, J HUM EVOL, V11, P131, DOI 10.1016/S0047-2484(82)80045-6
   PELLICCIARI C, 1988, CYTOGENET CELL GENET, V47, P1, DOI 10.1159/000132492
   Pellicciari C., 1990, Human Evolution, V5, P261, DOI 10.1007/BF02437242
   Ratomponirina C, 1988, KEW CHROMOSOME, VIII, P65
   REDI CA, 1986, CHROMOSOMA, V94, P31, DOI 10.1007/BF00293527
   ROMANINI MGM, 1985, MAMMALIA, V49, P369
   ROMANINI MGM, 1978, 46 CONV UZI CAT S31, V45
   RUMPLER Y, 1976, CYTOGENET CELL GENET, V17, P268, DOI 10.1159/000130722
   RUMPLER Y, 1989, J HUM EVOL, V4, P157
   SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547
   SUMMER A T, 1972, Experimental Cell Research, V75, P304
NR 21
TC 9
Z9 10
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1993
VL 63
IS 1
BP 1
EP 5
DI 10.1159/000133490
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA KW929
UT WOS:A1993KW92900001
PM 8449031
DA 2020-12-08
ER

PT J
AU MONTAGNON, D
   CROVELLA, S
   RUMPLER, Y
AF MONTAGNON, D
   CROVELLA, S
   RUMPLER, Y
TI COMPARISON OF HIGHLY REPEATED DNA-SEQUENCES IN SOME LEMURIDAE AND
   TAXONOMIC IMPLICATIONS
SO CYTOGENETICS AND CELL GENETICS
LA English
DT Article
ID ALPHA-SATELLITE DNA; EVOLUTION; HUMANS; APES; MAPS
AB Highly repeated DNA sequences of Eulemur fulvus mayottensis, E. coronatus, Lemur catta, and Hapalemur griseus griseus have been identified and compared. Sequence analysis of highly repeated DNA fragments isolated from L. catta and Hapalemur showed a high percentage of similarity (nearly 95%), as did fragments isolated from the two very close Eulemur species, whereas comparison of the DNA fragments isolated from the two Eulemur species and the L. catta/Hapalemur group showed a very low percentage (approximately 40%) of identity, as might be expected for distant species. These results confirm our previous data, obtained by Southern blot hybridization techniques on the same species, and strongly support the existence of a common trunk between L. catta and Hapalemur, but different from that leading to the Eulemur species.
C1 UNIV STRASBOURG 1,FAC MED,INST EMBRYOL,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR BALDINI A, 1991, CHROMOSOMA, V100, P156, DOI 10.1007/BF00337244
   CROVELLA S, 1993, IN PRESS PRIMATES
   FANNING TG, 1988, CYTOGENET CELL GENET, V48, P214, DOI 10.1159/000132631
   FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432
   JONES KW, 1979, COMP KARYOLOGY PRIMA, P61
   JUNG KY, 1992, FOLIA PRIMATOL, V58, P224, DOI 10.1159/000156634
   LALLEY PA, 1987, CYTOGENET CELL GENET, V46, P367, DOI 10.1159/000132486
   MANIATIS T, 1982, MOL CLONING
   SCHERTHAN H, 1990, HEREDITAS, V12, P13
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0
   TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x
   WAYE JS, 1989, CHROMOSOMA, V98, P273, DOI 10.1007/BF00327313
NR 13
TC 14
Z9 14
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-0171
J9 CYTOGENET CELL GENET
JI Cytogenet. Cell Genet.
PY 1993
VL 63
IS 2
BP 131
EP 134
DI 10.1159/000133518
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA LA202
UT WOS:A1993LA20200011
PM 8467713
DA 2020-12-08
ER

PT J
AU CROVELLA, S
   ARDITO, G
   MONTAGNON, D
   STANYON, R
   WOLF, C
AF CROVELLA, S
   ARDITO, G
   MONTAGNON, D
   STANYON, R
   WOLF, C
TI HIGHLY REPETITIVE DNA PATTERNS IN HUMANS AND SELECTED CATARRHINE
   PRIMATES (PAN-TROGLODYTES, CERCOPITHECUS-AETHIOPS, MACACA-FASCICULARIS)
SO FOLIA PRIMATOLOGICA
LA English
DT Note
DE RESTRICTION ENZYMES; REPETITIVE DNA; PAN; MACACA; CERCOPITHECUS; HOMO
ID SEQUENCES
C1 UNIV FLORENCE, INST ANTHROPOL, I-50121 FLORENCE, ITALY.
   UNIV STRASBOURG 1, INST EMBRYOL, F-67070 STRASBOURG, FRANCE.
   UNIV GENOA, INST ANTHROPOL, I-16126 GENOA, ITALY.
   UNIV STRASBOURG 1, INSERM, LGME, F-67070 STRASBOURG, FRANCE.
RP CROVELLA, S (corresponding author), UNIV TURIN, DIPARTIMENTO BIOL ANIM, V ACCADEMIA ALERTINA 17, I-10123 TURIN, ITALY.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; Stanyon,
   Roscoe/0000-0002-7229-1092
CR CROVELLA S, 1990, B SOC ITAL BIOL SPER, V6, P505
   DANDIEU S, 1984, BIOCHEM SYST ECOL, V12, P237, DOI 10.1016/0305-1978(84)90042-5
   FELSENSTEIN J, 1987, PHYLIP PHYLOGENY INF
   FUNDERBURK SJ, 1987, CHROMOSOMA, V95, P148, DOI 10.1007/BF00332188
   HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121
   JONES KW, 1979, COMP KARYOLOGY PRIMA, P61
   MAIO JJ, 1977, J MOL BIOL, V117, P637, DOI 10.1016/0022-2836(77)90062-6
   SHAFITZAGARDO B, 1982, NUCLEIC ACIDS RES, V10, P3175, DOI 10.1093/nar/10.10.3175
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
NR 11
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0015-5713
EI 1421-9980
J9 FOLIA PRIMATOL
JI Folia Primatol.
PY 1992
VL 58
IS 4
BP 219
EP 223
DI 10.1159/000156633
PG 5
WC Zoology
SC Zoology
GA JV551
UT WOS:A1992JV55100007
PM 1330856
DA 2020-12-08
ER

PT J
AU JUNG, KY
   CROVELLA, S
   RUMPLER, Y
AF JUNG, KY
   CROVELLA, S
   RUMPLER, Y
TI PHYLOGENETIC-RELATIONSHIPS AMONG LEMURIFORM SPECIES DETERMINED FROM
   RESTRICTION GENOMIC DNA BANDING-PATTERNS
SO FOLIA PRIMATOLOGICA
LA English
DT Note
DE LEMUR; EULEMUR; HAPALEMUR; REPETITIVE DNA; EVOLUTION; PHYLOGENETIC TREE;
   RESTRICTION ENZYMES
ID CHROMOSOMAL EVOLUTION; HUMANS; CATTA
C1 UNIV STRASBOURG 1,FAC MED,INST EMBRYOL,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168
CR Affolter M., 1938, Bulletin de l'Academie Malgache Tananarive, V20, P77
   BAKER WK, 1968, ADV GENET, V14, P133, DOI 10.1016/S0065-2660(08)60426-5
   CROVELLA S, 1992, FOLIA PRIMATOL, V58, P219, DOI 10.1159/000156633
   CROVELLA S, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P505
   DANDIEU S, 1984, BIOCHEM SYST ECOL, V12, P237, DOI 10.1016/0305-1978(84)90042-5
   GROVES CP, 1988, J HUM EVOL, V17, P513, DOI 10.1016/0047-2484(88)90040-1
   LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8
   Pocock R. I., 1918, P ZOOL SOC LOND, V55, P19
   RUMPLER Y, 1978, CYTOGENET CELL GENET, V21, P201, DOI 10.1159/000130897
   RUMPLER Y, 1986, MAMMALIA, V50, P82
   SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547
   TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x
NR 12
TC 24
Z9 24
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0015-5713
J9 FOLIA PRIMATOL
JI Folia Primatol.
PY 1992
VL 58
IS 4
BP 224
EP 229
DI 10.1159/000156634
PG 6
WC Zoology
SC Zoology
GA JV551
UT WOS:A1992JV55100008
PM 1330857
DA 2020-12-08
ER

PT J
AU MOGGICECCHI, J
   CROVELLA, S
AF MOGGICECCHI, J
   CROVELLA, S
TI OCCURRENCE OF ENAMEL HYPOPLASIA IN THE DENTITIONS OF SIMIAN PRIMATES
SO FOLIA PRIMATOLOGICA
LA English
DT Note
DE TEETH; ENAMEL HYPOPLASIA; CEBOIDEA; CERCOPITHECOIDEA; HOMINOIDEA; TOOTH
   DEVELOPMENT
ID ETIOLOGY; DEFECTS
C1 UNIV FLORENCE,IST ANTROPOL,I-50121 FLORENCE,ITALY.
   UNIV TURIN,DEPT BIOL ANIM,I-10124 TURIN,ITALY.
RI Crovella, Sergio/K-5050-2016
OI Crovella, Sergio/0000-0001-8493-1168; MOGGI CECCHI,
   IACOPO/0000-0001-5055-8369
CR COLYER F, 1936, VARIATIONS DISEASE T
   ELNAJJAR MY, 1978, AM J PHYS ANTHROPOL, V48, P185, DOI 10.1002/ajpa.1330480210
   GOODMAN AH, 1985, AM J PHYS ANTHROPOL, V68, P479, DOI 10.1002/ajpa.1330680404
   Hillson S., 1986, TEETH
   MOGGICECCHI J, 1988, ANTROPOL CONT, V11, P113
   MOGGICECCHI J, 1989, ANAL ENAMEL MACRODEF
   MOLNAR S, 1975, AM J PHYS ANTHROPOL, V43, P3, DOI 10.1002/ajpa.1330430103
   PINDBORG JJ, 1982, INT DENT J, V32, P123
   SCHUMAN EL, 1956, AM J PHYS ANTHROPOL, V14, P193, DOI 10.1002/ajpa.1330140216
   Skinner M.F., 1986, J HUM EVOL, V1, P289, DOI DOI 10.1007/BF02436704
   TOBIAS PV, 1986, FOSSIL MAN NEW FACTS, P63
   VITZTHUM VJ, 1988, AM J PHYS ANTHROPOL, V75, P284
NR 12
TC 27
Z9 27
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0015-5713
J9 FOLIA PRIMATOL
JI Folia Primatol.
PY 1991
VL 57
IS 2
BP 106
EP 110
DI 10.1159/000156571
PG 5
WC Zoology
SC Zoology
GA GW326
UT WOS:A1991GW32600006
PM 1786905
DA 2020-12-08
ER

EF